Clustering O 0 0.003556915558874607
of O 0 0.0009060165612027049
missense O 0 0.0022010491229593754
mutations O 0 0.00031843336182646453
in O 0 9.676303307060152e-05
the O 0 0.0003991197154391557
ataxia B-Disease 1 0.9999977350234985
- I-Disease 0 0.40590548515319824
telangiectasia I-Disease 1 0.9924966096878052
gene O 0 0.00010976189514622092
in O 0 6.217641930561513e-05
a O 0 0.00017487550212536007
sporadic B-Disease 0 0.0919094905257225
T I-Disease 1 0.9996150732040405
- I-Disease 0 0.023447712883353233
cell I-Disease 0 0.01806914247572422
leukaemia I-Disease 1 0.9945571422576904
. O 0 0.001155685051344335

Ataxia B-Disease 1 0.9999819993972778
- I-Disease 1 0.8957914710044861
telangiectasia I-Disease 1 0.9996694326400757
( O 0 0.0023491124156862497
A B-Disease 1 0.988105297088623
- I-Disease 0 0.367183655500412
T I-Disease 1 0.69124436378479
) O 0 5.0012535211862996e-05
is O 0 3.334043503855355e-05
a O 0 0.00010491057764738798
recessive B-Disease 0 0.0010736377444118261
multi I-Disease 1 0.7602644562721252
- I-Disease 1 0.9238579273223877
system I-Disease 0 0.42718347907066345
disorder I-Disease 1 0.9999978542327881
caused O 1 0.9714514017105103
by O 0 4.23396922997199e-05
mutations O 0 4.624230132321827e-05
in O 0 2.5219116650987417e-05
the O 0 6.0909907915629447e-05
ATM O 0 0.0002983049489557743
gene O 0 6.42019440419972e-05
at O 0 0.00019564093963708729
11q22 O 0 0.005688013043254614
- O 0 0.0005348707782104611
q23 O 0 0.004341268911957741
( O 0 0.0002106296451529488
ref O 0 0.0017912425100803375
. O 0 6.226216646609828e-05
3 O 0 0.00019562190573196858
) O 0 0.00023905717534944415
. O 0 0.00041288151987828314

The O 0 0.0022548921406269073
risk O 0 0.002220412017777562
of O 0 0.03646748512983322
cancer B-Disease 1 0.9999300241470337
, O 0 0.00049176363972947
especially O 0 0.0009163652430288494
lymphoid B-Disease 1 0.9997791647911072
neoplasias I-Disease 1 0.99933260679245
, O 0 0.00011718153109541163
is O 0 6.83758407831192e-05
substantially O 0 0.00014802324585616589
elevated O 0 0.001285202568396926
in O 0 0.0001272265799343586
A B-Disease 1 0.9945446252822876
- I-Disease 1 0.9920364022254944
T I-Disease 1 0.9999384880065918
patients O 0 0.00023065666027832776
and O 0 3.670553633128293e-05
has O 0 3.725989881786518e-05
long O 0 6.0302660131128505e-05
been O 0 6.700209632981569e-05
associated O 0 0.0001660026900935918
with O 0 0.00018550711683928967
chromosomal O 1 0.999832034111023
instability O 1 0.9999376535415649
. O 0 0.0022134664468467236

By O 0 0.0023436485789716244
analysing O 0 0.006327461451292038
tumour B-Disease 1 0.9999771118164062
DNA O 0 0.0008962780702859163
from O 0 0.00023221941955853254
patients O 0 0.0002393958711763844
with O 0 9.437239350518212e-05
sporadic B-Disease 0 0.005024100188165903
T I-Disease 1 0.9818583726882935
- I-Disease 0 0.0007567254942841828
cell I-Disease 0 0.0019367921631783247
prolymphocytic I-Disease 1 0.9910564422607422
leukaemia I-Disease 1 0.9998225569725037
( O 0 0.0007264508749358356
T B-Disease 1 0.643362283706665
- I-Disease 0 0.0005230809911154211
PLL I-Disease 0 0.11154628545045853
) O 0 4.931915464112535e-05
, O 0 5.897563823964447e-05
a O 0 0.00011356927279848605
rare O 0 0.0003249775618314743
clonal B-Disease 0 0.004203603137284517
malignancy I-Disease 0 0.47831201553344727
with O 0 7.912136061349884e-05
similarities O 0 9.368289465783164e-05
to O 0 3.9268335967790335e-05
a O 0 0.00015757788787595928
mature B-Disease 0 0.0006192100699990988
T I-Disease 1 0.7568355202674866
- I-Disease 0 0.00048422024701721966
cell I-Disease 0 0.0009088047663681209
leukaemia I-Disease 0 0.25022971630096436
seen O 0 0.00011696416913764551
in O 0 7.763103349134326e-05
A B-Disease 0 0.07405853271484375
- I-Disease 0 0.004476203583180904
T I-Disease 0 0.03785889595746994
, O 0 4.362086474429816e-05
we O 0 2.6421463189763017e-05
demonstrate O 0 6.651761941611767e-05
a O 0 5.1004051783820614e-05
high O 0 6.748378655174747e-05
frequency O 0 4.69164879177697e-05
of O 0 6.793518696213141e-05
ATM O 0 0.0007906247046776116
mutations O 0 0.00026934969355352223
in O 0 0.00032431029831059277
T B-Disease 1 0.7478892207145691
- I-Disease 0 0.0030783843249082565
PLL I-Disease 1 0.6733570694923401
. O 0 0.0017147616017609835

In O 0 0.0009912310633808374
marked O 0 0.0011626037303358316
contrast O 0 0.00020837642659898847
to O 0 6.296474748523906e-05
the O 0 0.00011150690261274576
ATM O 0 0.0004739864671137184
mutation O 0 7.807588553987443e-05
pattern O 0 0.00022016445291228592
in O 0 6.354951619869098e-05
A B-Disease 0 0.469681978225708
- I-Disease 0 0.016696622595191002
T I-Disease 0 0.14467953145503998
, O 0 4.091463051736355e-05
the O 0 3.559271863196045e-05
most O 0 1.9051798517466523e-05
frequent O 0 5.145624163560569e-05
nucleotide O 0 9.038530697580427e-05
changes O 0 4.000733679276891e-05
in O 0 4.430412809597328e-05
this O 0 0.00010574945190455765
leukaemia B-Disease 1 0.9201759099960327
were O 0 0.00030533294193446636
missense O 0 0.004394544754177332
mutations O 0 0.0013091579312458634
. O 0 0.0008438708609901369

These O 0 0.00039334717439487576
clustered O 0 0.0007592341280542314
in O 0 0.00011230808013351634
the O 0 9.305714775109664e-05
region O 0 7.222733256639913e-05
corresponding O 0 2.711521665332839e-05
to O 0 1.590868123457767e-05
the O 0 4.283377711544745e-05
kinase O 0 9.925479389494285e-05
domain O 0 4.912464282824658e-05
, O 0 2.5790899599087425e-05
which O 0 1.2726947716146242e-05
is O 0 1.671216159593314e-05
highly O 0 3.5269906220491976e-05
conserved O 0 6.874477548990399e-05
in O 0 4.8178990255109966e-05
ATM O 0 0.0003193941665813327
- O 0 0.00014962881687097251
related O 0 6.39289864921011e-05
proteins O 0 6.45696054561995e-05
in O 0 7.423640636261553e-05
mouse O 0 0.0005437766667455435
, O 0 0.00017259508604183793
yeast O 0 0.0008617393905296922
and O 0 0.00027915879036299884
Drosophila O 0 0.0027387114241719246
. O 0 0.0008451197645626962

The O 0 0.0013742808951064944
resulting O 0 0.0011001942912116647
amino O 0 0.0005406597047112882
- O 0 0.00039827669388614595
acid O 0 0.00025181553792208433
substitutions O 0 0.0002107528125634417
are O 0 1.7315485820290633e-05
predicted O 0 9.809304174268618e-05
to O 0 2.7808768209069967e-05
interfere O 0 0.00012014781532343477
with O 0 5.690270700142719e-05
ATP O 0 0.03536252677440643
binding O 0 0.00022388082288671285
or O 0 0.000207492194022052
substrate O 0 0.0007597665535286069
recognition O 0 0.0009983868803828955
. O 0 0.0011624402832239866

Two O 0 0.00041003822116181254
of O 0 0.0006382900755852461
seventeen O 0 0.0022579794749617577
mutated O 0 0.01323656551539898
T B-Disease 1 0.7688385248184204
- I-Disease 0 0.0004935240722261369
PLL I-Disease 0 0.0045265923254191875
samples O 0 8.77711790963076e-05
had O 0 5.066626181360334e-05
a O 0 7.684301817789674e-05
previously O 0 9.760848479345441e-05
reported O 0 0.0002321060746908188
A B-Disease 0 0.10116815567016602
- I-Disease 0 0.0641828402876854
T I-Disease 1 0.9702367782592773
allele O 0 0.0014583547599613667
. O 0 0.0008503460558131337

In O 0 0.0009725476847961545
contrast O 0 0.0005811941809952259
, O 0 0.00014431020827032626
no O 0 8.864087430993095e-05
mutations O 0 7.448558608302847e-05
were O 0 3.318722156109288e-05
detected O 0 9.790025796974078e-05
in O 0 2.0104502254980616e-05
the O 0 6.37401535641402e-05
p53 O 0 0.0002979217970278114
gene O 0 5.456949656945653e-05
, O 0 2.2992688172962517e-05
suggesting O 0 6.487481005024165e-05
that O 0 2.3773269276716746e-05
this O 0 7.658696995349601e-05
tumour B-Disease 1 0.9999985694885254
suppressor O 1 0.8123998045921326
is O 0 8.830325532471761e-05
not O 0 2.3158881958806887e-05
frequently O 0 7.954160537337884e-05
altered O 0 0.00021891979849897325
in O 0 0.0001094121253117919
this O 0 0.0002150262735085562
leukaemia B-Disease 1 0.9908932447433472
. O 0 0.0008573074010200799

Occasional O 0 0.008122903294861317
missense O 0 0.004848979879170656
mutations O 0 0.0004318125720601529
in O 0 0.0001222441642312333
ATM O 0 0.0004430853296071291
were O 0 5.820778096676804e-05
also O 0 2.768981721601449e-05
found O 0 3.0136987334117293e-05
in O 0 7.03402838553302e-05
tumour B-Disease 1 0.9998753070831299
DNA O 0 0.00022863440972287208
from O 0 7.03444384271279e-05
patients O 0 7.260576967382804e-05
with O 0 4.361508399597369e-05
B B-Disease 0 0.0009153264109045267
- I-Disease 0 0.00048365170368924737
cell I-Disease 0 0.0007415362633764744
non I-Disease 0 0.0006902372115291655
- I-Disease 0 0.006417850498110056
Hodgkins I-Disease 1 0.9999966621398926
lymphomas I-Disease 1 0.9027530550956726
( O 0 0.00021260172070469707
B B-Disease 0 0.00047052334412001073
- I-Disease 0 0.00010821277101058513
NHL I-Disease 0 0.00016501068603247404
) O 0 2.143210804206319e-05
and O 0 2.728865365497768e-05
a O 0 6.996804586378857e-05
B B-Disease 0 0.0006283538532443345
- I-Disease 0 0.0005210273084230721
NHL I-Disease 0 0.0015587251400575042
cell O 0 0.0016013766871765256
line O 0 0.0009394281660206616
. O 0 0.00046327142626978457

The O 0 0.0006596489110961556
evidence O 0 0.0003179570776410401
of O 0 0.0001008037434075959
a O 0 5.681236871168949e-05
significant O 0 5.073249485576525e-05
proportion O 0 3.983503484050743e-05
of O 0 5.5628956033615395e-05
loss O 0 0.0015352535992860794
- O 0 8.347351831616834e-05
of O 0 9.465567563893273e-05
- O 0 0.0001722276647342369
function O 0 4.847846503253095e-05
mutations O 0 3.3119431464001536e-05
and O 0 1.8702063243836164e-05
a O 0 3.670640944619663e-05
complete O 0 8.62155357026495e-05
absence O 0 0.00010862850467674434
of O 0 5.240236350800842e-05
the O 0 7.216097583295777e-05
normal O 0 6.530177779495716e-05
copy O 0 6.0039168602088466e-05
of O 0 5.175501428311691e-05
ATM O 0 0.00011552793148439378
in O 0 1.6750756913097575e-05
the O 0 3.6396118957782164e-05
majority O 0 3.2935811759671196e-05
of O 0 0.00012178703036624938
mutated O 0 0.0028441858012229204
tumours B-Disease 1 0.9994611144065857
establishes O 0 0.0012487611966207623
somatic O 0 0.0013746864860877395
inactivation O 0 0.0012312516337260604
of O 0 7.742763409623876e-05
this O 0 3.0363646146724932e-05
gene O 0 3.33227617375087e-05
in O 0 2.2398153305402957e-05
the O 0 6.865103205200285e-05
pathogenesis O 0 0.0055596181191504
of O 0 0.0004189288301859051
sporadic B-Disease 1 0.6866319179534912
T I-Disease 1 0.9994590878486633
- I-Disease 0 0.001315040048211813
PLL I-Disease 0 0.20772746205329895
and O 0 7.471074059139937e-05
suggests O 0 8.871395402820781e-05
that O 0 3.516686410875991e-05
ATM O 0 0.0003496835706755519
acts O 0 0.00016410829266533256
as O 0 0.00015011098003014922
a O 0 0.0019058426842093468
tumour B-Disease 1 0.9999990463256836
suppressor O 1 0.9962953925132751
. O 0 0.0019361943705007434

As O 0 0.0010703104780986905
constitutional O 0 0.0011669130763038993
DNA O 0 0.0005952583742327988
was O 0 0.0003089474921580404
not O 0 3.217567063984461e-05
available O 0 1.722715205687564e-05
, O 0 2.8288626708672382e-05
a O 0 0.00010533550084801391
putative O 0 0.0011840779334306717
hereditary O 1 0.9797421097755432
predisposition O 1 0.998421311378479
to O 0 0.0012636046158149838
T B-Disease 1 0.9997654557228088
- I-Disease 0 0.0014682321343570948
PLL I-Disease 0 0.15491288900375366
will O 0 6.714447954436764e-05
require O 0 4.2559993744362146e-05
further O 0 8.350407733814791e-05
investigation O 0 0.0003221605729777366
. O 0 0.00018624297808855772
. O 0 0.0004907247493974864

Myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.999998927116394
protein O 0 0.004362961743026972
kinase O 0 0.0016767722554504871
is O 0 0.00011409866419853643
involved O 0 9.909469372360036e-05
in O 0 5.8026820624945685e-05
the O 0 8.426166459685192e-05
modulation O 0 0.0002005860151257366
of O 0 0.0001222433493239805
the O 0 0.00033077617990784347
Ca2 O 0 0.11616336554288864
+ O 0 0.016964081674814224
homeostasis O 1 0.9623335599899292
in O 0 0.0016212612390518188
skeletal O 1 0.9999969005584717
muscle O 1 0.9999767541885376
cells O 0 0.05097800865769386
. O 0 0.0007579998346045613

Myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9952642917633057
DM B-Disease 1 0.9999990463256836
) O 0 0.0003519526217132807
, O 0 0.0001122499379562214
the O 0 0.00014062432455830276
most O 0 0.00018028066551778466
prevalent O 1 0.9983739852905273
muscular B-Disease 1 1.0
disorder I-Disease 1 0.9999997615814209
in O 0 0.0012396180536597967
adults O 0 0.00011406135308789089
, O 0 4.483007069211453e-05
is O 0 3.6370787711348385e-05
caused O 0 0.00024610047694295645
by O 0 4.0736893424764276e-05
( O 0 9.335311187896878e-05
CTG O 0 0.0038302503526210785
) O 0 6.058619692339562e-05
n O 0 0.0001408068201271817
- O 0 0.00010872114216908813
repeat O 0 0.0001586045982548967
expansion O 0 9.816518286243081e-05
in O 0 3.0302813684102148e-05
a O 0 5.3381361794890836e-05
gene O 0 4.851639096159488e-05
encoding O 0 4.62406242149882e-05
a O 0 7.569232548121363e-05
protein O 0 0.00010647688031895086
kinase O 0 0.00023126931046135724
( O 0 0.00017039361409842968
DM B-Disease 1 0.8688613772392273
protein O 0 0.0002490320475772023
kinase O 0 0.0005011530010960996
; O 0 9.359842078993097e-05
DMPK O 0 0.21843339502811432
) O 0 7.554694457212463e-05
and O 0 6.791970372432843e-05
involves O 0 0.00018271434237249196
changes O 0 7.509473653044552e-05
in O 0 0.00016294415399897844
cytoarchitecture O 1 0.8905839323997498
and O 0 0.00059188884915784
ion O 0 0.22294770181179047
homeostasis O 1 0.9719616174697876
. O 0 0.0014693266712129116

To O 0 0.00044110906310379505
obtain O 0 0.00021572798141278327
clues O 0 0.00027712693554349244
to O 0 4.1061954107135534e-05
the O 0 9.156216401606798e-05
normal O 0 0.00013297483383212239
biological O 0 0.0001790414535207674
role O 0 0.0002130264329025522
of O 0 0.0002554437378421426
DMPK O 1 0.9981710910797119
in O 0 0.0003255624324083328
cellular O 0 0.002046663546934724
ion O 0 0.002727436600252986
homeostasis O 0 0.006689263507723808
, O 0 7.903810910647735e-05
we O 0 2.677096563274972e-05
have O 0 1.767854882928077e-05
compared O 0 4.240430280333385e-05
the O 0 6.40849320916459e-05
resting O 0 0.001343936542980373
[ O 0 0.00035793567076325417
Ca2 O 0 0.0008979427511803806
+ O 0 0.0002867126895580441
] O 0 0.00021366067812778056
i O 0 6.146967643871903e-05
, O 0 2.253446109534707e-05
the O 0 4.440158591023646e-05
amplitude O 0 0.00012128613161621615
and O 0 4.202375566819683e-05
shape O 0 0.00025683865533210337
of O 0 0.00046113019925542176
depolarization O 1 0.9988765120506287
- O 0 0.010861795395612717
induced O 1 0.9723021984100342
Ca2 O 0 0.005953261163085699
+ O 0 0.0007159955566748977
transients O 0 0.0006959828897379339
, O 0 3.7980520573910326e-05
and O 0 2.0407120246090926e-05
the O 0 4.029950650874525e-05
content O 0 3.281892713857815e-05
of O 0 9.720989328343421e-05
ATP O 0 0.08942630887031555
- O 0 0.00043979051406495273
driven O 0 0.0007546732085756958
ion O 0 0.0013430888066068292
pumps O 0 0.001576166250742972
in O 0 0.0002977398398797959
cultured O 0 0.014479010365903378
skeletal O 1 0.9998739957809448
muscle O 1 0.8918645977973938
cells O 0 0.00019206023716833442
of O 0 8.822068775771186e-05
wild O 0 0.00016325176693499088
- O 0 0.00012062087625963613
type O 0 0.00012988707749173045
and O 0 8.676516154082492e-05
DMPK O 1 0.7557747960090637
[ O 0 0.0005679760943166912
- O 0 0.0003755527432076633
/ O 0 0.0008307587122544646
- O 0 0.0007896515890024602
] O 0 0.0016978394705802202
knockout O 0 0.009248453192412853
mice O 0 0.001947193406522274
. O 0 0.0006220277864485979

In O 0 0.0016757437260821462
vitro O 0 0.003067542100325227
- O 0 0.0010946118272840977
differentiated O 0 0.0016516005853191018
DMPK O 1 0.9941837191581726
[ O 0 0.0015002562431618571
- O 0 0.0006296883220784366
/ O 0 0.0007305159233510494
- O 0 0.00031530464184470475
] O 0 0.00036773638566955924
myotubes O 0 0.0011141527211293578
exhibit O 0 0.0002556225226726383
a O 0 0.00011327152606099844
higher O 0 0.00014367562835104764
resting O 0 0.0011672822292894125
[ O 0 0.0005439767264761031
Ca2 O 0 0.000867439026478678
+ O 0 0.0003753263736143708
] O 0 0.00018573580018710345
i O 0 8.196409908123314e-05
than O 0 2.1269708668114617e-05
do O 0 2.0683020920841955e-05
wild O 0 7.267823093570769e-05
- O 0 0.0001096844716812484
type O 0 0.00012845400488004088
myotubes O 0 0.0018168886890634894
because O 0 2.5271070626331493e-05
of O 0 2.5590074073988944e-05
an O 0 2.9496330171241425e-05
altered O 0 5.941210110904649e-05
open O 0 4.381314283818938e-05
probability O 0 2.7525293262442574e-05
of O 0 8.347128459718078e-05
voltage O 0 0.0004928290145471692
- O 0 0.0002466576697770506
dependent O 0 0.00017216494597960263
l O 0 0.0007066556718200445
- O 0 0.00024513262906111777
type O 0 0.00031117809703573585
Ca2 O 0 0.0014730168040841818
+ O 0 0.0005764381494373083
and O 0 0.0002864002017304301
Na O 0 0.008039235137403011
+ O 0 0.0020542440470308065
channels O 0 0.0008378273341804743
. O 0 0.0008916337974369526

The O 0 0.0040091886185109615
mutant O 0 0.020782526582479477
myotubes O 0 0.3510693311691284
exhibit O 0 0.0011226979549974203
smaller O 0 0.00019156532653141767
and O 0 0.00015462309238500893
slower O 0 0.00042543906602077186
Ca2 O 0 0.0006249483558349311
+ O 0 0.00027490430511534214
responses O 0 0.00011671037646010518
upon O 0 0.0001661003625486046
triggering O 0 0.0009776513325050473
by O 0 0.00012411347415763885
acetylcholine O 0 0.0008458657539449632
or O 0 0.0001051611834554933
high O 0 0.0003854492970276624
external O 0 0.0006396515527740121
K O 0 0.0016842129407450557
+ O 0 0.0011900675017386675
. O 0 0.0005835117190144956

In O 0 0.0005225836066529155
addition O 0 0.0002136234106728807
, O 0 7.717568951193243e-05
we O 0 3.2025422115111724e-05
observed O 0 4.9558282626094297e-05
that O 0 2.1803141862619668e-05
these O 0 2.7838217647513375e-05
Ca2 O 0 0.000795593427028507
+ O 0 0.0004890505224466324
transients O 0 0.0012128661619499326
partially O 0 0.0003242410020902753
result O 0 5.656510256812908e-05
from O 0 4.062668085680343e-05
an O 0 4.463001459953375e-05
influx O 0 0.0002873448538593948
of O 0 0.00012411347415763885
extracellular O 0 0.00043540511978790164
Ca2 O 0 0.000572670716792345
+ O 0 0.00014603820454794914
through O 0 4.865056325797923e-05
the O 0 9.446621697861701e-05
l O 0 0.0007133421022444963
- O 0 0.00027525366749614477
type O 0 0.00038963599945418537
Ca2 O 0 0.0014142333529889584
+ O 0 0.0006006102194078267
channel O 0 0.0005144853494130075
. O 0 0.00040941659244708717

Neither O 0 0.0019703111611306667
the O 0 0.0003781275008805096
content O 0 0.0001494059688411653
nor O 0 0.00017775784363038838
the O 0 9.695543121779338e-05
activity O 0 0.00013115206093061715
of O 0 0.00016551319276914
Na O 0 0.08886051177978516
+ O 0 0.0007497824844904244
/ O 0 0.0006292159087024629
K O 0 0.0007733610109426081
+ O 0 0.0006065492634661496
ATPase O 0 0.0017008325085043907
and O 0 0.000232710997806862
sarcoplasmic O 0 0.05027361214160919
reticulum O 0 0.01344274915754795
Ca2 O 0 0.0038270459044724703
+ O 0 0.0009508145740255713
- O 0 0.00027869181940332055
ATPase O 0 0.0006549489917233586
are O 0 3.848945925710723e-05
affected O 0 0.0001632341736694798
by O 0 0.00012568075908347964
DMPK O 1 0.9984763264656067
absence O 0 0.007952583953738213
. O 0 0.0009690120932646096

In O 0 0.0006765072466805577
conclusion O 0 0.000708247534930706
, O 0 0.00010290410864399746
our O 0 7.917843322502449e-05
data O 0 2.9771892513963394e-05
suggest O 0 8.204104233300313e-05
that O 0 3.986019146395847e-05
DMPK O 0 0.36299100518226624
is O 0 3.580723932827823e-05
involved O 0 8.957439422374591e-05
in O 0 5.237719233264215e-05
modulating O 0 0.0004096955817658454
the O 0 5.715972656616941e-05
initial O 0 5.138092456036247e-05
events O 0 6.104219937697053e-05
of O 0 0.0001344952906947583
excitation O 0 0.002931759227067232
- O 0 0.0017838487401604652
contraction O 0 0.23014335334300995
coupling O 0 0.005493719596415758
in O 0 0.0006882920861244202
skeletal O 1 0.9999709129333496
muscle O 1 0.9989203214645386
. O 0 0.0004719691351056099
. O 0 0.0006047424976713955

Constitutional O 0 0.03142789006233215
RB1 O 1 0.9998730421066284
- O 0 0.008755131624639034
gene O 0 0.0006985868094488978
mutations O 0 0.000264868198428303
in O 0 0.00010668238246580586
patients O 0 0.0002835955237969756
with O 0 0.00013312442752067
isolated O 0 0.003844044404104352
unilateral B-Disease 0 0.02458145283162594
retinoblastoma I-Disease 1 0.9991753697395325
. O 0 0.0019259756663814187

In O 0 0.0006907138740643859
most O 0 0.00026172754587605596
patients O 0 0.0002892664633691311
with O 0 9.812410280574113e-05
isolated O 0 0.0010427332017570734
unilateral B-Disease 0 0.022933553904294968
retinoblastoma I-Disease 1 0.9999517202377319
, O 0 0.0015797368250787258
tumor B-Disease 1 0.9994450211524963
development O 0 0.0002410259039606899
is O 0 5.3014675359008834e-05
initiated O 0 0.00023437323397956789
by O 0 4.485269164433703e-05
somatic O 0 0.0003036062989849597
inactivation O 0 0.0006537391454912722
of O 0 8.708436507731676e-05
both O 0 4.2973006202373654e-05
alleles O 0 8.845681441016495e-05
of O 0 0.0001220729318447411
the O 0 0.0009880647994577885
RB1 O 1 0.9998646974563599
gene O 0 0.001061681774444878
. O 0 0.0006817828398197889

However O 0 0.0005927825113758445
, O 0 0.00010249768092762679
some O 0 3.532955815899186e-05
of O 0 7.974338950589299e-05
these O 0 4.8353016609326005e-05
patients O 0 0.00023294362472370267
can O 0 8.605980110587552e-05
transmit O 0 0.0007407176890410483
retinoblastoma B-Disease 1 0.7547236084938049
predisposition O 0 0.006009030621498823
to O 0 0.00013957550982013345
their O 0 0.00017254620615858585
offspring O 0 0.001064168638549745
. O 0 0.0005415943451225758

To O 0 0.0003117301093880087
determine O 0 0.00011966747842961922
the O 0 8.000023080967367e-05
frequency O 0 4.928136331727728e-05
and O 0 2.9589977202704176e-05
nature O 0 9.887947089737281e-05
of O 0 0.00012034491373924538
constitutional O 0 0.0010033767903223634
RB1 O 1 0.999944806098938
- O 0 0.0009715547785162926
gene O 0 9.421630966244265e-05
mutations O 0 6.528826634166762e-05
in O 0 3.3198739401996136e-05
patients O 0 9.597264579497278e-05
with O 0 3.9499202102888376e-05
isolated O 0 0.00028518031467683613
unilateral B-Disease 0 0.0007761961314827204
retinoblastoma I-Disease 1 0.6080316305160522
, O 0 8.149755740305409e-05
we O 0 2.9683895263588056e-05
analyzed O 0 6.935676356079057e-05
DNA O 0 0.00015563411579933017
from O 0 0.00013313686940819025
peripheral O 1 0.7261984348297119
blood O 0 0.1688431352376938
and O 0 0.0005636681453324854
from O 0 0.47864866256713867
tumor B-Disease 1 0.9999990463256836
tissue O 1 0.9988614320755005
. O 0 0.0014248669613152742

The O 0 0.001087753102183342
analysis O 0 0.0002458837698213756
of O 0 0.00029290805105119944
tumors B-Disease 1 0.7931210994720459
from O 0 9.019020217237994e-05
54 O 0 0.00017664236656855792
( O 0 5.333902663551271e-05
71 O 0 0.00013069564010947943
% O 0 2.9483730031643063e-05
) O 0 2.290241900482215e-05
of O 0 5.368295751395635e-05
76 O 0 0.0003151885757688433
informative O 0 0.0004022186913061887
patients O 0 0.0002181513700634241
showed O 0 0.00027192480047233403
loss O 0 0.0003047536010853946
of O 0 0.00021722333622165024
constitutional O 0 0.0015500696608796716
heterozygosity O 1 0.9999191761016846
( O 0 0.013141552917659283
LOH O 1 0.9999635219573975
) O 0 0.0003081299946643412
at O 0 0.0013698667753487825
intragenic O 0 0.2813042104244232
loci O 0 0.004146161023527384
. O 0 0.0011009647278115153

Three O 0 0.0008101672283373773
of O 0 0.0007033534348011017
13 O 0 0.0016070441342890263
uninformative O 1 0.9050710797309875
patients O 0 0.0019467469537630677
had O 0 0.0007607971201650798
constitutional O 0 0.0017343797953799367
deletions O 0 0.00849541462957859
. O 0 0.0012707362184301019

For O 0 0.000555520411580801
39 O 0 0.0009479445870965719
randomly O 0 0.0004221678536850959
selected O 0 0.0007506851106882095
tumors B-Disease 1 0.9856438636779785
, O 0 0.0003188057744409889
SSCP O 1 0.9965108036994934
, O 0 0.00036371173337101936
hetero O 0 0.004815501160919666
- O 0 0.00034902759944088757
duplex O 0 0.0007953345775604248
analysis O 0 3.29425347445067e-05
, O 0 3.77149845007807e-05
sequencing O 0 9.4991410151124e-05
, O 0 2.621580642880872e-05
and O 0 3.3379055821569636e-05
Southern O 0 0.00013850704999640584
blot O 0 0.0004780228773597628
analysis O 0 3.891080996254459e-05
were O 0 3.4681946999626234e-05
used O 0 3.717784056789242e-05
to O 0 3.286474384367466e-05
identify O 0 0.00016557713388465345
mutations O 0 0.0006800230476073921
. O 0 0.0007560717640444636

Mutations O 0 0.0013981241500005126
were O 0 0.00030326758860610425
detected O 0 0.0003020525036845356
in O 0 6.836847023805603e-05
21 O 0 9.612698340788484e-05
( O 0 3.0431887353188358e-05
91 O 0 8.09491757536307e-05
% O 0 3.071045284741558e-05
) O 0 2.7753527319873683e-05
of O 0 0.00014449404261540622
23 O 0 0.0036316360346972942
tumors B-Disease 1 0.9999182224273682
with O 0 0.0017379788914695382
LOH O 1 0.9999654293060303
. O 0 0.0023757570888847113

In O 0 0.00036427806480787694
6 O 0 0.0003119292960036546
( O 0 8.606824849266559e-05
38 O 0 0.00010161849058931693
% O 0 3.0484257877105847e-05
) O 0 2.7464986487757415e-05
of O 0 9.74849535850808e-05
16 O 0 0.0007088028942234814
tumors B-Disease 1 0.99981290102005
without O 0 0.00041786927613429725
LOH O 1 0.999825656414032
, O 0 7.080045179463923e-05
one O 0 5.085227530798875e-05
mutation O 0 9.730210149427876e-05
was O 0 0.0001397978194290772
detected O 0 7.834101415937766e-05
, O 0 1.423885169060668e-05
and O 0 9.527475413051434e-06
in O 0 1.2629810953512788e-05
9 O 0 3.8698839489370584e-05
( O 0 1.59595856530359e-05
56 O 0 4.685059320763685e-05
% O 0 1.2655176760745235e-05
) O 0 1.2412703654263169e-05
of O 0 6.229832797544077e-05
the O 0 0.00029747450025752187
tumors B-Disease 1 0.999971866607666
without O 0 0.001106173382140696
LOH O 1 0.9999911785125732
, O 0 8.75850601005368e-05
both O 0 4.60161900264211e-05
mutations O 0 0.00010299284622306004
were O 0 7.205906149465591e-05
found O 0 0.0001691894285613671
. O 0 0.0003833259397652

Thus O 0 0.0007506615365855396
, O 0 0.00013905437663197517
a O 0 9.360663534607738e-05
total O 0 7.05121346982196e-05
of O 0 4.785045894095674e-05
45 O 0 8.350407733814791e-05
mutations O 0 3.473483957350254e-05
were O 0 2.0068318917765282e-05
identified O 0 5.236915239947848e-05
in O 0 5.9086822147946805e-05
tumors B-Disease 1 0.717728853225708
of O 0 0.0003510521783027798
36 O 0 0.0009915388654917479
patients O 0 0.0013457341119647026
. O 0 0.0005000464152544737

Thirty O 0 0.0015914654359221458
- O 0 0.00026801376952789724
nine O 0 0.00011040927347494289
of O 0 0.00010460539488121867
the O 0 9.370156476506963e-05
mutations O 0 6.384484004229307e-05
- O 0 6.261710223043337e-05
including O 0 2.6823430744116195e-05
34 O 0 7.046233076835051e-05
small O 0 4.8704823711887e-05
mutations O 0 6.125170330051333e-05
, O 0 3.053733234992251e-05
2 O 0 5.7761815696721897e-05
large O 0 8.048152085393667e-05
structural O 0 0.0010749850189313293
alterations O 0 0.0008202298195101321
, O 0 7.797343278070912e-05
and O 0 7.128062134142965e-05
hypermethylation O 0 0.008042464032769203
in O 0 0.00013289714115671813
3 O 0 0.0006095886928960681
tumors O 1 0.9924705028533936
- O 0 8.561524737160653e-05
were O 0 2.266720730403904e-05
not O 0 8.551464816264343e-06
detected O 0 3.042582466150634e-05
in O 0 1.4401953194465023e-05
the O 0 5.519049591384828e-05
corresponding O 0 0.00021914075477980077
peripheral O 1 0.9592298269271851
blood O 0 0.2859712541103363
DNA O 0 0.0014084752183407545
. O 0 0.0004230799386277795

In O 0 0.0004872529534623027
6 O 0 0.0004359512240625918
( O 0 0.0001219400655827485
17 O 0 9.409205085830763e-05
% O 0 2.449521707603708e-05
) O 0 1.406083902111277e-05
of O 0 3.3590960811125115e-05
the O 0 5.598349162028171e-05
36 O 0 0.00014634669059887528
patients O 0 0.00011604851169977337
, O 0 3.8249752833507955e-05
a O 0 4.960211299476214e-05
mutation O 0 6.866183684905991e-05
was O 0 0.00013323643361218274
detected O 0 8.48989948281087e-05
in O 0 1.9988954591099173e-05
constitutional O 0 5.8630106650525704e-05
DNA O 0 4.617901868186891e-05
, O 0 1.218897887156345e-05
and O 0 1.1564118722162675e-05
1 O 0 2.205299460911192e-05
of O 0 2.1029291019658558e-05
these O 0 1.0989219845214393e-05
mutations O 0 3.353417923790403e-05
is O 0 1.9818655346171e-05
known O 0 4.485692625166848e-05
to O 0 1.727491144265514e-05
be O 0 2.2975153115112334e-05
associated O 0 5.111370046506636e-05
with O 0 8.001731475815177e-05
reduced O 0 0.0007626560400240123
expressivity O 0 0.3325634300708771
. O 0 0.0006847705226391554

The O 0 0.000782240298576653
presence O 0 0.0004218687827233225
of O 0 0.00016496601165272295
a O 0 0.00014794310845900327
constitutional O 0 0.00030111888190731406
mutation O 0 0.0001431237324140966
was O 0 0.00012263072130735964
not O 0 1.3806566130369902e-05
associated O 0 1.309840808971785e-05
with O 0 9.371344276587479e-06
an O 0 2.9314276616787538e-05
early O 0 0.00014534055662807077
age O 0 0.0002559259010013193
at O 0 0.0006794665241613984
treatment O 0 0.007130315061658621
. O 0 0.0005829966976307333

In O 0 0.0010770633816719055
1 O 0 0.0008216716232709587
patient O 0 0.0011069598840549588
, O 0 0.000302244647173211
somatic O 0 0.007001862395554781
mosaicism O 1 0.9870429039001465
was O 0 0.0008364318055100739
demonstrated O 0 0.0003499241720419377
by O 0 4.603822890203446e-05
molecular O 0 0.00010330710938433185
analysis O 0 3.3558175346115604e-05
of O 0 8.81034939084202e-05
DNA O 0 0.00015922010061331093
and O 0 0.00010205967555521056
RNA O 0 0.000399249664042145
from O 0 0.0003754741919692606
peripheral O 1 0.8750740885734558
blood O 0 0.07235734164714813
. O 0 0.0007006594096310437

In O 0 0.0008369431598111987
2 O 0 0.0005506211309693754
patients O 0 0.00024275975010823458
without O 0 7.297608681255952e-05
a O 0 0.0001056009205058217
detectable O 0 0.0018037569243460894
mutation O 0 0.00022511370480060577
in O 0 0.00011842897947644815
peripheral O 1 0.9858413934707642
blood O 0 0.1363416612148285
, O 0 0.00014963294961489737
mosaicism O 1 0.7783957719802856
was O 0 0.00027716654585674405
suggested O 0 3.964852658100426e-05
because O 0 1.5158639143919572e-05
1 O 0 1.6974347090581432e-05
of O 0 5.62940513191279e-05
the O 0 0.0001777219003997743
patients O 0 0.08952552825212479
showed O 1 0.9310898184776306
multifocal O 1 0.9999998807907104
tumors B-Disease 1 0.9999958276748657
and O 0 8.874533523339778e-05
the O 0 9.878796117845923e-05
other O 0 3.3132953831227496e-05
later O 0 0.00024080353614408523
developed O 0 0.0004389896639622748
bilateral B-Disease 0 0.0024589402601122856
retinoblastoma I-Disease 1 0.9798994064331055
. O 0 0.0011804760433733463

In O 0 0.0006790062761865556
conclusion O 0 0.0005767975235357881
, O 0 0.00011696416913764551
our O 0 8.908704330679029e-05
results O 0 6.779972318327054e-05
emphasize O 0 0.0001347715442534536
that O 0 3.526271029841155e-05
the O 0 9.51562324189581e-05
manifestation O 0 0.045325152575969696
and O 0 0.00015252656885422766
transmissibility O 0 0.044147830456495285
of O 0 0.00022403667389880866
retinoblastoma B-Disease 0 0.008581695146858692
depend O 0 6.196091271704063e-05
on O 0 3.198687409167178e-05
the O 0 3.4224729461129755e-05
nature O 0 3.887453567585908e-05
of O 0 2.2373154934030026e-05
the O 0 3.714895501616411e-05
first O 0 4.474153683986515e-05
mutation O 0 3.2949385058600456e-05
, O 0 8.445569619652815e-06
its O 0 5.604991201835219e-06
time O 0 9.169199074676726e-06
in O 0 1.5263358363881707e-05
development O 0 3.281285535194911e-05
, O 0 1.1988958249276038e-05
and O 0 1.0888988072110806e-05
the O 0 1.8375565559836105e-05
number O 0 1.2204449376440607e-05
and O 0 1.6998192222672515e-05
types O 0 2.4227099856943823e-05
of O 0 9.540063911117613e-05
cells O 0 0.00012751710892189294
that O 0 1.9903092834283598e-05
are O 0 1.5395309674204327e-05
affected O 0 0.00011201320739928633
. O 0 8.54260433698073e-05
. O 0 0.0003044631739612669

Hereditary B-Disease 1 0.999972939491272
deficiency I-Disease 1 0.999993085861206
of I-Disease 0 0.004194540437310934
the I-Disease 0 0.0032411690335720778
fifth I-Disease 1 0.806272029876709
component I-Disease 0 0.0018243270460516214
of I-Disease 0 0.0003359602123964578
complement I-Disease 0 0.0005417254869826138
in O 0 0.00024470785865560174
man O 0 0.0014112256467342377
. O 0 0.0005118308472447097

I O 0 0.041294656693935394
. O 0 0.006351422052830458

Clinical O 0 0.01890101097524166
, O 0 0.0011140385176986456
immunochemical O 1 0.986302375793457
, O 0 0.0003310971078462899
and O 0 0.00022301326680462807
family O 0 0.0004400471516419202
studies O 0 0.00044860693742521107
. O 0 0.0007517141639254987

The O 0 0.0008371114963665605
first O 0 0.0003633863525465131
recognized O 0 0.0004118405922781676
human O 0 0.0003105186624452472
kindred O 1 0.8985812067985535
with O 0 0.0014013460604473948
hereditary B-Disease 1 0.9999982118606567
deficiency I-Disease 1 0.9999996423721313
of I-Disease 0 0.06208265572786331
the I-Disease 0 0.006495204288512468
fifth I-Disease 0 0.35958895087242126
component I-Disease 0 0.0006073593976907432
of I-Disease 0 0.00013142696116119623
complement I-Disease 0 0.0006094806012697518
( O 0 0.00024299780488945544
C5 O 1 0.6825319528579712
) O 0 0.00015756016364321113
is O 0 0.00015346270811278373
described O 0 0.0006588211981579661
. O 0 0.0005774758174084127

The O 0 0.002109677530825138
proband O 0 0.009064664132893085
, O 0 0.00016455454169772565
a O 0 0.0001526927517261356
20 O 0 0.000183989352080971
- O 0 0.00023669414804317057
year O 0 0.00011646101484075189
- O 0 0.0002520307316444814
old O 0 0.000557159015443176
black O 0 0.0009788386523723602
female O 0 0.0019471609266474843
with O 0 0.262807160615921
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9433035850524902
age O 0 0.030418582260608673
11 O 0 0.0008758438634686172
, O 0 0.00021371468028519303
lacked O 0 0.016131887212395668
serum O 1 0.9951927661895752
hemolytic O 1 0.9999959468841553
complement O 0 0.0009772824123501778
activity O 0 0.0003717223007697612
, O 0 8.332256402354687e-05
even O 0 0.00014205818297341466
during O 0 0.0006900296430103481
remission O 0 0.09179646521806717
. O 0 0.0011988418409600854

C5 O 1 0.9991158843040466
was O 0 0.008383854292333126
undetectable O 0 0.014559224247932434
in O 0 0.00023348622198682278
her O 0 0.000600120984017849
serum O 0 0.023005465045571327
by O 0 0.00013741725706495345
both O 0 0.00022813181567471474
immunodiffusion O 1 0.9988872408866882
and O 0 0.00330090313218534
hemolytic O 1 0.9999979734420776
assays O 0 0.004956900607794523
. O 0 0.0014519375981763005

Other O 0 0.0004936892073601484
complement O 0 0.0007234503864310682
components O 0 0.00043353147339075804
were O 0 8.093343785731122e-05
normal O 0 0.0001663703005760908
during O 0 0.00029057165374979377
remission O 0 0.0118204765021801
of O 0 0.0034699023235589266
lupus O 1 0.9999986886978149
, O 0 0.00035169164766557515
but O 0 0.00012768623128067702
C1 O 1 0.9976667165756226
, O 0 0.0001988520089071244
C4 O 1 0.9818038940429688
, O 0 0.00021674419986084104
C2 O 0 0.07834462821483612
, O 0 0.00011705321230692789
and O 0 0.00013875687727704644
C3 O 1 0.9740492105484009
levels O 0 0.0005401256494224072
fell O 0 0.0039210207760334015
during O 0 0.0015926531050354242
exacerbations O 1 0.9488250613212585
. O 0 0.0009664940880611539

A O 0 0.0034883501939475536
younger O 0 0.002040258375927806
half O 0 0.00037362443981692195
- O 0 0.0005037920782342553
sister O 0 0.0003829816705547273
, O 0 5.131590296514332e-05
who O 0 6.590623524971306e-05
had O 0 9.875095565803349e-05
no O 0 0.0002016937651205808
underlying O 1 0.9998024106025696
disease O 1 0.9999958276748657
, O 0 0.00012591300765052438
was O 0 0.0004060687788296491
also O 0 4.1655966924736276e-05
found O 0 2.752411091933027e-05
to O 0 5.759280247730203e-05
lack O 0 0.0007502888911403716
immunochemically O 1 0.9993436932563782
detectable O 1 0.9648560285568237
C5 O 1 0.998134434223175
. O 0 0.0009714252664707601

By O 0 0.00382751296274364
hemolytic O 1 0.9999895095825195
assay O 0 0.0021773974876850843
, O 0 0.00021758423827122897
she O 0 0.0001459275372326374
exhibited O 0 0.0002140058350050822
1 O 0 7.17826042091474e-05
- O 0 7.435763109242544e-05
2 O 0 3.2801592169562355e-05
% O 0 9.01422663446283e-06
of O 0 3.0480681743938476e-05
the O 0 6.531317922053859e-05
normal O 0 0.00015963906480465084
serum O 0 0.032853879034519196
C5 O 0 0.38435864448547363
level O 0 0.00012363202404230833
and O 0 4.5314303861232474e-05
normal O 0 5.204786793910898e-05
concentrations O 0 7.16784197720699e-05
of O 0 6.692764145554975e-05
other O 0 6.402177677955478e-05
complement O 0 0.0006599468761123717
components O 0 0.0007888824329711497
. O 0 0.0004997938522137702

C5 O 1 0.983656644821167
levels O 0 0.0008257259614765644
of O 0 0.0001842215860961005
other O 0 4.212708518025465e-05
family O 0 6.124849460320547e-05
members O 0 2.0894834960927255e-05
were O 0 2.321756983292289e-05
either O 0 2.45190312853083e-05
normal O 0 5.258418241282925e-05
or O 0 2.1776917492388748e-05
approximately O 0 2.9709128284594044e-05
half O 0 3.9873080822872e-05
- O 0 0.00010535078035900369
normal O 0 7.48573656892404e-05
, O 0 3.661722075776197e-05
consistent O 0 9.067000792128965e-05
with O 0 5.841502206749283e-05
autosomal O 0 0.0007005585357546806
codominant O 0 0.31896039843559265
inheritance O 0 0.0005639945156872272
of O 0 0.0002393903851043433
the O 0 0.0006035321857780218
gene O 0 0.0013744410825893283
determining O 0 0.03358053043484688
C5 B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999995231628418
. O 0 0.0027015255764126778

Normal O 0 0.33820727467536926
hemolytic O 1 0.9999861717224121
titers O 0 0.35073864459991455
were O 0 0.00040372219518758357
restored O 0 0.0006415300886146724
to O 0 8.702999184606597e-05
both O 0 0.00012463149323593825
homozygous O 0 0.002734068315476179
C5 B-Disease 1 0.9999921321868896
- I-Disease 0 0.363823264837265
deficient I-Disease 1 0.9989537000656128
( O 0 0.0007357498398050666
C5D B-Disease 1 0.999962568283081
) O 0 0.00024117412976920605
sera O 0 0.0011830736184492707
by O 0 5.78291728743352e-05
addition O 0 7.522747182520106e-05
of O 0 0.00015480352158192545
highly O 0 0.0003243829414714128
purified O 0 0.03584832698106766
human O 0 0.0013014859287068248
C5 O 1 0.997461199760437
. O 0 0.0010121897794306278

In O 0 0.001142395194619894
specific O 0 0.0008071170304901898
C5 O 1 0.9986081719398499
titrations O 0 0.07047708332538605
, O 0 0.00016302884614560753
however O 0 7.63674543122761e-05
, O 0 4.219482798362151e-05
it O 0 2.5436598662054166e-05
was O 0 9.611753921490163e-05
noted O 0 5.2691855671582744e-05
that O 0 1.2917161257064436e-05
when O 0 3.352298881509341e-05
limited O 0 2.405496343271807e-05
amounts O 0 3.383911098353565e-05
of O 0 8.020294626476243e-05
C5 O 0 0.11972709000110626
were O 0 6.671238952549174e-05
assayed O 0 0.0002592462406028062
in O 0 2.731888525886461e-05
the O 0 4.8665966460248455e-05
presence O 0 8.510487532475963e-05
of O 0 8.414073818130419e-05
low O 0 0.00018811588233802468
dilutions O 0 0.001279083313420415
of O 0 0.00022331434593070298
either O 0 0.00046140546328388155
C5D B-Disease 1 0.9999943971633911
serum O 0 0.1841532588005066
, O 0 0.000126319209812209
curving O 0 0.00045754393795505166
rather O 0 5.275636067381129e-05
than O 0 2.1775878849439323e-05
linear O 0 8.118535333778709e-05
dose O 0 0.00033249519765377045
- O 0 0.0001088505086954683
response O 0 5.1117745897499844e-05
plots O 0 0.00010943133383989334
were O 0 3.46027227351442e-05
consistently O 0 7.210077455965802e-05
obtained O 0 6.564974319189787e-05
, O 0 4.7443070798181e-05
suggesting O 0 0.0001411500124959275
some O 0 7.501986692659557e-05
inhibitory O 0 0.001133363344706595
effect O 0 0.0008432005415670574
. O 0 0.0004709292552433908

Further O 0 0.0011450010351836681
studies O 0 0.00023858922941144556
suggested O 0 0.0002837050415109843
that O 0 6.631634460063651e-05
low O 0 0.00020867265993729234
dilutions O 0 0.0020583104342222214
of O 0 0.0007764678448438644
C5D B-Disease 1 0.9999891519546509
serum O 0 0.018329504877328873
contain O 0 0.00022097982582636178
a O 0 0.00013573080650530756
factor O 0 0.0001754719705786556
( O 0 5.2901203162036836e-05
or O 0 3.603826553444378e-05
factors O 0 4.408249515108764e-05
) O 0 1.4439717233472038e-05
interfering O 0 4.658097168430686e-05
at O 0 3.963114431826398e-05
some O 0 1.820188481360674e-05
step O 0 6.45440595690161e-05
in O 0 3.187390757375397e-05
the O 0 0.0001681402063695714
hemolytic O 1 0.9999649524688721
assay O 0 0.0009405001765117049
of O 0 0.00058508082292974
C5 O 1 0.984372615814209
, O 0 5.9057139878859743e-05
rather O 0 4.173330307821743e-05
than O 0 2.0631881852750666e-05
a O 0 8.056844671955332e-05
true O 0 0.0008182415040209889
C5 O 1 0.999670147895813
inhibitor O 1 0.7294645309448242
or O 0 0.0004918643971905112
inactivator O 0 0.10063929110765457
. O 0 0.0010244478471577168

Of O 0 0.0010646407026797533
clinical O 0 0.000808875949587673
interest O 0 0.00010666549496818334
are O 0 1.5060972145874985e-05
( O 0 3.9781654777470976e-05
a O 0 4.6630488213850185e-05
) O 0 2.5322118744952604e-05
the O 0 5.31945624970831e-05
documentation O 0 0.00023633109231013805
of O 0 0.000946193584240973
membranous O 1 0.9999960660934448
glomerulonephritis B-Disease 1 1.0
, O 1 0.9973711967468262
vasculitis B-Disease 1 1.0
, O 0 0.4518066346645355
and O 1 0.5943214893341064
arthritis B-Disease 1 0.9999998807907104
in O 0 0.00036836921935901046
an O 0 0.00021355191711336374
individual O 0 0.00019543358939699829
lacking O 0 0.04587132856249809
C5 O 1 0.9983561635017395
( O 0 9.535569552099332e-05
and O 0 3.364116491866298e-05
its O 0 2.898304592235945e-05
biologic O 0 0.0006968928501009941
functions O 0 4.143283513258211e-05
) O 0 2.2073887521401048e-05
, O 0 1.6508785847690888e-05
and O 0 2.09158897632733e-05
( O 0 3.6714423913508654e-05
b O 0 6.0595382819883525e-05
) O 0 2.144959034922067e-05
a O 0 5.530265480047092e-05
remarkable O 0 0.00020374068117234856
propensity O 0 0.0009153102291747928
to O 0 0.00019407914078328758
bacterial B-Disease 1 0.9999607801437378
infections I-Disease 1 0.9997749924659729
in O 0 0.00013576628407463431
the O 0 0.00022935972083359957
proband O 1 0.9021579027175903
, O 0 5.4291285778163e-05
even O 0 3.3989374060183764e-05
during O 0 6.080829189158976e-05
periods O 0 7.409735553665087e-05
of O 0 9.080005111172795e-05
low O 0 0.0001642542047193274
- O 0 0.0001750324881868437
dose O 0 0.00029438233468681574
or O 0 7.604472921229899e-05
alternate O 0 0.00023490523744840175
- O 0 0.0006242911331355572
day O 0 0.0012322434922680259
corticosteroid O 1 0.8800545930862427
therapy O 0 0.05732234939932823
. O 0 0.0009843759471550584

Other O 0 0.00031905999640002847
observations O 0 0.0003014802641700953
indicate O 0 0.00017524976283311844
that O 0 4.2492309148656204e-05
the O 0 0.00015223553054966033
C5D B-Disease 1 0.9996154308319092
state O 0 7.472320430679247e-05
is O 0 4.0793423977447674e-05
compatible O 0 6.89859880367294e-05
with O 0 3.256633135606535e-05
normal O 0 0.000213520965189673
coagulation O 0 0.00743626244366169
function O 0 4.3437186832306907e-05
and O 0 2.2907510356162675e-05
the O 0 4.5569373469334096e-05
capacity O 0 0.00013185727584641427
to O 0 5.0387996452627704e-05
mount O 0 0.0017468268051743507
a O 0 0.0006403541774488986
neutrophilic O 1 0.9992283582687378
leukocytosis O 1 0.9995973706245422
during O 1 0.7687317728996277
pyogenic B-Disease 1 0.9998704195022583
infection I-Disease 1 0.9988346695899963
. O 0 0.0005509990733116865
. O 0 0.0007925531244836748

Susceptibility O 1 0.853014349937439
to O 0 0.007027037441730499
ankylosing B-Disease 1 0.9999998807907104
spondylitis I-Disease 1 1.0
in O 0 0.012602203525602818
twins O 0 0.07708843052387238
: O 0 9.871630754787475e-05
the O 0 6.537917215609923e-05
role O 0 0.000152124252053909
of O 0 0.00017219054279848933
genes O 0 0.00018939425353892148
, O 0 0.00016797581338323653
HLA O 1 0.9978074431419373
, O 0 8.269280078820884e-05
and O 0 8.815508772386238e-05
the O 0 0.0002416999195702374
environment O 0 0.0005057001835666597
. O 0 0.0005556602263823152

OBJECTIVE O 0 0.0020958599634468555
To O 0 0.00019818477449007332
determine O 0 9.311608300777152e-05
the O 0 8.461086690658703e-05
relative O 0 0.00015082317986525595
effects O 0 0.0002686562074813992
of O 0 0.00015846341557335109
genetic O 0 0.00021759523951914161
and O 0 9.407041943632066e-05
environmental O 0 0.00018603532225824893
factors O 0 8.430289017269388e-05
in O 0 8.515545778209344e-05
susceptibility O 0 0.24776439368724823
to O 0 0.001556873437948525
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.8257743120193481
AS B-Disease 1 0.8449192047119141
) O 0 0.0005867578438483179
. O 0 0.0008069620234891772

METHODS O 0 0.002406734274700284
Twins O 0 0.0025204408448189497
with O 0 0.0001582162658451125
AS B-Disease 0 0.0003143007052130997
were O 0 3.9749196730554104e-05
identified O 0 5.108485129312612e-05
from O 0 3.406751056900248e-05
the O 0 0.000124872982269153
Royal O 0 0.004335888661444187
National O 0 0.33755478262901306
Hospital O 1 0.9999783039093018
for O 0 0.4818968176841736
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 0.9999997615814209
database O 0 0.012082960456609726
. O 0 0.0020913768094033003

Clinical O 0 0.007743760012090206
and O 0 0.0008634378318674862
radiographic O 0 0.007774545345455408
examinations O 0 0.0005728162359446287
were O 0 0.00011106480087619275
performed O 0 0.00013333505194168538
to O 0 3.6595400160877034e-05
establish O 0 0.00023159498232416809
diagnoses O 0 0.07684719562530518
, O 0 0.00023729429813101888
and O 0 0.0006230244762264192
disease O 1 0.9999407529830933
severity O 1 0.9375206828117371
was O 0 0.001851013395935297
assessed O 0 0.00010479060438228771
using O 0 1.7291642507188953e-05
a O 0 3.7371781218098477e-05
combination O 0 7.6572090620175e-05
of O 0 7.55269211367704e-05
validated O 0 0.00034977306495420635
scoring O 0 0.00036164242192171514
systems O 0 0.0007117412169463933
. O 0 0.00045761570800095797

HLA O 1 0.9380844235420227
typing O 0 0.0085081085562706
for O 0 0.001184513559564948
HLA O 1 0.9984756112098694
- O 0 0.0026125069707632065
B27 O 1 0.7608271241188049
, O 0 0.0005276951706036925
HLA O 1 0.9978392720222473
- O 0 0.0009737455984577537
B60 O 0 0.023313140496611595
, O 0 0.00013689816114492714
and O 0 0.00019943607912864536
HLA O 1 0.9997504353523254
- O 0 0.001701494213193655
DR1 O 0 0.4399638772010803
was O 0 0.0004828819364774972
performed O 0 0.0002137896663043648
by O 0 8.84941837284714e-05
polymerase O 0 0.0004302214365452528
chain O 0 0.00017574023513589054
reaction O 0 6.052815660950728e-05
with O 0 1.7845308320829645e-05
sequence O 0 3.9959522837307304e-05
- O 0 6.424555613193661e-05
specific O 0 2.7972713724011555e-05
primers O 0 0.0001502282393630594
, O 0 4.94934429298155e-05
and O 0 8.908891322789714e-05
zygosity O 0 0.004504780285060406
was O 0 0.00048646863433532417
assessed O 0 0.00045871848124079406
using O 0 0.00025059832842089236
microsatellite O 0 0.01089041493833065
markers O 0 0.005551714915782213
. O 0 0.0015486475313082337

Genetic O 0 0.001949097029864788
and O 0 0.0003384227165952325
environmental O 0 0.00044992813491262496
variance O 0 0.00013806753850076348
components O 0 0.00014346258831210434
were O 0 4.505378819885664e-05
assessed O 0 6.437316915253177e-05
with O 0 1.920261092891451e-05
the O 0 5.38554995728191e-05
program O 0 9.715347550809383e-05
Mx O 0 0.0007994952029548585
, O 0 2.873549055948388e-05
using O 0 8.956182682595681e-06
data O 0 9.121700713876635e-06
from O 0 1.2086456990800798e-05
this O 0 9.348047569801565e-06
and O 0 1.3968952771392651e-05
previous O 0 3.9104244933696464e-05
studies O 0 2.9777145755360834e-05
of O 0 0.0001075668988050893
twins O 0 0.0011069276370108128
with O 0 0.00016919490008149296
AS B-Disease 0 0.002422634745016694
. O 0 0.0006735877250321209

RESULTS O 0 0.0008336173486895859
Six O 0 0.0003631221188697964
of O 0 0.0002503146533854306
8 O 0 0.000548854935914278
monozygotic O 0 0.017782796174287796
( O 0 0.0007439339533448219
MZ O 1 0.9853464365005493
) O 0 0.00020889303414151073
twin O 0 0.0008476966177113354
pairs O 0 0.00014347340038511902
were O 0 0.00013096995826344937
disease O 0 0.32147955894470215
concordant O 0 0.001321217860095203
, O 0 5.998228880343959e-05
compared O 0 4.3183958041481674e-05
with O 0 1.1750045814551413e-05
4 O 0 2.9495964554371312e-05
of O 0 3.9070542698027566e-05
15 O 0 0.00011009596346411854
B27 O 0 0.0026561496779322624
- O 0 0.00015992746921256185
positive O 0 8.830746810417622e-05
dizygotic O 0 0.0013549858704209328
( O 0 0.00013764413597527891
DZ O 0 0.014851707033813
) O 0 4.172350963926874e-05
twin O 0 0.00021397566888481379
pairs O 0 5.256196891423315e-05
( O 0 3.31750707118772e-05
27 O 0 8.472301124129444e-05
% O 0 1.7827991541707888e-05
) O 0 1.2221476026752498e-05
and O 0 1.4455590644502081e-05
4 O 0 3.1492661946685985e-05
of O 0 6.483837933046743e-05
32 O 0 0.00023056648205965757
DZ O 0 0.2148973047733307
twin O 0 0.0005044094868935645
pairs O 0 8.816315676085651e-05
overall O 0 0.00014095376536715776
( O 0 4.14956703025382e-05
12 O 0 8.047292067203671e-05
. O 0 2.7425203370512463e-05
5 O 0 9.870783105725423e-05
% O 0 0.00010710231435950845
) O 0 0.0001933183812070638
. O 0 0.00046640392974950373

Nonsignificant O 1 0.5903113484382629
increases O 0 0.0007969026919454336
in O 0 6.999287870712578e-05
similarity O 0 0.00012648894335143268
with O 0 3.170163108734414e-05
regard O 0 0.00010213015775661916
to O 0 7.35289795557037e-05
age O 0 0.00031071831472218037
at O 0 0.3656870424747467
disease O 1 0.9999855756759644
onset O 1 0.999909520149231
and O 0 5.329153282218613e-05
all O 0 2.2026340957381763e-05
of O 0 8.933758363127708e-05
the O 0 0.000689912645611912
disease O 1 0.9991161227226257
severity O 0 0.03501414507627487
scores O 0 7.086731784511358e-05
assessed O 0 5.116803367855027e-05
were O 0 2.0843925085500814e-05
noted O 0 5.651059473166242e-05
in O 0 0.00010070228745462373
disease O 1 0.9875796437263489
- O 0 0.0016413492849096656
concordant O 0 0.19172009825706482
MZ O 1 0.9995061159133911
twins O 0 0.002704746788367629
compared O 0 0.0003709749726112932
with O 0 0.00019794871332123876
concordant O 0 0.09689276665449142
DZ O 1 0.9997181296348572
twins O 0 0.11387459933757782
. O 0 0.0012785961152985692

HLA O 1 0.9997599720954895
- O 0 0.013043145649135113
B27 O 0 0.41660264134407043
and O 0 0.0006084745400585234
B60 O 0 0.03339948505163193
were O 0 0.00014992601063568145
associated O 0 6.431359361158684e-05
with O 0 3.977854430559091e-05
the O 0 0.00026996570522896945
disease O 1 0.9998264908790588
in O 0 0.0002976240066345781
probands O 1 0.979042112827301
, O 0 3.557375384843908e-05
and O 0 2.0913495973218232e-05
the O 0 3.6011577321914956e-05
rate O 0 4.0830236684996635e-05
of O 0 7.293928501894698e-05
disease O 0 0.4926711618900299
concordance O 0 0.0006295542698353529
was O 0 0.00035634468076750636
significantly O 0 8.189026993932202e-05
increased O 0 5.750077616539784e-05
among O 0 7.545521657448262e-05
DZ O 0 0.4479072391986847
twin O 0 0.0005971813225187361
pairs O 0 7.019333861535415e-05
in O 0 3.538414603099227e-05
which O 0 2.5124729290837422e-05
the O 0 8.072887430898845e-05
co O 0 0.00038194129592739046
- O 0 0.0003385786258149892
twin O 0 0.0009935786947607994
was O 0 0.00032045613625086844
positive O 0 0.00010813345579663292
for O 0 4.032441574963741e-05
both O 0 0.00011101482959929854
B27 O 1 0.679801881313324
and O 0 0.0008876517531462014
DR1 O 1 0.9724805951118469
. O 0 0.0015136689180508256

Additive O 0 0.005469118244946003
genetic O 0 0.0010836698347702622
effects O 0 0.0003926798817701638
were O 0 6.985764048295096e-05
estimated O 0 6.277181819314137e-05
to O 0 1.851401430030819e-05
contribute O 0 4.272138903615996e-05
97 O 0 8.389068534597754e-05
% O 0 1.827121013775468e-05
of O 0 3.750191172002815e-05
the O 0 7.73191059124656e-05
population O 0 8.41276632854715e-05
variance O 0 0.0002856192004401237
. O 0 0.000458602822618559

CONCLUSION O 0 0.007095105014741421
Susceptibility O 0 0.0036619198508560658
to O 0 0.00017613207455724478
AS B-Disease 0 0.0008940187399275601
is O 0 0.0001225604792125523
largely O 0 0.00015287134738173336
genetically O 0 0.00012789118045475334
determined O 0 6.657048652414232e-05
, O 0 3.6817047657677904e-05
and O 0 2.223513183707837e-05
the O 0 3.735781865543686e-05
environmental O 0 0.00015255302423611283
trigger O 0 0.0004036125901620835
for O 0 6.747111183358356e-05
the O 0 0.0012464984320104122
disease O 1 0.9999567270278931
is O 0 0.0002917425590567291
probably O 0 0.0008111250936053693
ubiquitous O 0 0.0021245768293738365
. O 0 0.0005628687213174999

HLA O 1 0.9993896484375
- O 0 0.005277102347463369
B27 O 0 0.006926242262125015
accounts O 0 0.00018539537268225104
for O 0 4.3347961764084175e-05
a O 0 6.170906272018328e-05
minority O 0 5.6117496569640934e-05
of O 0 6.773730274289846e-05
the O 0 0.00012595548469107598
overall O 0 0.0007984499097801745
genetic O 0 0.0005183286848478019
susceptibility O 0 0.0030599527526646852
to O 0 0.0001519372162874788
AS B-Disease 0 0.0018964270129799843
. O 0 0.0004172383341938257

Cell O 0 0.007530939765274525
cycle O 0 0.003927307203412056
- O 0 0.0012943742331117392
dependent O 0 0.0005063404678367078
colocalization O 0 0.006587199866771698
of O 0 0.0006493864930234849
BARD1 O 1 0.9999316930770874
and O 0 0.00046700987149961293
BRCA1 O 0 0.004356408957391977
proteins O 0 0.00013255390513222665
in O 0 8.839018846629187e-05
discrete O 0 0.00039232405833899975
nuclear O 0 0.001015643123537302
domains O 0 0.0009635234600864351
. O 0 0.000683965627104044

Germ O 1 0.997736930847168
- O 0 0.0021987338550388813
line O 0 0.0005576015682891011
mutations O 0 0.00014467698929365724
of O 0 0.0001312739186687395
the O 0 0.000359806464985013
BRCA1 O 1 0.8577191233634949
gene O 0 0.0002477123634889722
predispose O 0 0.0006137982709333301
women O 0 9.802927525015548e-05
to O 0 4.898028782918118e-05
early O 0 0.00040751698543317616
- O 0 0.04642445594072342
onset O 1 0.9999974966049194
breast B-Disease 1 0.9999995231628418
and I-Disease 1 0.9998984336853027
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999980926513672
by O 0 0.00016178381338249892
compromising O 0 0.001047126716002822
the O 0 0.00014413308235816658
genes O 0 9.713985491544008e-05
presumptive O 0 0.023830367252230644
function O 0 0.00011665006604744121
as O 0 0.0001327395875705406
a O 0 0.0011487642768770456
tumor B-Disease 1 0.9999593496322632
suppressor O 1 0.9632097482681274
. O 0 0.0010214807698503137

Although O 0 0.0009374553337693214
the O 0 0.0004038469342049211
biochemical O 0 0.001663809409365058
properties O 0 0.0005109249614179134
of O 0 0.000626930792350322
BRCA1 O 1 0.6522318720817566
polypeptides O 0 0.00032640245626680553
are O 0 2.0548488464555703e-05
not O 0 1.912618063215632e-05
understood O 0 6.0937629314139485e-05
, O 0 2.3386211978504434e-05
their O 0 1.7006655980367213e-05
expression O 0 7.748570351395756e-05
pattern O 0 0.0001771615498000756
and O 0 7.426721276715398e-05
subcellular O 0 0.0010664500296115875
localization O 0 0.00047687668120488524
suggest O 0 8.222494216170162e-05
a O 0 5.642212272505276e-05
role O 0 0.00013887998647987843
in O 0 0.00014236505376175046
cell O 0 0.0013327249325811863
- O 0 0.0009567140368744731
cycle O 0 0.0011483862763270736
regulation O 0 0.0009220487554557621
. O 0 0.0006911547388881445

When O 0 0.006715433672070503
resting O 1 0.8471420407295227
cells O 0 0.001198116224259138
are O 0 8.480602991767228e-05
induced O 0 0.0009108714875765145
to O 0 5.7983350416179746e-05
proliferate O 0 0.0002569238713476807
, O 0 2.9279966838657856e-05
the O 0 3.969919271185063e-05
steady O 0 0.00016762924497015774
- O 0 4.3227752030361444e-05
state O 0 1.4357194231706671e-05
levels O 0 2.672441587492358e-05
of O 0 4.0487328078597784e-05
BRCA1 O 0 0.00043143934453837574
increase O 0 2.4175282305805013e-05
in O 0 2.657852746779099e-05
late O 0 0.00011569647904252633
G1 O 0 0.0028361668810248375
and O 0 2.7584683266468346e-05
reach O 0 5.371337465476245e-05
a O 0 5.075635272078216e-05
maximum O 0 0.000119954020192381
during O 0 0.00041410824633203447
S O 0 0.002994455397129059
phase O 0 0.0025860473979264498
. O 0 0.0007495275349356234

Moreover O 0 0.0017379795899614692
, O 0 0.00024654646404087543
in O 0 0.00017788060358725488
S O 0 0.026383522897958755
phase O 0 0.39155814051628113
cells O 0 0.0008638690924271941
, O 0 0.0001230532507179305
BRCA1 O 0 0.0015605035005137324
polypeptides O 0 0.00024392794875893742
are O 0 2.547036092437338e-05
hyperphosphorylated O 0 0.001027671154588461
and O 0 7.39355236873962e-05
accumulate O 0 0.00010882092465180904
into O 0 9.005674655782059e-05
discrete O 0 0.0005262605845928192
subnuclear O 0 0.0667530819773674
foci O 0 0.01589333452284336
termed O 0 0.013979891315102577
" O 0 0.0015246643451973796
BRCA1 O 0 0.12252981960773468
nuclear O 0 0.002930127549916506
dots O 0 0.0031363635789602995
. O 0 0.0010078849736601114

" O 0 0.007752913981676102
BRCA1 O 0 0.08296062052249908
associates O 0 0.001295505091547966
in O 0 0.0001561263925395906
vivo O 0 0.0005507519817911088
with O 0 6.600070628337562e-05
a O 0 0.00023068941663950682
structurally O 0 0.002074434654787183
related O 0 0.0005844420520588756
protein O 0 0.0010421316837891936
termed O 0 0.013256935402750969
BARD1 O 1 0.998013973236084
. O 0 0.0014736201846972108

Here O 0 0.00097876344807446
we O 0 0.00013840908650308847
show O 0 0.00010160387319047004
that O 0 2.599788422230631e-05
the O 0 5.702727139578201e-05
steady O 0 0.00022741970315109938
- O 0 6.446347833843902e-05
state O 0 2.7735932235373184e-05
levels O 0 4.10492648370564e-05
of O 0 8.338026236742735e-05
BARD1 O 1 0.8668956160545349
, O 0 3.776537414523773e-05
unlike O 0 3.310017200419679e-05
those O 0 1.6256284652627073e-05
of O 0 5.718142710975371e-05
BRCA1 O 0 0.00789749063551426
, O 0 3.8520374801009893e-05
remain O 0 5.147803676663898e-05
relatively O 0 6.215294706635177e-05
constant O 0 0.00015605973021592945
during O 0 0.0007078463095240295
cell O 0 0.002631164388731122
cycle O 0 0.0025640639942139387
progression O 0 0.027704037725925446
. O 0 0.0009267206769436598

However O 0 0.0021732242312282324
, O 0 0.0010547396959736943
immunostaining O 0 0.4645162522792816
revealed O 0 0.0021004024893045425
that O 0 0.00022206439462024719
BARD1 O 1 0.9878218770027161
resides O 0 0.0012621779460459948
within O 0 0.0003245905099902302
BRCA1 O 0 0.005001557990908623
nuclear O 0 0.0005554831004701555
dots O 0 0.0003636784676928073
during O 0 0.00019143604731652886
S O 0 0.0003987371164839715
phase O 0 0.0001378348533762619
of O 0 3.2432690204586834e-05
the O 0 6.467418279498816e-05
cell O 0 0.0001459350751247257
cycle O 0 0.00013421266339719296
, O 0 2.630724156915676e-05
but O 0 1.0404707609268371e-05
not O 0 1.081988011719659e-05
during O 0 0.0001488398847868666
the O 0 0.00036605240893550217
G1 O 1 0.9158191680908203
phase O 0 0.0038010478019714355
. O 0 0.0009630325366742909

Nevertheless O 0 0.008940515108406544
, O 0 0.0013467989629134536
BARD1 O 1 0.860931932926178
polypeptides O 0 0.0007095916080288589
are O 0 3.0122364478302188e-05
found O 0 4.1293005779152736e-05
exclusively O 0 3.785750232054852e-05
in O 0 2.2772246666136198e-05
the O 0 4.9905484047485515e-05
nuclear O 0 0.0001255693641724065
fractions O 0 0.00010985183325828984
of O 0 5.930726183578372e-05
both O 0 5.012588371755555e-05
G1 O 0 0.4525712728500366
- O 0 0.0001955943153006956
and O 0 0.00010167946311412379
S O 0 0.003535256255418062
- O 0 0.0010910741984844208
phase O 0 0.003225984750315547
cells O 0 0.001041642390191555
. O 0 0.000627986853942275

Therefore O 0 0.0012166937813162804
, O 0 0.0003188489063177258
progression O 0 0.0006737983785569668
to O 0 7.408583769574761e-05
S O 0 0.0017947475425899029
phase O 0 0.0004967665881849825
is O 0 4.703470767708495e-05
accompanied O 0 0.00012763826816808432
by O 0 2.2380239897756837e-05
the O 0 6.719776865793392e-05
aggregation O 0 0.0001432160206604749
of O 0 0.00016149079601746053
nuclear O 0 0.0016624919371679425
BARD1 O 1 0.8229629397392273
polypeptides O 0 0.0008860420784913003
into O 0 0.0003810067137237638
BRCA1 O 0 0.03643634915351868
nuclear O 0 0.0018938042921945453
dots O 0 0.002373178256675601
. O 0 0.0006304221460595727

This O 0 0.0009394147200509906
cell O 0 0.0019905329681932926
cycle O 0 0.001221714192070067
- O 0 0.00046179883065633476
dependent O 0 0.00020290511019993573
colocalization O 0 0.0028900864999741316
of O 0 0.00034349446650594473
BARD1 O 1 0.9998403787612915
and O 0 0.00022151076700538397
BRCA1 O 0 0.003521123668178916
indicates O 0 0.00019364195759408176
a O 0 7.930477295303717e-05
role O 0 0.00014789077977184206
for O 0 7.134793850127608e-05
BARD1 O 1 0.9966903924942017
in O 0 0.00048659200547263026
BRCA1 O 1 0.998525083065033
- O 0 0.018188904970884323
mediated O 0 0.4611821472644806
tumor B-Disease 1 0.9999408721923828
suppression O 1 0.9975516200065613
. O 0 0.0016083347145467997

Ethnic O 0 0.0017205479089170694
differences O 0 0.00065149727743119
in O 0 0.00027197200688533485
the O 0 0.00041888930718414485
HFE O 1 0.7983478307723999
codon O 0 0.0020512326154857874
282 O 0 0.002708006650209427
( O 0 0.0006687570712529123
Cys O 0 0.3453882038593292
/ O 0 0.006298398599028587
Tyr O 0 0.4370407462120056
) O 0 0.0006975247524678707
polymorphism O 0 0.001954719889909029
. O 0 0.0009718764922581613

Recent O 0 0.0011013230541720986
studies O 0 0.00016175048949662596
have O 0 5.7477525842841715e-05
shown O 0 0.0001154824421973899
that O 0 0.00014559508417733014
hereditary B-Disease 1 0.9999992847442627
hemochromatosis I-Disease 1 1.0
( O 1 0.9994435906410217
HH B-Disease 1 0.9999984502792358
) O 0 9.316653449786827e-05
is O 0 4.0708742744755e-05
likely O 0 2.6572368369670585e-05
to O 0 8.757805517234374e-06
be O 0 1.5461546354345046e-05
caused O 0 0.00011776817700592801
by O 0 2.8539161576190963e-05
homozygosity O 0 0.0016526057152077556
for O 0 5.204638000577688e-05
a O 0 0.0001433895668014884
Cys282Tyr O 0 0.19298933446407318
mutation O 0 0.00016252472414635122
in O 0 6.930663948878646e-05
the O 0 0.00023186720500234514
HFE O 0 0.4323098063468933
gene O 0 0.00028210238087922335
located O 0 0.0004913133452646434
4 O 0 0.000536822306457907
. O 0 0.0004893862060271204

5 O 0 0.0032533772755414248
Mb O 0 0.011453966610133648
telomeric O 0 0.021727805957198143
to O 0 0.0013716487446799874
HLA O 1 0.9992938041687012
- O 0 0.0024967859499156475
A O 0 0.0022075881715863943
. O 0 0.001174249453470111

Population O 0 0.0002677545417100191
studies O 0 0.00010665175796020776
of O 0 9.037859126692638e-05
this O 0 3.3097017876571044e-05
polymorphism O 0 0.00010832562111318111
are O 0 1.2867231816926505e-05
facilitated O 0 9.125785436481237e-05
by O 0 1.869867446657736e-05
the O 0 4.315135083743371e-05
fact O 0 3.893181201419793e-05
that O 0 2.7012256396119483e-05
the O 0 0.00014622646267525852
Cys282Tyr O 1 0.7937189340591431
mutation O 0 0.00035714011755771935
creates O 0 0.0003461141895968467
a O 0 0.0002849484735634178
Rsal O 0 0.09551607817411423
restriction O 0 0.000829635071568191
site O 0 0.0009273399482481182
. O 0 0.0004087799752596766

We O 0 0.00043822888983413577
have O 0 8.370770228793845e-05
studied O 0 0.00019836115825455636
the O 0 0.0002094037481583655
codon O 0 0.0008807643898762763
282 O 0 0.001798984594643116
( O 0 0.00043141940841451287
Cys O 0 0.26407018303871155
/ O 0 0.0026316239964216948
Tyr O 0 0.014266655780375004
) O 0 0.00012705950939562172
polymorphism O 0 0.000205163742066361
in O 0 5.3232666687108576e-05
different O 0 2.8338738047750667e-05
ethnic O 0 0.00016301019059028476
groups O 0 0.00016503175720572472
. O 0 0.000468602025648579

In O 0 0.0006277331849560142
agreement O 0 0.0002913045173045248
with O 0 6.215354369487613e-05
previous O 0 8.749841072130948e-05
observations O 0 0.00013136582856532186
the O 0 0.00015633182192686945
Tyr O 0 0.13076527416706085
allele O 0 0.0002332953008590266
appeared O 0 9.400845738127828e-05
to O 0 2.0509372916421853e-05
be O 0 2.4649876650073566e-05
rare O 0 7.689652557019144e-05
or O 0 5.050359686720185e-05
absent O 0 0.00017240463057532907
in O 0 6.907663191668689e-05
Asiatic O 0 0.0011437480570748448
( O 0 0.00012620579218491912
Indian O 0 0.00019514872110448778
, O 0 0.00013221811968833208
Chinese O 0 0.0003880541189573705
) O 0 0.00016679282998666167
populations O 0 0.00021550655947066844
. O 0 0.000552957528270781

The O 0 0.0009635592577978969
highest O 0 0.0008117948309518397
allele O 0 0.0003034092951565981
frequency O 0 7.594363705720752e-05
( O 0 3.224585816496983e-05
7 O 0 5.0259237468708307e-05
. O 0 1.5058831195347011e-05
5 O 0 2.886837683035992e-05
% O 0 2.7164025595993735e-05
) O 0 2.514325751690194e-05
was O 0 0.00011191935482202098
found O 0 5.4372838349081576e-05
in O 0 8.04387018433772e-05
Swedes O 0 0.0012962499167770147
. O 0 0.0005497138481587172

Saamis O 0 0.025432247668504715
( O 0 0.0006145641673356295
2 O 0 0.00023220678849611431
% O 0 7.190338510554284e-05
) O 0 3.9373851905111223e-05
and O 0 4.109034489374608e-05
Mordvinians O 0 0.0010584344854578376
( O 0 4.5160293666413054e-05
1 O 0 3.769032264244743e-05
. O 0 1.1108030776085798e-05
8 O 0 3.6173005355522037e-05
% O 0 1.9246466763434e-05
) O 0 1.730802614474669e-05
had O 0 3.680458394228481e-05
significantly O 0 3.941280738217756e-05
lower O 0 5.9963589592371136e-05
frequencies O 0 4.28934145020321e-05
of O 0 7.291243673535064e-05
the O 0 0.0003236949851270765
Tyr O 0 0.27148452401161194
allele O 0 0.0017519070534035563
. O 0 0.0007592711481265724

Comparisons O 0 0.00238051638007164
with O 0 0.0002376354968873784
allele O 0 0.00034850044175982475
frequencies O 0 8.253225678345188e-05
based O 0 4.4852433347841725e-05
on O 0 6.355388177325949e-05
prevalence O 0 0.0003244111139792949
estimates O 0 9.514579869573936e-05
of O 0 0.00019959888595622033
HH B-Disease 1 0.9971515536308289
showed O 0 0.00021643958461936563
some O 0 3.827741238637827e-05
disagreements O 0 0.00018747073772829026
with O 0 3.617776383180171e-05
the O 0 0.0001228954060934484
RFLP O 0 0.001831389032304287
data O 0 5.239827078185044e-05
, O 0 5.061256160843186e-05
particularly O 0 9.159133333014324e-05
in O 0 0.00013311502698343247
Finns O 0 0.001971718156710267
. O 0 0.0006692843744531274

The O 0 0.00193581182975322
newly O 0 0.0041160364635288715
described O 0 0.002322358777746558
HFE O 1 0.989409327507019
marker O 0 0.002086363499984145
provides O 0 0.00011205241753486916
a O 0 6.310246681096032e-05
new O 0 4.288228592486121e-05
approach O 0 4.43242461187765e-05
to O 0 1.9091319700237364e-05
the O 0 3.3135293051600456e-05
screening O 0 7.390492100967094e-05
of O 0 0.00012214045273140073
HH B-Disease 1 0.9980822801589966
as O 0 8.143665763782337e-05
well O 0 2.3795655579306185e-05
as O 0 2.5091185307246633e-05
studies O 0 1.5060568330227397e-05
of O 0 4.351313691586256e-05
the O 0 9.195056190947071e-05
relationship O 0 0.00017452819156460464
between O 0 0.00016021152259781957
the O 0 0.0007291627116501331
HFE O 1 0.9999431371688843
Tyr O 1 0.9982751607894897
allele O 0 0.0009328284068033099
and O 0 0.0002655032731126994
different O 0 0.00029513463960029185
disorders O 1 0.9999779462814331
including O 0 0.1815415918827057
cancer B-Disease 1 0.9999839067459106

Autosomal B-Disease 1 0.9988362193107605
dominant I-Disease 1 0.9998230338096619
neurohypophyseal I-Disease 1 0.9999997615814209
diabetes I-Disease 1 0.9999998807907104
insipidus I-Disease 1 0.999930739402771
associated O 0 0.0004446788807399571
with O 0 9.729615703690797e-05
a O 0 0.00029846455436199903
missense O 0 0.0008766396786086261
mutation O 0 0.00025159475626423955
encoding O 0 0.00022024275676812977
Gly23 O 0 0.27060607075691223
- O 0 0.0012099266750738025
- O 0 0.000749062339309603
> O 0 0.0012461754959076643
Val O 0 0.005523203406482935
in O 0 0.0007023246143944561
neurophysin O 1 0.9896723031997681
II O 1 0.998513400554657
. O 0 0.002605327870696783

Autosomal B-Disease 1 0.9975671768188477
dominant I-Disease 1 0.9997432827949524
neurohypophyseal I-Disease 1 0.9999996423721313
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999985694885254
( O 0 0.4455975294113159
ADNDI B-Disease 1 0.9999754428863525
) O 0 0.0002234244457213208
is O 0 0.00010860229667741805
an O 0 0.0005953054642304778
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999969005584717
by O 0 0.03118715062737465
progressive O 1 0.9999887943267822
degeneration O 1 0.9999998807907104
of O 0 0.2038462907075882
the O 0 0.026581989601254463
magnocellular O 1 0.9987936019897461
neurons O 0 0.0004248750628903508
of O 0 7.176904182415456e-05
the O 0 0.00013209741155151278
hypothalamus O 0 0.010527366772294044
leading O 0 0.00016540606156922877
to O 0 4.5820019295206293e-05
decreased O 0 0.00012171737034805119
ability O 0 2.452146145515144e-05
to O 0 1.820685065467842e-05
produce O 0 6.118323653936386e-05
the O 0 0.00018422951688989997
hormone O 0 0.002365994732826948
arginine O 0 0.0016286681639030576
vasopressin O 0 0.011484377086162567
( O 0 0.00048552750376984477
AVP O 1 0.6580634117126465
) O 0 0.0004311250813771039
. O 0 0.0006419793353416026

Affected O 0 0.0012683552922680974
individuals O 0 0.00010827420192072168
are O 0 2.0215204131091014e-05
not O 0 3.341106275911443e-05
symptomatic O 1 0.7272117137908936
at O 0 0.0007825885550118983
birth O 0 0.0006978967576287687
, O 0 5.125017196405679e-05
but O 0 3.2088613806990907e-05
usually O 0 7.24338460713625e-05
develop O 0 0.00043631502194330096
diabetes B-Disease 1 0.9916700124740601
insipidus I-Disease 1 0.7947176694869995
at O 0 0.0004371293180156499
1 O 0 0.00021340414241421968
- O 0 0.0002671232505235821
6 O 0 0.00031121313804760575
yr O 0 0.003992407117038965
of O 0 0.0002924576692748815
age O 0 0.0007887267856858671
. O 0 0.0007115258486010134

The O 0 0.0011677324073389173
genetic O 0 0.0005790319410152733
locus O 0 0.0006891502998769283
of O 0 0.00019447313388809562
the O 0 0.0007885171216912568
disease O 1 0.9996165037155151
is O 0 8.929831528803334e-05
the O 0 0.0003985858347732574
AVP O 1 0.9997628331184387
- O 0 0.0014256990980356932
neurophysin O 1 0.9485809803009033
II O 1 0.9997231364250183
( O 0 0.0003100380126852542
NPII O 1 0.9941543936729431
) O 0 5.562916703638621e-05
gene O 0 4.406383231980726e-05
, O 0 2.720465272432193e-05
and O 0 2.5423501938348636e-05
mutations O 0 6.718872464261949e-05
that O 0 4.958050340064801e-05
cause O 0 0.2332078218460083
ADNDI B-Disease 1 0.9998332262039185
have O 0 2.0440173102542758e-05
been O 0 1.7534268408780918e-05
found O 0 1.3476674212142825e-05
in O 0 1.5631841961294413e-05
both O 0 1.659006557019893e-05
the O 0 5.02915536344517e-05
signal O 0 0.00017805182142183185
peptide O 0 0.00013450784899760038
of O 0 8.338591578649357e-05
the O 0 0.00018160846957471222
prepro O 1 0.9918036460876465
- O 0 0.005867557600140572
AVP O 1 0.999457061290741
- O 0 0.002391126938164234
NPII O 1 0.9790128469467163
precursor O 0 0.0035311663523316383
and O 0 0.0003799757978413254
within O 0 0.0007015142473392189
NPII O 1 0.9955422282218933
itself O 0 0.001698182080872357
. O 0 0.0009080561576411128

An O 0 0.0011311910348013043
affected O 0 0.0008928473689593375
girl O 0 0.000838393927551806
who O 0 9.29028756218031e-05
presented O 0 0.00011283728235866874
at O 0 0.0001062537485267967
9 O 0 7.928888953756541e-05
months O 0 4.50790612376295e-05
of O 0 3.333913264214061e-05
age O 0 8.384302782360464e-05
and O 0 4.6409604692598805e-05
her O 0 0.00010816626308951527
similarly O 0 0.000165130608365871
affected O 0 0.00016454402066301554
younger O 0 0.00019496624008752406
brother O 0 0.0003791150520555675
and O 0 3.571651905076578e-05
father O 0 8.51570803206414e-05
were O 0 2.5537661713315174e-05
all O 0 1.2436459655873477e-05
found O 0 1.3485262570611667e-05
to O 0 8.343977242475376e-06
have O 0 7.989088771864772e-06
a O 0 4.7746256313985214e-05
novel O 0 0.00012583917123265564
missense O 0 0.00032685117912478745
mutation O 0 0.0001249010965693742
( O 0 8.916352817323059e-05
G1758 O 0 0.1192755326628685
- O 0 0.0006493889377452433
- O 0 0.000439215888036415
> O 0 0.00043903946061618626
T O 0 0.0002892082848120481
) O 0 2.1759811716037802e-05
encoding O 0 2.5994786483352073e-05
the O 0 4.196244844933972e-05
amino O 0 8.290512050734833e-05
acid O 0 0.0002574304526206106
substitution O 0 0.0007874220027588308
Gly23 O 0 0.29220908880233765
- O 0 0.0012406128225848079
- O 0 0.000866470392793417
> O 0 0.0011745956726372242
Val O 0 0.004024224355816841
within O 0 0.0011859614169225097
NPII O 1 0.9738417863845825
. O 0 0.0018022139556705952

The O 0 0.0013402909971773624
mutation O 0 0.0006257884670048952
was O 0 0.0005864162230864167
confirmed O 0 0.0003069168305955827
by O 0 0.00011968664330197498
restriction O 0 0.0006163585348986089
endonuclease O 0 0.0035484633408486843
analysis O 0 0.000779930327553302
. O 0 0.0009029399370774627

A O 0 0.008846421726047993
T1 O 1 0.970955491065979
- O 0 0.0013953692978248
weighted O 0 0.0006367990281432867
magnetic O 0 0.0007520619546994567
resonance O 0 0.0005604749312624335
imaging O 0 0.00043881015153601766
of O 0 0.00022133911261335015
the O 0 0.000646296888589859
fathers O 1 0.7789685130119324
pituitary O 1 0.9999924898147583
gland O 1 0.9997828602790833
demonstrates O 0 0.03644406795501709
an O 0 0.0008902746485546231
attenuated O 1 0.9820725917816162
posterior O 1 0.9992262125015259
pituitary O 1 0.9999611377716064
bright O 1 0.5753774046897888
spot O 0 0.007170472759753466
. O 0 0.0014927518786862493

This O 0 0.0007571359747089446
mutation O 0 0.0007341942400671542
may O 0 0.00016462565690744668
be O 0 3.4538668842287734e-05
valuable O 0 0.0001536948257125914
for O 0 4.766759229823947e-05
developing O 0 9.878720447886735e-05
models O 0 8.903819980332628e-05
of O 0 0.00020394549937918782
dominantly B-Disease 1 0.9994034767150879
inherited I-Disease 1 0.9999939203262329
neurodegeneration I-Disease 1 0.9999995231628418
, O 0 0.00014774783630855381
as O 0 3.292472683824599e-05
the O 0 4.237956090946682e-05
early O 0 5.593797322944738e-05
age O 0 4.264624658389948e-05
of O 0 0.00011484036804176867
onset O 1 0.999864935874939
of O 0 0.2504866123199463
symptoms O 1 0.9999204874038696
suggests O 0 0.00025516937603242695
that O 0 2.794802639982663e-05
this O 0 2.0032579413964413e-05
mutation O 0 4.983671533409506e-05
may O 0 3.0332708774949424e-05
be O 0 1.628617064852733e-05
particularly O 0 4.353164695203304e-05
deleterious O 0 0.0001856477902038023
to O 0 4.3175848986720666e-05
the O 0 0.00027079603751190007
magnocellular O 1 0.9975470900535583
neuron O 1 0.6256847381591797
. O 0 0.0002567630144767463
. O 0 0.0005465769208967686

Frequent O 0 0.0064316606149077415
inactivation O 0 0.042853645980358124
of O 0 0.004545373842120171
PTEN O 1 0.9999638795852661
/ O 1 0.8902091979980469
MMAC1 O 1 0.9998825788497925
in O 0 0.006772232707589865
primary O 1 0.9996248483657837
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
. O 0 0.0031694602221250534

Sporadic B-Disease 1 0.9998651742935181
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.0005322120268829167
the O 0 0.00018117141735274345
most O 0 5.268175664241426e-05
common O 0 8.311180135933682e-05
male B-Disease 0 0.0012836598325520754
cancer I-Disease 0 0.29420220851898193
in O 0 2.644450250954833e-05
the O 0 5.176908234716393e-05
Western O 0 6.020820001140237e-05
world O 0 5.947479803580791e-05
, O 0 1.2045171388308518e-05
yet O 0 1.51024805745692e-05
many O 0 5.354113454814069e-06
of O 0 2.217091059719678e-05
the O 0 4.542718670563772e-05
major O 0 0.00014929019380360842
genetic O 0 6.359862891258672e-05
events O 0 5.640630843117833e-05
involved O 0 3.528329762048088e-05
in O 0 2.8358204872347414e-05
the O 0 5.470366158988327e-05
progression O 0 0.0012032296508550644
of O 0 0.00022233133495319635
this O 0 9.661439253250137e-05
often O 0 0.00022678091772831976
fatal O 1 0.9999923706054688
cancer B-Disease 1 0.9989577531814575
remain O 0 0.00012122543557779863
to O 0 5.64792389923241e-05
be O 0 0.0001112180543714203
elucidated O 0 0.0029085208661854267
. O 0 0.0005653470871038735

Numerous O 0 0.004057529382407665
cytogenetic O 0 0.06403098255395889
and O 0 0.0005935287335887551
allelotype O 0 0.0717451348900795
studies O 0 0.00010195015056524426
have O 0 2.950704401882831e-05
reported O 0 5.609571235254407e-05
frequent O 0 0.00012741281534545124
loss O 0 0.0003191521391272545
of O 0 0.00023641019652131945
heterozygosity O 1 0.9910353422164917
on O 0 0.0005353405140340328
chromosomal O 1 0.7608289122581482
arm O 1 0.9650982618331909
10q O 1 0.9995866417884827
in O 0 0.006051344331353903
sporadic B-Disease 1 0.9999374151229858
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999977350234985
. O 0 0.003119983244687319

Deletion O 0 0.0039596399292349815
mapping O 0 0.0008433515904471278
studies O 0 0.00016915040032472461
have O 0 3.753332930500619e-05
unambiguously O 0 0.00018421879212837666
identified O 0 5.778148624813184e-05
a O 0 5.241711187409237e-05
region O 0 7.693408406339586e-05
of O 0 0.00013311172369867563
chromosome O 0 0.000653509923722595
10q23 O 0 0.030791025608778
to O 0 3.650282815215178e-05
be O 0 1.8235035895486362e-05
the O 0 4.4190244807396084e-05
minimal O 0 0.0001529850997030735
area O 0 0.00018730384181253612
of O 0 0.00038483887328766286
loss O 0 0.016613483428955078
. O 0 0.0005560722202062607

A O 0 0.0033664843067526817
new O 0 0.001813835115171969
tumor B-Disease 1 0.9997809529304504
suppressor O 1 0.9106446504592896
gene O 0 0.0006026429473422468
, O 0 0.00040202465606853366
PTEN O 1 0.999478280544281
/ O 0 0.010440406389534473
MMAC1 O 1 0.9976831674575806
, O 0 0.00010540282528381795
was O 0 0.0001765373017406091
isolated O 0 0.00011198853462701663
recently O 0 6.387693429132923e-05
at O 0 3.272775575169362e-05
this O 0 1.1203460417164024e-05
region O 0 2.9889779398217797e-05
of O 0 6.711732567055151e-05
chromosome O 0 0.00040649075526744127
10q23 O 0 0.06979888677597046
and O 0 2.925152875832282e-05
found O 0 1.938472814799752e-05
to O 0 1.3776315427094232e-05
be O 0 2.0328761820564978e-05
inactivated O 0 0.00018095372070092708
by O 0 2.5784087483771145e-05
mutation O 0 7.47770318412222e-05
in O 0 9.073194087250158e-05
three O 0 0.0016727723414078355
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
cell O 1 0.7435505390167236
lines O 0 0.0011140672722831368
. O 0 0.0007116955239325762

We O 0 0.0011513775680214167
screened O 0 0.0027653805445879698
80 O 0 0.021089717745780945
prostate B-Disease 1 0.9999933242797852
tumors I-Disease 1 0.9995408058166504
by O 0 0.00012925424380227923
microsatellite O 0 0.001597880618646741
analysis O 0 6.221758667379618e-05
and O 0 4.058827107655816e-05
found O 0 8.576436812290922e-05
chromosome O 0 0.00021049071801826358
10q23 O 0 0.0010362950852140784
to O 0 2.2349955543177202e-05
be O 0 2.158265488105826e-05
deleted O 0 0.00010339255823055282
in O 0 5.351102299755439e-05
23 O 0 0.0002673510171007365
cases O 0 0.0003701054083649069
. O 0 0.0005795006873086095

We O 0 0.0004938534693792462
then O 0 0.00033417087979614735
proceeded O 0 0.00037392054218798876
with O 0 2.9366827220655978e-05
sequence O 0 3.489144000923261e-05
analysis O 0 2.4587097868788987e-05
of O 0 4.81748538732063e-05
the O 0 9.178577602142468e-05
entire O 0 0.0016811442328616977
PTEN O 1 0.9996500015258789
/ O 0 0.004254271741956472
MMAC1 O 1 0.9839134812355042
coding O 0 0.0003910080995410681
region O 0 0.0001592284388607368
and O 0 4.3105988879688084e-05
tested O 0 0.00010812314576469362
for O 0 2.0397779735503718e-05
homozygous O 0 0.00011617672862485051
deletion O 0 0.0001057069021044299
with O 0 2.713580397539772e-05
new O 0 8.933349454309791e-05
intragenic O 0 0.02296162210404873
markers O 0 0.00022118468768894672
in O 0 2.2332611479214393e-05
these O 0 1.1383316632418428e-05
23 O 0 5.609523577732034e-05
cases O 0 3.1532326829619706e-05
with O 0 5.3383089834824204e-05
10q23 O 1 0.8337454199790955
loss O 0 0.02958841435611248
of O 0 0.0010190469911321998
heterozygosity O 1 0.9975365400314331
. O 0 0.0015371112385764718

The O 0 0.000784198404289782
identification O 0 0.0002551277866587043
of O 0 0.00014297667075879872
the O 0 0.00015371182234957814
second O 0 0.00027620370383374393
mutational O 0 0.0012964081251993775
event O 0 0.00018429064948577434
in O 0 2.995138493133709e-05
10 O 0 3.094617204624228e-05
( O 0 2.6988263925886713e-05
43 O 0 9.493581455899402e-05
% O 0 7.264753367053345e-05
) O 0 0.00018901089788414538
tumors B-Disease 1 0.9865779876708984
establishes O 0 0.012152434326708317
PTEN O 1 0.9998623132705688
/ O 0 0.0038451547734439373
MMAC1 O 0 0.37770211696624756
as O 0 0.00013951363507658243
a O 0 0.00010727035987656564
main O 0 0.0001700381690170616
inactivation O 0 0.0008322801440954208
target O 0 0.0001046950274030678
of O 0 0.00016210885951295495
10q O 1 0.9157921075820923
loss O 0 0.146962508559227
in O 0 0.0007517152116633952
sporadic B-Disease 1 0.9998975992202759
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.0009242359083145857
. O 0 0.0009675969486124814

Risk O 0 0.005764691159129143
reversals O 0 0.007383411284536123
in O 0 0.0008096756064333022
predictive O 0 0.002341655781492591
testing O 0 0.002395044080913067
for O 0 0.001996679464355111
Huntington B-Disease 1 0.9999994039535522
disease I-Disease 1 0.9999991655349731
. O 0 0.003690600860863924

The O 0 0.0007098171045072377
first O 0 0.0003694161132443696
predictive O 0 0.0005625646444968879
testing O 0 0.0003900511364918202
for O 0 0.0002616394485812634
Huntington B-Disease 1 0.9999995231628418
disease I-Disease 1 0.9999990463256836
( O 0 0.0006787924794480205
HD B-Disease 0 0.0015620533376932144
) O 0 3.745531284948811e-05
was O 0 8.64069806993939e-05
based O 0 1.1957386050198693e-05
on O 0 1.478054855397204e-05
analysis O 0 1.9083583538304083e-05
of O 0 4.89733720314689e-05
linked O 0 0.00019732363580260426
polymorphic O 0 0.0003641634830273688
DNA O 0 0.00015667223487980664
markers O 0 0.0001392433186993003
to O 0 1.855960363172926e-05
estimate O 0 2.2154170437715948e-05
the O 0 2.4340157324331813e-05
likelihood O 0 4.744474426843226e-05
of O 0 5.9864683862542734e-05
inheriting O 0 0.0010199501411989331
the O 0 0.0001991259487112984
mutation O 0 0.00031082204077392817
for O 0 0.00018998731684405357
HD B-Disease 0 0.0034215818159282207
. O 0 0.0004842835187446326

Limits O 0 0.0009296740754507482
to O 0 0.0002207749057561159
accuracy O 0 0.00022846920182928443
included O 0 0.00012976587458979338
recombination O 0 0.00018792063929140568
between O 0 4.867724419455044e-05
the O 0 7.126077252905816e-05
DNA O 0 0.00011724780779331923
markers O 0 0.0002313217701157555
and O 0 4.7339624870801345e-05
the O 0 7.126676064217463e-05
mutation O 0 0.00010633949568727985
, O 0 3.8498343201354146e-05
pedigree O 0 0.00018571471446193755
structure O 0 7.011098932707682e-05
, O 0 1.8412998542771675e-05
and O 0 1.3520391803467646e-05
whether O 0 1.2803447134501766e-05
DNA O 0 3.2981195545289665e-05
samples O 0 2.5448827727814205e-05
were O 0 1.6819461961858906e-05
available O 0 1.3257800674182363e-05
from O 0 2.937074714282062e-05
family O 0 0.00011903719860129058
members O 0 0.00012615913874469697
. O 0 0.0004426775558385998

With O 0 0.0002809583966154605
direct O 0 0.00016584795957896858
tests O 0 0.00010025254596257582
for O 0 4.366157008917071e-05
the O 0 0.00015473150415346026
HD B-Disease 0 0.003075150540098548
mutation O 0 9.931331442203373e-05
, O 0 1.8564136553322896e-05
we O 0 1.2077112842234783e-05
have O 0 6.519785983982729e-06
assessed O 0 2.0750489056808874e-05
the O 0 2.176468842662871e-05
accuracy O 0 3.555635339580476e-05
of O 0 2.9116436053300276e-05
results O 0 1.9221630282117985e-05
obtained O 0 2.5585730327293277e-05
by O 0 2.3927979782456532e-05
linkage O 0 0.00018725528207141906
approaches O 0 7.483773515559733e-05
when O 0 2.9107302907505073e-05
requested O 0 3.7728226743638515e-05
to O 0 1.2235027497808915e-05
do O 0 1.1935308066313155e-05
so O 0 1.2181809324829374e-05
by O 0 1.3045590094407089e-05
the O 0 7.502036896767095e-05
test O 0 0.00019847658404614776
individuals O 0 0.00013652481720782816
. O 0 0.00033807801082730293

For O 0 0.00045345252146944404
six O 0 0.00024083085008896887
such O 0 5.3092091548023745e-05
individuals O 0 4.272057776688598e-05
, O 0 3.2711563108023256e-05
there O 0 6.443237361963838e-05
was O 0 0.00029775709845125675
significant O 0 0.00021714196191169322
disparity O 0 0.0007652353961020708
between O 0 0.0001184934881166555
the O 0 0.00027505954494699836
tests O 0 0.0004426501109264791
. O 0 0.00044898808118887246

Three O 0 0.0003663722600322217
went O 0 0.0003676513733807951
from O 0 0.00010646713053574786
a O 0 0.00017029192531481385
decreased O 0 0.000543737318366766
risk O 0 5.033704292145558e-05
to O 0 1.3367337487579789e-05
an O 0 1.6770305592217483e-05
increased O 0 3.4371521905995905e-05
risk O 0 1.8176700905314647e-05
, O 0 8.330906894116197e-06
while O 0 6.68742131892941e-06
in O 0 7.1099666456575505e-06
another O 0 1.9738379705813713e-05
three O 0 1.7017702703014947e-05
the O 0 7.865307270549238e-05
risk O 0 0.00030739736394025385
was O 0 0.0016707382164895535
decreased O 0 0.005814137868583202
. O 0 0.0006431385409086943

Knowledge O 0 0.0011877284850925207
of O 0 0.0002876252692658454
the O 0 0.00013217967352829874
potential O 0 0.00012468095519579947
reasons O 0 4.450022242963314e-05
for O 0 1.2456223885237705e-05
these O 0 7.148387339839246e-06
changes O 0 1.3077301446173806e-05
in O 0 1.1284545507805888e-05
results O 0 1.915505708893761e-05
and O 0 1.2365183465590235e-05
impact O 0 3.3759657526388764e-05
of O 0 2.722663339227438e-05
these O 0 1.5810353943379596e-05
risk O 0 5.509237598744221e-05
reversals O 0 0.00048286010860465467
on O 0 6.689132715109736e-05
both O 0 4.2040875996463e-05
patients O 0 7.789443043293431e-05
and O 0 2.7636606318992563e-05
the O 0 6.970632239244878e-05
counseling O 0 0.00019643682753667235
team O 0 4.437973984749988e-05
can O 0 8.797290320217144e-06
assist O 0 3.118483436992392e-05
in O 0 1.3275981473270804e-05
the O 0 2.5733384973136708e-05
development O 0 4.108337452635169e-05
of O 0 3.382381328265183e-05
strategies O 0 4.385703141451813e-05
for O 0 1.7799826309783384e-05
the O 0 5.140484790899791e-05
prevention O 0 0.0010460788616910577
and O 0 2.5979792553698644e-05
, O 0 1.9529459677869454e-05
where O 0 2.4465660317218862e-05
necessary O 0 2.914115975727327e-05
, O 0 1.739585968607571e-05
management O 0 3.6578825529431924e-05
of O 0 4.615969737642445e-05
a O 0 0.00011789818381657824
risk O 0 0.00010860343900276348
reversal O 0 0.00034988977131433785
in O 0 4.0218383219325915e-05
any O 0 6.104534259065986e-05
predictive O 0 0.0002605391782708466
testing O 0 0.00023916842474136502
program O 0 0.00019095640163868666
. O 0 0.00012317311484366655
. O 0 0.0003372688661329448

A O 0 0.0031726646702736616
novel O 0 0.0013034751173108816
common O 0 0.0003724894195329398
missense O 0 0.0016594475600868464
mutation O 0 0.00031424136250279844
G301C O 0 0.0017418192001059651
in O 0 7.515519973821938e-05
the O 0 0.00013358995784074068
N O 0 0.0005093009094707668
- O 0 0.00023477335344068706
acetylgalactosamine O 0 0.0031055237632244825
- O 0 0.0002672388800419867
6 O 0 0.00040385444299317896
- O 0 0.0006765672005712986
sulfate O 0 0.015631457790732384
sulfatase O 1 0.5510687232017517
gene O 0 0.0006641176878474653
in O 0 0.0005445292918011546
mucopolysaccharidosis B-Disease 1 0.9939040541648865
IVA I-Disease 1 0.9993653893470764
. O 0 0.002222977578639984

Mucopolysaccharidosis B-Disease 1 0.999670147895813
IVA I-Disease 1 0.9999641180038452
( O 0 0.010782563127577305
MPS B-Disease 1 0.9966104626655579
IVA I-Disease 1 0.9999911785125732
) O 0 0.0003217741032131016
is O 0 0.00020148120529484004
an O 0 0.000287987437332049
autosomal B-Disease 1 0.8531322479248047
recessive I-Disease 1 0.9999417066574097
lysosomal I-Disease 1 0.9999996423721313
storage I-Disease 1 0.9999990463256836
disorder I-Disease 1 0.9999998807907104
caused O 1 0.9974762797355652
by O 0 9.613494330551475e-05
a O 0 0.0002761668583843857
genetic B-Disease 0 0.007254602387547493
defect I-Disease 1 0.9929291605949402
in O 0 0.00012663085362873971
N O 0 0.000912194256670773
- O 0 0.00030305140535347164
acetylgalactosamine O 0 0.008199155330657959
- O 0 0.00047822430497035384
6 O 0 0.0006648612907156348
- O 0 0.0014047861332073808
sulfate O 0 0.3662368059158325
sulfatase O 1 0.9931604862213135
( O 0 0.0014486483996734023
GALNS O 1 0.9951117634773254
) O 0 0.0008713005227036774
. O 0 0.0008474086062051356

In O 0 0.0007211097981780767
previous O 0 0.00038120613317005336
studies O 0 9.573726856615394e-05
, O 0 5.389737634686753e-05
we O 0 1.6699574189260602e-05
have O 0 7.605475730088074e-06
found O 0 1.1164560419274494e-05
two O 0 1.3733841115026735e-05
common O 0 2.9007131161051802e-05
mutations O 0 6.243595271371305e-05
in O 0 5.7046137953875586e-05
Caucasians O 0 0.0006880045984871686
and O 0 8.626479393569753e-05
Japanese O 0 0.0007236861856654286
, O 0 0.0001811553374864161
respectively O 0 0.0004722431767731905
. O 0 0.00038962613325566053

To O 0 0.0007849778048694134
characterize O 0 0.001387183670885861
the O 0 0.00039557216223329306
mutational O 0 0.0024608755484223366
spectrum O 0 0.00022219867969397455
in O 0 3.846171603072435e-05
various O 0 1.7655635019764304e-05
ethnic O 0 2.163405042665545e-05
groups O 0 1.2052398233208805e-05
, O 0 1.5709072613390163e-05
mutations O 0 2.8009448215016164e-05
in O 0 3.680068766698241e-05
the O 0 0.00010206668957835063
GALNS O 1 0.9871783256530762
gene O 0 0.00018504884792491794
in O 0 8.760719356359914e-05
Colombian O 0 0.000981986871920526
MPS B-Disease 1 0.5453776717185974
IVA I-Disease 1 0.999991774559021
patients O 0 0.0015339894453063607
were O 0 0.00013620559184346348
investigated O 0 0.0004279655695427209
, O 0 0.00011398197966627777
and O 0 5.689478348358534e-05
genetic O 0 7.870973786339164e-05
backgrounds O 0 7.828485104255378e-05
were O 0 3.211096191080287e-05
extensively O 0 6.520390161313117e-05
analyzed O 0 3.598877810873091e-05
to O 0 1.1387984159227926e-05
identify O 0 1.9744347810046747e-05
racial O 0 6.112409755587578e-05
origin O 0 2.175659392378293e-05
, O 0 1.470849929319229e-05
based O 0 1.1654337868094444e-05
on O 0 3.201903746230528e-05
mitochondrial O 0 0.00019605847774073482
DNA O 0 0.0001909187121782452
( O 0 0.00013467558892443776
mtDNA O 0 0.0002907052403315902
) O 0 9.505357593297958e-05
lineages O 0 0.0005448911688290536
. O 0 0.0003910027153324336

Three O 0 0.001269763452000916
novel O 0 0.0015194171573966742
missense O 0 0.003461153246462345
mutations O 0 0.00034653692273423076
never O 0 0.0002119318232871592
identified O 0 6.453113746829331e-05
previously O 0 5.0215643568662927e-05
in O 0 2.6403153242426924e-05
other O 0 9.692657840787433e-06
populations O 0 1.075472027878277e-05
and O 0 1.0294264939147979e-05
found O 0 9.294958545069676e-06
in O 0 1.5456917026313022e-05
16 O 0 3.236600969103165e-05
out O 0 1.9569806681829505e-05
of O 0 6.671156006632373e-05
19 O 0 0.0001475770550314337
Colombian O 0 0.0005677719600498676
MPS B-Disease 0 0.003637684741988778
IVA I-Disease 1 0.9968735575675964
unrelated O 0 0.0006347237504087389
alleles O 0 0.00020474649500101805
account O 0 9.166157542495057e-05
for O 0 7.666282181162387e-05
84 O 0 0.0012627652613446116
. O 0 0.000570043979678303

2 O 0 0.0008087892783805728
% O 0 0.0001770791132003069
of O 0 0.00014698063023388386
the O 0 0.00014362794172484428
alleles O 0 0.00017329180263914168
in O 0 9.454535029362887e-05
this O 0 9.139562462223694e-05
study O 0 0.00028029782697558403
. O 0 0.000313284108415246

The O 0 0.0030491782817989588
G301C O 1 0.7075870037078857
and O 0 0.0008277181768789887
S162F O 0 0.22085607051849365
mutations O 0 0.0003306516446173191
account O 0 0.00017257714353036135
for O 0 0.00013735097309108824
68 O 0 0.001285305479541421
. O 0 0.0009351558983325958

4 O 0 0.0012634245213121176
% O 0 0.00036500461283139884
and O 0 0.0004323288449086249
10 O 0 0.0006084715714678168
. O 0 0.0007966901175677776

5 O 0 0.00046122982166707516
% O 0 0.00011333289148751646
of O 0 0.0001067474004230462
mutations O 0 0.00011234021076234058
, O 0 4.352674659457989e-05
respectively O 0 5.734754813602194e-05
, O 0 3.353936335770413e-05
whereas O 0 4.078782512806356e-05
the O 0 3.840963472612202e-05
remaining O 0 0.0001507718552602455
F69V O 1 0.709519624710083
is O 0 5.630886880680919e-05
limited O 0 3.5067936551058665e-05
to O 0 2.9108970920788124e-05
a O 0 0.0001236739772139117
single O 0 0.0003231960581615567
allele O 0 0.0006866044132038951
. O 0 0.00042299870983697474

The O 0 0.002013862831518054
skewed O 0 0.0019915825687348843
prevalence O 0 0.0015925249317660928
of O 0 0.00046572418068535626
G301C O 0 0.27859190106391907
in O 0 0.00013533768651541322
only O 0 8.038188389036804e-05
Colombian O 0 0.0004548636497929692
patients O 0 0.0001023882650770247
and O 0 5.2067327487748116e-05
haplotype O 0 0.00020624639000743628
analysis O 0 3.717964864335954e-05
by O 0 2.301757012901362e-05
restriction O 0 6.003974340273999e-05
fragment O 0 0.00010086143447551876
length O 0 4.694522067438811e-05
polymorphisms O 0 9.131052502198145e-05
in O 0 3.0123253964120522e-05
the O 0 0.0001175541037810035
GALNS O 1 0.9610916972160339
gene O 0 0.00019424127822276205
suggest O 0 0.00010335362458135933
that O 0 3.669724173960276e-05
G301C O 0 0.0011667684884741902
originated O 0 0.00022555844043381512
from O 0 7.580869714729488e-05
a O 0 0.00022551223810296506
common O 0 0.00031094648875296116
ancestor O 0 0.0024341410025954247
. O 0 0.000987592269666493

Investigation O 0 0.0020553842186927795
of O 0 0.00039105245377868414
the O 0 0.0002167915372410789
genetic O 0 0.00015712762251496315
background O 0 0.0001082841117749922
by O 0 3.344635115354322e-05
means O 0 4.241558781359345e-05
of O 0 3.74121154891327e-05
mtDNA O 0 7.022808131296188e-05
lineages O 0 6.821738497819752e-05
indicate O 0 4.115286355954595e-05
that O 0 1.278815670957556e-05
all O 0 1.877919930848293e-05
our O 0 5.7833145547192544e-05
patients O 0 5.5410826462320983e-05
are O 0 9.116057299252134e-06
probably O 0 8.654667908558622e-05
of O 0 0.0001249425404239446
native O 0 0.00046307058073580265
American O 0 0.001208085916005075
descent O 0 0.005488001275807619

Low O 0 0.0022910325787961483
frequency O 0 0.0006270072772167623
of O 0 0.0006452850066125393
BRCA1 O 0 0.16151651740074158
germline O 0 0.003374932799488306
mutations O 0 0.00014057070075068623
in O 0 6.554627907462418e-05
45 O 0 0.00033008441096171737
German O 1 0.9798509478569031
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999986886978149
families O 0 0.0015316854696720839
. O 0 0.0009452393278479576

In O 0 0.00036854358040727675
this O 0 8.703115599928424e-05
study O 0 5.983889059280045e-05
we O 0 5.4814157920191064e-05
investigated O 0 0.0003060539602302015
45 O 0 0.0004237237444613129
German O 0 0.45831334590911865
breast B-Disease 1 0.999998927116394
/ I-Disease 1 0.9999953508377075
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999809265136719
families O 0 0.0002449573948979378
for O 0 0.00012930898810736835
germline O 0 0.17532919347286224
mutations O 0 0.0001613958302186802
in O 0 0.00011797858314821497
the O 0 0.0004361960745882243
BRCA1 O 1 0.6968756318092346
gene O 0 0.0013305003521963954
. O 0 0.000897269113920629

We O 0 0.0005920397816225886
identified O 0 0.00031858886359259486
four O 0 0.00026158630498684943
germline O 0 0.0029454005416482687
mutations O 0 0.0001378658489556983
in O 0 7.644003198947757e-05
three O 0 0.0002512555511202663
breast B-Disease 1 0.9997357726097107
cancer I-Disease 1 0.925544023513794
families O 0 5.389475336414762e-05
and O 0 3.091691542067565e-05
in O 0 7.6671814895235e-05
one O 0 0.0007391201797872782
breast B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999980926513672
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
family O 0 0.00043542380444705486
. O 0 2.475754081388004e-05
among O 0 1.804584826459177e-05
these O 0 8.603769856563304e-06
were O 0 1.8132930563297123e-05
one O 0 4.45540645159781e-05
frameshift O 0 0.0007778998697176576
mutation O 0 8.569129568058997e-05
, O 0 3.3626696676947176e-05
one O 0 5.2190167480148375e-05
nonsense O 0 0.0005318889743648469
mutation O 0 0.00010890333942370489
, O 0 3.8144513382576406e-05
one O 0 5.666261131409556e-05
novel O 0 0.00015591633564326912
splice O 0 0.0006168807158246636
site O 0 0.00026612114743329585
mutation O 0 0.00015434424858540297
, O 0 5.7322289649164304e-05
and O 0 6.149676482891664e-05
one O 0 0.00019119544595014304
missense O 0 0.0028165034018456936
mutation O 0 0.001081929076462984
. O 0 0.0006942703621461987

The O 0 0.0021612709388136864
missense O 0 0.003951745573431253
mutation O 0 0.0006088417139835656
was O 0 0.00030369378509931266
also O 0 3.970744728576392e-05
found O 0 4.058203921886161e-05
in O 0 7.401523180305958e-05
2 O 0 0.0003950397076550871
. O 0 0.00035171263152733445

8 O 0 0.0006227698177099228
% O 0 7.700439891777933e-05
of O 0 7.008465036051348e-05
the O 0 5.884519487153739e-05
general O 0 6.246305565582588e-05
population O 0 2.5938075850717723e-05
, O 0 2.102880898746662e-05
suggesting O 0 5.310014239512384e-05
that O 0 1.241655172634637e-05
it O 0 1.5242164408846293e-05
is O 0 5.827814675285481e-05
not O 0 7.755947444820777e-05
disease O 1 0.9718170166015625
associated O 0 0.0009192042052745819
. O 0 0.0008532826905138791

The O 0 0.0008156069670803845
average O 0 0.00044345128117129207
age O 0 0.00040584278758615255
of O 0 0.0070013185031712055
disease O 1 0.9999964237213135
onset O 1 0.9999797344207764
in O 0 0.00011380689829820767
those O 0 4.883202200289816e-05
families O 0 9.861225407803431e-05
harbouring O 1 0.9719650149345398
causative O 0 0.490043580532074
mutations O 0 0.00027749763103201985
was O 0 0.0003375014348421246
between O 0 0.0003088011289946735
32 O 0 0.0006937287980690598
. O 0 0.0006359402323141694

3 O 0 0.0030407162848860025
and O 0 0.0011129433987662196
37 O 0 0.0031559995841234922
. O 0 0.0017642604652792215

4 O 0 0.0011577068362385035
years O 0 0.00042416242649778724
, O 0 0.000148831371916458
whereas O 0 0.00017311179544776678
the O 0 8.975214586826041e-05
family O 0 0.0002164773759432137
harbouring O 0 0.033977895975112915
the O 0 0.00017539819236844778
missense O 0 0.000678357551805675
mutation O 0 8.190643711714074e-05
had O 0 3.834211020148359e-05
an O 0 1.9474040527711622e-05
average O 0 4.16957882407587e-05
age O 0 6.601543282158673e-05
of O 0 0.00012443045852705836
onset O 1 0.8571163415908813
of O 0 0.0007408055826090276
51 O 0 0.0012951608514413238
. O 0 0.0008629641379229724

2 O 0 0.005312839988619089
years O 0 0.003632728010416031
. O 0 0.0018277228809893131

These O 0 0.00032863501110114157
findings O 0 0.0003447195631451905
show O 0 0.00026675191475078464
that O 0 6.95470444043167e-05
BRCA1 O 0 0.002374479314312339
is O 0 5.12760816491209e-05
implicated O 0 0.0003380209964234382
in O 0 3.493089388939552e-05
a O 0 6.296474748523906e-05
small O 0 4.789391459780745e-05
fraction O 0 0.00019345134205650538
of O 0 0.001103706075809896
breast B-Disease 1 0.9999995231628418
/ I-Disease 1 0.9999961853027344
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999514818191528
families O 0 0.0001010427949950099
suggesting O 0 0.00012388893810566515
the O 0 4.689743582275696e-05
involvement O 0 0.00016916330787353218
of O 0 0.00012783630518242717
another O 0 0.0003875389520544559
susceptibility O 0 0.05364174395799637
gene O 0 0.0004738204297609627
( O 0 0.00032820511842146516
s O 0 0.0019071109127253294
) O 0 0.0007327350904233754

Paternal O 1 0.9901622533798218
transmission O 1 0.9998401403427124
of O 1 0.9999778270721436
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9941038489341736

We O 0 0.0007517188205383718
report O 0 0.0003760250983759761
a O 0 0.00025380431907251477
rare O 0 0.00038372009294107556
case O 0 0.00042580420267768204
of O 0 0.00458148680627346
paternally O 1 0.9999911785125732
transmitted O 1 0.9999990463256836
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999936819076538
DM B-Disease 1 1.0
) O 0 0.0014369621640071273
. O 0 0.0011894612107425928

The O 0 0.0015329067828133702
proband O 0 0.008385091088712215
is O 0 0.00014494846982415766
a O 0 0.00014203853788785636
23 O 0 0.0002629917289596051
year O 0 0.00015413554501719773
old O 0 0.0007804757333360612
, O 0 0.0005190970259718597
mentally B-Disease 1 0.999976396560669
retarded I-Disease 1 0.9999781847000122
male O 1 0.8914880156517029
who O 1 0.992287278175354
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.6264879107475281

He O 0 0.0033833489287644625
presented O 0 0.0020675971172749996
with O 0 0.0016721569700166583
respiratory O 1 0.9999990463256836
and O 0 0.0075700730085372925
feeding O 0 0.3346867859363556
difficulties O 1 0.9769260287284851
at O 0 0.13534797728061676
birth O 0 0.01117501687258482
. O 0 0.0008512799977324903

His O 0 0.005649979691952467
two O 0 0.0020248680375516415
sibs O 1 0.9991815686225891
suffer O 1 0.9808485507965088
from O 0 0.008636800572276115
childhood O 1 0.9999799728393555
onset O 1 0.9999998807907104
DM B-Disease 1 0.9999998807907104
. O 0 0.005960424430668354

Their O 0 0.0004491552826948464
late O 0 0.0007284779567271471
father O 0 0.0006210603169165552
had O 0 0.0001508440327597782
the O 0 9.447153570363298e-05
adult O 0 7.050373824313283e-05
type O 0 0.00012286470155231655
of O 0 0.0004222678835503757
DM B-Disease 1 0.9999946355819702
, O 0 8.128838089760393e-05
with O 0 4.736423579743132e-05
onset O 0 0.147023543715477
around O 0 0.0002588382048998028
30 O 0 0.00025507964892312884
years O 0 0.0003318947274237871
. O 0 0.0004998844233341515

Only O 0 0.0002847114228643477
six O 0 0.00016676246013958007
other O 0 3.983735223300755e-05
cases O 0 7.337935676332563e-05
of O 0 0.00019504806550685316
paternal O 1 0.941648006439209
transmission O 1 0.9998669624328613
of O 1 0.9999504089355469
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.0003882728051394224
been O 0 0.00025650241877883673
reported O 0 0.0002831527090165764
recently O 0 0.0006237291963770986
. O 0 0.0004408471577335149

We O 0 0.0004842100606765598
review O 0 0.00024261881480924785
the O 0 0.00014446911518462002
sex O 0 0.00022615407942794263
related O 0 0.0001868951367214322
effects O 0 0.0006570369005203247
on O 0 0.0004421116318553686
transmission O 1 0.9084620475769043
of O 1 0.9952214360237122
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.010831269435584545

Decreased O 0 0.024104434996843338
fertility O 0 0.003242192091420293
of O 0 0.0004474760207813233
males O 0 0.00011446352436905727
with O 0 0.00011916064977413043
adult O 0 0.0005455065984278917
onset O 1 0.9999531507492065
DM B-Disease 1 0.9999978542327881
and O 0 0.00022181255917530507
contraction O 0 0.0009750804747454822
of O 0 0.00010165415733354166
the O 0 0.00010723088053055108
repeat O 0 0.0002748922270257026
upon O 0 0.00011434742918936536
male O 0 0.0001801880425773561
transmission O 0 0.00013174655032344162
contribute O 0 3.633220330812037e-05
to O 0 1.3821926586388145e-05
the O 0 3.943013507523574e-05
almost O 0 3.707597716129385e-05
absent O 0 0.0001069300778908655
occurrence O 0 0.00016428004892077297
of O 0 0.00021588971139863133
paternal O 0 0.04348916560411453
transmission O 1 0.9730010628700256
of O 1 0.9987723231315613
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.014174538664519787

Also O 0 0.0006353743956424296
the O 0 0.0003123188216704875
fathers O 0 0.0003335263463668525
of O 0 0.00017038742953445762
the O 0 0.00020676500571426004
reported O 0 0.0007024290389381349
congenitally O 0 0.40895935893058777
affected O 0 0.000298101658700034
children O 0 0.00011853090109070763
showed O 0 0.0001306044141529128
, O 0 2.971587127831299e-05
on O 0 4.0246653952635825e-05
average O 0 6.562646012753248e-05
, O 0 5.1414946938166395e-05
shorter O 0 0.00021308758005034178
CTG O 0 0.00990485679358244
repeat O 0 0.0004022786451969296
lengths O 0 0.00022995969629846513
and O 0 7.356390415225178e-05
hence O 0 0.0001587913284311071
less O 0 0.00010567656136117876
severe O 1 0.9979817867279053
clinical O 1 0.5805277228355408
symptoms O 1 0.9929887652397156
than O 0 8.10209967312403e-05
the O 0 0.00014387138071469963
mothers O 0 0.00019773648818954825
of O 0 0.0002264620125060901
children O 0 0.0008114857482723892
with O 0 0.40175724029541016
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.011454733088612556

We O 0 0.0010854355059564114
conclude O 0 0.0012672165175899863
that O 0 0.00023203525051940233
paternal O 0 0.002920194761827588
transmission O 1 0.6930468082427979
of O 1 0.9993472695350647
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 0.0230617243796587
rare O 0 0.0006505749188363552
and O 0 5.353163942345418e-05
preferentially O 0 0.0001283924066228792
occurs O 0 5.4642194299958646e-05
with O 0 2.8271364499232732e-05
onset O 0 0.033573877066373825
of O 0 0.00044178214739076793
DM B-Disease 1 0.9999585151672363
past O 0 0.00013165611017029732
30 O 0 6.983367347856984e-05
years O 0 4.866202289122157e-05
in O 0 4.275651735952124e-05
the O 0 0.00015011355571914464
father O 0 0.0009089109371416271
. O 0 0.00019012614211533219
. O 0 0.0004689796478487551

The O 0 0.006667396053671837
RB1 O 1 0.9979162812232971
gene O 0 0.0009387123864144087
mutation O 0 0.00033399026142433286
in O 0 0.0001146903305198066
a O 0 0.00028259799000807106
child O 0 0.0016112055163830519
with O 0 0.0012174154398962855
ectopic B-Disease 1 0.9999853372573853
intracranial I-Disease 1 0.9999974966049194
retinoblastoma I-Disease 1 0.9999576807022095
. O 0 0.004968554712831974

The O 0 0.004916282836347818
RB1 O 1 0.9986880421638489
gene O 0 0.0011684162309393287
mutation O 0 0.0004779461305588484
was O 0 0.0002511230995878577
investigated O 0 0.00022881342738401145
in O 0 5.0395010475767776e-05
a O 0 0.00011968036415055394
child O 0 0.0005983111332170665
with O 0 0.00017884864064399153
ectopic B-Disease 1 0.9995101690292358
intracranial I-Disease 1 0.9999141693115234
retinoblastoma I-Disease 1 0.5960153341293335
using O 0 4.460431227926165e-05
DNA O 0 6.361347914207727e-05
obtained O 0 2.3791048079147004e-05
from O 0 1.9534414605004713e-05
both O 0 3.218214260414243e-05
the O 0 0.00018889053899329156
pineal B-Disease 1 0.998829185962677
and I-Disease 0 0.0016491430578753352
retinal I-Disease 1 0.9999856948852539
tumours I-Disease 1 0.9999896287918091
of O 0 0.008430148474872112
the O 0 0.12602193653583527
patient O 1 0.665291428565979
. O 0 0.0008565593743696809

A O 0 0.002090851543471217
nonsense O 0 0.0029224157333374023
mutation O 0 0.00032605102751404047
in O 0 0.00010745914187282324
exon O 0 0.0007171133765950799
17 O 0 0.00021104900224599987
( O 0 7.887773244874552e-05
codon O 0 0.00027181205223314464
556 O 0 0.0003145483206026256
) O 0 3.145988375763409e-05
of O 0 5.432913894765079e-05
the O 0 0.00011308331158943474
RB1 O 1 0.9948639273643494
gene O 0 0.00013684087025467306
was O 0 0.00013122397649567574
found O 0 2.600529660412576e-05
to O 0 1.40430020110216e-05
be O 0 1.6899273759918287e-05
present O 0 5.500754195963964e-05
homozygously O 0 0.0008735607261769474
in O 0 4.9531066906638443e-05
both O 0 3.960269532399252e-05
the O 0 0.0001990919845411554
retinal B-Disease 1 0.9981266856193542
and I-Disease 0 0.0003762605774682015
the I-Disease 0 0.028030429035425186
pineal I-Disease 1 0.9999845027923584
tumours I-Disease 1 0.9999850988388062
. O 0 0.0021561267785727978

The O 0 0.0007433687569573522
same O 0 0.0002264177455799654
mutation O 0 0.00021908016060478985
was O 0 0.00022316514514386654
present O 0 9.845374006545171e-05
heterozygously O 0 0.00070046610198915
in O 0 2.4756998755037785e-05
the O 0 2.6140960471821018e-05
DNA O 0 3.02270200336352e-05
from O 0 1.3786684576189145e-05
the O 0 2.543880691519007e-05
constitutional O 0 0.00010358726285630837
cells O 0 4.757010538014583e-05
of O 0 4.8707472160458565e-05
the O 0 6.285808194661513e-05
patient O 0 0.00021679277415387332
, O 0 2.799160938593559e-05
proving O 0 0.00015034318494144827
it O 0 1.103549038816709e-05
to O 0 1.1260337487328798e-05
be O 0 1.7773685613065027e-05
of O 0 0.00012572077685035765
germline O 0 0.003759785322472453
origin O 0 0.0004145375278312713
. O 0 0.0006233262247405946

The O 0 0.0009599800105206668
initial O 0 0.0006614496232941747
mutation O 0 0.0003427868941798806
was O 0 0.0001892377476906404
shown O 0 6.29733331152238e-05
to O 0 2.034307544818148e-05
have O 0 2.0602563381544314e-05
occurred O 0 0.00022281304700300097
in O 0 5.5557655286975205e-05
the O 0 0.00025816712877713144
paternally O 0 0.00856102630496025
derived O 0 0.0021462340373545885
RB1 O 1 0.9802979826927185
allele O 0 0.0029802320059388876
. O 0 0.0013708560727536678

The O 0 0.0010316706029698253
mutation O 0 0.00041705844341777265
is O 0 5.583059464697726e-05
in O 0 3.374848893145099e-05
an O 0 3.559543256415054e-05
area O 0 5.8184748922940344e-05
of O 0 5.3800114983459935e-05
the O 0 5.278565367916599e-05
gene O 0 3.9666949305683374e-05
that O 0 1.1056390576413833e-05
encodes O 0 3.380784983164631e-05
the O 0 3.221847509848885e-05
protein O 0 3.8329060771502554e-05
- O 0 4.358921796665527e-05
binding O 0 2.07543489523232e-05
region O 0 3.8392419810406864e-05
known O 0 3.921193638234399e-05
as O 0 2.5173392714350484e-05
the O 0 4.1775991121539846e-05
pocket O 0 0.0002142112352885306
region O 0 6.709800072712824e-05
and O 0 2.1870844648219645e-05
has O 0 1.8932405509985983e-05
been O 0 1.8255044778925367e-05
detected O 0 4.4417756726033986e-05
in O 0 1.208558114740299e-05
other O 0 1.1318884389766026e-05
cases O 0 3.218588972231373e-05
of O 0 0.00030702276853844523
retinoblastoma B-Disease 1 0.9956369996070862
. O 0 0.0002850438468158245
. O 0 0.0005687973462045193

Low O 0 0.0019542016088962555
levels O 0 0.0004469234845601022
of O 0 0.00022761123545933515
beta O 0 0.00031408920767717063
hexosaminidase O 0 0.005487130023539066
A O 0 0.0002551008074078709
in O 0 6.80902594467625e-05
healthy O 0 0.0001441638742107898
individuals O 0 2.9130907932994887e-05
with O 0 0.00011249049566686153
apparent O 1 0.999432384967804
deficiency O 1 0.9999994039535522
of O 0 0.12034112215042114
this O 0 0.0007358437869697809
enzyme O 0 0.002377874683588743
. O 0 0.0005965522141195834

Appreciable O 0 0.019184362143278122
beta O 0 0.003194896737113595
hexosaminidase O 0 0.016185877844691277
A O 0 0.0006500961608253419
( O 0 0.0002402210666332394
hex O 0 0.0007725746836513281
A O 0 0.00020894264162052423
) O 0 4.832831473322585e-05
activity O 0 8.192956011043862e-05
has O 0 3.484469198156148e-05
been O 0 4.250580241205171e-05
detected O 0 0.00017409918655175716
in O 0 0.00012738972145598382
cultured O 1 0.5316400527954102
skin O 1 0.9999563694000244
fibroblasts O 1 0.9997521042823792
and O 0 0.3658151626586914
melanoma B-Disease 1 1.0
tissue O 1 0.9997925162315369
from O 0 0.00036110292421653867
healthy O 0 0.00026855122996494174
individuals O 0 2.357670928176958e-05
previously O 0 6.607652903767303e-05
reported O 0 9.364519792143255e-05
as O 0 7.655112858628854e-05
having O 0 0.0003428893396630883
deficiency B-Disease 1 0.9999150037765503
of I-Disease 0 0.0005188262439332902
hex I-Disease 0 0.00284446869045496
A I-Disease 0 0.0003112487029284239
activity O 0 0.00011199824803043157
indistinguishable O 0 0.00012117215374018997
from O 0 2.576619226601906e-05
that O 0 2.509457954147365e-05
of O 0 9.904008766170591e-05
patients O 0 0.00103391008451581
with O 0 0.004708810243755579
Tay B-Disease 1 1.0
- I-Disease 1 0.9999884366989136
Sachs I-Disease 1 0.9999978542327881
disease I-Disease 1 0.999998927116394
( O 0 0.13404127955436707
TSD B-Disease 1 0.9999033212661743
) O 0 0.0006730105960741639
. O 0 0.0007662419811822474

Identification O 0 0.0022017706651240587
and O 0 0.0006339281680993736
quantitation O 0 0.004792211577296257
of O 0 0.000638335186522454
hex O 0 0.002211617771536112
A O 0 0.00046979845501482487
, O 0 0.00011702206393238157
amounting O 0 0.0004245141753926873
to O 0 8.960898412624374e-05
3 O 0 0.00026115644141100347
. O 0 0.00037292976048775017

5 O 0 0.0016439438331872225
% O 0 0.0008545075543224812
- O 0 0.0014524816069751978
6 O 0 0.0012990550603717566
. O 0 0.0008014658815227449

9 O 0 0.0010009515099227428
% O 0 0.0001652348873903975
of O 0 0.000184322998393327
total O 0 0.0002628200454637408
beta O 0 0.00047687874757684767
hexosaminidase O 0 0.022488530725240707
activity O 0 0.00014230261149350554
, O 0 3.534354254952632e-05
has O 0 2.9153750801924616e-05
been O 0 4.5052500354358926e-05
obtained O 0 7.054570596665144e-05
by O 0 0.00010390709212515503
cellulose O 0 0.013149245642125607
acetate O 0 0.013054192066192627
gel O 0 0.008290402591228485
electrophoresis O 0 0.001903628814034164
, O 0 0.00035854941233992577
DEAE O 1 0.9775919318199158
- O 0 0.0010870408732444048
cellulose O 0 0.002845323644578457
ion O 0 0.0013311489019542933
- O 0 0.0003862717712763697
exchange O 0 0.0004938647616654634
chromatography O 0 0.004098179750144482
, O 0 0.0003478465077932924
radial O 0 0.009116841480135918
immunodiffusion O 1 0.9433489441871643
, O 0 0.00030146617791615427
and O 0 0.00042066563037224114
radioimmunoassay O 1 0.9487919211387634
. O 0 0.001162688946351409

Previous O 0 0.0013811929384246469
family O 0 0.0003950817044824362
studies O 0 0.00010258196562062949
suggested O 0 0.00012255988258402795
that O 0 1.818809141695965e-05
these O 0 8.790715583018027e-06
individuals O 0 1.6442400010419078e-05
may O 0 4.9002435844158754e-05
be O 0 4.098374483874068e-05
compound O 0 0.0007906585233286023
heterozygotes O 0 0.0005355456960387528
for O 0 3.781380655709654e-05
the O 0 9.882726590149105e-05
common O 0 0.00019296536629553884
mutant O 0 0.006202722899615765
TSD B-Disease 1 0.9972513318061829
gene O 0 0.00011696384171955287
and O 0 5.296248127706349e-05
a O 0 9.434198727831244e-05
rare O 0 0.0003850814246106893
( O 0 0.00028146084514446557
allelic O 0 0.002095026196911931
) O 0 0.00022801199520472437
mutant O 0 0.0016899349866434932
gene O 0 0.000737638387363404
. O 0 0.0005522019928321242

Thus O 0 0.0008113794610835612
, O 0 0.00016417325241491199
the O 0 0.00017544486036058515
postulated O 0 0.0006078308215364814
rate O 0 0.00017567722534295171
mutant O 0 0.0003333448839839548
gene O 0 6.552154081873596e-05
appears O 0 3.4066051739500836e-05
to O 0 7.962861673149746e-06
code O 0 9.008314009406604e-06
for O 0 7.253253897943068e-06
the O 0 2.551268698880449e-05
expression O 0 3.426320108701475e-05
of O 0 5.349041020963341e-05
low O 0 8.265607175417244e-05
amounts O 0 6.663660315098241e-05
of O 0 0.0001486482797190547
hex O 0 0.0015113718109205365
A O 0 0.0010500962380319834
. O 0 0.0007039314950816333

Heterozygotes O 0 0.0076318965293467045
for O 0 0.0003344000142533332
the O 0 0.0003383758303243667
rare O 0 0.0007353608380071819
mutant O 0 0.002293841214850545
may O 0 7.37465888960287e-05
be O 0 3.921825555153191e-05
indistinguishable O 0 0.0001655438099987805
from O 0 9.875057730823755e-05
heterozygotes O 0 0.0006597262108698487
for O 0 6.818616384407505e-05
the O 0 0.0002894093922805041
common O 0 0.0009708372526802123
TSD B-Disease 1 0.9993715882301331
mutant O 0 0.01172562688589096
. O 0 0.001464984379708767

However O 0 0.0009120377944782376
, O 0 0.0003047027566935867
direct O 0 0.0002666509535629302
visualization O 0 0.0007506036199629307
and O 0 9.948306251317263e-05
quantitation O 0 0.0019175383495166898
of O 0 0.00023040806991048157
hex O 0 0.0006782153504900634
A O 0 0.00012015824904665351
by O 0 2.2353577151079662e-05
the O 0 2.7525738914846443e-05
methods O 0 4.3120049667777494e-05
described O 0 0.00010314262908650562
may O 0 5.858495205757208e-05
prevent O 0 0.0001597515947651118
false O 0 0.0002853908226825297
- O 0 0.00025530444690957665
positive O 0 0.00018673980957828462
prenatal O 0 0.003815108211711049
diagnosis O 0 0.004791145212948322
of O 0 0.0009248141432181001
TSD B-Disease 1 0.999862551689148
in O 0 0.00024933330132625997
fetuses O 0 0.0008299227920360863
having O 0 8.987453475128859e-05
the O 0 0.0001039296985254623
incomplete O 0 0.0004121320089325309
hex B-Disease 0 0.0023786802776157856
A I-Disease 0 0.002619481645524502
deficiency I-Disease 1 0.9963173866271973
of O 0 0.00012155150034232065
the O 0 0.00012502525351010263
type O 0 0.00030450354097411036
described O 0 0.0001109708973672241
in O 0 4.114881812711246e-05
the O 0 8.764405356487259e-05
four O 0 0.00016800766752567142
healthy O 0 0.000706637161783874
individuals O 0 0.00041963584953919053

The O 0 0.008390977047383785
tumor B-Disease 1 0.9999603033065796
suppressor O 1 0.996915340423584
gene O 0 0.0036986307241022587
Smad4 O 1 0.997930645942688
/ O 0 0.010946626774966717
Dpc4 O 0 0.15000170469284058
is O 0 0.0001368771627312526
required O 0 7.990469748619944e-05
for O 0 4.859106775256805e-05
gastrulation O 0 0.015060599893331528
and O 0 7.94671504991129e-05
later O 0 0.00012350475299172103
for O 0 7.179211388574913e-05
anterior O 0 0.004308607894927263
development O 0 0.00028520586783997715
of O 0 0.0003301731776446104
the O 0 0.000882049382198602
mouse O 0 0.0027068457566201687
embryo O 0 0.002412297995761037
. O 0 0.0006433976232074201

Mutations O 0 0.0015785017749294639
in O 0 0.0004507241537794471
the O 0 0.0009367075399495661
SMAD4 O 1 0.9999582767486572
/ O 1 0.9965605139732361
DPC4 O 1 0.9999973773956299
tumor B-Disease 1 0.9999929666519165
suppressor O 1 0.7604637145996094
gene O 0 0.00021953768737148494
, O 0 4.111751331947744e-05
a O 0 4.892483048024587e-05
key O 0 0.00010922981891781092
signal O 0 0.00022446943330578506
transducer O 0 0.0004924508393742144
in O 0 4.0799652197165415e-05
most O 0 5.540892016142607e-05
TGFbeta O 1 0.8012667298316956
- O 0 0.0002918142999988049
related O 0 0.00010587750148260966
pathways O 0 0.00024174580175895244
, O 0 1.6669073374941945e-05
are O 0 3.810621137745329e-06
involved O 0 2.3284754206542857e-05
in O 0 2.0433564714039676e-05
50 O 0 5.4513326176675037e-05
% O 0 8.55710095493123e-05
of O 0 0.005532613955438137
pancreatic B-Disease 1 0.9999996423721313
cancers I-Disease 1 0.999915361404419
. O 0 0.0014266009675338864

Homozygous O 0 0.035045772790908813
Smad4 O 1 0.9854588508605957
mutant O 0 0.3835196793079376
mice O 0 0.0038815902080386877
die O 0 0.0017516077496111393
before O 0 0.0004501057555899024
day O 0 0.0005875785718671978
7 O 0 0.0009446212789043784
. O 0 0.0005658918526023626

5 O 0 0.0034784339368343353
of O 0 0.002380287740379572
embryogenesis O 0 0.32576170563697815
. O 0 0.003380154026672244

Mutant O 0 0.012439709156751633
embryos O 0 0.001104361959733069
have O 0 8.610658551333472e-05
reduced O 0 0.00013966429105494171
size O 0 0.00010760987788671628
, O 0 5.8573110436555e-05
fail O 0 0.00011124541924800724
to O 0 4.293859456083737e-05
gastrulate O 0 0.002027598675340414
or O 0 7.186060247477144e-05
express O 0 0.00012010989303234965
a O 0 0.000206711221835576
mesodermal O 0 0.3777700364589691
marker O 0 0.013801781460642815
, O 0 0.00014517670206259936
and O 0 0.00017893410404212773
show O 0 0.000698624353390187
abnormal O 0 0.27787065505981445
visceral O 1 0.9962539672851562
endoderm O 1 0.9996036887168884
development O 0 0.004103133454918861
. O 0 0.0009886722546070814

Growth B-Disease 1 0.9652921557426453
retardation I-Disease 1 0.9993399977684021
of O 0 0.0010950466385111213
the O 0 0.005018501542508602
Smad4 O 1 0.9999790191650391
- O 0 0.2062447965145111
deficient O 0 0.005510642658919096
embryos O 0 0.00021614674187730998
results O 0 8.274667925434187e-05
from O 0 7.38319504307583e-05
reduced O 0 0.0002626461791805923
cell O 0 0.0004760997253470123
proliferation O 0 0.0005845190025866032
rather O 0 0.00011142228322569281
than O 0 9.164828952634707e-05
increased O 0 0.0003791345516219735
apoptosis O 0 0.003686931449919939
. O 0 0.0005885880091227591

Aggregation O 0 0.0024531797971576452
of O 0 0.0009647167753428221
mutant O 0 0.19292746484279633
Smad4 O 1 0.9998238682746887
ES O 1 0.9985607266426086
cells O 0 0.00035263487370684743
with O 0 6.699059304082766e-05
wild O 0 0.00026978558162227273
- O 0 0.0003460361040197313
type O 0 0.000436125643318519
tetraploid O 0 0.003682971466332674
morulae O 0 0.27993395924568176
rescues O 0 0.007778107654303312
the O 0 0.0017015272751450539
gastrulation B-Disease 1 0.9993403553962708
defect I-Disease 1 0.9989039897918701
. O 0 0.0015483946772292256

These O 0 0.0002701750199776143
results O 0 0.00017160394054371864
indicate O 0 0.00015406383317895234
that O 0 6.124066567281261e-05
Smad4 O 0 0.011178643442690372
is O 0 6.852211663499475e-05
initially O 0 5.0505615945439786e-05
required O 0 2.0057872461620718e-05
for O 0 1.208734556712443e-05
the O 0 3.533077324391343e-05
differentiation O 0 0.00015545747010037303
of O 0 7.309804641408846e-05
the O 0 0.00019426648213993758
visceral O 1 0.5511822700500488
endoderm O 1 0.7123335003852844
and O 0 7.055350579321384e-05
that O 0 5.271010013530031e-05
the O 0 0.00011829118739115074
gastrulation B-Disease 1 0.9435517191886902
defect I-Disease 0 0.18069912493228912
in O 0 0.0001021623975248076
the O 0 0.00019641210383269936
epiblast O 1 0.8885583281517029
is O 0 0.00010139343794435263
secondary O 0 0.00020246447820682079
and O 0 9.893965761875734e-05
non O 0 0.00026844575768336654
- O 0 0.000637704273685813
cell O 0 0.0007676704553887248
autonomous O 0 0.0006112768314778805
. O 0 0.00045846099965274334

Rescued O 0 0.1037042960524559
embryos O 0 0.00884968787431717
show O 0 0.004960865713655949
severe O 1 0.9997439980506897
anterior O 1 0.9998020529747009
truncations O 1 0.9970685839653015
, O 0 0.000295426812954247
indicating O 0 0.0002361697843298316
a O 0 0.00010179325909120962
second O 0 0.00011333591828588396
important O 0 6.681164813926443e-05
role O 0 0.00013551497249864042
for O 0 6.599805783480406e-05
Smad4 O 1 0.8512007594108582
in O 0 0.0004055644676554948
anterior O 1 0.9977715015411377
patterning O 1 0.9926965236663818
during O 0 0.07597703486680984
embryogenesis O 1 0.7899139523506165
. O 0 0.0020379219204187393

Prevalence O 0 0.009954297915101051
of O 0 0.0016414681449532509
p16 O 0 0.2531608045101166
and O 0 0.0008368410635739565
CDK4 O 1 0.9999189376831055
germline O 0 0.11716912686824799
mutations O 0 0.00018603817443363369
in O 0 0.00017689334345050156
48 O 0 0.0015658604679629207
melanoma B-Disease 1 0.9999988079071045
- O 0 0.013383143581449986
prone O 0 0.004411740694195032
families O 0 0.00014121852291282266
in O 0 0.00017874942568596452
France O 0 0.0008348125265911222
. O 0 0.0006076338468119502

The O 0 0.004620406311005354
French O 0 0.35005712509155273
Familial B-Disease 1 0.9999828338623047
Melanoma I-Disease 1 0.9999997615814209
Study O 0 0.004648406989872456
Group O 0 0.0012734410120174289
. O 0 0.0012843008153140545

Germline O 0 0.3188818097114563
mutations O 0 0.0011067957384511828
in O 0 0.0003154365986119956
the O 0 0.00040918579907156527
p16 O 0 0.07482409477233887
and O 0 0.0003472345124464482
CDK4 O 1 0.9991078972816467
genes O 0 0.00011555878154467791
have O 0 2.441759716020897e-05
been O 0 2.3518907255493104e-05
reported O 0 2.5761817596503533e-05
in O 0 1.2407449503371026e-05
a O 0 6.546763324877247e-05
subset O 0 0.00016521629004273564
of O 0 0.0005271492409519851
melanoma B-Disease 1 0.9999926090240479
pedigrees O 0 0.0023427801206707954
, O 0 0.0001003435900202021
but O 0 3.989045580965467e-05
their O 0 2.8769329219358042e-05
prevalence O 0 0.0003406500618439168
is O 0 3.092765109613538e-05
not O 0 2.926564593508374e-05
well O 0 7.525143882958218e-05
known O 0 0.0003185466048307717
. O 0 0.0004592868499457836

We O 0 0.00063171616056934
searched O 0 0.000939789810217917
for O 0 0.00014595341053791344
such O 0 0.0001254631788469851
germline O 0 0.0012162013445049524
mutations O 0 0.0001363309711450711
in O 0 6.911200762260705e-05
48 O 0 0.0004105985281057656
French O 0 0.034453872591257095
melanoma B-Disease 1 0.9999990463256836
- O 0 0.0019308634800836444
prone O 0 0.0010971700539812446
families O 0 8.876506035448983e-05
selected O 0 5.241236067377031e-05
according O 0 2.125956780218985e-05
to O 0 1.2907974451081827e-05
two O 0 1.4364656635734718e-05
major O 0 6.15951867075637e-05
criteria O 0 2.680259058251977e-05
families O 0 1.7705626305541955e-05
with O 0 1.386619533150224e-05
at O 0 4.436133167473599e-05
least O 0 1.293528202950256e-05
three O 0 1.3253703400550876e-05
affected O 0 2.453095839882735e-05
members O 0 1.5226909454213455e-05
( O 0 1.93009454960702e-05
n O 0 4.0022292523644865e-05
= O 0 4.827625889447518e-05
20 O 0 3.6112476664129645e-05
) O 0 1.2128612979722675e-05
or O 0 9.899285942083225e-06
families O 0 9.732466423884034e-06
with O 0 6.770225354557624e-06
two O 0 1.618804526515305e-05
affected O 0 3.952918996219523e-05
members O 0 1.983139918593224e-05
, O 0 1.907248588395305e-05
one O 0 1.5114078451006208e-05
of O 0 2.8910140827065334e-05
them O 0 2.4587943698861636e-05
affected O 0 4.626762165571563e-05
before O 0 3.324182762298733e-05
the O 0 3.0165054340614006e-05
age O 0 2.679699355212506e-05
of O 0 3.831817230093293e-05
50 O 0 3.342932541272603e-05
( O 0 2.6697338398662396e-05
n O 0 6.091571776778437e-05
= O 0 7.145458221202716e-05
28 O 0 6.742955883964896e-05
) O 0 1.221171442011837e-05
, O 0 1.979721855605021e-05
and O 0 2.1615202058455907e-05
one O 0 3.206475230399519e-05
additional O 0 0.00011384153185645118
minor O 0 0.0011266737710684538
criterion O 0 0.0017328523099422455
. O 0 0.0005887405714020133

Sixteen O 0 0.0041491626761853695
different O 0 0.00036919626290909946
p16 O 0 0.035895708948373795
germline O 0 0.008995693176984787
mutations O 0 0.00016669154865667224
were O 0 3.955596548621543e-05
found O 0 3.718284278875217e-05
in O 0 2.7616975785349496e-05
21 O 0 6.321490945992991e-05
families O 0 3.04327295452822e-05
, O 0 2.5925368390744552e-05
while O 0 3.221930091967806e-05
one O 0 4.1980863898061216e-05
germline O 0 0.0019762106239795685
mutation O 0 9.836177196120843e-05
, O 0 5.098654219182208e-05
Arg24His O 0 0.03477514535188675
, O 0 7.53791318857111e-05
was O 0 0.00019518555200193077
detected O 0 0.00017468967416789383
in O 0 7.769256626488641e-05
the O 0 0.00031879727612249553
CDK4 O 1 0.9992082715034485
gene O 0 0.001106682000681758
. O 0 0.0008397530764341354

The O 0 0.0013028105022385716
frequency O 0 0.00039747197297401726
of O 0 0.0003185022796969861
p16 O 0 0.002349568298086524
gene O 0 0.0001525946572655812
mutation O 0 6.989176472416148e-05
in O 0 2.012234108406119e-05
our O 0 2.8573364033945836e-05
sample O 0 2.3541324480902404e-05
( O 0 1.9400114979362115e-05
44 O 0 3.5328212106833234e-05
% O 0 1.698880805633962e-05
) O 0 9.600404155207798e-06
is O 0 1.1483160051284358e-05
among O 0 1.2967198017577175e-05
the O 0 2.677178054000251e-05
highest O 0 9.241187945008278e-05
rates O 0 2.3245884221978486e-05
yet O 0 2.3710959794698283e-05
reported O 0 1.8108150470652618e-05
and O 0 1.726837217574939e-05
the O 0 5.9579015214694664e-05
CDK4 O 1 0.9682286381721497
mutation O 0 7.974643813213333e-05
is O 0 2.4642262360430323e-05
the O 0 2.985733408422675e-05
second O 0 9.74677677731961e-05
mutation O 0 7.894584268797189e-05
detected O 0 8.002860704436898e-05
in O 0 2.55780469160527e-05
this O 0 4.261015055817552e-05
gene O 0 0.0001976486382773146
worldwide O 0 0.0002697352028917521
. O 0 0.00033068255288526416

In O 0 0.0010549005819484591
summary O 0 0.0009069713414646685
, O 0 0.00017891943571157753
our O 0 0.00013780119479633868
results O 0 8.31809375085868e-05
show O 0 8.248473022831604e-05
frequent O 0 8.965753659140319e-05
involvement O 0 0.00014701203326694667
of O 0 0.00010999040387105197
the O 0 0.00022438427549786866
p16 O 0 0.15679529309272766
gene O 0 0.00015867465117480606
in O 0 0.00014297776215244085
familial B-Disease 1 0.994848370552063
melanoma I-Disease 1 0.9999966621398926
and O 0 0.00011791380529757589
confirm O 0 7.790221570758149e-05
the O 0 7.330969674512744e-05
role O 0 9.00751183507964e-05
of O 0 0.00010546979319769889
the O 0 0.0001611407205928117
CDK4 O 1 0.9979121088981628
gene O 0 0.00014770320558454841
as O 0 6.0884241975145414e-05
a O 0 0.0004371964605525136
melanoma B-Disease 1 0.9999991655349731
- O 0 0.1718928962945938
predisposing O 0 0.4403708875179291
gene O 0 0.0008006414864212275
. O 0 0.00035966443829238415
. O 0 0.000812550017144531

Progression O 0 0.01900060847401619
of O 0 0.002082292689010501
somatic O 0 0.08530256152153015
CTG O 1 0.9307133555412292
repeat O 0 0.0009220105712302029
length O 0 0.00022831413662061095
heterogeneity O 0 0.0005696687148883939
in O 0 0.00010004511568695307
the O 0 0.00044406464439816773
blood O 1 0.8831287622451782
cells O 0 0.11006736755371094
of O 1 0.976070761680603
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9998096823692322
. O 0 0.0025847710203379393

The O 0 0.0011856677010655403
genetic O 0 0.0006937026046216488
basis O 0 0.0003469205694273114
of O 0 0.10337615013122559
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9867411255836487
DM B-Disease 1 0.9999991655349731
) O 0 0.00012580642942339182
is O 0 4.805294156540185e-05
the O 0 5.1451974286464974e-05
expansion O 0 0.00010107401612913236
of O 0 9.460973524255678e-05
an O 0 0.0001341747702099383
unstable O 0 0.23352877795696259
CTG O 1 0.8359744548797607
repeat O 0 0.00031476400909014046
in O 0 4.796924986294471e-05
the O 0 6.541490438394248e-05
34 O 0 0.00011716431617969647
UTR O 0 0.0010179935488849878
of O 0 0.00011559359700186178
the O 0 0.0002403298713034019
DM B-Disease 1 0.9983843564987183
protein O 0 0.0002626015921123326
kinase O 0 0.0002971807844005525
gene O 0 0.00011750647536246106
on O 0 0.00010527063568588346
chromosome O 0 0.00046597394975833595
19 O 0 0.0009561527986079454
. O 0 0.0007664976292289793

One O 0 0.0006539918831549585
of O 0 0.0002962916623800993
the O 0 0.0001562148390803486
principal O 0 0.00023985189909581095
features O 0 8.832321327645332e-05
of O 0 0.00012261504889465868
the O 0 0.00036489847116172314
DM B-Disease 1 0.9999946355819702
mutation O 0 0.00018756209465209395
is O 0 2.7186470106244087e-05
an O 0 3.528447268763557e-05
extraordinarily O 0 0.00021712976740673184
high O 0 9.910784137900919e-05
level O 0 8.285572403110564e-05
of O 0 9.507223148830235e-05
somatic O 0 0.002806050004437566
mosaicism O 1 0.7969798445701599
, O 0 7.091464067343622e-05
due O 0 4.498081034398638e-05
to O 0 1.201255690830294e-05
an O 0 2.0281417164369486e-05
extremely O 0 4.874404476140626e-05
high O 0 6.662974192295223e-05
degree O 0 0.000100898185337428
of O 0 0.00017913244664669037
somatic O 0 0.0026845792308449745
instability O 0 0.0012934289406985044
both O 0 3.558569369488396e-05
within O 0 5.727420648327097e-05
and O 0 3.6325691326055676e-05
between O 0 8.385902037844062e-05
different O 0 7.671950152143836e-05
tissues O 0 0.0019181753741577268
. O 0 0.0006179613992571831

This O 0 0.0014528683386743069
instability O 0 0.01040184311568737
appears O 0 0.00041228430927731097
to O 0 6.578040483873338e-05
be O 0 4.150857057538815e-05
biased O 0 0.00012606025848072022
towards O 0 0.0001596217043697834
further O 0 7.491334690712392e-05
expansion O 0 0.0001810298126656562
and O 0 4.16020120610483e-05
continuous O 0 8.60299332998693e-05
throughout O 0 3.925399141735397e-05
the O 0 2.653271258168388e-05
life O 0 3.662312155938707e-05
of O 0 3.094611383858137e-05
an O 0 2.3170279746409506e-05
individual O 0 1.6717580365366302e-05
, O 0 1.8531043679104187e-05
features O 0 1.613262611499522e-05
that O 0 8.254180102085229e-06
could O 0 1.229653298651101e-05
be O 0 7.056642971292604e-06
associated O 0 1.2629665434360504e-05
with O 0 1.392986723658396e-05
the O 0 7.248076144605875e-05
progressive O 0 0.0022761719301342964
nature O 0 0.00028029060922563076
of O 0 0.0007589093875139952
the O 0 0.06896312534809113
disease O 1 0.999955415725708
. O 0 0.0010905847884714603

Although O 0 0.000663063838146627
increasing O 0 0.00034115934977307916
measured O 0 0.00022331350191961974
allele O 0 0.00019574019825085998
size O 0 7.869907130952924e-05
between O 0 8.370482100872323e-05
patients O 0 0.00012592693383339792
clearly O 0 8.047875599004328e-05
correlates O 0 0.00012725230772048235
with O 0 1.6242711353697814e-05
an O 0 2.8889251552755013e-05
increased O 0 6.151594425318763e-05
severity O 0 0.0018490033689886332
of O 0 0.0005462051485665143
symptoms O 1 0.7409607768058777
and O 0 2.21282407437684e-05
an O 0 2.0180994397378527e-05
earlier O 0 4.239475674694404e-05
age O 0 5.4457726946566254e-05
of O 0 7.657091919099912e-05
onset O 1 0.9962433576583862
, O 0 3.0136239729472436e-05
this O 0 1.74550532392459e-05
correlation O 0 2.8150463549536653e-05
is O 0 9.815210432861932e-06
not O 0 4.896551217825618e-06
precise O 0 2.2327862097881734e-05
and O 0 1.6889298422029242e-05
measured O 0 3.195388489984907e-05
allele O 0 4.034156881971285e-05
length O 0 2.800757829390932e-05
cannot O 0 1.8968006770592183e-05
be O 0 8.248562153312378e-06
used O 0 1.1492536032164935e-05
as O 0 1.3041186321061105e-05
an O 0 1.8760871171252802e-05
accurate O 0 7.876844028942287e-05
predictor O 0 0.0006741323159076273
of O 0 0.00022258181707002223
age O 0 0.0005922398995608091
of O 0 0.002710493514314294
onset O 1 0.9999409914016724
. O 0 0.0012002215953543782

In O 0 0.0008874915656633675
order O 0 0.0003220896178390831
to O 0 9.31280737859197e-05
further O 0 0.00010369301162427291
characterize O 0 0.0003616059257183224
the O 0 0.00020324975776020437
dynamics O 0 0.000946539337746799
of O 0 0.0014087160816416144
DM B-Disease 1 0.9999992847442627
CTG O 1 0.9998679161071777
repeat O 0 0.04036266729235649
somatic O 0 0.025874823331832886
instability O 0 0.005869042593985796
, O 0 5.595008406089619e-05
we O 0 2.6279185476596467e-05
have O 0 1.4260091120377183e-05
studied O 0 6.003745147609152e-05
repeat O 0 0.00012410779891069978
length O 0 2.9513039407902397e-05
changes O 0 1.8332242689211853e-05
over O 0 3.137784733553417e-05
time O 0 5.2904983022017404e-05
in O 0 0.0001209235197165981
111 O 1 0.7271324992179871
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.047299355268478394
with O 0 0.00013928300177212805
varying O 0 0.00028153762104921043
clinical O 0 0.04554039612412453
severity O 1 0.7190189957618713
and O 0 0.00031178953940980136
CTG O 1 0.860724687576294
repeat O 0 0.00023054365010466427
size O 0 6.46193147986196e-05
over O 0 2.3467509890906513e-05
time O 0 1.604721910553053e-05
intervals O 0 1.9064593288931064e-05
of O 0 2.435387796140276e-05
1 O 0 4.679307312471792e-05
- O 0 0.0001030615167110227
7 O 0 0.00015712509048171341
years O 0 0.00020089243480470031
. O 0 0.00023925442656036466

We O 0 0.0003808953915722668
have O 0 5.3935324103804305e-05
found O 0 4.19701354985591e-05
a O 0 6.374860095093027e-05
direct O 0 6.3791660068091e-05
progression O 0 0.0002856448118109256
of O 0 6.827335164416581e-05
the O 0 5.9195725043537095e-05
size O 0 5.588310887105763e-05
heterogeneity O 0 9.335115464637056e-05
over O 0 3.1735049560666084e-05
time O 0 2.4881115677999333e-05
related O 0 2.805013173201587e-05
to O 0 2.2846312276669778e-05
initial O 0 0.0001430577103747055
CTG O 0 0.006119453813880682
repeat O 0 0.0002869325689971447
size O 0 5.147504271008074e-05
and O 0 2.7776433853432536e-05
the O 0 3.733566336450167e-05
time O 0 4.273800732335076e-05
interval O 0 0.0001135425191023387
and O 0 4.1909137507900596e-05
always O 0 6.323667184915394e-05
biased O 0 0.00020597223192453384
towards O 0 0.0004269967903383076
further O 0 0.00029275508131831884
expansion O 0 0.0016662203706800938
. O 0 0.0007131731836125255

Attempts O 0 0.001376937609165907
to O 0 0.0001427467359462753
mathematically O 0 0.00025453275884501636
model O 0 0.00015743941185064614
the O 0 0.00010190853936364874
dynamics O 0 0.0003557123418431729
have O 0 3.8412308640545234e-05
proved O 0 0.00020083674462512136
only O 0 3.840143108391203e-05
partially O 0 0.00023889177828095853
successful O 0 0.00011625475599430501
suggesting O 0 7.974917389219627e-05
that O 0 1.3064288395980839e-05
individual O 0 1.1408778846089263e-05
specific O 0 2.06957665795926e-05
genetic O 0 6.0947037127334625e-05
and O 0 6.45446780254133e-05
/ O 0 0.0009342279518023133
or O 0 8.401814557146281e-05
environmental O 0 0.00020021400996483862
factors O 0 5.2881328883813694e-05
also O 0 3.6739329516422004e-05
play O 0 4.454377994989045e-05
a O 0 0.00010325816401746124
role O 0 0.00020437728380784392
in O 0 0.00021474537788890302
somatic O 0 0.02271759882569313
mosaicism O 1 0.9897224307060242
. O 0 0.00042842933908104897
. O 0 0.0011345125967636704

Aspartylglucosaminuria B-Disease 1 0.9980810880661011
among O 0 0.002442092401906848
Palestinian O 0 0.006997275166213512
Arabs O 0 0.007381712552160025
. O 0 0.002444594632834196

Aspartylglucosaminuria B-Disease 1 0.9999723434448242
( O 0 0.12194113433361053
AGU B-Disease 1 0.9999181032180786
) O 0 0.00025117862969636917
is O 0 0.00013854957069270313
a O 0 0.00022976286709308624
rare O 0 0.02424769476056099
disorder B-Disease 1 0.999984622001648
of I-Disease 1 0.9176479578018188
glycoprotein I-Disease 1 0.9999908208847046
metabolism I-Disease 1 0.9978421926498413
caused O 0 0.40215277671813965
by O 0 6.62081001792103e-05
the O 0 0.0003522533515933901
deficiency B-Disease 1 0.9998646974563599
of I-Disease 0 0.00038393211434595287
the I-Disease 0 0.002429934684187174
lysosomal I-Disease 1 0.9997225403785706
enzyme I-Disease 0 0.14457112550735474
aspartylglucosaminidase I-Disease 1 0.9983534812927246
( O 0 0.0009713456383906305
AGA O 1 0.9155446290969849
) O 0 0.00067872618092224
. O 0 0.0007470449199900031

AGU B-Disease 1 0.9999698400497437
is O 0 0.0026105099823325872
inherited O 1 0.8394745588302612
as O 0 0.0004985320847481489
an O 0 0.0007518825004808605
autosomal O 1 0.9960981607437134
recessive O 1 0.9997373223304749
trait O 1 0.8608300685882568
and O 0 0.00015791707846801728
occurs O 0 9.650638094171882e-05
with O 0 2.01487655431265e-05
a O 0 5.969754056422971e-05
high O 0 0.00010366819333285093
frequency O 0 3.460279185674153e-05
in O 0 1.9035815057577565e-05
Finland O 0 0.00010881200432777405
because O 0 3.607402686611749e-05
of O 0 8.045182039495558e-05
a O 0 0.0002150219661416486
founder O 0 0.0037582870572805405
effect O 0 0.0008229449158534408
. O 0 0.000583386339712888

While O 0 0.000965548912063241
very O 0 0.0002866403083316982
few O 0 0.00026159206754527986
patients O 0 0.000385041261324659
with O 0 0.00015188696852419525
AGU B-Disease 1 0.9999854564666748
have O 0 3.787292371271178e-05
been O 0 4.47682905360125e-05
reported O 0 4.72568572149612e-05
from O 0 2.7070153009844944e-05
non O 0 7.69191246945411e-05
- O 0 9.328548185294494e-05
Finnish O 0 0.0002198787115048617
origin O 0 3.69857152691111e-05
, O 0 3.8910064176889136e-05
we O 0 6.872845551697537e-05
diagnosed O 1 0.9707921147346497
the O 0 0.0003096602449659258
disorder O 1 0.9998701810836792
in O 0 7.624767749803141e-05
8 O 0 0.00015557433653157204
patients O 0 7.209452451206744e-05
originating O 0 4.5017364755040035e-05
from O 0 2.7647045499179512e-05
3 O 0 2.977356780320406e-05
unrelated O 0 7.207734597614035e-05
families O 0 1.9372086171642877e-05
, O 0 1.350348520645639e-05
all O 0 1.0117149940924719e-05
Palestinian O 0 6.440295692300424e-05
Arabs O 0 9.310152381658554e-05
from O 0 3.107552765868604e-05
the O 0 6.998313619988039e-05
region O 0 0.00011333407746860757
of O 0 0.00023255175619851798
Jerusalem O 0 0.006451231427490711
. O 0 0.0008222045144066215

The O 0 0.00281221279874444
clinical O 0 0.02567029930651188
diagnosis O 1 0.9905457496643066
of O 1 0.8997916579246521
AGU B-Disease 1 0.9999997615814209
is O 0 0.00017175078392028809
often O 0 2.953046714537777e-05
difficult O 0 3.529076639097184e-05
, O 0 1.5296351193683222e-05
in O 0 1.2636339306482114e-05
particular O 0 1.9511122445692308e-05
early O 0 2.4247323381132446e-05
in O 0 1.2433175470505375e-05
the O 0 2.2491540221381e-05
course O 0 6.263412069529295e-05
of O 0 5.7151013606926426e-05
the O 0 0.0012308581499382854
disease O 1 0.9970054030418396
, O 0 2.3767783204675652e-05
and O 0 1.3158266483515035e-05
most O 0 1.1528067261679098e-05
of O 0 4.5567896449938416e-05
the O 0 0.0001165094508905895
patients O 0 0.000338809157256037
are O 0 2.218745430582203e-05
diagnosed O 1 0.7827284336090088
after O 0 0.00015284455730579793
the O 0 7.372297841357067e-05
age O 0 7.179115345934406e-05
of O 0 0.00011855723278131336
5 O 0 0.000248230790020898
years O 0 0.00023576350940857083
. O 0 0.0004750743100885302

However O 0 0.0009176552994176745
, O 0 0.0003749583847820759
since O 0 0.0002801337686832994
these O 0 7.518881466239691e-05
patients O 0 0.00020430675067473203
excrete O 0 0.0007615674985572696
early O 0 0.00014425409608520567
large O 0 5.989529745420441e-05
amounts O 0 0.00010114892938872799
of O 0 0.00013653405767399818
aspartylglucosamine O 0 0.020006448030471802
in O 0 9.57885931711644e-05
urine O 0 0.00030323085957206786
, O 0 8.202219032682478e-05
biochemical O 0 0.00039570851367898285
screening O 0 0.0001476758625358343
is O 0 4.602067201631144e-05
easy O 0 0.00011760342749767005
by O 0 0.00014683845802210271
urine O 0 0.0009928917279466987
chromatography O 0 0.00658958125859499
. O 0 0.0004000075568910688
. O 0 0.0006181614007800817

Detection O 0 0.004813401494175196
of O 0 0.0008363867527805269
heterozygous O 0 0.0006722153048031032
carriers O 0 0.00027793290792033076
of O 0 0.00020490294264163822
the O 0 0.0006870633806101978
ataxia B-Disease 1 0.9999979734420776
- I-Disease 1 0.9369600415229797
telangiectasia I-Disease 1 0.9996588230133057
( O 0 0.00034448402584530413
ATM O 0 0.0007291877409443259
) O 0 4.0618157072458416e-05
gene O 0 8.457988587906584e-05
by O 0 6.365693116094917e-05
G2 O 0 0.2552942931652069
phase O 0 0.00414822855964303
chromosomal O 0 0.2187982201576233
radiosensitivity O 1 0.9963865280151367
of O 0 0.12749581038951874
peripheral O 1 0.9999799728393555
blood O 1 0.9998120665550232
lymphocytes O 1 0.9749137163162231
. O 0 0.0008344900561496615

In O 0 0.004904544446617365
ataxia B-Disease 1 0.9999821186065674
- I-Disease 0 0.4568375051021576
telangiectasia I-Disease 1 0.9998847246170044
( O 0 0.0025581158697605133
A B-Disease 1 0.9997285008430481
- I-Disease 1 0.990265429019928
T I-Disease 1 0.9998315572738647
) O 0 8.195823465939611e-05
patients O 0 7.827342778909951e-05
, O 0 2.6004405299318023e-05
mutations O 0 2.465690704411827e-05
in O 0 1.714456629997585e-05
a O 0 4.600487227435224e-05
single O 0 5.958020847174339e-05
gene O 0 5.612236418528482e-05
, O 0 3.361775088706054e-05
ATM O 0 0.00017088530876208097
, O 0 3.6396879295352846e-05
result O 0 5.687970042345114e-05
in O 0 7.361625466728583e-05
an O 0 0.0017090230248868465
autosomal B-Disease 1 0.9999990463256836
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.0004586164141073823
embraces O 0 0.0014216601848602295
a O 0 9.56053554546088e-05
variety O 0 6.470255902968347e-05
of O 0 8.276024891529232e-05
clinical O 0 0.00033335215994156897
features O 0 0.00012571348634082824
and O 0 8.512135536875576e-05
manifests O 0 0.0007640622789040208
extreme O 0 0.0012799924006685615
radiosensitivity O 0 0.27951252460479736
and O 0 5.012904148316011e-05
a O 0 0.00010681970888981596
strong O 0 0.00015703594544902444
pre O 0 0.0007658707909286022
- O 0 0.00039814115734770894
disposition O 0 0.0016446851659566164
to O 0 0.0003419531276449561
malignancy B-Disease 1 0.995506763458252
. O 0 0.0011865337146446109

Heterozygotes O 0 0.009245875291526318
for O 0 0.0002589631185401231
the O 0 0.00034465629141777754
ATM O 0 0.000950738089159131
gene O 0 0.0001050612554536201
have O 0 2.066949673462659e-05
no O 0 3.897449641954154e-05
clinical O 0 0.00011397339403629303
expression O 0 6.825576565461233e-05
of O 0 0.00011495573562569916
A B-Disease 1 0.9743078947067261
- I-Disease 0 0.43786463141441345
T I-Disease 1 0.9934606552124023
but O 0 3.9311231375904754e-05
may O 0 5.858885560883209e-05
be O 0 4.533228639047593e-05
cancer B-Disease 0 0.057088885456323624
prone O 0 0.0004491317376960069
with O 0 2.7617503292276524e-05
a O 0 7.043572986731306e-05
moderate O 0 0.0001341417955700308
increase O 0 3.596115857362747e-05
in O 0 4.7126661229413e-05
in O 0 0.00010184404527535662
vitro O 0 0.0013870666734874249
radiosensitivity O 0 0.05301137641072273
. O 0 0.0007067095721140504

We O 0 0.0014519691467285156
performed O 0 0.001439373125322163
a O 0 0.0007847945671528578
blind O 0 0.0014465894782915711
chromosomal O 0 0.0009196618921123445
analysis O 0 8.506471203872934e-05
on O 0 0.00015330490714404732
G2 O 1 0.9108400344848633
- O 0 0.0003302361583337188
phase O 0 0.0005546091706492007
lymphocytes O 0 0.0002983922604471445
from O 0 2.4965278498711996e-05
7 O 0 6.789910548832268e-05
unrelated O 0 0.00019640254322439432
A B-Disease 0 0.13616017997264862
- I-Disease 0 0.08818471431732178
T I-Disease 1 0.9807573556900024
patients O 0 0.00010248057515127584
, O 0 3.381833084858954e-05
13 O 0 0.0001020498457364738
obligate O 0 0.0002472015330567956
A B-Disease 0 0.22504088282585144
- I-Disease 0 0.07713990658521652
T I-Disease 1 0.9852098822593689
heterozygotes O 0 0.0006040679872967303
( O 0 4.7386547521455213e-05
parents O 0 3.098781598964706e-05
of O 0 3.497762736515142e-05
the O 0 7.939542410895228e-05
patients O 0 0.00013265923189464957
) O 0 2.403033613518346e-05
, O 0 1.5815376173122786e-05
and O 0 1.5813791833352298e-05
14 O 0 4.8028847231762484e-05
normal O 0 4.3159750930499285e-05
controls O 0 4.317996354075149e-05
following O 0 5.190329102333635e-05
X O 0 0.00017309017130173743
- O 0 9.49701206991449e-05
irradiation O 0 0.00019556371262297034
with O 0 2.4984115952975117e-05
1 O 0 8.03084039944224e-05
Gy O 0 0.0006762667326256633
in O 0 2.3844062525313348e-05
order O 0 2.290571683261078e-05
to O 0 1.0655144251359161e-05
evaluate O 0 3.6068144254386425e-05
this O 0 2.321610736544244e-05
cytogenetic O 0 0.00048397149657830596
method O 0 5.6169697927543893e-05
as O 0 3.5056502383667976e-05
a O 0 7.668548641959205e-05
tool O 0 0.00016444835637230426
for O 0 5.5306663853116333e-05
detection O 0 0.0003255876072216779
of O 0 0.00035954962368123233
ATM O 0 0.003473889548331499
carriers O 0 0.0011407638667151332
. O 0 0.0006856301915831864

Both O 0 0.001766433590091765
A B-Disease 1 0.9674186706542969
- I-Disease 1 0.9411895871162415
T I-Disease 1 0.9995129108428955
homozygotes O 0 0.012695974670350552
and O 0 0.0002182258467655629
heterozygotes O 0 0.0016819501761347055
showed O 0 0.00023950362810865045
significantly O 0 8.7522275862284e-05
increased O 0 6.295670027611777e-05
levels O 0 7.248650217661634e-05
of O 0 0.00010143967665499076
radiation O 1 0.8291722536087036
- O 0 0.004223708529025316
induced O 1 0.9808391332626343
chromatid O 1 0.9876654148101807
damage O 0 0.008099792525172234
relative O 0 8.816517220111564e-05
to O 0 2.464515455358196e-05
that O 0 2.5921661290340126e-05
of O 0 0.00014210383233148605
normal O 0 0.0003400204877834767
controls O 0 0.0006330210017040372
. O 0 0.00040984031511470675

These O 0 0.00019070057896897197
results O 0 9.561876504449174e-05
show O 0 0.00013039934856351465
that O 0 5.159648208064027e-05
the O 0 0.0001747606584103778
G2 O 1 0.9905906319618225
- O 0 0.0006352729978971183
phase O 0 0.0019260654225945473
chromosomal O 0 0.01412559300661087
radiosensitivity O 0 0.3140864968299866
assay O 0 0.00022987922420725226
can O 0 1.6931002392084338e-05
be O 0 8.676443940203171e-06
used O 0 9.728234545036685e-06
for O 0 8.551643986720592e-06
the O 0 3.492010000627488e-05
detection O 0 0.00015912190428934991
of O 0 0.00026995668304152787
A B-Disease 1 0.9954056739807129
- I-Disease 1 0.9617124199867249
T I-Disease 1 0.9980727434158325
heterozygotes O 0 0.0057426695711910725
. O 0 0.0005834486219100654

In O 0 0.0008980518323369324
combination O 0 0.0006387002649717033
with O 0 0.0001081118025467731
molecular O 0 0.00026513601187616587
genetic O 0 9.901213343255222e-05
analyses O 0 5.010314271203242e-05
, O 0 3.0331784728332423e-05
this O 0 2.234030034742318e-05
test O 0 3.050106533919461e-05
may O 0 1.43382285386906e-05
be O 0 5.574961960519431e-06
of O 0 1.0120024853677023e-05
value O 0 1.2020189387840219e-05
in O 0 1.515596522949636e-05
studies O 0 1.9340321159688756e-05
of O 0 5.4192583775147796e-05
familial B-Disease 0 0.06268592923879623
and I-Disease 0 0.00014080211985856295
sporadic I-Disease 0 0.08454395830631256
cancers I-Disease 1 0.5547868013381958
aimed O 0 0.00016758097626734525
at O 0 6.91400928189978e-05
determination O 0 6.42038430669345e-05
of O 0 3.3881995477713645e-05
the O 0 3.499217200442217e-05
potential O 0 4.6017245040275156e-05
involvement O 0 0.00012392234930302948
of O 0 0.0001308707142015919
ATM O 0 0.0029969634488224983
mutations O 0 0.0002350748545723036
in O 0 0.00018922907474916428
tumor B-Disease 1 0.9999686479568481
risk O 0 0.0006360493134707212
or O 0 0.00010866309457924217
development O 0 0.0003991674166172743
. O 0 0.0001396640291204676
. O 0 0.00038649889756925404

Ataxia B-Disease 1 0.9999943971633911
- I-Disease 1 0.8779529929161072
telangiectasia I-Disease 1 0.9977654218673706
: O 0 0.0002749614941421896
identification O 0 0.00012093481927877292
and O 0 7.695976091781631e-05
detection O 0 0.0001672588405199349
of O 0 0.00013264824519865215
founder O 0 0.018427250906825066
- O 0 0.00026029880973510444
effect O 0 9.125724318437278e-05
mutations O 0 4.1940722439903766e-05
in O 0 1.7316277080681175e-05
the O 0 7.474295125575736e-05
ATM O 0 0.00031014237902127206
gene O 0 7.344615005422384e-05
in O 0 4.566045754472725e-05
ethnic O 0 0.00012454121315386146
populations O 0 0.00018381998233962804
. O 0 0.00030686822719872

To O 0 0.0004598428204189986
facilitate O 0 0.00033234243164770305
the O 0 0.00017164256132673472
evaluation O 0 0.00024098934954963624
of O 0 0.0001677030959399417
ATM O 0 0.0015552605036646128
heterozygotes O 0 0.0005430090241134167
for O 0 4.4317061110632494e-05
susceptibility O 0 0.0004197804955765605
to O 0 4.29861611337401e-05
other O 0 4.910436473437585e-05
diseases O 1 0.9569228887557983
, O 0 5.663219781126827e-05
such O 0 5.9043341025244445e-05
as O 0 0.010739695280790329
breast B-Disease 1 0.9999970197677612
cancer I-Disease 1 0.999901294708252
, O 0 4.553592225420289e-05
we O 0 1.647467252041679e-05
have O 0 6.198597020556917e-06
attempted O 0 4.1396106098545715e-05
to O 0 7.392234692815691e-06
define O 0 1.804746534617152e-05
the O 0 3.086824290221557e-05
most O 0 1.5277966667781584e-05
common O 0 2.5732992071425542e-05
mutations O 0 2.5229723178199492e-05
and O 0 1.3088007108308375e-05
their O 0 9.032178240886424e-06
frequencies O 0 3.383542934898287e-05
in O 0 7.821366307325661e-05
ataxia B-Disease 1 0.9998579025268555
- I-Disease 0 0.004390757996588945
telangiectasia I-Disease 1 0.9960210919380188
( O 0 0.0002901547704823315
A B-Disease 1 0.5764767527580261
- I-Disease 0 0.005588713567703962
T I-Disease 0 0.07614219933748245
) O 0 5.8724333939608186e-05
homozygotes O 0 0.0004607285954989493
from O 0 6.033636964275502e-05
10 O 0 8.716953743714839e-05
ethnic O 0 0.00016072823200374842
populations O 0 0.0002632777323015034
. O 0 0.0003356392844580114

Both O 0 0.0012399009428918362
genomic O 0 0.0013796724379062653
mutations O 0 0.0003607139806263149
and O 0 9.631618013372645e-05
their O 0 6.162462523207068e-05
effects O 0 0.00028226166614331305
on O 0 0.00023280023015104234
cDNA O 0 0.0012871735962107778
were O 0 0.0002762273943517357
characterized O 0 0.0012572453124448657
. O 0 0.0007748740026727319

Protein O 0 0.0021270804572850466
- O 0 0.0011486492585390806
truncation O 0 0.0019974494352936745
testing O 0 0.0002693528076633811
of O 0 0.000127749313833192
the O 0 9.92090062936768e-05
entire O 0 0.00029104246641509235
ATM O 0 0.00030771433375775814
cDNA O 0 0.00030608021188527346
detected O 0 0.00012425817840266973
92 O 0 0.00015361334953922778
( O 0 3.7080822949064896e-05
66 O 0 9.00753730093129e-05
% O 0 3.654141255537979e-05
) O 0 3.349583130329847e-05
truncating O 0 0.00048319806228391826
mutations O 0 0.00012324453564360738
in O 0 8.735359733691439e-05
140 O 0 0.00048746480024419725
mutant O 0 0.0012274038745090365
alleles O 0 0.0006499103037640452
screened O 0 0.0012193704023957253
. O 0 0.0005938538233749568

The O 0 0.0013242237037047744
haplotyping O 0 0.4291782081127167
of O 0 0.0005664455820806324
patients O 0 0.00023474560293834656
with O 0 3.8007154216757044e-05
identical O 0 9.109119127970189e-05
mutations O 0 3.8439939089585096e-05
indicates O 0 3.105029099970125e-05
that O 0 5.866785159014398e-06
almost O 0 9.226760994351935e-06
all O 0 6.137861873867223e-06
of O 0 2.1478146663866937e-05
these O 0 7.358178663707804e-06
represent O 0 2.5071929485420696e-05
common O 0 2.5587900381651707e-05
ancestry O 0 8.002845424925908e-05
and O 0 3.949969323002733e-05
that O 0 2.9801180062349886e-05
very O 0 4.909298149868846e-05
few O 0 0.0001208777612191625
spontaneously O 0 0.001710290089249611
recurring O 0 0.0995808094739914
ATM O 0 0.0214486476033926
mutations O 0 0.0007758802967146039
exist O 0 0.0003742279368452728
. O 0 0.0006323851412162185

Assays O 0 0.002781845396384597
requiring O 0 0.0008468420128338039
minimal O 0 0.00044947501737624407
amounts O 0 0.00013884106010664254
of O 0 0.00010030226258095354
genomic O 0 0.00015264819376170635
DNA O 0 0.00013084251258987933
were O 0 3.94411945308093e-05
designed O 0 5.911906191613525e-05
to O 0 1.568015431985259e-05
allow O 0 4.5951073843752965e-05
rapid O 0 0.00031751240021549165
screening O 0 0.00016954664897639304
for O 0 6.378983380272985e-05
common O 0 0.00014930014731362462
ethnic O 0 0.00025211533647961915
mutations O 0 0.0007247442263178527
. O 0 0.0006073492695577443

These O 0 0.000698888732586056
rapid O 0 0.0017847140552476048
assays O 0 0.0004079262726008892
detected O 0 0.00037196531775407493
mutations O 0 5.64899601158686e-05
in O 0 2.256368679809384e-05
76 O 0 7.68236059229821e-05
% O 0 2.133149973815307e-05
of O 0 4.014806472696364e-05
Costa O 0 0.0001070269790943712
Rican O 0 0.00024705330724827945
patients O 0 5.790874638478272e-05
( O 0 2.379172838118393e-05
3 O 0 2.3939257516758516e-05
) O 0 8.065972906479146e-06
, O 0 7.292205737030599e-06
50 O 0 1.0179895980400033e-05
% O 0 8.427467946603429e-06
of O 0 2.320995190530084e-05
Norwegian O 0 0.0001386732910759747
patients O 0 5.9727721236413345e-05
( O 0 2.182898242608644e-05
1 O 0 2.7641957785817795e-05
) O 0 9.521334504825063e-06
, O 0 6.928377388248919e-06
25 O 0 1.4596557775803376e-05
% O 0 1.227615666721249e-05
of O 0 3.518397352308966e-05
Polish O 0 0.0050727082416415215
patients O 0 0.00011994256783509627
( O 0 4.0092356357490644e-05
4 O 0 5.3856216254644096e-05
) O 0 1.4021069546288345e-05
, O 0 1.119496846513357e-05
and O 0 8.673780030221678e-06
14 O 0 2.1367170120356604e-05
% O 0 1.0833209671545774e-05
of O 0 3.949837264372036e-05
Italian O 0 0.00024294847389683127
patients O 0 0.0001126762290368788
( O 0 2.6750934921437874e-05
1 O 0 2.9089487725286745e-05
) O 0 6.789739472878864e-06
, O 0 7.5180887506576255e-06
as O 0 7.427171112794895e-06
well O 0 8.076363883446902e-06
as O 0 1.4874439330014866e-05
in O 0 2.749200393736828e-05
patients O 0 6.0002432292094454e-05
of O 0 8.949301991378888e-05
Amish O 0 0.006129327695816755
/ O 0 0.0008817779598757625
Mennonite O 0 0.0012454090174287558
and O 0 0.0001778612786438316
Irish O 0 0.0006217011832632124
English O 0 0.00040513675776310265
backgrounds O 0 0.0005917958333157003
. O 0 0.0005096467211842537

Additional O 0 0.0009755390929058194
mutations O 0 0.0003386703028809279
were O 0 8.070046897046268e-05
observed O 0 7.65615695854649e-05
in O 0 3.453003955655731e-05
Japanese O 0 0.00022271406487561762
, O 0 5.5529846576973796e-05
Utah O 0 0.00033001520205289125
Mormon O 0 0.0005464394926093519
, O 0 7.625378930242732e-05
and O 0 6.501589086838067e-05
African O 0 0.000336425902787596
American O 0 0.0011488040909171104
patients O 0 0.0018914415268227458
. O 0 0.000610656279604882

These O 0 0.0006104902131482959
assays O 0 0.0005344288656488061
should O 0 9.531342220725492e-05
facilitate O 0 0.0001264197053387761
screening O 0 0.00011502821143949404
for O 0 4.886486567556858e-05
A B-Disease 0 0.029338115826249123
- I-Disease 0 0.008104560896754265
T I-Disease 1 0.5453938841819763
heterozygotes O 0 0.0004588361189235002
in O 0 4.424641156219877e-05
the O 0 5.981908907415345e-05
populations O 0 5.351877916837111e-05
studied O 0 0.0001779002632247284
. O 0 0.00013698541442863643
. O 0 0.0003909145307261497

The O 0 0.002830590819939971
von B-Disease 0 0.48620468378067017
Hippel I-Disease 1 0.9993079900741577
- I-Disease 1 0.9538788199424744
Lindau I-Disease 1 0.9999396800994873
tumor I-Disease 1 0.9999911785125732
suppressor O 1 0.901795506477356
gene O 0 0.0002420772216282785
is O 0 5.9257232351228595e-05
required O 0 7.413686398649588e-05
for O 0 5.934165892540477e-05
cell O 0 0.00041721592424437404
cycle O 0 0.0005513788782991469
exit O 0 0.0005277268937788904
upon O 0 0.00070758699439466
serum O 0 0.00960003212094307
withdrawal O 0 0.002639660844579339
. O 0 0.0007191919139586389

The O 0 0.0019704687874764204
inactivation O 0 0.005045183934271336
of O 0 0.00048623871407471597
the O 0 0.0005223305779509246
von B-Disease 0 0.039307065308094025
Hippel I-Disease 1 0.9931500554084778
- I-Disease 0 0.003725340124219656
Lindau I-Disease 1 0.9376758933067322
( I-Disease 0 0.0012877843109890819
VHL I-Disease 1 0.9998384714126587
) I-Disease 0 0.0009841955034062266
tumor I-Disease 1 0.9999443292617798
suppressor O 1 0.9914734363555908
gene O 0 0.0005725468508899212
predisposes O 0 0.010120703838765621
affected O 0 0.0001881354401120916
individuals O 0 3.485562410787679e-05
to O 0 5.4913089115871117e-05
the O 0 0.00038343138294294477
human O 1 0.9986507296562195
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.0027542070019990206
is O 0 0.00022302390425466
associated O 0 0.0002082135615637526
with O 0 0.00023371406132355332
sporadic B-Disease 1 0.9988754391670227
renal I-Disease 1 1.0
cell I-Disease 1 0.9999948740005493
carcinomas I-Disease 1 0.9999998807907104
( O 1 0.9687352776527405
RCC B-Disease 1 0.9999991655349731
) O 0 0.0005014423513785005
and O 0 0.0007547536515630782
brain B-Disease 1 0.9949237704277039
hemangioblastomas I-Disease 1 0.9918798804283142
. O 0 0.0011788515839725733

VHL O 1 0.9557867050170898
- O 0 0.002783165778964758
negative O 0 0.0008755092858336866
786 O 0 0.01340770348906517
- O 0 0.002017130609601736
0 O 0 0.0008210117812268436
RCC B-Disease 1 0.9998922348022461
cells O 0 0.00028298862162046134
are O 0 2.2421299945563078e-05
tumorigenic O 0 0.0031551008578389883
in O 0 0.00015186886594165117
nude O 0 0.003003101795911789
mice O 0 0.00018553064728621393
which O 0 2.8855960408691317e-05
is O 0 4.128733417019248e-05
suppressed O 0 0.00023833867453504354
by O 0 2.663119994394947e-05
the O 0 0.00012941926252096891
reintroduction O 0 0.0015018520643934608
of O 0 0.0011088961036875844
VHL B-Disease 1 0.9971480965614319
. O 0 0.002359696663916111

Remarkably O 0 0.006361671257764101
, O 0 0.0002720767806749791
this O 0 0.00011234276462346315
occurs O 0 0.00010255477536702529
without O 0 5.365455581340939e-05
affecting O 0 0.00012468000932130963
the O 0 6.682189996354282e-05
growth O 0 0.00010957616905216128
rate O 0 3.4311589843127877e-05
and O 0 2.495651824574452e-05
cell O 0 0.00013766578922513872
cycle O 0 0.00016120618965942413
profile O 0 6.370272603817284e-05
of O 0 6.62264137645252e-05
these O 0 3.981517147622071e-05
cells O 0 0.00016163161490112543
in O 0 0.00012363556015770882
culture O 0 0.000497372995596379
. O 0 0.00043907901272177696

The O 0 0.0012585093500092626
786 O 0 0.010163141414523125
- O 0 0.0009357990347780287
0 O 0 0.0003532149421516806
cell O 0 0.0004018362087663263
line O 0 0.00025604109396226704
, O 0 5.188948125578463e-05
like O 0 6.531977851409465e-05
many O 0 7.687160541536286e-05
cancer B-Disease 1 0.9980440139770508
cells O 0 0.00031255322392098606
, O 0 5.052758569945581e-05
fails O 0 9.568798850523308e-05
to O 0 1.4708287380926777e-05
exit O 0 0.00014666702190879732
the O 0 0.00012629645061679184
cell O 0 0.0004055971803609282
cycle O 0 0.0005060056573711336
upon O 0 0.00044267246266826987
serum O 0 0.01164254266768694
withdrawal O 0 0.00330245029181242
. O 0 0.0008336925529874861

Here O 0 0.0012200261699035764
, O 0 0.00021723723330069333
it O 0 4.917076148558408e-05
is O 0 3.84671802748926e-05
shown O 0 3.920509334420785e-05
that O 0 1.930939470184967e-05
reintroduction O 0 0.00011783680383814499
of O 0 4.853096470469609e-05
the O 0 7.49542232370004e-05
wild O 0 0.0001911664439830929
- O 0 0.0003173641161993146
type O 0 0.0004759574949275702
VHL B-Disease 1 0.8575806021690369
gene O 0 0.0001710783690214157
restores O 0 0.0004039393097627908
the O 0 8.464960410492495e-05
ability O 0 7.50456893001683e-05
of O 0 0.00015407764294650406
VHL O 1 0.999968409538269
- O 0 0.17497269809246063
negative O 0 0.011869368143379688
RCC B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9980162382125854
cells O 0 0.0001550925080664456
to O 0 3.219251811970025e-05
exit O 0 0.00017446462879888713
the O 0 9.300081728724763e-05
cell O 0 0.00025334832025691867
cycle O 0 0.0002744607045315206
and O 0 7.00247983331792e-05
enter O 0 0.0004303600871935487
G0 O 1 0.8625945448875427
/ O 0 0.0011729090474545956
quiescence O 0 0.0035108125302940607
in O 0 0.000292990735033527
low O 0 0.0009910091757774353
serum O 0 0.006669208873063326
. O 0 0.0008210854139178991

Both O 0 0.0030823510605841875
VHL O 1 0.9974070191383362
- O 0 0.0025319913402199745
positive O 0 0.0006164060905575752
and O 0 0.00041937915375456214
VHL O 1 0.9996955394744873
- O 0 0.00456952815875411
negative O 0 0.0010592510225251317
RCC B-Disease 1 0.9999083280563354
cells O 0 0.0003798475954681635
exit O 0 0.0003360583505127579
the O 0 0.00015179776528384537
cell O 0 0.0005705676740035415
cycle O 0 0.00041600066469982266
by O 0 0.00012590375263243914
contact O 0 0.0005707779200747609
inhibition O 0 0.0019474567379802465
. O 0 0.0007275950047187507

The O 0 0.0034943490754812956
cyclin O 0 0.01421314012259245
- O 0 0.0017700677271932364
dependent O 0 0.0008307345560751855
kinase O 0 0.001862956676632166
inhibitor O 0 0.004761865828186274
, O 0 0.00021676094911526889
p27 O 0 0.00365794962272048
, O 0 0.00011228301445953548
accumulates O 0 0.0007460993365384638
upon O 0 0.0002281731431139633
serum O 0 0.0017188630299642682
withdrawal O 0 0.0002903957793023437
, O 0 3.026919330295641e-05
only O 0 9.197224244417157e-06
in O 0 1.0299782843503635e-05
the O 0 2.652901821420528e-05
presence O 0 9.986343502532691e-05
of O 0 0.0001719031424727291
VHL B-Disease 1 0.9986055493354797
, O 0 6.726508581778035e-05
as O 0 3.584932710509747e-05
a O 0 4.075492688571103e-05
result O 0 2.893482451327145e-05
of O 0 3.91808025597129e-05
the O 0 6.012832818669267e-05
stabilization O 0 0.0004856193554587662
of O 0 0.0001678190747043118
the O 0 0.00026678034919314086
protein O 0 0.00048591833910904825
. O 0 0.0004710802750196308

We O 0 0.0005104800220578909
propose O 0 0.0003532551636453718
that O 0 4.672084469348192e-05
the O 0 6.516995199490339e-05
loss O 0 0.00018095457926392555
of O 0 0.00011272554547758773
wild O 0 0.0003947904915548861
- O 0 0.0006383874570019543
type O 0 0.0005758489132858813
VHL B-Disease 1 0.933074951171875
gene O 0 7.347809878410771e-05
results O 0 1.95997636183165e-05
in O 0 1.3253640645416453e-05
a O 0 4.400638863444328e-05
specific O 0 3.6104283935856074e-05
cellular O 0 0.0003168223483953625
defect O 0 0.060518164187669754
in O 0 0.00012761708057951182
serum O 0 0.11752677708864212
- O 0 0.00018626890960149467
dependent O 0 8.369189163204283e-05
growth O 0 6.840741116320714e-05
control O 0 5.818164208903909e-05
, O 0 3.69923873222433e-05
which O 0 4.291153891244903e-05
may O 0 0.0001857924653450027
initiate O 0 0.0019231928745284677
tumor B-Disease 1 0.9994069337844849
formation O 0 0.33546459674835205
. O 0 0.0012340929824858904

This O 0 0.000582626205869019
is O 0 0.00022426490613725036
corrected O 0 0.0004860677581746131
by O 0 3.941389877581969e-05
the O 0 6.411959475371987e-05
reintroduction O 0 0.0004667968605645001
of O 0 0.00014530411863233894
wild O 0 0.0003419351705815643
- O 0 0.0004553100443445146
type O 0 0.0006275354535318911
VHL B-Disease 1 0.9983622431755066
, O 0 0.00019606971181929111
implicating O 0 0.10541057586669922
VHL B-Disease 1 0.9325734376907349
as O 0 0.0001506384724052623
the O 0 0.00016175357450265437
first O 0 0.00040511589031666517
tumor B-Disease 1 0.9992706179618835
suppressor O 0 0.002322196727618575
involved O 0 6.532033876283094e-05
in O 0 2.2924468794371933e-05
the O 0 3.9175494748633355e-05
regulation O 0 4.9295784265268594e-05
of O 0 7.10057865944691e-05
cell O 0 0.0002796635963022709
cycle O 0 0.00022481600171886384
exit O 0 0.0001856490271165967
, O 0 4.871058263233863e-05
which O 0 1.7878150174510665e-05
is O 0 1.7501039110356942e-05
consistent O 0 4.0804006857797503e-05
with O 0 1.9225810319767334e-05
its O 0 5.494614379131235e-05
gatekeeper O 0 0.0030971504747867584
function O 0 0.00012184464139863849
in O 0 0.00012833488290198147
the O 0 0.0012374970829114318
kidney O 1 0.9999731779098511
. O 0 0.0005555389798246324
. O 0 0.0007330791559070349

Piebaldism B-Disease 1 0.9999364614486694
with O 0 0.020775938406586647
deafness B-Disease 1 0.9999995231628418
: O 0 0.00046730152098461986
molecular O 0 0.0003609927953220904
evidence O 0 0.00015143619384616613
for O 0 5.676796718034893e-05
an O 0 0.00023630856594536453
expanded O 0 0.016985755413770676
syndrome O 1 0.9999974966049194
. O 0 0.0012503542238846421

In O 0 0.000896924699191004
a O 0 0.00043391596409492195
South O 0 0.0008848085999488831
African O 0 0.0006142959464341402
girl O 0 0.0006110187387093902
of O 0 0.00019200146198272705
Xhosa O 0 0.3252984583377838
stock O 0 0.0003400174027774483
with O 0 0.00013583955296780914
severe O 1 0.999988317489624
piebaldism B-Disease 1 0.9999988079071045
and O 1 0.9956403970718384
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.0006734503549523652
identified O 0 9.228938142769039e-05
a O 0 7.447301322827116e-05
novel O 0 0.00010661363194230944
missense O 0 0.00023461940872948617
substitution O 0 0.00010024374932982028
at O 0 4.306100163375959e-05
a O 0 3.001073855557479e-05
highly O 0 3.1977571779862046e-05
conserved O 0 5.963017247267999e-05
residue O 0 0.00018929189536720514
in O 0 4.168524901615456e-05
the O 0 6.141424819361418e-05
intracellular O 0 0.00014715043653268367
kinase O 0 9.961178147932515e-05
domain O 0 7.669990009162575e-05
of O 0 9.222514927387238e-05
the O 0 0.00023860903456807137
KIT O 0 0.25616124272346497
proto O 0 0.3301834762096405
- O 0 0.0032653366215527058
oncogene O 0 0.43520405888557434
, O 0 0.0006416080868802965
R796G O 0 0.015882764011621475
. O 0 0.0011672566179186106

Though O 0 0.003040596144273877
auditory B-Disease 0 0.4675223231315613
anomalies I-Disease 0 0.006344132125377655
have O 0 7.178582018241286e-05
been O 0 6.322859553620219e-05
observed O 0 6.630875577684492e-05
in O 0 4.930241630063392e-05
mice O 0 9.988973761210218e-05
with O 0 1.9919916667276993e-05
dominant O 0 0.0001494017051300034
white O 0 0.00045953161315992475
spotting O 0 0.030083533376455307
( O 0 0.00015634478768333793
W O 0 0.0010697843972593546
) O 0 3.628466947702691e-05
due O 0 7.821694453014061e-05
to O 0 6.036468766978942e-05
KIT O 0 0.33829131722450256
mutations O 0 0.00043805851601064205
, O 0 0.00032859898055903614
deafness B-Disease 1 0.9999966621398926
is O 0 9.668527491157874e-05
not O 0 3.998087049694732e-05
typical O 0 0.00017537864914629608
in O 0 0.00010339542495785281
human O 0 0.00034597807098180056
piebaldism B-Disease 1 0.726224958896637
. O 0 0.000786391319707036

Thus O 0 0.001717453938908875
, O 0 0.00043961236951872706
the O 0 0.00029143228312022984
occurrence O 0 0.001059961155988276
of O 0 0.012437248602509499
sensorineural B-Disease 1 0.9999998807907104
deafness I-Disease 1 1.0
in O 0 0.00075423379894346
this O 0 0.000146595441037789
patient O 0 0.00044319822336547077
extends O 0 0.00021902020671404898
considerably O 0 0.0001020461495500058
the O 0 5.557794793276116e-05
phenotypic O 0 0.00015057530254125595
range O 0 5.394050822360441e-05
of O 0 0.00010504983220016584
piebaldism B-Disease 0 0.01840520091354847
due O 0 0.00018003262812271714
to O 0 6.812481296947226e-05
KIT O 0 0.007765788119286299
gene O 0 9.631783177610487e-05
mutation O 0 5.241300823399797e-05
in O 0 2.7428866815171205e-05
humans O 0 5.0003669457510114e-05
and O 0 4.3148469558218494e-05
tightens O 0 0.00025557162007316947
the O 0 7.495379395550117e-05
clinical O 0 0.0001498744240961969
similarity O 0 0.00018191593699157238
between O 0 0.00013519346248358488
piebaldism B-Disease 0 0.2465924620628357
and O 0 6.836019747424871e-05
the O 0 6.710465822834522e-05
various O 0 5.7599776482675225e-05
forms O 0 0.00026410436839796603
of O 1 0.9471985101699829
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0016859271563589573
. O 0 0.000977870193310082

Cycloheximide O 0 0.41467320919036865
facilitates O 0 0.0018369893077760935
the O 0 0.0003604355442803353
identification O 0 0.0002423991827527061
of O 0 0.00023658810823690146
aberrant O 0 0.0012013899395242333
transcripts O 0 0.00027096568373963237
resulting O 0 0.00016350131772924215
from O 0 5.200927262194455e-05
a O 0 9.196573228109628e-05
novel O 0 0.0001724789326544851
splice O 0 0.000521403388120234
- O 0 0.00014846866542939097
site O 0 0.000188551886822097
mutation O 0 9.525772475171834e-05
in O 0 5.958248220849782e-05
COL17A1 O 0 0.11058501899242401
in O 0 0.00010495000606169924
a O 0 0.00024225683591794223
patient O 0 0.0016912354622036219
with O 0 0.0006663043750450015
generalized O 1 0.9993676543235779
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999990463256836
epidermolysis I-Disease 1 0.9999980926513672
bullosa I-Disease 1 0.9999672174453735
. O 0 0.00373339606449008

Patients O 0 0.06617563962936401
with O 0 0.0031878871377557516
generalized O 1 0.9996762275695801
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999995231628418
epidermolysis I-Disease 1 0.9999995231628418
bullosa I-Disease 1 0.99997878074646
often O 0 0.0005730912089347839
show O 0 0.0004963012761436403
decreased O 0 0.0006129149114713073
expression O 0 0.0001861929049482569
of O 0 0.00025810234365053475
type O 0 0.3726351857185364
XVII O 1 0.9999967813491821
collagen O 1 0.9907523393630981
, O 0 0.00012774601054843515
a O 0 0.00022796545817982405
transmembrane O 0 0.0016957717016339302
hemidesmosomal O 0 0.009707110933959484
protein O 0 0.00018937927961815149
encoded O 0 0.00016680904082022607
by O 0 0.00021099085279274732
COL17A1 O 0 0.43564143776893616
. O 0 0.001129486015997827

This O 0 0.0004170886822976172
report O 0 0.00013501143257599324
documents O 0 0.00012107651855330914
a O 0 0.00010584054689388722
novel O 0 0.00021671508147846907
splice O 0 0.0007755443220958114
- O 0 0.00019575531769078225
site O 0 0.00014999136328697205
mutation O 0 9.08041256479919e-05
in O 0 5.7432269386481494e-05
COL17A1 O 0 0.11497507244348526
in O 0 6.953079719096422e-05
a O 0 0.00016251388296950608
patient O 0 0.0006423337035812438
with O 0 0.0003982597845606506
generalized O 1 0.9980260133743286
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999997615814209
bullosa I-Disease 1 0.9999898672103882
, O 0 0.0002240439353045076
and O 0 6.001610745443031e-05
applies O 0 6.010138167766854e-05
a O 0 3.938072404707782e-05
new O 0 2.975296047225129e-05
methodology O 0 6.283674156293273e-05
to O 0 1.833984970289748e-05
define O 0 5.485871224664152e-05
and O 0 4.1662198782432824e-05
characterize O 0 0.0002971320936921984
the O 0 0.00019532666192390025
resulting O 0 0.0006049462826922536
mRNA O 0 0.0007868403336033225
splice O 0 0.002678191987797618
variants O 0 0.0012965789064764977
. O 0 0.0007424018112942576

Mutational O 0 0.017763111740350723
analysis O 0 0.0008911284385249019
of O 0 0.000816464948002249
COL17A1 O 1 0.9050889611244202
identified O 0 0.0003786406305152923
a O 0 0.00034543342189863324
maternally O 0 0.003038194961845875
inherited O 0 0.08695986121892929
G O 0 0.0013211927143856883
- O 0 0.00020894980116281658
to O 0 5.785543180536479e-05
- O 0 0.0002209496742580086
T O 0 0.0005585834733210504
transversion O 0 0.0006152999121695757
at O 0 6.129805115051568e-05
the O 0 3.090205791522749e-05
- O 0 4.2810988816199824e-05
1 O 0 3.552130874595605e-05
position O 0 4.6327131713042036e-05
of O 0 0.00011986252502538264
exon O 0 0.0009443450253456831
32 O 0 0.0006297153886407614
. O 0 0.00043648184509947896

This O 0 0.0008226998033933342
acceptor O 0 0.0017694495618343353
splice O 0 0.0030723409727215767
- O 0 0.0004855064325965941
site O 0 0.0002921132545452565
mutation O 0 8.893654739949852e-05
led O 0 9.354220674140379e-05
to O 0 1.6625463103991933e-05
the O 0 3.5315140848979354e-05
formation O 0 0.0002487444435246289
of O 0 0.00013938518532086164
aberrant O 0 0.0007883766666054726
transcripts O 0 0.0002410534507362172
present O 0 6.402654253179207e-05
at O 0 0.00018202507635578513
extremely O 0 0.00020766991656273603
low O 0 0.0003200989158358425
levels O 0 0.00044123418047092855
. O 0 0.000412387860706076

Based O 0 0.0006494434783235192
on O 0 0.00026352659915573895
our O 0 0.00016890089318621904
recent O 0 0.00017112729256041348
finding O 0 0.0002937862591352314
that O 0 0.0001770784438122064
cycloheximide O 1 0.5802016854286194
stabilized O 0 0.1083989366889
mutant O 0 0.003755008801817894
COL17A1 O 1 0.7843525409698486
transcripts O 0 0.00044198689283803105
in O 0 0.00013462039350997657
keratinocytes O 0 0.0010577121283859015
homozygous O 0 0.00023829098790884018
for O 0 5.278857133816928e-05
a O 0 0.00022722721041645855
frameshift O 0 0.0025208010338246822
mutation O 0 0.0002205550263170153
, O 0 6.388151086866856e-05
the O 0 6.790972838643938e-05
effects O 0 0.00013466439850162715
of O 0 7.919428026070818e-05
the O 0 8.709458779776469e-05
splice O 0 0.0006505665951408446
- O 0 0.00013829614908900112
site O 0 0.00014381101937033236
mutation O 0 6.152140122139826e-05
on O 0 4.548097786027938e-05
splicing O 0 0.00017381027282681316
of O 0 0.00010685800953069702
COL17A1 O 0 0.011849775910377502
transcripts O 0 0.0001610854233149439
were O 0 3.327586091472767e-05
determined O 0 4.275810715625994e-05
using O 0 2.9632697987835854e-05
reverse O 0 0.00015104741032700986
transcriptase O 0 0.0004949867143295705
polymerase O 0 0.00021409158944152296
chain O 0 0.00017003249377012253
reaction O 0 5.7469194871373475e-05
of O 0 3.665875919978134e-05
total O 0 5.893972047488205e-05
RNA O 0 0.00013017696619499475
from O 0 7.076399197103456e-05
keratinocytes O 0 0.000917185447178781
incubated O 0 0.0005409782752394676
for O 0 8.769504347583279e-05
2 O 0 0.00043057187576778233
. O 0 0.0004056542238686234

5 O 0 0.0011018025688827038
h O 0 0.0008138209232129157
in O 0 8.254768181359395e-05
the O 0 8.88152644620277e-05
presence O 0 0.00011793820885941386
or O 0 5.361900184652768e-05
absence O 0 0.00015956252173054963
of O 0 0.0001562553661642596
10 O 0 0.00034108656109310687
microg O 0 0.26167237758636475
cycloheximide O 0 0.15777702629566193
per O 0 0.0008427618886344135
ml O 0 0.003325857687741518
. O 0 0.0008210180094465613

Using O 0 0.0003547322703525424
this O 0 9.747259900905192e-05
approach O 0 0.00019330014765728265
, O 0 6.013503661961295e-05
an O 0 8.087849710136652e-05
abnormally O 0 0.0009373468346893787
spliced O 0 0.00037814208189956844
transcript O 0 0.00020522181876003742
was O 0 0.0001298308779951185
identified O 0 3.59270597982686e-05
that O 0 1.116053681471385e-05
contains O 0 1.3888613466406241e-05
an O 0 1.4549053958035074e-05
extra O 0 2.97331644105725e-05
264 O 0 7.719791028648615e-05
bases O 0 5.524336302187294e-05
upstream O 0 9.714801126392558e-05
from O 0 2.4769960873527452e-05
exon O 0 0.00027350959135219455
32 O 0 8.730788249522448e-05
, O 0 3.903464676113799e-05
resulting O 0 7.820128666935489e-05
in O 0 3.192446456523612e-05
a O 0 0.00013377057621255517
premature O 0 0.0007003872888162732
termination O 0 0.0007484055240638554
codon O 0 0.0005940778064541519
27 O 0 0.00039553522947244346
bp O 0 0.001036329660564661
downstream O 0 0.00044543747208081186
from O 0 0.00011159369751112536
the O 0 0.0002378077624598518
cryptic O 0 0.0016032119747251272
splice O 0 0.0039036255329847336
site O 0 0.0019495682790875435
. O 0 0.0008873980841599405

Three O 0 0.0006093362462706864
other O 0 0.00013692806533072144
splice O 0 0.0008327405666932464
variants O 0 0.00014660117449238896
, O 0 3.4690678148763254e-05
including O 0 2.307950853719376e-05
one O 0 1.997262552322354e-05
derived O 0 3.2004754757508636e-05
from O 0 2.0184614186291583e-05
the O 0 4.1729283111635596e-05
skipping O 0 0.00023778894683346152
of O 0 0.00010086143447551876
exon O 0 0.00036631058901548386
32 O 0 0.0001249723427463323
, O 0 5.9336114645702764e-05
were O 0 5.553371011046693e-05
also O 0 7.032096618786454e-05
identified O 0 0.00028711510822176933
. O 0 0.00034837686689570546

These O 0 0.00036702348734252155
results O 0 0.0002439991367282346
indicate O 0 0.00023259031877387315
the O 0 0.00014420374645851552
usefulness O 0 0.0005325714009813964
of O 0 0.0003069724189117551
cycloheximide O 1 0.9871752858161926
treatment O 0 0.0007114896434359252
in O 0 6.125842628534883e-05
evaluating O 0 0.00010722096340032294
the O 0 6.123330967966467e-05
abnormal O 0 0.000281632092082873
processing O 0 0.00010420836042612791
of O 0 5.9224857977824286e-05
mRNA O 0 6.177289469633251e-05
due O 0 4.2527619370957837e-05
to O 0 1.6386205970775336e-05
splice O 0 0.00035396547173149884
- O 0 0.00012785264698322862
site O 0 0.00017378490883857012
mutations O 0 7.05827769706957e-05
, O 0 3.938109875889495e-05
because O 0 3.2478346838615835e-05
( O 0 3.956283399020322e-05
i O 0 6.992349517531693e-05
) O 0 3.4412387321935967e-05
aberrant O 0 0.0002594611141830683
splicing O 0 0.00011868651927215979
often O 0 2.5702407583594322e-05
generates O 0 5.459120438899845e-05
a O 0 7.446803647326306e-05
premature O 0 0.0005452394834719598
termination O 0 0.000504008203279227
codon O 0 0.0002784198441077024
, O 0 6.190947169670835e-05
( O 0 7.677592657273635e-05
ii O 0 0.0005856331554241478
) O 0 4.359765807748772e-05
transcripts O 0 0.00017548805044498295
with O 0 5.123941809870303e-05
premature O 0 0.0007389825186692178
termination O 0 0.0006658139755018055
codons O 0 0.000263782509136945
can O 0 2.6434467145008966e-05
occur O 0 5.0970353186130524e-05
at O 0 0.00010265007585985586
low O 0 0.00013813297846354544
or O 0 7.798606384312734e-05
undetectable O 0 0.0009731032769195735
levels O 0 0.0001258990669157356
due O 0 7.234218355733901e-05
to O 0 4.926453766529448e-05
nonsense O 0 0.0004401675541885197
- O 0 0.00013853676500730217
mediated O 0 0.00023706430511083454
mRNA O 0 0.00015809667820576578
decay O 0 0.0002721546043176204
, O 0 3.085914795519784e-05
and O 0 3.4949815017171204e-05
( O 0 5.502002386492677e-05
iii O 0 0.00034610970760695636
) O 0 2.1572859623120166e-05
the O 0 3.8288217183435336e-05
levels O 0 3.4466778743080795e-05
of O 0 2.8884211133117788e-05
these O 0 1.181252628157381e-05
transcripts O 0 6.322039553197101e-05
can O 0 1.5467712728423066e-05
be O 0 2.905679684772622e-05
increased O 0 7.804045162629336e-05
by O 0 0.00011485569120850414
cycloheximide O 0 0.014530648477375507
. O 0 0.0008534110966138542

A O 0 0.0035743366461247206
deletion O 0 0.0027345013804733753
mutation O 0 0.000620099832303822
in O 0 0.00022650585742667317
COL17A1 O 0 0.381971538066864
in O 0 0.00011241007450735196
five O 0 0.00012039726425427943
Austrian O 0 0.000721771502867341
families O 0 0.00018252927111461759
with O 0 0.00034630970912985504
generalized O 1 0.9917536973953247
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999990463256836
epidermolysis I-Disease 1 0.9999992847442627
bullosa I-Disease 1 0.9999680519104004
represents O 0 0.0018615616718307137
propagation O 0 0.0009977895533666015
of O 0 0.0002201476600021124
an O 0 0.00027373788179829717
ancestral O 0 0.004025195725262165
allele O 0 0.0015814669895917177
. O 0 0.0005622574244625866

Patients O 0 0.09248844534158707
with O 0 0.0030005231965333223
generalized O 1 0.9996556043624878
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999996423721313
epidermolysis I-Disease 1 0.9999996423721313
bullosa I-Disease 1 0.9999881982803345
, O 0 0.0005387399578467011
a O 0 0.0002588651259429753
usually O 0 0.00012133947166148573
nonlethal O 0 0.0008875909261405468
form O 0 0.00016414615674875677
of O 0 0.0009357588714919984
junctional B-Disease 1 0.9999674558639526
epidermolysis I-Disease 1 0.9999926090240479
bullosa I-Disease 1 0.999707043170929
, O 0 0.00032043876126408577
have O 0 8.895062637748197e-05
generalized O 0 0.0008351789438165724
blistering B-Disease 1 0.9680582284927368
, O 0 0.0027955779805779457
nail B-Disease 1 0.9999992847442627
dystrophy I-Disease 1 0.9999998807907104
, O 1 0.7002136707305908
patchy B-Disease 1 0.9999911785125732
alopecia I-Disease 1 1.0
, O 1 0.644549548625946
and O 1 0.7949674725532532
dental B-Disease 1 0.9999991655349731
abnormalities I-Disease 1 0.999995231628418
. O 0 0.002336779609322548

Skin B-Disease 1 0.9999164342880249
fragility I-Disease 1 0.998807430267334
in O 0 0.0003110775724053383
most O 0 8.069030445767567e-05
cases O 0 6.464107718784362e-05
is O 0 3.6873549106530845e-05
due O 0 3.8004251109668985e-05
to O 0 1.9414997950661927e-05
mutations O 0 3.1044077331898734e-05
in O 0 1.7567543181939982e-05
the O 0 4.8270045226672664e-05
gene O 0 8.039990643737838e-05
encoding O 0 0.00015860247367527336
type O 0 0.008181941695511341
XVII O 1 0.9999964237213135
collagen O 1 0.9999159574508667
( O 0 0.0020125352311879396
COL17A1 O 1 0.9988985061645508
) O 0 0.0005150128272362053
. O 0 0.000677313597407192

Recently O 0 0.002294014673680067
, O 0 0.00028099483461119235
we O 0 9.228110866388306e-05
reported O 0 0.00012452386727090925
five O 0 7.215932419057935e-05
Austrian O 0 0.0006703690160065889
families O 0 0.00020890976884402335
with O 0 0.00034787223557941616
generalized O 1 0.9991150498390198
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999996423721313
epidermolysis I-Disease 1 0.9999995231628418
bullosa I-Disease 1 0.9999247789382935
who O 0 0.0004247402830515057
share O 0 0.00015820268890820444
the O 0 0.00030997657449916005
same O 0 0.0005062880809418857
COL17A1 O 1 0.9987452030181885
mutation O 0 0.00259733316488564
. O 0 0.0009603729122318327

Affected O 0 0.0019539925269782543
individuals O 0 0.00013940990902483463
in O 0 8.694497955730185e-05
three O 0 4.93285660922993e-05
families O 0 4.5400203816825524e-05
are O 0 1.5742547475383617e-05
homozygous O 0 0.00010836230649147183
for O 0 3.66343701898586e-05
4003delTC O 0 0.0029885906260460615
, O 0 6.425787432817742e-05
whereas O 0 4.2450752516742796e-05
those O 0 1.0668280083336867e-05
in O 0 1.5428438928211108e-05
two O 0 2.792399754980579e-05
others O 0 6.917155405972153e-05
are O 0 5.1949980843346566e-05
compound O 0 0.003895420581102371
heterozygotes O 0 0.006084343884140253
. O 0 0.0008423726540058851

To O 0 0.00033230852568522096
determine O 0 0.000171894280356355
if O 0 7.061193173285574e-05
the O 0 9.182080248137936e-05
occurrence O 0 0.0002625883789733052
of O 0 0.00017873272008728236
4003delTC O 0 0.004764922894537449
in O 0 6.038333594915457e-05
these O 0 2.2001693650963716e-05
unrelated O 0 0.00014685819041915238
families O 0 6.79235890856944e-05
signifies O 0 0.0004257546679582447
propagation O 0 0.00019710700144059956
of O 0 5.235052594798617e-05
an O 0 5.04055387864355e-05
ancestral O 0 0.00029698878643102944
allele O 0 0.00011493513738969341
or O 0 3.8073325413279235e-05
a O 0 7.229432230815291e-05
mutational O 0 0.002124382648617029
hot O 0 0.0006372975767590106
spot O 0 0.0002998503914568573
, O 0 7.174407073762268e-05
haplotypes O 0 0.0001353339321212843
were O 0 2.2332822481985204e-05
determined O 0 4.3669857404893264e-05
for O 0 2.2756898033549078e-05
polymorphisms O 0 0.0001654841616982594
both O 0 3.9933129301061854e-05
within O 0 0.0001197963792947121
and O 0 0.0002518777037039399
flanking O 1 0.9675514101982117
COL17A1 O 1 0.9998437166213989
. O 0 0.0020703754853457212

Five O 0 0.0033426398877054453
intragenic O 0 0.1706833392381668
polymorphisms O 0 0.001166400732472539
were O 0 0.00015739152149762958
chosen O 0 0.00019666716980282217
based O 0 7.831113180145621e-05
on O 0 0.0001339904119959101
their O 0 0.00025522217038087547
informativeness O 0 0.13997328281402588
. O 0 0.0011973525397479534

One O 0 0.0003429309872444719
of O 0 0.00016657315427437425
these O 0 2.6186293325736187e-05
, O 0 2.8504018700914457e-05
not O 0 1.1054081369366031e-05
previously O 0 3.979630128014833e-05
reported O 0 4.0128652472049e-05
, O 0 2.9561830160673708e-05
was O 0 0.00016625993885099888
2988 O 0 0.0023223161697387695
A O 0 0.00027234459412284195
or O 0 4.9897014832822606e-05
C O 0 0.00012503753532655537
that O 0 1.3196104191592894e-05
introduces O 0 5.540754500543699e-05
a O 0 3.435553298913874e-05
new O 0 4.841706686420366e-05
restriction O 0 0.00011411042214604095
site O 0 0.00020929497259203345
for O 0 0.00015280490333680063
Eco0109 O 0 0.05061028525233269
I O 0 0.0029765432700514793
. O 0 0.0011243289336562157

All O 0 0.0007075004396028817
the O 0 0.0008330969139933586
4003delTC O 0 0.02423170767724514
alleles O 0 0.0005103771109133959
showed O 0 0.00031310139456763864
the O 0 0.00010442959319334477
same O 0 7.238703256007284e-05
haplotype O 0 0.00025492574786767364
for O 0 3.0084673198871315e-05
these O 0 3.047257268917747e-05
five O 0 0.00014317738532554358
polymorphic O 0 0.0014805517857894301
markers O 0 0.0027201815973967314
. O 0 0.0011200192384421825

Fourteen O 0 0.009175663813948631
microsatellite O 0 0.014467671513557434
polymorphisms O 0 0.0013978811912238598
were O 0 0.00010447142994962633
selected O 0 9.105930803343654e-05
based O 0 2.7224636141909286e-05
on O 0 2.9023789466009475e-05
their O 0 3.089415986323729e-05
high O 0 0.00026838327175937593
heterozygosity O 0 0.0025934649165719748
and O 0 5.224987762630917e-05
their O 0 3.182087675668299e-05
location O 0 0.00014562616706825793
within O 0 0.00020585228048730642
10q23 O 0 0.26868703961372375
- O 0 0.001294333953410387
q25 O 0 0.12176598608493805
near O 0 0.012009353376924992
COL17A1 O 1 0.9966482520103455
. O 0 0.0017728590173646808

Three O 0 0.000991145963780582
families O 0 0.0005478989332914352
shared O 0 0.0006373588694259524
microsatellite O 0 0.0036974484100937843
polymorphisms O 0 0.0008448223234154284
covering O 0 0.00047671847278252244
at O 0 0.00015215134772006422
most O 0 3.866659608320333e-05
19 O 0 0.00012113612319808453
cM O 0 0.00015382104902528226
, O 0 4.530397563939914e-05
whereas O 0 4.7198846004903316e-05
the O 0 4.722820085589774e-05
others O 0 2.883032721001655e-05
shared O 0 4.266780524631031e-05
smaller O 0 2.4468181436532177e-05
regions O 0 1.626662924536504e-05
consistent O 0 4.83887197333388e-05
with O 0 1.6860107280081138e-05
cross O 0 8.131768845487386e-05
- O 0 6.795034278184175e-05
over O 0 2.675355972314719e-05
events O 0 3.006711631314829e-05
during O 0 3.492429823381826e-05
passage O 0 4.05386344937142e-05
of O 0 3.07426271319855e-05
this O 0 2.6108098609256558e-05
mutation O 0 6.000809298711829e-05
through O 0 3.602435390348546e-05
several O 0 0.00010029002442024648
generations O 0 0.0007174100610427558
. O 0 0.00045846254215575755

These O 0 0.00031594705069437623
results O 0 0.00020350438717287034
indicate O 0 0.0001753696269588545
that O 0 7.051866123219952e-05
4003delTC O 0 0.001430943375453353
occurs O 0 9.7144118626602e-05
on O 0 5.309006155584939e-05
a O 0 9.731323370942846e-05
single O 0 0.00012812689237762243
ancestral O 0 0.0014204657636582851
allele O 0 0.00048164077452383935
. O 0 0.00018309331790078431
. O 0 0.00030687934486195445

The O 0 0.004362135659903288
haptoglobin O 0 0.14997437596321106
- O 0 0.002383260754868388
gene O 0 0.0006784946308471262
deletion O 0 0.0011908737942576408
responsible O 0 0.0009748947340995073
for O 0 0.00042902646237052977
anhaptoglobinemia B-Disease 1 0.7159256339073181
. O 0 0.0010726336622610688

We O 0 0.00034263249835930765
have O 0 6.494004628621042e-05
found O 0 6.139668403193355e-05
an O 0 6.602986104553565e-05
allelic O 0 0.0006646633264608681
deletion O 0 0.00030948841595090926
of O 0 0.00011627227650023997
the O 0 0.00028441110043786466
haptoglobin O 0 0.0233323872089386
( O 0 0.00013502856018021703
Hp O 0 0.0004525096737779677
) O 0 3.279283191659488e-05
gene O 0 6.509083323180676e-05
from O 0 3.5344484786037356e-05
an O 0 4.147280196775682e-05
individual O 0 7.882916543167084e-05
with O 0 0.00016761613369453698
anhaptoglobinemia B-Disease 1 0.9184058308601379
. O 0 0.001208578352816403

The O 0 0.002808368531987071
Hp O 0 0.003930320963263512
gene O 0 0.0006709122681058943
cluster O 0 0.0006267832359299064
consists O 0 0.00015715727931819856
of O 0 9.106408833758906e-05
coding O 0 0.0001208497560583055
regions O 0 3.9670350815868005e-05
of O 0 5.339643030310981e-05
the O 0 0.00011844604159705341
alpha O 0 0.0002553677186369896
chain O 0 0.00011385824473109096
and O 0 2.6711675673141144e-05
beta O 0 8.581083966419101e-05
chain O 0 8.806023834040388e-05
of O 0 4.236388485878706e-05
the O 0 0.00010122873936779797
haptoglobin O 0 0.0028428961522877216
gene O 0 0.00012050131772411987
( O 0 5.573855378315784e-05
Hp O 0 0.00021082656166981906
) O 0 1.740412335493602e-05
and O 0 2.1498248315765522e-05
of O 0 4.798365262104198e-05
the O 0 8.654181146994233e-05
alpha O 0 0.0003351184132043272
chain O 0 0.00016377642168663442
and O 0 4.4391039409674704e-05
beta O 0 0.00012120277096983045
chain O 0 8.190252992790192e-05
of O 0 5.139592394698411e-05
the O 0 9.333175694337115e-05
haptoglobin O 0 0.002581279957666993
- O 0 0.00013576394121628255
related O 0 5.920933108427562e-05
gene O 0 8.590761717641726e-05
( O 0 5.802731902804226e-05
Hpr O 0 0.0008822081726975739
) O 0 3.214962998754345e-05
, O 0 1.934327337949071e-05
in O 0 2.5003422706504352e-05
tandem O 0 0.00019394650007598102
from O 0 7.446989184245467e-05
the O 0 0.000137072303914465
5 O 0 0.0003182015207130462
side O 0 0.0006797304376959801
. O 0 0.0004128296277485788

Southern O 0 0.005685176234692335
blot O 0 0.010571162216365337
and O 0 0.0005964339361526072
PCR O 0 0.001032428233884275
analyses O 0 0.00010846558143384755
have O 0 2.9713350158999674e-05
indicated O 0 5.1273931603645906e-05
that O 0 1.1811467629740946e-05
the O 0 3.045015000679996e-05
individual O 0 3.1674942874815315e-05
with O 0 3.405390089028515e-05
anhaptoglobinemia B-Disease 0 0.310776025056839
was O 0 0.00031681900145485997
homozygous O 0 0.00010640765685820952
for O 0 2.0154260710114613e-05
the O 0 5.016701470594853e-05
gene O 0 6.37319462839514e-05
deletion O 0 7.413714774884284e-05
and O 0 1.6038649846450426e-05
that O 0 1.0375912097515538e-05
the O 0 2.3311684344662353e-05
gene O 0 4.170338434050791e-05
deletion O 0 8.832827006699517e-05
was O 0 7.315089897019789e-05
included O 0 2.754640627244953e-05
at O 0 4.9412603402743116e-05
least O 0 1.7846976334112696e-05
from O 0 2.447936094540637e-05
the O 0 5.0101327360607684e-05
promoter O 0 0.0006168078398332
region O 0 0.00013631732144858688
of O 0 0.00013761749141849577
Hp O 0 0.0005821704398840666
to O 0 9.559276804793626e-05
Hpr O 0 0.0016290248604491353
alpha O 0 0.00019356371194589883
but O 0 2.0258470613043755e-05
not O 0 1.3035902156843804e-05
to O 0 4.195172368781641e-05
Hpr O 0 0.002284008776769042
beta O 0 0.00043667579302564263
( O 0 0.0003803966101258993
Hpdel O 0 0.058501049876213074
) O 0 0.00047601197729818523
. O 0 0.000674859038554132

In O 0 0.0005900990217924118
addition O 0 0.00022102090588305146
, O 0 6.243868847377598e-05
we O 0 1.8215083400718868e-05
found O 0 1.615177643543575e-05
seven O 0 2.5269962861784734e-05
individuals O 0 9.702599527372513e-06
with O 0 1.4215487681212835e-05
hypohaptoglobinemia B-Disease 0 0.005169258918613195
in O 0 2.7552370738703758e-05
three O 0 1.7694672351353802e-05
families O 0 1.537680691399146e-05
, O 0 1.614373832126148e-05
and O 0 1.0617814950819593e-05
the O 0 2.2544971216120757e-05
genotypes O 0 7.681811257498339e-05
of O 0 2.745278470683843e-05
six O 0 2.7684562155627646e-05
of O 0 2.5946388632291928e-05
the O 0 1.963051727216225e-05
seven O 0 2.2672462364425883e-05
individuals O 0 9.922897334035952e-06
were O 0 1.4952876881579868e-05
found O 0 2.3408592824125662e-05
to O 0 3.0252627766458318e-05
be O 0 0.0001270905340788886
Hp2 O 1 0.9126573801040649
/ O 0 0.011750645004212856
Hpdel O 1 0.8839019536972046
. O 0 0.0014369927812367678

The O 0 0.001643711468204856
phenotypes O 0 0.0019249098841100931
and O 0 0.000139917028718628
genotypes O 0 0.00046132036368362606
in O 0 3.7672787584597245e-05
one O 0 2.059209691651631e-05
of O 0 3.0047942345845513e-05
these O 0 7.892724170233123e-06
three O 0 1.7965707229450345e-05
families O 0 2.21968275582185e-05
showed O 0 6.278618820942938e-05
the O 0 4.113995237275958e-05
father O 0 0.0001132435500039719
to O 0 2.406446037639398e-05
be O 0 4.577276195050217e-05
hypohaptoglobinemic B-Disease 0 0.006149566266685724
( O 0 0.00013066722021903843
Hp2 O 0 0.013146498240530491
) O 0 6.764048157492653e-05
and O 0 7.216930680442601e-05
Hp2 O 0 0.4741092622280121
/ O 0 0.0012141902698203921
Hpdel O 0 0.05239984393119812
, O 0 6.179764750413597e-05
the O 0 4.4088083086535335e-05
mother O 0 9.637901530368254e-05
to O 0 1.6055515516200103e-05
be O 0 2.15968848351622e-05
Hp2 O 0 0.002119536278769374
- O 0 0.0001121461609727703
1 O 0 5.957441317150369e-05
and O 0 6.362033309414983e-05
Hp1 O 0 0.24428243935108185
/ O 0 0.0005515129305422306
Hp2 O 0 0.006794068031013012
, O 0 3.6973444366594777e-05
one O 0 1.365156003885204e-05
of O 0 1.732770942908246e-05
the O 0 2.0521327314781956e-05
two O 0 1.1993989573966246e-05
children O 0 1.7709509847918525e-05
to O 0 1.2260747098480351e-05
be O 0 2.0698096705018543e-05
hypohaptoglobinemic B-Disease 0 0.005316989496350288
( O 0 8.362192602362484e-05
Hp2 O 0 0.009571542963385582
) O 0 4.2208430386381224e-05
and O 0 8.590614015702158e-05
Hp2 O 1 0.8538970947265625
/ O 0 0.002116304589435458
Hpdel O 0 0.37792742252349854
, O 0 4.188073580735363e-05
and O 0 2.8430587917682715e-05
the O 0 4.1574410715838894e-05
other O 0 1.4251335414883215e-05
child O 0 8.096786768874153e-05
to O 0 2.509843216103036e-05
be O 0 5.9059613704448566e-05
Hp1 O 0 0.06007927283644676
and O 0 0.0002274611033499241
Hp1 O 1 0.9987292885780334
/ O 0 0.01457780972123146
Hpdel O 1 0.6785151362419128
, O 0 0.0001445570233045146
showing O 0 0.00016846985090523958
an O 0 7.11275715730153e-05
anomalous O 0 0.0006883193273097277
inheritance O 0 0.00034000686719082296
of O 0 0.0003165923117194325
Hp O 0 0.009979556314647198
phenotypes O 0 0.0004396094591356814
in O 0 7.16055219527334e-05
the O 0 0.0001386309741064906
child O 0 0.0005946715245954692
with O 0 0.00026058536604978144
Hp1 O 1 0.995690643787384
. O 0 0.0013177783694118261

The O 0 0.005294014699757099
Hp2 O 1 0.9971760511398315
/ O 0 0.08212308585643768
Hpdel O 1 0.580031156539917
individuals O 0 0.00013052363647148013
had O 0 0.00015131324471440166
an O 0 6.596880120923743e-05
extremely O 0 0.00015215409803204238
low O 0 7.649492908967659e-05
level O 0 5.372541272663511e-05
of O 0 9.696291090222076e-05
Hp O 0 0.000345926295267418
( O 0 4.7170226025627926e-05
mean O 0 9.241673251381144e-05
+ O 0 0.00017198921705130488
/ O 0 0.00015830498887225986
- O 0 0.00014530452608596534
SD O 0 0.0005727763054892421
= O 0 0.0001538970391266048
0 O 0 6.29993446636945e-05
. O 0 4.64422300865408e-05
049 O 0 0.0010584791889414191
+ O 0 0.00020185191533528268
/ O 0 0.00015964060730766505
- O 0 0.0001017663671518676
0 O 0 6.640810170210898e-05
. O 0 5.00097667099908e-05
043 O 0 0.0007864393992349505
mg O 0 0.0005272598355077207
/ O 0 0.00021932910021860152
ml O 0 0.00032924464903771877
; O 0 2.839473745552823e-05
n O 0 6.783517164876685e-05
= O 0 6.577156455023214e-05
6 O 0 4.3809883209178224e-05
) O 0 1.2315791536821052e-05
, O 0 8.863396942615509e-06
compared O 0 1.1999893104075454e-05
with O 0 6.9641691879951395e-06
the O 0 2.0482279069256037e-05
level O 0 4.645259468816221e-05
( O 0 2.3602939108968712e-05
1 O 0 3.518598896334879e-05
. O 0 2.0204990505590104e-05
64 O 0 9.055197006091475e-05
+ O 0 0.00014168737106956542
/ O 0 0.00011425869888626039
- O 0 7.562385872006416e-05
1 O 0 5.8704634284367785e-05
. O 0 3.6559471482178196e-05
07 O 0 0.0007739957654848695
mg O 0 0.0005738014588132501
/ O 0 0.00028390312218107283
ml O 0 0.00035072368336841464
) O 0 3.524862040649168e-05
obtained O 0 4.010696284240112e-05
from O 0 5.470370888360776e-05
52 O 0 0.0002388491848250851
healthy O 0 0.0003180019848514348
volunteers O 0 0.00028150217258371413
having O 0 0.0002499230613466352
phenotype O 0 0.0009013806120492518
Hp2 O 0 0.07390425354242325
, O 0 8.874820923665538e-05
whereas O 0 0.00010360870510339737
the O 0 0.00011824821558548138
serum O 0 0.0010559592628851533
Hp O 0 0.00033147225622087717
level O 0 7.454564183717594e-05
of O 0 4.767691279994324e-05
an O 0 3.826693500741385e-05
individual O 0 3.458500941633247e-05
with O 0 6.432033842429519e-05
Hp1 O 1 0.9860418438911438
/ O 0 0.004910238087177277
Hpdel O 1 0.721784770488739
was O 0 0.0017309372778981924
0 O 0 0.0006305206334218383
. O 0 0.0005773712764494121

50 O 0 0.003009611973538995
mg O 0 0.005332425702363253
/ O 0 0.0015121923061087728
ml O 0 0.001200956292450428
, O 0 7.134691986721009e-05
which O 0 1.6794698240119033e-05
was O 0 6.750477041350678e-05
approximately O 0 2.8153363018645905e-05
half O 0 2.1227699107839726e-05
the O 0 3.567577005014755e-05
level O 0 4.345263369032182e-05
of O 0 6.219148053787649e-05
Hp O 0 0.00031593922176398337
in O 0 7.08266525180079e-05
control O 0 0.00011629753862507641
sera O 0 0.000525197247043252
from O 0 5.2101502660661936e-05
the O 0 8.997322584036738e-05
Hp1 O 0 0.06312713772058487
phenotype O 0 0.00018805149011313915
( O 0 2.5800076400628313e-05
1 O 0 1.709302705421578e-05
. O 0 1.1375025678717066e-05
26 O 0 6.652098090853542e-05
+ O 0 6.979904719628394e-05
/ O 0 6.421413127100095e-05
- O 0 3.629082493716851e-05
0 O 0 2.5864570488920435e-05
. O 0 1.7721135009196587e-05
33 O 0 0.00012134281860198826
mg O 0 0.00032591522904112935
/ O 0 0.0002743989753071219
ml O 0 0.0003191737923771143
; O 0 4.4129774323664606e-05
n O 0 9.701820818008855e-05
= O 0 8.326147508341819e-05
9 O 0 8.623444591648877e-05
) O 0 1.9402372345211916e-05
, O 0 2.352976480324287e-05
showing O 0 0.00012299376248847693
a O 0 0.00013230300100985914
gene O 0 0.0002846354618668556
- O 0 0.0004153017362114042
dosage O 0 0.0013608501758426428
effect O 0 0.0006977255106903613
. O 0 0.0005320958443917334

The O 0 0.0006666581612080336
other O 0 0.0001796375581761822
allele O 0 0.0002979269193019718
( O 0 0.00011006417480530217
Hp2 O 0 0.0021512224338948727
) O 0 4.360036109574139e-05
of O 0 5.8817826356971636e-05
individuals O 0 3.523830309859477e-05
with O 0 8.795691974228248e-05
Hp2 O 1 0.9996013045310974
/ O 0 0.11126919835805893
Hpdel O 1 0.9631191492080688
was O 0 0.00019664915453176945
found O 0 2.847076757461764e-05
to O 0 1.2533690096461214e-05
have O 0 7.793329132255167e-06
, O 0 1.3625548490381334e-05
in O 0 1.3159083209757227e-05
all O 0 1.640030495764222e-05
exons O 0 0.00013899855548515916
, O 0 2.6208304916508496e-05
no O 0 5.275545481708832e-05
mutation O 0 5.270738620311022e-05
, O 0 3.2502663088962436e-05
by O 0 5.468368181027472e-05
DNA O 0 0.0003942766925320029
sequencing O 0 0.0007657445967197418
. O 0 0.00043110348633490503

On O 0 0.00041577802039682865
the O 0 0.0001605084544280544
basis O 0 6.267247954383492e-05
of O 0 5.36999614269007e-05
the O 0 6.38265919405967e-05
present O 0 6.27038607490249e-05
study O 0 2.9445625841617584e-05
, O 0 1.9980321667389944e-05
the O 0 3.479856241028756e-05
mechanism O 0 8.435065683443099e-05
of O 0 0.00011570685455808416
anhaptoglobinemia B-Disease 0 0.030450809746980667
and O 0 4.2960797145497054e-05
the O 0 5.992002479615621e-05
mechanism O 0 0.00010061887587653473
of O 0 0.0001334523258265108
anomalous O 0 0.0013116714544594288
inheritance O 0 0.0006815554224886
of O 0 0.0005608673673123121
Hp O 0 0.12071964889764786
phenotypes O 0 0.0007458888576366007
were O 0 0.000168746366398409
well O 0 0.00018827198073267937
explained O 0 0.0008604011381976306
. O 0 0.0007953208987601101

However O 0 0.0010117028141394258
, O 0 0.0002941825659945607
the O 0 0.0002890817413572222
mechanism O 0 0.0008006041753105819
of O 0 0.000891301257070154
hypohaptoglobinemia B-Disease 1 0.9985431432723999
remains O 0 0.016054654493927956
unknown O 0 0.005731121636927128

ATM O 0 0.02211134135723114
mutations O 0 0.0017782036447897553
and O 0 0.0004084745596628636
phenotypes O 0 0.002954901894554496
in O 0 0.0007939569186419249
ataxia B-Disease 1 0.9999986886978149
- I-Disease 1 0.9423479437828064
telangiectasia I-Disease 1 0.9974073767662048
families O 0 0.0001708965573925525
in O 0 6.189194391481578e-05
the O 0 9.082542965188622e-05
British O 0 0.0002121513825841248
Isles O 0 0.00031465000938624144
: O 0 4.793102198163979e-05
expression O 0 7.011098932707682e-05
of O 0 7.268183253472671e-05
mutant O 0 0.0003192142175976187
ATM O 0 0.0002292761782882735
and O 0 2.128285268554464e-05
the O 0 5.1902447012253106e-05
risk O 0 0.00014308906975202262
of O 0 0.03494798392057419
leukemia B-Disease 1 1.0
, O 1 0.9998118281364441
lymphoma B-Disease 1 1.0
, O 1 0.984893262386322
and O 1 0.9816821217536926
breast B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999912977218628
. O 0 0.001976677915081382

We O 0 0.0007446204544976354
report O 0 0.00025128500419668853
the O 0 0.00013600598322227597
spectrum O 0 0.00023974878422450274
of O 0 0.00016323837917298079
59 O 0 0.00041839564801193774
ATM O 0 0.0007856400916352868
mutations O 0 0.00016552234592381865
observed O 0 9.447045158594847e-05
in O 0 0.00011168459604959935
ataxia B-Disease 1 0.999909520149231
- I-Disease 0 0.04721415787935257
telangiectasia I-Disease 1 0.9997311234474182
( O 0 0.0004425845108926296
A B-Disease 1 0.9959486126899719
- I-Disease 1 0.8237993717193604
T I-Disease 1 0.9956423044204712
) O 0 6.179080810397863e-05
patients O 0 6.125024810899049e-05
in O 0 3.37394121743273e-05
the O 0 0.00010787804058054462
British O 0 0.0005377656198106706
Isles O 0 0.0022638868540525436
. O 0 0.0009162115748040378

Of O 0 0.0014832639135420322
51 O 0 0.0015315643977373838
ATM O 0 0.0022608786821365356
mutations O 0 0.0001893247535917908
identified O 0 7.348159851972014e-05
in O 0 2.438087722111959e-05
families O 0 2.2667163648293354e-05
native O 0 3.2937663490884006e-05
to O 0 1.1378573617548682e-05
the O 0 3.115636354777962e-05
British O 0 8.879646338755265e-05
Isles O 0 0.00013195625797379762
, O 0 2.53266825893661e-05
11 O 0 4.966141568729654e-05
were O 0 3.667949931696057e-05
founder O 0 0.0004360011371318251
mutations O 0 8.045926369959489e-05
, O 0 1.780310230969917e-05
and O 0 1.5165073818934616e-05
2 O 0 1.9909130060113966e-05
of O 0 2.627038884384092e-05
these O 0 9.590906302037183e-06
11 O 0 6.938639126019552e-05
conferred O 0 0.0001682200818322599
a O 0 9.10939706955105e-05
milder O 0 0.00032519359956495464
clinical O 0 0.00020820143981836736
phenotype O 0 0.00017231998208444566
with O 0 2.751461033767555e-05
respect O 0 0.00011219696898479015
to O 0 6.986883818171918e-05
both O 0 0.0006161637720651925
cerebellar B-Disease 1 0.9999998807907104
degeneration I-Disease 1 1.0
and O 1 0.5286146402359009
cellular O 1 0.508711576461792
features O 0 0.00086110649863258
. O 0 0.0005847502616234124

We O 0 0.0004976117634214461
report O 0 0.00013987674901727587
, O 0 4.648037793231197e-05
in O 0 3.477311838651076e-05
two O 0 4.1431649151491e-05
A B-Disease 0 0.004229096695780754
- I-Disease 0 0.000983412261120975
T I-Disease 0 0.008158045820891857
families O 0 4.228997931932099e-05
, O 0 2.0638473870349117e-05
an O 0 3.595817543100566e-05
ATM O 0 0.0002596320991870016
mutation O 0 9.029639477375895e-05
( O 0 7.918099436210468e-05
7271T O 0 0.003611197229474783
- O 0 0.00018783628183882684
- O 0 0.00015195287414826453
> O 0 0.00022763446031603962
G O 0 0.00027791433967649937
) O 0 1.9220035028411075e-05
that O 0 8.375804100069217e-06
may O 0 1.0865947842830792e-05
be O 0 8.133144547173288e-06
associated O 0 1.3902661521569826e-05
with O 0 7.286588243005099e-06
an O 0 2.305966518179048e-05
increased O 0 7.743819151073694e-05
risk O 0 0.0001815959985833615
of O 0 0.030001560226082802
breast B-Disease 1 0.9999990463256836
cancer I-Disease 1 0.999664306640625
in O 0 8.860691013978794e-05
both O 0 8.12540456536226e-05
homozygotes O 0 0.0014624272007495165
and O 0 7.226936577353626e-05
heterozygotes O 0 0.00034660828532651067
( O 0 4.25263169745449e-05
relative O 0 7.409100362565368e-05
risk O 0 4.1809980757534504e-05
12 O 0 4.7251134674297646e-05
. O 0 1.3961866898171138e-05
7 O 0 4.7415393055416644e-05
; O 0 2.4761129679973237e-05
P O 0 0.00023618555860593915
= O 0 0.00015001394785940647
. O 0 4.230389095027931e-05
0025 O 0 0.0014012133469805121
) O 0 2.7509180654305965e-05
, O 0 1.3675133232027292e-05
although O 0 1.2130162758694496e-05
there O 0 1.0821469913935289e-05
is O 0 1.0186216968577355e-05
a O 0 3.38277495757211e-05
less O 0 6.57664131722413e-05
severe O 1 0.9963791966438293
A B-Disease 1 0.999476969242096
- I-Disease 1 0.6652696132659912
T I-Disease 1 0.8504869341850281
phenotype O 0 0.00016464071813970804
in O 0 2.0667723219958134e-05
terms O 0 2.1128113075974397e-05
of O 0 4.985882333130576e-05
the O 0 9.335258073406294e-05
degree O 0 0.0010001246118918061
of O 1 0.7081015706062317
cerebellar B-Disease 1 0.9999998807907104
degeneration I-Disease 1 1.0
. O 0 0.02039395458996296

This O 0 0.000740522111300379
mutation O 0 0.0007287744083441794
( O 0 0.0003253489558119327
7271T O 0 0.15187208354473114
- O 0 0.0011165911564603448
- O 0 0.0007620382239110768
> O 0 0.0008083200664259493
G O 0 0.0006064018816687167
) O 0 4.5538701670011505e-05
also O 0 2.5380237275385298e-05
allows O 0 1.4489569366560318e-05
expression O 0 3.572067726054229e-05
of O 0 4.192172855255194e-05
full O 0 4.6843215386616066e-05
- O 0 6.939619197510183e-05
length O 0 3.620567804318853e-05
ATM O 0 0.00012285767297726125
protein O 0 2.9332342819543555e-05
at O 0 3.08858543576207e-05
a O 0 2.5357447157148272e-05
level O 0 3.583052966860123e-05
comparable O 0 3.681866292026825e-05
with O 0 1.5052973139972892e-05
that O 0 2.3090338800102472e-05
in O 0 6.143850623629987e-05
unaffected O 0 0.0007902698125690222
individuals O 0 0.00019970606081187725
. O 0 0.00041361310286447406

In O 0 0.0005734296864829957
addition O 0 0.00022026649094186723
, O 0 7.443041977239773e-05
we O 0 2.6010258807218634e-05
have O 0 1.241162681253627e-05
studied O 0 5.3277413826435804e-05
18 O 0 0.00013498531188815832
A B-Disease 1 0.5951350927352905
- I-Disease 1 0.5073173642158508
T I-Disease 1 0.9979056119918823
patients O 0 0.0001082178350770846
, O 0 2.5781482690945268e-05
in O 0 1.7183951058541425e-05
15 O 0 3.778597601922229e-05
families O 0 2.6743178750621155e-05
, O 0 3.323656346765347e-05
who O 0 0.00013669402687810361
developed O 0 0.05644319951534271
leukemia B-Disease 1 0.9999998807907104
, O 1 0.8870401978492737
lymphoma B-Disease 1 1.0
, O 0 0.012254542671144009
preleukemic O 1 0.9999724626541138
T O 1 0.999234676361084
- O 0 0.0012880892027169466
cell O 0 0.001343218027614057
proliferation O 0 0.012813870795071125
, O 0 0.0002803183742798865
or O 1 0.5498454570770264
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.000699959578923881
mostly O 0 0.0002853516780305654
in O 0 0.00036828892189078033
childhood O 0 0.08925221860408783
. O 0 0.0007825325592420995

A O 0 0.0018767168512567878
wide O 0 0.0006757591036148369
variety O 0 0.00022679800167679787
of O 0 0.00023436543415300548
ATM O 0 0.0018744654953479767
mutation O 0 0.0001391919213347137
types O 0 4.951869777869433e-05
, O 0 4.37955568486359e-05
including O 0 3.9344315155176446e-05
missense O 0 0.0004060606297571212
mutations O 0 7.529047434218228e-05
and O 0 2.161441807402298e-05
in O 0 3.2171650673262775e-05
- O 0 0.00014292380365077406
frame O 0 0.000327566172927618
deletions O 0 0.0002294255536980927
, O 0 3.819096309598535e-05
were O 0 4.51323066954501e-05
seen O 0 0.00010932338773272932
in O 0 6.869183562230319e-05
these O 0 8.738076576264575e-05
patients O 0 0.0005712792044505477
. O 0 0.00036175482091493905

We O 0 0.0004284482856746763
also O 0 0.00010265986929880455
show O 0 7.07783765392378e-05
that O 0 1.5436913599842228e-05
25 O 0 2.8251179173821583e-05
% O 0 1.5655965398764238e-05
of O 0 3.720643144333735e-05
all O 0 3.812444265349768e-05
A B-Disease 1 0.6943671703338623
- I-Disease 0 0.3055260181427002
T I-Disease 1 0.9149978756904602
patients O 0 8.733818685868755e-05
carried O 0 5.6852473790058866e-05
in O 0 4.779700611834414e-05
- O 0 0.00015008119225967675
frame O 0 0.00044210467603988945
deletions O 0 0.0003303523117210716
or O 0 9.105557546718046e-05
missense O 0 0.0005408130818977952
mutations O 0 7.434572034981102e-05
, O 0 2.58541385846911e-05
many O 0 1.116236762754852e-05
of O 0 2.8127436962677166e-05
which O 0 1.913497362693306e-05
were O 0 2.5680556063889526e-05
also O 0 2.0427465642569587e-05
associated O 0 2.7767984647653066e-05
with O 0 2.0729425159515813e-05
expression O 0 7.818950689397752e-05
of O 0 0.00018481837469153106
mutant O 0 0.0033889764454215765
ATM O 0 0.0027948375791311264
protein O 0 0.0007206552545540035
. O 0 0.0008160854340530932

The O 0 0.004810504149645567
DMPK O 1 0.9985430240631104
gene O 0 0.0021786855068057775
of O 0 0.018787791952490807
severely O 1 0.9999874830245972
affected O 1 0.9999698400497437
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.999948263168335
is O 0 0.154796302318573
hypermethylated O 1 0.9998921155929565
proximal O 1 0.9598891139030457
to O 0 0.0001296759583055973
the O 0 0.00023099096142686903
largely O 0 0.0005966557073406875
expanded O 0 0.0012036849511787295
CTG O 0 0.4630437195301056
repeat O 0 0.0037883715704083443
. O 0 0.0012321501271799207

Using O 0 0.000906758417841047
methylation O 0 0.0011177570559084415
- O 0 0.0006949197850190103
sensitive O 0 0.0005744882510043681
restriction O 0 0.0002930837799794972
enzymes O 0 0.00016975888865999877
, O 0 4.2947074689436704e-05
we O 0 2.2073716536397114e-05
characterized O 0 9.490756929153576e-05
the O 0 5.7805511460173875e-05
methylation O 0 6.757135997759178e-05
pattern O 0 0.00010112849122378975
on O 0 3.716281207744032e-05
the O 0 4.858921965933405e-05
5 O 0 4.9409965868107975e-05
side O 0 5.8316843933425844e-05
of O 0 6.4707244746387e-05
the O 0 0.00016970158321782947
CTG O 0 0.019020628184080124
repeat O 0 0.00022471827105619013
in O 0 3.592781285988167e-05
the O 0 8.383343083551154e-05
DMPK O 1 0.549181342124939
gene O 0 5.054060238762759e-05
of O 0 5.814907854073681e-05
normal O 0 5.824503386975266e-05
individuals O 0 1.6595397028140724e-05
and O 0 2.8077000024495646e-05
of O 0 0.00021341942192520946
patients O 0 0.12964603304862976
affected O 0 0.025234539061784744
with O 0 0.13092316687107086
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.0009879866847768426
showing O 0 0.0005960449343547225
expansions O 0 0.0005694238352589309
of O 0 0.00012020843132631853
the O 0 0.00023737983428873122
repetitive O 0 0.0019842442125082016
sequence O 0 0.0005816380144096911
. O 0 0.00037218202487565577

The O 0 0.001875418471172452
gene O 0 0.000765919394325465
segment O 0 0.0005824618274345994
analyzed O 0 0.00016890799452085048
corresponds O 0 0.00016526512627024204
to O 0 4.468887345865369e-05
the O 0 0.0001335750421276316
genomic O 0 0.00046969903632998466
SacI O 0 0.016866611316800117
- O 0 0.0006049788789823651
HindIII O 0 0.0028931384440511465
fragment O 0 0.0003758411039598286
carrying O 0 0.00029949095915071666
exons O 0 0.00041706819320097566
11 O 0 0.0002952052454929799
- O 0 0.0003792740753851831
15 O 0 0.00045671212137676775
. O 0 0.0005923524149693549

There O 0 0.0009479016880504787
is O 0 0.0003008457424584776
constitutive O 0 0.0014865330886095762
methylation O 0 0.00029038666980341077
in O 0 0.00010423111234558746
intron O 0 0.0008063497953116894
12 O 0 0.00013712799409404397
at O 0 0.00011400111543480307
restriction O 0 7.509759598178789e-05
sites O 0 3.596805618144572e-05
of O 0 6.42300583422184e-05
SacII O 0 0.03264456242322922
and O 0 8.995537791633978e-05
HhaI O 0 0.07189042866230011
, O 0 6.841569120297208e-05
localized O 0 0.00015530084783677012
1 O 0 5.842739119543694e-05
, O 0 2.4381064577028155e-05
159 O 0 0.00011292212002445012
- O 0 7.433877181028947e-05
1 O 0 6.2180457462091e-05
, O 0 4.52245949418284e-05
232 O 0 0.00021276925690472126
bp O 0 0.00027804210549220443
upstream O 0 0.00015306200657505542
of O 0 6.85799095663242e-05
the O 0 0.00012835924280807376
CTG O 0 0.45067575573921204
repeat O 0 0.0004502398078329861
, O 0 4.0863273170543835e-05
whereas O 0 4.139263182878494e-05
most O 0 1.227719803864602e-05
, O 0 1.2920932022097986e-05
if O 0 7.089709015417611e-06
not O 0 3.1460904210689478e-06
all O 0 5.638687980535906e-06
, O 0 9.03815816855058e-06
of O 0 1.646502823859919e-05
the O 0 1.8000093405134976e-05
other O 0 7.241483672260074e-06
sites O 0 2.611250602058135e-05
of O 0 7.232217467390001e-05
SacII O 1 0.6813095211982727
, O 0 0.00011688522499753162
HhaI O 0 0.18398252129554749
, O 0 7.054374873405322e-05
and O 0 6.315947393886745e-05
HpaII O 0 0.002112708752974868
in O 0 3.384562660357915e-05
this O 0 1.585981408425141e-05
region O 0 5.053857603343204e-05
are O 0 1.2033161510771606e-05
unmethylated O 0 0.00048581944429315627
, O 0 3.083514457102865e-05
in O 0 2.0789293557754718e-05
normal O 0 4.3825555621879175e-05
individuals O 0 1.3338722965272609e-05
and O 0 1.948637691384647e-05
most O 0 3.3217740565305576e-05
of O 0 0.00010414377902634442
the O 0 0.00035037382622249424
patients O 0 0.0019419711316004395
. O 0 0.0003956023429054767

In O 0 0.00030192124540917575
a O 0 0.00015452330990228802
number O 0 3.584792648325674e-05
of O 0 0.0001197576493723318
young O 0 0.0008356546168215573
and O 0 0.00036728024133481085
severely O 1 0.9991338849067688
affected O 0 0.007711079437285662
patients O 0 0.0004232885839883238
, O 0 4.3840766011271626e-05
however O 0 3.6410488974070176e-05
, O 0 1.985244125535246e-05
complete O 0 5.062713535153307e-05
methylation O 0 3.555059083737433e-05
of O 0 2.7323027097736485e-05
these O 0 1.1834377801278606e-05
restriction O 0 2.868831143132411e-05
sites O 0 2.3741889890516177e-05
was O 0 6.0875358030898497e-05
found O 0 1.891742431325838e-05
in O 0 2.6958705348079093e-05
the O 0 0.0001458999904571101
mutated O 0 0.0013249377952888608
allele O 0 0.0009713156032375991
. O 0 0.0007001964841037989

In O 0 0.00039172350079752505
most O 0 0.00013338273856788874
of O 0 0.00014994818775448948
these O 0 6.012832818669267e-05
patients O 0 0.00014418450882658362
, O 0 4.4643333239946514e-05
the O 0 0.0001251565699931234
onset O 1 0.9978275895118713
of O 0 0.1403122991323471
the O 1 0.9998015761375427
disease O 1 1.0
was O 1 0.9999985694885254
congenital O 1 1.0
. O 0 0.047413937747478485

Preliminary O 0 0.0020135734230279922
in O 0 0.0010020039044320583
vivo O 0 0.0021011303178966045
footprinting O 0 0.00498692411929369
data O 0 0.00010761049634311348
gave O 0 9.102129115490243e-05
evidence O 0 4.549468940240331e-05
for O 0 1.9514156520017423e-05
protein O 0 5.753252480644733e-05
- O 0 6.236687477212399e-05
DNA O 0 5.341354335541837e-05
contact O 0 4.4945649278815836e-05
in O 0 3.1278745154850185e-05
normal O 0 6.391136412275955e-05
genes O 0 3.4833792597055435e-05
at O 0 7.310738874366507e-05
an O 0 6.266895070439205e-05
Sp1 O 0 0.0011980439303442836
consensus O 0 9.383363794768229e-05
binding O 0 4.985763007425703e-05
site O 0 8.53956735227257e-05
upstream O 0 0.00013699338887818158
of O 0 5.34041719220113e-05
the O 0 0.00010397787264082581
CTG O 0 0.0844622552394867
repeat O 0 0.0002606388006825
and O 0 2.5555813408573158e-05
for O 0 1.595336289028637e-05
a O 0 3.07391383103095e-05
significant O 0 4.634463039110415e-05
reduction O 0 7.693306542932987e-05
of O 0 3.162586654070765e-05
this O 0 1.6228481399593875e-05
interaction O 0 3.9454396755900234e-05
in O 0 3.048693179152906e-05
cells O 0 5.0201997510157526e-05
with O 0 2.6882891688728705e-05
a O 0 0.000261371664237231
hypermethylated O 1 0.9926784038543701
DMPK O 1 0.9998136162757874
gene O 0 0.0007916122558526695
. O 0 0.0002779554342851043
. O 0 0.00046697669313289225

The O 0 0.009798994287848473
hemochromatosis B-Disease 1 0.9999966621398926
gene O 0 0.0010788562940433621
product O 0 0.00042171598761342466
complexes O 0 0.00041740728192962706
with O 0 5.9479556512087584e-05
the O 0 0.0002373644383624196
transferrin O 0 0.33076849579811096
receptor O 0 0.0002757091133389622
and O 0 0.0001135444690589793
lowers O 0 0.0005520488484762609
its O 0 4.140206510783173e-05
affinity O 0 0.00017607214977033436
for O 0 7.617283699801192e-05
ligand O 0 0.001328475191257894
binding O 0 0.0007822314510121942
. O 0 0.0008189856889657676

We O 0 0.0007504626410081983
recently O 0 0.0005054899957031012
reported O 0 0.00013507813855540007
the O 0 9.16340432013385e-05
positional O 0 0.00046601222129538655
cloning O 0 0.00021129866945557296
of O 0 7.215808727778494e-05
a O 0 0.00010506646503927186
candidate O 0 0.0003079755406361073
gene O 0 0.00036860385444015265
for O 0 0.00036367413122206926
hereditary B-Disease 1 0.9999985694885254
hemochromatosis I-Disease 1 1.0
called O 1 0.9993035793304443
HFE O 1 0.999919056892395
. O 0 0.003281132783740759

The O 0 0.0010120657971128821
gene O 0 0.0005766307003796101
product O 0 0.00016335217515006661
, O 0 3.844023012788966e-05
a O 0 4.6450997615465894e-05
member O 0 5.017955118091777e-05
of O 0 6.990989641053602e-05
the O 0 0.00010089894931297749
major O 0 0.0008937439997680485
histocompatibility O 1 0.9998884201049805
complex O 0 0.0012528755469247699
class O 0 0.0003818056720774621
I O 0 0.0005482698907144368
- O 0 7.510905561503023e-05
like O 0 2.2057116439100355e-05
family O 0 3.5308272344991565e-05
, O 0 1.7114343791035935e-05
was O 0 5.080342452856712e-05
found O 0 2.1670102796633728e-05
to O 0 8.474631613353267e-06
have O 0 8.175196853699163e-06
a O 0 3.176297104801051e-05
mutation O 0 6.310300523182377e-05
, O 0 4.659732076106593e-05
Cys O 0 0.0015555855352431536
- O 0 0.00019646418513730168
282 O 0 0.0005156410043127835
- O 0 0.00025289534823969007
- O 0 0.0002931346243713051
> O 0 0.0004767485079355538
Tyr O 0 0.003470952622592449
( O 0 0.00011989671475021169
C282Y O 0 0.0010990964947268367
) O 0 3.026203739864286e-05
, O 0 1.8665927200345322e-05
in O 0 2.3625436369911768e-05
85 O 0 8.733143477002159e-05
% O 0 6.215164466993883e-05
of O 0 0.00023433145543094724
patient O 0 0.0020293272100389004
chromosomes O 0 0.0014231529785320163
. O 0 0.0008163101738318801

This O 0 0.0012168880784884095
mutation O 0 0.0007832085248082876
eliminates O 0 0.0009773862548172474
the O 0 0.00016843320918269455
ability O 0 0.00015055247058626264
of O 0 0.00019394909031689167
HFE O 0 0.21545125544071198
to O 0 7.710779027547687e-05
associate O 0 0.00027574587147682905
with O 0 8.924680878408253e-05
beta2 O 1 0.9139313697814941
- O 0 0.0010592383332550526
microglobulin O 1 0.8186283707618713
( O 0 0.0003401944413781166
beta2m O 0 0.06614284217357635
) O 0 0.00012557103764265776
and O 0 9.067622886504978e-05
prevents O 0 0.0009058360592462122
cell O 0 0.001773561118170619
- O 0 0.000682267127558589
surface O 0 0.0006586380768567324
expression O 0 0.0006247757119126618
. O 0 0.000556241488084197

A O 0 0.001800174475647509
second O 0 0.0008167614578269422
mutation O 0 0.00016488408436998725
that O 0 2.2029198589734733e-05
has O 0 2.774476888589561e-05
no O 0 3.215266406186856e-05
effect O 0 4.945941691403277e-05
on O 0 5.163078458281234e-05
beta2m O 0 0.3118841052055359
association O 0 0.0001453578588552773
, O 0 7.107618148438632e-05
H63D O 1 0.9916453957557678
, O 0 5.027222869102843e-05
was O 0 7.976887718541548e-05
found O 0 1.7587623005965725e-05
in O 0 1.3391069842327852e-05
eight O 0 1.998015068238601e-05
out O 0 2.3729260647087358e-05
of O 0 7.845890650060028e-05
nine O 0 0.00017373338050674647
patients O 0 0.00013012485578656197
heterozygous O 0 9.844631858868524e-05
for O 0 4.932922456646338e-05
the O 0 0.00022389786317944527
C282Y O 1 0.7790510058403015
mutant O 0 0.0052223773673176765
. O 0 0.0006568033713847399

In O 0 0.0005708475946448743
this O 0 0.00013041241618338972
report O 0 8.255508146248758e-05
, O 0 4.4710657675750554e-05
we O 0 2.551910984038841e-05
demonstrate O 0 9.071048407349735e-05
in O 0 7.979070505825803e-05
cultured O 0 0.0008907255833037198
293 O 0 0.0018289925064891577
cells O 0 0.0004672450013458729
overexpressing O 0 0.0015463054878637195
wild O 0 0.00027235294692218304
- O 0 0.00019558050553314388
type O 0 0.00014681968605145812
or O 0 8.039821841521189e-05
mutant O 0 0.0008852062746882439
HFE O 0 0.03141700476408005
proteins O 0 3.611881038523279e-05
that O 0 1.390095076203579e-05
both O 0 1.268729738512775e-05
the O 0 3.025164915015921e-05
wild O 0 9.975408465834334e-05
- O 0 0.00019202489056624472
type O 0 0.00021085067419335246
and O 0 0.00016347139899153262
H63D O 1 0.9997500777244568
HFE O 1 0.9838236570358276
proteins O 0 0.00014787173131480813
form O 0 8.039261592784896e-05
stable O 0 0.00023429057910107076
complexes O 0 0.00022283407452050596
with O 0 4.9458900321042165e-05
the O 0 0.00021733851463068277
transferrin O 0 0.41971004009246826
receptor O 0 0.0007331891101785004
( O 0 0.0003106623189523816
TfR O 0 0.0372183583676815
) O 0 0.0002836101339198649
. O 0 0.0004846339870709926

The O 0 0.0031168912537395954
C282Y O 1 0.8849627375602722
mutation O 0 0.001282928860746324
nearly O 0 0.0005113095976412296
completely O 0 0.000452889857115224
prevents O 0 0.0002344794338569045
the O 0 0.00010397430742159486
association O 0 9.656585461925715e-05
of O 0 7.299167918972671e-05
the O 0 0.00018316875502932817
mutant O 0 0.0035830491688102484
HFE O 1 0.9429931640625
protein O 0 0.00020861935627181083
with O 0 0.00013113653403706849
the O 0 0.0006496123969554901
TfR O 1 0.8723185658454895
. O 0 0.0013737076660618186

Studies O 0 0.0004969735164195299
on O 0 0.00025576294865459204
cell O 0 0.0004297335399314761
- O 0 0.00019725103629752994
associated O 0 8.968173642642796e-05
transferrin O 0 0.0005629416555166245
at O 0 9.594309085514396e-05
37 O 0 7.283919694600627e-05
degrees O 0 6.622066575801e-05
C O 0 0.00010788626241264865
suggest O 0 4.4543696276377887e-05
that O 0 1.1759786502807401e-05
the O 0 5.4395655752159655e-05
overexpressed O 0 0.0006300032255239785
wild O 0 0.00021992737310938537
- O 0 0.0002907695306930691
type O 0 0.0003610165149439126
HFE O 0 0.02983708679676056
protein O 0 0.00011068808089476079
decreases O 0 9.967126970877871e-05
the O 0 4.558519140118733e-05
affinity O 0 5.886871804250404e-05
of O 0 6.986363587202504e-05
the O 0 0.0001779365848051384
TfR O 1 0.7041691541671753
for O 0 0.0003319595707580447
transferrin O 0 0.16669176518917084
. O 0 0.001086745411157608

The O 0 0.0029304716736078262
overexpressed O 0 0.30308544635772705
H63D O 1 0.9985595345497131
protein O 0 0.0003163527580909431
does O 0 3.67085485777352e-05
not O 0 1.3165321433916688e-05
have O 0 8.14955637906678e-06
this O 0 1.0814536835823674e-05
effect O 0 2.1309417206794024e-05
, O 0 1.253744267160073e-05
providing O 0 1.5491761587327346e-05
the O 0 1.279209664062364e-05
first O 0 2.9444923711707816e-05
direct O 0 2.5471988919889554e-05
evidence O 0 2.9415481549222022e-05
for O 0 1.4765711057407316e-05
a O 0 5.480270920088515e-05
functional O 0 0.00010864363139262423
consequence O 0 0.000281295069726184
of O 0 0.00022861563775222749
the O 0 0.000997620285488665
H63D O 1 0.9999319314956665
mutation O 0 0.002542189322412014
. O 0 0.0007752706296741962

Addition O 0 0.0011255955323576927
of O 0 0.0008045255090110004
soluble O 0 0.0028361682780086994
wild O 0 0.0009822616120800376
- O 0 0.0013761563459411263
type O 0 0.002060376573354006
HFE O 1 0.9992953538894653
/ O 0 0.005298372823745012
beta2m O 0 0.1838359236717224
heterodimers O 0 0.0034397493582218885
to O 0 0.0001260856370208785
cultured O 0 0.0011757821775972843
cells O 0 0.00028277019737288356
also O 0 6.93756082910113e-05
decreased O 0 0.00017405969265382737
the O 0 6.717674841638654e-05
apparent O 0 0.00019195019558537751
affinity O 0 0.00011031203030142933
of O 0 5.502164640347473e-05
the O 0 0.00012358921230770648
TfR O 0 0.003574387403205037
for O 0 3.617055335780606e-05
its O 0 2.223803494416643e-05
ligand O 0 0.00011142982839373872
under O 0 6.49906723992899e-05
steady O 0 0.00028004671912640333
- O 0 6.122956983745098e-05
state O 0 2.6640826035873033e-05
conditions O 0 6.024576214258559e-05
, O 0 2.000571839744225e-05
both O 0 1.948306817212142e-05
in O 0 6.464187754318118e-05
293 O 0 0.0011946650920435786
cells O 0 0.00024337321519851685
and O 0 9.690023580333218e-05
in O 0 0.00043491003452800214
HeLa O 1 0.9959719777107239
cells O 0 0.0013477311003953218
. O 0 0.0005002328543923795

Furthermore O 0 0.0011572990333661437
, O 0 0.00014230411034077406
at O 0 0.00012451935617718846
4 O 0 0.000110897388367448
degrees O 0 0.00010959581413771957
C O 0 0.0002241883921669796
, O 0 3.500251841614954e-05
the O 0 4.173839624854736e-05
added O 0 0.0001221798302140087
soluble O 0 0.00022814093972556293
complex O 0 0.0001977070642169565
of O 0 0.0002630255767144263
HFE O 1 0.9997214674949646
/ O 0 0.0033848334569483995
beta2m O 0 0.012000427581369877
inhibited O 0 0.0007140399538911879
binding O 0 0.00010019481123890728
of O 0 0.00017289139213971794
transferrin O 0 0.007322986144572496
to O 0 0.00017585084424354136
HeLa O 1 0.891005277633667
cell O 0 0.0008251489489339292
TfR O 0 0.0023843857925385237
in O 0 6.167207175167277e-05
a O 0 0.00014804612146690488
concentration O 0 0.0025554404128342867
- O 0 0.0003993450081907213
dependent O 0 0.00024114931875374168
manner O 0 0.0005197862046770751
. O 0 0.00046717814984731376

Scatchard O 0 0.0071160560473799706
plots O 0 0.001489004003815353
of O 0 0.00022061918571125716
these O 0 4.463601726456545e-05
data O 0 3.474978439044207e-05
indicate O 0 4.937577250530012e-05
that O 0 1.7337099052383564e-05
the O 0 4.792681647813879e-05
added O 0 0.00014112335338722914
heterodimer O 0 0.0010212803026661277
substantially O 0 0.00017095639486797154
reduced O 0 0.00010455254960106686
the O 0 0.00010015851876232773
affinity O 0 0.0002552034566178918
of O 0 0.0003168401890434325
TfR O 1 0.8336077928543091
for O 0 0.0006151094567030668
transferrin O 1 0.5768697261810303
. O 0 0.0016139999497681856

These O 0 0.0002696284791454673
results O 0 0.00015482387971132994
establish O 0 0.00015525674098171294
a O 0 0.00018055384862236679
molecular O 0 0.0003027326019946486
link O 0 0.0003234133473597467
between O 0 0.00016017637972254306
HFE O 1 0.6645402908325195
and O 0 6.372665666276589e-05
a O 0 7.87166427471675e-05
key O 0 0.00010219299292657524
protein O 0 6.072449832572602e-05
involved O 0 5.2038882131455466e-05
in O 0 6.950871465960518e-05
iron O 1 0.957673192024231
transport O 0 0.0002782454830594361
, O 0 5.795791730633937e-05
the O 0 9.01351886568591e-05
TfR O 1 0.7366094589233398
, O 0 5.047374725108966e-05
and O 0 1.9188644728274085e-05
raise O 0 3.49565852957312e-05
the O 0 3.714261401910335e-05
possibility O 0 5.364938988350332e-05
that O 0 1.8058743080473505e-05
alterations O 0 9.673018212197348e-05
in O 0 2.830292760336306e-05
this O 0 2.4886619939934462e-05
regulatory O 0 7.294123497558758e-05
mechanism O 0 0.0001208320027217269
may O 0 2.723000943660736e-05
play O 0 3.0401777621591464e-05
a O 0 3.9626345824217424e-05
role O 0 8.226023783208802e-05
in O 0 4.848678509006277e-05
the O 0 0.0002460193063598126
pathogenesis O 1 0.9987745881080627
of O 1 0.9409672021865845
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.02307792939245701
. O 0 0.0015805846778675914

Genomic O 0 0.001852422603406012
organization O 0 0.00035653155646286905
of O 0 0.0002498337416909635
the O 0 0.0004242780851200223
UBE3A O 1 0.9998794794082642
/ O 0 0.19161269068717957
E6 O 1 0.9987490177154541
- O 0 0.0012170856352895498
AP O 0 0.0008813142776489258
gene O 0 0.00019096169853582978
and O 0 0.0001040648712660186
related O 0 0.00037441705353558064
pseudogenes O 0 0.00303092272952199
. O 0 0.0007159142987802625

The O 0 0.004644159227609634
UBE3A O 0 0.253539502620697
gene O 0 0.0009683254756964743
encodes O 0 0.0007168339216150343
the O 0 0.00038293475518003106
E6 O 0 0.23991930484771729
- O 0 0.0009037632262334228
AP O 0 0.0008393402677029371
ubiquitin O 0 0.0017048823647201061
- O 0 0.0002575370017439127
protein O 0 0.00012934498954564333
ligase O 0 0.0005408911965787411
and O 0 4.050115603604354e-05
has O 0 3.048077087441925e-05
recently O 0 5.221839819569141e-05
been O 0 2.357178345846478e-05
shown O 0 2.901883635786362e-05
to O 0 1.6640720787108876e-05
be O 0 3.9688289689365774e-05
mutated O 0 0.0009190565906465054
in O 0 0.04626823216676712
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9922305941581726
who O 0 0.0011309582041576505
lack O 0 0.34113526344299316
15q11 O 1 0.999880313873291
- O 0 0.005814512725919485
q13 O 0 0.46050605177879333
deletions O 0 0.0014040004462003708
or O 0 0.0002637754660099745
chromosome O 0 0.0010267049074172974
15 O 0 0.0008959510014392436
paternal O 0 0.03182332590222359
uniparental B-Disease 1 0.9997699856758118
disomy I-Disease 1 0.9985857009887695
. O 0 0.0030752792954444885

Previous O 0 0.006503145210444927
UBE3A O 0 0.21875618398189545
cDNA O 0 0.00254269246943295
analysis O 0 0.0002321618376299739
has O 0 9.355345537187532e-05
shown O 0 7.022707723081112e-05
a O 0 0.00011547275062184781
coding O 0 0.0001745415065670386
region O 0 9.167101961793378e-05
of O 0 9.90914850262925e-05
approximately O 0 0.00023173504450824112
2 O 0 0.0003726326976902783
. O 0 0.00038040350773371756

6 O 0 0.002819897374138236
kb O 0 0.002486987505108118
and O 0 0.0002006552676903084
a O 0 0.00016782883903943002
3 O 0 0.0002071429044008255
- O 0 0.00017253994883503765
untranslated O 0 0.0006130802794359624
region O 0 0.00014264823403209448
( O 0 7.7871183748357e-05
UTR O 0 0.0007452679565176368
) O 0 2.4750152078922838e-05
of O 0 3.460674997768365e-05
< O 0 0.00018633784202393144
50 O 0 6.814013613620773e-05
bp O 0 0.00022472983982879668
, O 0 2.446594044158701e-05
whereas O 0 2.476271038176492e-05
Northern O 0 3.628612103057094e-05
analysis O 0 1.577072180225514e-05
has O 0 1.495072319812607e-05
indicated O 0 3.455290061538108e-05
mRNA O 0 4.093949246453121e-05
sizes O 0 2.5019571694429033e-05
of O 0 4.8535686801187694e-05
5 O 0 0.00010304717579856515
- O 0 0.00025191204622387886
8 O 0 0.00038243955350480974
kb O 0 0.0026676340494304895
. O 0 0.0006890577496960759

We O 0 0.00053449283586815
have O 0 9.403068543178961e-05
analyzed O 0 0.0001565811107866466
additional O 0 0.00018062410526908934
cDNA O 0 0.0010167999425902963
clones O 0 0.00041665229946374893
and O 0 3.0000954211573116e-05
provide O 0 2.181027412007097e-05
evidence O 0 5.023547782911919e-05
for O 0 1.9117447664029896e-05
an O 0 4.230336708133109e-05
additional O 0 0.0001245383609784767
0 O 0 0.00031953578582033515
. O 0 0.0005016180220991373

5 O 0 0.001013107248581946
kb O 0 0.0015728313010185957
of O 0 0.00034954806324094534
5 O 0 0.0002656098804436624
- O 0 0.00028682287666015327
UTR O 0 0.0013309946516528726
and O 0 7.258334517246112e-05
> O 0 0.00014756101882085204
2 O 0 9.40168829401955e-05
kb O 0 0.00034803373273462057
of O 0 0.00017244093760382384
3 O 0 0.00035696974373422563
- O 0 0.0009631288121454418
UTR O 0 0.010735364630818367
. O 0 0.0009158140164799988

We O 0 0.0005328747793100774
have O 0 6.105640932219103e-05
established O 0 0.00011205860937479883
the O 0 0.00010762291640276089
genomic O 0 0.00015712073945906013
organization O 0 0.00013682208373211324
of O 0 0.00018374022329226136
UBE3A O 0 0.19212698936462402
and O 0 7.234734221128747e-05
the O 0 8.05409363238141e-05
sequence O 0 9.889135253615677e-05
of O 0 0.0002016201033256948
intron O 0 0.04495244100689888
- O 0 0.0007666631718166173
exon O 0 0.0021455204114317894
borders O 0 0.0006481028976850212
. O 0 0.0006224802345968783

We O 0 0.00050230702618137
have O 0 9.623786900192499e-05
also O 0 5.1104347221553326e-05
mapped O 0 0.0001541709789307788
two O 0 5.575354953180067e-05
highly O 0 0.00014525368169415742
homologous O 0 0.000450232473667711
processed O 0 0.0002827982243616134
pseudogenes O 0 0.0011097757378593087
, O 0 0.00016426014190074056
UBE3AP1 O 1 0.8304649591445923
and O 0 0.0002033018972724676
UBE3AP2 O 0 0.3482096791267395
, O 0 4.8683141358196735e-05
to O 0 2.0925743228872307e-05
chromosomes O 0 3.713273326866329e-05
2 O 0 3.0730199796380475e-05
and O 0 1.9872804841725156e-05
21 O 0 5.082266216049902e-05
, O 0 3.550613473635167e-05
respectively O 0 6.380334525601938e-05
, O 0 3.5298377042636275e-05
and O 0 2.668099659786094e-05
determined O 0 5.402344686444849e-05
their O 0 4.626303052646108e-05
genomic O 0 0.0003847357875201851
organization O 0 0.0004484081582631916
. O 0 0.0005841547390446067

These O 0 0.00038858625339344144
results O 0 0.00020621296425815672
will O 0 2.9431674192892388e-05
form O 0 3.503828702378087e-05
the O 0 2.4514845790690742e-05
basis O 0 1.985520611924585e-05
for O 0 1.2320056157477666e-05
studies O 0 2.1860858396394178e-05
of O 0 5.2011750085512176e-05
mutation O 0 0.00011036653449991718
and O 0 8.976549725048244e-05
imprinting O 0 0.002243773313239217
of O 0 0.0010671274503692985
UBE3A O 1 0.9994456171989441
. O 0 0.0013290845090523362

Mutation O 0 0.003337416099384427
spectrum O 0 0.0011297889286652207
and O 0 0.0002883935230784118
genotype O 0 0.0011054102797061205
- O 0 0.0006088303634896874
phenotype O 0 0.00044864884694106877
analyses O 0 0.0001159616804216057
in O 0 0.00017685235070530325
Cowden B-Disease 1 0.9999954700469971
disease I-Disease 1 0.9999949932098389
and O 0 0.0972108468413353
Bannayan B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999796152114868
Zonana I-Disease 1 0.9999996423721313
syndrome I-Disease 1 0.9999997615814209
, O 0 0.0005656782886944711
two O 0 0.0005532712093554437
hamartoma B-Disease 1 0.9999961853027344
syndromes I-Disease 1 0.9999966621398926
with O 0 0.33061885833740234
germline O 1 0.9999966621398926
PTEN O 1 0.9999954700469971
mutation O 0 0.016864905133843422
. O 0 0.0012848763726651669

The O 0 0.05660933628678322
tumour B-Disease 1 0.9999995231628418
suppressor O 1 0.9998571872711182
gene O 0 0.015864653512835503
PTEN O 1 0.9972341656684875
, O 0 0.00022650712344329804
which O 0 0.0001161111649707891
maps O 0 0.00032657867996022105
to O 0 0.00030188955133780837
10q23 O 0 0.016896702349185944
. O 0 0.00130625965539366

3 O 0 0.0013057931791990995
and O 0 0.00029744330095127225
encodes O 0 0.0002857722865883261
a O 0 0.00017662535537965596
403 O 0 0.0005293243448249996
amino O 0 0.00019209447782486677
acid O 0 0.00016762172162998468
dual O 0 0.00016707790200598538
specificity O 0 0.0003014285466633737
phosphatase O 0 0.0019539115019142628
( O 0 0.00010907951218541712
protein O 0 0.00014850815932732075
tyrosine O 0 0.0004915267345495522
phosphatase O 0 0.001674769097007811
; O 0 9.426860196981579e-05
PTPase O 0 0.011486688628792763
) O 0 6.179911724757403e-05
, O 0 5.151752338861115e-05
was O 0 0.00015769213496241719
shown O 0 5.267542655928992e-05
recently O 0 6.86241255607456e-05
to O 0 1.4632764759880956e-05
play O 0 2.4485898393322714e-05
a O 0 5.8632344007492065e-05
broad O 0 0.00014334690058603883
role O 0 0.000231413752771914
in O 0 0.00025171926245093346
human O 0 0.0017094826325774193
malignancy B-Disease 1 0.999943733215332
. O 0 0.0016015025321394205

Somatic O 1 0.9541395306587219
PTEN O 1 0.9979538917541504
deletions O 0 0.004776541143655777
and O 0 0.000348959700204432
mutations O 0 0.00015921508020255715
were O 0 5.980009154882282e-05
observed O 0 9.754997154232115e-05
in O 0 8.463732956442982e-05
sporadic B-Disease 0 0.010020256973803043
breast I-Disease 1 0.9998818635940552
, I-Disease 0 0.010975470766425133
brain I-Disease 1 0.9999703168869019
, I-Disease 0 0.07263807207345963
prostate I-Disease 1 0.9999998807907104
and I-Disease 1 0.9977741837501526
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cell O 1 0.8623521327972412
lines O 0 0.00014772969007026404
and O 0 2.7400184990256093e-05
in O 0 2.8731601560139097e-05
several O 0 3.800649938057177e-05
primary O 0 0.00045472278725355864
tumours B-Disease 1 0.9997890591621399
such O 0 0.0001667276374064386
as O 0 0.10896733403205872
endometrial B-Disease 1 0.9999998807907104
carcinomas I-Disease 1 1.0
, O 1 0.9999904632568359
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999994039535522
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.16200768947601318

In O 0 0.0011567027540877461
addition O 0 0.0007083106320351362
, O 0 0.0004075043834745884
PTEN O 1 0.9274662137031555
was O 0 0.0006484921905212104
identified O 0 0.0001567041763337329
as O 0 0.00010623124398989603
the O 0 0.00020932989718858153
susceptibility O 0 0.0010686737950891256
gene O 0 0.00018614355940371752
for O 0 0.00012647337280213833
two O 0 0.0003942503535654396
hamartoma B-Disease 1 0.9999985694885254
syndromes I-Disease 1 0.9999998807907104
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
( O 0 0.058125197887420654
CD B-Disease 0 0.01943090371787548
; O 0 0.0002607757633086294
MIM O 1 0.8632409572601318
158350 O 0 0.010410666465759277
) O 0 0.00014700797328259796
and O 0 0.00014894864580128342
Bannayan B-Disease 1 0.5139879584312439
- I-Disease 0 0.0013048091204836965
Zonana I-Disease 0 0.28174883127212524
( I-Disease 0 0.0006360954139381647
BZS I-Disease 0 0.011183339171111584
) I-Disease 0 0.00018095631094183773
or I-Disease 0 0.000184193515451625
Ruvalcaba I-Disease 0 0.1254868060350418
- I-Disease 0 0.0013793447287753224
Riley I-Disease 0 0.35527271032333374
- I-Disease 0 0.059974655508995056
Smith I-Disease 1 0.9527153372764587
syndrome I-Disease 1 0.9999997615814209
( O 0 0.06781426817178726
MIM O 1 0.9999549388885498
153480 O 1 0.9984167814254761
) O 0 0.0006535819265991449
. O 0 0.0008057787199504673

Constitutive O 0 0.01441588718444109
DNA O 0 0.0014947248855605721
from O 0 0.00036261044442653656
37 O 0 0.0005716569721698761
CD B-Disease 0 0.00044903179514221847
families O 0 9.539099119137973e-05
and O 0 5.0804344937205315e-05
seven O 0 0.00011942421406274661
BZS B-Disease 0 0.008222181349992752
families O 0 0.00016587071877438575
was O 0 0.00042243217467330396
screened O 0 0.0007178846863098443
for O 0 0.0003726678842213005
germline O 1 0.9946891069412231
PTEN O 1 0.9995755553245544
mutations O 0 0.002059618476778269
. O 0 0.0011902489932253957

PTEN O 1 0.9955321550369263
mutations O 0 0.0009668238344602287
were O 0 0.00015763920964673162
identified O 0 9.591143316356465e-05
in O 0 2.6822994186659344e-05
30 O 0 4.5279266487341374e-05
of O 0 3.1383922760142013e-05
37 O 0 8.430868183495477e-05
( O 0 3.720937456819229e-05
81 O 0 0.00011134729720652103
% O 0 3.2505515264347196e-05
) O 0 2.1881334760109894e-05
CD B-Disease 0 0.00010036597814178094
families O 0 2.1562844267464243e-05
, O 0 2.1352037947508506e-05
including O 0 2.790504186123144e-05
missense O 0 0.00017806827963795513
and O 0 4.8303154471796006e-05
nonsense O 0 0.0005003566038794816
point O 0 0.00016750860959291458
mutations O 0 0.00010554625623626634
, O 0 3.840494537143968e-05
deletions O 0 0.00020851552835665643
, O 0 4.387196895550005e-05
insertions O 0 0.0003297699149698019
, O 0 5.803058229503222e-05
a O 0 0.00014805021055508405
deletion O 0 0.0006148061365820467
/ O 0 0.0006067643407732248
insertion O 0 0.0008391803712584078
and O 0 0.0002313703007530421
splice O 0 0.0022088615223765373
site O 0 0.0011070414911955595
mutations O 0 0.0006445386097766459
. O 0 0.0006454357062466443

These O 0 0.00030697358306497335
mutations O 0 0.000239262604736723
were O 0 6.685491825919598e-05
scattered O 0 0.00012458515993785113
over O 0 4.5131710066925734e-05
the O 0 5.912086635362357e-05
entire O 0 0.0001520701334811747
length O 0 6.630660936934873e-05
of O 0 0.0001358320441795513
PTEN O 1 0.9511674046516418
, O 0 3.799801925197244e-05
with O 0 1.4523408026434481e-05
the O 0 2.487352139723953e-05
exception O 0 2.6340429030824453e-05
of O 0 2.4108196157612838e-05
the O 0 4.726631595985964e-05
first O 0 7.631540938746184e-05
, O 0 5.7564688177080825e-05
fourth O 0 0.00022746023023501039
and O 0 7.8425626270473e-05
last O 0 0.00036076249671168625
exons O 0 0.00194046541582793
. O 0 0.0008146984037011862

A O 0 0.0032318774610757828
hot O 0 0.0028320406563580036
spot O 0 0.0010450641857460141
for O 0 0.00022183626424521208
PTEN O 1 0.9866123199462891
mutation O 0 0.00021425492013804615
in O 0 6.947597285034135e-05
CD B-Disease 0 0.00023271697864402086
was O 0 0.00016914588923100382
identified O 0 6.202080840012059e-05
in O 0 3.977384403697215e-05
exon O 0 0.0002292600111104548
5 O 0 4.297948180465028e-05
that O 0 1.4072281373955775e-05
contains O 0 3.225397813366726e-05
the O 0 5.77310383960139e-05
PTPase O 0 0.002036686986684799
core O 0 0.0003792198549490422
motif O 0 0.00017593738448340446
, O 0 2.077242788800504e-05
with O 0 7.414601896016393e-06
13 O 0 2.1874451704206876e-05
of O 0 2.611795935081318e-05
30 O 0 3.8684116589138284e-05
( O 0 2.7256506655248813e-05
43 O 0 9.803433204069734e-05
% O 0 6.836702959844843e-05
) O 0 6.540997856063768e-05
CD B-Disease 0 0.00036741330404765904
mutations O 0 0.00014676763385068625
identified O 0 9.569291432853788e-05
in O 0 9.394912922289222e-05
this O 0 0.00010619519889587536
exon O 0 0.002500921953469515
. O 0 0.0007563367253169417

Seven O 0 0.00048584651085548103
of O 0 0.0002454878995195031
30 O 0 0.00018535894923843443
( O 0 6.261571979848668e-05
23 O 0 9.993623098125681e-05
% O 0 2.2648753656540066e-05
) O 0 1.3169716112315655e-05
were O 0 1.4682879736938048e-05
within O 0 1.7787608157959767e-05
the O 0 3.903464676113799e-05
core O 0 0.00021063406893517822
motif O 0 0.00015692472516093403
, O 0 2.6076870199176483e-05
the O 0 1.8957245629280806e-05
majority O 0 1.2167376553406939e-05
( O 0 1.0997365279763471e-05
five O 0 9.359358045912813e-06
of O 0 1.1226808965147939e-05
seven O 0 1.0726306754804682e-05
) O 0 5.348352260625688e-06
of O 0 8.157751835824456e-06
which O 0 6.479039257101249e-06
were O 0 1.792373222997412e-05
missense O 0 0.0002694367722142488
mutations O 0 4.1801049519563094e-05
, O 0 1.954980871232692e-05
possibly O 0 5.9091387811349705e-05
pointing O 0 0.00010012527491198853
to O 0 1.6788548236945644e-05
the O 0 3.620353891164996e-05
functional O 0 9.816396777750924e-05
significance O 0 0.00021377866505645216
of O 0 0.00015768084267619997
this O 0 0.00010765134356915951
region O 0 0.0006111733964644372
. O 0 0.0005071164341643453

Germline O 1 0.9987128973007202
PTEN O 1 0.9963142275810242
mutations O 0 0.0005007953732274473
were O 0 7.129462028387934e-05
identified O 0 4.0784903831081465e-05
in O 0 1.475371936976444e-05
four O 0 1.3196494364819955e-05
of O 0 2.438876254018396e-05
seven O 0 4.517412162385881e-05
( O 0 3.2820804335642606e-05
57 O 0 0.00010265340097248554
% O 0 6.603564543183893e-05
) O 0 0.00011616531264735386
BZS B-Disease 0 0.006026574410498142
families O 0 0.00020574514928739518
studied O 0 0.000652570161037147
. O 0 0.0005285655497573316

Interestingly O 0 0.0039201597683131695
, O 0 0.0003883303434122354
none O 0 0.00025628533330745995
of O 0 0.00015078233263920993
these O 0 4.03014273615554e-05
mutations O 0 9.807900642044842e-05
was O 0 0.00016383077309001237
observed O 0 9.069318184629083e-05
in O 0 7.142364484025165e-05
the O 0 0.00025400647427886724
PTPase O 1 0.9249827861785889
core O 0 0.008749241940677166
motif O 0 0.00419258326292038
. O 0 0.0011470949975773692

It O 0 0.00031314496300183237
is O 0 0.00010604370618239045
also O 0 5.1802264351863414e-05
worthy O 0 0.00016362345195375383
of O 0 6.919701263541356e-05
note O 0 4.2104991734959185e-05
that O 0 1.4500488759949803e-05
a O 0 2.6119429094251245e-05
single O 0 5.674171552527696e-05
nonsense O 0 0.00030112461536191404
point O 0 0.00012676687038037926
mutation O 0 8.324060763698071e-05
, O 0 4.862240530201234e-05
R233X O 0 0.0017026097048074007
, O 0 5.241046164883301e-05
was O 0 0.0001118186628445983
observed O 0 4.201410411042161e-05
in O 0 2.9387272661551833e-05
the O 0 8.610486838733777e-05
germline O 0 0.0007729697972536087
DNA O 0 0.00013884290819987655
from O 0 4.191976768197492e-05
two O 0 3.554065915523097e-05
unrelated O 0 0.00021845378796570003
CD B-Disease 0 0.00040115794399753213
families O 0 6.90494998707436e-05
and O 0 8.983210864244029e-05
one O 0 0.00021313228353392333
BZS B-Disease 1 0.6810945272445679
family O 0 0.0014446194982156157
. O 0 0.0010497135808691382

Genotype O 0 0.016958244144916534
- O 0 0.0026799668557941914
phenotype O 0 0.0012347566662356257
studies O 0 8.50493015605025e-05
were O 0 3.4316693927394226e-05
not O 0 2.3609200070495717e-05
performed O 0 7.640337571501732e-05
on O 0 2.895177385653369e-05
this O 0 2.6318684831494465e-05
small O 0 4.6848534111632034e-05
group O 0 7.225951412692666e-05
of O 0 0.00029068972798995674
BZS B-Disease 1 0.702739953994751
families O 0 0.0007373142871074378
. O 0 0.0008596742409281433

However O 0 0.001449862844310701
, O 0 0.0005913106142543256
genotype O 0 0.0014883873518556356
- O 0 0.0005502763669937849
phenotype O 0 0.0003862312878482044
analysis O 0 8.208298095269129e-05
inthe O 0 0.001020557712763548
group O 0 7.032780558802187e-05
of O 0 0.00012285356933716685
CD B-Disease 0 0.0002772053994704038
families O 0 3.692404425237328e-05
revealed O 0 7.363092299783602e-05
two O 0 1.0768349966383539e-05
possible O 0 2.361194674449507e-05
associations O 0 2.200148446718231e-05
worthy O 0 0.00012333435006439686
of O 0 5.756507016485557e-05
follow O 0 5.164994581718929e-05
- O 0 9.169943950837478e-05
up O 0 4.87532488477882e-05
in O 0 3.8073540054028854e-05
independent O 0 7.003559585427865e-05
analyses O 0 0.0002279695909237489
. O 0 0.00028332878719083965

The O 0 0.0006678386707790196
first O 0 0.00025997101329267025
was O 0 0.0003061607712879777
an O 0 6.494797708000988e-05
association O 0 0.0001061067232512869
noted O 0 4.131742025492713e-05
in O 0 1.80071856448194e-05
the O 0 1.977825195353944e-05
group O 0 2.582301567599643e-05
of O 0 6.664442480541766e-05
CD B-Disease 0 0.0002988138876389712
families O 0 0.0001035019668051973
with O 0 0.000744211080018431
breast B-Disease 1 0.9999988079071045
disease I-Disease 1 0.9999953508377075
. O 0 0.0014188834466040134

A O 0 0.0015935099218040705
correlation O 0 0.0005940145929343998
was O 0 0.0003514955460559577
observed O 0 8.778833580436185e-05
between O 0 5.1884533604606986e-05
the O 0 7.364503835560754e-05
presence O 0 0.00016913200670387596
/ O 0 0.0002529860066715628
absence O 0 0.00018954365805257112
of O 0 0.00011638108844636008
a O 0 0.0003521707549225539
PTEN O 1 0.999038577079773
mutation O 0 0.00013327086344361305
and O 0 3.225004184059799e-05
the O 0 5.564577440964058e-05
type O 0 0.0001409962569596246
of O 0 0.00030193242128007114
breast O 1 0.9704408645629883
involvement O 0 0.00890482496470213
( O 0 0.0004908031551167369
unaffected O 0 0.02422652766108513
versus O 0 0.3690302073955536
benign O 1 0.9998171925544739
versus O 1 0.9960893392562866
malignant O 1 0.9999949932098389
) O 0 0.0008281155023723841
. O 0 0.0008227331563830376

Specifically O 0 0.0010291477665305138
and O 0 0.00016858763410709798
more O 0 5.431131648947485e-05
directly O 0 6.993208808125928e-05
, O 0 3.854959140880965e-05
an O 0 5.844299812451936e-05
association O 0 0.0001313506654696539
was O 0 0.0001290773943765089
also O 0 2.851486897270661e-05
observed O 0 3.697101419675164e-05
between O 0 2.185966877732426e-05
the O 0 3.1739287805976346e-05
presence O 0 9.839564881986007e-05
of O 0 0.0001015434245346114
a O 0 0.0007365011260844767
PTEN O 1 0.9999905824661255
mutation O 1 0.6179397702217102
and O 1 0.787468433380127
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
. O 0 0.009267022833228111

Secondly O 0 0.00841076672077179
, O 0 0.00033814809285104275
there O 0 0.00013582156680058688
appeared O 0 0.00011727306991815567
to O 0 2.3895123376860283e-05
be O 0 2.0009783838759176e-05
an O 0 5.115456951898523e-05
interdependent O 0 0.0005986490286886692
association O 0 0.0001435223821317777
between O 0 0.00010936186299659312
mutations O 0 6.975366704864427e-05
upstream O 0 0.00013649188622366637
and O 0 2.9435408578137867e-05
within O 0 4.273394006304443e-05
the O 0 6.566189404111356e-05
PTPase O 0 0.08756615966558456
core O 0 0.0005948508623987436
motif O 0 0.0003323304117657244
, O 0 4.481314681470394e-05
the O 0 6.869091157568619e-05
core O 0 0.0003094854764640331
motif O 0 0.0002065021835733205
containing O 0 5.822882303618826e-05
the O 0 3.1721952836960554e-05
majority O 0 2.8227048460394144e-05
of O 0 5.2358813263708726e-05
missense O 0 0.0005253444542177022
mutations O 0 5.5123065976658836e-05
, O 0 1.928587516886182e-05
and O 0 1.636565320950467e-05
the O 0 3.243194805691019e-05
involvement O 0 9.668721031630412e-05
of O 0 5.348587001208216e-05
all O 0 3.6865429137833416e-05
major O 0 0.0006169112748466432
organ O 1 0.8269729614257812
systems O 0 0.0004003442300017923
( O 0 6.951965769985691e-05
central O 0 0.00022179608640726656
nervous O 0 0.09707468003034592
system O 0 0.000398545729694888
, O 0 0.0016896807355806231
thyroid O 1 0.9999998807907104
, O 0 0.31423503160476685
breast O 1 0.9999973773956299
, O 1 0.7915252447128296
skin O 1 0.9999991655349731
and O 1 0.9987039566040039
gastrointestinal O 1 1.0
tract O 1 0.9999995231628418
) O 0 0.0014174639945849776
. O 0 0.0009881039150059223

However O 0 0.0007434095023199916
, O 0 0.00017454767657909542
these O 0 2.4469207346555777e-05
observations O 0 6.181165372254327e-05
would O 0 2.3945649445522577e-05
need O 0 2.9314807761693373e-05
to O 0 1.5737892681499943e-05
be O 0 1.4304603610071354e-05
confirmed O 0 2.8085622034268454e-05
by O 0 1.2927698662679177e-05
studying O 0 3.533124254317954e-05
a O 0 4.353061012807302e-05
larger O 0 4.820458707399666e-05
number O 0 3.6034522054251283e-05
of O 0 0.00013128919817972928
CD B-Disease 0 0.0007114533218555152
families O 0 0.00026876150513999164
. O 0 0.0004029827832709998

Molecular O 0 0.275137335062027
defects O 1 0.9989443421363831
leading O 0 0.0018809465691447258
to O 0 0.00021822126291226596
human O 0 0.0004628942406270653
complement B-Disease 0 0.07611212134361267
component I-Disease 1 0.9999517202377319
C6 I-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
in O 0 0.00017513064085505903
an O 0 0.00011248984083067626
African O 0 0.0005078928079456091
- O 0 0.00042229448445141315
American O 0 0.0002978701377287507
family O 0 0.0005400859517976642
. O 0 0.0005379251088015735

Complement B-Disease 0 0.269440233707428
component I-Disease 1 0.9999024868011475
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.42385628819465637
C6D B-Disease 1 0.9999876022338867
) O 0 0.0003016481932718307
was O 0 0.001107964082621038
diagnosed O 0 0.04939281567931175
in O 0 3.999772161478177e-05
a O 0 6.274513725657016e-05
16 O 0 9.232009324477986e-05
- O 0 0.00012302110553719103
year O 0 6.534146086778492e-05
- O 0 0.00012506866187322885
old O 0 0.0002708623942453414
African O 0 0.0002712401910685003
- O 0 0.0003508995578158647
American O 0 0.0003966247313655913
male O 0 0.0007608355954289436
with O 0 0.0014668423682451248
meningococcal B-Disease 1 0.9999997615814209
meningitis I-Disease 1 0.9999992847442627
. O 0 0.0031284140422940254

The O 0 0.0031912236008793116
patients O 0 0.0022328512277454138
father O 0 0.0013535749167203903
and O 0 9.957285510608926e-05
two O 0 7.748643838567659e-05
brothers O 0 0.00033722881926223636
also O 0 8.704053470864892e-05
had O 0 0.00020246331405360252
C6D B-Disease 1 0.9922218918800354
, O 0 7.767634087940678e-05
but O 0 2.0190544091747142e-05
gave O 0 4.8223158955806866e-05
no O 0 2.6325211365474388e-05
history O 0 0.00011713314597727731
of O 0 0.000553100137040019
meningitis B-Disease 1 0.9999971389770508
or O 0 0.001031871186569333
other O 0 0.0006064261542633176
neisserial B-Disease 1 0.999988317489624
infection I-Disease 1 0.9997958540916443
. O 0 0.0016375109553337097

By O 0 0.0005518773687072098
using O 0 0.00023749798128847033
exon O 0 0.0010241077980026603
- O 0 0.0002118415286531672
specific O 0 7.421509508276358e-05
polymerase O 0 0.000351903960108757
chain O 0 0.0002065565495286137
reaction O 0 0.0001334630069322884
( O 0 4.84814663650468e-05
PCR O 0 0.0002609172952361405
) O 0 2.889173265430145e-05
/ O 0 0.00011623424506979063
single O 0 5.449284799396992e-05
- O 0 9.89047548500821e-05
strand O 0 0.00022275994706433266
conformation O 0 0.00017137566464953125
polymorphism O 0 8.995091775432229e-05
as O 0 2.4161156034097075e-05
a O 0 4.396461008582264e-05
screening O 0 9.461055014980957e-05
step O 0 0.0001289851061301306
and O 0 3.375209416844882e-05
nucleotide O 0 7.87121316534467e-05
sequencing O 0 7.964186079334468e-05
of O 0 4.23398960265331e-05
target O 0 6.254154141061008e-05
exons O 0 0.00017225509509444237
, O 0 2.7613183192443103e-05
we O 0 1.1043650374631397e-05
determined O 0 2.0937481167493388e-05
that O 0 1.3976014997751918e-05
the O 0 5.0785354687832296e-05
proband O 0 0.0032202457077801228
was O 0 0.0002975212992168963
a O 0 0.00013552259770222008
compound O 0 0.001039703143760562
heterozygote O 0 0.0010518778581172228
for O 0 8.877774962456897e-05
two O 0 0.00022624187113251537
C6 O 1 0.9997019171714783
gene O 0 0.001124413451179862
mutations O 0 0.0008356486796401441
. O 0 0.0005673137493431568

The O 0 0.0008241856121458113
first O 0 0.0004321574524510652
, O 0 0.00019595531921368092
1195delC O 0 0.0015751550672575831
located O 0 0.00028251472394913435
in O 0 7.82500792411156e-05
exon O 0 0.0004115211486350745
7 O 0 0.0001076238404493779
, O 0 3.568720421753824e-05
is O 0 1.8016580725088716e-05
a O 0 4.18327545048669e-05
novel O 0 0.0001101833549910225
mutation O 0 4.978555443813093e-05
, O 0 2.22343260247726e-05
while O 0 1.9536240870365873e-05
the O 0 3.077683140872978e-05
second O 0 0.00012310041347518563
, O 0 5.707922173314728e-05
1936delG O 0 0.0005970606580376625
in O 0 5.03308983752504e-05
exon O 0 0.00030592267285101116
12 O 0 8.440649980911985e-05
, O 0 3.169373667333275e-05
has O 0 2.8233913326403126e-05
been O 0 3.384963201824576e-05
described O 0 7.130944868549705e-05
before O 0 8.525848534191027e-05
to O 0 6.286036659730598e-05
cause O 0 0.0042545427568256855
C6D B-Disease 1 0.9946034550666809
in O 0 9.596367453923449e-05
an O 0 9.885298641165718e-05
unrelated O 0 0.0006817139801569283
African O 0 0.0005515655502676964
- O 0 0.0006405021995306015
American O 0 0.0004148148582316935
individual O 0 0.00022642593830823898
. O 0 0.0005414957995526493

Both O 0 0.0009391981293447316
mutations O 0 0.0006110574468038976
result O 0 0.0003456327540334314
in O 0 0.0002646482898853719
premature O 0 0.021135268732905388
termination O 0 0.025304069742560387
codons O 0 0.0018540897872298956
and O 0 0.0004990441375412047
C6 O 1 0.9994468092918396
null O 0 0.004630740266293287
alleles O 0 0.0020192908123135567
. O 0 0.0011179805733263493

Allele O 0 0.0035787513479590416
- O 0 0.0008913627825677395
specific O 0 0.00017652602400630713
PCR O 0 0.0005654373671859503
indicated O 0 0.0001685988827375695
that O 0 2.8235206627869047e-05
the O 0 6.552490958711132e-05
probands O 0 0.002664986765012145
two O 0 8.635698759462684e-05
brothers O 0 0.00033910287311300635
also O 0 0.00011715258733602241
inherited O 0 0.002505979500710964
the O 0 0.00027416020748205483
1195delC O 1 0.7602858543395996
mutation O 0 0.00010035755985882133
from O 0 4.360510502010584e-05
their O 0 2.7166666768607683e-05
heterozygous O 0 0.0001392955018673092
mother O 0 0.00019634565978776664
and O 0 6.446716724894941e-05
the O 0 0.00012404529843479395
1936delG O 0 0.030360719189047813
mutation O 0 0.00011499695392558351
from O 0 5.381535811466165e-05
their O 0 7.142323738662526e-05
homozygous O 0 0.00045805174158886075
father O 0 0.0012045233743265271
. O 0 0.00027704265085048974
. O 0 0.0006093148258514702

PAX6 O 1 0.9973798394203186
mutations O 0 0.012394602410495281
reviewed O 0 0.005527390167117119
. O 0 0.002531943377107382

Mutations O 0 0.004531106445938349
in O 0 0.0006483191391453147
PAX6 O 0 0.48269757628440857
are O 0 5.376462286221795e-05
responsible O 0 0.00015327712753787637
for O 0 6.689687870675698e-05
human O 0 0.0003101468028035015
aniridia B-Disease 1 0.9999138116836548
and O 0 4.361674655228853e-05
have O 0 1.2220823009556625e-05
also O 0 1.0246418241877109e-05
been O 0 1.197348774439888e-05
found O 0 1.1309162800898775e-05
in O 0 2.234914427390322e-05
patients O 0 8.368829730898142e-05
with O 0 8.179544965969399e-05
Peters B-Disease 1 0.9999300241470337
anomaly I-Disease 1 0.9999929666519165
, O 0 0.030807096511125565
with O 1 0.9913787841796875
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.8929324150085449
with O 0 0.051288530230522156
autosomal B-Disease 1 0.9999421834945679
dominant I-Disease 1 0.9999644756317139
keratitis I-Disease 1 0.9999997615814209
, O 0 0.0007797167054377496
and O 0 0.00027575428248383105
with O 0 0.000558260886464268
isolated B-Disease 1 0.998381495475769
foveal I-Disease 1 0.9999983310699463
hypoplasia I-Disease 1 0.9999982118606567
. O 0 0.005630619823932648

No O 0 0.0012368166353553534
locus O 0 0.0010830763494595885
other O 0 9.093600965570658e-05
than O 0 0.0001454527082387358
chromosome O 0 0.0005760673666372895
11p13 O 0 0.1631060242652893
has O 0 8.005745621630922e-05
been O 0 7.299648132175207e-05
implicated O 0 0.0011198592837899923
in O 0 0.00015384731523226947
aniridia B-Disease 1 0.9999552965164185
, O 0 0.00019096916366834193
and O 0 0.0001391729456372559
PAX6 O 1 0.9970301389694214
is O 0 5.956026507192291e-05
clearly O 0 4.6276272769318894e-05
the O 0 3.621642099460587e-05
major O 0 8.917007653508335e-05
, O 0 3.10536015604157e-05
if O 0 1.3478396795107983e-05
not O 0 1.1281780643912498e-05
only O 0 2.2023694327799603e-05
, O 0 6.949002272449434e-05
gene O 0 0.0001996145147131756
responsible O 0 0.0005579651915468276
. O 0 0.0005132669466547668

Twenty O 0 0.0026208136696368456
- O 0 0.00048554770182818174
eight O 0 0.00014377868501469493
percent O 0 7.266477769007906e-05
of O 0 8.015714411158115e-05
identified O 0 0.00017270440002903342
PAX6 O 1 0.715130090713501
mutations O 0 9.380786650581285e-05
are O 0 1.8849641492124647e-05
C O 0 0.00027584107010625303
- O 0 0.00016200980462599546
T O 0 0.0002827634452842176
changes O 0 3.6614463169826195e-05
at O 0 8.327537216246128e-05
CpG O 0 0.00042987853521481156
dinucleotides O 0 0.0011613286333158612
, O 0 3.617052061599679e-05
20 O 0 3.6785884731216356e-05
% O 0 1.9331193470861763e-05
are O 0 1.0320626643078867e-05
splicing O 0 0.00014152831863611937
errors O 0 0.00012930171214975417
, O 0 2.700455479498487e-05
and O 0 1.5220985915220808e-05
more O 0 1.3219154425314628e-05
than O 0 1.2376438462524675e-05
30 O 0 4.163777703070082e-05
% O 0 2.131405199179426e-05
are O 0 1.63532022270374e-05
deletion O 0 0.0003035400586668402
or O 0 0.00016982380475383252
insertion O 0 0.00181583222001791
events O 0 0.0010623919079080224
. O 0 0.001099172281101346

There O 0 0.0005788214621134102
is O 0 0.0001950430596480146
a O 0 0.00027447822503745556
noticeably O 0 0.001182290492579341
elevated O 0 0.00202548922970891
level O 0 0.00012670175055973232
of O 0 0.00010751869558589533
mutation O 0 6.144208600744605e-05
in O 0 2.6624673409969546e-05
the O 0 4.3921489123022184e-05
paired O 0 6.53109309496358e-05
domain O 0 5.057338421465829e-05
compared O 0 3.203871165169403e-05
with O 0 1.1238474144192878e-05
the O 0 4.466245445655659e-05
rest O 0 0.00011207442730665207
of O 0 0.00011586253822315484
the O 0 0.0003313951601739973
gene O 0 0.0004678504483308643
. O 0 0.0004194760986138135

Increased O 0 0.0010465322993695736
mutation O 0 0.00033169484231621027
in O 0 7.996590284164995e-05
the O 0 0.000152695516590029
homeodomain O 0 0.0010891736019402742
is O 0 7.571492460556328e-05
accounted O 0 9.269898146158084e-05
for O 0 2.51093279075576e-05
by O 0 4.4931290176464245e-05
the O 0 0.00015040698053780943
hypermutable O 0 0.04502404108643532
CpG O 0 0.003263958729803562
dinucleotide O 0 0.0041053807362914085
in O 0 0.00040433116373606026
codon O 0 0.0017209468642249703
240 O 0 0.0015285544795915484
. O 0 0.0007856468437239528

Very O 0 0.0009086402715183794
nearly O 0 0.0004124558763578534
all O 0 9.354711073683575e-05
mutations O 0 0.00010112926975125447
appear O 0 6.172448775032535e-05
to O 0 3.041851414309349e-05
cause O 0 0.000471425533760339
loss O 0 0.00042009021854028106
of O 0 5.9647976740961894e-05
function O 0 3.3713422453729436e-05
of O 0 5.4125186579767615e-05
the O 0 5.7319884945172817e-05
mutant O 0 0.00033941195579245687
allele O 0 6.209867569850758e-05
, O 0 1.346210774499923e-05
and O 0 7.271663889696356e-06
more O 0 4.464736321097007e-06
than O 0 9.558582860336173e-06
80 O 0 2.5576582629582845e-05
% O 0 2.1884132365812548e-05
of O 0 9.27943256101571e-05
exonic O 0 0.003262427868321538
substitutions O 0 0.00047843909123912454
result O 0 0.00013400716125033796
in O 0 0.00011909692693734542
nonsense O 0 0.001608415856026113
codons O 0 0.0011542689753696322
. O 0 0.0004794957931153476

In O 0 0.0007037792238406837
a O 0 0.00034070448600687087
gene O 0 0.00010879457113333046
with O 0 4.313329191063531e-05
such O 0 4.264913150109351e-05
extraordinarily O 0 0.00034683060948736966
high O 0 0.00016912540013436228
sequence O 0 6.344633584376425e-05
conservation O 0 9.769518510438502e-05
throughout O 0 6.684254913125187e-05
evolution O 0 7.004081271588802e-05
, O 0 2.084877633024007e-05
there O 0 1.6075862731668167e-05
are O 0 7.256934623001143e-06
presumed O 0 0.00019910241826437414
undiscovered O 0 0.004071563016623259
missense O 0 0.001086608855985105
mutations O 0 8.438396616838872e-05
, O 0 2.292923272761982e-05
these O 0 7.296928743016906e-06
are O 0 5.634973149426514e-06
hypothesized O 0 4.9506896175444126e-05
to O 0 1.0774266229418572e-05
exist O 0 1.5473820894840173e-05
in O 0 1.7144337107311003e-05
as O 0 4.563590482575819e-05
- O 0 0.00015031063230708241
yet O 0 0.00013466838572639972
unidentified O 0 0.0008101757848635316
phenotypes O 0 0.0010241218842566013
. O 0 0.0002532323997002095
. O 0 0.0006340520340017974

Genetic O 0 0.004909073002636433
heterogeneity O 0 0.002740690018981695
and O 0 0.0002458420640323311
penetrance O 0 0.0014660387532785535
analysis O 0 7.781371823512018e-05
of O 0 8.89145812834613e-05
the O 0 0.0003901831805706024
BRCA1 O 1 0.966666042804718
and O 0 0.000289194198558107
BRCA2 O 1 0.6356285214424133
genes O 0 0.0003626464167609811
in O 0 0.0011894204653799534
breast B-Disease 1 0.9999886751174927
cancer I-Disease 1 0.9998061060905457
families O 0 0.000950512127019465
. O 0 0.0009404983138665557

The O 1 0.9697206020355225
Breast B-Disease 1 0.9999996423721313
Cancer I-Disease 1 0.9999988079071045
Linkage O 1 0.9979047775268555
Consortium O 0 0.008466736413538456
. O 0 0.0018344162963330746

The O 0 0.0013936236500740051
contribution O 0 0.0015784279676154256
of O 0 0.0010871330741792917
BRCA1 O 1 0.9156081676483154
and O 0 0.000554912316147238
BRCA2 O 1 0.9770873785018921
to O 0 0.0014275583671405911
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
was O 1 0.8338646292686462
assessed O 0 0.00029061766690574586
by O 0 5.653867992805317e-05
linkage O 0 0.0004344320623204112
and O 0 5.825914195156656e-05
mutation O 0 4.2797641071956605e-05
analysis O 0 1.538669312139973e-05
in O 0 1.3617599506687839e-05
237 O 0 7.524196553276852e-05
families O 0 1.639320544200018e-05
, O 0 9.099598173634149e-06
each O 0 4.4396051634976175e-06
with O 0 7.79819947638316e-06
at O 0 3.5822606150759384e-05
least O 0 1.3467912140185945e-05
four O 0 2.5101257051574066e-05
cases O 0 3.665620897663757e-05
of O 0 0.0009400665876455605
breast B-Disease 1 0.9999929666519165
cancer I-Disease 1 0.9982362985610962
, O 0 4.937572521157563e-05
collected O 0 6.412858056137338e-05
by O 0 6.869497883599252e-05
the O 0 0.0022266472224146128
Breast B-Disease 1 0.9999997615814209
Cancer I-Disease 1 0.9999984502792358
Linkage O 1 0.9906719923019409
Consortium O 0 0.005359667353332043
. O 0 0.0010954143945127726

Families O 0 0.0007065341924317181
were O 0 0.00017197134729940444
included O 0 8.757394971325994e-05
without O 0 4.698759221355431e-05
regard O 0 4.7166086005745456e-05
to O 0 2.051706178463064e-05
the O 0 6.518263398902491e-05
occurrence O 0 0.0004625023284461349
of O 0 0.02393832616508007
ovarian B-Disease 1 0.9999984502792358
or I-Disease 0 0.0015008470509201288
other I-Disease 0 0.000425403326516971
cancers I-Disease 1 0.9722895622253418
. O 0 0.0009776611113920808

Overall O 0 0.11709986627101898
, O 0 0.004646832123398781
disease O 1 0.9998672008514404
was O 0 0.027043282985687256
linked O 0 0.0005000760429538786
to O 0 4.4623331632465124e-05
BRCA1 O 0 0.0003360308473929763
in O 0 1.9572642486309633e-05
an O 0 1.662023350945674e-05
estimated O 0 2.7782367396866903e-05
52 O 0 3.510581882437691e-05
% O 0 1.1122064279334154e-05
of O 0 2.2486823581857607e-05
families O 0 2.4775585188763216e-05
, O 0 1.416646864527138e-05
to O 0 1.6488300389028154e-05
BRCA2 O 0 0.00018306226411368698
in O 0 2.190225677622948e-05
32 O 0 3.4294378565391526e-05
% O 0 1.5136522051761858e-05
of O 0 3.358968024258502e-05
families O 0 2.6668431019061245e-05
, O 0 1.2921104826091323e-05
and O 0 1.006412821880076e-05
to O 0 1.1275596079940442e-05
neither O 0 3.195940007572062e-05
gene O 0 1.3715399290958885e-05
in O 0 1.587924634804949e-05
16 O 0 3.566556915757246e-05
% O 0 1.2451508155209012e-05
( O 0 2.0706584109575488e-05
95 O 0 3.6452383938012645e-05
% O 0 2.870618482120335e-05
confidence O 0 0.00015683542005717754
interval O 0 0.00014876639761496335
[ O 0 0.00019956885080318898
CI O 0 0.0019220446702092886
] O 0 0.00020806353131774813
6 O 0 7.351124077104032e-05
% O 0 1.9195653294445947e-05
- O 0 5.262857666821219e-05
28 O 0 5.404586408985779e-05
% O 0 2.4691567887202837e-05
) O 0 2.8355823815218173e-05
, O 0 4.105286643607542e-05
suggesting O 0 0.00020075785869266838
other O 0 9.760075772646815e-05
predisposition O 0 0.01036100648343563
genes O 0 0.0005983179435133934
. O 0 0.0004255230014678091

The O 0 0.000646413944195956
majority O 0 0.00012725144915748388
( O 0 8.588967466494069e-05
81 O 0 0.0002113778464263305
% O 0 3.920060771633871e-05
) O 0 2.6629448257153854e-05
of O 0 5.9186917496845126e-05
the O 0 0.000732463551685214
breast B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999961853027344
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999871253967285
families O 0 8.882246766006574e-05
were O 0 6.0155165556352586e-05
due O 0 7.836805889382958e-05
to O 0 2.6243245883961208e-05
BRCA1 O 0 0.00063444854458794
, O 0 2.1373345589381643e-05
with O 0 9.088201295526233e-06
most O 0 1.3899133591621649e-05
others O 0 1.973412508959882e-05
( O 0 2.3359420083579607e-05
14 O 0 7.129149889806286e-05
% O 0 3.864322934532538e-05
) O 0 4.879566768067889e-05
due O 0 0.000130828280816786
to O 0 0.00016956377658061683
BRCA2 O 0 0.007847322151064873
. O 0 0.0009510254021733999

Conversely O 0 0.00325612910091877
, O 0 0.00031157027115114033
the O 0 9.837566176429391e-05
majority O 0 4.138955409871414e-05
of O 0 5.4259708122117445e-05
families O 0 3.970369652961381e-05
with O 0 3.502068284433335e-05
male B-Disease 0 0.00017996707174461335
and I-Disease 0 0.00013443603529594839
female I-Disease 1 0.9550725817680359
breast I-Disease 1 0.9999979734420776
cancer I-Disease 1 0.9991335272789001
were O 0 0.00010544222459429875
due O 0 0.00015082232130225748
to O 0 6.644548557233065e-05
BRCA2 O 0 0.0019160943338647485
( O 0 0.00010089567513205111
76 O 0 0.0004148553416598588
% O 0 0.00018323164840694517
) O 0 0.0002507843018975109
. O 0 0.0003659285430330783

The O 0 0.0010621288092806935
largest O 0 0.0007666426827199757
proportion O 0 0.00028587772976607084
( O 0 6.228312122402713e-05
67 O 0 0.000130784887005575
% O 0 3.156909588142298e-05
) O 0 1.4082887901167851e-05
of O 0 3.5736044083023444e-05
families O 0 2.1595029465970583e-05
due O 0 2.6031029847217724e-05
to O 0 8.755325325182639e-06
other O 0 8.442510079476051e-06
genes O 0 1.982039430004079e-05
was O 0 4.634069773601368e-05
found O 0 9.703330761112738e-06
in O 0 1.0326385563530494e-05
families O 0 7.960104994708672e-06
with O 0 5.7207739700970706e-06
four O 0 1.3230341210146435e-05
or O 0 1.3010316251893528e-05
five O 0 2.070472874038387e-05
cases O 0 3.371982165845111e-05
of O 0 0.0002961137215606868
female O 1 0.9992609620094299
breast B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999662637710571
only O 0 0.0003771286574192345
. O 0 0.0006149426917545497

These O 0 0.0002717470342759043
estimates O 0 0.0001446205860702321
were O 0 6.184043013490736e-05
not O 0 3.3995012927334756e-05
substantially O 0 0.00011144109885208309
affected O 0 4.2059320549014956e-05
either O 0 2.6269161025993526e-05
by O 0 2.2458150851889513e-05
changing O 0 3.4639604564290494e-05
the O 0 4.953276948072016e-05
assumed O 0 0.00020353424770291895
penetrance O 0 0.0008209823863580823
model O 0 0.00010265439050272107
for O 0 4.996224379283376e-05
BRCA1 O 0 0.0011278442107141018
or O 0 4.324853580328636e-05
by O 0 3.649517020676285e-05
including O 0 6.276535714277998e-05
or O 0 0.00015256350161507726
excluding O 0 0.0006022901507094502
BRCA1 O 0 0.0963701605796814
mutation O 0 0.0005304288933984935
data O 0 0.00018899394490290433
. O 0 0.0003136714512947947

Among O 0 0.0006695957272313535
those O 0 0.00014116737293079495
families O 0 0.00017933908384293318
with O 0 0.0001971258025150746
disease O 1 0.9999537467956543
due O 0 0.00923770759254694
to O 0 9.576530283084139e-05
BRCA1 O 0 0.020928185433149338
that O 0 1.672663893259596e-05
were O 0 1.7926467990037054e-05
tested O 0 3.7871006497880444e-05
by O 0 7.326816557906568e-06
one O 0 1.3251100426714402e-05
of O 0 2.461759686411824e-05
the O 0 3.8916969060664997e-05
standard O 0 3.6001620173919946e-05
screening O 0 3.882762757712044e-05
methods O 0 2.2268703105510212e-05
, O 0 1.662420982029289e-05
mutations O 0 3.0109957151580602e-05
were O 0 1.5918301869533025e-05
detected O 0 4.054157398059033e-05
in O 0 1.761222847562749e-05
the O 0 3.191575888195075e-05
coding O 0 6.0474158090073615e-05
sequence O 0 2.6974752472597174e-05
or O 0 1.7811305951909162e-05
splice O 0 0.00011377532791811973
sites O 0 1.705411159491632e-05
in O 0 1.0459802979312371e-05
an O 0 1.3062818652542774e-05
estimated O 0 2.6468473151908256e-05
63 O 0 5.6989862059708685e-05
% O 0 1.7616597688174807e-05
( O 0 1.3924740414950065e-05
95 O 0 3.5938574001193047e-05
% O 0 2.3107213564799167e-05
CI O 0 0.0007755894330330193
51 O 0 0.00012226024409756064
% O 0 5.51950215594843e-05
- O 0 0.00012092261022189632
77 O 0 0.0002262451162096113
% O 0 9.800329280551523e-05
) O 0 0.00013211554323788732
. O 0 0.00037979744956828654

The O 0 0.001127946306951344
estimated O 0 0.0006354906945489347
sensitivity O 0 0.0005966409225948155
was O 0 0.00031457527074962854
identical O 0 6.812091305619106e-05
for O 0 2.7153042537975125e-05
direct O 0 4.221290146233514e-05
sequencing O 0 0.0001406207011314109
and O 0 6.650334398727864e-05
other O 0 5.624017649097368e-05
techniques O 0 0.0005442708497866988
. O 0 0.00046406922047026455

The O 0 0.002046567155048251
penetrance O 0 0.012454754672944546
of O 0 0.0012664919486269355
BRCA2 O 0 0.1804560273885727
was O 0 0.00045216301805339754
estimated O 0 0.00011425478442106396
by O 0 3.367483805050142e-05
maximizing O 0 0.00018614853615872562
the O 0 7.0108515501488e-05
LOD O 0 0.0030500711873173714
score O 0 0.00011515826190588996
in O 0 0.00012635836901608855
BRCA2 O 0 0.03232787176966667
- O 0 0.00022631628962699324
mutation O 0 8.23666705400683e-05
families O 0 3.311804175609723e-05
, O 0 3.0105906262178905e-05
over O 0 5.6136497732950374e-05
all O 0 5.2960211178287864e-05
possible O 0 0.00026634809910319746
penetrance O 0 0.0038088213186711073
functions O 0 0.0004921237123198807
. O 0 0.000582821958232671

The O 0 0.0006964927888475358
estimated O 0 0.00034017773577943444
cumulative O 0 0.0006778528331778944
risk O 0 0.00023017730563879013
of O 0 0.0008447945001535118
breast B-Disease 1 0.999980092048645
cancer I-Disease 1 0.9902323484420776
reached O 0 0.0002490971237421036
28 O 0 8.909723692340776e-05
% O 0 1.6366917407140136e-05
( O 0 1.8831655324902385e-05
95 O 0 4.052889198646881e-05
% O 0 1.719506508379709e-05
CI O 0 0.0004237790999468416
9 O 0 5.496684752870351e-05
% O 0 1.6576685084146447e-05
- O 0 2.9649010684806854e-05
44 O 0 2.40539538935991e-05
% O 0 1.2369311662041582e-05
) O 0 6.900760581629584e-06
by O 0 9.427582881471608e-06
age O 0 2.5962874133256264e-05
50 O 0 2.902625419665128e-05
years O 0 2.0855477487202734e-05
and O 0 1.967639764188789e-05
84 O 0 8.619835716672242e-05
% O 0 2.313905679329764e-05
( O 0 2.617386053316295e-05
95 O 0 5.5281881941482425e-05
% O 0 3.285296043031849e-05
CI O 0 0.0004755620320793241
43 O 0 7.781179738231003e-05
% O 0 3.316966103739105e-05
- O 0 5.006550418329425e-05
95 O 0 4.8514906666241586e-05
% O 0 1.574167617945932e-05
) O 0 1.333206000708742e-05
by O 0 2.0091831174795516e-05
age O 0 6.274237966863438e-05
70 O 0 0.00024528667563572526
years O 0 0.00031342037254944444
. O 0 0.0006245946860872209

The O 0 0.01008178386837244
corresponding O 1 0.9987069368362427
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
risks O 0 0.411443293094635
were O 0 0.0007764908368699253
0 O 0 0.0007001247140578926
. O 0 0.0006393272778950632

4 O 0 0.0008256601868197322
% O 0 0.00018076349806506187
( O 0 9.449216304346919e-05
95 O 0 0.00012676579353865236
% O 0 3.577340976335108e-05
CI O 0 0.0007618926465511322
0 O 0 3.959782043239102e-05
% O 0 2.0473413314903155e-05
- O 0 2.378957469773013e-05
1 O 0 1.920900285767857e-05
% O 0 8.475455615553074e-06
) O 0 5.904120826016879e-06
by O 0 6.610784566873917e-06
age O 0 1.3848341041011736e-05
50 O 0 2.400539415248204e-05
years O 0 2.0331941414042376e-05
and O 0 1.2479800716391765e-05
27 O 0 4.233153958921321e-05
% O 0 2.189289989473764e-05
( O 0 2.182386197091546e-05
95 O 0 7.24744750186801e-05
% O 0 4.118862489121966e-05
CI O 0 0.0005690668476745486
0 O 0 3.833640948869288e-05
% O 0 1.917081135616172e-05
- O 0 2.958233017125167e-05
47 O 0 4.070268914802e-05
% O 0 1.647919816605281e-05
) O 0 1.926100958371535e-05
by O 0 2.6805557354236953e-05
age O 0 0.00013885879889130592
70 O 0 0.0003279398661106825
years O 0 0.00048352815792895854
. O 0 0.0004793870321009308

The O 0 0.0017067005392163992
lifetime O 0 0.0051451390609145164
risk O 0 0.004603457171469927
of O 1 0.704645037651062
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999741315841675
appears O 0 0.00027941117878071964
similar O 0 3.036729685845785e-05
to O 0 1.750576302583795e-05
the O 0 4.834739229409024e-05
risk O 0 9.202065120916814e-05
in O 0 8.461288234684616e-05
BRCA1 O 0 0.422544002532959
carriers O 0 0.00010073224984807894
, O 0 2.1290243239491247e-05
but O 0 1.2234677342348732e-05
there O 0 1.4543616089213174e-05
was O 0 3.6699901102110744e-05
some O 0 1.3136100278643426e-05
suggestion O 0 7.353971159318462e-05
of O 0 4.696698670159094e-05
a O 0 7.042437209747732e-05
lower O 0 0.00020225126354489475
risk O 0 0.00012338245869614184
in O 0 8.902402623789385e-05
BRCA2 O 0 0.0014093663776293397
carriers O 0 0.00017815743922255933
< O 0 0.0002312933065695688
50 O 0 6.792476051487029e-05
years O 0 6.894094258313999e-05
of O 0 0.00016581601812504232
age O 0 0.0005069702165201306
. O 0 0.0007006673840805888

Eye B-Disease 1 0.9993957281112671
movement I-Disease 1 0.9299336671829224
abnormalities I-Disease 1 0.9896824955940247
correlate O 0 0.001462131622247398
with O 0 0.00034527163370512426
genotype O 0 0.0014117922401055694
in O 0 0.000501090195029974
autosomal O 1 0.9902641773223877
dominant O 1 0.9999691247940063
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999887943267822
I I-Disease 1 0.9991000890731812
. O 0 0.0010665415320545435

We O 0 0.001522540464065969
compared O 0 0.0016949331620708108
horizontal O 0 0.0037516478914767504
eye O 0 0.0234869122505188
movements O 0 0.0005238463054411113
( O 0 0.00020184497407171875
visually O 0 0.0006401568534784019
guided O 0 0.001090770703740418
saccades O 0 0.36268067359924316
, O 0 0.0001787170476745814
antisaccades O 0 0.015504339709877968
, O 0 5.6195203796960413e-05
and O 0 3.0090639484114945e-05
smooth O 0 0.00015795232320670038
pursuit O 0 0.0003583806101232767
) O 0 2.3637832782696933e-05
in O 0 2.049587965302635e-05
control O 0 4.791758328792639e-05
subjects O 0 6.415793905034661e-05
( O 0 2.8146114345872775e-05
n O 0 6.361481064232066e-05
= O 0 6.532190309371799e-05
14 O 0 4.899262057733722e-05
) O 0 2.4844839572324418e-05
and O 0 2.247284646728076e-05
patients O 0 3.163214205414988e-05
with O 0 1.695048740657512e-05
three O 0 2.45582741627004e-05
forms O 0 5.727518873754889e-05
of O 0 0.0003814116935245693
autosomal O 1 0.8623439073562622
dominant O 1 0.9932920932769775
cerebellar B-Disease 1 0.9999994039535522
ataxias I-Disease 1 0.9999951124191284
type I-Disease 1 0.9165273308753967
I I-Disease 0 0.2738729417324066
spinocerebellar B-Disease 1 0.9988755583763123
ataxias I-Disease 0 0.04610317945480347
1 I-Disease 0 0.00013593547919299453
and I-Disease 0 5.844979750690982e-05
2 I-Disease 0 6.509703962365165e-05
( O 0 7.024215301498771e-05
SCA1 B-Disease 0 0.002255152678117156
, O 0 5.344289093045518e-05
n O 0 9.938729635905474e-05
= O 0 9.531115210847929e-05
11 O 0 0.00011250197712797672
; O 0 5.256803706288338e-05
SCA2 B-Disease 0 0.0015496949199587107
, O 0 5.23951712239068e-05
n O 0 9.49193345149979e-05
= O 0 8.481863915221766e-05
10 O 0 5.013238842366263e-05
) O 0 3.7623740354320034e-05
and O 0 7.954221655381843e-05
SCA3 B-Disease 1 0.9975252747535706
/ O 0 0.0014058956876397133
Machado B-Disease 0 0.005679694004356861
- I-Disease 0 0.0012090983800590038
Joseph I-Disease 0 0.023164929822087288
disease I-Disease 1 0.9994753003120422
( O 0 0.00046841983566991985
MJD B-Disease 1 0.9999237060546875
) O 0 0.00011351103603374213
( O 0 9.215447789756581e-05
n O 0 0.00021150063548702747
= O 0 0.0002926875604316592
16 O 0 0.00029572076164186
) O 0 0.0002684319333638996
. O 0 0.0004965199041180313

In O 0 0.0027617900632321835
SCA1 B-Disease 1 0.8523429036140442
, O 0 0.0008144283783622086
saccade O 0 0.005406602285802364
amplitude O 0 0.0008949055336415768
was O 0 0.00041244388557970524
significantly O 0 0.0001825280487537384
increased O 0 0.00011647290375549346
, O 0 5.2495001000352204e-05
resulting O 0 0.00021225902310106903
in O 0 0.00016870036779437214
hypermetria B-Disease 1 0.8305217027664185
. O 0 0.000797581800725311

The O 0 0.0017288069939240813
smooth O 0 0.0036822401452809572
pursuit O 0 0.009793794713914394
gain O 0 0.003146050963550806
was O 0 0.006110325455665588
decreased O 0 0.006689111236482859
. O 0 0.0012296282220631838

In O 0 0.002783294301480055
SCA2 B-Disease 1 0.9861310720443726
, O 0 0.0011222375323995948
saccade O 0 0.015049398876726627
velocity O 0 0.0025887596420943737
was O 0 0.00328277051448822
markedly O 0 0.0067276968620717525
decreased O 0 0.004243375733494759
. O 0 0.0008019746746867895

The O 0 0.0007728556520305574
percentage O 0 0.0003294377529527992
of O 0 0.00018725867266766727
errors O 0 0.0005644559860229492
in O 0 0.00018293522589374334
antisaccades O 1 0.9950886368751526
was O 0 0.001401446876116097
greatly O 0 0.0002634695847518742
increased O 0 5.964541924186051e-05
and O 0 3.098630622844212e-05
was O 0 0.00012094301200704649
significantly O 0 5.995243554934859e-05
correlated O 0 7.389287202386186e-05
with O 0 3.534509232849814e-05
age O 0 0.0006786542944610119
at O 1 0.9671191573143005
disease O 1 0.9999961853027344
onset O 1 0.9999899864196777
. O 0 0.0013840984320268035

In O 0 0.0004969246219843626
addition O 0 0.00017405588005203754
, O 0 7.563733379356563e-05
a O 0 9.766109724296257e-05
correlation O 0 0.00012074907863279805
between O 0 9.378979302709922e-05
smooth O 0 0.00039886354352347553
pursuit O 0 0.0006548033561557531
gain O 0 0.00012179608893347904
and O 0 3.343688149470836e-05
the O 0 3.370599733898416e-05
number O 0 2.5701476261019707e-05
of O 0 0.00013732348452322185
trinucleotide O 1 0.5673957467079163
repeats O 0 0.0009410782949998975
was O 0 0.000972317939158529
found O 0 0.0003830786154139787
. O 0 0.0004867746029049158

In O 0 0.006195766851305962
SCA3 B-Disease 1 0.9999192953109741
, O 0 0.0024251865688711405
gaze B-Disease 0 0.4552239775657654
- I-Disease 0 0.030299484729766846
evoked I-Disease 1 0.878288209438324
nystagmus I-Disease 1 0.9345479607582092
was O 0 0.0006864333990961313
often O 0 9.867658081930131e-05
present O 0 0.00010812396794790402
as O 0 0.00011886683205375448
was O 0 0.0008004317060112953
saccade O 0 0.01020977646112442
hypometria O 0 0.04745705425739288
and O 0 0.00022811615781392902
smooth O 0 0.0005589206120930612
pursuit O 0 0.0022244302090257406
gain O 0 0.0006017509731464088
was O 0 0.0024220170453190804
markedly O 0 0.004678335506469011
decreased O 0 0.0030806753784418106
. O 0 0.0006925136549398303

Three O 0 0.001016749651171267
major O 0 0.0013212619815021753
criteria O 0 0.0003907690697815269
, O 0 0.0002918755344580859
saccade O 0 0.002969730645418167
amplitude O 0 0.0006945737404748797
, O 0 0.00013834401033818722
saccade O 0 0.0012779171811416745
velocity O 0 0.00022645379067398608
, O 0 3.560609548003413e-05
and O 0 2.311757270945236e-05
presence O 0 6.202754593687132e-05
of O 0 0.00010830454993993044
gaze B-Disease 0 0.1350121945142746
- I-Disease 0 0.0014333128929138184
evoked I-Disease 0 0.014451668597757816
nystagmus I-Disease 0 0.005720094777643681
, O 0 4.3254884076304734e-05
permitted O 0 4.312127930461429e-05
the O 0 2.687066989892628e-05
correct O 0 4.697280746768229e-05
assignment O 0 7.561658276244998e-05
of O 0 4.588683441397734e-05
90 O 0 3.7642115785274655e-05
% O 0 1.2397005775710568e-05
of O 0 3.162459688610397e-05
the O 0 6.141600897535682e-05
SCA1 B-Disease 0 0.04144800454378128
, O 0 2.342275001865346e-05
90 O 0 2.750495696091093e-05
% O 0 1.4561852367478423e-05
of O 0 2.4617409508209676e-05
the O 0 4.5627417421201244e-05
SCA2 B-Disease 0 0.2639673352241516
, O 0 2.4674760425114073e-05
and O 0 1.5672472727601416e-05
93 O 0 4.67002610093914e-05
% O 0 1.3255347766971681e-05
of O 0 4.3233652831986547e-05
the O 0 9.186388342641294e-05
patients O 0 0.00013919352204538882
with O 0 4.9211434088647366e-05
SCA3 B-Disease 1 0.9998387098312378
to O 0 3.624994133133441e-05
their O 0 2.5999943318311125e-05
genetically O 0 6.60977020743303e-05
confirmed O 0 9.172487625619397e-05
patient O 0 0.0001021635762299411
group O 0 3.3019274269463494e-05
and O 0 3.209987698937766e-05
, O 0 3.436909901211038e-05
therefore O 0 3.100206231465563e-05
, O 0 4.051784344483167e-05
may O 0 5.679763853549957e-05
help O 0 0.0001083397728507407
orient O 0 0.0011243310291320086
diagnoses O 0 0.0010517948539927602
of O 0 0.0007069854182191193
SCA1 B-Disease 1 0.9999943971633911
, O 0 0.0005174825782887638
SCA2 B-Disease 1 0.9993155002593994
, O 0 0.0001512275484856218
and O 0 0.00011437315697548911
SCA3 B-Disease 1 0.998729407787323
at O 0 0.00022341932344716042
early O 0 0.00010350205411668867
clinical O 0 0.00021504145115613937
stages O 0 0.00035884694079868495
of O 0 0.00034400090225972235
the O 0 0.013347347266972065
diseases O 1 0.9998694658279419
. O 0 0.00029918900690972805
. O 0 0.0005674029816873372

Genetic O 0 0.0023321881890296936
basis O 0 0.0003796353121288121
and O 0 0.00048344660899601877
molecular O 0 0.0020078965462744236
mechanism O 0 0.31174182891845703
for O 0 0.36206066608428955
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 0.09642183780670166

Ventricular B-Disease 1 0.9999997615814209
fibrillation I-Disease 1 0.9999960660934448
causes O 0 0.16156139969825745
more O 0 7.751554949209094e-05
than O 0 5.3636496886610985e-05
300 O 0 8.389420690946281e-05
, O 0 3.2754920539446175e-05
000 O 0 0.00020702146866824478
sudden O 0 0.0004102563834749162
deaths O 0 0.00010167490836465731
each O 0 1.6045045413193293e-05
year O 0 3.692400787258521e-05
in O 0 3.4352156944805756e-05
the O 0 0.00012879434507340193
USA O 0 0.0009871775982901454
alone O 0 0.000673617934808135
. O 0 0.0004289286443963647

In O 0 0.0003148555406369269
approximately O 0 0.0002130814827978611
5 O 0 0.00010969879804179072
- O 0 7.25476274965331e-05
12 O 0 4.622677806764841e-05
% O 0 1.3267893336887937e-05
of O 0 2.2532161892740987e-05
these O 0 7.89186560723465e-06
cases O 0 1.6616872017038986e-05
, O 0 1.5671455912524834e-05
there O 0 1.497562334407121e-05
are O 0 7.016071776888566e-06
no O 0 4.848456592299044e-05
demonstrable O 1 0.9658315181732178
cardiac O 1 0.9999654293060303
or O 0 0.0004536957130767405
non O 0 0.06714694201946259
- O 1 0.5368387699127197
cardiac O 1 0.9998331069946289
causes O 0 0.0005887185106985271
to O 0 2.5248185920645483e-05
account O 0 1.9779910871875472e-05
for O 0 1.061032344296109e-05
the O 0 4.199912291369401e-05
episode O 0 0.0002491144696250558
, O 0 5.063741991762072e-05
which O 0 2.428205516480375e-05
is O 0 3.82229482056573e-05
therefore O 0 9.783838322618976e-05
classified O 0 0.00046876020496711135
as O 0 0.014294654130935669
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9993715882301331
IVF B-Disease 1 0.9999783039093018
) O 0 0.000804679119028151
. O 0 0.0006933248951099813

A O 0 0.0016073998995125294
distinct O 0 0.00035386293893679976
group O 0 0.0002884452696889639
of O 0 0.003133106278255582
IVF B-Disease 1 0.9999960660934448
patients O 0 0.0017552843783050776
has O 0 5.792266529169865e-05
been O 0 3.1193460017675534e-05
found O 0 2.1965886844554916e-05
to O 0 1.6708369003026746e-05
present O 0 3.9856924558989704e-05
with O 0 3.5930657759308815e-05
a O 0 0.00018549263768363744
characteristic O 0 0.009337720461189747
electrocardiographic O 1 0.9995899796485901
pattern O 0 0.09288546442985535
. O 0 0.0011698065791279078

Because O 0 0.0005295761511661112
of O 0 0.00022214846103452146
the O 0 0.00012581553892232478
small O 0 6.0120302805444226e-05
size O 0 4.72820975119248e-05
of O 0 3.617217589635402e-05
most O 0 2.6675756089389324e-05
pedigrees O 0 0.0001240582059836015
and O 0 2.5799117793212645e-05
the O 0 4.382697443361394e-05
high O 0 0.00014624932373408228
incidence O 0 0.0005989921046420932
of O 0 0.0001587138103786856
sudden B-Disease 1 0.9982263445854187
death I-Disease 0 0.11618556827306747
, O 0 3.285361890448257e-05
however O 0 2.009319359785877e-05
, O 0 1.531859379610978e-05
molecular O 0 3.59066434612032e-05
genetic O 0 3.1035844585858285e-05
studies O 0 2.169044455513358e-05
of O 0 0.00011112190986750647
IVF B-Disease 1 0.9693283438682556
have O 0 2.4823313651722856e-05
not O 0 1.1723843272193335e-05
yet O 0 4.39568939327728e-05
been O 0 8.405364496866241e-05
done O 0 0.00030772548052482307
. O 0 0.00043413424282334745

Because O 0 0.18901826441287994
IVF B-Disease 1 0.9999959468841553
causes O 1 0.9999926090240479
cardiac O 1 0.9999998807907104
rhythm O 1 0.9999926090240479
disturbance O 1 0.9999414682388306
, O 0 0.00013618884258903563
we O 0 4.300588625483215e-05
investigated O 0 0.00012187856191303581
whether O 0 5.233175397734158e-05
malfunction O 0 0.021535037085413933
of O 0 8.889711170922965e-05
ion O 0 0.00022668775636702776
channels O 0 5.284195867716335e-05
could O 0 4.803360934602097e-05
cause O 0 0.0004641347040887922
the O 0 0.0001271198852919042
disorder O 1 0.9973586201667786
by O 0 3.770664625335485e-05
studying O 0 0.00011783601803472266
mutations O 0 9.020534344017506e-05
in O 0 4.9792815843829885e-05
the O 0 0.00017268610827159137
cardiac O 1 0.9968940019607544
sodium O 0 0.001472335308790207
channel O 0 0.0006871147197671235
gene O 0 0.0007860238547436893
SCN5A O 1 0.6356668472290039
. O 0 0.001143027562648058

We O 0 0.0004359305021353066
have O 0 8.576217805966735e-05
now O 0 8.277675078716129e-05
identified O 0 7.57882371544838e-05
a O 0 0.0001046836405294016
missense O 0 0.0008611191879026592
mutation O 0 0.00014209408254828304
, O 0 6.109903188189492e-05
a O 0 8.83260800037533e-05
splice O 0 0.001166301779448986
- O 0 0.0004097855999134481
donor O 0 0.0002179361617891118
mutation O 0 0.0001366864744341001
, O 0 4.856587474932894e-05
and O 0 3.371795537532307e-05
a O 0 9.715273336041719e-05
frameshift O 0 0.0010995070915669203
mutation O 0 9.058833529707044e-05
in O 0 2.91832911898382e-05
the O 0 4.837210872210562e-05
coding O 0 7.944933895487338e-05
region O 0 8.482745033688843e-05
of O 0 0.00012415039236657321
SCN5A O 1 0.9490044116973877
in O 0 0.00010634426143951714
three O 0 0.00021546032803598791
IVF B-Disease 0 0.49047529697418213
families O 0 0.0004122783720958978
. O 0 0.0005991245270706713

We O 0 0.0006141648627817631
show O 0 0.0003681139787659049
that O 0 6.554472201969475e-05
sodium O 0 0.00011723572242772207
channels O 0 4.309398354962468e-05
with O 0 2.8395792469382286e-05
the O 0 0.00011177857231814414
missense O 0 0.0006209940183907747
mutation O 0 0.00018073608225677162
recover O 0 0.0004290644428692758
from O 0 7.479215128114447e-05
inactivation O 0 0.0013606214197352529
more O 0 2.8247353839105926e-05
rapidly O 0 9.091875108424574e-05
than O 0 1.9368284483789466e-05
normal O 0 2.958424920507241e-05
and O 0 1.1834265023935586e-05
that O 0 1.26980448840186e-05
the O 0 8.082931890385225e-05
frameshift O 0 0.002376886550337076
mutation O 0 0.00013790187949780375
causes O 0 0.00016194987983908504
the O 0 7.66048688092269e-05
sodium O 0 0.00012542144395411015
channel O 0 6.276990461628884e-05
to O 0 2.0194009266560897e-05
be O 0 3.879028736264445e-05
non O 0 0.0001839286705944687
- O 0 0.0005405876436270773
functional O 0 0.0009050467633642256
. O 0 0.0006851314683444798

Our O 0 0.0013899760087952018
results O 0 0.000354867399437353
indicate O 0 0.00017794506857171655
that O 0 6.149101682240143e-05
mutations O 0 0.000132407367345877
in O 0 0.00012289106962271035
cardiac O 1 0.9992679953575134
ion O 0 0.003042522119358182
- O 0 0.00024404612486250699
channel O 0 8.175458060577512e-05
genes O 0 3.5156535886926576e-05
contribute O 0 3.689591903821565e-05
to O 0 2.067935565719381e-05
the O 0 6.226708501344547e-05
risk O 0 0.00013811296958010644
of O 0 0.00022748539049644023
developing O 0 0.00466961320489645
IVF B-Disease 1 0.9992927312850952
. O 0 0.00041012887959368527
. O 0 0.0007207184680737555

Molecular O 0 0.003873201087117195
heterogeneity O 0 0.004738066345453262
in O 0 0.0009204972884617746
mucopolysaccharidosis B-Disease 1 0.9981654286384583
IVA I-Disease 1 0.9984368681907654
in O 0 0.00017108587780967355
Australia O 0 0.0001466432586312294
and O 0 4.5576154661830515e-05
Northern O 0 0.0001416341692674905
Ireland O 0 0.00016025977674871683
: O 0 5.157610939932056e-05
nine O 0 0.0001002814169623889
novel O 0 0.00013853398559149355
mutations O 0 0.00011071795597672462
including O 0 7.406994700431824e-05
T312S O 0 0.023956838995218277
, O 0 6.736908107995987e-05
a O 0 9.465874609304592e-05
common O 0 9.567046799929813e-05
allele O 0 0.0002451127511449158
that O 0 7.382821786450222e-05
confers O 0 0.0010541179217398167
a O 0 0.0008336257888004184
mild O 1 0.8422602415084839
phenotype O 0 0.013233484700322151
. O 0 0.000990683794952929

Mucopolysaccharidosis B-Disease 1 0.9995243549346924
IVA I-Disease 1 0.9999432563781738
( O 0 0.009471745230257511
MPS B-Disease 1 0.9832857251167297
IVA I-Disease 1 0.9999722242355347
) O 0 0.0003324590506963432
is O 0 0.00022516782337334007
an O 0 0.00029569820617325604
autosomal B-Disease 1 0.8211057782173157
recessive I-Disease 1 0.9999700784683228
lysosomal I-Disease 1 0.9999998807907104
storage I-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
caused O 1 0.9992382526397705
by O 0 6.631608994212002e-05
a O 0 0.00026845134561881423
genetic B-Disease 0 0.007307145278900862
defect I-Disease 1 0.9982470273971558
in O 0 0.00010960322106257081
N O 0 0.0006243887473829091
- O 0 0.00027566333301365376
acetylgalactosamine O 0 0.0026325490325689316
- O 0 0.0003248864959459752
6 O 0 0.0005585776525549591
- O 0 0.0008942141430452466
sulfate O 0 0.24323102831840515
sulfatase O 1 0.995557963848114
( O 0 0.0014451822498813272
GALNS O 1 0.9979526996612549
) O 0 0.0007862736820243299
. O 0 0.0008027541916817427

Previous O 0 0.0010273009538650513
studies O 0 0.00013653405767399818
of O 0 0.00014942747657187283
patients O 0 0.00017477165965829045
from O 0 4.7371460823342204e-05
a O 0 8.129838533932343e-05
British O 0 0.0001772002287907526
- O 0 8.284505747724324e-05
Irish O 0 7.35358553356491e-05
population O 0 1.1233148143219296e-05
showed O 0 3.1698786187916994e-05
that O 0 1.2735117707052268e-05
the O 0 4.368834925116971e-05
I113F O 0 0.01902003400027752
mutation O 0 6.58800927340053e-05
is O 0 1.3638601558341179e-05
the O 0 1.7035174096236005e-05
most O 0 1.3816088539897464e-05
common O 0 2.1923948224866763e-05
single O 0 8.395560143981129e-05
mutation O 0 0.0001623365533305332
among O 0 0.00012571467959787697
MPS B-Disease 1 0.9767279028892517
IVA I-Disease 1 0.9999992847442627
patients O 0 0.007212836295366287
and O 0 0.00015274356701411307
produces O 0 0.00033398138475604355
a O 0 0.0006564679788425565
severe O 1 0.9998856782913208
clinical O 1 0.967878520488739
phenotype O 1 0.7129431366920471
. O 0 0.0006992538692429662

We O 0 0.00044346056529320776
studied O 0 0.0004137250653002411
mutations O 0 0.0001725105248624459
in O 0 8.249645179603249e-05
the O 0 0.00016620209498796612
GALNS O 0 0.2998078167438507
gene O 0 8.824560063658282e-05
from O 0 3.302346158307046e-05
23 O 0 0.00011315537994960323
additional O 0 0.00010076818580273539
MPS B-Disease 0 0.003038017312064767
IVA I-Disease 1 0.9998476505279541
patients O 0 0.00024240519269369543
( O 0 3.415273749851622e-05
15 O 0 3.711634417413734e-05
from O 0 2.416827373963315e-05
Australia O 0 4.2835003114305437e-05
, O 0 2.5407212888239883e-05
8 O 0 3.635157554526813e-05
from O 0 2.0972833226551302e-05
Northern O 0 5.7114451919915155e-05
Ireland O 0 6.947511428734288e-05
) O 0 1.593686465639621e-05
, O 0 2.0942910850862972e-05
with O 0 1.29505388031248e-05
various O 0 2.163157296308782e-05
clinical O 0 0.0010007178643718362
phenotypes O 0 0.10114268213510513
( O 0 0.00028547467081807554
severe O 1 0.9599131345748901
, O 0 3.663181632873602e-05
16 O 0 5.161365697858855e-05
cases O 0 2.236314867332112e-05
; O 0 9.279954610974528e-06
intermediate O 0 5.1492763304850087e-05
, O 0 1.9702854842762463e-05
4 O 0 4.6410354116233066e-05
cases O 0 3.197455225745216e-05
; O 0 2.1406962332548574e-05
mild O 0 0.0002523685689084232
, O 0 3.383911098353565e-05
3 O 0 0.00010549915896262974
cases O 0 8.049610914895311e-05
) O 0 0.00012174824951216578
. O 0 0.00024000884150154889

We O 0 0.0003721360699273646
found O 0 0.00016660685651004314
two O 0 4.888686817139387e-05
common O 0 7.662137795705348e-05
mutations O 0 4.6393543016165495e-05
that O 0 1.7681146346149035e-05
together O 0 2.5011555408127606e-05
accounted O 0 5.6936787586892024e-05
for O 0 1.2012831575702876e-05
32 O 0 2.7948424758506007e-05
% O 0 1.4355701750901062e-05
of O 0 2.8627588108065538e-05
the O 0 5.370138751459308e-05
44 O 0 0.00012672120647039264
unrelated O 0 0.0002498487592674792
alleles O 0 0.00012217785115353763
in O 0 7.423682836815715e-05
these O 0 0.00010283121810061857
patients O 0 0.0007217666716314852
. O 0 0.0006924677290953696

One O 0 0.0005525599699467421
is O 0 0.0002996491966769099
the O 0 0.00024376474902965128
T312S O 1 0.6237895488739014
mutation O 0 0.0003469750809017569
, O 0 6.128080713097006e-05
a O 0 0.00010645982547430322
novel O 0 0.00016936891188379377
mutation O 0 7.64104479458183e-05
found O 0 5.907211743760854e-05
exclusively O 0 0.0001608124002814293
in O 0 0.0002341643994441256
milder O 0 0.0043398053385317326
patients O 0 0.0024246443063020706
. O 0 0.0008689540554769337

The O 0 0.0007306609768420458
other O 0 9.798954852158204e-05
is O 0 9.390390187036246e-05
the O 0 0.00012021370639558882
previously O 0 0.00021702854428440332
described O 0 0.0004568789154291153
I113F O 0 0.3140162527561188
that O 0 0.00014687207294628024
produces O 0 0.0003741084656212479
a O 0 0.00063049461459741
severe O 1 0.9998675584793091
phenotype O 1 0.6484214663505554
. O 0 0.0008321305504068732

The O 0 0.0029918369837105274
I113F O 0 0.07947218418121338
and O 0 0.000599182560108602
T312S O 0 0.014775671996176243
mutations O 0 0.00020867923740297556
accounted O 0 0.00012940840679220855
for O 0 1.9943792722187936e-05
8 O 0 3.8333339034579694e-05
( O 0 1.882219294202514e-05
18 O 0 2.3245884221978486e-05
% O 0 1.2397289538057521e-05
) O 0 7.5235398071527015e-06
and O 0 8.789223102212418e-06
6 O 0 3.158704566885717e-05
( O 0 1.5157151210587472e-05
14 O 0 2.0742752894875593e-05
% O 0 9.641436008678284e-06
) O 0 8.208564395317808e-06
of O 0 4.1973096813308075e-05
44 O 0 0.0001295880792895332
unrelated O 0 0.00026552152121439576
alleles O 0 0.0002856903010979295
, O 0 0.00020607341139111668
respectively O 0 0.0005124068120494485
. O 0 0.0004443288780748844

The O 0 0.0012804216239601374
relatively O 0 0.0006607750547118485
high O 0 0.0010228353785350919
residual O 0 0.013854107819497585
GALNS O 1 0.9986873269081116
activity O 0 0.0006298558437265456
seen O 0 0.0002808389544952661
when O 0 0.00011501691915327683
the O 0 0.00012233489542268217
T312S O 0 0.00441720150411129
mutant O 0 0.000832998426631093
cDNA O 0 0.000918337085749954
is O 0 0.00017268380906898528
overexpressed O 0 0.0007591068278998137
in O 0 0.00012744514970108867
mutant O 0 0.0006855478277429938
cells O 0 8.165182225639e-05
provides O 0 2.2691538106300868e-05
an O 0 1.4522951460094191e-05
explanation O 0 4.210370752844028e-05
for O 0 1.9694683942361735e-05
the O 0 8.87045607669279e-05
mild O 0 0.06562576442956924
phenotype O 0 0.0008589897770434618
in O 0 7.347626524278894e-05
patients O 0 0.00015720359806437045
with O 0 6.429562927223742e-05
this O 0 0.0001304121542489156
mutation O 0 0.0005181005108170211
. O 0 0.00041579254320822656

The O 0 0.0007490815478377044
distribution O 0 0.00027375377248972654
and O 0 8.3454571722541e-05
relative O 0 0.00010960657527903095
frequencies O 0 5.640442395815626e-05
of O 0 6.799682887503877e-05
the O 0 0.00010741580626927316
I113F O 0 0.0535159632563591
and O 0 0.00013776611012872308
T312S O 0 0.037273723632097244
mutations O 0 8.845149568514898e-05
in O 0 2.9055439881631173e-05
Australia O 0 4.5902412239229307e-05
corresponded O 0 5.290992703521624e-05
to O 0 1.4077355444896966e-05
those O 0 1.4191931768436916e-05
observed O 0 2.7537713322089985e-05
in O 0 1.7531441699247807e-05
Northern O 0 5.132294609211385e-05
Ireland O 0 4.148740117670968e-05
and O 0 1.4683872905152384e-05
are O 0 3.2627888231218094e-06
unique O 0 1.1058288691856433e-05
to O 0 6.08214440944721e-06
these O 0 3.9287865547521506e-06
two O 0 8.352240911335684e-06
populations O 0 1.4055409337743185e-05
, O 0 1.7527012460050173e-05
suggesting O 0 4.84810043417383e-05
that O 0 9.518728802504484e-06
both O 0 1.5638835975551046e-05
mutations O 0 3.9774902688805014e-05
were O 0 1.8781849576043896e-05
probably O 0 4.947847992298193e-05
introduced O 0 3.223934254492633e-05
to O 0 9.434563253307715e-06
Australia O 0 3.692950485856272e-05
by O 0 1.7619520804146305e-05
Irish O 0 8.132265793392435e-05
migrants O 0 5.7312670833198354e-05
during O 0 0.00012635873281396925
the O 0 0.00013969467545393854
19th O 0 0.0014027514262124896
century O 0 0.001262726727873087
. O 0 0.0005765749956481159

Haplotype O 0 0.004490942228585482
analysis O 0 0.00027471306384541094
using O 0 0.00011177174019394442
6 O 0 0.00032900177757255733
RFLPs O 0 0.001423165900632739
provides O 0 4.977007847628556e-05
additional O 0 2.4431667043245398e-05
data O 0 1.1282695595582481e-05
that O 0 1.0304794159310404e-05
the O 0 4.651816561818123e-05
I113F O 0 0.0028619582299143076
mutation O 0 9.687076817499474e-05
originated O 0 9.076370042748749e-05
from O 0 4.439248368726112e-05
a O 0 0.00014620886940974742
common O 0 0.00023083199630491436
ancestor O 0 0.0020907162688672543
. O 0 0.0009356540977023542

The O 0 0.00040981703205034137
other O 0 0.0001235872186953202
9 O 0 0.00024537229910492897
novel O 0 0.0002454977366141975
mutations O 0 9.018933633342385e-05
identified O 0 3.8277008570730686e-05
in O 0 1.784243249858264e-05
these O 0 1.3088344530842733e-05
23 O 0 9.87285457085818e-05
patients O 0 5.593642345047556e-05
were O 0 2.0231711459928192e-05
each O 0 8.585647265135776e-06
limited O 0 1.9982075173174962e-05
to O 0 1.6131301890709437e-05
a O 0 8.314081787830219e-05
single O 0 0.0002005280985031277
family O 0 0.0003841063880827278
. O 0 0.00038804725045338273

These O 0 0.000256622995948419
data O 0 0.0001406263472745195
provide O 0 6.665637192782015e-05
further O 0 6.923701585037634e-05
evidence O 0 0.00010987005953211337
for O 0 4.747099592350423e-05
extensive O 0 0.00032154505606740713
allelic O 0 0.001789129339158535
heterogeneity O 0 0.0010363321052864194
in O 0 0.00025472501874901354
MPS B-Disease 0 0.023315269500017166
IVA I-Disease 1 0.9992530941963196
in O 0 0.00018107384676113725
British O 0 0.0006573556456714869
- O 0 0.00040082537452690303
Irish O 0 0.0005145449540577829
patients O 0 8.504372090101242e-05
and O 0 2.5720773919601925e-05
provide O 0 1.6705993402865715e-05
evidence O 0 3.1902520277071744e-05
for O 0 1.4270076462707948e-05
their O 0 1.547561987536028e-05
transmission O 0 5.9674996009562165e-05
to O 0 1.9922350475098938e-05
Australia O 0 4.170386091573164e-05
by O 0 2.4582714104326442e-05
British O 0 0.00012328698358032852
- O 0 0.00018357369117438793
Irish O 0 0.0002912001218646765
migrants O 0 0.00021614118304569274
. O 0 0.00014261111209634691
. O 0 0.00026608153712004423

Identification O 0 0.0018111502286046743
of O 0 0.0009721835376694798
constitutional O 0 0.0037823300808668137
WT1 O 1 0.9999300241470337
mutations O 0 0.0007598052034154534
, O 0 0.00014505146828014404
in O 0 9.974694694392383e-05
patients O 0 0.0003713935147970915
with O 0 0.00019146964768879116
isolated O 1 0.997983455657959
diffuse B-Disease 1 0.9999972581863403
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.00023681875609327108
and O 0 8.388996502617374e-05
analysis O 0 3.722598194144666e-05
of O 0 0.00011831577285192907
genotype O 0 0.0010535437613725662
/ O 0 0.0007616530638188124
phenotype O 0 0.0002635170822031796
correlations O 0 0.00010308569471817464
by O 0 2.7505062462296337e-05
use O 0 1.3979640243633185e-05
of O 0 6.979404861340299e-05
a O 0 0.00020646479970309883
computerized O 0 0.0006275620544329286
mutation O 0 0.0004611486801877618
database O 0 0.0003675597545225173
. O 0 0.0006346843438223004

Constitutional O 0 0.001961681293323636
mutations O 0 0.00042374597978778183
of O 0 0.00023800555209163576
the O 0 0.0002727517858147621
WT1 O 1 0.9937042593955994
gene O 0 0.00012653524754568934
, O 0 3.374147127033211e-05
encoding O 0 7.733960956102237e-05
a O 0 0.0001398799504386261
zinc O 0 0.0511845126748085
- O 0 0.00022583690588362515
finger O 0 0.0006019397987984121
transcription O 0 0.0003430828801356256
factor O 0 0.00027782798861153424
involved O 0 0.0001589558378327638
in O 0 0.00021023157751187682
renal O 1 0.9999992847442627
and O 0 0.0034523927606642246
gonadal O 1 0.9999767541885376
development O 0 0.0006264466792345047
, O 0 4.90401143906638e-05
are O 0 5.821373633807525e-06
found O 0 1.044056989485398e-05
in O 0 1.269848053198075e-05
most O 0 2.2287080355454236e-05
patients O 0 8.34867314551957e-05
with O 0 0.00010507967817829922
Denys B-Disease 1 0.9999871253967285
- I-Disease 1 0.9999111890792847
Drash I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 0 0.13438114523887634
DDS B-Disease 1 0.9999884366989136
) O 0 0.00016276712995022535
, O 0 0.0001362242765026167
or O 0 0.00036744741373695433
diffuse B-Disease 1 0.999458372592926
mesangial I-Disease 1 0.9999998807907104
sclerosis I-Disease 1 1.0
( O 1 0.61741703748703
DMS B-Disease 1 0.9999098777770996
) O 0 0.00014715225552208722
associated O 0 9.397565736435354e-05
with O 0 9.448405035072938e-05
pseudohermaphroditism B-Disease 1 0.998306155204773
and O 0 0.0003999707114417106
/ O 0 0.026848193258047104
or O 0 0.00885041244328022
Wilms B-Disease 1 0.9999992847442627
tumor I-Disease 1 0.9999923706054688
( O 0 0.0025702642742544413
WT B-Disease 1 0.9988377690315247
) O 0 0.0005555427051149309
. O 0 0.0007120516384020448

Most O 0 0.0013883356004953384
mutations O 0 0.0011259152088314295
in O 0 0.0007410678663291037
DDS B-Disease 1 0.9999511241912842
patients O 0 0.00105803064070642
lie O 0 0.0007999840890988708
in O 0 0.0001800552854547277
exon O 0 0.0007511592120863497
8 O 0 0.00014595493848901242
or O 0 6.081403262214735e-05
exon O 0 0.00031526913517154753
9 O 0 0.0001336005370831117
, O 0 6.491856038337573e-05
encoding O 0 0.00013259715342428535
zinc O 0 0.0014193751849234104
finger O 0 0.0006633530138060451
2 O 0 0.000147910657688044
or O 0 0.00012347579468041658
zinc O 0 0.012197533622384071
finger O 0 0.0007837243610993028
3 O 0 8.410013833781704e-05
, O 0 2.774879067146685e-05
respectively O 0 2.8654520065174438e-05
, O 0 1.1299202014924958e-05
with O 0 7.809851922502276e-06
a O 0 4.139267184655182e-05
hot O 0 0.00019607793365139514
spot O 0 0.00019865490321535617
( O 0 6.808597390772775e-05
R394W O 0 0.0008552020881325006
) O 0 3.776602170546539e-05
in O 0 4.625720976036973e-05
exon O 0 0.0006843931041657925
9 O 0 0.0008779516792856157
. O 0 0.0005881581455469131

We O 0 0.000393516878830269
analyzed O 0 0.00017065572319552302
a O 0 7.945759716676548e-05
series O 0 9.157526073977351e-05
of O 0 8.075904770521447e-05
24 O 0 0.00013035298616159707
patients O 0 7.916937465779483e-05
, O 0 2.26396405196283e-05
10 O 0 3.257154821767472e-05
with O 0 4.578114385367371e-05
isolated B-Disease 0 0.0012030090438202024
DMS I-Disease 1 0.9995810389518738
( O 0 0.0003528194793034345
IDMS B-Disease 1 0.9327806234359741
) O 0 3.554428622010164e-05
, O 0 2.8674416171270423e-05
10 O 0 4.5856078941142187e-05
with O 0 4.384854037198238e-05
DDS B-Disease 1 0.9459825158119202
, O 0 7.787690265104175e-05
and O 0 5.0311078666709363e-05
4 O 0 0.00023816766042727977
with O 0 0.00023522504488937557
urogenital B-Disease 1 0.9999988079071045
abnormalities I-Disease 1 0.9999922513961792
and O 0 0.009072382934391499
/ O 1 0.8187804818153381
or O 0 0.0025873342528939247
WT B-Disease 1 0.9987480640411377
. O 0 0.0012752643087878823

We O 0 0.001642130664549768
report O 0 0.0009531928226351738
WT1 O 0 0.13873758912086487
heterozygous O 0 0.0005747330724261701
mutations O 0 0.00015350601461250335
in O 0 6.367861351463944e-05
16 O 0 0.00018636944878380746
patients O 0 9.381699055666104e-05
, O 0 3.754664430744015e-05
4 O 0 6.597251922357827e-05
of O 0 9.155937004834414e-05
whom O 0 0.0001497495686635375
presented O 0 0.000411547051044181
with O 0 0.0004341671010479331
IDMS B-Disease 1 0.9996687173843384
. O 0 0.001463333610445261

One O 0 0.000994020840153098
male O 0 0.0007474372396245599
and O 0 0.00020242085156496614
two O 0 0.00017302102060057223
female O 0 0.1925876885652542
IDMS B-Disease 1 0.9999966621398926
patients O 0 0.4680614173412323
with O 0 0.0029078284278512
WT1 O 1 0.9999980926513672
mutations O 0 0.3460051417350769
underwent O 1 0.9999605417251587
normal O 0 0.06853882968425751
puberty O 1 0.9780532121658325
. O 0 0.0013753478415310383

Two O 0 0.0010688075562939048
mutations O 0 0.0007406093063764274
associated O 0 0.0003079570597037673
with O 0 0.00014883563562761992
IDMS B-Disease 1 0.9730660915374756
are O 0 2.859227970475331e-05
different O 0 1.6352969396393746e-05
from O 0 4.715223258244805e-05
those O 0 5.068810787633993e-05
described O 0 0.0004204904253128916
in O 0 0.000746059522498399
DDS B-Disease 1 0.9999958276748657
patients O 0 0.12739655375480652
. O 0 0.0016122261295095086

No O 0 0.005233272910118103
WT1 O 1 0.9929431080818176
mutations O 0 0.000556469545699656
were O 0 0.00012618677283171564
detected O 0 0.0001957963831955567
in O 0 5.6482094805687666e-05
the O 0 6.618127372348681e-05
six O 0 0.00012453217641450465
other O 0 0.00014744455984327942
IDMS B-Disease 1 0.9999850988388062
patients O 0 0.001065111835487187
, O 0 8.298413740703836e-05
suggesting O 0 0.00023328550742007792
genetic O 0 9.542828047415242e-05
heterogeneity O 0 0.0005358147318474948
of O 0 0.000547642121091485
this O 0 0.0008669320377521217
disease O 1 0.9999105930328369
. O 0 0.001324312062934041

We O 0 0.0008435954805463552
analyzed O 0 0.0007728268974460661
genotype O 0 0.0018435900565236807
/ O 0 0.000935133604798466
phenotype O 0 0.00044961515231989324
correlations O 0 0.000113392568891868
, O 0 2.766645593510475e-05
on O 0 1.5856334357522428e-05
the O 0 1.619400609342847e-05
basis O 0 1.573234112584032e-05
of O 0 2.6169544071308337e-05
the O 0 4.478088885662146e-05
constitution O 0 3.870806540362537e-05
of O 0 6.817004032200202e-05
a O 0 0.00018563275807537138
WT1 O 0 0.10592691600322723
mutation O 0 8.501736738253385e-05
database O 0 4.279331551515497e-05
of O 0 6.581428897334263e-05
84 O 0 0.00075180409476161
germ O 1 0.9941670894622803
- O 0 0.00034404834150336683
line O 0 0.00022116675972938538
mutations O 0 5.603690806310624e-05
, O 0 1.9258031898061745e-05
to O 0 1.0566157470748294e-05
compare O 0 1.96041746676201e-05
the O 0 2.1684199964511208e-05
distribution O 0 2.1394820578279905e-05
and O 0 1.4016430213814601e-05
type O 0 4.0548689867137e-05
of O 0 5.90436247875914e-05
mutations O 0 4.4128762965556234e-05
, O 0 1.8814080249285325e-05
according O 0 1.537822936370503e-05
to O 0 1.5877125406404957e-05
the O 0 9.435943502467126e-05
different O 0 0.0001229073532158509
symptoms O 0 0.12818872928619385
. O 0 0.0007540149963460863

This O 0 0.00045725470408797264
demonstrated O 0 0.00035514900810085237
( O 0 8.822969539323822e-05
1 O 0 7.000756886554882e-05
) O 0 3.5709672374650836e-05
the O 0 4.187498416285962e-05
association O 0 5.5482687457697466e-05
between O 0 2.3649083232157864e-05
mutations O 0 2.6547621018835343e-05
in O 0 1.8378490494797006e-05
exons O 0 9.353435598313808e-05
8 O 0 5.268266249913722e-05
and O 0 2.703413883864414e-05
9 O 0 7.215271762106568e-05
and O 0 3.960718822781928e-05
DMS B-Disease 0 0.008881641551852226
; O 0 1.8635353626450524e-05
( O 0 2.8497714083641768e-05
2 O 0 4.316538979765028e-05
) O 0 2.7285872420179658e-05
among O 0 3.377811299287714e-05
patients O 0 6.276260683080181e-05
with O 0 3.936202483600937e-05
DMS B-Disease 1 0.5935401320457458
, O 0 3.7987512769177556e-05
a O 0 3.80294477508869e-05
higher O 0 3.231121081626043e-05
frequency O 0 1.7982763893087395e-05
of O 0 2.2560845536645502e-05
exon O 0 0.00018367348820902407
8 O 0 4.4606269511859864e-05
mutations O 0 3.6790301237488165e-05
among O 0 2.4762097382335924e-05
46 O 0 0.00010646753798937425
, O 0 0.00010246464080410078
XY O 0 0.23619292676448822
patients O 0 0.00011396361514925957
with O 0 2.90583775495179e-05
female O 0 0.00016453934949822724
phenotype O 0 0.0001411730336258188
than O 0 2.5378398277098313e-05
among O 0 2.888228300435003e-05
46 O 0 0.00011855439515784383
, O 0 0.00012384203728288412
XY O 1 0.5495280027389526
patients O 0 0.00013007970119360834
with O 0 2.54914539254969e-05
sexual O 0 0.00011926101433346048
ambiguity O 0 0.00026503237313590944
or O 0 6.549105455633253e-05
male O 0 0.00016586312267463654
phenotype O 0 0.00018466179608367383
; O 0 1.1464896488178056e-05
and O 0 1.5325214917538688e-05
( O 0 2.223705996584613e-05
3 O 0 2.9862172596040182e-05
) O 0 1.375051124341553e-05
statistically O 0 2.239123386971187e-05
significant O 0 2.3657566998736e-05
evidence O 0 2.477908128639683e-05
that O 0 1.1380363503121771e-05
mutations O 0 2.0913215848850086e-05
in O 0 2.1067229681648314e-05
exons O 0 0.00010436229058541358
8 O 0 4.993942638975568e-05
and O 0 2.8870221285615116e-05
9 O 0 9.865447646006942e-05
preferentially O 0 8.098362013697624e-05
affect O 0 6.387468602042645e-05
amino O 0 5.049232640885748e-05
acids O 0 3.060852759517729e-05
with O 0 1.6055546439019963e-05
different O 0 1.995787170017138e-05
functions O 0 5.99658778810408e-05
. O 0 0.0001293558452744037
. O 0 0.0003365423472132534

The O 0 0.004288272932171822
185delAG O 1 0.980549156665802
BRCA1 O 0 0.2973913550376892
mutation O 0 0.0005735321901738644
originated O 0 0.0003055784327443689
before O 0 7.451152487192303e-05
the O 0 5.327121471054852e-05
dispersion O 0 0.00013740781287197024
of O 0 4.511346560320817e-05
Jews O 0 8.690974209457636e-05
in O 0 2.9908000215073116e-05
the O 0 4.772727334056981e-05
diaspora O 0 8.830939623294398e-05
and O 0 3.6370613088365644e-05
is O 0 2.0484605556703173e-05
not O 0 1.9364959371159784e-05
limited O 0 4.665521555580199e-05
to O 0 0.00012175821757409722
Ashkenazim O 0 0.0032039755024015903
. O 0 0.0008606110350228846

The O 0 0.0020091973710805178
185delAG O 1 0.7425150275230408
mutation O 0 0.0010325360344722867
in O 0 0.00023463147226721048
BRCA1 O 0 0.01385475229471922
is O 0 8.998670091386884e-05
detected O 0 0.00016470320406369865
in O 0 5.3007293900009245e-05
Ashkenazi O 0 0.0002592274686321616
Jews O 0 0.00010428937821416184
both O 0 4.323138273321092e-05
in O 0 0.0001003442594083026
familial B-Disease 1 0.9999083280563354
breast I-Disease 1 0.9999998807907104
and I-Disease 1 0.9999853372573853
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
and O 0 0.00023493012122344226
in O 0 7.907293911557645e-05
the O 0 0.00010880255285883322
general O 0 0.0003217572520952672
population O 0 0.00015584172797389328
. O 0 0.00033382061519660056

All O 0 0.0009531566756777465
tested O 0 0.0012090700911357999
Ashkenazi O 0 0.0014943056739866734
mutation O 0 0.00023349112598225474
carriers O 0 0.00010293864033883438
share O 0 2.906513873313088e-05
the O 0 6.25968023086898e-05
same O 0 8.563281153328717e-05
allelic O 0 0.0010870258556678891
pattern O 0 0.0006632293807342649
at O 0 0.0005307177198119462
the O 0 0.0008166925399564207
BRCA1 O 1 0.7545803785324097
locus O 0 0.006794293411076069
. O 0 0.0009160317131318152

Our O 0 0.0010355667909607291
previous O 0 0.00029105524299666286
study O 0 9.298937948187813e-05
showed O 0 0.00013325270265340805
that O 0 2.883654087781906e-05
this O 0 2.866088652808685e-05
Ashkenazi O 0 0.0003129357937723398
mutation O 0 7.998450746526942e-05
also O 0 3.7252120819175616e-05
occurs O 0 4.558932414511219e-05
in O 0 2.0302839402575046e-05
Iraqi O 0 0.00012488823267631233
Jews O 0 8.508288738084957e-05
with O 0 2.668099659786094e-05
a O 0 0.0001029818449751474
similar O 0 0.00016927624528761953
allelic O 0 0.0039062462747097015
pattern O 0 0.0030611425172537565
. O 0 0.0009398086695000529

We O 0 0.0005294933798722923
extended O 0 0.00029952582553960383
our O 0 0.00010611239849822596
analysis O 0 3.0451108614215627e-05
to O 0 2.2111811631475575e-05
other O 0 2.8337008188827895e-05
non O 0 9.75551811279729e-05
- O 0 0.0001138287188950926
Ashkenazi O 0 0.0003298790252301842
subsets O 0 0.00036025981535203755
354 O 0 0.0004847878299187869
of O 0 0.00010776185808936134
Moroccan O 0 0.0004524648829828948
origin O 0 0.00011009911395376548
, O 0 7.137761713238433e-05
200 O 0 0.0002275153383379802
Yemenites O 0 0.0020181110594421625
and O 0 9.926691564032808e-05
150 O 0 0.00019440620962996036
Iranian O 0 0.0005019954987801611
Jews O 0 0.0007918276241980493
. O 0 0.000524439848959446

Heteroduplex O 0 0.048215869814157486
analysis O 0 0.0007700414280407131
complemented O 0 0.0010108038550242782
by O 0 0.00013635035429615527
direct O 0 0.00011289841495454311
DNA O 0 0.00018096854910254478
sequencing O 0 0.0002942111750598997
of O 0 0.00018435392121318728
abnormally O 0 0.0016969700809568167
migrating O 0 0.0003394747036509216
bands O 0 0.0003130679833702743
were O 0 0.00015484691539313644
employed O 0 0.0004838333697989583
. O 0 0.00037391515797935426

Four O 0 0.0003877900307998061
of O 0 0.0002459653769619763
Moroccan O 0 0.0004131087043788284
origin O 0 7.939193892525509e-05
( O 0 4.5721197238890454e-05
1 O 0 3.699993612826802e-05
. O 0 1.758742109814193e-05
1 O 0 3.458085120655596e-05
% O 0 2.2360847651725635e-05
) O 0 1.8120070308214054e-05
and O 0 1.9685106963152066e-05
none O 0 3.698801083373837e-05
of O 0 4.016353341285139e-05
the O 0 0.00010652745550032705
Yemenites O 0 0.0025337368715554476
or O 0 7.804557390045375e-05
Iranians O 0 0.00014520854165311903
was O 0 0.00018511556845624
a O 0 9.922300523612648e-05
carrier O 0 0.00018003331206273288
of O 0 0.00012850337952841073
the O 0 0.00040498460293747485
185delAG O 1 0.9755467176437378
mutation O 0 0.0024373922497034073
. O 0 0.0009849956259131432

BRCA1 O 1 0.8228410482406616
allelic O 0 0.005775449797511101
patterns O 0 0.0003141634806524962
were O 0 6.551491242134944e-05
determined O 0 6.236776243895292e-05
for O 0 1.7268323063035496e-05
four O 0 1.1668128536257427e-05
of O 0 1.9603427062975243e-05
these O 0 6.735462193319108e-06
individuals O 0 5.114148279972142e-06
and O 0 1.0111381925526075e-05
for O 0 9.541423423797823e-06
12 O 0 3.3976248232647777e-05
additional O 0 4.0066559449769557e-05
non O 0 0.00013535933976527303
- O 0 0.0001893395237857476
Ashkenazi O 0 0.0006388667388819158
185delAG O 0 0.00713906018063426
mutation O 0 0.000361626356607303
carriers O 0 0.0002543709706515074
who O 0 0.00021717096387874335
had O 0 0.09796836227178574
breast B-Disease 1 0.9999996423721313
/ I-Disease 1 0.9999992847442627
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
. O 0 0.004171187523752451

Six O 0 0.0017209794605150819
non O 0 0.0014601729344576597
- O 0 0.00043758441461250186
Ashkenazi O 0 0.00047716672997921705
individuals O 0 5.12709011672996e-05
shared O 0 6.857827247586101e-05
the O 0 7.09483283571899e-05
common O 0 6.357115489663556e-05
Ashkenazi O 0 0.0007490526768378913
haplotype O 0 0.0002695618895813823
, O 0 4.8443394916830584e-05
four O 0 3.563802965800278e-05
had O 0 5.2671402954729274e-05
a O 0 5.210885501583107e-05
closely O 0 4.78642359666992e-05
related O 0 6.141062476672232e-05
pattern O 0 0.00012867442274000496
, O 0 3.427019328228198e-05
and O 0 2.3986583983059973e-05
the O 0 4.0766666643321514e-05
rest O 0 9.363992285216227e-05
( O 0 4.3878917495021597e-05
n O 0 0.00010236288653686643
= O 0 7.296996773220599e-05
6 O 0 6.067957656341605e-05
) O 0 3.205301254638471e-05
displayed O 0 0.0001386469666613266
a O 0 0.0001181964689749293
distinct O 0 0.0003447662456892431
BRCA1 O 0 0.26311513781547546
allelic O 0 0.016882354393601418
pattern O 0 0.005183188244700432
. O 0 0.0014198364224284887

We O 0 0.0005794242606498301
conclude O 0 0.0008802626398392022
that O 0 0.00011080393596785143
the O 0 0.0002518148103263229
185delAG O 1 0.812553346157074
BRCA1 O 0 0.33967190980911255
mutation O 0 0.0002921082195825875
occurs O 0 0.00010667760216165334
in O 0 2.8274278520257212e-05
some O 0 2.7587104341364466e-05
non O 0 7.084982644300908e-05
- O 0 9.372578642796725e-05
Ashkenazi O 0 0.0001840767654357478
populations O 0 2.903699169110041e-05
at O 0 8.829828584566712e-05
rates O 0 4.058938429807313e-05
comparable O 0 6.869150092825294e-05
with O 0 2.940241392934695e-05
that O 0 4.505318793235347e-05
of O 0 0.000351889175362885
Ashkenazim O 0 0.01302698627114296
. O 0 0.0011164844036102295

The O 0 0.0005501137929968536
majority O 0 0.0001606174628250301
of O 0 0.00018496523262001574
Jewish O 0 0.0007188150193542242
185delAG O 1 0.9793850183486938
mutation O 0 0.00030988111393526196
carriers O 0 8.030725439311936e-05
have O 0 1.0879780347750057e-05
a O 0 3.236286647734232e-05
common O 0 4.4116979552200064e-05
allelic O 0 0.0004523447423707694
pattern O 0 0.00021912736701779068
, O 0 4.990239176549949e-05
supporting O 0 6.177742761792615e-05
the O 0 7.32148255337961e-05
founder O 0 0.0006703754770569503
effect O 0 6.48623172310181e-05
notion O 0 7.486057438654825e-05
, O 0 2.477024645486381e-05
but O 0 1.3553206372307613e-05
dating O 0 3.7419857108034194e-05
the O 0 3.244738400098868e-05
mutations O 0 1.8717977582127787e-05
origin O 0 1.4469976122200023e-05
to O 0 1.018380862660706e-05
an O 0 1.4357125110109337e-05
earlier O 0 3.679528526845388e-05
date O 0 3.886786362272687e-05
than O 0 2.1376383301685564e-05
currently O 0 5.1036699005635455e-05
estimated O 0 0.00019705742306541651
. O 0 0.00022650045866612345

However O 0 0.0008657267899252474
, O 0 0.0001988057338166982
the O 0 0.0001145025817095302
different O 0 3.4904820495285094e-05
allelic O 0 0.0006091795512475073
pattern O 0 0.0002140235883416608
at O 0 0.0002255466242786497
the O 0 0.00015359871031250805
BRCA1 O 0 0.05856190621852875
locus O 0 0.000251210032729432
even O 0 2.8650747481151484e-05
in O 0 1.887279358925298e-05
some O 0 1.4774699593544938e-05
Jewish O 0 0.00014059789828024805
mutation O 0 0.00018477487901691347
carriers O 0 9.889748616842553e-05
, O 0 3.8578127714572474e-05
might O 0 5.6396409490844235e-05
suggest O 0 4.2121140722883865e-05
that O 0 2.212465369666461e-05
the O 0 6.838607805548236e-05
mutation O 0 0.00020952997147105634
arose O 0 0.0003785389708355069
independently O 0 0.00014890859893057495
. O 0 0.00015773453924339265
. O 0 0.0004704865568783134

Crystal O 0 0.014562766999006271
structure O 0 0.0023356981109827757
of O 0 0.0010552669409662485
the O 0 0.003710438497364521
hemochromatosis B-Disease 1 0.9999998807907104
protein O 0 0.005920474883168936
HFE O 1 0.9980055689811707
and O 0 0.00010100618965225294
characterization O 0 0.0003295951464679092
of O 0 9.751136531122029e-05
its O 0 6.783743447158486e-05
interaction O 0 0.00014879336231388152
with O 0 0.00017041084356606007
transferrin O 0 0.3799431324005127
receptor O 0 0.0018314943881705403
. O 0 0.0006615350721403956

HFE O 1 0.9331933856010437
is O 0 0.0006774188950657845
an O 0 0.00042937175021506846
MHC O 0 0.1343117654323578
- O 0 0.0002874991623684764
related O 0 0.00010851462138816714
protein O 0 6.68252760078758e-05
that O 0 1.9506340322550386e-05
is O 0 2.9040342269581743e-05
mutated O 0 9.015839168569073e-05
in O 0 5.878687079530209e-05
the O 0 0.0007456974126398563
iron B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999955892562866
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9270986318588257

HFE O 1 0.6089838147163391
binds O 0 0.002953538205474615
to O 0 0.000586184614803642
transferrin O 0 0.0544765368103981
receptor O 0 0.0009561931947246194
( O 0 0.0003467910864856094
TfR O 0 0.013493971899151802
) O 0 6.34198950137943e-05
and O 0 4.322709355619736e-05
reduces O 0 0.0001385540672345087
its O 0 2.9400729545159265e-05
affinity O 0 0.0001182199121103622
for O 0 7.941419607959688e-05
iron O 1 0.994382381439209
- O 0 0.001098050968721509
loaded O 0 0.001715768943540752
transferrin O 0 0.06229538843035698
, O 0 0.00042507643229328096
implicating O 1 0.7881416082382202
HFE O 1 0.9998496770858765
in O 0 0.0025832594837993383
iron O 1 0.9999837875366211
metabolism O 1 0.9906587600708008
. O 0 0.001496005803346634

The O 0 0.0042192707769572735
2 O 0 0.00443139998242259
. O 0 0.002715255366638303

6 O 0 0.003387827891856432
A O 0 0.002282246947288513
crystal O 0 0.004394478630274534
structure O 0 0.0007856625597923994
of O 0 0.0005482129636220634
HFE O 1 0.9937145113945007
reveals O 0 0.0006404588930308819
the O 0 8.37644693092443e-05
locations O 0 0.00011154112871736288
of O 0 0.00054804707178846
hemochromatosis B-Disease 1 0.9999998807907104
mutations O 0 0.00032939063385128975
and O 0 5.9370864619268104e-05
a O 0 0.0001386941730743274
patch O 1 0.535142719745636
of O 0 0.0003646708792075515
histidines O 1 0.9206973314285278
that O 0 4.9034268158720806e-05
could O 0 3.5602497518993914e-05
be O 0 1.4202330021362286e-05
involved O 0 6.962514453334734e-05
in O 0 9.694165055407211e-05
pH O 0 0.0018109726952388883
- O 0 0.0005964029696770012
dependent O 0 0.000397100840928033
interactions O 0 0.00043621979421004653
. O 0 0.00038019163184799254

We O 0 0.0008354774909093976
also O 0 0.00030811564647592604
demonstrate O 0 0.0004952304298058152
that O 0 0.00022296160750556737
soluble O 0 0.0030918989796191454
TfR O 1 0.9715914726257324
and O 0 0.00036810102756135166
HFE O 1 0.8774285316467285
bind O 0 0.00020047934958711267
tightly O 0 0.00012228508421685547
at O 0 7.178608939284459e-05
the O 0 4.255512249073945e-05
basic O 0 7.527218258474022e-05
pH O 0 0.00016853025590535253
of O 0 3.886348713422194e-05
the O 0 7.692234794376418e-05
cell O 0 0.00022941612405702472
surface O 0 0.00013252875942271203
, O 0 2.2692469428875484e-05
but O 0 8.812102350930218e-06
not O 0 6.320340162346838e-06
at O 0 3.852356894640252e-05
the O 0 6.618360930588096e-05
acidic O 0 0.0005535272648558021
pH O 0 0.0008866129792295396
of O 0 0.0005483480636030436
intracellular O 0 0.0043048011139035225
vesicles O 0 0.005830481182783842
. O 0 0.0006481602904386818

TfR O 1 0.9787973165512085
HFE O 1 0.8767161965370178
stoichiometry O 0 0.0049096946604549885
( O 0 0.00044977670768275857
2 O 0 0.00028111596475355327
1 O 0 0.00015504607290495187
) O 0 5.979404886602424e-05
differs O 0 0.00011761980567825958
from O 0 0.00016766694898251444
TfR O 0 0.007148492615669966
transferrin O 0 0.004591949284076691
stoichiometry O 0 0.0009279673104174435
( O 0 0.00010085489338962361
2 O 0 7.781965541653335e-05
2 O 0 7.090868894010782e-05
) O 0 2.3872686142567545e-05
, O 0 2.942286300822161e-05
implying O 0 8.726451051188633e-05
a O 0 3.563673817552626e-05
different O 0 9.397289431944955e-06
mode O 0 7.387046935036778e-05
of O 0 4.078860365552828e-05
binding O 0 6.404016312444583e-05
for O 0 5.867228173883632e-05
HFE O 1 0.8792553544044495
and O 0 0.0002354595490032807
transferrin O 0 0.015406242571771145
to O 0 0.00010772486712085083
TfR O 0 0.09355027228593826
, O 0 6.463607860496268e-05
consistent O 0 9.157211752608418e-05
with O 0 2.731617678364273e-05
our O 0 9.489254443906248e-05
demonstration O 0 0.0005333683802746236
that O 0 0.0001296252739848569
HFE O 1 0.9822863936424255
, O 0 0.00019288258044980466
transferrin O 0 0.03361198678612709
, O 0 0.00010732950613601133
and O 0 0.00011928809544770047
TfR O 0 0.13132472336292267
form O 0 0.00022037362214177847
a O 0 0.0005951492348685861
ternary O 0 0.009141488000750542
complex O 0 0.004792018793523312
. O 0 0.0013555758632719517

Identification O 0 0.000961739628110081
of O 0 0.0005262380000203848
three O 0 0.0001449238625355065
novel O 0 0.0002464184071868658
mutations O 0 7.906826795078814e-05
and O 0 2.2014097339706495e-05
a O 0 4.115113551961258e-05
high O 0 4.768155486090109e-05
frequency O 0 1.6718171536922455e-05
of O 0 2.2061029085307382e-05
the O 0 6.199761992320418e-05
Arg778Leu O 0 0.23935024440288544
mutation O 0 0.00011882909166160971
in O 0 5.267452070256695e-05
Korean O 0 0.010647711344063282
patients O 0 0.0007798935985192657
with O 0 0.0003040625888388604
Wilson B-Disease 1 0.9997802376747131
disease I-Disease 1 0.9999722242355347
. O 0 0.0014673243276774883

Four O 0 0.0015365141443908215
mutations O 0 0.0018281701486557722
- O 0 0.001624755677767098
- O 0 0.0007999872323125601
R778L O 0 0.07938504964113235
, O 0 0.0003150561242364347
A874V O 0 0.024278387427330017
, O 0 0.0002603459870442748
L1083F O 0 0.004634690936654806
, O 0 0.00013537509948946536
and O 0 9.203732042806223e-05
2304delC O 0 0.004806847311556339
- O 0 0.0002181180752813816
- O 0 0.00010725164611358196
in O 0 2.89065319520887e-05
the O 0 9.385278826812282e-05
copper O 0 0.004355637356638908
- O 0 0.00025148846907541156
transporting O 0 0.0003928753430955112
enzyme O 0 0.00016391859389841557
, O 0 6.137174204923213e-05
P O 0 0.0003627914993558079
- O 0 0.00012004234304185957
type O 0 0.00018145408830605447
ATPase O 0 0.0011883038096129894
( O 0 0.00011456790525699034
ATP7B O 0 0.14550726115703583
) O 0 3.090146856266074e-05
, O 0 1.9442621123744175e-05
were O 0 1.5317853467422538e-05
identified O 0 3.928072328562848e-05
in O 0 6.269675213843584e-05
Korean O 0 0.011203388683497906
Patients O 0 0.004782956093549728
with O 0 0.0004499092174228281
Wilson B-Disease 1 0.9999266862869263
disease I-Disease 1 0.9999915361404419
. O 0 0.001802124665118754

Arg778Leu O 1 0.696664035320282
, O 0 0.00033714945311658084
the O 0 0.00010433771967655048
most O 0 3.052679312531836e-05
frequently O 0 4.0010272641666234e-05
reported O 0 4.9981263146037236e-05
mutation O 0 3.2778389140730724e-05
of O 0 2.4118455257848836e-05
this O 0 2.3230946680996567e-05
enzyme O 0 6.428827327908948e-05
, O 0 2.305662928847596e-05
was O 0 4.787245416082442e-05
found O 0 1.6104280803119764e-05
in O 0 9.648776540416293e-06
six O 0 2.2760263163945638e-05
of O 0 6.306402065092698e-05
eight O 0 0.0001049709171638824
unrelated O 0 0.00028601079247891903
patients O 0 0.0001196887023979798
studied O 0 7.04323683748953e-05
, O 0 3.093195118708536e-05
an O 0 4.2567098716972396e-05
allele O 0 0.0001082511807908304
frequency O 0 6.024013055139221e-05
of O 0 0.00014919314708095044
37 O 0 0.0005415035411715508
. O 0 0.000447357859229669

5 O 0 0.0005615924601443112
% O 0 0.00017055877833627164
, O 0 5.646313729812391e-05
which O 0 2.0617779227904975e-05
is O 0 2.825290175678674e-05
considerably O 0 4.5050437620375305e-05
higher O 0 1.856797643995378e-05
than O 0 7.612107765453402e-06
those O 0 8.113234798656777e-06
in O 0 2.416189272480551e-05
other O 0 3.093219129368663e-05
Asian O 0 0.00030512138619087636
populations O 0 0.00020610839419532567
. O 0 0.0004924705717712641

The O 0 0.0009217935730703175
novel O 0 0.0005813913303427398
single O 0 0.0002512787759769708
nucleotide O 0 0.00032940981327556074
deletion O 0 0.0002835119958035648
, O 0 9.70444962149486e-05
2304delC O 0 0.0036445630248636007
, O 0 0.00010860654583666474
was O 0 0.0001960607332875952
found O 0 8.81981395650655e-05
in O 0 0.00012574333231896162
one O 0 0.0002284874935867265
patient O 0 0.0017148349434137344
. O 0 0.0006841556751169264

Since O 0 0.0012115234276279807
a O 0 0.0004899047198705375
mutation O 0 0.00033340396475978196
at O 0 0.0002713203721214086
cDNA O 0 0.0008728218963369727
nucleotide O 0 0.0008811727748252451
2302 O 0 0.010733343660831451
( O 0 0.00015346708823926747
2302insC O 0 0.0015408898470923305
) O 0 3.725094938999973e-05
had O 0 5.650148887070827e-05
been O 0 3.218149868189357e-05
previously O 0 3.708563235704787e-05
described O 0 4.7591795009793714e-05
, O 0 1.5188521501841024e-05
this O 0 1.2858707123086788e-05
region O 0 3.534314237185754e-05
of O 0 5.642766700475477e-05
the O 0 0.000198370820726268
ATP7B O 1 0.9999724626541138
gene O 0 0.00016621364920865744
may O 0 4.8036450607469305e-05
be O 0 3.0112425520201214e-05
susceptible O 0 0.00018200752674601972
to O 0 7.538100180681795e-05
gene O 0 0.000612630567047745
rearrangements O 1 0.9635570049285889
causing O 1 0.9999544620513916
Wilson B-Disease 1 0.9999154806137085
disease I-Disease 1 0.999983549118042
. O 0 0.0014436678029596806

Disruption O 0 0.010650922544300556
of O 0 0.0009196242899633944
splicing O 0 0.0007941433577798307
regulated O 0 0.00023406617401633412
by O 0 6.812409264966846e-05
a O 0 0.0001934269821504131
CUG O 1 0.9745970368385315
- O 0 0.0007643341668881476
binding O 0 0.000255631806794554
protein O 0 0.0005557903205044568
in O 0 0.0010718951234593987
myotonic B-Disease 1 0.9999994039535522
dystrophy I-Disease 1 0.9999997615814209
. O 0 0.006856263615190983

Myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9981958270072937
DM B-Disease 1 0.9999996423721313
) O 0 0.0005738249747082591
is O 0 0.0001836279552662745
caused O 0 0.0006847652257420123
by O 0 6.25723332632333e-05
a O 0 0.00017499712703283876
CTG O 0 0.0032102682162076235
expansion O 0 0.00018863711738958955
in O 0 3.295975329820067e-05
the O 0 4.3295498471707106e-05
3 O 0 7.839166937628761e-05
untranslated O 0 0.0002939072728622705
region O 0 8.688397065270692e-05
of O 0 0.0001555859053041786
the O 0 0.001026428653858602
DM B-Disease 1 0.999995231628418
gene O 0 0.0013617186341434717
. O 0 0.0009165154187940061

One O 0 0.0013196873478591442
model O 0 0.000979829579591751
of O 0 0.0018557495204731822
DM B-Disease 1 0.999998927116394
pathogenesis O 1 0.9994099140167236
suggests O 0 0.00036321725929155946
that O 0 3.8896781916264445e-05
RNAs O 0 0.0001239670382346958
from O 0 2.8037187803420238e-05
the O 0 3.9752987504471093e-05
expanded O 0 6.80963639752008e-05
allele O 0 4.917708793072961e-05
create O 0 2.8670861865975894e-05
a O 0 2.585396396170836e-05
gain O 0 4.448851177585311e-05
- O 0 5.496978701557964e-05
of O 0 6.610117270611227e-05
- O 0 0.0001522291568107903
function O 0 5.91125208302401e-05
mutation O 0 7.244053995236754e-05
by O 0 2.2771964722778648e-05
the O 0 4.1666451579658315e-05
inappropriate O 0 8.977782272268087e-05
binding O 0 2.537956061132718e-05
of O 0 5.5091008107410744e-05
proteins O 0 4.5003718696534634e-05
to O 0 4.3468135118018836e-05
the O 0 0.00027603103080764413
CUG O 1 0.9904882907867432
repeats O 0 0.0023717787116765976
. O 0 0.0006079913000576198

Data O 0 0.0007968494901433587
presented O 0 0.0005782083026133478
here O 0 0.00016994448378682137
indicate O 0 0.00015027166227810085
that O 0 3.515305070322938e-05
the O 0 8.620797598268837e-05
conserved O 0 0.0002596623089630157
heterogeneous O 0 0.0007538641220889986
nuclear O 0 0.001562392571941018
ribonucleoprotein O 0 0.07792303711175919
, O 0 0.0002876614744309336
CUG O 0 0.009557900950312614
- O 0 0.00019222493574488908
binding O 0 8.547372272005305e-05
protein O 0 0.00011269406968494877
( O 0 0.0001313186076004058
CUG O 1 0.9247150421142578
- O 0 0.0003769678296521306
BP O 0 0.0013420870527625084
) O 0 4.1170093027176335e-05
, O 0 3.5426619433565065e-05
may O 0 3.7796249671373516e-05
mediate O 0 0.00014406960690394044
the O 0 7.389921665890142e-05
trans O 0 0.0002989412460010499
- O 0 0.00015699492359999567
dominant O 0 0.0001971331366803497
effect O 0 8.677144796820357e-05
of O 0 0.00010599780944176018
the O 0 0.00019081734353676438
RNA O 0 0.0010687209432944655
. O 0 0.0006111226393841207

CUG O 1 0.9995642304420471
- O 0 0.011559244245290756
BP O 0 0.010624975897371769
was O 0 0.0005773624288849533
found O 0 7.320840813918039e-05
to O 0 3.18265228997916e-05
bind O 0 9.497854625806212e-05
to O 0 4.1339179006172344e-05
the O 0 0.00015869508206378669
human O 0 0.003354825545102358
cardiac O 1 0.9999986886978149
troponin O 1 0.9999982118606567
T O 1 0.9962789416313171
( O 0 0.0002621221065055579
cTNT O 0 0.007493854500353336
) O 0 0.0001301692973356694
pre O 0 0.0007176849176175892
- O 0 0.00035769896931014955
messenger O 0 0.00052814552327618
RNA O 0 0.0002364866086281836
and O 0 5.7153192756231874e-05
regulate O 0 0.00017986996681429446
its O 0 7.153256592573598e-05
alternative O 0 0.00040459007141180336
splicing O 0 0.0015570067334920168
. O 0 0.0005218682927079499

Splicing O 0 0.006582608446478844
of O 0 0.0022034014109522104
cTNT O 1 0.996122419834137
was O 0 0.20098158717155457
disrupted O 1 0.8328167200088501
in O 0 0.002804285380989313
DM B-Disease 1 0.9999998807907104
striated O 1 0.9999830722808838
muscle O 1 0.9979661703109741
and O 0 0.00013139101793058217
in O 0 0.00010384817142039537
normal O 0 0.0003139515465591103
cells O 0 0.00024598505115136504
expressing O 0 0.00020127995230723172
transcripts O 0 0.00026825640816241503
that O 0 7.070073479553685e-05
contain O 0 0.0003584932128433138
CUG O 1 0.8876428008079529
repeats O 0 0.0025618139188736677
. O 0 0.000884419132489711

Altered O 0 0.0030682131182402372
expression O 0 0.0007192518678493798
of O 0 0.0003450281510595232
genes O 0 0.00024873591610230505
regulated O 0 0.00017659689183346927
posttranscriptionally O 0 0.006219022907316685
by O 0 0.00021696690237149596
CUG O 1 0.999822199344635
- O 0 0.0014340735506266356
BP O 0 0.003118818160146475
therefore O 0 0.00015669790445826948
may O 0 0.00012671758304350078
contribute O 0 0.00023496727226302028
to O 0 0.00039090990321710706
DM B-Disease 1 0.9999951124191284
pathogenesis O 1 0.9995697140693665
. O 0 0.0005932776839472353
. O 0 0.000990642816759646

Identification O 0 0.0012034984538331628
of O 0 0.0003911594394594431
a O 0 0.0004192304622847587
novel O 0 0.000546772382222116
nonsense O 0 0.0014465564163401723
mutation O 0 0.00010714236850617453
and O 0 4.291051664040424e-05
a O 0 7.688011100981385e-05
missense O 0 0.0003018535498995334
substitution O 0 0.00013861933257430792
in O 0 5.010237873648293e-05
the O 0 0.00014031412138137966
vasopressin O 0 0.0027337446808815002
- O 0 0.0005469487514346838
neurophysin O 0 0.45254239439964294
II O 1 0.918019711971283
gene O 0 0.00012745098501909524
in O 0 6.0407121054595336e-05
two O 0 4.045992682222277e-05
Spanish O 0 0.00042476248927414417
kindreds O 0 0.0029156028758734465
with O 0 0.0007673652144148946
familial B-Disease 1 0.999971866607666
neurohypophyseal I-Disease 1 0.9999998807907104
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999904632568359
. O 0 0.004919900093227625

Familial B-Disease 1 0.9999713897705078
neurohypophyseal I-Disease 1 0.9999996423721313
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999995231628418
( O 1 0.9449780583381653
FNDI B-Disease 1 0.9999988079071045
) O 0 0.00022727251052856445
is O 0 8.855292981024832e-05
an O 0 0.00013522982771974057
autosomal B-Disease 1 0.9860142469406128
dominant I-Disease 1 0.9999779462814331
disease I-Disease 1 1.0
caused O 1 0.9999986886978149
by O 0 0.3664952516555786
deficiency O 1 0.9999992847442627
in O 0 0.00032074927003122866
the O 0 0.0023927779402583838
antidiuretic O 1 0.9982712268829346
hormone O 0 0.0802190899848938
arginine O 0 0.0016522485530003905
vasopressin O 0 0.00215722294524312
( O 0 0.00015503601753152907
AVP O 0 0.003340413561090827
) O 0 4.761094896821305e-05
encoded O 0 3.7522630009334534e-05
by O 0 3.2501298846909776e-05
the O 0 9.307968866778538e-05
AVP O 1 0.9533707499504089
- O 0 0.001282066572457552
neurophysin O 1 0.9692397117614746
II O 1 0.9997279047966003
( O 0 0.001361892675049603
AVP O 1 0.9989380240440369
- O 0 0.002157165203243494
NPII O 1 0.8596267104148865
) O 0 0.00019575588521547616
gene O 0 0.000256438332144171
on O 0 0.00028929681866429746
chromosome O 0 0.002308944473043084
20p13 O 0 0.31058838963508606
. O 0 0.0011393174063414335

In O 0 0.0005886685103178024
this O 0 9.109753591474146e-05
study O 0 6.561513873748481e-05
, O 0 3.064778502448462e-05
we O 0 1.901045470731333e-05
analyzed O 0 2.670742105692625e-05
two O 0 9.603279067960102e-06
families O 0 2.0385470634209923e-05
with O 0 2.7577294531511143e-05
FNDI B-Disease 1 0.9059965014457703
using O 0 3.080620081163943e-05
direct O 0 4.487523983698338e-05
automated O 0 0.00016873380809556693
fluorescent O 0 0.00020595868409145623
, O 0 3.8466558180516586e-05
solid O 0 0.00016136844351422042
phase O 0 0.000253029924351722
, O 0 3.239565558033064e-05
single O 0 4.950845323037356e-05
- O 0 0.00010255106462864205
stranded O 0 0.00014458788791671395
DNA O 0 0.00014907537843100727
sequencing O 0 0.00015617971075698733
of O 0 0.00017239920271094888
PCR O 0 0.0016210490139201283
- O 0 0.001021001604385674
amplified O 0 0.002853736048564315
AVP O 1 0.992212176322937
- O 0 0.004185480531305075
NPII O 1 0.9631398320198059
DNA O 0 0.0022690584883093834
. O 0 0.0010028014658018947

In O 0 0.000246572308242321
one O 0 5.21613510500174e-05
of O 0 7.939898205222562e-05
the O 0 9.344208956463262e-05
families O 0 6.109815876698121e-05
, O 0 4.576490755425766e-05
affected O 0 6.846176984254271e-05
individuals O 0 2.1698742784792557e-05
presented O 0 7.871844718465582e-05
a O 0 0.00010161694081034511
novel O 0 0.00017499712703283876
nonsense O 0 0.00047620071563869715
mutation O 0 7.003706559771672e-05
in O 0 3.300907337688841e-05
exon O 0 0.0001358859590254724
3 O 0 3.2869542337721214e-05
of O 0 3.541182741173543e-05
the O 0 4.1373888961970806e-05
gene O 0 2.748867336777039e-05
, O 0 1.1823436580016278e-05
consisting O 0 2.14588399103377e-05
in O 0 1.8247283151140437e-05
a O 0 6.229440623428673e-05
G O 0 0.0002514920779503882
to O 0 4.1989835153799504e-05
T O 0 0.0005308305262587965
transition O 0 0.00029612251091748476
at O 0 0.00021515999105758965
nucleotide O 0 0.00038602991844527423
2101 O 0 0.002545040799304843
, O 0 6.351267802529037e-05
which O 0 3.332730557303876e-05
produces O 0 5.564466118812561e-05
a O 0 6.540766480611637e-05
stop O 0 0.00013790871889796108
signal O 0 0.00014008818834554404
in O 0 5.7467605074634776e-05
codon O 0 0.0003467947244644165
82 O 0 0.0004401473852340132
( O 0 0.00016834268171805888
Glu O 0 0.011818832717835903
) O 0 0.00016847290680743754
of O 0 0.0004993496113456786
NPII O 1 0.9922256469726562
. O 0 0.0008288969984278083

The O 0 0.002583133988082409
premature O 0 0.011845149099826813
termination O 0 0.0035324320197105408
eliminates O 0 0.0008456844952888787
part O 0 0.00019501105998642743
of O 0 0.00013779896835330874
the O 0 0.00017783395014703274
C O 0 0.00040597995393909514
- O 0 0.00017178156122099608
terminal O 0 0.0002861277898773551
domain O 0 5.806257831864059e-05
of O 0 8.421114034717903e-05
NPII O 0 0.39284902811050415
, O 0 3.005656981258653e-05
including O 0 1.637745663174428e-05
a O 0 2.8506572562037036e-05
cysteine O 0 6.434028182411566e-05
residue O 0 0.00012134444114053622
in O 0 1.9691491615958512e-05
position O 0 3.7586338294204324e-05
85 O 0 5.487059024744667e-05
, O 0 1.6212608898058534e-05
which O 0 8.822477866488043e-06
could O 0 7.101441951817833e-06
be O 0 6.520675469801063e-06
involved O 0 1.9438599338172935e-05
in O 0 1.698281630524434e-05
the O 0 6.0085341829108074e-05
correct O 0 0.00017593671509530395
folding O 0 0.0007537524215877056
of O 0 0.0002711359993554652
the O 0 0.0009387602913193405
prohormone O 1 0.9926438927650452
. O 0 0.0015732485335320234

In O 0 0.0005262414924800396
the O 0 0.00032473166356794536
second O 0 0.00032411987194791436
family O 0 0.0001759803417371586
, O 0 7.681446004426107e-05
a O 0 0.00011849992733914405
G279A O 0 0.0013505115639418364
substitution O 0 0.00019777797569986433
at O 0 0.00011304590589134023
position O 0 9.396042150910944e-05
- O 0 5.476290243677795e-05
1 O 0 2.651088834682014e-05
of O 0 3.1379044230561703e-05
the O 0 4.1929404687834904e-05
signal O 0 0.0001638457615626976
peptide O 0 0.00014126216410659254
was O 0 8.007333235582337e-05
observed O 0 4.378369703772478e-05
in O 0 2.8657854272751138e-05
all O 0 4.345997149357572e-05
affected O 0 0.0001837992895161733
individuals O 0 0.0001476493926020339
. O 0 0.0004288370837457478

This O 0 0.001288153580389917
missense O 0 0.00425068149343133
mutation O 0 0.0007970230071805418
, O 0 0.00017315868171863258
which O 0 0.00018608021491672844
replaces O 0 0.0025461281184107065
Ala O 0 0.010000248439610004
with O 0 0.0001521249650977552
Thr O 1 0.7651137709617615
, O 0 0.00010480849596206099
is O 0 6.462979217758402e-05
frequent O 0 0.00020168608170934021
among O 0 0.00040564165101386607
FNDI B-Disease 1 0.9999998807907104
patients O 0 0.13908682763576508
and O 0 9.494394907960668e-05
is O 0 5.874590351595543e-05
thought O 0 7.237584941321984e-05
to O 0 2.0443194443942048e-05
reduce O 0 3.2396212191088125e-05
the O 0 4.0216156776295975e-05
efficiency O 0 0.00016778257850091904
of O 0 0.0001147581497207284
cleavage O 0 0.0013093723682686687
by O 0 0.000113836103992071
signal O 0 0.0007222507265396416
peptidases O 0 0.0038642040453851223
. O 0 0.00022743770387023687
. O 0 0.00044612647616304457

Genetic O 0 0.004186730831861496
heterogeneity O 0 0.00554634677246213
of O 0 0.007823813706636429
Saethre B-Disease 1 0.9999973773956299
- I-Disease 1 0.9999418258666992
Chotzen I-Disease 1 0.9999995231628418
syndrome I-Disease 1 0.9999998807907104
, O 0 0.0004219349066261202
due O 0 0.0007029141997918487
to O 0 0.0002102387952618301
TWIST O 1 0.6312574744224548
and O 0 0.0008829583530314267
FGFR O 1 0.999910831451416
mutations O 0 0.0025262064300477505
. O 0 0.0009693140746094286

Thirty O 0 0.004278911277651787
- O 0 0.0009441492729820311
two O 0 0.00013377108552958816
unrelated O 0 0.00039491543429903686
patients O 0 0.00013067046529613435
with O 0 3.744291825569235e-05
features O 0 0.00010082556400448084
of O 0 0.001210125396028161
Saethre B-Disease 1 0.9999986886978149
- I-Disease 1 0.9999451637268066
Chotzen I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999998807907104
, O 0 0.00019993699970655143
a O 0 0.0002822842507157475
common O 0 0.0005893452907912433
autosomal B-Disease 0 0.42916983366012573
dominant I-Disease 1 0.860263466835022
condition I-Disease 1 0.9960492253303528
of O 1 0.9956414699554443
craniosynostosis B-Disease 1 1.0
and O 1 0.9993206262588501
limb B-Disease 1 0.9999998807907104
anomalies I-Disease 1 0.999813973903656
, O 0 0.00013573392061516643
were O 0 6.534707063110545e-05
screened O 0 9.956829308066517e-05
for O 0 3.0144405172904953e-05
mutations O 0 7.7637771028094e-05
in O 0 7.923885277705267e-05
TWIST O 0 0.18867774307727814
, O 0 0.000453355023637414
FGFR2 O 1 0.9994056224822998
, O 0 0.0003258058277424425
and O 0 0.0005314992740750313
FGFR3 O 1 0.9959505796432495
. O 0 0.0014397645136341453

Nine O 0 0.0028005901258438826
novel O 0 0.0014338071923702955
and O 0 0.0002581983571872115
three O 0 0.00018502064631320536
recurrent O 1 0.7672195434570312
TWIST O 1 0.8984333276748657
mutations O 0 0.00018987178918905556
were O 0 5.7309553085360676e-05
found O 0 3.5906301491195336e-05
in O 0 3.8143753045005724e-05
12 O 0 0.00012534910638350993
families O 0 0.00021482586453203112
. O 0 0.0003195902972947806

Seven O 0 0.0011752481805160642
families O 0 0.0002193646359955892
were O 0 7.329396612476557e-05
found O 0 4.6556237066397443e-05
to O 0 2.319119084859267e-05
have O 0 2.813975152093917e-05
the O 0 0.00013526204566005617
FGFR3 O 1 0.999672532081604
P250R O 1 0.997856080532074
mutation O 0 0.00023764297657180578
, O 0 2.6532534320722334e-05
and O 0 1.6434389181085862e-05
one O 0 1.5348749002441764e-05
individual O 0 1.3403398952505086e-05
was O 0 6.184703670442104e-05
found O 0 2.009564559557475e-05
to O 0 1.6149326256709173e-05
have O 0 1.852788045653142e-05
an O 0 0.00011114342487417161
FGFR2 O 1 0.9753168821334839
VV269 O 0 0.433208703994751
- O 0 0.0007168352603912354
270 O 0 0.0010568357538431883
deletion O 0 0.002099459059536457
. O 0 0.0007562835817225277

To O 0 0.0003652179439086467
date O 0 0.00039015451329760253
, O 0 0.00013353940448723733
our O 0 0.00016028333629947156
detection O 0 0.0002910302428063005
rate O 0 8.862753020366654e-05
for O 0 5.160849104868248e-05
TWIST O 0 0.001056347624398768
or O 0 0.00016094493912532926
FGFR O 1 0.9419375061988831
mutations O 0 0.00014063237176742405
is O 0 3.317266600788571e-05
68 O 0 9.949236118700355e-05
% O 0 3.638809721451253e-05
in O 0 6.696159107377753e-05
our O 0 0.000338894926244393
Saethre B-Disease 1 0.9999120235443115
- I-Disease 1 0.9994006156921387
Chotzen I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
patients O 0 0.023477846756577492
, O 0 8.077753591351211e-05
including O 0 4.269263445166871e-05
our O 0 6.975885480642319e-05
five O 0 8.019170491024852e-05
patients O 0 0.00021675205789506435
elsewhere O 0 0.0001161711843451485
reported O 0 0.00014302332419902086
with O 0 0.000100848832516931
TWIST O 0 0.3542693853378296
mutations O 0 0.0010596435749903321
. O 0 0.0005887072766199708

More O 0 0.0002541740832384676
than O 0 0.00011048193118767813
35 O 0 0.0001373781997244805
different O 0 4.589948002831079e-05
TWIST O 0 0.0012074565747752786
mutations O 0 9.655168105382472e-05
are O 0 1.6892296116566285e-05
now O 0 4.6061151806497946e-05
known O 0 7.078600174281746e-05
in O 0 6.198396295076236e-05
the O 0 0.00022273743525147438
literature O 0 0.0006064443150535226
. O 0 0.0005830122390761971

The O 0 0.0012658275663852692
most O 0 0.0002770093851722777
common O 0 0.00019609587616287172
phenotypic O 0 0.0005871125031262636
features O 0 9.864675666904077e-05
, O 0 3.048306462005712e-05
present O 0 2.0552897694869898e-05
in O 0 8.846220225677826e-06
more O 0 4.2123515413550194e-06
than O 0 4.8896263251663186e-06
a O 0 2.0554445654852316e-05
third O 0 3.846611798508093e-05
of O 0 4.3455991544760764e-05
our O 0 8.959103433880955e-05
patients O 0 0.00011745550000341609
with O 0 3.944476702599786e-05
TWIST O 1 0.6632589101791382
mutations O 0 0.0001209039255627431
, O 0 7.633688801433891e-05
are O 0 3.679675864987075e-05
coronal B-Disease 0 0.3546440899372101
synostosis I-Disease 1 0.7075726985931396
, O 0 0.0001523974642623216
brachycephaly B-Disease 1 0.706183135509491
, O 0 0.00027543638134375215
low B-Disease 0 0.011240617372095585
frontal I-Disease 1 0.9999688863754272
hairline I-Disease 1 0.9999998807907104
, O 1 0.565216064453125
facial B-Disease 1 0.9999966621398926
asymmetry I-Disease 1 0.9999676942825317
, O 0 0.10291863232851028
ptosis B-Disease 1 0.9999898672103882
, O 0 0.0008579533896408975
hypertelorism B-Disease 1 0.9809123277664185
, O 0 0.00023497086658608168
broad B-Disease 0 0.0007950610015541315
great I-Disease 0 0.06190497428178787
toes I-Disease 1 0.9152745008468628
, O 0 0.00039811551687307656
and O 0 0.0006550526595674455
clinodactyly B-Disease 1 0.9639242887496948
. O 0 0.0018282491946592927

Significant O 0 0.0037432133685797453
intra O 0 0.09565635025501251
- O 0 0.001884430181235075
and O 0 0.00039394909981638193
interfamilial O 0 0.2870838940143585
phenotypic O 0 0.0011850196169689298
variability O 0 0.0003310130850877613
is O 0 6.98893636581488e-05
present O 0 7.086205732775852e-05
for O 0 4.757273200084455e-05
either O 0 0.00012698974751401693
TWIST O 0 0.139714777469635
mutations O 0 0.001187888439744711
or O 0 0.000878424383699894
FGFR O 1 0.9997485280036926
mutations O 0 0.0019228020682930946
. O 0 0.0007562483078800142

The O 0 0.0009399349801242352
overlap O 0 0.0004060364735778421
in O 0 0.00021248498524073511
clinical O 0 0.000327535584801808
features O 0 9.406189928995445e-05
and O 0 4.8907942982623354e-05
the O 0 5.9324454923626035e-05
presence O 0 7.721594738541171e-05
, O 0 1.6604421034571715e-05
in O 0 1.2801347111235373e-05
the O 0 1.835810144257266e-05
same O 0 1.4607695447921287e-05
genes O 0 1.552626781631261e-05
, O 0 8.570267709728796e-06
of O 0 1.8837314200936817e-05
mutations O 0 1.924334719660692e-05
for O 0 7.435562565660803e-06
more O 0 7.244951120810583e-06
than O 0 1.2958544175489806e-05
one O 0 4.460027412278578e-05
craniosynostotic B-Disease 0 0.12161269783973694
condition I-Disease 0 0.0006039792788214982
- O 0 0.0001055372049449943
such O 0 2.7462683647172526e-05
as O 0 7.755873230053112e-05
Saethre B-Disease 1 0.8903904557228088
- I-Disease 0 0.0009405534947291017
Chotzen I-Disease 1 0.5758760571479797
, I-Disease 0 0.00024123485491145402
Crouzon I-Disease 1 0.5383691191673279
, I-Disease 0 0.00019702452118508518
and I-Disease 0 0.0002729882544372231
Pfeiffer I-Disease 1 0.999862790107727
syndromes I-Disease 1 0.9995680451393127
- O 0 0.0003396662068553269
support O 0 7.474765152437612e-05
the O 0 7.890263805165887e-05
hypothesis O 0 0.0001679979031905532
that O 0 3.079817906836979e-05
TWIST O 0 0.0008012910257093608
and O 0 7.217287929961458e-05
FGFRs O 0 0.002610541181638837
are O 0 1.5753585103084333e-05
components O 0 5.305296144797467e-05
of O 0 2.575479265942704e-05
the O 0 3.4811375371646136e-05
same O 0 3.388852201169357e-05
molecular O 0 8.460731623927131e-05
pathway O 0 0.00014228199142962694
involved O 0 3.3544991310918704e-05
in O 0 2.30944569921121e-05
the O 0 5.898261952097528e-05
modulation O 0 0.0004085331747774035
of O 0 0.0007734405808150768
craniofacial O 1 0.9999990463256836
and O 0 0.10024118423461914
limb O 1 0.9999959468841553
development O 0 0.0023618570994585752
in O 0 0.00024337321519851685
humans O 0 0.00026479343068785965
. O 0 0.00011949745385209098
. O 0 0.0003800631675403565

Mutation O 0 0.0020224794279783964
analysis O 0 0.00048133553355000913
of O 0 0.001529135275632143
UBE3A O 1 0.9999967813491821
in O 1 0.9998200535774231
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999686479568481
. O 0 0.00596770690754056

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.7197049856185913
AS B-Disease 1 0.9554811120033264
) O 0 0.00017009461589623243
is O 0 0.00013128419232089072
caused O 0 0.0008854837506078184
by O 0 9.393963409820572e-05
chromosome O 0 0.0009138340246863663
15q11 O 1 0.8603984713554382
- O 0 0.0004669424088206142
q13 O 0 0.003578152507543564
deletions O 0 0.00047197044477798045
of O 0 0.00015408631588798016
maternal O 0 0.0004396609729155898
origin O 0 8.953604265116155e-05
, O 0 6.565055809915066e-05
by O 0 0.00010057963663712144
paternal O 0 0.0024942539166659117
uniparental B-Disease 1 0.9998611211776733
disomy I-Disease 1 0.9997405409812927
( O 0 0.0008730260888114572
UPD B-Disease 1 0.998924195766449
) O 0 5.426198913482949e-05
15 O 0 8.156115654855967e-05
, O 0 3.5570872569223866e-05
by O 0 5.9238529502181336e-05
imprinting O 1 0.5918787717819214
defects O 1 0.9996439218521118
, O 0 7.171247125370428e-05
and O 0 3.906890196958557e-05
by O 0 3.39643593179062e-05
mutations O 0 0.0001002651551971212
in O 0 6.26481487415731e-05
the O 0 0.00041128345765173435
UBE3A O 1 0.9985754489898682
gene O 0 0.001041863695718348
. O 0 0.0004986832500435412

UBE3A O 0 0.15604962408542633
encodes O 0 0.0019552106969058514
a O 0 0.0008271682308986783
ubiquitin O 0 0.0030511636286973953
- O 0 0.0004905996611341834
protein O 0 0.0002878087689168751
ligase O 0 0.0012313912156969309
and O 0 0.00012712446914520115
shows O 0 0.0003819090488832444
brain O 0 0.18427139520645142
- O 0 0.0005816579796373844
specific O 0 0.00024422910064458847
imprinting O 0 0.005480503663420677
. O 0 0.0009251062292605639

Here O 0 0.0019199801608920097
we O 0 0.0004956488264724612
describe O 0 0.0009916446870192885
UBE3A O 0 0.4472682774066925
coding O 0 0.00092865782789886
- O 0 0.00033761694794520736
region O 0 0.0001846153027145192
mutations O 0 0.00015190044359769672
detected O 0 0.00014876810018904507
by O 0 3.6398407246451825e-05
SSCP O 0 0.002702877391129732
analysis O 0 3.2221760193351656e-05
in O 0 2.865665010176599e-05
13 O 0 0.00011116800305899233
AS B-Disease 0 0.000255084247328341
individuals O 0 4.201298361294903e-05
or O 0 9.222884546034038e-05
families O 0 0.00028600613586604595
. O 0 0.00052284961566329

Two O 0 0.000566129747312516
identical O 0 0.0008515242370776832
de O 0 0.0012865535682067275
novo O 0 0.0015681590884923935
5 O 0 0.0004159586096648127
- O 0 0.0003418904962018132
bp O 0 0.000707278260961175
duplications O 0 0.0009508916991762817
in O 0 0.00012932575191371143
exon O 0 0.000821615569293499
16 O 0 0.00019070730195380747
were O 0 0.00015288374561350793
found O 0 0.000257846579188481
. O 0 0.00041339610470458865

Among O 0 0.00039156072307378054
the O 0 0.00013788676005788147
other O 0 4.5721983042312786e-05
11 O 0 0.00013731364742852747
unique O 0 9.494322148384526e-05
mutations O 0 6.366852903738618e-05
, O 0 4.145769344177097e-05
8 O 0 4.7355923015857115e-05
were O 0 2.9270697268657386e-05
small O 0 3.289716551080346e-05
deletions O 0 0.00018188399553764611
or O 0 4.8328223783755675e-05
insertions O 0 0.00034238252555951476
predicted O 0 0.0001353447587462142
to O 0 4.4226795580470935e-05
cause O 0 0.000566830625757575
frameshifts O 0 0.01725209504365921
, O 0 4.402741978992708e-05
1 O 0 5.091366620035842e-05
was O 0 9.820478589972481e-05
a O 0 4.5814824261469766e-05
mutation O 0 2.9508986699511297e-05
to O 0 6.901727374497568e-06
a O 0 3.3805237762862816e-05
stop O 0 6.048621435184032e-05
codon O 0 0.00011209281365154311
, O 0 2.5284138246206567e-05
1 O 0 3.573733556549996e-05
was O 0 7.045379607006907e-05
a O 0 4.367118890513666e-05
missense O 0 0.0002561563451308757
mutation O 0 6.2443214119412e-05
, O 0 2.6470341254025698e-05
and O 0 3.262339669163339e-05
1 O 0 6.77239295328036e-05
was O 0 0.00012662349035963416
predicted O 0 0.000104251186712645
to O 0 3.1522558856522664e-05
cause O 0 0.00014931437908671796
insertion O 0 0.00019240281835664064
of O 0 9.887852502288297e-05
an O 0 0.00010955736070172861
isoleucine O 0 0.0014889882877469063
in O 0 7.051401917124167e-05
the O 0 0.00011659201845759526
hect O 0 0.0008747193496674299
domain O 0 8.259185415226966e-05
of O 0 5.824014078825712e-05
the O 0 0.00013623468112200499
UBE3A O 1 0.6558825373649597
protein O 0 7.383927004411817e-05
, O 0 2.6425545001984574e-05
which O 0 1.3693351320398506e-05
functions O 0 2.7237541871727444e-05
in O 0 5.213316035224125e-05
E2 O 0 0.0011420919327065349
binding O 0 0.00011049141903640702
and O 0 9.14646007004194e-05
ubiquitin O 0 0.001291787251830101
transfer O 0 0.000410414591897279
. O 0 0.000534799590241164

Eight O 0 0.0005314546870067716
of O 0 0.00017565343296155334
the O 0 0.00013486256648320705
cases O 0 7.567110878881067e-05
were O 0 6.28782290732488e-05
familial O 0 0.02330172248184681
, O 0 6.619717896683142e-05
and O 0 3.9679056499153376e-05
five O 0 5.992579826852307e-05
were O 0 0.00012056613195454702
sporadic O 0 0.0010057397885248065
. O 0 0.0003817494143731892

In O 0 0.0006600130000151694
two O 0 0.0003258282085880637
familial O 0 0.002596671227365732
cases O 0 0.00016160972882062197
and O 0 7.327692583203316e-05
one O 0 5.4354688472812995e-05
sporadic O 0 0.0003936919092666358
case O 0 0.00016825311467982829
, O 0 8.196143608074635e-05
mosaicism O 0 0.028956996276974678
for O 0 0.00010252045467495918
UBE3A O 1 0.9907001852989197
mutations O 0 0.00011263389023952186
was O 0 0.00010606909199850634
detected O 0 7.747668860247359e-05
in O 0 1.5237615116348024e-05
the O 0 2.1289084543241188e-05
mother O 0 5.220599632593803e-05
of O 0 3.5252218367531896e-05
three O 0 3.566975283320062e-05
AS B-Disease 0 0.00032107942388392985
sons O 0 0.000281855056528002
, O 0 1.9903738575521857e-05
in O 0 1.9344342945259996e-05
the O 0 3.8509941077791154e-05
maternal O 0 0.00013702183787245303
grandfather O 0 0.00023670475638937205
of O 0 4.798635563929565e-05
two O 0 1.818731107050553e-05
AS B-Disease 0 0.000157051210408099
first O 0 7.478715997422114e-05
cousins O 0 0.00010637986270012334
, O 0 1.8992081095348112e-05
and O 0 1.5904857718851417e-05
in O 0 1.6959800632321276e-05
the O 0 5.6516470067435876e-05
mother O 0 0.00013166065036784858
of O 0 8.64111862028949e-05
an O 0 0.00019951614376623183
AS B-Disease 0 0.0226628128439188
daughter O 0 0.010110482573509216
. O 0 0.0008934753714129329

The O 0 0.0007680108537897468
frequencies O 0 0.00016779554425738752
with O 0 5.113217775942758e-05
which O 0 2.8745989766321145e-05
we O 0 2.5758328774827532e-05
detected O 0 8.32288569654338e-05
mutations O 0 2.8241398467798717e-05
were O 0 1.391365731251426e-05
5 O 0 2.5048340830835514e-05
( O 0 1.4607055163651239e-05
14 O 0 2.6005991458077915e-05
% O 0 1.1624867511272896e-05
) O 0 5.080843493487919e-06
of O 0 1.1291370356047992e-05
35 O 0 2.1008565454394557e-05
in O 0 1.0595550520520192e-05
sporadic O 0 5.8716155763249844e-05
cases O 0 1.5248023373715114e-05
and O 0 1.41255941343843e-05
8 O 0 2.777712325041648e-05
( O 0 1.5721632735221647e-05
80 O 0 3.4956119634443894e-05
% O 0 1.041220184561098e-05
) O 0 1.0465710147400387e-05
of O 0 2.224057971034199e-05
10 O 0 3.613163062254898e-05
in O 0 4.9187266995431855e-05
familial O 0 0.0016132654855027795
cases O 0 0.00019704745500348508
. O 0 0.0002282109926454723
. O 0 0.0004654148651752621

The O 0 0.006650323513895273
hemochromatosis B-Disease 1 0.9999866485595703
845 O 1 0.9686647653579712
G O 0 0.09739662706851959
- O 0 0.0008473800262436271
- O 0 0.000304556917399168
> O 0 0.00017257549916394055
A O 0 6.622407818213105e-05
and O 0 3.056110654142685e-05
187 O 0 0.00011006574641214684
C O 0 0.0002637961006257683
- O 0 0.00014072090561967343
- O 0 0.0001389695389661938
> O 0 0.00031012672116048634
G O 0 0.00036531579098664224
mutations O 0 8.956131932791322e-05
: O 0 4.9781847337726504e-05
prevalence O 0 0.00025174758047796786
in O 0 7.357780123129487e-05
non O 0 0.0004384052590467036
- O 0 0.0005013082991354167
Caucasian O 0 0.002154982415959239
populations O 0 0.0005544297164306045
. O 0 0.0007622782723046839

Hemochromatosis B-Disease 1 0.9999713897705078
, O 0 0.0027074492536485195
the O 0 0.061054304242134094
inherited B-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
of I-Disease 1 0.9999841451644897
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999741315841675
, O 0 0.0002862656256183982
leads O 0 0.0004043267108500004
, O 0 9.621978824725375e-05
if O 0 7.345889753196388e-05
untreated O 1 0.8131178021430969
, O 0 5.536804019357078e-05
to O 0 7.706125325057656e-05
progressive O 1 0.9959529638290405
iron B-Disease 1 0.9999995231628418
overload I-Disease 1 0.9999974966049194
and O 0 0.00810151919722557
premature B-Disease 1 0.9972284436225891
death I-Disease 0 0.27244678139686584
. O 0 0.0009480507578700781

The O 0 0.010836998000741005
hemochromatosis B-Disease 1 0.9999995231628418
gene O 0 0.0048035685904324055
, O 0 0.0004638604586943984
HFE O 1 0.9988961219787598
, O 0 0.0001306627382291481
recently O 0 0.0001122339817811735
has O 0 3.3785261621233076e-05
been O 0 2.422869329166133e-05
identified O 0 4.686819374910556e-05
, O 0 2.3928892915137112e-05
and O 0 2.6885891202255152e-05
characterization O 0 0.00013861246407032013
of O 0 6.052250319044106e-05
this O 0 2.220332680735737e-05
gene O 0 2.6862111553782597e-05
has O 0 1.4614815881941468e-05
shown O 0 1.3309269888850395e-05
that O 0 6.393499916157452e-06
it O 0 4.5536244215327315e-06
contains O 0 8.200903721444774e-06
two O 0 8.021352186915465e-06
mutations O 0 2.400720404693857e-05
that O 0 8.966984751168638e-06
result O 0 2.3130121917347424e-05
in O 0 2.8835494958912022e-05
amino O 0 4.751705637318082e-05
acid O 0 0.00010878242756007239
substitutions O 0 0.00014417666534427553
- O 0 8.039875683607534e-05
cDNA O 0 0.00026181386783719063
nucleotides O 0 0.00021401687990874052
845 O 0 0.0010420146863907576
G O 0 0.0006093241390772164
- O 0 0.00023191671061795205
- O 0 0.00012069796503055841
> O 0 0.00019625897402875125
A O 0 0.0001248103508260101
( O 0 5.795504694106057e-05
C282Y O 0 0.0008126964094117284
) O 0 3.1435647542821243e-05
and O 0 3.8843143556732684e-05
187 O 0 0.0001670213823672384
C O 0 0.0003035557165276259
- O 0 0.00020963768474757671
- O 0 0.0003375280066393316
> O 0 0.0008238130249083042
G O 0 0.001496967626735568
( O 0 0.00035521891550160944
H63D O 1 0.5355721712112427
) O 0 0.0004227012686897069
. O 0 0.000681592442560941

Although O 0 0.00610395148396492
hemochromatosis B-Disease 1 0.999997615814209
is O 0 0.0003334325738251209
common O 0 0.00016381828754674643
in O 0 0.00010460359771968797
Caucasians O 0 0.0007918426999822259
, O 0 7.623190322192386e-05
affecting O 0 0.00017906876746565104
> O 0 0.0002430119493510574
= O 0 9.763949492480606e-05
1 O 0 5.533294097403996e-05
/ O 0 0.00010971888696076348
300 O 0 6.587400275748223e-05
individuals O 0 1.340701783192344e-05
of O 0 2.8692198611679487e-05
northern O 0 4.730293221655302e-05
European O 0 2.3596234314027242e-05
origin O 0 1.941614391398616e-05
, O 0 2.0630188373615965e-05
it O 0 1.2818302820960525e-05
has O 0 2.194742046413012e-05
not O 0 8.28419524623314e-06
been O 0 2.143366145901382e-05
recognized O 0 5.016070281271823e-05
in O 0 4.4713553506881e-05
other O 0 5.608432911685668e-05
populations O 0 0.00017306490917690098
. O 0 0.00030177010921761394

The O 0 0.001022587763145566
present O 0 0.00045272716670297086
study O 0 0.00015237132902257144
used O 0 6.555609434144571e-05
PCR O 0 0.0004089233698323369
and O 0 6.016738552716561e-05
restriction O 0 0.0001585533464094624
- O 0 0.0001449115516152233
enzyme O 0 0.00010997289064107463
digestion O 0 0.00012401326966937631
to O 0 1.2980337487533689e-05
analyze O 0 2.1541816749959253e-05
the O 0 1.334254011453595e-05
frequency O 0 1.665354830038268e-05
of O 0 1.9151806554873474e-05
the O 0 4.753364191856235e-05
845 O 0 0.0010948516428470612
G O 0 0.0005977821419946849
- O 0 0.00014659389853477478
- O 0 9.026110637933016e-05
> O 0 7.798503065714613e-05
A O 0 5.3233932703733444e-05
and O 0 2.8261605621082708e-05
187 O 0 0.00013184570707380772
C O 0 0.0001711302320472896
- O 0 0.00013805371418129653
- O 0 0.0001653401559451595
> O 0 0.0003113700950052589
G O 0 0.00041690716170705855
mutations O 0 0.00012134374992456287
in O 0 9.89105028565973e-05
HLA O 0 0.004596001002937555
- O 0 0.00013773130194749683
typed O 0 0.00013685497106052935
samples O 0 3.993297286797315e-05
from O 0 5.101791612105444e-05
non O 0 0.000185704993782565
- O 0 0.00015513374819420278
Caucasian O 0 0.00039759022183716297
populations O 0 6.425401079468429e-05
, O 0 4.3041254684794694e-05
comprising O 0 0.00014913328050170094
Australian O 0 0.00027227113605476916
Aboriginal O 0 0.000427769438829273
, O 0 8.220173913286999e-05
Chinese O 0 0.0002607240458019078
, O 0 0.0001355246640741825
and O 0 0.00015596272714901716
Pacific O 0 0.0013261573622003198
Islanders O 0 0.0021069191861897707
. O 0 0.0009396676323376596

Results O 0 0.0008106422028504312
showed O 0 0.0002968412882182747
that O 0 3.1632200261810794e-05
the O 0 0.00011293008719803765
845 O 0 0.0032541474793106318
G O 0 0.001915372908115387
- O 0 0.0002984016318805516
- O 0 0.00017039247904904187
> O 0 0.00020333912107162178
A O 0 0.00018467518384568393
mutation O 0 9.683281678007916e-05
was O 0 6.624050001846626e-05
present O 0 2.4912456865422428e-05
in O 0 1.341031656920677e-05
these O 0 7.5511566137720365e-06
populations O 0 1.2540157513285521e-05
( O 0 1.3538170605897903e-05
allele O 0 2.287081406393554e-05
frequency O 0 1.4193529750627931e-05
0 O 0 9.831565876083914e-06
. O 0 6.458324151026318e-06
32 O 0 1.2935011000081431e-05
% O 0 9.637024049879983e-06
) O 0 1.0205760190729052e-05
, O 0 1.2808381143258885e-05
and O 0 1.5392901332234032e-05
, O 0 1.5880730643402785e-05
furthermore O 0 3.744412970263511e-05
, O 0 2.1721891243942082e-05
it O 0 1.699814310995862e-05
was O 0 6.761506665498018e-05
always O 0 4.9815382226370275e-05
seen O 0 6.483683682745323e-05
in O 0 3.073412517551333e-05
conjunction O 0 0.0001467264664825052
with O 0 0.0001080880974768661
HLA O 1 0.9798422455787659
haplotypes O 0 0.00047679347335360944
common O 0 0.00011243999324506149
in O 0 8.079356484813616e-05
Caucasians O 0 0.0005019160453230143
, O 0 4.5661588956136256e-05
suggesting O 0 9.899929136736318e-05
that O 0 3.7530320696532726e-05
845 O 0 0.0009671116713434458
G O 0 0.0010033518774434924
- O 0 0.00023627994232811034
- O 0 0.00014160755381453782
> O 0 0.00020850660803262144
A O 0 0.00011279932368779555
may O 0 2.6870822694036178e-05
have O 0 9.83105110208271e-06
been O 0 2.273236350447405e-05
introduced O 0 4.236906170262955e-05
into O 0 3.749100869754329e-05
these O 0 2.739101546467282e-05
populations O 0 8.125885506160557e-05
by O 0 0.0001030766507028602
Caucasian O 0 0.002481259172782302
admixture O 0 0.007263582199811935
. O 0 0.0012008578050881624

187 O 0 0.002606016816571355
C O 0 0.002023478737100959
- O 0 0.0007198982057161629
- O 0 0.0003212208684999496
> O 0 0.0004395931027829647
G O 0 0.00041458752821199596
was O 0 0.00013870686234440655
present O 0 5.9613914345391095e-05
at O 0 7.135856139939278e-05
an O 0 3.329595710965805e-05
allele O 0 7.691053178859875e-05
frequency O 0 4.902140790363774e-05
of O 0 8.03883231128566e-05
2 O 0 0.00023097840312402695
. O 0 0.00040428564534522593

68 O 0 0.0014083411078900099
% O 0 0.0001258152915397659
in O 0 5.458558371174149e-05
the O 0 4.649381298804656e-05
two O 0 2.3125820007408038e-05
populations O 0 2.3553155187983066e-05
analyzed O 0 7.317643758142367e-05
( O 0 4.982607424608432e-05
Australian O 0 0.00019487128884065896
Aboriginal O 0 0.00028593637398444116
and O 0 8.836205233819783e-05
Chinese O 0 0.0003680032677948475
) O 0 0.0001663522416492924
. O 0 0.0004008265386801213

In O 0 0.0006162963109090924
the O 0 0.0003376335371285677
Australian O 0 0.0005759586929343641
Aboriginal O 0 0.00038853968726471066
samples O 0 7.438033208018169e-05
, O 0 3.8179125112947077e-05
187 O 0 0.00018284001271240413
C O 0 0.0002389247965766117
- O 0 0.0001354375999653712
- O 0 0.00011373042070772499
> O 0 0.0001957838685484603
G O 0 0.0002032296033576131
was O 0 8.033835911192e-05
found O 0 2.1871866920264438e-05
to O 0 1.4953461686673108e-05
be O 0 1.5512474419665523e-05
associated O 0 4.5246677473187447e-05
with O 0 4.277666812413372e-05
HLA O 1 0.996654748916626
haplotypes O 0 0.00036337663186714053
common O 0 6.762926204828545e-05
in O 0 4.6015094994800165e-05
Caucasians O 0 0.0007452746503986418
, O 0 4.449980042409152e-05
suggesting O 0 7.642698619747534e-05
that O 0 1.5521647583227605e-05
it O 0 1.7658094293437898e-05
was O 0 9.691354352980852e-05
introduced O 0 0.00013584889529738575
by O 0 5.252925257082097e-05
recent O 0 0.000261101929936558
admixture O 0 0.002225032541900873
. O 0 0.0006327580776996911

In O 0 0.00042657856829464436
the O 0 0.000271466065896675
Chinese O 0 0.00025737794931046665
samples O 0 6.717321957694367e-05
analyzed O 0 5.6840879551600665e-05
, O 0 4.187738159089349e-05
187 O 0 0.00013693537039216608
C O 0 0.00015962582256179303
- O 0 9.435313404537737e-05
- O 0 0.00012118070299038664
> O 0 0.00022241761325858533
G O 0 0.0002482630079612136
was O 0 0.00011034505587304011
present O 0 4.08001578762196e-05
in O 0 3.334609209559858e-05
association O 0 5.3745348850497976e-05
with O 0 2.191205567214638e-05
a O 0 7.62468043831177e-05
wide O 0 9.720637899590656e-05
variety O 0 8.26463001430966e-05
of O 0 0.0003009747888427228
HLA O 1 0.9996308088302612
haplotypes O 0 0.0004274380626156926
, O 0 4.272619844414294e-05
showing O 0 8.83536267792806e-05
this O 0 1.6912430510274135e-05
mutation O 0 2.391128145973198e-05
to O 0 8.87630449142307e-06
be O 0 1.3391619177127723e-05
widespread O 0 6.844688323326409e-05
and O 0 2.262457383039873e-05
likely O 0 2.9954926503705792e-05
to O 0 1.462707223254256e-05
predate O 0 0.00012178191536804661
the O 0 3.0145956770866178e-05
more O 0 1.4181189726514276e-05
genetically O 0 5.087269892101176e-05
restricted O 0 6.900736480019987e-05
845 O 0 0.0011898124357685447
G O 0 0.001158507657237351
- O 0 0.00045329565182328224
- O 0 0.0003757017257157713
> O 0 0.0006966185756027699
A O 0 0.0005789025453850627
mutation O 0 0.0009203736553899944
. O 0 0.0005055232322774827

Genotype O 0 0.03456363081932068
- O 0 0.00845214631408453
phenotype O 0 0.003984655719250441
correlations O 0 0.002361389808356762
in O 0 0.001843770849518478
attenuated B-Disease 1 0.9995718598365784
adenomatous I-Disease 1 0.9999996423721313
polyposis I-Disease 1 0.9999996423721313
coli I-Disease 1 0.9999899864196777
. O 0 0.006225774995982647

Germ O 1 0.9968344569206238
- O 0 0.004014559555798769
line O 0 0.0009752612095326185
mutations O 0 0.0003306245489511639
of O 0 0.0003306088037788868
the O 0 0.0028131785802543163
tumor B-Disease 1 0.9999978542327881
suppressor O 1 0.9996261596679688
APC O 1 0.7476199865341187
are O 0 7.726346666458994e-05
implicated O 0 0.0015839716652408242
in O 0 0.000679861637763679
attenuated B-Disease 1 0.9994396567344666
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999992847442627
( O 0 0.3105887472629547
AAPC B-Disease 1 0.9999516010284424
) O 0 0.00018976391584146768
, O 0 7.911079592304304e-05
a O 0 0.00014401714724954218
variant O 0 0.0004156645154580474
of O 0 0.0005984422750771046
familial B-Disease 1 0.9999951124191284
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9982019662857056
FAP B-Disease 1 0.9999804496765137
) O 0 0.0012090068776160479
. O 0 0.0009900049772113562

AAPC B-Disease 1 0.9977947473526001
is O 0 0.0006914877449162304
recognized O 0 0.00029470582376234233
by O 0 7.575385097879916e-05
the O 0 0.00013497269537765533
occurrence O 0 0.0003467467613518238
of O 0 0.0002464200370013714
< O 0 0.001538748387247324
100 O 0 0.0005786559777334332
colonic B-Disease 1 0.935269832611084
adenomas I-Disease 0 0.0029428054112941027
and O 0 4.541856833384372e-05
a O 0 5.70027987123467e-05
later O 0 0.0001913497399073094
onset O 1 0.9988368153572083
of O 1 0.9980446100234985
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
( O 0 0.0006075096898712218
age O 0 0.00032824708614498377
> O 0 0.00029918274958617985
40 O 0 0.00013518056948669255
years O 0 0.00015497631102334708
) O 0 0.000155035566422157
. O 0 0.0003174972953274846

The O 0 0.0007983954856172204
aim O 0 0.00036091069341637194
of O 0 0.00014073149941395968
this O 0 4.502230149228126e-05
study O 0 5.037843220634386e-05
was O 0 0.00014057486259844154
to O 0 6.042026143404655e-05
assess O 0 0.0002064769942080602
genotype O 0 0.0006979645695537329
- O 0 0.0004596893850248307
phenotype O 0 0.0005853683687746525
correlations O 0 0.0005545879830606282
in O 0 0.00038689124630764127
AAPC B-Disease 1 0.9994375109672546
families O 0 0.0008953912183642387
. O 0 0.000774048559833318

By O 0 0.0009450715151615441
protein O 0 0.0005002104444429278
- O 0 0.00041953151230700314
truncation O 0 0.0013295409735292196
test O 0 0.00025219900999218225
( O 0 0.00013868624228052795
PTT O 0 0.0009614290320314467
) O 0 4.8587546189082786e-05
assay O 0 0.00013736225082539022
, O 0 2.429662345093675e-05
the O 0 3.82509570044931e-05
entire O 0 0.00012465848703868687
coding O 0 0.00010430737893329933
region O 0 6.952641706448048e-05
of O 0 8.453046757495031e-05
the O 0 0.00016789861547295004
APC B-Disease 1 0.5960089564323425
gene O 0 0.00013575605407822877
was O 0 0.00014670913515146822
screened O 0 0.00013821730681229383
in O 0 4.26364058512263e-05
affected O 0 6.09634917054791e-05
individuals O 0 2.109422712237574e-05
from O 0 8.214845001930371e-05
11 O 0 0.0010514325695112348
AAPC B-Disease 1 0.9999699592590332
kindreds O 0 0.08723746985197067
, O 0 0.00011896582145709544
and O 0 6.621939974138513e-05
their O 0 6.843689334345981e-05
phenotypic O 0 0.0005612465320155025
differences O 0 0.0002714596048463136
were O 0 0.00020953356579411775
examined O 0 0.0011747052194550633
. O 0 0.0006843757582828403

Five O 0 0.002210499718785286
novel O 0 0.003133412916213274
germ O 1 0.9957751631736755
- O 0 0.003116757608950138
line O 0 0.001966167474165559
APC B-Disease 1 0.5919702649116516
mutations O 0 0.00019314262317493558
were O 0 6.310048047453165e-05
identified O 0 8.985361637314782e-05
in O 0 8.134522795444354e-05
seven O 0 0.00037007121136412024
kindreds O 0 0.009245892986655235
. O 0 0.0007819873280823231

Mutations O 0 0.0011959944386035204
were O 0 0.00018897952395491302
located O 0 0.00018206775712314993
in O 0 3.12892188958358e-05
three O 0 1.5357138181570917e-05
different O 0 6.464960733865155e-06
regions O 0 1.610612525837496e-05
of O 0 3.518894300214015e-05
the O 0 9.477986168349162e-05
APC B-Disease 0 0.08012179285287857
gene O 0 4.9104972276836634e-05
( O 0 2.138021773134824e-05
1 O 0 3.0396300644497387e-05
) O 0 1.1671456377371214e-05
at O 0 2.5806622943491675e-05
the O 0 2.3635329853277653e-05
5 O 0 3.929792364942841e-05
end O 0 7.641320553375408e-05
spanning O 0 0.0001345383789157495
exons O 0 0.00016289071936625987
4 O 0 7.554435433121398e-05
and O 0 2.6244822947774082e-05
5 O 0 3.721470056916587e-05
, O 0 1.4970311895012856e-05
( O 0 1.8419232219457626e-05
2 O 0 2.0172492440906353e-05
) O 0 8.530270861228928e-06
within O 0 1.4053987797524314e-05
exon O 0 0.00010973939060932025
9 O 0 4.358980368124321e-05
, O 0 1.606329533387907e-05
and O 0 9.640737516747322e-06
( O 0 1.669998891884461e-05
3 O 0 2.247012707812246e-05
) O 0 1.1083903700637165e-05
at O 0 2.9897733838879503e-05
the O 0 3.566074155969545e-05
3 O 0 5.314329973771237e-05
distal O 0 0.00044351007090881467
end O 0 0.00014006253331899643
of O 0 0.00011123969306936488
the O 0 0.00029155181255191565
gene O 0 0.000419201678596437
. O 0 0.0004661846032831818

Variability O 0 0.0019815550185739994
in O 0 0.00018734259356278926
the O 0 0.00017036536883097142
number O 0 9.323185804532841e-05
of O 0 0.3022468388080597
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999991655349731
was O 0 0.2097008228302002
most O 0 5.489115937962197e-05
apparent O 0 0.00028394395485520363
in O 0 3.2250409276457503e-05
individuals O 0 1.5249186617438681e-05
with O 0 1.7197755369124934e-05
mutations O 0 3.247304994147271e-05
in O 0 2.2974583771429025e-05
region O 0 5.62847635592334e-05
1 O 0 7.18788433005102e-05
, O 0 6.506699719466269e-05
and O 0 9.072882676264271e-05
upper O 1 0.8811410069465637
- O 1 0.8075593709945679
gastrointestinal O 1 0.9998437166213989
manifestations O 1 0.5436117053031921
were O 0 0.00015153009735513479
more O 0 7.70694823586382e-05
severe O 0 0.4431670606136322
in O 0 0.00013741057773586363
them O 0 0.00013673417561221868
. O 0 0.00032378878677263856

In O 0 0.0003764212306123227
individuals O 0 9.164426592178643e-05
with O 0 5.545935709960759e-05
mutations O 0 5.977757973596454e-05
in O 0 3.1027502700453624e-05
either O 0 3.4140070056309924e-05
region O 0 4.740110307466239e-05
2 O 0 3.259516233811155e-05
or O 0 1.7218941138708033e-05
region O 0 2.7593363483902067e-05
3 O 0 2.6501104002818465e-05
, O 0 1.6331350707332604e-05
the O 0 1.5794064893270843e-05
average O 0 1.7760625269147567e-05
number O 0 8.555919521313626e-06
of O 0 5.201115709496662e-05
adenomas B-Disease 0 0.010328937321901321
tended O 0 5.2201765356585383e-05
to O 0 9.39478832151508e-06
be O 0 5.716629402741091e-06
lower O 0 1.3342425518203527e-05
than O 0 4.09388712796499e-06
those O 0 3.335115025038249e-06
in O 0 5.6616477195348125e-06
individuals O 0 3.979877874371596e-06
with O 0 8.783131306699943e-06
mutations O 0 2.317690996278543e-05
in O 0 1.7194426618516445e-05
region O 0 3.919436130672693e-05
1 O 0 2.940345075330697e-05
, O 0 1.6706742826499976e-05
although O 0 2.104770828736946e-05
age O 0 0.00010877122986130416
at O 0 0.00033399442327208817
diagnosis O 0 0.006320045329630375
was O 0 0.0008468545274809003
similar O 0 0.000314247386995703
. O 0 0.00038990669418126345

In O 0 0.0023391565773636103
all O 0 0.0011911822948604822
AAPC B-Disease 1 0.9983615279197693
kindreds O 0 0.005974907428026199
, O 0 0.00018615100998431444
a O 0 0.00021537653810810298
predominance O 0 0.0022563214879482985
of O 0 0.0011087143793702126
right O 0 0.3706905245780945
- O 1 0.9926639795303345
sided O 1 0.9999657869338989
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999997615814209
and O 1 0.9789757132530212
rectal B-Disease 1 0.9999996423721313
polyp I-Disease 1 0.9999985694885254
sparing O 1 0.991531252861023
was O 0 0.02713056653738022
observed O 0 0.0011449253652244806
. O 0 0.0005829436122439802

No O 0 0.0445106141269207
desmoid B-Disease 1 0.9999520778656006
tumors I-Disease 1 0.9997798800468445
were O 0 0.00027715018950402737
found O 0 0.00016146601410582662
in O 0 0.0001545306877233088
these O 0 0.0001774191769072786
kindreds O 0 0.005809383001178503
. O 0 0.0007448952528648078

Our O 0 0.0009375007939524949
data O 0 0.00013999523071106523
suggest O 0 0.00012030820653308183
that O 0 4.946215631207451e-05
, O 0 6.725579441990703e-05
in O 0 0.00010222768469247967
AAPC B-Disease 1 0.987929105758667
families O 0 8.538769179722294e-05
, O 0 3.729594754986465e-05
the O 0 4.269198325346224e-05
location O 0 8.58218118082732e-05
of O 0 0.00012177726603113115
the O 0 0.00039054377702996135
APC B-Disease 1 0.9995032548904419
mutation O 0 0.0009351197513751686
may O 0 0.00016457101446576416
partially O 0 0.0006172118009999394
predict O 0 0.00044259062269702554
specific O 0 0.00024981325259432197
phenotypic O 0 0.0017494270578026772
expression O 0 0.0013230418553575873
. O 0 0.0008213631226681173

This O 0 0.0005251486436463892
should O 0 0.00014665514754597098
help O 0 0.00010305070463800803
in O 0 5.457095176097937e-05
the O 0 6.093687261454761e-05
design O 0 0.0001961097150342539
of O 0 0.0001053430387401022
tailored O 0 0.00028517350438050926
clinical O 0 0.0005938287358731031
- O 0 0.00028293521609157324
management O 0 0.00018023874145001173
protocols O 0 0.00010329755605198443
in O 0 3.559692777344026e-05
this O 0 3.7783604057040066e-05
subset O 0 0.00025091058341786265
of O 0 0.00041677741683088243
FAP B-Disease 1 0.9999359846115112
patients O 0 0.003096724860370159
. O 0 0.0003423766465857625
. O 0 0.0007570234593003988

Wilms B-Disease 1 0.9999480247497559
' I-Disease 0 0.20018050074577332
tumor I-Disease 1 0.9736909866333008
1 O 0 0.0004152095061726868
and O 0 0.00014433595060836524
Dax O 0 0.40890735387802124
- O 0 0.00031449072412215173
1 O 0 9.689579746918753e-05
modulate O 0 0.00018804287537932396
the O 0 8.574606181355193e-05
orphan O 0 0.0006739119999110699
nuclear O 0 0.0003989536489825696
receptor O 0 0.00025266542797908187
SF O 0 0.005664058495312929
- O 0 0.00011831361916847527
1 O 0 4.372773764771409e-05
in O 0 3.137096427963115e-05
sex O 0 0.00010928450501523912
- O 0 0.00012137152953073382
specific O 0 5.977079854346812e-05
gene O 0 0.0002935768279712647
expression O 0 0.0003860352444462478
. O 0 0.00036236923187971115

Products O 0 0.0015973685076460242
of O 0 0.0008327278192155063
steroidogenic O 0 0.4430685341358185
factor O 0 0.0007539722719229758
1 O 0 0.0002487140882294625
( O 0 0.000171278792549856
SF O 0 0.03585798665881157
- O 0 0.00023077325022313744
1 O 0 8.770507702138275e-05
) O 0 7.46035948395729e-05
and O 0 0.00013409087841864675
Wilms B-Disease 1 0.999889612197876
tumor I-Disease 1 0.9996408224105835
1 O 0 0.00044944885303266346
( O 0 0.00022066818200983107
WT1 O 0 0.4184262454509735
) O 0 6.184290396049619e-05
genes O 0 3.0589297239203006e-05
are O 0 7.107078545232071e-06
essential O 0 4.614719364326447e-05
for O 0 2.2456393708125688e-05
mammalian O 0 0.0002471694606356323
gonadogenesis O 0 0.0024921910371631384
prior O 0 0.00016291634528897703
to O 0 0.00014929317694623023
sexual O 0 0.0005213675904087722
differentiation O 0 0.002684694714844227
. O 0 0.0006310747121460736

In O 0 0.0007074723835103214
males O 0 0.0003156258608214557
, O 0 0.000330938957631588
SF O 1 0.9624977707862854
- O 0 0.0003351698105689138
1 O 0 9.513218537904322e-05
participates O 0 0.00010586841381154954
in O 0 3.634083259385079e-05
sexual O 0 5.5228192650247365e-05
development O 0 6.522379408124834e-05
by O 0 3.3987394999712706e-05
regulating O 0 8.459295349894091e-05
expression O 0 6.365565786836669e-05
of O 0 7.660033588763326e-05
the O 0 0.0002518448163755238
polypeptide O 0 0.2374708354473114
hormone O 1 0.6052572131156921
Mullerian O 1 0.9985030889511108
inhibiting O 0 0.4446012079715729
substance O 1 0.5457307696342468
( O 0 0.0007479281630367041
MIS O 1 0.7286607623100281
) O 0 0.0005085405427962542
. O 0 0.0006698382785543799

Here O 0 0.0014269780367612839
, O 0 0.0003119331377092749
we O 0 0.00014992528303992003
show O 0 0.0002948888286482543
that O 0 0.00028598352218978107
WT1 O 1 0.9494829773902893
- O 0 0.0015413903165608644
KTS O 0 0.05955588072538376
isoforms O 0 0.0004032719589304179
associate O 0 0.00035284404293634
and O 0 0.00016244911239482462
synergize O 0 0.002516320440918207
with O 0 0.00020542563288472593
SF O 1 0.99795001745224
- O 0 0.00033345387782901525
1 O 0 0.00013005439541302621
to O 0 9.195170423481613e-05
promote O 0 0.0006067279609851539
MIS O 1 0.5322790145874023
expression O 0 0.0010087508708238602
. O 0 0.0005896557122468948

In O 0 0.0018717509228736162
contrast O 0 0.0024028290063142776
, O 0 0.000937152944970876
WT1 O 1 0.9992969036102295
missense O 0 0.005032108165323734
mutations O 0 0.00035382661735638976
, O 0 8.218386938096955e-05
associated O 0 7.00948730809614e-05
with O 0 5.4846106650074944e-05
male B-Disease 0 0.00039467288297601044
pseudohermaphroditism I-Disease 1 0.999705970287323
in O 0 0.0010462485952302814
Denys B-Disease 1 0.9999877214431763
- I-Disease 1 0.9998754262924194
Drash I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999998807907104
, O 0 0.0003751706099137664
fail O 0 0.0003223021631129086
to O 0 8.374209573958069e-05
synergize O 0 0.006185721606016159
with O 0 0.000295411329716444
SF O 1 0.9997709393501282
- O 0 0.0011966709280386567
1 O 0 0.0009027149644680321
. O 0 0.0005566287436522543

Additionally O 0 0.001260952209122479
, O 0 0.00023162721481639892
the O 0 0.00023450689332094043
X O 0 0.0010459083132445812
- O 0 0.00031450693495571613
linked O 0 0.0001849803957156837
, O 0 4.909176641376689e-05
candidate O 0 0.00015974808775354177
dosage O 0 0.00032421507057733834
- O 0 0.00014287367230281234
sensitive O 0 0.00019434874411672354
sex O 0 8.897328370949253e-05
- O 0 9.755853534443304e-05
reversal O 0 0.00032707591890357435
gene O 0 8.803269156487659e-05
, O 0 7.305483450181782e-05
Dax O 0 0.10345568507909775
- O 0 0.0001671367062954232
1 O 0 0.00011953929060837254
, O 0 6.974595453357324e-05
antagonizes O 0 0.0005845941486768425
synergy O 0 0.000626186141744256
between O 0 0.00016481395869050175
SF O 1 0.9899494647979736
- O 0 0.0002679882163647562
1 O 0 9.619895718060434e-05
and O 0 6.140815821709111e-05
WT1 O 0 0.3764694333076477
, O 0 4.1053259337786585e-05
most O 0 2.476932422723621e-05
likely O 0 2.4180817490560003e-05
through O 0 1.76356261363253e-05
a O 0 2.744937955867499e-05
direct O 0 4.8744786909082904e-05
interaction O 0 9.667356061981991e-05
with O 0 0.00011968390754191205
SF O 1 0.9989306330680847
- O 0 0.0005993826780468225
1 O 0 0.0003334329230710864
. O 0 0.0004885197849944234

We O 0 0.0008030583267100155
propose O 0 0.0007700881105847657
that O 0 0.00023919511295389384
WT1 O 0 0.13267038762569427
and O 0 0.0002454406348988414
Dax O 1 0.9740366339683533
- O 0 0.000570497359149158
1 O 0 0.00012277066707611084
functionally O 0 0.0001704960159258917
oppose O 0 4.927318514091894e-05
each O 0 1.2756572687067091e-05
other O 0 1.5782170521561056e-05
in O 0 6.252174352994189e-05
testis O 0 0.002526405965909362
development O 0 0.00021806608128827065
by O 0 0.00011362061923136935
modulating O 0 0.0637889876961708
SF O 1 0.9978551268577576
- O 0 0.0004820617032237351
1 O 0 0.0002692901180125773
- O 0 0.00042511895298957825
mediated O 0 0.001558921067044139
transactivation O 0 0.00725032202899456
. O 0 0.0005082771531306207
. O 0 0.0005389630678109825

A O 0 0.004492370877414942
mouse O 0 0.002303984947502613
model O 0 0.0010821862379088998
for O 0 0.000727395061403513
Prader B-Disease 1 0.9999982118606567
- I-Disease 1 0.9999799728393555
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999914169311523
- O 1 0.9978600144386292
centre O 1 0.9759819507598877
mutations O 0 0.002319502644240856
. O 0 0.000951478024944663

Imprinting O 0 0.010705497115850449
in O 0 0.0006196956383064389
the O 0 0.0009106606594286859
15q11 O 1 0.8905504941940308
- O 0 0.0015112451510503888
q13 O 0 0.004727938212454319
region O 0 0.00020121701527386904
involves O 0 0.00018979178275913
an O 0 8.717660239199176e-05
imprinting O 0 0.0028909470420330763
centre O 0 0.003389138961210847
( O 0 0.0002395447518210858
IC O 0 0.08782974630594254
) O 0 2.9863025702070445e-05
, O 0 2.3894370315247215e-05
mapping O 0 4.158083174843341e-05
in O 0 1.2807904568035156e-05
part O 0 2.4022339857765473e-05
to O 0 1.2135370525356848e-05
the O 0 4.1145838622469455e-05
promoter O 0 0.00047790075768716633
and O 0 6.014105383655988e-05
first O 0 0.00016911780403461307
exon O 0 0.0011295473668724298
of O 0 0.0006041508750058711
SNRPN O 1 0.9982445240020752
. O 0 0.0009592888527549803

Deletion O 0 0.005628079175949097
of O 0 0.0012707605492323637
this O 0 0.0004528825229499489
IC O 0 0.16719181835651398
abolishes O 0 0.004621186759322882
local O 0 0.0003646682598628104
paternally O 0 0.001695724087767303
derived O 0 0.00019249455363024026
gene O 0 0.00012942506873514503
expression O 0 9.712725295685232e-05
and O 0 5.069409962743521e-05
results O 0 9.253180178347975e-05
in O 0 0.0003332994529046118
Prader B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999943971633911
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9994522929191589
PWS B-Disease 1 0.9999998807907104
) O 0 0.001194216893054545
. O 0 0.0009934916161000729

We O 0 0.0006071874522604048
have O 0 9.842604049481452e-05
created O 0 0.0002222393377451226
two O 0 9.622786456020549e-05
deletion O 0 0.0008462229161523283
mutations O 0 0.0002309512929059565
in O 0 0.0001271283399546519
mice O 0 0.0002828758442774415
to O 0 9.982736082747579e-05
understand O 0 0.0003841911966446787
PWS B-Disease 1 0.9997159838676453
and O 0 0.0001286672049900517
the O 0 0.00010568119614617899
mechanism O 0 0.0001734930119710043
of O 0 0.00021928454225417227
this O 0 0.00023350604169536382
IC O 1 0.7521265149116516
. O 0 0.0011180737055838108

Mice O 0 0.00770809268578887
harbouring O 0 0.08767689764499664
an O 0 0.0006895263795740902
intragenic O 1 0.9490272998809814
deletion O 0 0.0018679829081520438
in O 0 0.00032335479045286775
Snrpn O 1 0.6472089886665344
are O 0 7.25940044503659e-05
phenotypically O 0 0.0010910802520811558
normal O 0 0.00012726298882625997
, O 0 4.1412178688915446e-05
suggesting O 0 0.00010545067925704643
that O 0 2.1990203094901517e-05
mutations O 0 6.198538176249713e-05
of O 0 0.0001263851299881935
SNRPN O 1 0.9901329278945923
are O 0 2.716822382353712e-05
not O 0 2.630265043990221e-05
sufficient O 0 0.0001783746702130884
to O 0 0.0001339838927378878
induce O 0 0.009929824620485306
PWS B-Disease 1 0.9999737739562988
. O 0 0.001953624188899994

Mice O 0 0.0024135697167366743
with O 0 0.0002008627780014649
a O 0 0.00026172155048698187
larger O 0 0.00024096867127809674
deletion O 0 0.0004211290506646037
involving O 0 0.00026613459340296686
both O 0 8.687857916811481e-05
Snrpn O 0 0.020229073241353035
and O 0 0.00010047093383036554
the O 0 0.0002332636940991506
putative O 1 0.8551036715507507
PWS O 1 0.9999997615814209
- O 0 0.033578917384147644
IC O 0 0.32169991731643677
lack O 0 0.00023869593860581517
expression O 0 7.441977504640818e-05
of O 0 7.89816040196456e-05
the O 0 0.00016372503887396306
imprinted O 0 0.0019500143826007843
genes O 0 0.00018180010374635458
Zfp127 O 0 0.23481661081314087
( O 0 0.0002310517302248627
mouse O 0 0.0004968065186403692
homologue O 0 0.001415979815647006
of O 0 0.000364245061064139
ZNF127 O 1 0.999235987663269
) O 0 0.00019838573643937707
, O 0 0.000254593207500875
Ndn O 0 0.08442384749650955
and O 0 0.00031548531842418015
Ipw O 0 0.0418214276432991
, O 0 0.0002883762354031205
and O 0 0.00011757988977478817
manifest O 0 0.000867732975166291
several O 0 0.0002072286297334358
phenotypes O 0 0.0019781969022005796
common O 0 0.0006001701694913208
to O 0 0.000984798651188612
PWS B-Disease 1 0.9999986886978149
infants O 1 0.9896522164344788
. O 0 0.002726687118411064

These O 0 0.0002701510675251484
data O 0 0.00011196196282980964
demonstrate O 0 0.00013662262063007802
that O 0 2.434403359075077e-05
both O 0 1.7765400116331875e-05
the O 0 3.463606844889e-05
position O 0 4.5728174882242456e-05
of O 0 6.151518027763814e-05
the O 0 0.00014896769425831735
IC O 0 0.10300873219966888
and O 0 3.273683978477493e-05
its O 0 1.727514245430939e-05
role O 0 5.2546085498761386e-05
in O 0 2.1859939806745388e-05
the O 0 3.6533339880406857e-05
coordinate O 0 5.813204916194081e-05
expression O 0 6.271582242334262e-05
of O 0 5.905843499931507e-05
genes O 0 4.0349266782868654e-05
is O 0 2.453861088724807e-05
conserved O 0 8.371831791009754e-05
between O 0 6.432273221435025e-05
mouse O 0 0.0001789288071449846
and O 0 3.137332896585576e-05
human O 0 3.5877681511919945e-05
, O 0 1.866542879724875e-05
and O 0 1.9694571165018715e-05
indicate O 0 2.8344604288577102e-05
that O 0 8.981414794106968e-06
the O 0 3.0180794055922888e-05
mouse O 0 7.424539944622666e-05
is O 0 2.480140028637834e-05
a O 0 4.072780939168297e-05
suitable O 0 7.983302202774212e-05
model O 0 5.9613514167722315e-05
system O 0 2.9383129003690556e-05
in O 0 1.0751602530945092e-05
which O 0 8.741708370507695e-06
to O 0 7.239598289743299e-06
investigate O 0 4.085765976924449e-05
the O 0 4.676354365074076e-05
molecular O 0 9.481603046879172e-05
mechanisms O 0 8.169846842065454e-05
of O 0 8.091785275610164e-05
imprinting O 0 0.0003901191521435976
in O 0 3.420834764256142e-05
this O 0 1.59291139425477e-05
region O 0 3.4598371712490916e-05
of O 0 6.195883906912059e-05
the O 0 0.00016199499077629298
genome O 0 0.00036835408536717296
. O 0 0.00014382254448719323
. O 0 0.0003953778650611639

Mutations O 0 0.0013301983708515763
of O 0 0.0006126220687292516
the O 0 0.0003846599138341844
ATM O 0 0.0011307548265904188
gene O 0 0.00016448287351522595
detected O 0 0.00023851556761655957
in O 0 0.0001086098636733368
Japanese O 0 0.19610537588596344
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9995160102844238
telangiectasia I-Disease 1 0.9999833106994629
patients O 0 0.002033491851761937
: O 0 6.314086203929037e-05
possible O 0 6.618442421313375e-05
preponderance O 0 0.00042847098666243255
of O 0 7.527210982516408e-05
the O 0 8.904321293812245e-05
two O 0 8.33214508020319e-05
founder O 0 0.00998280756175518
mutations O 0 0.0009592125425115228
4612del165 O 1 0.7888491153717041
and O 0 0.0006846000906080008
7883del5 O 1 0.8030828833580017
. O 0 0.0016083132941275835

The O 0 0.0016795739065855742
ATM O 0 0.004421804565936327
( O 0 0.000685791193973273
A O 0 0.2885386049747467
- O 0 0.03354478254914284
T O 1 0.7469813227653503
, O 0 8.730463741812855e-05
mutated O 0 0.0002169060753658414
) O 0 5.696144580724649e-05
gene O 0 0.0001202891580760479
on O 0 0.00013674565707333386
human O 0 0.0003820373967755586
chromosome O 0 0.0023985670413821936
11q22 O 1 0.6557062864303589
. O 0 0.0012236416805535555

3 O 0 0.0009684021351858974
has O 0 0.00016167123976629227
recently O 0 0.00019680222612805665
been O 0 5.143093585502356e-05
identified O 0 4.6060889872023836e-05
as O 0 2.9655571779585443e-05
the O 0 5.423425682238303e-05
gene O 0 6.031197699485347e-05
responsible O 0 5.8513371186563745e-05
for O 0 2.9668330171261914e-05
the O 0 0.00013640368706546724
human O 0 0.10486645996570587
recessive B-Disease 1 0.9999959468841553
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999580383300781
telangiectasia I-Disease 1 0.9999977350234985
( O 0 0.01619180105626583
A B-Disease 1 0.9997127652168274
- I-Disease 1 0.9624837636947632
T I-Disease 1 0.9935856461524963
) O 0 0.0002108130865963176
. O 0 0.0003420316497795284

In O 0 0.00047519413055852056
order O 0 0.00016758800484240055
to O 0 4.0126931708073243e-05
define O 0 7.402892515528947e-05
the O 0 9.869747736956924e-05
types O 0 0.00012681040971074253
of O 0 0.008442137390375137
disease O 1 0.9999991655349731
- O 1 0.5575658082962036
causing O 1 0.6108294725418091
ATM O 0 0.0005315403686836362
mutations O 0 5.0439055485185236e-05
in O 0 2.561243854870554e-05
Japanese O 0 0.0002831473248079419
A B-Disease 1 0.8528128862380981
- I-Disease 0 0.4418761730194092
T I-Disease 1 0.9975913763046265
patients O 0 5.459604290081188e-05
as O 0 2.0446117559913546e-05
well O 0 1.3260050764074549e-05
as O 0 2.040933759417385e-05
to O 0 1.976273415493779e-05
look O 0 4.422683923621662e-05
for O 0 3.641524745034985e-05
possible O 0 0.00012480025179684162
mutational O 0 0.005336655769497156
hotspots O 0 0.0014672589022666216
, O 0 9.918280557030812e-05
reverse O 0 0.00021417977404780686
- O 0 0.0001365845964755863
transcribed O 0 0.0001231708884006366
RNA O 0 9.745912393555045e-05
derived O 0 4.9170481361215934e-05
from O 0 2.5172166715492494e-05
ten O 0 6.177736941026524e-05
patients O 0 3.697845386341214e-05
belonging O 0 6.072374526411295e-05
to O 0 1.7409467545803636e-05
eight O 0 4.602224726113491e-05
unrelated O 0 0.00012686521222349256
Japanese O 0 0.0007857010932639241
A B-Disease 0 0.47719940543174744
- I-Disease 0 0.007419240660965443
T I-Disease 0 0.11189558357000351
families O 0 7.269825437106192e-05
was O 0 0.00015655990864615887
analyzed O 0 8.864130359143019e-05
for O 0 3.070178354391828e-05
mutations O 0 5.9749712818302214e-05
by O 0 2.418146323179826e-05
the O 0 0.00013176063657738268
restriction O 0 0.00032186429598368704
endonuclease O 0 0.0021816762164235115
fingerprinting O 0 0.0011593445669859648
method O 0 0.0006386783788911998
. O 0 0.0007294709212146699

As O 0 0.00069404550595209
has O 0 0.00017292783013544977
been O 0 7.959706272231415e-05
reported O 0 9.618327749194577e-05
by O 0 3.200313585693948e-05
others O 0 5.142082954989746e-05
, O 0 4.364479536889121e-05
mutations O 0 4.307964627514593e-05
that O 0 2.229758320027031e-05
lead O 0 6.986230437178165e-05
to O 0 4.261461799615063e-05
exon O 0 0.0007415337604470551
skipping O 0 0.0008984267478808761
or O 0 0.00011870666639879346
premature O 0 0.0005641583120450377
protein O 0 0.0001527815911686048
truncation O 0 0.0005381220253184438
were O 0 5.742481880588457e-05
also O 0 3.9011163607938215e-05
predominant O 0 0.00021034045494161546
in O 0 7.995911437319592e-05
our O 0 0.00021462356380652636
mutants O 0 0.0013563132379204035
. O 0 0.00040959834586828947

Six O 0 0.0006115763681009412
different O 0 0.00011049120803363621
mutations O 0 0.00010895237210206687
were O 0 2.8943768484168686e-05
identified O 0 2.5143879611277953e-05
on O 0 3.348928294144571e-05
12 O 0 5.8346489822724834e-05
of O 0 5.1629802328534424e-05
the O 0 9.922802564688027e-05
16 O 0 0.0003064420016016811
alleles O 0 0.00041382721974514425
examined O 0 0.0009089537197723985
. O 0 0.0005110525526106358

Four O 0 0.0006585301598533988
were O 0 0.0002475402143318206
deletions O 0 0.0006342822453007102
involving O 0 0.00021753944747615606
a O 0 0.00012544011406134814
loss O 0 0.00029274728149175644
of O 0 9.335614595329389e-05
a O 0 9.917221177602187e-05
single O 0 8.421106031164527e-05
exon O 0 0.0003362830320838839
exon O 0 0.0002623976324684918
7 O 0 8.188433275790885e-05
, O 0 4.0101149352267385e-05
exon O 0 0.00024740854860283434
16 O 0 8.41849614516832e-05
, O 0 6.415317329810932e-05
exon O 0 0.0004915009485557675
33 O 0 0.00028800807194784284
or O 0 0.0001691345969447866
exon O 0 0.0013266620226204395
35 O 0 0.0007547914865426719
. O 0 0.0008181865559890866

The O 0 0.00102800817694515
others O 0 0.00036082454607822
were O 0 0.0002023012493737042
minute O 0 0.0003131425764877349
deletions O 0 0.00045541077270172536
, O 0 0.00011204268230358139
4649delA O 0 0.0012811414198949933
in O 0 0.00014650907542090863
exon O 0 0.000652913236990571
33 O 0 0.00033418330713175237
and O 0 0.00010574219049885869
7883del5 O 0 0.0018248752458021045
in O 0 0.0001921657531056553
exon O 0 0.0017655305564403534
55 O 0 0.0009481062297709286
. O 0 0.0005697417072951794

The O 0 0.0025648113805800676
mutations O 0 0.001875822083093226
4612del165 O 0 0.2699526250362396
and O 0 0.0002871755859814584
7883del5 O 0 0.007961455732584
were O 0 7.94377556303516e-05
found O 0 3.011874287039973e-05
in O 0 1.4210295375960413e-05
more O 0 6.936866157047916e-06
than O 0 7.217167421913473e-06
two O 0 7.420728252327535e-06
unrelated O 0 4.101029480807483e-05
families O 0 1.744490145938471e-05
; O 0 6.3912202676874585e-06
44 O 0 2.6001333026215434e-05
% O 0 1.426866128895199e-05
( O 0 1.1479753993626218e-05
7 O 0 2.7549980586627498e-05
of O 0 3.143864523735829e-05
16 O 0 5.2320872782729566e-05
) O 0 1.7958154785446823e-05
of O 0 3.6438101233216e-05
the O 0 6.442917947424576e-05
mutant O 0 0.0004760754818562418
alleles O 0 0.0001084817195078358
had O 0 4.5749504351988435e-05
one O 0 3.4219538065372035e-05
of O 0 5.9208370657870546e-05
the O 0 0.00011069663742091507
two O 0 0.00012460809375625104
mutations O 0 0.0006697240169160068
. O 0 0.0004733252280857414

The O 0 0.00259582931175828
4612del165 O 0 0.44741615653038025
mutations O 0 0.00036983966128900647
in O 0 6.0040259995730594e-05
three O 0 2.3944119675434195e-05
different O 0 8.683364285388961e-06
families O 0 1.948425779119134e-05
were O 0 1.692133446340449e-05
all O 0 1.5316174540203065e-05
ascribed O 0 7.879474287619814e-05
to O 0 1.527990389149636e-05
the O 0 3.488787842798047e-05
same O 0 5.8962032198905945e-05
T O 0 0.0011446935823187232
- O 0 9.591261914465576e-05
- O 0 8.25470415293239e-05
> O 0 0.00011309851106489077
A O 0 7.460053166141734e-05
substitution O 0 0.00010036119056167081
at O 0 6.259996735025197e-05
the O 0 6.263799878070131e-05
splice O 0 0.0003561692137736827
donor O 0 0.00011431537859607488
site O 0 0.00024883385049179196
in O 0 0.00011262894986430183
intron O 0 0.003210107795894146
33 O 0 0.00133659434504807
. O 0 0.0006184004014357924

Microsatellite O 0 0.03932284563779831
genotyping O 0 0.007936905138194561
around O 0 0.0006530448445118964
the O 0 0.00034403454628773034
ATM O 0 0.0012983176857233047
locus O 0 0.0005607354105450213
also O 0 4.9555543228052557e-05
indicated O 0 6.076469799154438e-05
that O 0 1.4354071936395485e-05
a O 0 3.325133729958907e-05
common O 0 4.346904461272061e-05
haplotype O 0 0.0002076998061966151
was O 0 0.00011213342804694548
shared O 0 5.900984979234636e-05
by O 0 3.470259252935648e-05
the O 0 9.16638455237262e-05
mutant O 0 0.0005073100328445435
alleles O 0 0.00015034661919344217
in O 0 9.475772094447166e-05
both O 0 0.00014329211262520403
mutations O 0 0.0006984303472563624
. O 0 0.0004738001443911344

This O 0 0.0003993238788098097
suggests O 0 0.00025030941469594836
that O 0 3.803543222602457e-05
these O 0 1.702524969005026e-05
two O 0 4.250519486959092e-05
founder O 0 0.0022604463156312704
mutations O 0 0.0002155980037059635
may O 0 0.00011152996012242511
be O 0 5.21164620295167e-05
predominant O 0 0.00024464906891807914
among O 0 8.998275006888434e-05
Japanese O 0 0.0009515913552604616
ATM O 0 0.0036261221393942833
mutant O 0 0.002764202421531081
alleles O 0 0.0009795186342671514
. O 0 0.0004527875571511686

W474C O 0 0.0422031469643116
amino O 0 0.002204383723437786
acid O 0 0.0016594319604337215
substitution O 0 0.0006241656374186277
affects O 0 0.0003190603165421635
early O 0 9.622282232157886e-05
processing O 0 7.417894812533632e-05
of O 0 5.271180998533964e-05
the O 0 4.542082024272531e-05
alpha O 0 0.0001026891332003288
- O 0 6.526373908855021e-05
subunit O 0 6.175651651574299e-05
of O 0 6.55191033729352e-05
beta O 0 0.00024237559409812093
- O 0 0.00017752646817825735
hexosaminidase O 0 0.0008299267501570284
A O 0 0.00018160846957471222
and O 0 5.0823196943383664e-05
is O 0 3.24511929647997e-05
associated O 0 6.959420716157183e-05
with O 0 9.00182785699144e-05
subacute O 1 0.9999856948852539
G B-Disease 1 0.9959864020347595
( I-Disease 0 0.001001217751763761
M2 I-Disease 1 0.8526416420936584
) I-Disease 0 0.0005388113204389811
gangliosidosis I-Disease 0 0.01216309703886509
. O 0 0.000790619058534503

Mutations O 0 0.00170663942117244
in O 0 0.00036156849819235504
the O 0 0.0006040414446033537
HEXA O 1 0.9702760577201843
gene O 0 0.00014420926163438708
, O 0 2.9432487281155773e-05
encoding O 0 3.1734900403534994e-05
the O 0 4.901463398709893e-05
alpha O 0 8.683965279487893e-05
- O 0 4.0475744754076004e-05
subunit O 0 3.581423879950307e-05
of O 0 5.4999989515636116e-05
beta O 0 0.00013566468260250986
- O 0 0.0001396078587276861
hexosaminidase O 0 0.0008538084803149104
A O 0 0.00018572162662167102
( O 0 6.560188194271177e-05
Hex O 0 0.0004976326017640531
A O 0 0.0002492810017429292
) O 0 4.3519859900698066e-05
, O 0 4.145334241911769e-05
that O 0 3.489563096081838e-05
abolish O 0 0.0003436254628468305
Hex O 0 0.0010175268398597836
A O 0 0.0005129037890583277
enzyme O 0 0.0005332362488843501
activity O 0 0.0009492175304330885
cause O 1 0.9987095594406128
Tay B-Disease 1 0.9999998807907104
- I-Disease 1 0.9994137287139893
Sachs I-Disease 1 0.9999849796295166
disease I-Disease 1 0.9999934434890747
( O 0 0.0017244713380932808
TSD B-Disease 1 0.9998227953910828
) O 0 6.934988050488755e-05
, O 0 5.515902739716694e-05
the O 0 0.00012659777712542564
fatal O 1 0.9887399077415466
infantile B-Disease 1 0.9046847820281982
form I-Disease 0 0.00015074783004820347
of I-Disease 0 0.0003724068228621036
G I-Disease 0 0.055346954613924026
( I-Disease 0 0.00019453433924354613
M2 I-Disease 0 0.034359827637672424
) I-Disease 0 0.00010109262075275183
gangliosidosis I-Disease 0 0.0017267202492803335
, I-Disease 0 0.00013022066559642553
Type I-Disease 0 0.0003488071961328387
1 I-Disease 0 0.0005249396781437099
. O 0 0.00044009918929077685

Less O 0 0.0029320605099201202
severe O 1 0.9983121156692505
, O 0 0.0014837307389825583
subacute O 1 0.9999865293502808
( O 0 0.02960183657705784
juvenile O 1 0.9996808767318726
- O 0 0.4697797894477844
onset O 1 0.9998979568481445
) O 0 0.00015143044583965093
and O 0 0.00019940546189900488
chronic O 1 0.999984622001648
( O 0 0.00023779440380167216
adult O 0 0.0001984614209504798
- O 0 0.0008478363743051887
onset O 1 0.9199946522712708
) O 0 3.68557266483549e-05
variants O 0 3.283802288933657e-05
are O 0 6.171964287204901e-06
characterized O 0 3.5842971556121483e-05
by O 0 1.2212203728267923e-05
a O 0 4.1613326175138354e-05
broad O 0 9.356736700283363e-05
spectrum O 0 0.0001446998940082267
of O 0 0.00013808635412715375
clinical O 0 0.005805084947496653
manifestations O 1 0.5237507820129395
and O 0 5.920170951867476e-05
are O 0 9.822831998462789e-06
associated O 0 3.453797762631439e-05
with O 0 3.0419352697208524e-05
residual O 0 0.00040787336183711886
levels O 0 0.00011851145973196253
of O 0 0.0001462660584365949
Hex O 0 0.0018071789527311921
A O 0 0.0008627171046100557
enzyme O 0 0.0009384852601215243
activity O 0 0.0008291703416034579
. O 0 0.0005051408079452813

We O 0 0.0005722912610508502
identified O 0 0.0003244540421292186
a O 0 0.00044048784184269607
1422 O 0 0.03649893030524254
G O 0 0.0020458251237869263
- O 0 0.0004114960611332208
- O 0 0.00025677011581137776
> O 0 0.00027249165577813983
C O 0 0.00021921870938967913
( O 0 4.5022905396763235e-05
amino O 0 5.016132490709424e-05
acid O 0 0.00012235564645379782
W474C O 0 0.0006418936536647379
) O 0 1.860335578385275e-05
substitution O 0 4.587222065310925e-05
in O 0 1.3015393051318824e-05
the O 0 2.520644738979172e-05
first O 0 3.207637200830504e-05
position O 0 4.927440750179812e-05
of O 0 6.336313526844606e-05
exon O 0 0.00044361341861076653
13 O 0 0.0001243263395735994
of O 0 0.00014243010082282126
HEXA O 0 0.21096967160701752
of O 0 0.00013799211592413485
a O 0 0.00016866014630068094
non O 0 0.0002576971601229161
- O 0 0.00028348228079266846
Jewish O 0 0.00048612701357342303
proband O 0 0.02609921805560589
who O 0 0.00027322550886310637
manifested O 0 0.0019916659221053123
a O 0 0.0004086398985236883
subacute O 1 0.9987093210220337
variant O 0 0.0010192206827923656
of O 0 0.0008696693694218993
G B-Disease 1 0.7207231521606445
( I-Disease 0 0.0005601152079179883
M2 I-Disease 1 0.5511482954025269
) I-Disease 0 0.00048306037206202745
gangliosidosis I-Disease 0 0.011342678219079971
. O 0 0.001196257071569562

On O 0 0.0009906012564897537
the O 0 0.0006512285326607525
second O 0 0.0012664414243772626
maternally O 0 0.0065193939954042435
inherited O 0 0.48470091819763184
allele O 0 0.00035693132667802274
, O 0 6.381453567883e-05
we O 0 3.4234097256558016e-05
identified O 0 7.084530079737306e-05
the O 0 0.00014226665371097624
common O 0 0.0008002487011253834
infantile O 1 0.9999992847442627
disease O 1 0.9999995231628418
- O 0 0.45590972900390625
causing O 1 0.5987324714660645
4 O 0 0.00027993996627628803
- O 0 0.0001961761008715257
bp O 0 0.0003926347999367863
insertion O 0 0.0003005177713930607
, O 0 8.379491191590205e-05
+ O 0 0.0005122515722177923
TATC O 1 0.7452049255371094
1278 O 0 0.018602434545755386
, O 0 0.00014090620970819145
in O 0 0.0001323026226600632
exon O 0 0.0015757280634716153
11 O 0 0.0009155182633548975
. O 0 0.0007302775047719479

Pulse O 0 0.020841097459197044
- O 0 0.0015893044183030725
chase O 0 0.0009853425435721874
analysis O 0 0.00013987341662868857
using O 0 0.00012241341755725443
proband O 0 0.29384520649909973
fibroblasts O 0 0.003004548605531454
revealed O 0 0.00020620117720682174
that O 0 3.250306690461002e-05
the O 0 8.915179205359891e-05
W474C O 0 0.003506541019305587
- O 0 0.00017222568567376584
containing O 0 0.00012070084630977362
alpha O 0 0.000194641383131966
- O 0 7.320561417145655e-05
subunit O 0 0.00010892650607274845
precursor O 0 0.0003604999801609665
was O 0 0.00013152879546396434
normally O 0 5.4712370911147445e-05
synthesized O 0 0.00012610752310138196
, O 0 2.2302643628790975e-05
but O 0 1.0768616448331159e-05
not O 0 1.0850384569494054e-05
phosphorylated O 0 0.00016960324137471616
or O 0 4.0750652260612696e-05
secreted O 0 9.2403068265412e-05
, O 0 3.1207742722472176e-05
and O 0 2.4652557840454392e-05
the O 0 7.630747859366238e-05
mature O 0 0.00023657141719013453
lysosomal O 0 0.002258062129840255
alpha O 0 0.0003737204533535987
- O 0 9.9483149824664e-05
subunit O 0 0.0001268044870812446
was O 0 0.00019962746591772884
not O 0 9.805618901737034e-05
detected O 0 0.0007277933182194829
. O 0 0.0005420183297246695

When O 0 0.0016503422521054745
the O 0 0.0006693782052025199
W474C O 0 0.009494063444435596
- O 0 0.0005319635383784771
containing O 0 0.00021576850849669427
alpha O 0 0.00031790253706276417
- O 0 0.00013514937018044293
subunit O 0 0.0001645870361244306
was O 0 0.00021781609393656254
transiently O 0 0.0008752815774641931
co O 0 0.00025379436556249857
- O 0 7.86578020779416e-05
expressed O 0 4.845503281103447e-05
with O 0 2.7464515369501896e-05
the O 0 8.422422251896933e-05
beta O 0 0.00010179461969528347
- O 0 6.738803494954482e-05
subunit O 0 4.779071605298668e-05
to O 0 2.549799501139205e-05
produce O 0 5.567019252339378e-05
Hex O 0 0.0002616943384055048
A O 0 0.00016451282135676593
( O 0 9.700350346975029e-05
alphabeta O 0 0.0010113221360370517
) O 0 3.827865293715149e-05
in O 0 4.478050323086791e-05
COS O 0 0.04204535856842995
- O 0 0.00018427941540721804
7 O 0 0.0001595544454175979
cells O 0 7.263769657583907e-05
, O 0 2.0102777853026055e-05
the O 0 3.3579690352780744e-05
mature O 0 5.560837598750368e-05
alpha O 0 0.00010736737021943554
- O 0 4.0983784856507555e-05
subunit O 0 7.070383435348049e-05
was O 0 6.076283898437396e-05
present O 0 2.8128779376856983e-05
, O 0 1.8722977983998135e-05
but O 0 9.004165804071818e-06
its O 0 9.61652312980732e-06
level O 0 2.5357858248753473e-05
was O 0 5.5014250392559916e-05
much O 0 1.942594099091366e-05
lower O 0 3.81090612791013e-05
than O 0 8.440802957920823e-06
that O 0 8.894506208889652e-06
from O 0 1.661928035900928e-05
normal O 0 6.379592377925292e-05
alpha O 0 0.00012276820780243725
- O 0 0.00010335726983612403
subunit O 0 0.0001300174481002614
transfections O 0 0.0008448190637864172
, O 0 2.710572698561009e-05
although O 0 1.4787751752010081e-05
higher O 0 1.8284981706528924e-05
than O 0 7.968803402036428e-06
in O 0 1.2589020116138272e-05
those O 0 1.4925834875612054e-05
cells O 0 6.384404696291313e-05
transfected O 0 0.00034409688669256866
with O 0 2.272937126690522e-05
an O 0 3.7273475754773244e-05
alpha O 0 0.00022556316980626434
- O 0 0.00012447923654690385
subunit O 0 0.00011678752343868837
associated O 0 0.00016874975699465722
with O 0 0.0002970550558529794
infantile O 1 0.9993922710418701
TSD B-Disease 1 0.9998248219490051
. O 0 0.0016156204510480165

Furthermore O 0 0.0016386477509513497
, O 0 0.0002534529485274106
the O 0 0.00016600204980932176
precursor O 0 0.00042840055539272726
level O 0 0.00014203907630871981
of O 0 9.971841791411862e-05
the O 0 0.00010729819041443989
W474C O 0 0.0031667526345700026
alpha O 0 0.00023089826572686434
- O 0 5.1124523452017456e-05
subunit O 0 5.0333106628386304e-05
was O 0 5.578471609624103e-05
found O 0 1.7766824385034852e-05
to O 0 1.4532136447087396e-05
accumulate O 0 3.2761763577582315e-05
in O 0 1.5574789358652197e-05
comparison O 0 3.0543389584636316e-05
to O 0 1.309872095589526e-05
the O 0 6.538496381836012e-05
normal O 0 0.00012627178512047976
alpha O 0 0.00021702772937715054
- O 0 0.00017707304505165666
subunit O 0 0.000361323676770553
precursor O 0 0.0014692681143060327
levels O 0 0.0004600940446835011
. O 0 0.0004541634989436716

We O 0 0.0006791965570300817
conclude O 0 0.0007315343245863914
that O 0 7.911773718660697e-05
the O 0 0.00024247429973911494
1422 O 0 0.10532229393720627
G O 0 0.003300197422504425
- O 0 0.0005780463106930256
- O 0 0.00027863390278071165
> O 0 0.0003664779069367796
C O 0 0.00024070413201116025
mutation O 0 6.715497875120491e-05
is O 0 2.4627132006571628e-05
the O 0 3.6538345739245415e-05
cause O 0 0.00018757370708044618
of O 0 0.0002374735486228019
Hex B-Disease 0 0.34127551317214966
A I-Disease 1 0.7485218644142151
enzyme I-Disease 1 0.9984320998191833
deficiency I-Disease 1 0.99998939037323
in O 0 0.00021536338317673653
the O 0 0.0006890905788168311
proband O 1 0.8954523801803589
. O 0 0.0009087077341973782

The O 0 0.0026988431345671415
resulting O 0 0.0029714659322053194
W474C O 0 0.06956734508275986
substitution O 0 0.0012062420137226582
clearly O 0 0.000454201566753909
interferes O 0 0.00037927788798697293
with O 0 4.69459846499376e-05
alpha O 0 0.00017108391330111772
- O 0 8.008769509615377e-05
subunit O 0 5.5475335102528334e-05
processing O 0 8.071755291894078e-05
, O 0 1.113328107749112e-05
but O 0 9.869302630249877e-06
because O 0 1.0954459867207333e-05
the O 0 2.7491241780808195e-05
base O 0 7.664345321245492e-05
substitution O 0 0.00013855326687917113
falls O 0 0.0002406238199910149
at O 0 6.109955575084314e-05
the O 0 3.172337164869532e-05
first O 0 4.3515294237295166e-05
position O 0 4.3294548959238455e-05
of O 0 7.556553464382887e-05
exon O 0 0.0005379907670430839
13 O 0 0.0001693580998107791
, O 0 8.821706433082e-05
aberrant O 0 0.0007431579870171845
splicing O 0 0.0003235437907278538
may O 0 5.671774488291703e-05
also O 0 2.1768299120594747e-05
contribute O 0 5.412420796346851e-05
to O 0 5.591893568634987e-05
Hex B-Disease 0 0.0037528069224208593
A I-Disease 0 0.164823517203331
deficiency I-Disease 1 0.9999831914901733
in O 0 0.00025733033544383943
this O 0 0.0002593977842479944
proband O 1 0.8005544543266296
. O 0 0.00043432030361145735
. O 0 0.0004482707299757749

Two O 0 0.0010186019353568554
frequent O 0 0.00288069318048656
missense O 0 0.019214075058698654
mutations O 0 0.005134629551321268
in O 0 0.016953062266111374
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
. O 0 0.027707498520612717

Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
is O 1 0.7846787571907043
an O 1 0.9977495074272156
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999974966049194
by O 1 0.9603558778762817
early O 1 0.9998952150344849
childhood O 1 0.9999998807907104
deafness B-Disease 1 1.0
and O 1 0.9999014139175415
goiter B-Disease 1 1.0
. O 0 0.06482142955064774

A O 0 0.00220478349365294
century O 0 0.0009623363730497658
after O 0 0.0003273944603279233
its O 0 8.705448271939531e-05
recognition O 0 0.00012977120059076697
as O 0 0.00012540780880954117
a O 0 0.000864114030264318
syndrome O 1 0.9999969005584717
by O 0 0.00014498551900032908
Vaughan O 1 0.7002279758453369
Pendred O 1 0.9990437626838684
, O 0 0.00023912580218166113
the O 0 0.000781762704718858
disease O 1 0.9999175071716309
gene O 0 0.0004075319448020309
( O 0 0.00016888948448468
PDS O 1 0.9661672711372375
) O 0 7.575369818368927e-05
was O 0 0.00020147926989011467
mapped O 0 0.00030520802829414606
to O 0 0.00016503145161550492
chromosome O 0 0.0013591911410912871
7q22 O 1 0.9119489192962646
- O 0 0.0033947289921343327
q31 O 0 0.41145482659339905
. O 0 0.0008338939514942467

1 O 0 0.0010333743412047625
and O 0 0.000257789040915668
, O 0 0.00010040331835625693
recently O 0 0.00013370018859859556
, O 0 4.252757571521215e-05
found O 0 3.343595744809136e-05
to O 0 3.327078229631297e-05
encode O 0 0.00012491800589486957
a O 0 0.0003075195709243417
putative O 0 0.006651007570326328
sulfate O 1 0.9072750806808472
transporter O 0 0.3435993492603302
. O 0 0.0016243975842371583

We O 0 0.0008080385159701109
performed O 0 0.0005733727593906224
mutation O 0 0.00018690993601921946
analysis O 0 4.567308860714547e-05
of O 0 6.210264837136492e-05
the O 0 0.00012751710892189294
PDS B-Disease 1 0.9979931116104126
gene O 0 0.00010830062092281878
in O 0 5.345507088350132e-05
patients O 0 5.9404286730568856e-05
from O 0 4.154595444560982e-05
14 O 0 0.00014480092795565724
Pendred B-Disease 0 0.002986086765304208
families O 0 4.9443151510786265e-05
originating O 0 5.460026295622811e-05
from O 0 1.8080057998304255e-05
seven O 0 2.303874134668149e-05
countries O 0 1.0723483683250379e-05
and O 0 2.5442470359848812e-05
identified O 0 7.947147241793573e-05
all O 0 0.00011805669055320323
mutations O 0 0.0004928229609504342
. O 0 0.00043178643682040274

The O 0 0.0009082949254661798
mutations O 0 0.00026151028578169644
include O 0 8.605282346252352e-05
three O 0 5.9775757108582184e-05
single O 0 9.045773185789585e-05
base O 0 0.00027686363318935037
deletions O 0 0.0002767920959740877
, O 0 4.3177038605790585e-05
one O 0 4.8163507017306983e-05
splice O 0 0.0005064686411060393
site O 0 0.00022365098993759602
mutation O 0 0.00010764148464659229
and O 0 6.30031936452724e-05
10 O 0 0.00017473383923061192
missense O 0 0.002412219764664769
mutations O 0 0.000788187375292182
. O 0 0.0005400637746788561

One O 0 0.0014823180390521884
missense O 0 0.004671027418226004
mutation O 0 0.001117750070989132
( O 0 0.0003897954011335969
L236P O 0 0.02144700475037098
) O 0 5.494341894518584e-05
was O 0 0.00011496077786432579
found O 0 3.074978303629905e-05
in O 0 1.8669397832127288e-05
a O 0 3.381197893759236e-05
homozygous O 0 7.904806261649355e-05
state O 0 2.441759716020897e-05
in O 0 1.897198671940714e-05
two O 0 2.3762957425788045e-05
consanguineous O 0 0.00034731472260318696
families O 0 3.401031790417619e-05
and O 0 2.037619924522005e-05
in O 0 2.172576387238223e-05
a O 0 3.4942957427119836e-05
heterozygous O 0 3.89106608054135e-05
state O 0 1.4693595403514337e-05
in O 0 1.6647974916850217e-05
five O 0 2.426316677883733e-05
additional O 0 5.589702050201595e-05
non O 0 0.00016293855151161551
- O 0 0.00038595980731770396
consanguineous O 0 0.0028435883577913046
families O 0 0.000401662866352126
. O 0 0.0005360492505133152

Another O 0 0.002286853501573205
missense O 0 0.0044842856004834175
mutation O 0 0.000828971213195473
( O 0 0.00023107751621864736
T416P O 0 0.057509999722242355
) O 0 7.190502947196364e-05
was O 0 0.000110330329334829
found O 0 2.805569783959072e-05
in O 0 1.7970112821785733e-05
a O 0 2.7977570425719023e-05
homozygous O 0 5.5545096984133124e-05
state O 0 9.401618626725394e-06
in O 0 1.1966912097705062e-05
one O 0 1.7887598005472682e-05
family O 0 4.19225289078895e-05
and O 0 1.9226561562390998e-05
in O 0 1.685084862401709e-05
a O 0 3.388202821952291e-05
heterozygous O 0 3.0416133085964248e-05
state O 0 1.7478472727816552e-05
in O 0 3.6155757697997615e-05
four O 0 9.156888700090349e-05
families O 0 0.0002655070857144892
. O 0 0.00040514933061785996

Pendred B-Disease 1 0.9960709810256958
patients O 0 0.0014170928625389934
in O 0 0.0002027329901466146
three O 0 0.00018053043459076434
non O 0 0.0002799370267894119
- O 0 0.0002788015699479729
consanguineous O 0 0.0009122072369791567
families O 0 5.111598875373602e-05
were O 0 2.9065029593766667e-05
shown O 0 3.544010178302415e-05
to O 0 2.2579462893190794e-05
be O 0 4.647364403354004e-05
compound O 0 0.0009399345144629478
heterozygotes O 0 0.000976488518062979
for O 0 0.00016945791139733046
L236P O 0 0.48372456431388855
and O 0 0.0006133113638497889
T416P O 0 0.38305631279945374
. O 0 0.0012737619690597057

In O 0 0.0004719686694443226
total O 0 0.0002504232688806951
, O 0 7.211811316665262e-05
one O 0 3.100280082435347e-05
or O 0 2.0829498680541292e-05
both O 0 1.1402460586396046e-05
of O 0 2.357666198804509e-05
these O 0 1.0522255251999013e-05
mutations O 0 2.275257975270506e-05
were O 0 1.4364233720698394e-05
found O 0 1.2093779332644772e-05
in O 0 1.2484395483625121e-05
nine O 0 2.5488878236501478e-05
of O 0 3.337848465889692e-05
the O 0 6.261267844820395e-05
14 O 0 0.0001369069068459794
families O 0 0.00011734679719666019
analyzed O 0 0.00029048966825939715
. O 0 0.00032914953771978617

The O 0 0.0007190727046690881
identification O 0 0.0002277051971759647
of O 0 0.00015889978385530412
two O 0 8.024172711884603e-05
frequent O 0 0.00042680776095949113
PDS B-Disease 1 0.999535322189331
mutations O 0 0.00013262155698612332
will O 0 3.161049244226888e-05
facilitate O 0 7.08675870555453e-05
the O 0 0.00011099905532319099
molecular O 0 0.0006456781411543489
diagnosis O 1 0.966382622718811
of O 1 0.9960732460021973
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.01186094805598259

Insertional O 1 0.7587335705757141
mutation O 0 0.002071319380775094
by O 0 0.00032318432931788266
transposable O 0 0.011068177409470081
element O 0 0.0010704501764848828
, O 0 0.0001850522094173357
L1 O 0 0.0014708477538079023
, O 0 7.248719339258969e-05
in O 0 5.2282870456110686e-05
the O 0 0.00023277648142538965
DMD B-Disease 1 0.9997718930244446
gene O 0 0.00018782839470077306
results O 0 8.195893315132707e-05
in O 0 0.00018344387353863567
X B-Disease 0 0.19026687741279602
- I-Disease 0 0.06585590541362762
linked I-Disease 0 0.22224459052085876
dilated I-Disease 1 0.9997454285621643
cardiomyopathy I-Disease 1 0.9999996423721313
. O 0 0.006561161484569311

X B-Disease 1 0.9266608953475952
- I-Disease 0 0.3644227981567383
linked I-Disease 1 0.9656098484992981
dilated I-Disease 1 0.999993085861206
cardiomyopathy I-Disease 1 1.0
( O 1 0.9678506255149841
XLDCM B-Disease 1 0.9999895095825195
) O 0 0.00015335138596128672
is O 0 7.15005153324455e-05
a O 0 0.00014311772247310728
clinical O 0 0.00037385636824183166
phenotype O 0 0.0005172379896976054
of O 0 0.00028094317531213164
dystrophinopathy B-Disease 1 0.9965090155601501
which O 0 5.5102253099903464e-05
is O 0 5.016127397539094e-05
characterized O 0 0.00017477398796472698
by O 0 9.147087985184044e-05
preferential O 0 0.0016181237297132611
myocardial B-Disease 1 0.9999980926513672
involvement I-Disease 0 0.00792565755546093
without O 0 9.959496674127877e-05
any O 0 8.893170888768509e-05
overt O 0 0.0014940801775082946
clinical O 0 0.07639351487159729
signs O 1 0.9173323512077332
of O 1 0.9951508045196533
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.011229640804231167

To O 0 0.0005359007627703249
date O 0 0.00041280893492512405
, O 0 8.006005373317748e-05
several O 0 6.141606718301773e-05
mutations O 0 0.00019797608547378331
in O 0 0.0001529229775769636
the O 0 0.03462410718202591
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9970108270645142
, O 0 0.15249867737293243
DMD O 1 0.9999978542327881
, O 0 5.904170757276006e-05
have O 0 1.0163792467210442e-05
been O 0 1.752206480887253e-05
identified O 0 2.7919044441659935e-05
in O 0 3.445399124757387e-05
patients O 0 0.0001247916807187721
with O 0 7.035114686004817e-05
XLDCM B-Disease 1 0.9999271631240845
, O 0 6.851571379229426e-05
but O 0 2.3857935957494192e-05
a O 0 6.766059959772974e-05
pathogenic O 0 0.00013625339488498867
correlation O 0 6.20413848082535e-05
of O 0 0.00010601226676953956
these O 0 5.8012821682495996e-05
cardiospecific O 0 0.2444930225610733
mutations O 0 0.00016801695164758712
in O 0 0.00011357956827851012
DMD O 1 0.9981405735015869
with O 0 9.678350761532784e-05
the O 0 0.0004038170736748725
XLDCM B-Disease 1 0.9999768733978271
phenotype O 0 0.0013721550349146128
has O 0 0.00010578706860542297
remained O 0 0.00020568864420056343
to O 0 7.248194015119225e-05
be O 0 0.0001748336508171633
elucidated O 0 0.003940110560506582
. O 0 0.0007753640529699624

We O 0 0.00044974632328376174
report O 0 0.0001135324637289159
here O 0 5.546676038648002e-05
the O 0 4.799468661076389e-05
identification O 0 5.0369406380923465e-05
of O 0 8.798897761153057e-05
a O 0 0.0001029887207550928
unique O 0 0.0001734597608447075
de O 0 0.0005902309203520417
novo O 0 0.001105896313674748
L1 O 0 0.0018665733514353633
insertion O 0 0.0004094864707440138
in O 0 7.228728645714e-05
the O 0 0.00012219813652336597
muscle O 0 0.002748240018263459
exon O 0 0.000588567228987813
1 O 0 0.00010659127292456105
in O 0 8.133157098200172e-05
DMD O 1 0.9943907856941223
in O 0 9.495780250290409e-05
three O 0 0.00013588815636467189
XLDCM B-Disease 1 0.9996411800384521
patients O 0 0.00020670688536483794
from O 0 7.105076656443998e-05
two O 0 4.193816494080238e-05
unrelated O 0 0.0003161052009090781
Japanese O 0 0.0009110697428695858
families O 0 0.0004153306072112173
. O 0 0.00048176266136579216

The O 0 0.001271826564334333
insertion O 0 0.001927301287651062
was O 0 0.00043479373562149704
a O 0 0.00013201743422541767
5 O 0 0.00013494373706635088
- O 0 0.0001467750407755375
truncated O 0 0.00027318199863657355
form O 0 4.589970194501802e-05
of O 0 0.0001078570494428277
human O 0 0.0001226372696692124
L1 O 0 0.001256447983905673
inversely O 0 0.00030718816560693085
integrated O 0 0.00015030460781417787
in O 0 2.234633211628534e-05
the O 0 3.897776696248911e-05
5 O 0 6.886898336233571e-05
- O 0 0.00010178685624850914
untranslated O 0 0.00028142891824245453
region O 0 6.389588816091418e-05
in O 0 3.189187191310339e-05
the O 0 0.00011492285557324067
muscle O 0 0.01732710190117359
exon O 0 0.0005508271278813481
1 O 0 6.110684626037255e-05
, O 0 2.576683255028911e-05
which O 0 1.3450776350509841e-05
affected O 0 2.1962265236652456e-05
the O 0 3.0429073376581073e-05
transcription O 0 7.280752470251173e-05
or O 0 1.9548877389752306e-05
the O 0 4.053979500895366e-05
stability O 0 0.00010849661339307204
of O 0 9.494667028775439e-05
the O 0 0.0002719245385378599
muscle O 0 0.11049576103687286
form O 0 8.75852201716043e-05
of O 0 0.00013758914428763092
dystrophin O 0 0.052668824791908264
transcripts O 0 0.00012649231939576566
but O 0 1.4332145838125143e-05
not O 0 6.11501673120074e-06
that O 0 7.561065103800502e-06
of O 0 3.224248212063685e-05
the O 0 0.00019233216880820692
brain O 1 0.9941883087158203
or O 0 0.0004779155715368688
Purkinje O 1 0.9999737739562988
cell O 0 0.0013241777196526527
form O 0 5.429884186014533e-05
, O 0 3.29229369526729e-05
probably O 0 9.160356421489269e-05
due O 0 3.8934635085752234e-05
to O 0 1.742156018735841e-05
its O 0 2.2666450604447164e-05
unique O 0 8.907659503165632e-05
site O 0 0.0002931564231403172
of O 0 0.00028561893850564957
integration O 0 0.0013865622458979487
. O 0 0.000920620106626302

We O 0 0.0005497807287611067
speculate O 0 0.0003562067577149719
that O 0 4.734639514936134e-05
this O 0 2.9574657673947513e-05
insertion O 0 0.00014760464546270669
of O 0 6.081942774471827e-05
an O 0 5.9363334003137425e-05
L1 O 0 0.0013161164242774248
sequence O 0 0.0001330038794549182
in O 0 0.0001212967763422057
DMD O 1 0.9979745745658875
is O 0 4.627905218512751e-05
responsible O 0 2.9693323085666634e-05
for O 0 9.213104931404814e-06
some O 0 6.534888143505668e-06
of O 0 2.0196897821733728e-05
the O 0 2.4265456886496395e-05
population O 0 2.085893902403768e-05
of O 0 6.838692934252322e-05
Japanese O 0 0.0011941025732085109
patients O 0 0.0004946981789544225
with O 0 0.00015151867410168052
XLDCM B-Disease 1 0.9999372959136963
. O 0 0.00032101114629767835
. O 0 0.00045929430052638054

Severe O 1 0.9992454051971436
early O 1 0.6912081241607666
- O 1 0.9997125267982483
onset O 1 0.9999998807907104
obesity B-Disease 1 1.0
, O 1 0.9998354911804199
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9942744374275208
red O 1 0.9999936819076538
hair O 1 0.9999785423278809
pigmentation O 1 0.999994158744812
caused O 1 0.999790370464325
by O 0 0.0009233838063664734
POMC O 1 0.9999747276306152
mutations O 0 0.0005131541984155774
in O 0 0.0001894979359349236
humans O 0 0.0006832359940744936
. O 0 0.0005246383952908218

Sequential O 0 0.0064780935645103455
cleavage O 0 0.004058421589434147
of O 0 0.0004589236341416836
the O 0 0.0002609665389172733
precursor O 0 0.0007972505409270525
protein O 0 0.0002630611998029053
pre O 0 0.0008628313080407679
- O 0 0.00039072809158824384
pro O 0 0.0007878975011408329
- O 0 0.0004743631579913199
opiomelanocortin O 0 0.024508947506546974
( O 0 0.00027996368589811027
POMC O 0 0.05196131020784378
) O 0 0.00013747035700362176
generates O 0 0.0003737791848834604
the O 0 0.0003016976115759462
melanocortin O 0 0.01602354645729065
peptides O 0 0.002235611667856574
adrenocorticotrophin O 0 0.438183456659317
( O 0 0.0007258197292685509
ACTH O 0 0.3931025266647339
) O 0 0.0001723449386190623
, O 0 0.0002565405739005655
melanocyte O 0 0.4323924481868744
- O 0 0.0015742538962513208
stimulating O 0 0.00692436657845974
hormones O 0 0.002324104541912675
( O 0 0.00019153956964146346
MSH O 0 0.09360677748918533
) O 0 7.43167256587185e-05
alpha O 0 0.0001664613955654204
, O 0 4.381009057397023e-05
beta O 0 8.296711894217879e-05
and O 0 2.292035787831992e-05
gamma O 0 7.278614066308364e-05
as O 0 1.6963926100288518e-05
well O 0 1.40771671794937e-05
as O 0 2.496056549716741e-05
the O 0 5.120038986206055e-05
opioid O 0 0.0008023660629987717
- O 0 0.00035665323957800865
receptor O 0 0.0004259570559952408
ligand O 0 0.0011636839481070638
beta O 0 0.0015044979518279433
- O 0 0.0011719263857230544
endorphin O 0 0.01589081436395645
. O 0 0.0008246891666203737

While O 0 0.000514096871484071
a O 0 0.0002657385775819421
few O 0 0.0001456402096664533
cases O 0 0.00011933872883673757
of O 0 0.000902024912647903
isolated O 1 0.999854326248169
ACTH B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999927282333374
have O 0 6.403673614840955e-05
been O 0 0.00010513140296097845
reported O 0 0.00021111420937813818
( O 0 0.00021908601047471166
OMIM O 1 0.9891534447669983
201400 O 0 0.28788164258003235
) O 0 6.385775486705825e-05
, O 0 4.9041937018046156e-05
an O 0 0.00019473215797916055
inherited O 1 0.9999778270721436
POMC O 1 0.9999997615814209
defect O 1 0.9999544620513916
has O 0 0.00010492239380255342
not O 0 2.5839572117547505e-05
been O 0 5.8897749113384634e-05
described O 0 0.0001054718013620004
so O 0 7.17102739145048e-05
far O 0 0.0002260600886074826
. O 0 0.00039401440881192684

Recent O 0 0.0009116520523093641
studies O 0 0.00023820919159334153
in O 0 0.0002095827367156744
animal O 0 0.0003938244190067053
models O 0 0.00016200702521018684
elucidated O 0 0.0005464481073431671
a O 0 9.739269444253296e-05
central O 0 7.917419861769304e-05
role O 0 7.633950735908002e-05
of O 0 0.0001124938135035336
alpha O 0 0.0005982734728604555
- O 0 0.00034769895137287676
MSH O 0 0.005452632438391447
in O 0 4.873651050729677e-05
the O 0 4.559397712000646e-05
regulation O 0 6.475707050412893e-05
of O 0 4.795845234184526e-05
food O 0 8.076150697888806e-05
intake O 0 7.957505295053124e-05
by O 0 1.3310552276379894e-05
activation O 0 5.372935993364081e-05
of O 0 5.762450018664822e-05
the O 0 0.00016309322381857783
brain O 0 0.02383868396282196
melanocortin O 0 0.04921170324087143
- O 0 0.00015247553528752178
4 O 0 8.602943125879392e-05
- O 0 0.00014740631741005927
receptor O 0 0.00019754766253754497
( O 0 0.00014016969362273812
MC4 O 0 0.00715918093919754
- O 0 0.0002990313514601439
R O 0 0.00037454310222528875
; O 0 4.526186967268586e-05
refs O 0 0.000285796559182927
3 O 0 6.347017915686592e-05
- O 0 5.112438157084398e-05
5 O 0 3.327487502247095e-05
) O 0 1.2463910024962388e-05
and O 0 1.3558506907429546e-05
the O 0 3.716614446602762e-05
linkage O 0 0.0002540786226745695
of O 0 0.00013807043433189392
human O 0 0.0002939218538813293
obesity B-Disease 1 0.6202694773674011
to O 0 2.8024596758768894e-05
chromosome O 0 7.308835483854637e-05
2 O 0 3.392958387848921e-05
in O 0 1.537731986900326e-05
close O 0 4.962828097632155e-05
proximity O 0 0.00010690550698200241
to O 0 3.60288868250791e-05
the O 0 0.00015827524475753307
POMC O 1 0.9935290217399597
locus O 0 0.000673463218845427
, O 0 5.320267882780172e-05
led O 0 7.671430648770183e-05
to O 0 1.7396590919815935e-05
the O 0 2.333815245947335e-05
proposal O 0 2.9887070922995917e-05
of O 0 3.3560700103407726e-05
an O 0 3.27721681969706e-05
association O 0 0.0001532680616946891
of O 0 0.000680467754136771
POMC O 1 0.9999750852584839
with O 0 0.0007167468429543078
human O 0 0.041357655078172684
obesity B-Disease 1 0.999875545501709
. O 0 0.0008469618041999638

The O 0 0.0009658686467446387
dual O 0 0.0009612074354663491
role O 0 0.0005849542212672532
of O 0 0.000765662407502532
alpha O 0 0.0035233127418905497
- O 0 0.0015661101788282394
MSH O 0 0.1595156043767929
in O 0 0.00017818888591136783
regulating O 0 0.00034268898889422417
food O 0 0.00028401249437592924
intake O 0 0.000497241213452071
and O 0 0.00011082062701461837
influencing O 0 0.0010223755380138755
hair O 1 0.6317479014396667
pigmentation O 1 0.9791434407234192
predicts O 0 0.000493513944093138
that O 0 5.365983088267967e-05
the O 0 0.00012455202522687614
phenotype O 0 0.00024421929265372455
associated O 0 3.790616392507218e-05
with O 0 2.3944416170706972e-05
a O 0 0.00022296309180092067
defect O 1 0.9917359948158264
in O 0 0.00023581496498081833
POMC O 1 0.9995506405830383
function O 0 0.00016801246965769678
would O 0 7.64800570323132e-05
include O 0 0.0001247722830157727
obesity B-Disease 1 0.9975225329399109
, O 0 0.00017514399951323867
alteration O 1 0.8026432991027832
in O 0 0.005275517702102661
pigmentation O 1 0.9999938011169434
and O 1 0.9891487956047058
ACTH B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999996423721313
. O 0 0.00236522126942873

The O 0 0.0011810862924903631
observation O 0 0.0015208219410851598
of O 0 0.0004312114033382386
these O 0 0.00014253740664571524
symptoms O 0 0.004964652005583048
in O 0 8.828169666230679e-05
two O 0 6.766021397197619e-05
probands O 0 0.0654984787106514
prompted O 0 0.00024881988065317273
us O 0 4.163321136729792e-05
to O 0 1.7851249140221626e-05
search O 0 4.188280945527367e-05
for O 0 2.540324021538254e-05
mutations O 0 7.320848089875653e-05
within O 0 9.140983456745744e-05
their O 0 0.00015344018174801022
POMC O 1 0.9884148836135864
genes O 0 0.0007094222819432616
. O 0 0.0007258632685989141

Patient O 0 0.005157812032848597
1 O 0 0.00040647757123224437
was O 0 0.00033035737578757107
found O 0 4.58459799119737e-05
to O 0 2.3789685656083748e-05
be O 0 1.7663314793026075e-05
a O 0 5.469260213430971e-05
compound O 0 0.00037770200287923217
heterozygote O 0 0.0004949698923155665
for O 0 2.3522359697381034e-05
two O 0 2.020429565163795e-05
mutations O 0 3.6443627323023975e-05
in O 0 3.3678621548460796e-05
exon O 0 0.0004369410453364253
3 O 0 0.00010578909132163972
( O 0 0.0001264900347450748
G7013T O 0 0.0039034809451550245
, O 0 0.00013757891429122537
C7133delta O 0 0.0059464056976139545
) O 0 5.686055374098942e-05
which O 0 3.1649786251364276e-05
interfere O 0 9.417444380233064e-05
with O 0 4.02405894419644e-05
appropriate O 0 9.138325549429283e-05
synthesis O 0 0.0003490014642011374
of O 0 0.0004794496053364128
ACTH O 1 0.9585688710212708
and O 0 0.00047040023491717875
alpha O 0 0.003178409533575177
- O 0 0.0026938600931316614
MSH O 1 0.7236993312835693
. O 0 0.0013381462777033448

Patient O 0 0.0039568012580275536
2 O 0 0.0007069534040056169
was O 0 0.00045973341912031174
homozygous O 0 0.0002460563846398145
for O 0 2.8544578526634723e-05
a O 0 4.9632773880148306e-05
mutation O 0 7.382582407444715e-05
in O 0 3.7126719689695165e-05
exon O 0 0.0003016360860783607
2 O 0 0.00011259609891567379
( O 0 0.00011863152758451179
C3804A O 0 0.0024361310061067343
) O 0 0.00011843699758173898
which O 0 0.00018363793788012117
abolishes O 0 0.007017969619482756
POMC O 1 0.9679974913597107
translation O 0 0.0018625488737598062
. O 0 0.00133613555226475

These O 0 0.00019967790285591036
findings O 0 0.00015697546768933535
represent O 0 7.165327406255528e-05
the O 0 6.59953584545292e-05
first O 0 7.083753007464111e-05
examples O 0 6.70483786961995e-05
of O 0 9.416205284651369e-05
a O 0 0.00027148600202053785
genetic B-Disease 0 0.4847450256347656
defect I-Disease 1 0.9998188614845276
within O 0 0.00021517989807762206
the O 0 0.0005011138273403049
POMC O 1 0.9990170001983643
gene O 0 9.291333117289469e-05
and O 0 2.697894706216175e-05
define O 0 7.078303315211087e-05
a O 0 0.00011929753236472607
new O 0 0.00035840721102431417
monogenic B-Disease 1 0.9999970197677612
endocrine I-Disease 1 0.999998927116394
disorder I-Disease 1 0.999995231628418
resulting O 0 0.006258687935769558
in O 0 0.00014056265354156494
early O 0 0.006572584621608257
- O 1 0.8736822605133057
onset O 1 0.999998927116394
obesity B-Disease 1 0.9999998807907104
, O 1 0.9957558512687683
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9832242727279663
red O 1 0.9999758005142212
hair O 1 0.9999254941940308
pigmentation O 1 0.9998262524604797
. O 0 0.0005684770294465125
. O 0 0.00045753829181194305

A O 0 0.0025879889726638794
European O 0 0.0008641737513244152
multicenter O 0 0.0038150972686707973
study O 0 0.0004573248734232038
of O 0 0.0015643329825252295
phenylalanine B-Disease 1 0.9999427795410156
hydroxylase I-Disease 1 0.9999790191650391
deficiency I-Disease 1 0.9999992847442627
: O 0 0.00010019136243499815
classification O 0 0.00012641295325011015
of O 0 9.715996566228569e-05
105 O 0 0.0002787318953778595
mutations O 0 7.706214091740549e-05
and O 0 2.139253592758905e-05
a O 0 3.2550462492508814e-05
general O 0 6.505595229100436e-05
system O 0 5.6700442655710503e-05
for O 0 3.30787843267899e-05
genotype O 0 0.0002459287643432617
- O 0 0.00013176842185202986
based O 0 6.940015737200156e-05
prediction O 0 0.0004230160848237574
of O 0 0.0008732569986023009
metabolic O 1 0.9990837574005127
phenotype O 0 0.05185576155781746
. O 0 0.00105329230427742

Phenylketonuria B-Disease 1 0.9999208450317383
( O 0 0.028168935328722
PKU B-Disease 1 0.999674916267395
) O 0 0.0003675210173241794
and O 0 0.0003524078638292849
mild B-Disease 1 0.9519580602645874
hyperphenylalaninemia I-Disease 1 0.9999988079071045
( O 0 0.36344942450523376
MHP B-Disease 1 0.9999992847442627
) O 0 0.0001307649363297969
are O 0 6.43375824438408e-05
allelic B-Disease 1 0.9969080090522766
disorders I-Disease 1 0.9999955892562866
caused O 1 0.9932168126106262
by O 0 0.0001058105772244744
mutations O 0 7.218134123831987e-05
in O 0 3.223107341909781e-05
the O 0 0.00011039210221497342
gene O 0 0.000156455731485039
encoding O 0 0.00029356000595726073
phenylalanine O 0 0.004868419375270605
hydroxylase O 0 0.4492459297180176
( O 0 0.0017252546967938542
PAH O 1 0.9999681711196899
) O 0 0.0006431845831684768
. O 0 0.0005416831700131297

Previous O 0 0.001309755491092801
studies O 0 0.00019881482876371592
have O 0 5.18146189278923e-05
suggested O 0 9.677962952991948e-05
that O 0 3.242276216042228e-05
the O 0 0.00010662806016625836
highly O 0 0.00030216711456887424
variable O 0 0.00035760586615651846
metabolic O 1 0.9911231994628906
phenotypes O 1 0.9478257894515991
of O 1 0.9998492002487183
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9814333319664001
with O 1 0.61988365650177
PAH O 1 0.9999998807907104
genotypes O 1 0.8547385334968567
. O 0 0.0018562873592600226

We O 0 0.0007214293582364917
identified O 0 0.00042345968540757895
both O 0 0.00017947815649677068
causative O 0 0.0030044084414839745
mutations O 0 0.0003671162121463567
in O 0 0.0001960259396582842
686 O 1 0.6148340702056885
patients O 0 0.00045239043538458645
from O 0 0.00012258233618922532
seven O 0 0.0002490114129614085
European O 0 0.00023586602765135467
centers O 0 0.000567656650673598
. O 0 0.0005230241222307086

On O 0 0.0003840763820335269
the O 0 0.00021099891455378383
basis O 0 6.534164276672527e-05
of O 0 9.291386959375814e-05
the O 0 7.717568951193243e-05
phenotypic O 0 0.00027150646201334894
characteristics O 0 0.00015669925778638572
of O 0 0.00024095532717183232
297 O 0 0.018730051815509796
functionally O 0 0.01786898635327816
hemizygous O 1 0.9071974158287048
patients O 0 0.00014509214088320732
, O 0 2.3376691387966275e-05
105 O 0 6.820392445661128e-05
of O 0 3.607815597206354e-05
the O 0 3.0694238375872374e-05
mutations O 0 2.8948046747245826e-05
were O 0 1.4654803635494318e-05
assigned O 0 3.553022179403342e-05
to O 0 7.528779406129615e-06
one O 0 1.9969997083535418e-05
of O 0 4.368139707366936e-05
four O 0 7.848652603570372e-05
arbitrary O 0 0.0003241232770960778
phenotype O 0 0.0012522228062152863
categories O 0 0.0005478642997331917
. O 0 0.0006790338084101677

We O 0 0.0005946065066382289
proposed O 0 0.0002657788572832942
and O 0 0.0001250074856216088
tested O 0 0.00019094694289378822
a O 0 0.00011891489702975377
simple O 0 8.85022891452536e-05
model O 0 5.8499925216892734e-05
for O 0 3.362365168868564e-05
correlation O 0 0.00012178818724351004
between O 0 9.818999387789518e-05
genotype O 0 0.0005757281905971467
and O 0 0.00016336713451892138
phenotypic O 0 0.0011601378209888935
outcome O 0 0.0009471410303376615
. O 0 0.0007826809887774289

The O 0 0.0017722329357638955
observed O 0 0.0009272837778553367
phenotype O 0 0.001043923432007432
matched O 0 0.00023564079310745
the O 0 0.00010196989023825154
predicted O 0 0.00015283406537491828
phenotype O 0 8.113528019748628e-05
in O 0 1.7717213268042542e-05
79 O 0 5.7739740441320464e-05
% O 0 9.526366739009973e-06
of O 0 1.8598337192088366e-05
the O 0 2.787628909572959e-05
cases O 0 2.2708640244673006e-05
, O 0 1.6025043805711903e-05
and O 0 9.945209058059845e-06
in O 0 1.01150371847325e-05
only O 0 6.321311047940981e-06
5 O 0 1.5766239812364802e-05
of O 0 4.447781975613907e-05
184 O 0 0.00018558106967248023
patients O 0 9.475465049035847e-05
was O 0 7.134141924325377e-05
the O 0 4.1227573092328385e-05
observed O 0 6.43410166958347e-05
phenotype O 0 7.488420669687912e-05
more O 0 6.8585409280785825e-06
than O 0 1.057674307958223e-05
one O 0 1.5517312931478955e-05
category O 0 2.8399017537594773e-05
away O 0 4.9436410336056724e-05
from O 0 2.9669290597666986e-05
that O 0 3.2070103770820424e-05
expected O 0 0.0001947754353750497
. O 0 0.0002651587419677526

Among O 0 0.0005194217665120959
the O 0 0.0002104004379361868
seven O 0 0.00020438857609406114
contributing O 0 0.00030616921139881015
centers O 0 0.00018230486602988094
, O 0 3.491370807751082e-05
the O 0 4.323311077314429e-05
proportion O 0 5.714458166039549e-05
of O 0 7.132638711482286e-05
patients O 0 6.804618169553578e-05
for O 0 2.153894274670165e-05
whom O 0 5.686240183422342e-05
the O 0 5.001415775041096e-05
observed O 0 9.519887680653483e-05
phenotype O 0 0.00012521685857791454
did O 0 1.9751070794882253e-05
not O 0 8.807498488749843e-06
match O 0 2.4533674150006846e-05
the O 0 2.743245022429619e-05
predicted O 0 5.251291804597713e-05
phenotype O 0 5.600399526883848e-05
was O 0 3.183104490744881e-05
4 O 0 2.088826113322284e-05
% O 0 1.1061199984396808e-05
- O 0 1.9976721887360327e-05
23 O 0 3.364418080309406e-05
% O 0 2.0593195586116053e-05
( O 0 3.7750105548184365e-05
P O 0 0.00034258823143318295
< O 0 0.00027265428798273206
. O 0 5.121879803482443e-05
0001 O 0 0.0006317565566860139
) O 0 3.209332498954609e-05
, O 0 2.2336358597385697e-05
suggesting O 0 4.635731966118328e-05
that O 0 1.1053101843572222e-05
differences O 0 1.9004979549208656e-05
in O 0 1.2891491678601597e-05
methods O 0 1.694715683697723e-05
used O 0 1.9674953364301473e-05
for O 0 1.9468507161946036e-05
mutation O 0 9.090228559216484e-05
detection O 0 0.0002393792092334479
or O 0 7.429108518408611e-05
phenotype O 0 0.00033703280496411026
classification O 0 9.60712568485178e-05
may O 0 3.138700776617043e-05
account O 0 1.972374229808338e-05
for O 0 1.0319819921278395e-05
a O 0 3.503798507153988e-05
considerable O 0 0.00017583776207175106
proportion O 0 0.00018505167099647224
of O 0 0.00029926319257356226
genotype O 0 0.007905085571110249
- O 0 0.0023220486473292112
phenotype O 0 0.0023333504796028137
inconsistencies O 0 0.0037695227656513453
. O 0 0.0013032190036028624

Our O 0 0.0008556462125852704
data O 0 0.00018525293853599578
indicate O 0 0.00013116856280248612
that O 0 7.526880654040724e-05
the O 0 0.00048268752289004624
PAH O 1 0.9999986886978149
- O 0 0.001259958720766008
mutation O 0 0.00024794272030703723
genotype O 0 0.0002456484944559634
is O 0 3.162731445627287e-05
the O 0 6.285041308728978e-05
main O 0 0.0001786264037946239
determinant O 0 0.0008575700921937823
of O 0 0.0004833588027395308
metabolic O 1 0.9971256852149963
phenotype O 0 0.0010638878447934985
in O 0 0.00012886842887382954
most O 0 0.00022897864982951432
patients O 1 0.8736215233802795
with O 1 0.998211145401001
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.004260627087205648

In O 0 0.00046950075193308294
the O 0 0.0001787049404811114
present O 0 0.00015380508557427675
study O 0 6.327962182695046e-05
, O 0 3.434223253862001e-05
the O 0 6.089614544180222e-05
classification O 0 0.00016518982010893524
of O 0 0.00023642393352929503
105 O 1 0.5135776996612549
PAH O 1 0.9999994039535522
mutations O 0 0.00016238779062405229
may O 0 3.191459836671129e-05
allow O 0 1.3250469237391371e-05
the O 0 2.378485442022793e-05
prediction O 0 9.538498852634802e-05
of O 0 4.362823165138252e-05
the O 0 9.29171364987269e-05
biochemical O 0 0.0006394920637831092
phenotype O 0 0.00026346981758251786
in O 0 4.4568172597792e-05
> O 0 0.0001156328507931903
10 O 0 2.7145715648657642e-05
, O 0 3.573549838620238e-05
000 O 0 0.00012397875252645463
genotypes O 0 0.00020737765589728951
, O 0 3.610603744164109e-05
which O 0 1.6080339264590293e-05
may O 0 1.743934626574628e-05
be O 0 9.437775588594377e-06
useful O 0 1.918375892273616e-05
for O 0 1.2249363862792961e-05
the O 0 2.733913788688369e-05
management O 0 0.00010882361675612628
of O 0 0.00028702945564873517
hyperphenylalaninemia B-Disease 1 0.999984622001648
in O 0 0.0007776523707434535
newborns O 0 0.017176073044538498
. O 0 0.00044541238457895815

Somatic O 0 0.019741885364055634
instability O 0 0.008149146102368832
of O 0 0.0008738800534047186
the O 0 0.0011919558746740222
CTG O 1 0.9958202838897705
repeat O 0 0.0018480707658454776
in O 0 0.00026869538123719394
mice O 0 0.00041206838795915246
transgenic O 0 0.0005108346231281757
for O 0 0.0001051100407494232
the O 0 0.0010938923805952072
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 0.9999998807907104
region O 0 0.0014483698178082705
is O 0 0.0001380131725454703
age O 0 0.00013727476471103728
dependent O 0 4.3656407797243446e-05
but O 0 1.9504035662976094e-05
not O 0 1.0751726222224534e-05
correlated O 0 3.285023558419198e-05
to O 0 1.525825064163655e-05
the O 0 6.809545448049903e-05
relative O 0 0.0002855552302207798
intertissue O 1 0.5852201581001282
transcription O 0 0.001836920971982181
levels O 0 0.0009015657124109566
and O 0 0.0003824171144515276
proliferative O 1 0.9981865286827087
capacities O 0 0.008069545961916447
. O 0 0.001532401074655354

A O 0 0.005427267402410507
( O 0 0.0014076116494834423
CTG O 0 0.08242155611515045
) O 0 0.0002850775490514934
nexpansion O 0 0.0014241364551708102
in O 0 7.693599036429077e-05
the O 0 0.00010316721454728395
3 O 0 0.00015460731810890138
- O 0 0.00016886756930034608
untranslated O 0 0.000602060288656503
region O 0 0.0001399976317770779
( O 0 6.745772407157347e-05
UTR O 0 0.000617016339674592
) O 0 2.478735586919356e-05
of O 0 6.281434616539627e-05
the O 0 0.00014901514805387706
DM O 1 0.9995949864387512
protein O 0 0.0002289000403834507
kinase O 0 0.00022261215781327337
gene O 0 0.00016753558884374797
( O 0 9.69772445387207e-05
DMPK O 0 0.15365083515644073
) O 0 5.376933768275194e-05
is O 0 6.677794590359554e-05
responsible O 0 0.00015865269233472645
for O 0 0.000286847265670076
causing O 1 0.999984622001648
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9996689558029175
DM B-Disease 1 0.9999997615814209
) O 0 0.0011632783571258187
. O 0 0.000999755458906293

Major O 0 0.026752222329378128
instability O 0 0.3559289574623108
, O 0 0.0002452211920171976
with O 0 8.600392902735621e-05
very O 0 5.98911865381524e-05
large O 0 8.06231691967696e-05
expansions O 0 0.0002452228218317032
between O 0 6.665720138698816e-05
generations O 0 0.00011689816165016964
and O 0 3.3729083952493966e-05
high O 0 9.02685133041814e-05
levels O 0 7.282780279638246e-05
of O 0 8.9097666204907e-05
somatic O 0 0.004362758714705706
mosaicism O 1 0.7720390558242798
, O 0 7.970370643306524e-05
is O 0 3.869621650665067e-05
observed O 0 0.00010287133045494556
in O 0 0.00012377803795970976
patients O 0 0.0005209865630604327
. O 0 0.0003480594605207443

There O 0 0.0006225703982636333
is O 0 0.0001843289501266554
a O 0 0.00013821822358295321
good O 0 9.557964222040027e-05
correlation O 0 8.428215369349346e-05
between O 0 7.745378388790414e-05
repeat O 0 0.0001467393449274823
size O 0 6.18590711383149e-05
( O 0 2.892522570618894e-05
at O 0 5.400763257057406e-05
least O 0 2.2244377760216594e-05
in O 0 4.0216156776295975e-05
leucocytes O 0 0.002246050164103508
) O 0 3.82276157324668e-05
, O 0 3.404113886062987e-05
clinical O 0 0.00017778902838472277
severity O 0 0.0005635133711621165
and O 0 8.166652696672827e-05
age O 0 0.0004636330413632095
of O 0 0.004151953384280205
onset O 1 0.999977707862854
. O 0 0.002044289605692029

The O 0 0.004237854853272438
trinucleotide O 1 0.9922985434532166
repeat O 0 0.010501113720238209
instability O 0 0.13917222619056702
mechanisms O 0 0.0006890255608595908
involved O 0 0.0003687163407448679
in O 0 0.0004594153433572501
DM B-Disease 1 0.9999988079071045
and O 0 0.0002709429827518761
other O 0 0.0001292829547310248
human O 0 0.2960970103740692
genetic B-Disease 1 0.9998786449432373
diseases I-Disease 1 0.9999973773956299
are O 0 0.0001360749884042889
unknown O 0 0.0014407841954380274
. O 0 0.0007260064594447613

We O 0 0.0007961220107972622
studied O 0 0.0007448390242643654
somatic O 0 0.0014015575870871544
instability O 0 0.0009592554997652769
by O 0 0.00010861639020731673
measuring O 0 0.000581165892072022
the O 0 0.00026042270474135876
CTG O 1 0.5570608377456665
repeat O 0 0.00041701627196744084
length O 0 6.912169919814914e-05
at O 0 7.202313281595707e-05
several O 0 1.972359314095229e-05
ages O 0 5.8542504120850936e-05
in O 0 2.6845542379305698e-05
various O 0 3.97291878471151e-05
tissues O 0 0.00026271131355315447
of O 0 0.0001693256344879046
transgenic O 0 0.001142418012022972
mice O 0 0.00019281197455711663
carrying O 0 0.00015035163960419595
a O 0 0.00011177995475009084
( O 0 0.00014382871449925005
CTG O 0 0.007099392358213663
) O 0 0.00010981780360452831
55expansion O 0 0.0012189060216769576
surrounded O 0 0.000556234095711261
by O 0 4.370359602035023e-05
45 O 0 0.00010634791397023946
kb O 0 0.0002896832302212715
of O 0 8.345807145815343e-05
the O 0 0.00018060534785035998
human O 0 0.0005147011834196746
DM B-Disease 1 0.9999744892120361
region O 0 0.00023384735686704516
, O 0 5.982947186566889e-05
using O 0 6.068495713407174e-05
small O 0 0.00014971487689763308
- O 0 0.0005880740936845541
pool O 0 0.0017947135493159294
PCR O 0 0.002599649364128709
. O 0 0.0006142326747067273

These O 0 0.0008252307889051735
mice O 0 0.0009152604616247118
have O 0 7.384968921542168e-05
been O 0 6.101647159084678e-05
shown O 0 7.571542664663866e-05
to O 0 4.4401331251719967e-05
reproduce O 0 0.0001549588778289035
the O 0 0.00010583903349470347
intergenerational O 0 0.0010501460637897253
and O 0 0.00013077966286800802
somatic O 0 0.000639666395727545
instability O 0 0.0004625001747626811
of O 0 8.529434126103297e-05
the O 0 0.0001356580905849114
55 O 0 0.0004911316791549325
CTG O 0 0.42751672863960266
repeat O 0 0.00036195683060213923
suggesting O 0 0.00011260435712756589
that O 0 2.3484166376874782e-05
surrounding O 0 0.00016541047079954296
sequences O 0 4.951572555000894e-05
and O 0 2.5320210625068285e-05
the O 0 6.635928730247542e-05
chromatin O 0 0.00038264994509518147
environment O 0 0.00010100330109708011
are O 0 1.2803887329937425e-05
involved O 0 9.017507545650005e-05
in O 0 0.00017179713177029043
instability O 0 0.08642492443323135
mechanisms O 0 0.005336083937436342
. O 0 0.0012969706440344453

As O 0 0.0004878585459664464
observed O 0 0.0001613407366676256
in O 0 4.552423706627451e-05
some O 0 2.2521397113450803e-05
of O 0 6.220881186891347e-05
the O 0 0.0001342541363555938
tissues O 0 0.07946039736270905
of O 0 0.45915383100509644
DM B-Disease 1 1.0
patients O 0 0.02612130157649517
, O 0 4.8108377086464316e-05
there O 0 2.5589488359401003e-05
is O 0 3.522395854815841e-05
a O 0 5.560164572671056e-05
tendency O 0 0.00010934789315797389
for O 0 3.272984395152889e-05
repeat O 0 0.00018825189908966422
length O 0 9.359735122416168e-05
and O 0 7.069156708894297e-05
somatic O 0 0.0005505318404175341
mosaicism O 0 0.002118452684953809
to O 0 3.220523285563104e-05
increase O 0 2.6046103812404908e-05
with O 0 1.5646442989236675e-05
the O 0 5.181767846806906e-05
age O 0 8.63634777488187e-05
of O 0 0.00016225034778472036
the O 0 0.0006163174984976649
mouse O 0 0.0016838241135701537
. O 0 0.0005209594964981079

Furthermore O 0 0.001969092758372426
, O 0 0.0002460413670632988
we O 0 8.18445987533778e-05
observed O 0 6.746847066096961e-05
no O 0 3.989905599155463e-05
correlation O 0 4.387460649013519e-05
between O 0 3.159108018735424e-05
the O 0 8.114022784866393e-05
somatic O 0 0.0007779807201586664
mutation O 0 0.00021814803767483681
rate O 0 0.00012331741163507104
and O 0 0.0001414122962160036
tissue O 0 0.4788707494735718
proliferation O 0 0.0347391813993454
capacity O 0 0.0015325067797675729
. O 0 0.0005599537398666143

The O 0 0.0021197048481553793
somatic O 0 0.0037916498258709908
mutation O 0 0.0005589331267401576
rates O 0 0.00011064050340792164
in O 0 2.8801745429518633e-05
different O 0 3.424275200814009e-05
tissues O 0 0.00016776226402726024
were O 0 2.8611648303922266e-05
also O 0 2.2837619326310232e-05
not O 0 8.713161150808446e-06
correlated O 0 3.892505628755316e-05
to O 0 1.6168603906407952e-05
the O 0 3.381465285201557e-05
relative O 0 0.0001603203418198973
inter O 0 0.000737537513487041
- O 0 0.00037996695027686656
tissue O 0 0.00023638068523723632
difference O 0 3.207924964954145e-05
in O 0 1.7327378373011015e-05
transcriptional O 0 9.977758600143716e-05
levels O 0 2.379883335379418e-05
of O 0 1.8721157175605185e-05
the O 0 1.5255078324116766e-05
three O 0 1.5492012607865036e-05
genes O 0 4.214403452351689e-05
( O 0 8.007608266780153e-05
DMAHP O 1 0.8950685858726501
, O 0 0.00011295118747511879
DMPK O 0 0.23606549203395844
and O 0 7.937278132885695e-05
59 O 0 0.00021269702119752765
) O 0 4.659314436139539e-05
surrounding O 0 0.0002252893609693274
the O 0 0.0002378869103267789
repeat O 0 0.0010694951051846147
. O 0 0.00019667278684210032
. O 0 0.00038628317997790873

A O 0 0.002915163291618228
novel O 0 0.0014819185016676784
missense O 0 0.0021206431556493044
mutation O 0 0.0003548790991771966
in O 0 0.00010938803461613134
patients O 0 0.0001509407302364707
from O 0 7.855758303776383e-05
a O 0 0.0003242589591536671
retinoblastoma B-Disease 1 0.932558000087738
pedigree O 0 0.0016217912780120969
showing O 0 0.00034081056946888566
only O 0 8.232921391027048e-05
mild O 0 0.0006036190316081047
expression O 0 0.0001653116341913119
of O 0 0.00025416899006813765
the O 0 0.007133978884667158
tumor B-Disease 1 0.9999830722808838
phenotype O 0 0.014945653267204762
. O 0 0.0005841241218149662

We O 0 0.0005263698985800147
have O 0 7.173694757511839e-05
used O 0 8.326910028699785e-05
single O 0 0.000149038722156547
strand O 0 0.0002762273943517357
conformation O 0 0.00019276970124337822
polymorphism O 0 7.162485417211428e-05
analysis O 0 1.2223457815707661e-05
to O 0 6.5744757193897385e-06
study O 0 9.785208021639846e-06
the O 0 2.1236954125924967e-05
27 O 0 5.860450255568139e-05
exons O 0 8.98833604878746e-05
of O 0 5.356790279620327e-05
the O 0 0.00018304515106137842
RB1 O 1 0.9714602828025818
gene O 0 4.643107240553945e-05
in O 0 1.670558049227111e-05
individuals O 0 8.925630936573725e-06
from O 0 1.684010203462094e-05
a O 0 4.089485082658939e-05
family O 0 0.00010323354945285246
showing O 0 0.00030464757583104074
mild O 0 0.0008000931702554226
expression O 0 0.0001585038990015164
of O 0 0.0002978490956593305
the O 0 0.0012066459748893976
retinoblastoma B-Disease 1 0.9996678829193115
phenotype O 0 0.03807314485311508
. O 0 0.0007073833839967847

In O 0 0.0005947888130322099
this O 0 0.0001331338135059923
family O 0 0.00025938174803741276
affected O 0 0.00019045254157390445
individuals O 0 6.889552605571225e-05
developed O 0 0.0006377246463671327
unilateral B-Disease 1 0.6597709655761719
tumors I-Disease 1 0.9999939203262329
and O 0 0.00012410494673531502
, O 0 4.505645119934343e-05
as O 0 2.6346408048993908e-05
a O 0 4.598241139319725e-05
result O 0 3.8687805499648675e-05
of O 0 6.92954781698063e-05
linkage O 0 0.00039086182368919253
analysis O 0 7.488792471121997e-05
, O 0 5.375580440158956e-05
unaffected O 0 0.00035339294117875397
mutation O 0 0.00012437340046744794
carriers O 0 5.978880653856322e-05
were O 0 1.8329288650420494e-05
also O 0 2.387323183938861e-05
identified O 0 3.7784106098115444e-05
within O 0 6.084228152758442e-05
the O 0 0.00029293238185346127
pedigree O 0 0.0020024527329951525
. O 0 0.0009189795237034559

A O 0 0.0020785864908248186
single O 0 0.0007491500582545996
band O 0 0.0005848204018548131
shift O 0 0.00054912269115448
using O 0 0.00013052872964181006
SSCP O 0 0.05513814091682434
was O 0 0.0002835836203303188
identified O 0 6.122804916230962e-05
in O 0 3.8713860703865066e-05
exon O 0 0.00021989172091707587
21 O 0 7.369464583462104e-05
which O 0 1.944275209098123e-05
resulted O 0 6.302139809122309e-05
in O 0 2.308950206497684e-05
a O 0 6.194849993335083e-05
missense O 0 0.0002444947022013366
mutation O 0 7.082118099788204e-05
converting O 0 0.0001615203800611198
a O 0 0.00014278569142334163
cys O 0 0.002830429468303919
- O 0 0.000334010022925213
- O 0 0.00016220533871091902
> O 0 0.00032366689993068576
arg O 0 0.0004766012716572732
at O 0 0.000156820475240238
nucleotide O 0 0.00013133062748238444
position O 0 0.0001187566012958996
28 O 0 0.00018417260434944183
in O 0 0.00015056796837598085
the O 0 0.00038477228372357786
exon O 0 0.004528741352260113
. O 0 0.0009852040093392134

The O 0 0.0030665842350572348
mutation O 0 0.00190322648268193
destroyed O 0 0.003945114091038704
an O 0 0.0004957442288286984
NdeI O 1 0.5273052453994751
restriction O 0 0.001017351751215756
enzyme O 0 0.0008832789026200771
site O 0 0.0010614272905513644
. O 0 0.0006725979037582874

Analysis O 0 0.00031370975193567574
of O 0 0.00017719331663101912
all O 0 5.355451867217198e-05
family O 0 9.912398672895506e-05
members O 0 4.6260433009592816e-05
demonstrated O 0 0.0001265625178348273
that O 0 1.9194647393305786e-05
the O 0 4.882182474830188e-05
missense O 0 0.0004726165207102895
mutation O 0 0.0002198346919612959
co O 0 0.0003763824934139848
- O 0 0.00019073150178883225
segregated O 0 0.00037267731386236846
with O 0 6.0646307247225195e-05
patients O 0 0.0016708782641217113
with O 0 0.0004195957153569907
tumors B-Disease 1 0.9999957084655762
or O 0 0.00014157418627291918
who O 0 7.04045596648939e-05
, O 0 2.3428558051818982e-05
as O 0 2.4132326871040277e-05
a O 0 4.0550195990363136e-05
result O 0 3.1233976187650114e-05
of O 0 8.733693539397791e-05
linkage O 0 0.0003211431030649692
analysis O 0 4.256429383531213e-05
had O 0 5.871296889381483e-05
been O 0 4.2480598494876176e-05
predicted O 0 7.743236346868798e-05
to O 0 3.835136158159003e-05
carry O 0 0.0001227664470206946
the O 0 0.0002710478729568422
predisposing O 0 0.02438550628721714
mutation O 0 0.0016007707454264164
. O 0 0.0009602215141057968

These O 0 0.00024273080634884536
observations O 0 0.00020009776926599443
point O 0 0.0001306340709561482
to O 0 2.9822218493791297e-05
another O 0 7.891385030234233e-05
region O 0 7.212106720544398e-05
of O 0 9.740459063323215e-05
the O 0 0.0002643081534188241
RB1 O 1 0.9990677237510681
gene O 0 0.00017446129641029984
where O 0 6.345704605337232e-05
mutations O 0 3.78107069991529e-05
only O 0 1.4608949641115032e-05
modify O 0 2.7891339414054528e-05
the O 0 2.120509816450067e-05
function O 0 2.556439176260028e-05
of O 0 2.8347118131932802e-05
the O 0 3.871914304909296e-05
gene O 0 3.457138882367872e-05
and O 0 1.9578803403419442e-05
raise O 0 2.2186437490745448e-05
important O 0 2.5657322112238035e-05
questions O 0 3.797505269176327e-05
for O 0 2.447266160743311e-05
genetic O 0 0.00010632185149006546
counseling O 0 0.0002484107681084424
in O 0 4.002626519650221e-05
families O 0 4.613104465533979e-05
with O 0 3.8787402445450425e-05
these O 0 5.4275446018436924e-05
distinctive O 0 0.0008306942181661725
phenotypes O 0 0.002699337201192975
. O 0 0.0002824783732648939
. O 0 0.0006001690053381026

Maternal B-Disease 1 0.9522936344146729
disomy I-Disease 1 0.9993510842323303
and O 0 0.24584448337554932
Prader B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999969005584717
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
consistent O 0 0.020214373245835304
with O 0 0.00040876047569327056
gamete O 1 0.9238567352294922
complementation O 1 0.7309444546699524
in O 0 8.62420056364499e-05
a O 0 7.202285632956773e-05
case O 0 7.586358697153628e-05
of O 0 8.524596341885626e-05
familial O 0 0.0018245182000100613
translocation O 0 0.002446133643388748
( O 0 5.515019438462332e-05
3 O 0 4.2755786125781015e-05
; O 0 1.6737489204388112e-05
15 O 0 5.472531120176427e-05
) O 0 3.3011780033120885e-05
( O 0 6.526212382595986e-05
p25 O 0 0.0020570633932948112
; O 0 9.245594992535189e-05
q11 O 0 0.0018134793499484658
. O 0 8.709316898602992e-05
2 O 0 0.00028704176656901836
) O 0 0.00024133101396728307
. O 0 0.0003202185907866806

Maternal B-Disease 1 0.9860796332359314
uniparental I-Disease 1 0.99993896484375
disomy I-Disease 1 0.999874472618103
( I-Disease 0 0.008913026191294193
UPD I-Disease 1 0.9995324611663818
) I-Disease 0 0.00017540756380185485
for I-Disease 0 5.920063631492667e-05
chromosome I-Disease 0 0.00011451503814896569
15 I-Disease 0 3.838645352516323e-05
is O 0 1.5237470506690443e-05
responsible O 0 2.3528373276349157e-05
for O 0 9.486530871072318e-06
an O 0 1.0092539014294744e-05
estimated O 0 1.7466725694248453e-05
30 O 0 2.128654705302324e-05
% O 0 1.6471827620989643e-05
of O 0 3.467473652563058e-05
cases O 0 6.050178126315586e-05
of O 0 0.0023689372465014458
Prader B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9996138215065002
PWS B-Disease 1 0.9999998807907104
) O 0 0.0017580889398232102
. O 0 0.000981329008936882

We O 0 0.0003554115246515721
report O 0 7.96831154730171e-05
on O 0 3.145913069602102e-05
an O 0 3.833169103018008e-05
unusual O 0 6.66192572680302e-05
case O 0 0.0001107350763049908
of O 0 0.00012823299039155245
maternal B-Disease 0 0.004369141533970833
disomy I-Disease 1 0.9633134603500366
15 I-Disease 0 0.00021969871886540204
in O 0 0.000117067938845139
PWS B-Disease 1 0.9999560117721558
that O 0 3.6628258385462686e-05
is O 0 1.4571578503819183e-05
most O 0 1.0370342351961881e-05
consistent O 0 1.7890071831061505e-05
with O 0 1.0565048796706833e-05
adjacent O 0 0.0001869097468443215
- O 0 9.520904859527946e-05
1 O 0 4.636948142433539e-05
segregation O 0 0.0002809069992508739
of O 0 5.486630107043311e-05
a O 0 7.004134386079386e-05
paternal O 0 0.0002535244857426733
t O 0 0.00015884735330473632
( O 0 2.9008071578573436e-05
3 O 0 3.8709171349182725e-05
; O 0 1.463044827687554e-05
15 O 0 3.052262763958424e-05
) O 0 1.8157556041842327e-05
( O 0 3.606714744819328e-05
p25 O 0 0.0012948611984029412
; O 0 4.34182547905948e-05
q11 O 0 0.0006976929144002497
. O 0 3.5565444704843685e-05
2 O 0 5.4538697440875694e-05
) O 0 2.246740405098535e-05
with O 0 3.8234105886658654e-05
simultaneous O 0 0.0002304970403201878
maternal O 0 0.001517085824161768
meiotic O 1 0.9262285232543945
nondisjunction O 1 0.7034579515457153
for O 0 0.0003039698058273643
chromosome O 0 0.0010690906783565879
15 O 0 0.0006864791503176093
. O 0 0.0005614097462967038

The O 0 0.0015235061291605234
patient O 0 0.0033622030168771744
( O 0 0.000331717892549932
J O 0 0.02409655973315239
. O 0 4.4956708734389395e-05
B O 0 0.00013901645434089005
. O 0 1.4471011127170641e-05
) O 0 9.567776032781694e-06
, O 0 9.003461855172645e-06
a O 0 2.1664356609107926e-05
17 O 0 7.665273733437061e-05
- O 0 0.00010045522503787652
year O 0 6.005050818203017e-05
- O 0 0.00010322606976842508
old O 0 0.00013544199464377016
white O 0 0.00015246463590301573
male O 0 8.840072405291721e-05
with O 0 8.450531458947808e-05
PWS B-Disease 1 0.999998927116394
, O 0 8.766352402744815e-05
was O 0 0.000121583383588586
found O 0 2.0286079234210774e-05
to O 0 1.0452324204379693e-05
have O 0 8.99888800631743e-06
47 O 0 4.959478246746585e-05
chromosomes O 0 5.813049938296899e-05
with O 0 2.3229129510582425e-05
a O 0 0.0001163866400020197
supernumerary O 0 0.021532174199819565
, O 0 0.00011165169416926801
paternal O 0 0.0007255078526213765
der O 0 0.0010080131469294429
( O 0 4.798370355274528e-05
15 O 0 5.4236843425314873e-05
) O 0 1.4504887985822279e-05
consisting O 0 2.8151884180260822e-05
of O 0 4.506972982198931e-05
the O 0 5.850299203302711e-05
short O 0 6.228247366379946e-05
arm O 0 0.00023784766381140798
and O 0 3.620647476054728e-05
the O 0 8.716338197700679e-05
proximal O 0 0.13546030223369598
long O 0 0.0002038308302871883
arm O 0 0.0009853059891611338
of O 0 0.00017700722673907876
chromosome O 0 0.0003351567720528692
15 O 0 0.00017055225907824934
, O 0 0.0001262272271560505
and O 0 0.00022264615108724684
distal O 1 0.9712438583374023
chromosome O 1 0.5122680068016052
arm O 1 0.9845213294029236
3p O 1 0.9967628717422485
. O 0 0.0013600883539766073

The O 0 0.0012937394203618169
t O 0 0.0009240051731467247
( O 0 7.422889757435769e-05
3 O 0 7.251540955621749e-05
; O 0 2.238066736026667e-05
15 O 0 4.161098331678659e-05
) O 0 1.6991529264487326e-05
was O 0 5.268486711429432e-05
present O 0 2.6419347705086693e-05
in O 0 1.6867281374288723e-05
the O 0 2.243229391751811e-05
balanced O 0 2.999414391524624e-05
state O 0 1.4042573639017064e-05
in O 0 1.595785033714492e-05
the O 0 7.292509690159932e-05
patients O 0 0.00021842420392204076
father O 0 0.0005506748566403985
and O 0 7.618561357958242e-05
a O 0 0.00031851837411522865
sister O 0 0.0018982349429279566
. O 0 0.000605071138124913

Fluorescent O 0 0.012543284334242344
in O 0 0.0009266042034141719
situ O 0 0.0041142781265079975
hybridization O 0 0.0008304069633595645
analysis O 0 0.00019272153440397233
demonstrated O 0 0.00033115388941951096
that O 0 6.32389637758024e-05
the O 0 0.0002447195292916149
PWS B-Disease 1 0.99982088804245
critical O 0 0.00036081697908230126
region O 0 0.0001619105169083923
resided O 0 0.00028512917924672365
on O 0 4.182322300039232e-05
the O 0 4.9879890866577625e-05
derivative O 0 0.00012629439879674464
chromosome O 0 7.176541839726269e-05
3 O 0 3.742670742212795e-05
and O 0 1.3375359230849426e-05
that O 0 6.752435183443595e-06
there O 0 1.6748726920923218e-05
was O 0 6.972932897042483e-05
no O 0 3.342492345836945e-05
deletion O 0 0.00010366917558712885
of O 0 8.474441710859537e-05
the O 0 0.0002486043085809797
PWS B-Disease 1 0.9999738931655884
region O 0 0.0002467270824126899
on O 0 6.583796493941918e-05
the O 0 6.864494207547978e-05
normal O 0 7.507353438995779e-05
pair O 0 9.637304174248129e-05
of O 0 0.00013032465358264744
15s O 0 0.0017608292400836945
present O 0 0.00022518842888530344
in O 0 0.0002874810597859323
J O 0 0.03025037609040737
. O 0 0.0008612041128799319

B O 0 0.04145393520593643
. O 0 0.00655237166211009

Methylation O 0 0.0017182519659399986
analysis O 0 0.00033226198866032064
at O 0 0.00028573276358656585
exon O 0 0.0006576761952601373
alpha O 0 0.00020131490600761026
of O 0 8.081142732407898e-05
the O 0 7.003526843618602e-05
small O 0 7.68949103076011e-05
nuclear O 0 0.0005217608995735645
ribonucleoprotein O 0 0.020202677696943283
- O 0 0.00017577757535036653
associated O 0 9.883716120384634e-05
polypeptide O 0 0.0003764512366615236
N O 0 0.0003069601079914719
( O 0 0.00010436985758133233
SNRPN O 0 0.18884488940238953
) O 0 6.20918144704774e-05
gene O 0 7.700719288550317e-05
showed O 0 7.381251634797081e-05
a O 0 3.196269244654104e-05
pattern O 0 9.048319043358788e-05
characteristic O 0 6.519543967442587e-05
of O 0 4.783275653608143e-05
only O 0 3.010989894391969e-05
the O 0 7.938421913422644e-05
maternal O 0 0.0006527095101773739
chromosome O 0 0.0003049744700547308
15 O 0 0.00024789496092125773
in O 0 0.0002458043454680592
J O 0 0.00780548295006156
. O 0 0.0007092474843375385

B O 0 0.058716438710689545
. O 0 0.00662680808454752

Maternal B-Disease 0 0.20181231200695038
disomy I-Disease 1 0.9357441067695618
was O 0 0.0019286391325294971
confirmed O 0 0.00024069540086202323
by O 0 7.627895683981478e-05
polymerase O 0 0.0005378677160479128
chain O 0 0.00020965827570762485
reaction O 0 0.0001007764512905851
analysis O 0 2.917678102676291e-05
of O 0 8.183694444596767e-05
microsatellite O 0 0.0005110679194331169
repeats O 0 0.00016349040379282087
at O 0 0.00013981926895212382
the O 0 8.927566523198038e-05
gamma O 0 0.0004771813109982759
- O 0 0.0003786137094721198
aminobutyric O 0 0.004063513595610857
acid O 0 0.0007221424020826817
receptor O 0 0.000426850892836228
beta3 O 0 0.003414647653698921
subunit O 0 0.0007666887249797583
( O 0 0.0005358711932785809
GABRB3 O 1 0.8149816989898682
) O 0 0.0006597456522285938
locus O 0 0.004207908641546965
. O 0 0.0009992184350267053

A O 0 0.003941765520721674
niece O 0 0.06415300816297531
( O 0 0.0005533595685847104
B O 0 0.0007396338623948395
. O 0 4.6783174184383824e-05
B O 0 0.00014914806524757296
. O 0 1.1458206245151814e-05
) O 0 1.037078800436575e-05
with O 0 1.0182866390096024e-05
45 O 0 2.800071524688974e-05
chromosomes O 0 3.7109090044396e-05
and O 0 1.168341714219423e-05
the O 0 2.3301148758037016e-05
derivative O 0 5.22389673278667e-05
3 O 0 2.618007783894427e-05
but O 0 1.1466579962871037e-05
without O 0 1.1730866390280426e-05
the O 0 3.711032695719041e-05
der O 0 0.0003143753274343908
( O 0 3.680163717945106e-05
15 O 0 5.311112545314245e-05
) O 0 2.9278990041348152e-05
demonstrated O 0 0.00010634050704538822
a O 0 6.574183498742059e-05
phenotype O 0 0.00010602924157865345
consistent O 0 5.4439449741039425e-05
with O 0 1.609028004168067e-05
that O 0 1.7172907973872498e-05
reported O 0 4.67903955723159e-05
for O 0 3.1245119316736236e-05
haploinsufficiency O 0 0.0021205665543675423
of O 0 0.00034491418045945466
distal O 1 0.6855072975158691
3 O 0 0.0009382187854498625
p O 0 0.0023321029730141163
. O 0 0.0005892843473702669

Uniparental B-Disease 1 0.9998582601547241
disomy I-Disease 1 0.9978976249694824
associated O 0 0.001277556992135942
with O 0 0.0002583697496447712
unbalanced O 0 0.002916781697422266
segregation O 0 0.04480123147368431
of O 0 0.0005824871477670968
non O 0 0.001354594947770238
- O 0 0.0009922647150233388
Robertsonian O 1 0.6917983889579773
translocations O 0 0.0005738181062042713
has O 0 4.6737779484828934e-05
been O 0 2.4336535716429353e-05
reported O 0 2.6040341253974475e-05
previously O 0 2.824888906616252e-05
but O 0 1.410216009389842e-05
has O 0 1.5173608517216053e-05
not O 0 6.49496314508724e-06
, O 0 1.081000027625123e-05
to O 0 1.1019338671758305e-05
our O 0 3.4251112083438784e-05
knowledge O 0 7.362636097241193e-05
, O 0 2.8406248020473868e-05
been O 0 2.413589390926063e-05
observed O 0 3.3368298318237066e-05
in O 0 2.9369657568167895e-05
a O 0 7.105409167706966e-05
case O 0 0.00019312716904096305
of O 0 0.0007195767830125988
PWS B-Disease 1 0.9999959468841553
. O 0 0.001960798166692257

Furthermore O 0 0.0022175530903041363
, O 0 0.00023213792883325368
our O 0 0.00020407351257745177
findings O 0 0.00010448376997373998
are O 0 2.1937647034064867e-05
best O 0 8.99054721230641e-05
interpreted O 0 0.00011515299411257729
as O 0 0.00012798425450455397
true O 0 0.0004940681392326951
gamete O 0 0.029276326298713684
complementation O 1 0.9863433837890625
resulting O 0 0.003835453884676099
in O 0 0.0006420740974135697
maternal B-Disease 1 0.9720900058746338
UPD I-Disease 1 0.99998939037323
15 I-Disease 0 0.0042644888162612915
and O 0 0.0031324911396950483
PWS B-Disease 1 0.9999288320541382

Schwartz B-Disease 1 0.6100459694862366
- I-Disease 1 0.9197390675544739
Jampel I-Disease 1 0.9999847412109375
syndrome I-Disease 1 0.9999988079071045
type I-Disease 0 0.012391765601933002
2 I-Disease 0 0.0006709826411679387
and O 0 0.00036443123826757073
Stuve B-Disease 1 0.9999638795852661
- I-Disease 1 0.9959127306938171
Wiedemann I-Disease 1 0.9999809265136719
syndrome I-Disease 1 0.9999963045120239
: O 0 0.0001242631406057626
a O 0 0.00014400589861907065
case O 0 0.00020029304141644388
for O 0 7.386863580904901e-05
" O 0 0.0004101285303477198
lumping O 0 0.0023562114220112562
" O 0 0.00092330202460289
. O 0 0.000532837409991771

Recent O 0 0.0010421050246804953
studies O 0 0.00019021281332243234
demonstrated O 0 0.00033338871435262263
the O 0 8.904864807846025e-05
existence O 0 7.866395026212558e-05
of O 0 7.181293767644092e-05
a O 0 0.00010268483310937881
genetically O 0 7.860329060349613e-05
distinct O 0 4.4037456973455846e-05
, O 0 2.8201728127896786e-05
usually O 0 2.570375545474235e-05
lethal O 0 6.22830048087053e-05
form O 0 2.5897792511386797e-05
of O 0 4.844846989726648e-05
the O 0 0.00016096749459393322
Schwartz B-Disease 0 0.10860014706850052
- I-Disease 1 0.5228949785232544
Jampel I-Disease 1 0.9999936819076538
syndrome I-Disease 1 0.9999997615814209
( O 0 0.001974207116290927
SJS B-Disease 1 0.9983538389205933
) O 0 0.00014485340216197073
of O 0 0.0008467823499813676
myotonia B-Disease 1 0.9999982118606567
and O 0 0.11688750237226486
skeletal B-Disease 1 0.9999997615814209
dysplasia I-Disease 1 0.9999997615814209
, O 0 0.000420276599470526
which O 0 5.109196717967279e-05
we O 0 5.846663407282904e-05
called O 0 0.00024265330284833908
SJS B-Disease 0 0.43460384011268616
type I-Disease 0 0.0007222414715215564
2 I-Disease 0 0.000603493070229888
. O 0 0.0003592619323171675

This O 0 0.002947780769318342
disorder O 1 0.9997233748435974
is O 0 0.00020848930580541492
reminiscent O 0 0.004102161154150963
of O 0 0.00024868635227903724
another O 0 0.0005927526508457959
rare O 0 0.0005737281171604991
condition O 0 0.0008413064642809331
, O 0 6.496668356703594e-05
the O 0 0.0003156038583256304
Stuve B-Disease 1 0.9999638795852661
- I-Disease 1 0.9906429648399353
Wiedemann I-Disease 1 0.9999969005584717
syndrome I-Disease 1 1.0
( O 0 0.0022601846139878035
SWS B-Disease 1 0.9912645816802979
) O 0 6.744628626620397e-05
, O 0 3.2490639569005e-05
which O 0 2.2799365979153663e-05
comprises O 0 0.00011809485295088962
campomelia B-Disease 0 0.037958331406116486
at O 0 0.0005442635156214237
birth O 0 0.0037933276034891605
with O 0 0.0005984257441014051
skeletal B-Disease 1 0.9999997615814209
dysplasia I-Disease 1 1.0
, O 0 0.4106845259666443
contractures B-Disease 1 0.9999915361404419
, O 0 0.00018870117492042482
and O 0 0.00011257398728048429
early B-Disease 0 0.00027853986830450594
death I-Disease 0 0.0022778939455747604
. O 0 0.0005762408836744726

To O 0 0.00037748782779090106
test O 0 0.00027989590307697654
for O 0 8.042751142056659e-05
possible O 0 0.00011343431106070057
nosologic O 0 0.007126628886908293
identity O 0 0.00022748539049644023
between O 0 0.00016040992341004312
these O 0 0.00011073295900132507
disorders O 1 0.9997838139533997
, O 0 5.08438897668384e-05
we O 0 2.3931197574711405e-05
reviewed O 0 2.4300979930558242e-05
the O 0 1.8760261809802614e-05
literature O 0 3.653560270322487e-05
and O 0 1.1255205208726693e-05
obtained O 0 1.2720734957838431e-05
a O 0 1.3845370631315745e-05
follow O 0 1.6890007827896625e-05
- O 0 2.1941412342130207e-05
up O 0 1.6297559341182932e-05
of O 0 2.22957314690575e-05
the O 0 2.338864214834757e-05
only O 0 1.2647190487768967e-05
two O 0 1.6627540389890783e-05
surviving O 0 0.00032146109151653945
patients O 0 9.609252447262406e-05
, O 0 2.1960337107884698e-05
one O 0 1.898545269796159e-05
with O 0 3.1053306884132326e-05
SJS B-Disease 0 0.009108902886509895
type I-Disease 0 7.225613808259368e-05
2 I-Disease 0 3.761735206353478e-05
at O 0 4.1835548472590744e-05
age O 0 2.3155613234848715e-05
10 O 0 1.541220444778446e-05
years O 0 1.4110260053712409e-05
and O 0 1.077336219168501e-05
another O 0 3.541662226780318e-05
with O 0 3.2259638828691095e-05
SWS B-Disease 0 0.15927299857139587
at O 0 0.0002076942619169131
age O 0 0.0002260851179016754
7 O 0 0.00029268141952343285
years O 0 0.000437391281593591
. O 0 0.0005163357709534466

Patients O 0 0.008928071707487106
reported O 0 0.0008450710447505116
as O 0 0.0003700075321830809
having O 0 0.0004067936970386654
either O 0 0.0005554743693210185
neonatal O 1 0.9999908208847046
SJS B-Disease 1 0.9999165534973145
or O 0 0.0004962364328093827
SWS B-Disease 0 0.0783766582608223
presented O 0 0.0001853900757851079
a O 0 8.532094216207042e-05
combination O 0 7.712300430284813e-05
of O 0 8.227294165408239e-05
a O 0 0.00020403071539476514
severe O 1 0.9992813467979431
, O 0 0.0008400931837968528
prenatal O 1 0.9997089505195618
- O 1 0.9995995163917542
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9991397857666016
with O 1 0.998443067073822
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999692440032959
respiratory O 1 1.0
and O 1 0.5126950740814209
feeding O 1 0.701510488986969
difficulties O 1 0.9280398488044739
, O 0 0.00013291792129166424
tendency O 0 0.00028837239369750023
to O 0 6.745437713107094e-05
hyperthermia B-Disease 1 0.9997604489326477
, O 0 4.8429996240884066e-05
and O 0 3.596983879106119e-05
frequent O 0 9.501605381956324e-05
death O 0 0.0003389777848497033
in O 0 5.2652823796961457e-05
infancy O 0 0.00036717328475788236
) O 0 2.8557891710079275e-05
with O 0 2.1396903321146965e-05
a O 0 0.00015350207104347646
distinct O 0 0.0004173388588242233
campomelic B-Disease 1 0.9999730587005615
- I-Disease 1 0.9987854361534119
metaphyseal I-Disease 1 0.9999866485595703
skeletal I-Disease 1 0.9999984502792358
dysplasia I-Disease 1 0.9999988079071045
. O 0 0.005760762840509415

The O 0 0.0008103135623969138
similarity O 0 0.0005888918531127274
of O 0 0.00022025640646461397
the O 0 0.00022290783817879856
clinical O 0 0.0005709354300051928
and O 0 9.180223423754796e-05
radiographic O 0 0.08906715363264084
findings O 0 9.419689740752801e-05
is O 0 2.5838042347459123e-05
so O 0 1.4744970030733384e-05
extensive O 0 7.247005123645067e-05
that O 0 2.6433886887389235e-05
these O 0 3.329732135171071e-05
disorders O 1 0.9372869729995728
appear O 0 6.945690256543458e-05
to O 0 2.4287566702696495e-05
be O 0 2.636598946992308e-05
a O 0 9.427255281480029e-05
single O 0 0.00020920457609463483
entity O 0 0.0006610469426959753
. O 0 0.0004043823864776641

The O 0 0.0008637402788735926
follow O 0 0.00038132863119244576
- O 0 0.0002023320848820731
up O 0 6.82302052155137e-05
observation O 0 0.00011459894449217245
of O 0 5.47585150343366e-05
an O 0 4.649869151762687e-05
identical O 0 7.601000106660649e-05
and O 0 4.237919711158611e-05
unique O 0 6.391136412275955e-05
pattern O 0 0.0003763575805351138
of O 0 0.021816454827785492
progressive O 1 0.9999991655349731
bone B-Disease 1 1.0
dysplasia I-Disease 1 0.9999990463256836
in O 0 0.00012823371798731387
the O 0 9.436897380510345e-05
two O 0 2.3948756279423833e-05
patients O 0 3.999406180810183e-05
( O 0 1.981030436581932e-05
one O 0 2.478730857546907e-05
with O 0 2.711211345740594e-05
SJS B-Disease 0 0.03143928945064545
type I-Disease 0 0.00012049028737237677
2 I-Disease 0 4.600622924044728e-05
, O 0 2.5776835173019208e-05
one O 0 2.4695100364624523e-05
with O 0 4.141454701311886e-05
SWS B-Disease 0 0.009366038255393505
) O 0 4.643045394914225e-05
surviving O 0 0.0002157761191483587
beyond O 0 0.00014997647667769343
infancy O 0 0.00029572134371846914
adds O 0 9.585209772922099e-05
to O 0 1.3489056982507464e-05
the O 0 2.9807744795107283e-05
evidence O 0 4.3279149394948035e-05
in O 0 2.478915121173486e-05
favor O 0 5.35882827534806e-05
of O 0 0.00017080419638659805
identity O 0 0.0005285418592393398
. O 0 0.0006467075436376035

The O 0 0.0017313276184722781
hypothesis O 0 0.00135294278152287
that O 0 0.00025873014237731695
SWS B-Disease 1 0.5759414434432983
and O 0 0.00032160451519303024
SJS B-Disease 1 0.7511353492736816
type I-Disease 0 0.00029766769148409367
2 I-Disease 0 0.00010104183456860483
are O 0 1.2548076483653858e-05
the O 0 6.804566510254517e-05
same O 0 0.00013104254321660846
disorder O 1 0.9931025505065918
should O 0 5.9014859289163724e-05
be O 0 2.8864438718301244e-05
testable O 0 0.00018882140284404159
by O 0 3.547168307704851e-05
molecular O 0 0.00019477859314065427
methods O 0 0.00014364109665621072
. O 0 0.00017096813826356083
. O 0 0.0003720828681252897

A O 0 0.003302547615021467
mouse O 0 0.0019395300187170506
model O 0 0.0007928393315523863
of O 0 0.0020996967796236277
severe O 1 0.9999996423721313
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9998083710670471
defects O 1 0.9999997615814209
in O 1 0.9059603214263916
hemostasis O 1 0.9999990463256836
and O 1 0.6794938445091248
thrombosis B-Disease 1 0.999996542930603
. O 0 0.0031559437047690153

von B-Disease 1 0.9852421879768372
Willebrand I-Disease 1 0.9999732971191406
factor I-Disease 1 0.9888055324554443
( I-Disease 0 0.16837036609649658
vWf I-Disease 1 0.9998107552528381
) I-Disease 1 0.939845085144043
deficiency I-Disease 1 1.0
causes O 1 0.9999996423721313
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.8816736340522766
humans O 0 0.015841221436858177
. O 0 0.0005571457440964878

We O 0 0.0006098923040553927
generated O 0 0.00024697184562683105
a O 0 0.0001737999846227467
mouse O 0 0.0002613469841890037
model O 0 0.00010528339043958113
for O 0 4.5624852646142244e-05
this O 0 7.097877823980525e-05
disease O 0 0.02373518794775009
by O 0 6.288134318310767e-05
using O 0 8.74112593010068e-05
gene O 0 0.00025981091312132776
targeting O 0 0.0005791398580186069
. O 0 0.0004924648674204946

vWf B-Disease 1 0.9887149930000305
- I-Disease 0 0.3882025480270386
deficient I-Disease 1 0.6501831412315369
mice O 0 0.0007091230945661664
appeared O 0 0.00022708947653882205
normal O 0 0.00012166711530881003
at O 0 0.00012995560246054083
birth O 0 0.00016061990754678845
; O 0 1.5968660591170192e-05
they O 0 1.2042862181260716e-05
were O 0 3.997103340225294e-05
viable O 0 0.0002579587453510612
and O 0 0.00018550181994214654
fertile O 0 0.004057978745549917
. O 0 0.0016139415092766285

Neither O 0 0.01710527576506138
vWf O 0 0.037304025143384933
nor O 0 0.005079448688775301
vWf O 0 0.03701162338256836
propolypeptide O 1 0.8343788385391235
( O 0 0.0011216236744076014
von B-Disease 1 0.786761462688446
Willebrand I-Disease 1 0.999987006187439
antigen O 1 0.9697155952453613
II O 1 0.9988309741020203
) O 0 0.00010593455226626247
were O 0 8.086169691523537e-05
detectable O 0 0.0003167057875543833
in O 0 0.00010977309284498915
plasma O 0 0.000604242377448827
, O 0 0.00012114547280361876
platelets O 0 0.004142493009567261
, O 0 0.00014079405809752643
or O 0 0.0002568077761679888
endothelial O 1 0.6745688319206238
cells O 0 0.0001489875721745193
of O 0 0.00014937222294975072
the O 0 0.0002853329060599208
homozygous O 0 0.002082794439047575
mutant O 0 0.0058625806123018265
mice O 0 0.0017155077075585723
. O 0 0.0007918642368167639

The O 0 0.0051689911633729935
mutant O 1 0.9682388305664062
mice O 1 0.5426018834114075
exhibited O 1 0.9460774064064026
defects O 1 0.9999352693557739
in O 0 0.0003994536818936467
hemostasis O 1 0.9985968470573425
with O 0 0.00012142430932726711
a O 0 0.0004742745659314096
highly O 0 0.005590768530964851
prolonged O 1 0.9999744892120361
bleeding O 1 0.999997615814209
time O 0 0.0003145021037198603
and O 0 0.0003270902670919895
spontaneous O 0 0.3040231466293335
bleeding O 1 0.991811990737915
events O 0 0.00010134618787560612
in O 0 3.2024108804762363e-05
approximately O 0 6.887561903567985e-05
10 O 0 5.6030170526355505e-05
% O 0 6.276691419770941e-05
of O 0 0.0002974546514451504
neonates O 0 0.004746584687381983
. O 0 0.0007730175857432187

As O 0 0.0005749119445681572
in O 0 0.00015979989257175475
the O 0 0.00030751549638807774
human O 0 0.002377589698880911
disease O 1 0.9945425987243652
, O 0 5.795935430796817e-05
the O 0 0.00010048616968560964
factor O 0 0.0005637701833620667
VIII O 1 0.8103554248809814
level O 0 9.580622281646356e-05
in O 0 3.176847894792445e-05
these O 0 1.2599170077010058e-05
mice O 0 5.53355275769718e-05
was O 0 7.60552502470091e-05
reduced O 0 3.563310383469798e-05
strongly O 0 1.6138565115397796e-05
as O 0 1.455307847209042e-05
a O 0 2.0475425117183477e-05
result O 0 3.0508716008625925e-05
of O 0 4.7412766434717923e-05
the O 0 8.303146023536101e-05
lack O 0 0.00016960420180112123
of O 0 0.00016073606093414128
protection O 0 0.000665684521663934
provided O 0 0.0002504531294107437
by O 0 0.0002197605062974617
vWf O 0 0.005739000625908375
. O 0 0.000654436822514981

Defective O 1 0.9999598264694214
thrombosis B-Disease 1 0.9999827146530151
in O 0 0.0028228366281837225
mutant O 1 0.9812842011451721
mice O 0 0.0015926334308460355
was O 0 0.00020476817735470831
also O 0 3.227412889827974e-05
evident O 0 9.956772555597126e-05
in O 0 2.5573290258762427e-05
an O 0 2.9112910851836205e-05
in O 0 7.735133840469643e-05
vivo O 0 0.0006395612726919353
model O 0 0.0005741362692788243
of O 0 0.13484491407871246
vascular B-Disease 1 1.0
injury I-Disease 1 0.9999932050704956
. O 0 0.0020301337353885174

In O 0 0.0007276022806763649
this O 0 0.00019852141849696636
model O 0 0.00035993405617773533
, O 0 0.00010392552940174937
the O 0 0.00029319082386791706
exteriorized O 0 0.3383919894695282
mesentery O 1 0.8146563768386841
was O 0 0.032405320554971695
superfused O 1 0.9887513518333435
with O 0 0.0004661283746827394
ferric O 1 0.9999440908432007
chloride O 0 0.02562020905315876
and O 0 0.00010232688509859145
the O 0 0.0002146360493497923
accumulation O 0 0.0017575519159436226
of O 0 0.0007357323192991316
fluorescently O 1 0.9840606451034546
labeled O 0 0.010061322711408138
platelets O 0 0.049185995012521744
was O 0 0.0005394289619289339
observed O 0 0.00021911026851739734
by O 0 0.0001487788831582293
intravital O 0 0.020135674625635147
microscopy O 0 0.00332868960686028
. O 0 0.0007760078879073262

We O 0 0.0009052398381754756
conclude O 0 0.0009787388844415545
that O 0 0.00010911394929280505
these O 0 6.670557922916487e-05
mice O 0 0.0002164445468224585
very O 0 9.653096640249714e-05
closely O 0 0.0001555253693368286
mimic O 0 0.18681906163692474
severe O 1 0.9999911785125732
human O 1 0.9999169111251831
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.0018951883539557457
will O 0 5.1888837333535776e-05
be O 0 2.228327502962202e-05
very O 0 1.4164537788019516e-05
useful O 0 2.8460342946345918e-05
for O 0 1.257622989214724e-05
investigating O 0 5.93302320339717e-05
the O 0 4.8194153350777924e-05
role O 0 0.00010203514830209315
of O 0 0.00015187640383373946
vWf O 0 0.0020536594092845917
in O 0 8.49428033689037e-05
normal O 0 0.0003055947308894247
physiology O 0 0.055874116718769073
and O 0 0.00012205616803839803
in O 0 0.0002909392351284623
disease O 1 0.9997157454490662
models O 0 0.0004168430168647319
. O 0 0.0002530868514440954
. O 0 0.00042139532160945237

Oral O 0 0.02280610427260399
contraceptives O 0 0.013283264823257923
and O 0 0.0003180559433531016
the O 0 0.0006819497793912888
risk O 0 0.009812449105083942
of O 1 0.9923567771911621
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.08741156756877899

Hereditary B-Disease 1 0.9999997615814209
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 0.9999991655349731
Clinical O 1 0.9950947761535645
Study O 0 0.0022643674165010452
Group O 0 0.0011424109106883407
. O 0 0.0008614151156507432

BACKGROUND O 0 0.0043278224766254425
Women O 0 0.0005380373913794756
with O 0 0.00010275153181282803
mutations O 0 7.585187267977744e-05
in O 0 3.929878585040569e-05
either O 0 5.397437053034082e-05
the O 0 0.00011448925943113863
BRCA1 O 0 0.03019786812365055
or O 0 6.984378705965355e-05
the O 0 0.00012075898848706856
BRCA2 O 0 0.0015811906196177006
gene O 0 5.264399078441784e-05
have O 0 9.124667485593818e-06
a O 0 4.122143582208082e-05
high O 0 0.00019890280964318663
lifetime O 0 0.001650128629989922
risk O 0 0.007718351203948259
of O 1 0.998217761516571
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.004796746652573347

Oral O 0 0.020825045183300972
contraceptives O 1 0.8766607642173767
protect O 1 0.5358520746231079
against O 1 0.999065101146698
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999984502792358
in O 0 0.0002945451415143907
general O 0 0.0004590894386637956
, O 0 3.728666706592776e-05
but O 0 1.5768677258165553e-05
it O 0 7.143568836909253e-06
is O 0 9.690235856396612e-06
not O 0 5.862445505044889e-06
known O 0 2.516875792935025e-05
whether O 0 1.102626629290171e-05
they O 0 9.890774890664034e-06
also O 0 2.734534427872859e-05
protect O 0 9.748403681442142e-05
against O 0 0.00017428341379854828
hereditary B-Disease 1 0.9655003547668457
forms I-Disease 1 0.7528907060623169
of I-Disease 1 0.9999972581863403
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00782658252865076

METHODS O 0 0.0013539682840928435
We O 0 0.0003478365542832762
enrolled O 0 0.0006678591016680002
207 O 0 0.0012928290525451303
women O 0 0.00025839192676357925
with O 0 0.000359997182385996
hereditary B-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
and O 0 0.0002132977533619851
161 O 0 0.00035509010194800794
of O 0 8.678030280862004e-05
their O 0 2.1241306967567652e-05
sisters O 0 0.00017686415230855346
as O 0 2.4678620320628397e-05
controls O 0 2.3995071387616917e-05
in O 0 2.1290323275025003e-05
a O 0 6.84615079080686e-05
case O 0 0.0001327750360360369
- O 0 0.0002205489290645346
control O 0 0.00022016886214260012
study O 0 0.0002725069352891296
. O 0 0.0004958236822858453

All O 0 0.000479533220641315
the O 0 0.00031910286634229124
patients O 0 0.00023552286438643932
carried O 0 0.00013770005898550153
a O 0 9.459926513954997e-05
pathogenic O 0 0.00027347568538971245
mutation O 0 6.827413017163053e-05
in O 0 2.5828039724729024e-05
either O 0 7.108472345862538e-05
BRCA1 O 0 0.000555310514755547
( O 0 4.6984456275822595e-05
179 O 0 0.0001822096382966265
women O 0 5.3903338994132355e-05
) O 0 3.263939288444817e-05
or O 0 5.095096639706753e-05
BRCA2 O 0 0.0017547698225826025
( O 0 0.0001365938369417563
28 O 0 0.00035531612229533494
women O 0 0.00023169790802057832
) O 0 0.0001547011052025482
. O 0 0.0003905645862687379

The O 0 0.0009362740092910826
control O 0 0.00042576156556606293
women O 0 0.00012516409333329648
were O 0 6.591088458662853e-05
enrolled O 0 0.00013061687059234828
regardless O 0 7.052551518427208e-05
of O 0 6.011204459355213e-05
whether O 0 4.9996426241705194e-05
or O 0 2.378651151957456e-05
not O 0 1.1201258530491032e-05
they O 0 1.557303585286718e-05
had O 0 7.546097913291305e-05
either O 0 0.00015001394785940647
mutation O 0 0.00042691986891441047
. O 0 0.00036146974889561534

Lifetime O 0 0.003676559077575803
histories O 0 0.0009185847011394799
of O 0 0.0005275040748529136
oral O 0 0.003956534434109926
- O 0 0.0006408114568330348
contraceptive O 0 0.0005166067858226597
use O 0 1.979652006411925e-05
were O 0 1.352242998109432e-05
obtained O 0 2.3884573238319717e-05
by O 0 1.415989208908286e-05
interview O 0 4.345702473074198e-05
or O 0 1.4279087736213114e-05
by O 0 8.678744052303955e-06
written O 0 1.3681902601092588e-05
questionnaire O 0 2.9442537197610363e-05
and O 0 1.1659207302727737e-05
were O 0 1.8818980606738478e-05
compared O 0 3.2124589779414237e-05
between O 0 5.3145879064686596e-05
patients O 0 0.00010477481555426493
and O 0 3.448236020631157e-05
control O 0 7.491134601878002e-05
women O 0 4.236376844346523e-05
, O 0 2.5310699129477143e-05
after O 0 6.911497621331364e-05
adjustment O 0 0.00013202875561546534
for O 0 2.069541187665891e-05
year O 0 4.3618994823191315e-05
of O 0 0.00012211404100526124
birth O 0 0.0007558923680335283
and O 0 0.0002828950237017125
parity O 0 0.003444826928898692
. O 0 0.0007008998072706163

RESULTS O 0 0.0020798451732844114
The O 0 0.0005832773167639971
adjusted O 0 0.0010519374627619982
odds O 0 0.0009871539659798145
ratio O 0 0.0009604685474187136
for O 0 0.0016403041081503034
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999920129776001
associated O 0 0.00013216289517004043
with O 0 3.383052535355091e-05
any O 0 3.1923609640216455e-05
past O 0 4.419808465172537e-05
use O 0 2.209431659139227e-05
of O 0 6.41600854578428e-05
oral O 0 0.0004065537068527192
contraceptives O 0 0.0026347956154495478
was O 0 0.0006913287215866148
0 O 0 0.00032386378734372556
. O 0 0.00037830520886927843

5 O 0 0.0007832316914573312
( O 0 0.00017687445506453514
95 O 0 0.00022693275241181254
percent O 0 8.613837417215109e-05
confidence O 0 0.0001743091706885025
interval O 0 9.661070362199098e-05
, O 0 2.965330713777803e-05
0 O 0 2.5551938961143605e-05
. O 0 7.421803729812382e-06
3 O 0 2.1202997231739573e-05
to O 0 1.4567965081369039e-05
0 O 0 4.0491806430509314e-05
. O 0 3.1587405828759074e-05
8 O 0 0.00018467959307599813
) O 0 0.00016149018483702093
. O 0 0.00045247047091834247

The O 0 0.002211004728451371
risk O 0 0.001027118181809783
decreased O 0 0.0003979508182965219
with O 0 4.3003914470318705e-05
increasing O 0 8.22621223051101e-05
duration O 0 0.00010511716391192749
of O 0 6.0877624491695315e-05
use O 0 2.1872659999644384e-05
( O 0 3.961319453082979e-05
P O 0 0.0001797287113731727
for O 0 2.1715095499530435e-05
trend O 0 7.179992826422676e-05
, O 0 3.82460311811883e-05
< O 0 0.00012746617721859366
0 O 0 3.7391961086541414e-05
. O 0 2.274370490340516e-05
001 O 0 0.00030375487403944135
) O 0 1.5073817849042825e-05
; O 0 7.189613825175911e-06
use O 0 6.4476034822291695e-06
for O 0 9.210653843183536e-06
six O 0 1.8454944438417442e-05
or O 0 1.3140911505615804e-05
more O 0 7.466914212272968e-06
years O 0 1.8267828636453487e-05
was O 0 5.5621476349188015e-05
associated O 0 2.0293431589379907e-05
with O 0 6.913928245921852e-06
a O 0 3.0766739655518904e-05
60 O 0 5.9241920098429546e-05
percent O 0 7.878279575379565e-05
reduction O 0 0.00022038161114323884
in O 0 0.00010440927144372836
risk O 0 0.0004874899168498814
. O 0 0.0004393438284751028

Oral O 0 0.013372097164392471
- O 0 0.0031445377971976995
contraceptive O 0 0.0026365548837929964
use O 0 0.00018344036652706563
protected O 0 0.0017720996402204037
against O 1 0.617817759513855
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999701976776123
both O 0 7.547616405645385e-05
for O 0 4.314365651225671e-05
carriers O 0 5.6496905017411336e-05
of O 0 4.369564339867793e-05
the O 0 9.474551916355267e-05
BRCA1 O 0 0.016681652516126633
mutation O 0 0.00010195811773883179
( O 0 3.215248216292821e-05
odds O 0 7.163659756770357e-05
ratio O 0 2.6942976546706632e-05
, O 0 1.3104231584293302e-05
0 O 0 1.2996191799174994e-05
. O 0 6.301081157289445e-06
5 O 0 1.3341458725335542e-05
; O 0 7.539470516348956e-06
95 O 0 3.506834036670625e-05
percent O 0 1.810338653740473e-05
confidence O 0 6.415146344806999e-05
interval O 0 5.078312460682355e-05
, O 0 1.5090083252289332e-05
0 O 0 2.2081951101426966e-05
. O 0 9.134662832366303e-06
3 O 0 1.5999909010133706e-05
to O 0 8.986744433059357e-06
0 O 0 1.80678198375972e-05
. O 0 8.207382961700205e-06
9 O 0 2.8656102585955523e-05
) O 0 1.0464861588843632e-05
and O 0 1.3561339983425569e-05
for O 0 9.279113328375388e-06
carriers O 0 3.139182081213221e-05
of O 0 4.328137947595678e-05
the O 0 0.00012668714043684304
BRCA2 O 0 0.011764280498027802
mutation O 0 0.00011316507880110294
( O 0 4.8935835366137326e-05
odds O 0 0.00010728406778071076
ratio O 0 5.564275124925189e-05
, O 0 1.646273631195072e-05
0 O 0 1.4412999917112757e-05
. O 0 9.583162864146288e-06
4 O 0 2.0148823750787415e-05
; O 0 9.450601282878779e-06
95 O 0 3.933977131964639e-05
percent O 0 3.929638842237182e-05
confidence O 0 8.703306230017915e-05
interval O 0 4.101768718101084e-05
, O 0 1.266379786102334e-05
0 O 0 1.538618016638793e-05
. O 0 5.116835836815881e-06
2 O 0 1.151833203039132e-05
to O 0 1.061407874658471e-05
1 O 0 3.196473699063063e-05
. O 0 2.0766268789884634e-05
1 O 0 0.0001114146361942403
) O 0 0.0001727528142509982
. O 0 0.00035681272856891155

CONCLUSIONS O 0 0.005539922975003719
Oral O 0 0.005048936698585749
- O 0 0.0014457019278779626
contraceptive O 0 0.001293900771997869
use O 0 5.743161091231741e-05
may O 0 4.084246756974608e-05
reduce O 0 6.769351602997631e-05
the O 0 8.090596384136006e-05
risk O 0 0.0006403178558684886
of O 1 0.9909015893936157
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
in O 0 0.0002577182895038277
women O 0 0.00010167936852667481
with O 0 3.693034886964597e-05
pathogenic O 0 0.0004334304539952427
mutations O 0 6.77490679663606e-05
in O 0 5.440001405077055e-05
the O 0 0.0003834469534922391
BRCA1 O 1 0.9423055052757263
or O 0 0.0011290416587144136
BRCA2 O 0 0.47564056515693665
gene O 0 0.004533617291599512

A O 0 0.0031747014727443457
Japanese O 0 0.002926107030361891
family O 0 0.0005883395788259804
with O 0 0.000203860952751711
adrenoleukodystrophy B-Disease 1 0.999955415725708
with O 0 0.00018833913782145828
a O 0 0.00023113460338208824
codon O 0 0.0006095297285355628
291 O 0 0.0004924493841826916
deletion O 0 0.0003377004759386182
: O 0 5.355686880648136e-05
a O 0 8.688802336109802e-05
clinical O 0 0.00019351774244569242
, O 0 7.037262548692524e-05
biochemical O 0 0.0016777390846982598
, O 0 9.931274689733982e-05
pathological O 0 0.38485050201416016
, O 0 0.00018516145064495504
and O 0 0.00014661459135822952
genetic O 0 0.00048155832337215543
report O 0 0.0003547427477315068
. O 0 0.00044385730870999396

We O 0 0.0004735869588330388
report O 0 0.00013911988935433328
a O 0 0.00011042864935006946
Japanese O 0 0.000294244266115129
family O 0 0.00019393929687794298
with O 0 0.0002652480034157634
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9012933969497681
ALD B-Disease 1 0.9999983310699463
) O 0 7.207720773294568e-05
with O 0 2.8855411073891446e-05
a O 0 4.313937824917957e-05
three O 0 4.3311109038768336e-05
base O 0 0.00014285948418546468
pair O 0 0.00019317098485771567
deletion O 0 0.00031145475804805756
( O 0 9.07664725673385e-05
delGAG O 0 0.0017159406561404467
291 O 0 0.0004477042821235955
) O 0 6.85627746861428e-05
in O 0 0.00012119919847464189
the O 0 0.0005197059945203364
ALD B-Disease 1 0.9999892711639404
gene O 0 0.0020099852699786425
. O 0 0.000983908656053245

A O 0 0.0016437991289421916
variety O 0 0.00033161291503347456
of O 0 0.0002917494857683778
phenotypes O 0 0.00045606974163092673
were O 0 7.195214129751548e-05
observed O 0 9.864591993391514e-05
within O 0 6.971842230996117e-05
this O 0 8.492644701618701e-05
family O 0 0.000533060694579035
. O 0 0.000680693716276437

While O 0 0.0010031330166384578
the O 0 0.0005764479865320027
proband O 1 0.8298289179801941
( O 0 0.0003671202575787902
patient O 0 0.0005168935167603195
1 O 0 9.883414168143645e-05
) O 0 4.161967444815673e-05
was O 0 0.00011260060273343697
classified O 0 6.094506534282118e-05
as O 0 3.060435483348556e-05
having O 0 3.318937524454668e-05
a O 0 3.814222145592794e-05
rare O 0 0.00013610873429570347
intermediate O 0 0.00026947708101943135
type O 0 0.00011039947276003659
of O 0 0.00011771516437875107
adult O 0 0.00019341259030625224
cerebral O 1 0.9952390193939209
and O 0 0.0005331176216714084
cerebello O 1 0.9999924898147583
- O 1 0.9128702282905579
brain O 1 0.6841017603874207
stem O 0 0.00030306700500659645
forms O 0 4.71038329123985e-05
, O 0 4.7158442612271756e-05
his O 0 0.00010896380263147876
younger O 0 0.0003925215860363096
brother O 0 0.001127045601606369
( O 0 9.753973426995799e-05
patient O 0 0.00018978853768203408
2 O 0 7.626651495229453e-05
) O 0 2.4241957362391986e-05
and O 0 3.272310277679935e-05
nephew O 0 0.0011136640096083283
( O 0 0.00010619540262268856
patient O 0 0.00020414999744389206
3 O 0 8.850271115079522e-05
) O 0 4.5049964683130383e-05
had O 0 0.00011770990386139601
a O 0 0.00043485453352332115
childhood O 1 0.9973962306976318
ALD B-Disease 1 0.9999994039535522
type O 1 0.5578832626342773
. O 0 0.0012610801495611668

Another O 0 0.0031689477618783712
nephew O 0 0.0985167846083641
( O 0 0.0003795953234657645
patient O 0 0.00036785000702366233
4 O 0 0.0001218297693412751
) O 0 3.0837527447147295e-05
of O 0 7.811230170773342e-05
patient O 0 0.00021241451031528413
1 O 0 6.77986245136708e-05
was O 0 0.00010979518265230581
classified O 0 6.229322025319561e-05
as O 0 4.7528159484500065e-05
having O 0 7.760622975183651e-05
an O 0 0.0001203309147967957
adolescent O 0 0.006004178896546364
form O 0 0.0005019741365686059
. O 0 0.00043368188198655844

The O 0 0.0015707031125202775
tau O 0 0.0027735400944948196
level O 0 0.00037820753641426563
in O 0 0.00012233454617671669
the O 0 0.00030272052390500903
cerebrospinal O 1 0.9939720034599304
fluid O 1 0.9152879118919373
( O 0 0.0005802072701044381
CSF O 0 0.36615896224975586
) O 0 3.3944215829251334e-05
in O 0 3.109740646323189e-05
patient O 0 7.376488065347075e-05
1 O 0 3.883747922373004e-05
was O 0 6.196646427270025e-05
as O 0 1.9058375983149745e-05
high O 0 3.353507781866938e-05
as O 0 1.5724959666840732e-05
that O 0 1.3099706848151982e-05
of O 0 7.877310417825356e-05
patients O 0 0.0032659820280969143
with O 0 0.01604984886944294
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
( O 0 0.003575603710487485
AD B-Disease 0 0.002220541937276721
) O 0 0.0002554690290708095
. O 0 0.000374027993530035

His O 0 0.010729330591857433
brain O 1 0.9736549258232117
magnetic O 0 0.005174466874450445
resonance O 0 0.0027434625662863255
image O 0 0.0021305903792381287
( O 0 0.0006148943793959916
MRI O 0 0.2613137364387512
) O 0 0.00012345741561148316
showed O 0 0.0005240026512183249
abnormalities B-Disease 0 0.0032484172843396664
in I-Disease 0 7.723973976681009e-05
the I-Disease 0 0.0002499678812455386
bilateral I-Disease 0 0.29790255427360535
cerebellar I-Disease 1 0.9999991655349731
hemispheres I-Disease 1 0.9995113611221313
and O 0 0.21127045154571533
brain O 1 0.999968409538269
stem O 0 0.005241820123046637
, O 0 2.7167938242200762e-05
but O 0 7.690166057727765e-06
not O 0 5.080625214759493e-06
in O 0 2.0673360268119723e-05
the O 0 7.665142038604245e-05
cerebral O 1 0.9716423153877258
white O 0 0.00039836132782511413
matter O 0 9.73577843979001e-05
, O 0 3.554916474968195e-05
where O 0 3.3489312045276165e-05
marked O 0 0.00012636222527362406
reductions O 0 0.00010793812543852255
of O 0 9.474859689362347e-05
the O 0 0.0003209408023394644
cerebral O 1 0.9998538494110107
blood O 1 0.6055966019630432
flow O 0 0.00041855976451188326
and O 0 0.00016464763029944152
oxygen O 0 0.0021938830614089966
metabolism O 0 0.0005231514805927873
were O 0 4.396586518851109e-05
clearly O 0 8.24433664092794e-05
demonstrated O 0 0.00013270504132378846
by O 0 4.712270310847089e-05
positron O 0 0.0006010041106492281
emission O 0 0.00028520182240754366
tomography O 0 0.00044921456719748676
( O 0 0.00024970274535007775
PET O 0 0.0010546171106398106
) O 0 0.00026702595641836524
. O 0 0.0004945360124111176

In O 0 0.0009016730473376811
patients O 0 0.0002930443733930588
2 O 0 0.0001000531337922439
and O 0 4.431275010574609e-05
3 O 0 5.1294959121150896e-05
, O 0 2.809628495015204e-05
the O 0 4.094086034456268e-05
autopsy O 0 0.0003357800596859306
findings O 0 0.00014665319758933038
showed O 0 0.00040351791540160775
massive O 0 0.2596375644207001
demyelination B-Disease 1 0.999984860420227
of I-Disease 0 0.003459992352873087
the I-Disease 0 0.0566764734685421
cerebral I-Disease 1 0.9994922876358032
white I-Disease 0 0.0007937144255265594
matter I-Disease 0 8.798461203696206e-05
with O 0 2.1249716155580245e-05
sparing O 0 0.00021293808822520077
of O 0 8.285382500616834e-05
the O 0 0.0002095935051329434
U O 1 0.9987275004386902
- O 0 0.0011361300712451339
fibers O 0 0.001233125920407474
, O 0 3.434609607211314e-05
compatible O 0 3.3970158256124705e-05
with O 0 1.5763700503157452e-05
the O 0 5.474462886922993e-05
findings O 0 0.00014950701734051108
of O 0 0.000757988600526005
childhood O 1 0.999524712562561
ALD B-Disease 1 0.9999992847442627
. O 0 0.0035083612892776728

Oleic O 0 0.03721192479133606
and O 0 0.002037512604147196
erucic O 0 0.40442803502082825
acids O 0 0.0008305652299895883
( O 0 0.00032368171378038824
Lorenzos O 0 0.011177071370184422
Oil O 0 0.000315235200105235
) O 0 3.831430149148218e-05
were O 0 2.194147600675933e-05
administered O 0 4.151708708377555e-05
to O 0 1.6884821889107116e-05
patients O 0 4.30057589255739e-05
1 O 0 2.5534885935485363e-05
and O 0 1.9695924493134953e-05
4 O 0 4.819300738745369e-05
, O 0 2.181318632210605e-05
but O 0 1.5621111742802896e-05
sufficient O 0 8.767438703216612e-05
effectiveness O 0 0.00018047004414256662
was O 0 0.00015978008741512895
not O 0 3.942829425795935e-05
obtained O 0 0.00019777911074925214
. O 0 0.0004035187012050301

The O 0 0.0008351538563147187
findings O 0 0.00031830952502787113
in O 0 9.165178198600188e-05
this O 0 4.824201823794283e-05
family O 0 9.421595314051956e-05
suggest O 0 6.602444045711309e-05
that O 0 3.5544693673728034e-05
delGAG291 O 0 0.0010619862005114555
is O 0 5.254398274701089e-05
part O 0 7.226123852888122e-05
of O 0 8.402342791669071e-05
the O 0 0.00012937732390128076
cause O 0 0.0027462830767035484
of O 0 0.0004242486029397696
Japanese O 1 0.9536325931549072
ALD B-Disease 1 0.9999982118606567
with O 0 0.0004848372773267329
phenotypic O 0 0.002086459659039974
variations O 0 0.0008239515009336174
. O 0 0.0005540329730138183

Moreover O 0 0.0019439990865066648
, O 0 0.00018347028526477516
although O 0 5.798224447062239e-05
the O 0 5.231214527157135e-05
scale O 0 8.982576400740072e-05
of O 0 3.869607098749839e-05
the O 0 3.334679422550835e-05
study O 0 2.3898541257949546e-05
is O 0 1.4247611943574157e-05
limited O 0 1.4637036656495184e-05
, O 0 9.594345101504587e-06
there O 0 1.0554856999078766e-05
is O 0 1.3737155313719995e-05
a O 0 2.938458237622399e-05
possibility O 0 6.723577826051041e-05
that O 0 3.202218431397341e-05
PET O 0 0.000300936953863129
can O 0 2.6414911189931445e-05
detect O 0 0.00010321543959435076
an O 0 0.0001104094844777137
insidious B-Disease 1 0.9246544241905212
lesion I-Disease 1 0.9987772107124329
which O 0 6.562953058164567e-05
is O 0 5.2646297262981534e-05
undetectable O 0 0.000478592497529462
by O 0 3.237298733438365e-05
computed O 0 9.989553655032068e-05
tomogram O 0 0.01586897298693657
( O 0 0.00012411443458404392
CT O 0 0.0007417896413244307
) O 0 3.7150584830669686e-05
or O 0 3.841099169221707e-05
MRI O 0 0.00038254400715231895
analysis O 0 2.257352025480941e-05
, O 0 1.847233943408355e-05
and O 0 1.4599036148865707e-05
that O 0 1.1085425285273232e-05
the O 0 2.310298259544652e-05
higher O 0 2.461717667756602e-05
level O 0 4.446806633495726e-05
of O 0 5.1436374633340165e-05
tau O 0 0.0002902742999140173
reflects O 0 0.0001335731358267367
the O 0 7.695287058595568e-05
process O 0 0.00014757916505914181
of O 0 0.0006409009220078588
neuronal B-Disease 1 0.9986000657081604
degeneration I-Disease 1 0.9999998807907104
in O 1 0.6449456810951233
ALD B-Disease 1 0.9999996423721313
. O 0 0.002535820472985506

Lorenzos O 1 0.7908464670181274
Oil O 0 0.0025575198233127594
should O 0 0.00011537787213455886
be O 0 2.6000983780249953e-05
given O 0 2.786584445857443e-05
in O 0 3.6896552046528086e-05
the O 0 7.20689567970112e-05
early O 0 0.00023775355657562613
stage O 0 0.0012273583561182022
. O 0 0.0002566344919614494
. O 0 0.0003740948741324246

Nonsense O 0 0.01116135623306036
mutation O 0 0.0008090633200481534
in O 0 0.000164130367920734
exon O 0 0.0008595068356953561
4 O 0 0.00015689436986576766
of O 0 0.0001527668791823089
human O 0 0.000153653061715886
complement O 0 0.0008166860206983984
C9 O 1 0.9984170198440552
gene O 0 0.00014045255375094712
is O 0 6.125123763922602e-05
the O 0 8.50488941068761e-05
major O 0 0.0005543979932554066
cause O 0 0.0011364682577550411
of O 0 0.0007003576611168683
Japanese O 1 0.8502137660980225
complement B-Disease 1 0.9959523677825928
C9 I-Disease 1 0.9999991655349731
deficiency I-Disease 1 0.999998927116394
. O 0 0.0021231682039797306

Deficiency B-Disease 1 0.9996627569198608
of I-Disease 0 0.0010005587246268988
the I-Disease 0 0.000692342349793762
ninth I-Disease 1 0.9434307813644409
component I-Disease 0 0.0009694402106106281
of I-Disease 0 0.00015961669851094484
human I-Disease 0 0.0001381117763230577
complement I-Disease 0 0.0002686784719116986
( O 0 0.0001400522596668452
C9 O 1 0.9012920260429382
) O 0 2.5456931325607002e-05
is O 0 1.1223832188989036e-05
the O 0 1.6671314369887114e-05
most O 0 1.8836792150978e-05
common O 0 9.482613677391782e-05
complement B-Disease 1 0.9453453421592712
deficiency I-Disease 1 0.9999996423721313
in O 0 0.00010413087147753686
Japan O 0 0.0003265033010393381
but O 0 3.1603980460204184e-05
is O 0 2.0914651031489484e-05
rare O 0 6.92858302500099e-05
in O 0 3.183313674526289e-05
other O 0 2.933002178906463e-05
countries O 0 5.043054261477664e-05
. O 0 0.00021256160107441247

We O 0 0.0004471050633583218
studied O 0 0.00026126153534278274
the O 0 0.00010751788067864254
molecular O 0 0.0001772643008735031
basis O 0 0.0001279594871448353
of O 0 0.0006592349964194
C9 B-Disease 1 0.9999948740005493
deficiency I-Disease 1 0.9999643564224243
in O 0 0.00014267829828895628
four O 0 0.00022903431090526283
Japanese O 0 0.09487040340900421
C9 B-Disease 1 0.9999938011169434
- I-Disease 1 0.673156201839447
deficient I-Disease 1 0.8549826741218567
patients O 0 0.0005150699871592224
who O 0 0.00022860473836772144
had O 0 0.061918627470731735
suffered O 1 0.9999995231628418
from O 1 0.9997273087501526
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 0.9999998807907104
. O 0 0.005521864630281925

Direct O 0 0.0018821069970726967
sequencing O 0 0.0016356908017769456
of O 0 0.0007258771220222116
amplified O 0 0.003234019735828042
C9 O 1 0.7723392248153687
cDNA O 0 0.001629376201890409
and O 0 0.00014478311641141772
DNA O 0 0.0002680549514479935
revealed O 0 0.00034692202461883426
a O 0 0.00018978165462613106
nonsense O 0 0.0007761113229207695
substitution O 0 0.0004481846699491143
( O 0 0.0001561508106533438
CGA O 0 0.0017365291714668274
- O 0 0.0003622555814217776
- O 0 0.0004294976533856243
> O 0 0.0006195766618475318
TGA O 0 0.0019322304287925363
) O 0 7.938345515867695e-05
at O 0 0.00012155903823440894
codon O 0 0.0001968305732589215
95 O 0 6.418621342163533e-05
in O 0 2.1418865799205378e-05
exon O 0 0.00015621513011865318
4 O 0 4.7436555178137496e-05
in O 0 2.5639761588536203e-05
the O 0 0.00010560746886767447
four O 0 0.0003055682172998786
C9 B-Disease 1 0.9999055862426758
- I-Disease 0 0.016029424965381622
deficient I-Disease 0 0.007454745005816221
individuals O 0 0.0003653375606518239
. O 0 0.0005891220644116402

An O 0 0.0010068460833281279
allele O 0 0.0011154329404234886
- O 0 0.00033542828168720007
specific O 0 0.00011056118819396943
polymerase O 0 0.0007623040000908077
chain O 0 0.0002917572855949402
reaction O 0 0.00018731849559117109
system O 0 6.681018567178398e-05
designed O 0 4.9697471695253626e-05
to O 0 1.7996559108723886e-05
detect O 0 4.067300687893294e-05
exclusively O 0 2.1386355001595803e-05
only O 0 7.185151389421662e-06
one O 0 9.268633220926858e-06
of O 0 1.9141141820000485e-05
the O 0 3.232779272366315e-05
normal O 0 6.700771336909384e-05
and O 0 3.306156213511713e-05
mutant O 0 0.00019423462799750268
alleles O 0 5.2798844990320504e-05
indicated O 0 2.7229853003518656e-05
that O 0 6.213043434399879e-06
all O 0 5.4003689911041874e-06
the O 0 1.774470911186654e-05
four O 0 2.0719149688375182e-05
patients O 0 3.524122803355567e-05
were O 0 1.765726847224869e-05
homozygous O 0 5.9420824982225895e-05
for O 0 1.391096429870231e-05
the O 0 2.7006461095879786e-05
mutation O 0 2.9116297810105607e-05
in O 0 1.7860578736872412e-05
exon O 0 0.0001588765881024301
4 O 0 4.641310079023242e-05
and O 0 1.747283931763377e-05
that O 0 1.1050888133468106e-05
the O 0 2.2981508664088324e-05
parents O 0 3.5518398362910375e-05
of O 0 7.032579014776275e-05
patient O 0 0.00029957061633467674
2 O 0 0.00019390249508433044
were O 0 0.0001767414214555174
heterozygous O 0 0.0006154889124445617
. O 0 0.00046082749031484127

The O 0 0.0009666515397839248
common O 0 0.00030382120166905224
mutation O 0 0.00018996249127667397
at O 0 0.00019950034038629383
codon O 0 0.00023146782768890262
95 O 0 0.0001328212529188022
in O 0 4.2686446249717847e-05
exon O 0 0.0002752311120275408
4 O 0 7.539594662375748e-05
might O 0 4.422485289978795e-05
be O 0 1.628672907827422e-05
responsible O 0 4.715034447144717e-05
for O 0 3.528491288307123e-05
most O 0 0.0001271750224987045
Japanese O 1 0.6787695288658142
C9 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999997615814209
. O 0 0.0004728773783426732
. O 0 0.0006991069531068206

BRCA1 O 0 0.009348127990961075
required O 0 0.0004974132752977312
for O 0 0.00024788265000097454
transcription O 0 0.0015517988940700889
- O 0 0.0011886241845786572
coupled O 0 0.0032939750235527754
repair O 1 0.9926753640174866
of O 0 0.12281948328018188
oxidative O 1 0.9998433589935303
DNA O 0 0.061013609170913696
damage O 1 0.9407314658164978
. O 0 0.0008803657838143408

The O 0 0.01878664456307888
breast B-Disease 1 0.9999927282333374
and I-Disease 1 0.999393105506897
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999741315841675
gene O 0 0.004680406767874956
BRCA1 O 0 0.0197227131575346
encodes O 0 0.00024046670296229422
a O 0 0.0003001386357937008
zinc O 0 0.0843047946691513
finger O 0 0.0008250329410657287
protein O 0 0.00016034295549616218
of O 0 0.00015225078095681965
unknown O 0 0.0006196005851961672
function O 0 0.000373111164662987
. O 0 0.0004880743508692831

Association O 0 0.0017235808772966266
of O 0 0.0005675933789461851
the O 0 0.0004157124203629792
BRCA1 O 0 0.003689646953716874
protein O 0 0.0001219278565258719
with O 0 3.9942686271388084e-05
the O 0 0.00011742077913368121
DNA O 0 0.0004672941577155143
repair O 0 0.3247562646865845
protein O 0 0.0003978742170147598
Rad51 O 0 0.0040647778660058975
and O 0 4.964901017956436e-05
changes O 0 3.710190503625199e-05
in O 0 2.370211950619705e-05
the O 0 4.434221045812592e-05
phosphorylation O 0 0.0001427037495886907
and O 0 4.653924042941071e-05
cellular O 0 0.0001348639780189842
localization O 0 0.00016772981325630099
of O 0 4.4884567614644766e-05
the O 0 5.665547359967604e-05
protein O 0 5.1305381930433214e-05
after O 0 5.93610129726585e-05
exposure O 0 0.00012442465231288224
to O 0 2.5483117497060448e-05
DNA O 0 0.00013849581591784954
- O 0 0.00011452606850070879
damaging O 0 0.00025809177896007895
agents O 0 3.02691369142849e-05
are O 0 5.449226591736078e-06
consistent O 0 4.2351482989033684e-05
with O 0 2.0354505977593362e-05
a O 0 8.1099227827508e-05
role O 0 0.00018302768876310438
for O 0 0.00010992748866556212
BRCA1 O 0 0.0495658814907074
in O 0 0.0002708920801524073
DNA O 0 0.0020444965921342373
repair O 1 0.7967586517333984
. O 0 0.000924181193113327

Here O 0 0.0010131660383194685
, O 0 0.0002139550488209352
it O 0 7.090314466040581e-05
is O 0 4.637708480004221e-05
shown O 0 7.766560156596825e-05
that O 0 6.356734229484573e-05
mouse O 0 0.0007909660926088691
embryonic O 0 0.002948501380160451
stem O 0 0.003944050520658493
cells O 0 0.0005312637076713145
deficient B-Disease 0 0.001529232831671834
in I-Disease 0 0.00012919929577037692
BRCA1 I-Disease 0 0.002815417479723692
are O 0 2.317377038707491e-05
defective O 0 0.00040644867112860084
in O 0 2.2293712390819564e-05
the O 0 3.0490622521028854e-05
ability O 0 2.5538782210787758e-05
to O 0 1.212198731082026e-05
carry O 0 2.35110564972274e-05
out O 0 4.775081106345169e-05
transcription O 0 0.0002778772613964975
- O 0 0.0002526658936403692
coupled O 0 0.0008064009598456323
repair O 0 0.20605933666229248
of O 0 0.0014134489465504885
oxidative O 1 0.9984216690063477
DNA O 0 0.01950908452272415
damage O 1 0.7825703024864197
, O 0 7.477003964595497e-05
and O 0 4.9484380724607036e-05
are O 0 3.333903441671282e-05
hypersensitive O 0 0.0015108451480045915
to O 0 0.00021917920093983412
ionizing O 1 0.5436919331550598
radiation O 0 0.07463323324918747
and O 0 0.00022234997595660388
hydrogen O 0 0.0017420263029634953
peroxide O 0 0.005388248711824417
. O 0 0.0007341073942370713

These O 0 0.000555410806555301
results O 0 0.000345743668731302
suggest O 0 0.000258485582889989
that O 0 0.00011613575770752504
BRCA1 O 0 0.00363025045953691
participates O 0 0.00026375585002824664
, O 0 6.864906754344702e-05
directly O 0 5.1635266572702676e-05
or O 0 3.043092874577269e-05
indirectly O 0 6.988496897974983e-05
, O 0 2.8423863113857806e-05
in O 0 5.458641317090951e-05
transcription O 0 0.0003035386325791478
- O 0 0.0003381191345397383
coupled O 0 0.0005835999618284404
repair O 0 0.20444834232330322
of O 0 0.0024899549316614866
oxidative O 1 0.9992146492004395
DNA O 0 0.016835695132613182
damage O 1 0.915618896484375
. O 0 0.00024933379609137774
. O 0 0.0004983720136806369

Truncation O 0 0.028624864295125008
mutations O 0 0.0009080496383830905
in O 0 0.00019142638484481722
the O 0 0.0002542594447731972
transactivation O 0 0.0026987455785274506
region O 0 0.000310095347231254
of O 0 0.00034387517371214926
PAX6 O 1 0.9991845488548279
result O 0 0.00019840541062876582
in O 0 8.973450894700363e-05
dominant O 0 0.0009469524957239628
- O 0 0.0005238603334873915
negative O 0 0.00043939927127212286
mutants O 0 0.002042254665866494
. O 0 0.0006619317573495209

PAX6 O 1 0.8178460001945496
is O 0 0.0008356593898497522
a O 0 0.0004201259871479124
transcription O 0 0.0004112670721951872
factor O 0 0.00020329143444541842
with O 0 4.826346048503183e-05
two O 0 4.623339555109851e-05
DNA O 0 0.00016341031005140394
- O 0 0.00015545717906206846
binding O 0 4.585620990837924e-05
domains O 0 0.00011494860518723726
( O 0 5.797710400656797e-05
paired O 0 0.00016199298261199147
box O 0 0.0002695696020964533
and O 0 5.900613541598432e-05
homeobox O 0 0.0008042789995670319
) O 0 3.41110753652174e-05
and O 0 3.0240975320339203e-05
a O 0 0.00010463463695487007
proline O 0 0.0007696577813476324
- O 0 0.0002636105637066066
serine O 0 0.0008155863033607602
- O 0 0.0003434032551012933
threonine O 0 0.0012318622320890427
( O 0 0.00033281807554885745
PST O 0 0.007561165373772383
) O 0 0.00020835216855630279
- O 0 0.0004253792285453528
rich O 0 0.0006521103787235916
transactivation O 0 0.004370253067463636
domain O 0 0.0010966408299282193
. O 0 0.0007672331412322819

PAX6 O 1 0.9992702603340149
regulates O 0 0.01736101321876049
eye O 0 0.0218039657920599
development O 0 0.0006313776248134673
in O 0 0.00013533045421354473
animals O 0 0.00012776807125192136
ranging O 0 0.0001797664153855294
from O 0 8.381561929127201e-05
jellyfish O 0 0.00022048375103622675
to O 0 4.07103325414937e-05
Drosophila O 0 0.00026920746313408017
to O 0 6.89827575115487e-05
humans O 0 0.0002851085737347603
. O 0 0.00034327624598518014

Heterozygous O 0 0.0030332289170473814
mutations O 0 0.0006477207061834633
in O 0 0.00017324685177300125
the O 0 0.00028334229136817157
human O 0 0.0006921925814822316
PAX6 O 1 0.9997910857200623
gene O 0 0.00022146791161503643
result O 0 8.486556907882914e-05
in O 0 4.078665733686648e-05
various O 0 6.11553477938287e-05
phenotypes O 0 0.00044260243885219097
, O 0 0.00010580542584648356
including O 0 0.000152607899508439
aniridia B-Disease 1 0.9999524354934692
, O 0 0.0009959089802578092
Peters B-Disease 1 0.9991650581359863
anomaly I-Disease 1 0.9997792840003967
, O 0 0.0006453050300478935
autosomal B-Disease 0 0.3314915895462036
dominant I-Disease 1 0.9922506213188171
keratitis I-Disease 1 0.9999988079071045
, O 0 0.003186075249686837
and O 0 0.009104813449084759
familial B-Disease 1 0.9999935626983643
foveal I-Disease 1 0.9999996423721313
dysplasia I-Disease 1 0.9999998807907104
. O 0 0.025529347360134125

It O 0 0.0004418643075041473
is O 0 0.00013259462139103562
believed O 0 0.00020095452782697976
that O 0 4.605035064741969e-05
the O 0 8.621833694633096e-05
mutated O 0 0.00026696029817685485
allele O 0 0.00018203425861429423
of O 0 0.0001237081887666136
PAX6 O 1 0.7739245891571045
produces O 0 0.0001152175827883184
an O 0 5.248989327810705e-05
inactive O 0 0.0002549310738686472
protein O 0 0.00011340511991875246
and O 0 0.00010547280544415116
aniridia B-Disease 1 0.999017596244812
is O 0 0.00017257698345929384
caused O 0 0.006523265969008207
due O 0 0.0002888597082346678
to O 0 0.00013396333088167012
genetic O 0 0.0016508231637999415
haploinsufficiency O 1 0.9757353067398071
. O 0 0.0015059052966535091

However O 0 0.0006613314617425203
, O 0 0.00016915862215682864
several O 0 6.228775600902736e-05
truncation O 0 0.0012560029281303287
mutations O 0 7.935780013212934e-05
have O 0 1.4296692825155333e-05
been O 0 1.2467155102058314e-05
found O 0 1.2061700545018539e-05
to O 0 8.253204214270227e-06
occur O 0 1.2430959031917155e-05
in O 0 1.711202821752522e-05
the O 0 5.2871597290504724e-05
C O 0 0.0002714210713747889
- O 0 0.00014827639097347856
terminal O 0 0.00020782877982128412
half O 0 5.912419146625325e-05
of O 0 7.978887879289687e-05
PAX6 O 1 0.6780735850334167
in O 0 8.729147521080449e-05
patients O 0 0.00013858232705388218
with O 0 7.117221684893593e-05
Aniridia B-Disease 1 0.9999580383300781
resulting O 0 0.0006785084842704237
in O 0 4.9710029998095706e-05
mutant O 0 0.00024963944451883435
proteins O 0 2.0778035832336172e-05
that O 0 7.2269058364327066e-06
retain O 0 2.506748387531843e-05
the O 0 2.8265058062970638e-05
DNA O 0 6.989523535594344e-05
- O 0 4.852018173551187e-05
binding O 0 2.210963975812774e-05
domains O 0 2.482606032572221e-05
but O 0 1.595348476257641e-05
have O 0 1.3041496458754409e-05
lost O 0 7.900525815784931e-05
most O 0 3.071525497944094e-05
of O 0 0.00011181653098901734
the O 0 0.0002554315433371812
transactivation O 0 0.005323540419340134
domain O 0 0.0009343943675048649
. O 0 0.0008632614626549184

It O 0 0.00031257825321517885
is O 0 0.0001281287259189412
not O 0 4.019587504444644e-05
clear O 0 8.615331171313301e-05
whether O 0 7.11252650944516e-05
such O 0 4.961522063240409e-05
mutants O 0 0.0004711285582743585
really O 0 0.0001481159997638315
behave O 0 0.00011197786807315424
as O 0 5.393048559199087e-05
loss O 0 0.00027815293287858367
- O 0 0.00014753091090824455
of O 0 0.00011786208779085428
- O 0 0.0002510177728254348
function O 0 9.231102740159258e-05
mutants O 0 0.00047612586058676243
as O 0 9.717153443489224e-05
predicted O 0 0.0004362938925623894
by O 0 0.00020014873007312417
haploinsufficiency O 0 0.020371463149785995
. O 0 0.000640809943433851

Contrary O 0 0.001576217240653932
to O 0 0.00013148877769708633
this O 0 4.942716986988671e-05
theory O 0 0.00012389293988235295
, O 0 4.0644001273903996e-05
our O 0 3.710915916599333e-05
data O 0 2.582178422017023e-05
showed O 0 6.010236029396765e-05
that O 0 1.4326638847705908e-05
these O 0 1.2345506547717378e-05
mutants O 0 0.00010184725397266448
are O 0 1.1522265594976489e-05
dominant O 0 8.345551759703085e-05
- O 0 8.812072337605059e-05
negative O 0 5.8045196055900306e-05
in O 0 5.4400945373345166e-05
transient O 0 0.0009200787171721458
transfection O 0 0.0025390039663761854
assays O 0 0.00012757694639731199
when O 0 3.915021079592407e-05
they O 0 1.560394412081223e-05
are O 0 1.1632563655439299e-05
coexpressed O 0 0.0006642528460361063
with O 0 6.78149881423451e-05
wild O 0 0.0007500219508074224
- O 0 0.0022038964089006186
type O 0 0.0030295411124825478
PAX6 O 1 0.9898876547813416
. O 0 0.0015785618452355266

We O 0 0.00033025158336386085
found O 0 8.254500426119193e-05
that O 0 2.63730289589148e-05
the O 0 4.9375677917851135e-05
dominant O 0 0.0002795422915369272
- O 0 0.00016256254457402974
negative O 0 5.76250531594269e-05
effects O 0 9.338303789263591e-05
result O 0 2.7538053473108448e-05
from O 0 2.2615686248173006e-05
the O 0 4.2896685044979677e-05
enhanced O 0 0.00011172390804858878
DNA O 0 9.402809519087896e-05
binding O 0 4.7255052777472883e-05
ability O 0 4.6595901949331164e-05
of O 0 9.727222641231492e-05
these O 0 8.200576849048957e-05
mutants O 0 0.0025011850520968437
. O 0 0.0006770134787075222

Kinetic O 0 0.004736213944852352
studies O 0 0.00041325343772768974
of O 0 0.0002493142965249717
binding O 0 0.00014764968364033848
and O 0 0.00016086545656435192
dissociation O 0 0.0008729808614589274
revealed O 0 0.0003140101907774806
that O 0 3.573031790438108e-05
various O 0 4.1753763071028516e-05
truncation O 0 0.0004592164186760783
mutants O 0 0.0002284848887939006
have O 0 1.5365914805443026e-05
3 O 0 4.043377339257859e-05
- O 0 5.388226782088168e-05
5 O 0 4.71673920401372e-05
- O 0 6.003865200909786e-05
fold O 0 5.322449578670785e-05
higher O 0 2.5162711608572863e-05
affinity O 0 2.2077128960518166e-05
to O 0 9.38252287596697e-06
various O 0 1.4336997992359102e-05
DNA O 0 7.086853293003514e-05
- O 0 4.05215541832149e-05
binding O 0 1.6565607438678853e-05
sites O 0 1.9150016669300385e-05
when O 0 1.907608748297207e-05
compared O 0 1.906357465486508e-05
with O 0 1.026089012157172e-05
the O 0 8.268310193670914e-05
wild O 0 0.0004526693082880229
- O 0 0.0012081508757546544
type O 0 0.0016584066906943917
PAX6 O 1 0.8999017477035522
. O 0 0.0011039212113246322

These O 0 0.0003466657944954932
results O 0 0.0001195990334963426
provide O 0 3.5646291507873684e-05
a O 0 5.437822619569488e-05
new O 0 4.905077730654739e-05
insight O 0 0.00013576654600910842
into O 0 3.4510383557062596e-05
the O 0 8.069269097177312e-05
role O 0 0.00019412390247453004
of O 0 0.00031401257729157805
mutant O 0 0.27237436175346375
PAX6 O 1 0.9997656941413879
in O 0 0.000995747046545148
causing O 1 0.992268979549408
aniridia B-Disease 1 0.9998314380645752
. O 0 0.0007143808761611581
. O 0 0.0008216214482672513

Reversal O 1 0.7581820487976074
of O 1 0.9880003333091736
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9636223316192627
excellent O 1 0.5036466121673584
neuropsychologic O 1 0.9989237189292908
outcome O 0 0.00019237198284827173
in O 0 3.7186637200647965e-05
very B-Disease 0 7.142650429159403e-05
- I-Disease 0 0.00012040507135679945
long I-Disease 0 0.00011427613208070397
- I-Disease 0 0.0002609369403216988
chain I-Disease 0 0.00045349079300649464
acyl I-Disease 0 0.0006962993065826595
- I-Disease 0 0.0005341897485777736
coenzyme I-Disease 0 0.0018374010687693954
A I-Disease 0 0.1639540046453476
dehydrogenase I-Disease 1 0.9992362260818481
deficiency I-Disease 1 0.9999793767929077
. O 0 0.0014415013138204813

Very B-Disease 0 0.0018883357988670468
- I-Disease 0 0.0019211090402677655
long I-Disease 0 0.0008020640816539526
- I-Disease 0 0.0008058417588472366
chain I-Disease 0 0.0008539203554391861
acyl I-Disease 0 0.001385353272780776
- I-Disease 0 0.0003646880795713514
coenzyme I-Disease 0 0.0007945505785755813
A I-Disease 0 0.000865852169226855
dehydrogenase I-Disease 0 0.026415865868330002
( I-Disease 0 0.0008365653338842094
VLCAD I-Disease 1 0.9999656677246094
) I-Disease 0 0.0012713153846561909
deficiency I-Disease 1 0.999961256980896
is O 0 0.00016409043746534735
a O 0 0.0009522647596895695
disorder O 1 0.9999657869338989
of O 0 0.16648706793785095
fatty O 1 0.9175678491592407
acid O 0 0.017630567774176598
beta O 0 0.00031264027347788215
oxidation O 0 0.00014928847667761147
that O 0 3.8037389458622783e-05
reportedly O 0 0.000114954418677371
has O 0 5.96008358115796e-05
high O 0 0.0001835411530919373
rates O 0 9.688508725957945e-05
of O 0 0.0004895112942904234
morbidity O 0 0.3853587806224823
and O 0 0.0006173144793137908
mortality O 0 0.01716618239879608
. O 0 0.0007750500808469951

We O 0 0.0005742856883443892
describe O 0 0.00040897249709814787
the O 0 0.00013608123117592186
outcome O 0 0.00012176333257229999
of O 0 6.098110679886304e-05
a O 0 7.31848122086376e-05
5 O 0 9.228920680470765e-05
- O 0 0.00011848885333165526
year O 0 5.3600193496095017e-05
- O 0 9.906748164212331e-05
old O 0 0.0002935057273134589
girl O 0 0.001207303605042398
with O 0 0.0007875125738792121
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.0002616429701447487
was O 0 0.0003268617729190737
first O 0 6.979238969506696e-05
seen O 0 6.157075404189527e-05
at O 0 5.0409573304932564e-05
5 O 0 2.6591378627927043e-05
months O 0 2.8694743377855048e-05
of O 0 4.954798350809142e-05
age O 0 0.00021948137145955116
with O 0 0.0009610672714188695
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9999986886978149
hepatomegaly B-Disease 1 1.0
, O 1 0.9999494552612305
encephalopathy B-Disease 1 1.0
, O 0 0.00390663044527173
and O 0 0.0015404688892886043
hypotonia B-Disease 1 0.9977898597717285
. O 0 0.0012255464680492878

Biochemical O 0 0.021887734532356262
studies O 0 0.003887865459546447
indicated O 1 0.9902170896530151
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.999721109867096
by O 0 0.0001868981635197997
a O 0 0.0004756636044476181
stable O 0 0.0016235210932791233
yet O 0 0.0005383257521316409
inactive O 0 0.002008367795497179
enzyme O 0 0.0013175474014133215
. O 0 0.0006168190157040954

Molecular O 0 0.003581272205337882
genetic O 0 0.0006848498014733195
analysis O 0 0.0001615727524040267
of O 0 0.00024099118309095502
her O 0 0.0007415860891342163
VLCAD O 1 0.9998761415481567
gene O 0 0.0004303627647459507
revealed O 0 0.00038714532274752855
a O 0 0.0002566839102655649
T1372C O 1 0.5645507574081421
( O 0 0.0004591314645949751
F458L O 0 0.02136313170194626
) O 0 0.00014884443953633308
missense O 0 0.0010232515633106232
mutation O 0 0.00023888243595138192
and O 0 9.456102998228744e-05
a O 0 0.0004148854350205511
1668 O 1 0.7015127539634705
ACAG O 1 0.9990087747573853
1669 O 1 0.6643972992897034
splice O 0 0.008594033308327198
site O 0 0.002705394057556987
mutation O 0 0.001191590796224773
. O 0 0.0006659135688096285

After O 0 0.003442849963903427
initial O 0 0.0018347889417782426
treatment O 0 0.0026357145980000496
with O 0 0.0003376538516022265
intravenous O 1 0.995636522769928
glucose O 0 0.13091696798801422
and O 0 0.0001710640062810853
carnitine O 1 0.8359895944595337
, O 0 7.123359682736918e-05
the O 0 7.6575881394092e-05
patient O 0 0.00020806273096241057
has O 0 4.1583727579563856e-05
thrived O 0 0.00015014417294878513
on O 0 4.2993993702111766e-05
a O 0 0.00010157993528991938
low O 0 0.00013633565686177462
- O 0 0.00011686897050822154
fat O 0 0.0001575334172230214
diet O 0 0.0001305484038311988
supplemented O 0 0.00010173154441872612
with O 0 3.8212161598494276e-05
medium O 0 0.0002069141046376899
- O 0 0.0001691752258921042
chain O 0 0.00034103807411156595
triglyceride O 0 0.0010477324249222875
oil O 0 0.0003587844839785248
and O 0 0.0001318693539360538
carnitine O 0 0.04547543078660965
and O 0 0.0001928719284478575
avoidance O 0 0.007022260222584009
of O 0 0.0012921028537675738
fasting O 0 0.010990777052938938
. O 0 0.000995317124761641

Her O 1 0.9840134978294373
ventricular O 1 0.9999983310699463
hypertrophy O 1 0.9999816417694092
resolved O 0 0.0015723888063803315
significantly O 0 0.00018210266716778278
over O 0 4.602207263815217e-05
1 O 0 4.186867590760812e-05
year O 0 4.721874574897811e-05
, O 0 3.870503860525787e-05
and O 0 5.912396591156721e-05
cognitively O 0 0.0015252125449478626
, O 0 4.06189683417324e-05
she O 0 4.7920966608216986e-05
is O 0 2.3496848370996304e-05
in O 0 2.488911195541732e-05
the O 0 6.398130062734708e-05
superior O 0 0.00019570269796531647
range O 0 9.123984636971727e-05
for O 0 6.309325544862077e-05
age O 0 0.0005322102806530893
. O 0 0.0006557154119946063

Clinical O 0 0.00625207182019949
recognition O 0 0.005599552299827337
of O 1 0.9994118213653564
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.0008663606131449342
important O 0 0.00012357848754618317
because O 0 2.266299088660162e-05
it O 0 7.175852260843385e-06
is O 0 6.692639999528183e-06
one O 0 8.95623361429898e-06
of O 0 2.1971125534037128e-05
the O 0 5.570253779296763e-05
few O 0 6.72554670018144e-05
directly O 0 0.00026645121397450566
treatable O 1 0.9999784231185913
causes O 1 0.9911110997200012
of O 1 0.9852241277694702
cardiomyopathy B-Disease 1 1.0
in O 0 0.07288891822099686
children O 0 0.0007649150211364031
. O 0 0.00021973012189846486
. O 0 0.0003418868873268366

Cloning O 0 0.002034297911450267
of O 0 0.0002913819917012006
a O 0 0.00011471199104562402
novel O 0 0.00011658402218017727
member O 0 5.184402834856883e-05
of O 0 7.288046617759392e-05
the O 0 0.00012081311433576047
low O 0 0.0003431862860452384
- O 0 0.000313082302454859
density O 0 0.0004912039148621261
lipoprotein O 0 0.05016551539301872
receptor O 0 0.000832454941701144
family O 0 0.0006198622868396342
. O 0 0.0004301969020161778

A O 0 0.0028715285006910563
gene O 0 0.0005191254895180464
encoding O 0 0.000142757358844392
a O 0 0.00014697879669256508
novel O 0 0.00022355548571795225
transmembrane O 0 0.0004376409051474184
protein O 0 8.433432230958715e-05
was O 0 0.00010618830856401473
identified O 0 4.5448814489645883e-05
by O 0 1.4668267795059364e-05
DNA O 0 3.1402272725244984e-05
sequence O 0 2.494873660907615e-05
analysis O 0 1.657306529523339e-05
within O 0 3.502462641336024e-05
the O 0 0.00011250068200752139
insulin B-Disease 0 0.18398183584213257
- I-Disease 0 0.0020712960977107286
dependent I-Disease 0 0.0021276797633618116
diabetes I-Disease 1 0.9999992847442627
mellitus I-Disease 1 0.9999923706054688
( O 0 0.0028003437910228968
IDDM B-Disease 1 0.9996675252914429
) O 0 0.00029141228878870606
locus O 0 0.0023189843632280827
IDDM4 O 1 0.7654218673706055
on O 0 0.0008447712170891464
chromosome O 0 0.0026003713719546795
11q13 O 0 0.1336667537689209
. O 0 0.0011404725955799222

Based O 0 0.0003950374375563115
on O 0 0.0001795575808500871
its O 0 9.72015768638812e-05
chromosomal O 0 0.00046216652845032513
position O 0 0.00010352170647820458
, O 0 4.027180693810806e-05
this O 0 2.347623922105413e-05
gene O 0 3.7919977330602705e-05
is O 0 1.6992631572065875e-05
a O 0 3.7785117456223816e-05
candidate O 0 9.658124326961115e-05
for O 0 4.569243537844159e-05
conferring O 0 0.001424141926690936
susceptibility O 1 0.8400119543075562
to O 0 0.000616686709690839
diabetes B-Disease 1 0.9998737573623657
. O 0 0.0011213842080906034

The O 0 0.0012100073508918285
gene O 0 0.00045431609032675624
, O 0 0.00016117561608552933
termed O 0 0.0008273124694824219
low O 0 0.00039438530802726746
- O 0 0.00019186346617061645
density O 0 0.0001839644683059305
lipoprotein O 0 0.00095160718774423
receptor O 0 0.0001392741105519235
related O 0 6.067159119993448e-05
protein O 0 5.683811104972847e-05
5 O 0 7.885276863817126e-05
( O 0 7.907339750090614e-05
LRP5 O 0 0.03795790299773216
) O 0 3.7460635212482885e-05
, O 0 2.7222584321862087e-05
encodes O 0 5.415291161625646e-05
a O 0 3.2326097425539047e-05
protein O 0 4.807742152479477e-05
of O 0 8.074195648077875e-05
1615 O 0 0.0008870211313478649
amino O 0 7.236543024191633e-05
acids O 0 3.89322594855912e-05
that O 0 1.4618565728596877e-05
contains O 0 3.3634940336924046e-05
conserved O 0 6.87577630742453e-05
modules O 0 9.154574217973277e-05
which O 0 1.3106593542033806e-05
are O 0 3.627742216849583e-06
characteristic O 0 2.5998157070716843e-05
of O 0 2.7940939617110416e-05
the O 0 6.0710539401043206e-05
low O 0 0.00016195049101952463
- O 0 0.0001914803870022297
density O 0 0.00031850620871409774
lipoprotein O 0 0.12422297149896622
( O 0 0.00023350917035713792
LDL O 0 0.1529383659362793
) O 0 0.00011348126281518489
receptor O 0 0.0004579923115670681
family O 0 0.0006301188259385526
. O 0 0.0005745867965742946

These O 0 0.0004885081434622407
modules O 0 0.0009117597946897149
include O 0 0.00017822386871557683
a O 0 0.00017347199900541455
putative O 0 0.0009465024340897799
signal O 0 0.000328280555550009
peptide O 0 0.00017659318109508604
for O 0 2.4542940082028508e-05
protein O 0 3.260144148953259e-05
export O 0 5.7053046475630254e-05
, O 0 3.0976378184277564e-05
four O 0 6.040936932549812e-05
epidermal O 0 0.023013301193714142
growth O 0 0.000372323818737641
factor O 0 0.00042501118150539696
( O 0 0.00014047139848116785
EGF O 0 0.009562840685248375
) O 0 6.766034493921325e-05
repeats O 0 0.00015261721273418516
with O 0 3.6361630918690935e-05
associated O 0 9.152705752057955e-05
spacer O 0 0.0005563062732107937
domains O 0 0.00019967810658272356
, O 0 8.173719106707722e-05
three O 0 9.505538764642552e-05
LDL O 0 0.41542455554008484
- O 0 0.0003087716759182513
receptor O 0 0.00025363281019963324
( O 0 0.00010824942728504539
LDLR O 0 0.08122191578149796
) O 0 3.527872104314156e-05
repeats O 0 5.847036300110631e-05
, O 0 1.7988699255511165e-05
a O 0 3.4720800613285974e-05
single O 0 5.265764411888085e-05
transmembrane O 0 0.00037848937790840864
spanning O 0 0.0003331885382067412
domain O 0 0.00010290037607774138
, O 0 3.570565604604781e-05
and O 0 5.342933945939876e-05
a O 0 9.888871863950044e-05
cytoplasmic O 0 0.0005050998879596591
domain O 0 0.0004773330583702773
. O 0 0.000523286871612072

The O 0 0.0010961645748466253
encoded O 0 0.000343894847901538
protein O 0 0.00018461742729414254
has O 0 4.2595645936671644e-05
a O 0 4.3416312109911814e-05
unique O 0 6.358116661431268e-05
organization O 0 7.988511060830206e-05
of O 0 0.0002185258490499109
EGF O 1 0.9907887578010559
and O 0 0.0003303967823740095
LDLR O 1 0.9986861348152161
repeats O 0 0.0004939125501550734
; O 0 5.4564188758376986e-05
therefore O 0 6.183919322211295e-05
, O 0 7.117194763850421e-05
LRP5 O 0 0.11798609048128128
likely O 0 8.243919728556648e-05
represents O 0 9.398588008480147e-05
a O 0 3.719621236086823e-05
new O 0 2.9636516046593897e-05
category O 0 6.153143476694822e-05
of O 0 0.00010071112046716735
the O 0 0.0003368371690157801
LDLR O 1 0.9996663331985474
family O 0 0.0011570993810892105
. O 0 0.0011000355007126927

Both O 0 0.0008928155293688178
human O 0 0.0008246077341027558
and O 0 0.000539501488674432
mouse O 0 0.026551339775323868
LRP5 O 1 0.999951958656311
cDNAs O 1 0.8742227554321289
have O 0 6.551978731295094e-05
been O 0 4.6562625357182696e-05
isolated O 0 9.927240171236917e-05
and O 0 3.138024112558924e-05
the O 0 4.233505387674086e-05
encoded O 0 3.546390507835895e-05
mature O 0 4.254331361153163e-05
proteins O 0 2.168877108488232e-05
are O 0 6.2238900682132225e-06
95 O 0 2.6432398954057135e-05
% O 0 1.6531264918739907e-05
identical O 0 3.0322296879603527e-05
, O 0 2.2003330741426907e-05
indicating O 0 7.191106851678342e-05
a O 0 3.2286534406011924e-05
high O 0 6.683490209979936e-05
degree O 0 8.11030258773826e-05
of O 0 0.00014542636927217245
evolutionary O 0 0.0005776274483650923
conservation O 0 0.00031175537151284516
. O 0 0.00023089627211447805
. O 0 0.00038213611696846783

The O 0 0.006425244268029928
APC B-Disease 0 0.4843139052391052
variants O 0 0.0024377910885959864
I1307K O 1 0.6129193902015686
and O 0 0.00047846478992141783
E1317Q O 0 0.168091282248497
are O 0 5.119424531585537e-05
associated O 0 0.0003464817418716848
with O 1 0.8228992819786072
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.00045093760127201676
but O 0 2.4000953999347985e-05
not O 0 1.1760123015847057e-05
always O 0 3.077636210946366e-05
with O 0 1.7068610759451985e-05
a O 0 8.778984192758799e-05
family O 0 0.0003150086849927902
history O 0 0.0012943606125190854
. O 0 0.0008899799431674182

Classical O 0 0.04914317652583122
familial B-Disease 1 0.9999759197235107
adenomatous I-Disease 1 0.9999996423721313
polyposis I-Disease 1 1.0
( O 1 0.9803555011749268
FAP B-Disease 1 0.9999271631240845
) O 0 0.00017688676598481834
is O 0 0.00010956822370644659
a O 0 0.00013940577628090978
high O 0 0.0007475639577023685
- O 0 0.00237096450291574
penetrance O 1 0.9651020169258118
autosomal B-Disease 1 0.988134503364563
dominant I-Disease 1 0.9993473887443542
disease I-Disease 1 0.9999591112136841
that O 0 0.00010636545630404726
predisposes O 0 0.016266850754618645
to O 0 3.285499769845046e-05
hundreds O 0 8.701547631062567e-05
or O 0 6.2255458033178e-05
thousands O 0 0.00029886802076362073
of O 0 0.36868566274642944
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9961012601852417
carcinoma I-Disease 1 1.0
and O 0 0.00021669607667718083
that O 0 6.57415876048617e-05
results O 0 4.813559280592017e-05
from O 0 7.696005195612088e-05
truncating O 0 0.0010766683844849467
mutations O 0 0.00015823179273866117
in O 0 9.217153274221346e-05
the O 0 0.0002975170500576496
APC B-Disease 1 0.9166168570518494
gene O 0 0.000914915231987834
. O 0 0.0004879315383732319

A O 0 0.005877022165805101
variant O 0 0.004365749191492796
of O 0 0.0017338264733552933
FAP B-Disease 1 0.999613344669342
is O 0 0.0025806769262999296
attenuated B-Disease 1 0.99947589635849
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999997615814209
coli I-Disease 1 0.9999551773071289
, O 0 0.0001799787423806265
which O 0 4.138991062063724e-05
results O 0 3.385383024578914e-05
from O 0 3.588336403481662e-05
germ O 1 0.8064950108528137
- O 0 0.00016982704983092844
line O 0 6.888691859785467e-05
mutations O 0 1.2844477168982849e-05
in O 0 6.316339295153739e-06
the O 0 1.7588025002623908e-05
5 O 0 2.1150166503502987e-05
and O 0 1.0624175956763793e-05
3 O 0 2.364917418162804e-05
regions O 0 2.360168036830146e-05
of O 0 7.56711742724292e-05
the O 0 0.0002874665369745344
APC B-Disease 1 0.9142580032348633
gene O 0 0.00123321870341897
. O 0 0.0005427341093309224

Attenuated B-Disease 1 0.9999415874481201
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 0.9999994039535522
patients O 1 0.7277601361274719
have O 0 0.0001938416826305911
" O 0 0.0006320679094642401
multiple O 0 0.0011647174833342433
" O 1 0.9857147336006165
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999966621398926
( O 0 0.00015928540960885584
typically O 0 2.1623920474667102e-05
fewer O 0 1.9464421711745672e-05
than O 0 9.086277714231983e-06
100 O 0 3.508155350573361e-05
) O 0 1.104311286326265e-05
without O 0 1.5868043192313053e-05
the O 0 7.900126365711913e-05
florid O 0 0.002000875072553754
phenotype O 0 0.0008421245729550719
of O 0 0.0003593795991037041
classical O 0 0.003235097508877516
FAP B-Disease 1 0.9976887702941895
. O 0 0.0016933330334722996

Another O 0 0.0019360404694452882
group O 0 0.0003683491959236562
of O 0 0.00052623450756073
patients O 0 0.0006905493210069835
with O 0 0.00013772238162346184
multiple O 0 0.0017105693696066737
adenomas B-Disease 1 0.9996267557144165
has O 0 8.926468581194058e-05
no O 0 5.2400020649656653e-05
mutations O 0 3.0242130378610454e-05
in O 0 2.746527570707258e-05
the O 0 6.739150558132678e-05
APC B-Disease 0 0.3928658366203308
gene O 0 7.043035293463618e-05
, O 0 2.9578746762126684e-05
and O 0 2.2311749489745125e-05
their O 0 1.587573206052184e-05
phenotype O 0 0.00010832789121195674
probably O 0 7.010216359049082e-05
results O 0 2.6213505407213233e-05
from O 0 1.9669418179546483e-05
variation O 0 4.466377504286356e-05
at O 0 6.342781853163615e-05
a O 0 7.909948180895299e-05
locus O 0 0.0002652897092048079
, O 0 4.2526684410404414e-05
or O 0 4.665935557568446e-05
loci O 0 0.00019431744294706732
, O 0 4.5357021008385345e-05
elsewhere O 0 6.220940122148022e-05
in O 0 4.450120104593225e-05
the O 0 0.00019072130089625716
genome O 0 0.0006248960271477699
. O 0 0.0005941669805906713

Recently O 0 0.00239726435393095
, O 0 0.0002906002337113023
however O 0 9.113810665439814e-05
, O 0 7.039704360067844e-05
a O 0 0.00011646257917163894
missense O 0 0.0005189480725675821
variant O 0 0.00030330399749800563
of O 0 0.00024312481400556862
APC B-Disease 1 0.9805301427841187
( O 0 0.0002743581426329911
I1307K O 0 0.43294042348861694
) O 0 4.011553028249182e-05
was O 0 0.00011993044608971104
described O 0 6.81385790812783e-05
that O 0 1.7071166439563967e-05
confers O 0 0.00011580112186493352
an O 0 5.866881110705435e-05
increased O 0 0.00019400587189011276
risk O 0 0.0014242903562262654
of O 1 0.9986481070518494
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.0006736821378581226
including O 0 0.0002884983259718865
multiple O 0 0.0013031542766839266
adenomas B-Disease 1 0.9991737008094788
, O 0 0.00033316470216959715
in O 0 0.0003819298290181905
Ashkenazim O 0 0.01273147389292717
. O 0 0.0009128089877776802

We O 0 0.0005715542356483638
have O 0 6.104301428422332e-05
studied O 0 0.00012041322042932734
a O 0 6.540903996210545e-05
set O 0 4.730284126708284e-05
of O 0 9.945148485712707e-05
164 O 0 0.0007905515958555043
patients O 0 0.0004397548327688128
with O 0 0.00021366740111261606
multiple O 1 0.9817225337028503
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999998807907104
and I-Disease 1 0.5716513395309448
/ I-Disease 1 0.996921718120575
or I-Disease 0 0.011970427818596363
carcinoma I-Disease 1 0.9999967813491821
and O 0 0.00020829455752391368
analyzed O 0 0.0003449892974458635
codons O 0 0.0006718352087773383
1263 O 0 0.0048385807313025
- O 0 0.0005731048295274377
1377 O 0 0.004459810443222523
( O 0 0.00020776221936102957
exon O 0 0.0009739468805491924
15G O 0 0.0014054466737434268
) O 0 5.400191730586812e-05
of O 0 7.568987348349765e-05
the O 0 0.00017246002971660346
APC B-Disease 0 0.008115560747683048
gene O 0 0.00029597009415738285
for O 0 0.0001722122251521796
germ O 1 0.9987094402313232
- O 0 0.0016039259498938918
line O 0 0.0009971281979233027
variants O 0 0.000813788385130465
. O 0 0.0006868983618915081

Three O 0 0.0010911250719800591
patients O 0 0.0006010517245158553
with O 0 0.00013813245459459722
the O 0 0.00030926812905818224
I1307K O 1 0.6175979375839233
allele O 0 0.00022638602240476757
were O 0 4.612193879438564e-05
detected O 0 0.00012471424997784197
, O 0 3.3015432563843206e-05
each O 0 1.661588976276107e-05
of O 0 9.895229595713317e-05
Ashkenazi O 0 0.001066754455678165
descent O 0 0.001794069423340261
. O 0 0.000821014167740941

Four O 0 0.00148679013364017
patients O 0 0.0009480136213824153
had O 0 0.00031158808269537985
a O 0 0.0005771613214164972
germ O 1 0.999134361743927
- O 0 0.0015843019355088472
line O 0 0.0008069201721809804
E1317Q O 0 0.01059175468981266
missense O 0 0.0013864249922335148
variant O 0 0.0003345760051161051
of O 0 0.00016597007925156504
APC O 0 0.021004104986786842
that O 0 3.584710430004634e-05
was O 0 6.414717790903524e-05
not O 0 1.1238088518439326e-05
present O 0 2.085444430122152e-05
in O 0 1.6359379515051842e-05
controls O 0 3.7561218050541356e-05
; O 0 7.942074262246024e-06
one O 0 1.111212077375967e-05
of O 0 2.210959792137146e-05
these O 0 8.04236151452642e-06
individuals O 0 1.1027180335076991e-05
had O 0 4.034480298287235e-05
an O 0 4.040393832838163e-05
unusually O 0 0.00013062136713415384
large O 0 5.4041276598582044e-05
number O 0 4.129127410124056e-05
of O 0 0.00026238011196255684
metaplastic B-Disease 1 0.9956782460212708
polyps I-Disease 0 0.2000664919614792
of I-Disease 0 0.000576983904466033
the I-Disease 0 0.0010470334673300385
colorectum I-Disease 1 0.9616913795471191
. O 0 0.0012909305514767766

There O 0 0.0005908514722250402
is O 0 0.00018130344687961042
increasing O 0 9.47083899518475e-05
evidence O 0 5.856377902091481e-05
that O 0 2.430749373161234e-05
there O 0 5.613333632936701e-05
exist O 0 9.585895895725116e-05
germ O 0 0.13348333537578583
- O 0 0.00016420141037087888
line O 0 0.00013913314614910632
variants O 0 4.253682345733978e-05
of O 0 4.250223719282076e-05
the O 0 0.00011084800644312054
APC B-Disease 0 0.08340663462877274
gene O 0 0.00011295991134829819
that O 0 3.485735214781016e-05
predispose O 0 0.0001926796539919451
to O 0 2.056211269518826e-05
the O 0 6.123155617387965e-05
development O 0 0.00013309928181115538
of O 0 0.000743617070838809
multiple O 1 0.9993415474891663
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9997994303703308
carcinoma I-Disease 1 1.0
, O 0 0.0003439241845626384
but O 0 7.389716483885422e-05
without O 0 4.305422771722078e-05
the O 0 8.411811722908169e-05
florid O 0 0.0016560874646529555
phenotype O 0 0.000350276124663651
of O 0 0.00016279211558867246
classical O 0 0.0005770597490482032
FAP B-Disease 1 0.998799204826355
, O 0 7.731564255664125e-05
and O 0 3.3594613341847435e-05
possibly O 0 6.212605512700975e-05
with O 0 2.1044095774414018e-05
importance O 0 0.00030033846269361675
for O 0 0.01146031729876995
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
risk O 0 0.0006621487555094063
in O 0 5.333964145393111e-05
the O 0 8.758262993069366e-05
general O 0 0.00014464759442489594
population O 0 6.191808643052354e-05
. O 0 0.00013207169831730425
. O 0 0.00033344910480082035

Genomic O 0 0.0027412311173975468
structure O 0 0.0009095458663068712
of O 0 0.0006938730948604643
the O 0 0.02876044251024723
human O 1 0.9999737739562988
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999253749847412
CLD B-Disease 1 0.9999988079071045
) O 0 0.0007088791462592781
gene O 0 0.0005532556097023189
. O 0 0.0003147526003886014

Congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999998807907104
diarrhea I-Disease 1 1.0
( O 1 0.9998743534088135
CLD B-Disease 1 0.9999995231628418
) O 0 0.00036255570012144744
is O 0 0.00011747812095563859
caused O 0 0.0008937205420807004
by O 0 2.839164881152101e-05
mutations O 0 3.456183185335249e-05
in O 0 2.0147726900177076e-05
a O 0 5.881423567188904e-05
gene O 0 7.526887929998338e-05
which O 0 4.394734060042538e-05
encodes O 0 0.00033823566627688706
an O 0 0.00039526118780486286
intestinal O 1 0.9999860525131226
anion O 1 0.9931859970092773
transporter O 1 0.7868643403053284
. O 0 0.0017764572985470295

We O 0 0.0004709943023044616
report O 0 0.00014496712537948042
here O 0 9.471607336308807e-05
the O 0 8.954902295954525e-05
complete O 0 9.894221147987992e-05
genomic O 0 0.00011077816452598199
organization O 0 7.629321771673858e-05
of O 0 7.736380212008953e-05
the O 0 0.00012090462405467406
human O 0 0.0003259257646277547
CLD B-Disease 1 0.9990806579589844
gene O 0 0.00021365702559705824
which O 0 4.74186017527245e-05
spans O 0 0.0003262152022216469
approximately O 0 0.00020656165725085884
39kb O 0 0.007428210694342852
, O 0 0.00013795225822832435
and O 0 8.750675624469295e-05
comprises O 0 0.0005235216813161969
21 O 0 0.0011366086546331644
exons O 0 0.0030441104900091887
. O 0 0.0011311873095110059

All O 0 0.0018061386654153466
exon O 0 0.0071693770587444305
/ O 0 0.0016599708469584584
intron O 0 0.0016972802113741636
boundaries O 0 0.00017565996677149087
conform O 0 0.00023589842021465302
to O 0 7.340441516134888e-05
the O 0 0.00032709244987927377
GT O 0 0.4580521583557129
/ O 0 0.0044008526019752026
AG O 0 0.134455144405365
rule O 0 0.0013439281610772014
. O 0 0.0008766546961851418

An O 0 0.0008492901688441634
analysis O 0 0.0002015376667259261
of O 0 0.0001944510731846094
the O 0 0.0003519240708556026
putative O 0 0.00195722165517509
promoter O 0 0.002997708972543478
region O 0 0.0002230145619250834
sequence O 0 0.0001268058258574456
shows O 0 0.0001433068682672456
a O 0 0.00025082947104237974
putative O 0 0.004405086860060692
TATA O 1 0.999312162399292
box O 0 0.0011654826812446117
and O 0 0.0001790317182894796
predicts O 0 0.0003786494198720902
multiple O 0 0.00011930878827115521
transcription O 0 0.00031864471384324133
factor O 0 0.0004030090931337327
binding O 0 0.00020009969011880457
sites O 0 0.00027112464886158705
. O 0 0.0005666215438395739

The O 0 0.0008940409170463681
genomic O 0 0.0010661050910130143
structure O 0 0.0004278399865143001
was O 0 0.0002028335293289274
determined O 0 0.00010645535076037049
using O 0 2.6103341951966286e-05
DNA O 0 4.279927452444099e-05
from O 0 1.722031993267592e-05
several O 0 1.673008591751568e-05
sources O 0 2.100115489156451e-05
including O 0 2.4620672775199637e-05
multiple O 0 5.0984112021978945e-05
large O 0 0.00010569430742179975
- O 0 0.00037172602606005967
insert O 0 0.0005677053704857826
libaries O 0 0.0018114539561793208
and O 0 7.778494182275608e-05
genomic O 0 0.00023730650718789548
DNA O 0 0.00032809688127599657
from O 0 0.0002454796922393143
Finnish O 1 0.6300353407859802
CLD B-Disease 1 0.9999899864196777
patients O 0 0.009052783250808716
and O 0 0.0005806592525914311
controls O 0 0.001211725757457316
. O 0 0.0009223928209394217

Exon O 0 0.007511249277740717
- O 0 0.0009172946447506547
specific O 0 0.00013196759391576052
primers O 0 0.0006152026471681893
developed O 0 0.0001446400274289772
in O 0 3.3613840059842914e-05
this O 0 1.9123372112517245e-05
study O 0 1.7282276530750096e-05
will O 0 1.4079261745791882e-05
facilitate O 0 4.344605258665979e-05
mutation O 0 4.184907811577432e-05
screening O 0 2.701290213735774e-05
studies O 0 2.030721771006938e-05
of O 0 6.54498435324058e-05
patients O 0 0.00020003615645691752
with O 0 6.513267726404592e-05
the O 0 0.03349416330456734
disease O 1 0.9999631643295288
. O 0 0.000903336564078927

Genomic O 0 0.002610425464808941
sequencing O 0 0.0013435493456199765
of O 0 0.00047994073247537017
a O 0 0.000608864298556
BAC O 1 0.9881315231323242
clone O 1 0.9417132139205933
H O 1 0.995621383190155
_ O 0 0.0002479446120560169
RG364P16 O 0 0.004558774642646313
revealed O 0 0.00019191727915313095
the O 0 4.758035720442422e-05
presence O 0 7.302593439817429e-05
of O 0 5.6962202506838366e-05
another O 0 5.5099048040574417e-05
, O 0 4.030499985674396e-05
highly O 0 6.0811889852629974e-05
homologous O 0 7.540630758740008e-05
gene O 0 2.8148315323051065e-05
3 O 0 3.9284848753595725e-05
of O 0 5.1503524446161464e-05
the O 0 0.00011500814434839413
CLD B-Disease 1 0.9961351156234741
gene O 0 7.673493382753804e-05
, O 0 1.497953780926764e-05
with O 0 7.712338629062288e-06
a O 0 2.5236196961486712e-05
similar O 0 2.5217335860361345e-05
genomic O 0 6.919246516190469e-05
structure O 0 7.433607243001461e-05
, O 0 2.680162106116768e-05
recently O 0 5.068307655164972e-05
identified O 0 4.846390220336616e-05
as O 0 6.110555841587484e-05
the O 0 0.00047067072591744363
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
gene O 0 0.3324427604675293
( O 0 0.00299137644469738
PDS B-Disease 1 0.9997957348823547
) O 0 0.00022924972290638834
. O 0 0.00020625679462682456
. O 0 0.0004156989452894777

The O 0 0.0032503539696335793
APCI1307K O 1 0.9995695948600769
allele O 0 0.002948899520561099
and O 0 0.000732279964722693
cancer B-Disease 1 0.9728240370750427
risk O 0 0.00018932709645014256
in O 0 4.545045885606669e-05
a O 0 6.697666685795411e-05
community O 0 8.74628676683642e-05
- O 0 9.079528535949066e-05
based O 0 2.4592374757048674e-05
study O 0 5.2035506087122485e-05
of O 0 0.0001276594412047416
Ashkenazi O 0 0.0019008530071005225
Jews O 0 0.0019090272253379226
. O 0 0.0007844196516089141

Mutations O 0 0.003503195708617568
in O 0 0.0007535984041169286
APC O 1 0.5737322568893433
are O 0 0.00010707516776164994
classically O 0 0.004031953401863575
associated O 0 0.00037932328996248543
with O 0 0.0005078645190224051
familial B-Disease 1 0.9999990463256836
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9994003772735596
FAP B-Disease 1 0.9999856948852539
) O 0 0.00028318079421296716
, O 0 8.850768790580332e-05
a O 0 0.00023291456454899162
highly O 0 0.0015664494130760431
penetrant O 1 0.9999853372573853
autosomal B-Disease 1 0.9999957084655762
dominant I-Disease 1 0.9999984502792358
disorder I-Disease 1 1.0
characterized O 1 0.9999774694442749
by O 1 0.8313611149787903
multiple O 1 0.9999291896820068
intestinal O 1 1.0
polyps B-Disease 1 0.9999963045120239
and O 0 0.00044479037751443684
, O 0 9.006841719383374e-05
without O 0 6.808233592892066e-05
surgical O 0 0.24494723975658417
intervention O 0 0.0003983357164543122
, O 0 5.968672121525742e-05
the O 0 8.794401219347492e-05
development O 0 0.00041886314284056425
of O 1 0.9582911133766174
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.3693389892578125
CRC B-Disease 1 0.9995599389076233
) O 0 0.0004048983391840011
. O 0 0.0006372130592353642

APC B-Disease 0 0.05584093928337097
is O 0 0.0010541981318965554
a O 0 0.0021727359853684902
tumour O 1 0.9999984502792358
- O 0 0.04683030769228935
suppressor O 0 0.305600106716156
gene O 0 0.0001441703352611512
, O 0 5.215757119003683e-05
and O 0 4.954476753482595e-05
somatic O 0 0.004654477816075087
loss O 1 0.6439459323883057
occurs O 0 0.001582290162332356
in O 0 0.0007334400434046984
tumours B-Disease 1 0.999927282333374
. O 0 0.001643481431528926

The O 0 0.005059925839304924
germline O 1 0.9769863486289978
T O 0 0.08488040417432785
- O 0 0.0002928848844021559
to O 0 5.6299850257346407e-05
- O 0 0.00016835902351886034
A O 0 0.00026143796276301146
transversion O 0 0.001531098736450076
responsible O 0 0.00019705892191268504
for O 0 4.3853226088685915e-05
the O 0 0.00011942101264139637
APC O 0 0.08933781087398529
I1307K O 0 0.006604339461773634
allele O 0 0.00021219813788775355
converts O 0 8.283596980618313e-05
the O 0 3.257499702158384e-05
wild O 0 6.540392496390268e-05
- O 0 5.868397784070112e-05
type O 0 4.437013194547035e-05
sequence O 0 3.058778020204045e-05
to O 0 3.1831255910219625e-05
a O 0 0.00020222987222950906
homopolymer O 1 0.9992859959602356
tract O 1 0.9998958110809326
( O 0 0.0008236642461270094
A8 O 1 0.9904572367668152
) O 0 5.3232055506668985e-05
that O 0 2.3819016860215925e-05
is O 0 4.475292735151015e-05
genetically O 0 0.0002279400359839201
unstable O 0 0.007042222656309605
and O 0 0.00017552351346239448
prone O 0 0.05099349468946457
to O 0 0.0002783349191304296
somatic O 0 0.011255146935582161
mutation O 0 0.0013951328583061695
. O 0 0.0007169142481870949

The O 0 0.002443501725792885
I1307K O 0 0.11664606630802155
allele O 0 0.0011753540020436049
was O 0 0.00046106494846753776
found O 0 0.00016583593969698995
in O 0 0.00018105069466400892
6 O 0 0.0009727839496918023
. O 0 0.000761130650062114

1 O 0 0.0008304489310830832
% O 0 0.0002170006191590801
of O 0 0.0002906777954194695
unselected O 0 0.007401717361062765
Ashkenazi O 0 0.0010567855788394809
Jews O 0 0.0003372838255017996
and O 0 7.652091153431684e-05
higher O 0 6.30311988061294e-05
proportions O 0 0.00028592298622243106
of O 0 0.00011109584011137486
Ashkenazim O 0 0.0009190294658765197
with O 0 3.242155798943713e-05
family O 0 7.948109123390168e-05
or O 0 4.1580988181522116e-05
personal O 0 9.562022023601457e-05
histories O 0 0.00010831704275915399
of O 0 0.0002872980257961899
CRC B-Disease 1 0.9995570778846741
( O 0 0.00022019130119588226
ref O 0 0.002174150664359331
. O 0 6.707138527417555e-05
2 O 0 0.00016871273692231625
) O 0 0.00016024758224375546
. O 0 0.00033826002618297935

To O 0 0.0003205854445695877
evaluate O 0 0.00033597511355765164
the O 0 0.00017695489805191755
role O 0 0.00033659880864433944
of O 0 0.00033961032750084996
I1307K O 1 0.9991452693939209
in O 0 0.0005506087909452617
cancer B-Disease 1 0.9721250534057617
, O 0 9.202310320688412e-05
we O 0 0.00011154368257848546
genotyped O 0 0.003258171258494258
5 O 0 0.00018899250426329672
, O 0 0.00012639535998459905
081 O 0 0.0031069854740053415
Ashkenazi O 0 0.0007317459094338119
volunteers O 0 0.00027420828700996935
in O 0 7.406535587506369e-05
a O 0 0.00012780255929101259
community O 0 0.0002244985371362418
survey O 0 0.00048306703683920205
. O 0 0.00047830227413214743

Risk O 0 0.0051556420512497425
of O 0 0.0032749432139098644
developing O 1 0.9979872703552246
colorectal B-Disease 1 1.0
, I-Disease 0 0.3551267981529236
breast I-Disease 1 0.9998501539230347
and I-Disease 0 0.0002702276105992496
other I-Disease 0 9.398962720297277e-05
cancers I-Disease 0 0.028956472873687744
were O 0 9.790297190193087e-05
compared O 0 0.0001366189680993557
between O 0 0.00018861769058275968
genotyped O 1 0.9484611749649048
I1307K O 1 0.7399760484695435
carriers O 0 0.00022014512796886265
and O 0 6.653906893916428e-05
non O 0 9.279166988562793e-05
- O 0 8.34568782011047e-05
carriers O 0 4.847499803872779e-05
and O 0 1.5748282748972997e-05
their O 0 8.56062069942709e-06
first O 0 6.291061436058953e-05
- O 0 0.00015632556460332125
degree O 0 0.0003045331686735153
relatives O 0 0.0009487966308370233
. O 0 0.000878206396009773

Sperm O 0 0.002504478907212615
DNA O 0 0.0009750392637215555
analysis O 0 0.0002343368250876665
in O 0 0.00023534215870313346
a O 0 0.0010542324744164944
Friedreich B-Disease 1 0.9998432397842407
ataxia I-Disease 1 0.9999490976333618
premutation O 1 0.9998475313186646
carrier O 0 0.015037422068417072
suggests O 0 0.00031167457927949727
both O 0 9.411895734956488e-05
meiotic O 0 0.07221710681915283
and O 0 0.00010489527630852535
mitotic O 0 0.0016716421814635396
expansion O 0 0.0002505391021259129
in O 0 0.00010729122732300311
the O 0 0.00038842507638037205
FRDA B-Disease 1 0.9988524913787842
gene O 0 0.0009634229354560375
. O 0 0.0005786851979792118

Friedreich B-Disease 1 0.9999630451202393
ataxia I-Disease 1 0.99994957447052
is O 0 0.0014520881231874228
usually O 0 0.00025762099539861083
caused O 0 0.003012025263160467
by O 0 3.937133806175552e-05
an O 0 3.499364174786024e-05
expansion O 0 0.0002235382271464914
of O 0 0.00012737272481899709
a O 0 0.0001789516827557236
GAA O 0 0.0011442454997450113
trinucleotide O 0 0.005136243067681789
repeat O 0 0.0002901274128817022
in O 0 6.640962237725034e-05
intron O 0 0.0006855958490632474
1 O 0 9.822539141168818e-05
of O 0 0.0001559017546242103
the O 0 0.0003554377472028136
FRDA B-Disease 1 0.9979456067085266
gene O 0 0.001000194693915546
. O 0 0.0007536016637459397

Occasionally O 0 0.001025736564770341
, O 0 0.00024809688329696655
a O 0 0.00015942260506562889
fully O 0 0.000250402488745749
expanded O 0 0.00017491386097390205
allele O 0 0.00013265102461446077
has O 0 2.164630677725654e-05
been O 0 1.9276350940344855e-05
found O 0 2.4271290385513566e-05
to O 0 1.5969848391250707e-05
arise O 0 7.820218161214143e-05
from O 0 4.0572438592789695e-05
a O 0 8.08140539447777e-05
premutation O 0 0.0012954471167176962
of O 0 0.00014691294927615672
100 O 0 0.00014806955005042255
or O 0 6.979325553402305e-05
less O 0 0.00010627481242408976
triplet O 0 0.0017688029911369085
repeats O 0 0.0010709979105740786
. O 0 0.0006139453616924584

We O 0 0.0005181443993933499
have O 0 7.428329263348132e-05
examined O 0 0.00020573493384290487
the O 0 9.65913714026101e-05
sperm O 0 0.00014128802285995334
DNA O 0 0.0001505906693637371
of O 0 0.00013484508963301778
a O 0 0.00041328201768919826
premutation O 1 0.9401829838752747
carrier O 0 0.004275006242096424
. O 0 0.0010075977770611644

This O 0 0.0011833378812298179
mans O 0 0.006544080562889576
leucocyte O 0 0.020280564203858376
DNA O 0 0.0005563438753597438
showed O 0 0.00033554807305336
one O 0 8.1247380876448e-05
normal O 0 0.00010752639354905114
allele O 0 8.059148967731744e-05
and O 0 2.073440919048153e-05
one O 0 2.3876420527813025e-05
allele O 0 6.136987212812528e-05
of O 0 5.383788811741397e-05
approximately O 0 0.00011970182822551578
100 O 0 0.00028865598142147064
repeats O 0 0.0007426688098348677
. O 0 0.0004895718884654343

His O 0 0.002106458880007267
sperm O 0 0.0008370341965928674
showed O 0 0.00038636624231003225
an O 0 7.246417226269841e-05
expanded O 0 0.00016836995200719684
allele O 0 8.425226405961439e-05
in O 0 3.301278775325045e-05
a O 0 5.2465376938926056e-05
tight O 0 0.00016392595716752112
range O 0 6.265699630603194e-05
centering O 0 0.00022531770810019225
on O 0 3.985053626820445e-05
a O 0 5.8233094023307785e-05
size O 0 5.820983278681524e-05
of O 0 0.00010552100138738751
approximately O 0 0.00022680363326799124
320 O 0 0.0014185820473358035
trinucleotide O 0 0.01758263073861599
repeats O 0 0.0017651870148256421
. O 0 0.000870257499627769

His O 0 0.005541275721043348
affected O 0 0.0029600183479487896
son O 0 0.017468679696321487
has O 0 0.0003168000257574022
repeat O 0 0.0006194353336468339
sizes O 0 0.00016080243221949786
of O 0 0.00029413800803013146
1040 O 0 0.003396139480173588
and O 0 0.0004306561895646155
540 O 0 0.00324050965718925
. O 0 0.00079884979641065

These O 0 0.00021371549519244581
data O 0 0.00011068861203966662
suggest O 0 6.464138277806342e-05
that O 0 2.6847050321521237e-05
expansion O 0 0.00012597159366123378
occurs O 0 3.571284105419181e-05
in O 0 1.1508186616993044e-05
two O 0 1.1446258213254623e-05
stages O 0 5.6827433581929654e-05
, O 0 2.1700439901906066e-05
the O 0 3.289556480012834e-05
first O 0 6.160482007544488e-05
during O 0 0.00012331151810940355
meiosis O 0 0.00047752028331160545
followed O 0 0.00010865750664379448
by O 0 3.9206028304761276e-05
a O 0 0.00012153388524893671
second O 0 0.0005729105905629694
mitotic O 0 0.0050693233497440815
expansion O 0 0.0016467777313664556
. O 0 0.0008473897469229996

We O 0 0.0008125013555400074
also O 0 0.00017212751845363528
show O 0 8.55117104947567e-05
that O 0 2.4453996957163326e-05
in O 0 2.1492693122127093e-05
all O 0 2.4880948330974206e-05
informative O 0 0.00012424301530700177
carrier O 0 0.00017202120216097683
father O 0 0.0001828839594963938
to O 0 4.738122152048163e-05
affected O 0 0.00019274893566034734
child O 0 0.00024682164075784385
transmissions O 0 0.00015847200120333582
, O 0 2.8305250452831388e-05
with O 0 1.4381145774677861e-05
the O 0 3.0706996767548844e-05
notable O 0 5.6816486903699115e-05
exception O 0 6.827328616054729e-05
of O 0 7.486543472623453e-05
the O 0 0.00015718337090220302
premutation O 0 0.12503856420516968
carrier O 0 0.00037507619708776474
, O 0 6.0116286476841196e-05
the O 0 0.00010852941340999678
expansion O 0 0.00038251010118983686
size O 0 0.0003047727805096656
decreases O 0 0.0006167407846078277
. O 0 0.00016503238293807954
. O 0 0.00036298882332630455

The O 0 0.002875188598409295
R496H O 0 0.21686594188213348
mutation O 0 0.0007793916738592088
of O 0 0.0004190990293864161
arylsulfatase O 1 0.992595374584198
A O 0 0.0034838246647268534
does O 0 0.00020208876230753958
not O 0 0.0002322676737094298
cause O 1 0.9584122896194458
metachromatic B-Disease 1 0.999985933303833
leukodystrophy I-Disease 1 0.9999889135360718
. O 0 0.0030364636331796646

Deficiency B-Disease 1 0.9999397993087769
of I-Disease 0 0.007109062280505896
arylsulfatase I-Disease 1 0.9996347427368164
A I-Disease 1 0.5490702390670776
( O 0 0.001507384586147964
ARSA O 1 0.9977784752845764
) O 0 0.00033588524092920125
enzyme O 0 0.0008480350952595472
activity O 0 0.0009811298223212361
causes O 1 0.9423955678939819
metachromatic B-Disease 1 0.9999935626983643
leukodystrophy I-Disease 1 0.9999992847442627
( O 0 0.15312659740447998
MLD B-Disease 1 0.999983549118042
) O 0 0.0009128489182330668
. O 0 0.000933288421947509

A O 0 0.0019946368411183357
number O 0 0.0004848319513257593
of O 0 0.0011383161181584
ARSA O 1 0.9992119073867798
gene O 0 0.0005959441768936813
mutations O 0 0.00028343850863166153
responsible O 0 0.0003108806849922985
for O 0 0.00022132223239168525
MLD B-Disease 1 0.9999020099639893
have O 0 0.00015204737428575754
been O 0 0.00019263594003859907
identified O 0 0.0006652979063801467
. O 0 0.0004466467071324587

Recently O 0 0.0018781984690576792
, O 0 0.000381715246476233
the O 0 0.0003899994189850986
R496H O 0 0.01062691118568182
mutation O 0 0.0002745439123827964
of O 0 0.00021821811969857663
ARSA O 1 0.9862960577011108
was O 0 0.0002714500005822629
proposed O 0 4.4128260924480855e-05
to O 0 1.9463197531877086e-05
be O 0 2.3512986444984563e-05
a O 0 8.430554589722306e-05
cause O 0 0.0002111085777869448
of O 0 0.0003586475213523954
MLD B-Disease 1 0.999994158744812
( O 0 0.0004391175170894712
Draghia O 1 0.7533515095710754
et O 0 0.0011907240841537714
al O 0 0.0005214654956944287
. O 0 4.941430233884603e-05
, O 0 7.053170702420175e-05
1997 O 0 0.00027755502378568053
) O 0 0.00016197923105210066
. O 0 0.00035858768387697637

We O 0 0.0003617498150561005
have O 0 7.573478796985e-05
investigated O 0 0.00022387440549209714
the O 0 0.00020722270710393786
R496H O 0 0.09986424446105957
mutation O 0 9.11056122276932e-05
and O 0 3.081976683461107e-05
found O 0 1.7852560631581582e-05
this O 0 1.2561426956381183e-05
mutation O 0 2.6883020836976357e-05
at O 0 3.712300167535432e-05
a O 0 2.567553565313574e-05
relatively O 0 2.1303038010955788e-05
high O 0 2.8546157409437e-05
frequency O 0 1.7248061340069398e-05
in O 0 1.2861220966442488e-05
an O 0 1.539968616270926e-05
African O 0 4.192704727756791e-05
American O 0 3.255080446251668e-05
population O 0 1.6460631741210818e-05
( O 0 2.081639104289934e-05
f O 0 6.133604620117694e-05
= O 0 5.228840382187627e-05
0 O 0 2.462872907926794e-05
. O 0 2.0898103684885427e-05
09 O 0 0.0002504712319932878
, O 0 4.924687527818605e-05
n O 0 0.00016300598508678377
= O 0 0.00025959796039387584
61 O 0 0.00045434580533765256
subjects O 0 0.00044520015944726765
) O 0 0.0002308993716724217
. O 0 0.0005007118452340364

The O 0 0.004437332507222891
ARSA O 1 0.9903566241264343
enzyme O 0 0.0015764469280838966
activity O 0 0.00031385154579766095
in O 0 6.25503744231537e-05
subjects O 0 7.396345608867705e-05
with O 0 2.4287868654937483e-05
and O 0 2.471173502271995e-05
without O 0 3.610138810472563e-05
the O 0 9.269313886761665e-05
R496H O 1 0.6744386553764343
mutation O 0 0.00012578783207572997
was O 0 0.00015093224646989256
determined O 0 6.143897189758718e-05
and O 0 1.8022596123046242e-05
found O 0 2.9059430744382553e-05
to O 0 2.384833715041168e-05
be O 0 7.721285510342568e-05
normal O 0 0.0003854550013784319
. O 0 0.0002998274867422879

It O 0 0.00036145804915577173
is O 0 0.00014348777767736465
therefore O 0 0.0001054819585988298
concluded O 0 0.00011968847684329376
that O 0 3.4750046324916184e-05
the O 0 0.00011445042036939412
R496H O 0 0.06792838871479034
mutation O 0 0.0002925845910795033
of O 0 0.0002972219081129879
ARSA O 1 0.9950319528579712
does O 0 5.5592368880752474e-05
not O 0 1.3617079275718424e-05
negatively O 0 5.68821415072307e-05
influence O 0 5.5367516324622557e-05
the O 0 5.7096753153018653e-05
activity O 0 0.00010428280802443624
of O 0 0.00014701636973768473
ARSA O 1 0.9980934262275696
and O 0 9.540681639919057e-05
is O 0 6.517728616017848e-05
not O 0 4.04086422349792e-05
a O 0 0.00023680023150518537
cause O 0 0.0026362885255366564
of O 0 0.004955558571964502
MLD B-Disease 1 0.9999834299087524

Down O 0 0.006271901540458202
- O 0 0.0011516967788338661
regulation O 0 0.0005482821725308895
of O 0 0.00046158762415871024
transmembrane O 0 0.00834847241640091
carbonic O 1 0.946357250213623
anhydrases O 1 0.9996095299720764
in O 0 0.12225743383169174
renal B-Disease 1 1.0
cell I-Disease 1 0.9999973773956299
carcinoma I-Disease 1 1.0
cell O 0 0.030471088364720345
lines O 0 0.00020980826229788363
by O 0 5.7132812798954546e-05
wild O 0 0.00024746236158534884
- O 0 0.0003428710624575615
type O 0 0.00038355772267095745
von B-Disease 0 0.006698692217469215
Hippel I-Disease 1 0.9704382419586182
- I-Disease 0 0.0039634862914681435
Lindau I-Disease 0 0.3189622759819031
transgenes O 0 0.029603971168398857
. O 0 0.001499932841397822

To O 0 0.0009404177544638515
discover O 0 0.0008929272880777717
genes O 0 0.00017094171198550612
involved O 0 0.0001285014150198549
in O 0 0.0001594455388840288
von B-Disease 0 0.009418405592441559
Hippel I-Disease 1 0.9945574998855591
- I-Disease 0 0.004175973124802113
Lindau I-Disease 1 0.8980617523193359
( O 0 0.0008405252010561526
VHL B-Disease 1 0.99503493309021
) O 0 0.0002560381544753909
- O 0 0.0007036273018456995
mediated O 0 0.0016016840236261487
carcinogenesis O 1 0.9848749041557312
, O 0 0.00027819216484203935
we O 0 0.0003080427704844624
used O 0 0.0012341534020379186
renal B-Disease 1 0.9999997615814209
cell I-Disease 1 0.9999830722808838
carcinoma I-Disease 1 1.0
cell O 1 0.5447957515716553
lines O 0 0.0013983704848214984
stably O 0 0.00483015738427639
transfected O 0 0.0034831345546990633
with O 0 0.00016891927225515246
wild O 0 0.0008776212926022708
- O 0 0.0014567391481250525
type O 0 0.0017052540788426995
VHL O 1 0.998965859413147
- O 0 0.003243032144382596
expressing O 0 0.0025059243198484182
transgenes O 0 0.020445631816983223
. O 0 0.0016621991526335478

Large O 0 0.0018889721250161529
- O 0 0.0008079357794485986
scale O 0 0.0007304249447770417
RNA O 0 0.00032897511846385896
differential O 0 0.0002867556468117982
display O 0 0.0002182576572522521
technology O 0 8.93829928827472e-05
applied O 0 4.1531140595907345e-05
to O 0 2.6083534976351075e-05
these O 0 1.887446705950424e-05
cell O 0 9.856655378825963e-05
lines O 0 5.858729491592385e-05
identified O 0 4.1727846110006794e-05
several O 0 2.7076297556050122e-05
differentially O 0 0.00019355022232048213
expressed O 0 7.61874980526045e-05
genes O 0 5.50943186681252e-05
, O 0 2.4171733457478695e-05
including O 0 2.8213404220878147e-05
an O 0 8.904049900593236e-05
alpha O 0 0.0007496841717511415
carbonic O 0 0.008565410040318966
anhydrase O 1 0.5682729482650757
gene O 0 0.0006156854215078056
, O 0 0.00034355782554484904
termed O 0 0.0051518892869353294
CA12 O 1 0.9969051480293274
. O 0 0.0018287940183654428

The O 0 0.0010640905238687992
deduced O 0 0.0013171728933230042
protein O 0 0.00018435742822475731
sequence O 0 0.00012933401740156114
was O 0 0.00016942578076850623
classified O 0 5.55833030375652e-05
as O 0 2.7162133847014047e-05
a O 0 6.498366565210745e-05
one O 0 5.1523711590562016e-05
- O 0 0.00013556680642068386
pass O 0 0.00017123599536716938
transmembrane O 0 0.0009047203930094838
CA O 0 0.00045066900202073157
possessing O 0 0.00026298672310076654
an O 0 8.201992022804916e-05
apparently O 0 0.00023995943774934858
intact O 0 0.000363606377504766
catalytic O 0 0.0003442277666181326
domain O 0 0.00012884964235126972
in O 0 6.572924758074805e-05
the O 0 0.00022955704480409622
extracellular O 0 0.002569753210991621
CA O 0 0.00484220776706934
module O 0 0.009067950770258904
. O 0 0.0013259578263387084

Reintroduced O 0 0.00863699708133936
wild O 0 0.0029813346918672323
- O 0 0.001942794886417687
type O 0 0.0010549875441938639
VHL B-Disease 1 0.8383678197860718
strongly O 0 0.00023595418315380812
inhibited O 0 0.0004262326401658356
the O 0 9.025654435390607e-05
overexpression O 0 0.00029480530065484345
of O 0 8.096647798083723e-05
the O 0 0.00014753639698028564
CA12 O 1 0.9804410934448242
gene O 0 0.00010336929699406028
in O 0 4.292778976378031e-05
the O 0 0.000265812297584489
parental O 0 0.18050825595855713
renal B-Disease 1 1.0
cell I-Disease 1 0.9999988079071045
carcinoma I-Disease 1 1.0
cell O 1 0.9508464336395264
lines O 0 0.001399379689246416
. O 0 0.0005649591912515461

Similar O 0 0.0008548011537641287
results O 0 0.00017466305871494114
were O 0 7.603573612868786e-05
obtained O 0 0.00010134387412108481
with O 0 0.00010042504436569288
CA9 O 1 0.5399443507194519
, O 0 9.897891141008586e-05
encoding O 0 9.490095544606447e-05
another O 0 0.00018009856285061687
transmembrane O 0 0.0008679463062435389
CA O 0 0.0003189699200447649
with O 0 5.169330324861221e-05
an O 0 9.941498137777671e-05
intact O 0 0.001044039730913937
catalytic O 0 0.0016529998974874616
domain O 0 0.0006152572459541261
. O 0 0.0005451773758977652

Although O 0 0.0008645027410238981
both O 0 0.00023783631331752986
domains O 0 0.00031672813929617405
of O 0 0.00028230040334165096
the O 0 0.00038366191438399255
VHL B-Disease 1 0.99244225025177
protein O 0 0.00011691443796735257
contribute O 0 9.61658515734598e-05
to O 0 2.1738573195762e-05
regulation O 0 4.5333366870181635e-05
of O 0 8.529978367732838e-05
CA12 O 1 0.9979966282844543
expression O 0 0.00013593921903520823
, O 0 4.6650991862406954e-05
the O 0 6.944769120309502e-05
elongin O 0 0.0013809258816763759
binding O 0 7.651105988770723e-05
domain O 0 0.00011147957411594689
alone O 0 0.00023029495787341148
could O 0 0.00015659125347156078
effectively O 0 0.0006565486546605825
regulate O 0 0.0018684372771531343
CA9 O 1 0.7907347083091736
expression O 0 0.0016915437299758196
. O 0 0.0008800194482319057

We O 0 0.0020630103535950184
mapped O 0 0.0052106031216681
CA12 O 1 0.9732910990715027
and O 0 0.001433511613868177
CA9 O 1 0.9573270678520203
loci O 0 0.0021050930954515934
to O 0 0.000328693917253986
chromosome O 0 0.0012872227234765887
bands O 0 0.002065023873001337
15q22 O 1 0.9224342703819275
and O 0 0.0011068853782489896
17q21 O 1 0.9323382377624512
. O 0 0.0016950889257714152

2 O 0 0.0012435478856787086
respectively O 0 0.0005432555335573852
, O 0 0.0001660172565607354
regions O 0 0.00013690743071492761
prone O 0 0.0006034366670064628
to O 0 8.48901690915227e-05
amplification O 0 0.0008446029387414455
in O 0 0.00013291006325744092
some O 0 0.00015780598914716393
human O 0 0.0014431894524022937
cancers B-Disease 1 0.9653974771499634
. O 0 0.0014199682045727968

Additional O 0 0.000755798420868814
experiments O 0 0.0005101353162899613
are O 0 2.4624641810078174e-05
needed O 0 6.492840475402772e-05
to O 0 1.653817162150517e-05
define O 0 3.130389814032242e-05
the O 0 3.499464219203219e-05
role O 0 9.854400559561327e-05
of O 0 0.0003015828551724553
CA O 0 0.27751588821411133
IX O 1 0.9979835748672485
and O 0 0.0002049123140750453
CA O 0 0.001507834647782147
XII O 0 0.22122196853160858
enzymes O 0 7.597833609906957e-05
in O 0 2.201728966610972e-05
the O 0 2.4719960492802784e-05
regulation O 0 3.343496791785583e-05
of O 0 6.83302860124968e-05
pH O 0 0.0002780272625386715
in O 0 4.6477853175019845e-05
the O 0 7.718260167166591e-05
extracellular O 0 0.000389327818993479
microenvironment O 0 0.0008591572404839098
and O 0 5.268114909995347e-05
its O 0 4.431870911503211e-05
potential O 0 0.00010358114377595484
impact O 0 0.0003622189979068935
on O 0 0.0004890914424322546
cancer B-Disease 1 0.9998586177825928
cell O 0 0.09420811384916306
growth O 0 0.0013406554935500026
. O 0 0.0005227350629866123

A O 0 0.0024716919288039207
gene O 0 0.000496141379699111
encoding O 0 0.00018406621529720724
a O 0 0.00013780816516373307
transmembrane O 0 0.0006377948448061943
protein O 0 0.00018209501286037266
is O 0 9.113689156947657e-05
mutated O 0 0.00022174319019541144
in O 0 9.726573625812307e-05
patients O 0 0.004806341603398323
with O 0 0.319467157125473
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999967813491821
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9999839067459106
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.0014765699161216617
. O 0 0.0008370181894861162

Wolfram B-Disease 1 0.9999971389770508
syndrome I-Disease 1 1.0
( O 1 0.9640976786613464
WFS B-Disease 1 0.9999818801879883
; O 0 0.004064301028847694
OMIM O 1 0.9999599456787109
222300 O 1 0.9977772831916809
) O 0 0.0002315958554390818
is O 0 0.00019121768127661198
an O 0 0.0004144095000810921
autosomal B-Disease 1 0.9998669624328613
recessive I-Disease 1 0.9999996423721313
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 0.02446775883436203
by O 0 0.00043678440852090716
young O 0 0.018641799688339233
- O 0 0.048610150814056396
onset O 1 0.9999021291732788
non O 1 0.510130763053894
- O 1 0.979563295841217
immune O 1 0.9999228715896606
insulin B-Disease 1 0.9997619986534119
- I-Disease 1 0.7474552392959595
dependent I-Disease 0 0.47329387068748474
diabetes I-Disease 1 1.0
mellitus I-Disease 1 0.9999998807907104
and O 1 0.9996349811553955
progressive O 1 0.9999998807907104
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999996423721313
. O 0 0.011059386655688286

Linkage O 0 0.004971558693796396
to O 0 0.00026989440084435046
markers O 0 0.0008742226636968553
on O 0 0.0002509473997633904
chromosome O 0 0.0011411872692406178
4p O 1 0.985088050365448
was O 0 0.0006073973490856588
confirmed O 0 0.00012036454427288845
in O 0 7.046367682050914e-05
five O 0 0.00011519989493535832
families O 0 0.00025585709954611957
. O 0 0.0005494116339832544

On O 0 0.0010256667155772448
the O 0 0.00045496251550503075
basis O 0 0.00024581298930570483
of O 0 0.0007836571894586086
meiotic O 1 0.9998571872711182
recombinants O 1 0.9999748468399048
and O 0 0.12248338013887405
disease O 1 0.9999934434890747
- O 0 0.005467532202601433
associated O 0 0.00023547413002233952
haplotypes O 0 0.000438784685684368
, O 0 0.00012173338473076001
the O 0 0.00022982379596214741
WFS B-Disease 1 0.9199525713920593
gene O 0 0.0002216941793449223
was O 0 0.0002249682293040678
localized O 0 0.0002155012043658644
to O 0 4.5451153710018843e-05
a O 0 0.0002615561243146658
BAC O 0 0.13723640143871307
/ O 0 0.0011279569007456303
P1 O 0 0.012100659310817719
contig O 0 0.002744280267506838
of O 0 0.00017517057131044567
less O 0 0.00011095851368736476
than O 0 9.571125701768324e-05
250 O 0 0.0005979374400340021
kb O 0 0.00298841274343431
. O 0 0.0008519880357198417

Mutations O 0 0.0015651187859475613
in O 0 0.0003190326096955687
a O 0 0.0002603995962999761
novel O 0 0.0002883185225073248
gene O 0 0.00027590367244556546
( O 0 0.00016564865654800087
WFS1 O 0 0.060243651270866394
) O 0 3.686982381623238e-05
encoding O 0 3.0218030588002875e-05
a O 0 5.4978849220788106e-05
putative O 0 0.00028232301701791584
transmembrane O 0 0.00021364253188949078
protein O 0 4.5091954234521836e-05
were O 0 2.1728894353145733e-05
found O 0 2.203888652729802e-05
in O 0 1.457545567973284e-05
all O 0 8.977921424957458e-06
affected O 0 2.799003414111212e-05
individuals O 0 7.647930033272132e-06
in O 0 2.7444617444416508e-05
six O 0 8.77280835993588e-05
WFS B-Disease 1 0.9768518805503845
families O 0 5.2279181545600295e-05
, O 0 2.62870507867774e-05
and O 0 1.6066114767454565e-05
these O 0 1.090877594833728e-05
mutations O 0 2.5590563382138498e-05
were O 0 1.638636240386404e-05
associated O 0 3.4542521461844444e-05
with O 0 4.296653423807584e-05
the O 0 0.010062242858111858
disease O 1 0.9999963045120239
phenotype O 1 0.8386805653572083
. O 0 0.0007235820521600544

WFS1 O 1 0.9954119324684143
appears O 0 0.0010558050125837326
to O 0 0.00012098281149519607
function O 0 7.88365287007764e-05
in O 0 5.246162254479714e-05
survival O 0 0.00036824491689912975
of O 0 0.00022695420193485916
islet O 0 0.11038060486316681
beta O 0 0.0038235243409872055
- O 0 0.0013658303068950772
cells O 0 0.00028904539067298174
and O 0 8.953006181400269e-05
neurons O 0 0.0005314375157468021
. O 0 0.0001344656484434381
. O 0 0.00032443710369989276

Stable O 0 0.003369578393176198
interaction O 0 0.0003813333751168102
between O 0 0.00011609455395955592
the O 0 7.312607340281829e-05
products O 0 6.611415301449597e-05
of O 0 0.00011193035606993362
the O 0 0.000463909818790853
BRCA1 O 1 0.9940412640571594
and O 0 0.0011637011775746942
BRCA2 O 1 0.9996020197868347
tumor B-Disease 1 0.999921441078186
suppressor O 0 0.18628957867622375
genes O 0 0.00020675358246080577
in O 0 0.00020801076607313007
mitotic O 0 0.01548060029745102
and O 0 0.0007265269523486495
meiotic O 1 0.9985032081604004
cells O 0 0.003013000590726733
. O 0 0.0009038876742124557

BRCA1 O 1 0.9867161512374878
and O 0 0.0008921592961996794
BRCA2 O 0 0.0027094781398773193
account O 0 0.00011653755063889548
for O 0 2.475027031323407e-05
most O 0 2.7105908884550445e-05
cases O 0 3.755505895242095e-05
of O 0 0.00012164077634224668
familial O 1 0.5650854706764221
, O 0 0.00023159189731813967
early O 0 0.0020588492043316364
onset O 1 0.9999860525131226
breast B-Disease 1 0.9998611211776733
and I-Disease 0 0.0029367997776716948
/ I-Disease 1 0.9993101358413696
or I-Disease 1 0.9980898499488831
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999879598617554
and O 0 0.00010651678894646466
encode O 0 7.5590331107378e-05
products O 0 4.8415400669910014e-05
that O 0 1.6396224964410067e-05
each O 0 1.6000733012333512e-05
interact O 0 8.426897693425417e-05
with O 0 0.00012179236364318058
hRAD51 O 0 0.08662142604589462
. O 0 0.0007527238340117037

Results O 0 0.0017888969741761684
presented O 0 0.0006817913381382823
here O 0 0.0002948851615656167
show O 0 0.00024332724569831043
that O 0 0.00011469536548247561
BRCA1 O 0 0.06250574439764023
and O 0 0.00017629892681725323
BRCA2 O 0 0.013783639296889305
coexist O 0 0.00021585720242001116
in O 0 6.086067151045427e-05
a O 0 0.0001620031544007361
biochemical O 0 0.0005230609676800668
complex O 0 0.0003740383544936776
and O 0 0.0001787320215953514
colocalize O 0 0.0792512372136116
in O 0 0.0002489185717422515
subnuclear O 0 0.09352219104766846
foci O 0 0.0032818641047924757
in O 0 0.00022507848916575313
somatic O 0 0.0020303349010646343
cells O 0 0.0001837575837271288
and O 0 4.76911045552697e-05
on O 0 4.784142583957873e-05
the O 0 7.029936386970803e-05
axial O 0 0.0003254147304687649
elements O 0 0.00015901845472399145
of O 0 0.00020024283730890602
developing O 0 0.0009265922708436847
synaptonemal O 1 0.99543297290802
complexes O 0 0.023627927526831627
. O 0 0.0012760271783918142

Like O 0 0.010633350349962711
BRCA1 O 1 0.9754035472869873
and O 0 0.002283417619764805
RAD51 O 1 0.9993645548820496
, O 0 0.0012165791122242808
BRCA2 O 0 0.014180416241288185
relocates O 0 0.004899631720036268
to O 0 0.0005278496537357569
PCNA O 0 0.2695748805999756
+ O 0 0.0006644055247306824
replication O 0 0.0004003459180239588
sites O 0 0.00010740843572421
following O 0 0.00014501591795124114
exposure O 0 0.0003078763256780803
of O 0 0.0002339912171009928
S O 0 0.10255852341651917
phase O 0 0.005212799180299044
cells O 0 0.0003371348138898611
to O 0 0.00012712592433672398
hydroxyurea O 0 0.012049918062984943
or O 0 0.0006718655931763351
UV O 1 0.8601601123809814
irradiation O 0 0.004161720164120197
. O 0 0.0010594557970762253

Thus O 0 0.0026673346292227507
, O 0 0.0008206230122596025
BRCA1 O 1 0.511879026889801
and O 0 0.00029986409936100245
BRCA2 O 0 0.0024629016406834126
participate O 0 0.00010977246711263433
, O 0 5.2565126679837704e-05
together O 0 3.705042399815284e-05
, O 0 2.1118847143952735e-05
in O 0 2.4317116185557097e-05
a O 0 7.101411756593734e-05
pathway O 0 0.0006238500936888158
( O 0 7.467812247341499e-05
s O 0 0.000174211454577744
) O 0 1.401971803716151e-05
associated O 0 1.3940419194113929e-05
with O 0 8.171993613359518e-06
the O 0 4.856504165218212e-05
activation O 0 8.634438563603908e-05
of O 0 0.0001263049925910309
double O 0 0.00038163518183864653
- O 0 0.00024090758233796805
strand O 0 0.0003587579703889787
break O 0 0.0005597661947831511
repair O 0 0.08273002505302429
and O 0 0.00016817387950140983
/ O 0 0.0007114766631275415
or O 0 0.0002513511572033167
homologous O 0 0.0017261606408283114
recombination O 0 0.002697837306186557
. O 0 0.0008320892811752856

Dysfunction O 1 0.9991282820701599
of O 0 0.0017196547705680132
this O 0 0.00028833033866249025
pathway O 0 0.01369403675198555
may O 0 6.677788041997701e-05
be O 0 2.2473488570540212e-05
a O 0 4.3207561247982085e-05
general O 0 5.8050623920280486e-05
phenomenon O 0 6.763525743735954e-05
in O 0 1.5856183381401934e-05
the O 0 1.7909103917190805e-05
majority O 0 1.5314682968892157e-05
of O 0 3.182008731528185e-05
cases O 0 5.119004345033318e-05
of O 0 0.00038913890602998435
hereditary B-Disease 1 0.9999984502792358
breast I-Disease 1 0.9999995231628418
and I-Disease 1 0.9854788780212402
/ I-Disease 1 0.9999878406524658
or I-Disease 1 0.9999561309814453
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.0005582295707426965
. O 0 0.0006273979670368135

A O 0 0.0039736866019666195
novel O 0 0.0026288472581654787
Arg362Ser O 0 0.02788712829351425
mutation O 0 0.00027184601640328765
in O 0 6.375346856657416e-05
the O 0 0.00010643262066878378
sterol O 0 0.001402690657414496
27 O 0 0.00042158635915257037
- O 0 0.00045651081018149853
hydroxylase O 0 0.001156918122433126
gene O 0 0.00015662709483876824
( O 0 6.77463467582129e-05
CYP27 O 0 0.061373040080070496
) O 0 4.131703099119477e-05
: O 0 1.9805751435342245e-05
its O 0 1.2700539627985563e-05
effects O 0 6.21369545115158e-05
on O 0 4.491047002375126e-05
pre O 0 0.00027212867280468345
- O 0 0.00023683320614509284
mRNA O 0 0.00022312258079182357
splicing O 0 0.00042863585986196995
and O 0 0.00013822651817463338
enzyme O 0 0.0005869927699677646
activity O 0 0.000700684729963541
. O 0 0.00045816655620001256

A O 0 0.0017090165056288242
novel O 0 0.0006709775771014392
C O 0 0.00039590493543073535
to O 0 5.6438915635226294e-05
A O 0 0.00017613207455724478
mutation O 0 5.880666503799148e-05
in O 0 2.4192304408643395e-05
the O 0 6.406165630323812e-05
sterol O 0 0.0006717786309309304
27 O 0 0.00029107718728482723
- O 0 0.00020293179841246456
hydroxylase O 0 0.0010813855333253741
gene O 0 0.0001528755819890648
( O 0 0.00011241832544328645
CYP27 O 0 0.06921223551034927
) O 0 7.265604654094204e-05
was O 0 0.0001459765189792961
identified O 0 4.556898056762293e-05
by O 0 2.900107210734859e-05
sequencing O 0 0.00022624748817179352
amplified O 0 0.0005271507543511689
CYP27 O 0 0.4715522229671478
gene O 0 0.0001358908775728196
products O 0 5.3101510275155306e-05
from O 0 3.0302526283776388e-05
a O 0 0.00013369967928156257
patient O 0 0.0005217098514549434
with O 0 0.00025827198987826705
cerebrotendinous B-Disease 1 0.9999886751174927
xanthomatosis I-Disease 1 0.9999932050704956
( O 0 0.016436824575066566
CTX B-Disease 1 0.9998482465744019
) O 0 0.0007190486649051309
. O 0 0.0009434794774278998

The O 0 0.002228751312941313
mutation O 0 0.0010168232256546617
changed O 0 0.0005748785333707929
the O 0 0.0003354844229761511
adrenodoxin O 0 0.012405866757035255
cofactor O 0 0.0042361789382994175
binding O 0 0.0002065612789010629
residue O 0 0.001224207691848278
362Arg O 0 0.0037942463532090187
to O 0 0.00024281602236442268
362Ser O 0 0.024432282894849777
( O 0 0.0005278853350318968
CGT O 1 0.7305914163589478
362Arg O 0 0.03161872550845146
to O 0 0.00034668497391976416
AGT O 1 0.9998284578323364
362Ser O 1 0.6159774661064148
) O 0 8.836753113428131e-05
, O 0 4.85503624076955e-05
and O 0 3.924403426935896e-05
was O 0 0.00019311057985760272
responsible O 0 0.0001694645470706746
for O 0 0.00010031842248281464
deficiency O 1 0.9952057003974915
in O 0 4.0764025470707566e-05
the O 0 7.158250809879974e-05
sterol O 0 0.0012104621855542064
27 O 0 0.00023204188619274646
- O 0 0.00018267167615704238
hydroxylase O 0 0.0005189673975110054
activity O 0 6.487964128609747e-05
, O 0 1.8536748029873706e-05
as O 0 1.3686771126231179e-05
confirmed O 0 2.6631809305399656e-05
by O 0 2.2528422050527297e-05
expression O 0 4.73854634037707e-05
of O 0 7.054617162793875e-05
mutant O 0 0.0004007267998531461
cDNA O 0 0.000583465036470443
into O 0 0.000212381302844733
COS O 1 0.6630159616470337
- O 0 0.0007403490017168224
1 O 0 0.0005778857157565653
cells O 0 0.0008162106387317181
. O 0 0.0005406870623119175

Quantitative O 0 0.0015905412146821618
analysis O 0 0.00023672846145927906
showed O 0 0.00019784813048318028
that O 0 3.183495573466644e-05
the O 0 5.068714017397724e-05
expression O 0 0.00011173701932420954
of O 0 0.00015000592975411564
CYP27 O 1 0.9576854109764099
gene O 0 0.00010912600555457175
mRNA O 0 7.965751137817279e-05
in O 0 2.6286299544153735e-05
the O 0 6.07334150117822e-05
patient O 0 0.0001995954808080569
represented O 0 0.00015442211588378996
52 O 0 0.0006454363465309143
. O 0 0.000468259968329221

5 O 0 0.0007533797179348767
% O 0 0.00017108391330111772
of O 0 0.00017050608585122973
the O 0 0.0002864905691239983
normal O 0 0.00048129312926903367
level O 0 0.0007103707757778466
. O 0 0.000644570158328861

As O 0 0.0005559131968766451
the O 0 0.0002026386937359348
mutation O 0 0.0002018453524215147
occurred O 0 0.00028030850808136165
at O 0 0.00013269175542518497
the O 0 8.559867274016142e-05
penultimate O 0 0.0008027793955989182
nucleotide O 0 0.00012108840746805072
of O 0 7.691251812502742e-05
exon O 0 0.0003278820659033954
6 O 0 9.178822801914066e-05
( O 0 4.657733006752096e-05
- O 0 7.26685902918689e-05
2 O 0 4.705287574324757e-05
position O 0 6.612065044464543e-05
of O 0 6.093855336075649e-05
exon O 0 0.00034381961449980736
6 O 0 0.00021083741739857942
- O 0 0.00020836210751440376
intron O 0 0.0009453200618736446
6 O 0 0.0002178973372792825
splice O 0 0.0004619480750989169
site O 0 0.00016185107233468443
) O 0 2.615497578517534e-05
of O 0 3.843887316179462e-05
the O 0 5.3545682021649554e-05
gene O 0 5.1882358093280345e-05
, O 0 2.6144725779886357e-05
we O 0 2.2938638721825555e-05
hypothesized O 0 0.00010687531903386116
that O 0 1.6570251318626106e-05
the O 0 5.332203727448359e-05
mutation O 0 9.776163642527536e-05
may O 0 4.639893813873641e-05
partially O 0 0.00016507267719134688
affect O 0 5.016204158891924e-05
the O 0 5.335804962669499e-05
normal O 0 6.450935325119644e-05
splicing O 0 0.00011754043225664645
efficiency O 0 8.513596549164504e-05
in O 0 3.064597331103869e-05
exon O 0 0.000342207116773352
6 O 0 0.00012954123667441308
and O 0 5.3930281865177676e-05
cause O 0 0.00012931317905895412
alternative O 0 4.382011684356257e-05
splicing O 0 9.383014548802748e-05
elsewhere O 0 4.2082549043698236e-05
, O 0 2.2881395125295967e-05
which O 0 1.2158004210505169e-05
resulted O 0 7.723001908743754e-05
in O 0 3.543888669810258e-05
decreased O 0 0.00029171945061534643
transcript O 0 0.00021211842249613255
in O 0 6.324861897155643e-05
the O 0 0.0002083756262436509
patient O 0 0.0018759077647700906
. O 0 0.000931576534640044

Transfection O 0 0.02411315217614174
of O 0 0.001334632746875286
constructed O 0 0.009408046491444111
minigenes O 1 0.8779367804527283
, O 0 0.00010841180483112112
with O 0 3.386189928278327e-05
or O 0 3.202972948201932e-05
without O 0 2.1484189346665516e-05
the O 0 4.359237937023863e-05
mutation O 0 5.1491977501427755e-05
, O 0 2.168585342587903e-05
into O 0 5.3448398830369115e-05
COS O 0 0.41694164276123047
- O 0 0.00016988585412036628
1 O 0 7.699228444835171e-05
cells O 0 4.431220077094622e-05
confirmed O 0 3.310399188194424e-05
that O 0 1.5605044609401375e-05
the O 0 6.091456089052372e-05
mutant O 0 0.0006238275673240423
minigene O 0 0.017345907166600227
was O 0 0.0002954806841444224
responsible O 0 0.00011205209011677653
for O 0 2.43448703258764e-05
a O 0 6.015069084241986e-05
mRNA O 0 6.498044240288436e-05
species O 0 1.543823782412801e-05
alternatively O 0 7.810306851752102e-05
spliced O 0 0.0001621453557163477
at O 0 7.655302761122584e-05
an O 0 6.718975055264309e-05
activated O 0 0.00048228894593194127
cryptic O 0 0.0004634430806618184
5 O 0 0.00012957991566509008
splice O 0 0.0005117935361340642
site O 0 0.00017352229042444378
88 O 0 0.00022830588568467647
bp O 0 0.0003564934595488012
upstream O 0 0.0001579869567649439
from O 0 2.8039032258675434e-05
the O 0 3.8756967114750296e-05
3 O 0 4.5042532292427495e-05
end O 0 0.00011403274402255192
of O 0 0.00014982468564994633
exon O 0 0.0013752750819548965
6 O 0 0.0006197122274897993
. O 0 0.00044353966950438917

Our O 0 0.0014030300080776215
data O 0 0.00019198057998437434
suggest O 0 0.00010278994886903092
that O 0 2.671501351869665e-05
the O 0 5.6038512411760166e-05
C O 0 0.0001445458474336192
to O 0 2.1724605176132172e-05
A O 0 0.00013676313392352313
mutation O 0 8.211994281737134e-05
at O 0 9.310597670264542e-05
the O 0 8.940754196373746e-05
penultimate O 0 0.0009749880409799516
nucleotide O 0 0.00015755386266391724
of O 0 7.057860057102516e-05
exon O 0 0.0003853502275887877
6 O 0 9.656816109782085e-05
of O 0 6.840688729425892e-05
the O 0 0.00015359987446572632
CYP27 O 1 0.9887663722038269
gene O 0 8.954919030657038e-05
not O 0 1.8292481399839744e-05
only O 0 3.441048465901986e-05
causes O 0 0.0004897338803857565
the O 0 0.00020687031792476773
deficiency B-Disease 1 0.9992699027061462
in I-Disease 0 4.57911919511389e-05
the I-Disease 0 8.932821219787002e-05
sterol I-Disease 0 0.0012958303559571505
27 I-Disease 0 0.0003321862604934722
- I-Disease 0 0.00019847467774525285
hydroxylase I-Disease 0 0.000575624464545399
activity I-Disease 0 8.51090153446421e-05
, O 0 2.702926576603204e-05
but O 0 1.5101659300853498e-05
also O 0 3.412083606235683e-05
partially O 0 0.00014725206710863858
leads O 0 0.0001247502805199474
to O 0 4.394457573653199e-05
alternative O 0 0.0001337797730229795
pre O 0 0.00033652869751676917
- O 0 0.0001514152972958982
mRNA O 0 0.00016558692732360214
splicing O 0 0.00020667395438067615
of O 0 0.00011490521137602627
the O 0 0.0003032837703358382
gene O 0 0.0005077897221781313
. O 0 0.0007282786536961794

To O 0 0.0004966240376234055
our O 0 0.0003350388433318585
knowledge O 0 0.00019310653442516923
, O 0 5.9701866121031344e-05
this O 0 2.166878039133735e-05
is O 0 1.7803900846047327e-05
the O 0 2.1269261196721345e-05
first O 0 3.8042253436287865e-05
report O 0 1.9118268028250895e-05
regarding O 0 4.648344111046754e-05
effects O 0 7.684492447879165e-05
on O 0 3.275832568760961e-05
pre O 0 0.0001345225900877267
- O 0 4.421207995619625e-05
mRNA O 0 3.413489685044624e-05
splicing O 0 2.656846663739998e-05
of O 0 1.5612904462614097e-05
a O 0 1.9986209736089222e-05
mutation O 0 2.6644229365047067e-05
at O 0 4.029266710858792e-05
the O 0 2.5833902327576652e-05
- O 0 4.2697032768046483e-05
2 O 0 2.4473689336446114e-05
position O 0 2.858050174836535e-05
of O 0 3.10027135128621e-05
a O 0 9.416510874871165e-05
5 O 0 0.0001767990761436522
splice O 0 0.0012683795066550374
site O 0 0.0008455571369268
. O 0 0.00045864679850637913

ATM O 0 0.09011135995388031
germline O 0 0.06124143302440643
mutations O 0 0.001019211020320654
in O 0 0.00039328832644969225
classical O 0 0.024084120988845825
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.9997221827507019
telangiectasia I-Disease 1 0.9999923706054688
patients O 0 0.0015100525924935937
in O 0 0.0001110916055040434
the O 0 0.00025559449568390846
Dutch O 0 0.0007449398981407285
population O 0 0.00014870088489260525
. O 0 0.00029399245977401733

Germline O 0 0.4482657313346863
mutations O 0 0.0007581333629786968
in O 0 0.0001863069337559864
the O 0 0.0002517967950552702
ATM O 0 0.0010472703725099564
gene O 0 8.895037899492308e-05
are O 0 1.0715980351960752e-05
responsible O 0 7.305748295038939e-05
for O 0 5.9913054428761825e-05
the O 0 0.0024039801210165024
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.999998927116394
telangiectasia I-Disease 1 0.9999996423721313
( O 0 0.4022216796875
A B-Disease 1 0.9999388456344604
- I-Disease 1 0.993697464466095
T I-Disease 1 0.9981435537338257
) O 0 0.00022141277440823615
. O 0 0.00033624633215367794

In O 0 0.00048397498903796077
our O 0 0.00023678081925027072
study O 0 7.305783219635487e-05
, O 0 4.462209835764952e-05
we O 0 2.908127680711914e-05
have O 0 9.696513188828249e-06
determined O 0 3.989642937085591e-05
the O 0 5.987370968796313e-05
ATM O 0 0.00027431052876636386
mutation O 0 7.463640213245526e-05
spectrum O 0 6.054801633581519e-05
in O 0 2.319785016879905e-05
19 O 0 9.707920253276825e-05
classical O 0 0.00020989470067434013
A B-Disease 1 0.8055111169815063
- I-Disease 1 0.8411247730255127
T I-Disease 1 0.999092698097229
patients O 0 0.0001224385341629386
, O 0 1.969977529370226e-05
including O 0 1.8298915165360086e-05
some O 0 1.4208018910721876e-05
immigrant O 0 7.418107270495966e-05
populations O 0 2.580435830168426e-05
, O 0 1.4281185030995402e-05
as O 0 1.4281321455200668e-05
well O 0 1.2460380276024807e-05
as O 0 2.9543847631430253e-05
12 O 0 6.329447205644101e-05
of O 0 7.136591011658311e-05
Dutch O 0 0.0003300689859315753
ethnic O 0 0.00016397549188695848
origin O 0 0.00032174159423448145
. O 0 0.0005570915527641773

Both O 0 0.0005491789197549224
the O 0 0.0003605652891565114
protein O 0 0.00040156947216019034
truncation O 0 0.0017536607338115573
test O 0 0.0002958772820420563
( O 0 0.00016657014202792197
PTT O 0 0.0008011176832951605
) O 0 3.300214666523971e-05
and O 0 2.788759047689382e-05
the O 0 5.0017926696455106e-05
restriction O 0 0.00017677040887065232
endonuclease O 0 0.000798147520981729
fingerprinting O 0 0.0005070902989245951
( O 0 0.0001290863729082048
REF O 0 0.0023050406016409397
) O 0 2.6163530492340215e-05
method O 0 2.6315043214708567e-05
were O 0 1.3293361917021684e-05
used O 0 1.24917205539532e-05
and O 0 1.5635001545888372e-05
compared O 0 1.616660119907465e-05
for O 0 9.480281732976437e-06
their O 0 1.118082036555279e-05
detection O 0 0.00011110685591120273
efficiency O 0 0.00011822477245004848
, O 0 2.2177509890752845e-05
identifying O 0 5.273996794130653e-05
76 O 0 8.137268014252186e-05
% O 0 1.9004943169420585e-05
and O 0 1.3417426998785231e-05
60 O 0 2.5402490791748278e-05
% O 0 1.4646700037701521e-05
of O 0 3.6804900446441025e-05
the O 0 9.310384484706447e-05
mutations O 0 0.0001757960271788761
, O 0 0.0001026797472150065
respectively O 0 0.0003855158283840865
. O 0 0.0004712669178843498

Most O 0 0.001469893497414887
patients O 0 0.0006745693390257657
were O 0 8.968481415649876e-05
found O 0 7.093392196111381e-05
to O 0 7.436486339429393e-05
be O 0 0.0001366995129501447
compound O 0 0.004295315593481064
heterozygote O 0 0.008948249742388725
. O 0 0.0007343895267695189

Seventeen O 0 0.0035754069685935974
mutations O 0 0.00043501827167347074
were O 0 6.278631190070882e-05
distinct O 0 4.128355431021191e-05
, O 0 1.7194835891132243e-05
of O 0 2.29428169404855e-05
which O 0 1.6761334336479194e-05
10 O 0 1.934615102072712e-05
were O 0 2.3111026166589e-05
not O 0 2.2274372895481065e-05
reported O 0 0.00013902877981308848
previously O 0 0.00039859325625002384
. O 0 0.0004002997593488544

Mutations O 0 0.001437875092960894
are O 0 0.00013272176147438586
small O 0 0.0001570057065691799
deletions O 0 0.0005566058680415154
or O 0 0.00019213624182157218
point O 0 0.00041351572144776583
mutations O 0 0.00028166326228529215
frequently O 0 0.0003718941879924387
affecting O 0 0.0007265086169354618
splice O 0 0.003777632722631097
sites O 0 0.0013034212170168757
. O 0 0.0009928651852533221

Moreover O 0 0.0047088307328522205
, O 0 0.0007316399714909494
a O 0 0.0007712450460530818
16 O 0 0.0017998642288148403
. O 0 0.0016312352381646633

7 O 0 0.0029406447429209948
- O 0 0.0009840455604717135
kb O 0 0.0010822162730619311
genomic O 0 0.00033629091922193766
deletion O 0 0.00013600612874142826
of O 0 5.171756856725551e-05
the O 0 5.195385165279731e-05
3 O 0 5.110083657200448e-05
end O 0 5.003390469937585e-05
of O 0 5.019046875531785e-05
the O 0 5.1454426284180954e-05
gene O 0 5.0929007556987926e-05
, O 0 1.5744530173833482e-05
most O 0 9.58064993028529e-06
likely O 0 1.4550413652614225e-05
a O 0 2.1060781364212744e-05
result O 0 2.2855267161503434e-05
of O 0 4.208861355436966e-05
recombination O 0 0.00012752937618643045
between O 0 3.424751776037738e-05
two O 0 3.487420326564461e-05
LINE O 0 0.00028278204263187945
elements O 0 0.00012129654351156205
, O 0 8.525620796717703e-05
was O 0 0.0004258147091604769
identified O 0 0.0004790962266270071
. O 0 0.00048176266136579216

The O 0 0.001051443163305521
most O 0 0.0002380557416472584
frequently O 0 0.00021090434165671468
found O 0 0.00010510854190215468
mutation O 0 0.00010535911860642955
, O 0 2.850081364158541e-05
identified O 0 2.9917699066572823e-05
in O 0 2.59273929259507e-05
three O 0 3.006900988111738e-05
unrelated O 0 0.0001358598965452984
Turkish O 0 0.00022611356689594686
A B-Disease 1 0.8879910111427307
- I-Disease 0 0.07077768445014954
T I-Disease 1 0.5893312096595764
individuals O 0 2.854898957593832e-05
, O 0 3.1502029742114246e-05
was O 0 9.481856250204146e-05
previously O 0 6.078683873056434e-05
described O 0 5.960862472420558e-05
to O 0 1.1179402463312726e-05
be O 0 8.32250589155592e-06
a O 0 4.607160735758953e-05
Turkish O 0 0.00019379807054065168
A B-Disease 1 0.570744514465332
- I-Disease 0 0.11722879856824875
T I-Disease 1 0.9886387586593628
founder O 0 0.006727642845362425
mutation O 0 0.0011828505666926503
. O 0 0.0007473481819033623

The O 0 0.0008160597644746304
presence O 0 0.0004751823435071856
of O 0 0.0002511379716452211
a O 0 0.00028862792532891035
founder O 0 0.005053844768553972
mutation O 0 0.00017228319484274834
among O 0 4.6789951738901436e-05
relatively O 0 2.653731826285366e-05
small O 0 1.8615763110574335e-05
ethnic O 0 2.1129604647285305e-05
population O 0 1.0188276064582169e-05
groups O 0 6.620727162953699e-06
in O 0 1.1669641935441177e-05
Western O 0 4.390327740111388e-05
Europe O 0 4.7443885705433786e-05
could O 0 2.0055271306773648e-05
indicate O 0 3.184862362104468e-05
a O 0 4.0082573832478374e-05
high O 0 7.87101816968061e-05
carrier O 0 9.154732106253505e-05
frequency O 0 3.694169208756648e-05
in O 0 3.483771433820948e-05
such O 0 4.7635876398999244e-05
communities O 0 0.00023338693426921964
. O 0 0.000377058720914647

In O 0 0.0007659218972548842
patients O 0 0.0003789734037127346
of O 0 0.0001568955776747316
Dutch O 0 0.0002712210698518902
ethnic O 0 7.953106251079589e-05
origin O 0 6.457071140175685e-05
, O 0 4.4827676902059466e-05
however O 0 2.3850792786106467e-05
, O 0 2.1778992959298193e-05
no O 0 2.8498774554464035e-05
significant O 0 7.60130351409316e-05
founder O 0 0.0011369819985702634
effect O 0 0.0001612187916180119
could O 0 7.079295755829662e-05
be O 0 5.3410945838550106e-05
identified O 0 0.00024506275076419115
. O 0 0.00039889771142043173

The O 0 0.0011953730136156082
observed O 0 0.0006396212847903371
genetic O 0 0.0002587733615655452
heterogeneity O 0 0.00027912441873922944
including O 0 5.91307325521484e-05
the O 0 8.99823207873851e-05
relative O 0 0.00014931836631149054
high O 0 0.00012045421317452565
percentage O 0 7.141649257391691e-05
of O 0 7.697282126173377e-05
splice O 0 0.0006550289690494537
- O 0 0.00017771156853996217
site O 0 0.00018763133266475052
mutations O 0 5.623701144941151e-05
had O 0 7.154901686590165e-05
no O 0 5.699741450371221e-05
reflection O 0 0.00028558573103509843
on O 0 0.00010652846685843542
the O 0 0.00035129423486068845
phenotype O 0 0.0022126249969005585
. O 0 0.000521729001775384

All O 0 0.001328878803178668
patients O 0 0.0017664015758782625
manifested O 0 0.0031256177462637424
classical O 0 0.0010903972433879972
A B-Disease 1 0.9938659071922302
- I-Disease 0 0.2866916358470917
T I-Disease 1 0.7305160164833069
and O 0 0.00015030345821287483
increased O 0 0.00033157056896016
cellular O 0 0.0010948177659884095
radioresistant O 0 0.022657407447695732
DNA O 0 0.001052454230375588
synthesis O 0 0.0018764159176498652
. O 0 0.0007414267165586352

Determination O 0 0.002610281575471163
of O 0 0.0005060111288912594
the O 0 0.0001730952935758978
genomic O 0 0.00024771352764219046
structure O 0 0.0002046264853561297
of O 0 0.00013863362255506217
the O 0 0.0002636577992234379
COL4A4 O 1 0.9985160231590271
gene O 0 7.257447578012943e-05
and O 0 3.6393477785168216e-05
of O 0 0.0001271019282285124
novel O 0 0.004245932213962078
mutations O 1 0.7931874990463257
causing O 1 0.9999849796295166
autosomal B-Disease 1 0.9999988079071045
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.7709388732910156

Autosomal B-Disease 1 0.99998939037323
recessive I-Disease 1 0.9999998807907104
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.431362509727478
a O 1 0.814440131187439
progressive O 1 0.9999945163726807
hematuric B-Disease 1 0.9999996423721313
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9995536208152771
by O 0 0.022478828206658363
glomerular B-Disease 1 0.9999982118606567
basement I-Disease 1 0.9999953508377075
membrane I-Disease 1 0.9985117316246033
abnormalities I-Disease 1 0.9970197081565857
and O 0 7.935794565128163e-05
associated O 0 4.817471563001163e-05
with O 0 2.018136001424864e-05
mutations O 0 3.0121531381155364e-05
in O 0 2.5117589757428505e-05
either O 0 2.6627973056747578e-05
the O 0 6.678928184555843e-05
COL4A3 O 1 0.9837289452552795
or O 0 5.451047036331147e-05
the O 0 0.00012946221977472305
COL4A4 O 1 0.9939433932304382
gene O 0 0.00010134057811228558
, O 0 2.8414078769856133e-05
which O 0 1.4367547009896953e-05
encode O 0 4.718732452602126e-05
the O 0 9.173274884233251e-05
alpha3 O 0 0.004724154714494944
and O 0 0.00021327885042410344
alpha4 O 1 0.9959115982055664
type O 1 0.9608636498451233
IV O 1 0.9999988079071045
collagen O 1 0.9999802112579346
chains O 0 0.004743290599435568
, O 0 0.0002549327618908137
respectively O 0 0.000613149197306484
. O 0 0.0004184576391708106

To O 0 0.0005243336199782789
date O 0 0.000668760621920228
, O 0 0.00019703147700056434
mutation O 0 0.00012638862244784832
screening O 0 7.904165249783546e-05
in O 0 3.410177305340767e-05
the O 0 4.4581476686289534e-05
two O 0 2.850874989235308e-05
genes O 0 4.0845236071618274e-05
has O 0 2.7367461370886303e-05
been O 0 4.3220621591899544e-05
hampered O 0 0.0004651170165743679
by O 0 3.170549825881608e-05
the O 0 8.880036330083385e-05
lack O 0 0.00018631722196005285
of O 0 0.00024348111764993519
genomic O 0 0.00035043491516262293
structure O 0 0.0004983018734492362
information O 0 0.00018448369519319385
. O 0 0.0004522204108070582

We O 0 0.0005174226243980229
report O 0 0.0001595998037373647
here O 0 7.394884596578777e-05
the O 0 6.326508446363732e-05
complete O 0 0.00010529896098887548
characterization O 0 0.00017798070621211082
of O 0 5.1671035180334e-05
the O 0 3.477617065072991e-05
48 O 0 5.3847124945605174e-05
exons O 0 0.00015018512203823775
of O 0 6.389222835423425e-05
the O 0 0.00014529330655932426
COL4A4 O 1 0.9939708709716797
gene O 0 8.589582284912467e-05
, O 0 2.4330616724910215e-05
a O 0 4.034330413560383e-05
comprehensive O 0 7.640089461347088e-05
gene O 0 6.142889469629154e-05
screen O 0 8.290037658298388e-05
, O 0 1.7502492482890375e-05
and O 0 1.3619286619359627e-05
the O 0 2.2108753910288215e-05
subsequent O 0 6.55726034892723e-05
detection O 0 5.579509161179885e-05
of O 0 4.699382043327205e-05
10 O 0 6.0598624259000644e-05
novel O 0 0.00015928177163004875
mutations O 0 9.483283793088049e-05
in O 0 6.787625898141414e-05
eight O 0 0.000398095027776435
patients O 1 0.8262006640434265
diagnosed O 1 0.9999982118606567
with O 1 0.9683204889297485
autosomal B-Disease 1 0.9999996423721313
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9131433963775635

Furthermore O 0 0.0027263304218649864
, O 0 0.0003603278018999845
we O 0 0.00012093551777070388
identified O 0 0.00010911332356045023
a O 0 9.173274884233251e-05
glycine O 0 0.0002836726198438555
to O 0 4.232484207022935e-05
alanine O 0 0.0003039179719053209
substitution O 0 0.00013255138765089214
in O 0 3.75184063159395e-05
the O 0 0.00011136875400552526
collagenous O 0 0.025870969519019127
domain O 0 9.976864384952933e-05
that O 0 2.588843199191615e-05
is O 0 2.262360430904664e-05
apparently O 0 8.569627243559808e-05
silent O 0 0.000157117290655151
in O 0 2.6370691557531245e-05
the O 0 5.383871030062437e-05
heterozygous O 0 0.00010015728184953332
carriers O 0 6.195317109813914e-05
, O 0 3.1165276595856994e-05
in O 0 7.616513903485611e-05
11 O 0 0.0005261223996058106
. O 0 0.0006069907685741782

5 O 0 0.00042147040949203074
% O 0 8.651531970826909e-05
of O 0 6.643901724601164e-05
all O 0 3.360358459758572e-05
control O 0 6.841360300313681e-05
individuals O 0 1.7624932297621854e-05
, O 0 2.4220975319622084e-05
and O 0 1.26894265122246e-05
in O 0 1.83425781870028e-05
one O 0 2.8626878702198155e-05
control O 0 7.365655619651079e-05
individual O 0 2.8877242584712803e-05
homozygous O 0 8.580200665164739e-05
for O 0 3.443319656071253e-05
this O 0 7.743967580609024e-05
glycine O 0 0.0009295474737882614
substitution O 0 0.00175808637868613
. O 0 0.0007145616691559553

There O 0 0.00045889586908742785
has O 0 0.00010481848585186526
been O 0 4.175631329417229e-05
no O 0 2.810169644362759e-05
previous O 0 2.754771958279889e-05
finding O 0 5.107978722662665e-05
of O 0 4.44973811681848e-05
a O 0 7.660070696147159e-05
glycine O 0 0.00023335000150837004
substitution O 0 0.00016283264267258346
that O 0 2.8716451197396964e-05
is O 0 2.0224459149176255e-05
not O 0 1.271661039936589e-05
associated O 0 3.018001552845817e-05
with O 0 1.9042314306716435e-05
any O 0 5.4888911108719185e-05
obvious O 0 0.00055819092085585
phenotype O 0 0.0008939265972003341
in O 0 0.00016862894699443132
homozygous O 0 0.0009402447612956166
individuals O 0 0.00022136782354209572
. O 0 0.0004222174175083637

Founder O 1 0.9933007955551147
BRCA1 O 1 0.9973530769348145
and O 0 0.0014828507555648685
BRCA2 O 0 0.2225874960422516
mutations O 0 0.0003970123070757836
in O 0 0.00013773261161986738
French O 0 0.0009454694809392095
Canadian O 1 0.9359106421470642
breast B-Disease 1 0.999998927116394
and I-Disease 1 0.9996981620788574
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
families O 0 0.0034046682994812727
. O 0 0.0015692308079451323

We O 0 0.0004970021545886993
have O 0 6.564173236256465e-05
identified O 0 0.00010517040209379047
four O 0 4.494882159633562e-05
mutations O 0 5.032835542806424e-05
in O 0 1.667238029767759e-05
each O 0 1.311432060902007e-05
of O 0 5.5229142162716016e-05
the O 0 0.0008874573395587504
breast B-Disease 1 0.9999973773956299
cancer I-Disease 1 0.9999967813491821
- O 1 0.6730418801307678
susceptibility O 1 0.5699092149734497
genes O 0 0.0001346207718597725
, O 0 0.00010214135545538738
BRCA1 O 0 0.10829225927591324
and O 0 9.3473368906416e-05
BRCA2 O 0 0.0015797293744981289
, O 0 4.890150739811361e-05
in O 0 5.319537376635708e-05
French O 0 0.0006071455427445471
Canadian O 0 0.38604894280433655
breast B-Disease 1 0.9999974966049194
cancer I-Disease 1 0.9999990463256836
and O 1 0.9979950189590454
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
families O 0 0.0003966878866776824
from O 0 0.00035462138475850224
Quebec O 0 0.00419716676697135
. O 0 0.0009432133520022035

To O 0 0.000590189010836184
identify O 0 0.0008379246573895216
founder O 0 0.009784684516489506
effects O 0 0.0011584050953388214
, O 0 0.0001622998679522425
we O 0 7.407130033243448e-05
examined O 0 0.0001519854849902913
independently O 0 6.039289655745961e-05
ascertained O 0 0.00044047980918549
French O 0 0.00034202152164652944
Canadian O 0 0.0006480708252638578
cancer B-Disease 0 0.0017573684453964233
families O 0 3.1255578505806625e-05
for O 0 1.480924584029708e-05
the O 0 2.6397890906082466e-05
distribution O 0 2.8569767891895026e-05
of O 0 4.2232109990436584e-05
these O 0 2.4354854758712463e-05
eight O 0 0.00014274347631726414
mutations O 0 0.0004350149247329682
. O 0 0.00042546456097625196

Mutations O 0 0.0007992914761416614
were O 0 0.00011028384324163198
found O 0 9.075409616343677e-05
in O 0 4.54828841611743e-05
41 O 0 0.00013324443716555834
of O 0 0.00012913401587866247
97 O 0 0.0009157913154922426
families O 0 0.00026874509057961404
. O 0 0.0005410329322330654

Six O 0 0.0009874259121716022
of O 0 0.00032163364812731743
eight O 0 0.00027068424969911575
mutations O 0 0.0001429732801625505
were O 0 6.451396620832384e-05
observed O 0 0.00014178278797771782
at O 0 0.00026410992722958326
least O 0 0.00015953923866618425
twice O 0 0.0005979277193546295
. O 0 0.00041780478204600513

The O 0 0.004573996644467115
BRCA1 O 1 0.9777402877807617
C4446T O 1 0.9683893918991089
mutation O 0 0.0007585985586047173
was O 0 0.00023534170759376138
the O 0 6.765866419300437e-05
most O 0 2.4190319891204126e-05
common O 0 2.907944690377917e-05
mutation O 0 3.752760312636383e-05
found O 0 2.2713316866429523e-05
, O 0 2.3340602638199925e-05
followed O 0 7.356201240327209e-05
by O 0 4.8518748371861875e-05
the O 0 0.00024541065795347095
BRCA2 O 1 0.8868587613105774
8765delAG O 1 0.9849963188171387
mutation O 0 0.0019954342860728502
. O 0 0.0007804589695297182

Together O 0 0.0007701009744778275
, O 0 0.00016865113866515458
these O 0 3.708828808157705e-05
mutations O 0 4.639712642529048e-05
were O 0 1.990554119402077e-05
found O 0 1.3029550245846622e-05
in O 0 1.1684084711305331e-05
28 O 0 4.160721073276363e-05
of O 0 4.448358959052712e-05
41 O 0 9.079009760171175e-05
families O 0 3.3114378311438486e-05
identified O 0 2.7269481506664306e-05
to O 0 1.9018831153516658e-05
have O 0 3.837236363324337e-05
a O 0 0.0002433841145830229
mutation O 0 0.000728231854736805
. O 0 0.0005923225544393063

The O 0 0.0009185978560708463
odds O 0 0.0007277271361090243
of O 0 0.00027109644724987447
detection O 0 0.00023463818070013076
of O 0 8.453716145595536e-05
any O 0 3.512396142468788e-05
of O 0 5.503618376678787e-05
the O 0 9.526463691145182e-05
four O 0 0.00011860868107760325
BRCA1 O 0 0.08596839010715485
mutations O 0 0.00025724738952703774
was O 0 0.00067553436383605
18 O 0 0.0005861306563019753
. O 0 0.0007676598615944386

7x O 0 0.08245040476322174
greater O 0 0.00048222256009466946
if O 0 6.40807775198482e-05
one O 0 2.9713433832512237e-05
or O 0 2.379091347393114e-05
more O 0 1.809302921174094e-05
cases O 0 6.552028935402632e-05
of O 1 0.8354470729827881
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999980926513672
were O 0 0.00014124694280326366
also O 0 3.0872040952090174e-05
present O 0 4.31156913691666e-05
in O 0 3.900487718055956e-05
the O 0 0.000130162836285308
family O 0 0.0003612479194998741
. O 0 0.00038893811870366335

The O 0 0.0008129430934786797
odds O 0 0.0005850262241438031
of O 0 0.00021285163529682904
detection O 0 0.00021589011885225773
of O 0 5.138092456036247e-05
any O 0 2.416117968095932e-05
of O 0 5.1815011829603463e-05
the O 0 9.31165341171436e-05
four O 0 0.00011546140012796968
BRCA2 O 0 0.018443791195750237
mutations O 0 0.00022754659585189074
was O 0 0.000458040798548609
5 O 0 0.0003478599537629634
. O 0 0.0004941506194882095

3x O 0 0.01242575142532587
greater O 0 0.00040767010068520904
if O 0 6.758463860023767e-05
there O 0 4.003947469755076e-05
were O 0 1.6087857147795148e-05
at O 0 2.939164733106736e-05
least O 0 1.4562950127583463e-05
five O 0 1.6877609596122056e-05
cases O 0 4.115792762604542e-05
of O 0 0.0009951475076377392
breast B-Disease 1 0.999995231628418
cancer I-Disease 1 0.9996008276939392
in O 0 0.00015887644258327782
the O 0 0.00028632645262405276
family O 0 0.0006365993758663535
. O 0 0.0006861478323116899

Interestingly O 0 0.003281458979472518
, O 0 0.00023449506261385977
the O 0 0.00014829931023996323
presence O 0 0.00011124659067718312
of O 0 0.00010712070798035711
a O 0 0.0032497101929038763
breast B-Disease 1 0.9999712705612183
cancer I-Disease 1 0.9940987825393677
case O 0 0.00018138073210138828
< O 0 0.0002017145452555269
36 O 0 4.7280020226025954e-05
years O 0 2.797602428472601e-05
of O 0 4.028547846246511e-05
age O 0 7.442993228323758e-05
was O 0 0.00013293263327796012
strongly O 0 5.380930087994784e-05
predictive O 0 5.5025269830366597e-05
of O 0 3.505653512547724e-05
the O 0 3.173568984493613e-05
presence O 0 4.2701347410911694e-05
of O 0 2.859470623661764e-05
any O 0 1.7793054212233983e-05
of O 0 3.945541538996622e-05
the O 0 7.1880072937347e-05
eight O 0 0.0001753505493979901
mutations O 0 0.00032699675648473203
screened O 0 0.0008552093058824539
. O 0 0.0004564107512123883

Carriers O 0 0.0012153895804658532
of O 0 0.00021527551871258765
the O 0 0.00014364218804985285
same O 0 6.459854921558872e-05
mutation O 0 7.789198571117595e-05
, O 0 2.0845714971073903e-05
from O 0 1.330435861746082e-05
different O 0 7.67610708862776e-06
families O 0 1.7313503121840768e-05
, O 0 1.9947863620473072e-05
shared O 0 4.053785960422829e-05
similar O 0 3.2307234505424276e-05
haplotypes O 0 0.00011462428665254265
, O 0 2.620725535962265e-05
indicating O 0 5.9399186284281313e-05
that O 0 1.070684811566025e-05
the O 0 3.4805234463419765e-05
mutant O 0 0.00019230452016927302
alleles O 0 4.511174120125361e-05
were O 0 2.909048635046929e-05
likely O 0 2.134435999323614e-05
to O 0 1.20664517453406e-05
be O 0 9.427808436157648e-06
identical O 0 2.122986552421935e-05
by O 0 1.8783623090712354e-05
descent O 0 8.72377204359509e-05
for O 0 1.538324613648001e-05
a O 0 3.650303551694378e-05
mutation O 0 5.3052812290843576e-05
in O 0 3.587207174859941e-05
the O 0 0.0001040951392496936
founder O 0 0.0012284957338124514
population O 0 0.00014649273362010717
. O 0 0.0003326892328914255

The O 0 0.0009239324717782438
identification O 0 0.000705633545294404
of O 0 0.0005618598661385477
common O 0 0.0028989329002797604
BRCA1 O 1 0.9991494417190552
and O 0 0.00048183774924837053
BRCA2 O 0 0.4205543100833893
mutations O 0 0.00015832447388675064
will O 0 3.483489126665518e-05
facilitate O 0 7.235569501062855e-05
carrier O 0 0.0001616752560948953
detection O 0 0.00010050073615275323
in O 0 4.1705690819071606e-05
French O 0 0.0004117600910831243
Canadian O 0 0.010054460726678371
breast B-Disease 1 0.9999854564666748
cancer I-Disease 1 0.9999972581863403
and O 1 0.9859427809715271
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
families O 0 0.0015801889821887016
. O 0 0.0011846222914755344

Are O 0 0.001385493203997612
Dp71 O 1 0.9830474257469177
and O 0 0.0034028179943561554
Dp140 O 1 0.9999039173126221
brain O 1 0.9994747042655945
dystrophin O 1 0.653213381767273
isoforms O 0 0.0006183797377161682
related O 0 0.00035716244019567966
to O 0 0.00024518099962733686
cognitive B-Disease 1 0.9992654919624329
impairment I-Disease 1 0.9999973773956299
in O 1 0.9995905756950378
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9994865655899048

Molecular O 0 0.003188672009855509
study O 0 0.00044981276732869446
and O 0 0.00016243640857283026
neuropsychological O 0 0.0007052519940771163
analysis O 0 6.16319157416001e-05
were O 0 4.375623393571004e-05
performed O 0 0.0001474589080316946
concurrently O 0 0.00015756391803734004
on O 0 0.00012716763012576848
49 O 0 0.000636866083368659
patients O 0 0.0026590442284941673
with O 0 0.006460771430283785
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9998244643211365
DMD B-Disease 1 0.9999995231628418
) O 0 0.00011581371654756367
in O 0 4.3827807530760765e-05
order O 0 3.4730404877336696e-05
to O 0 9.207536095345858e-06
find O 0 2.7071908334619366e-05
a O 0 3.08431735902559e-05
molecular O 0 4.347853973740712e-05
explanation O 0 5.898470044485293e-05
for O 0 2.8585736799868755e-05
the O 0 0.00012089656229363754
cognitive B-Disease 0 0.1540592610836029
impairment I-Disease 1 0.9639523029327393
observed O 0 0.0002123375452356413
in O 0 0.00016812417015898973
most O 0 0.00044890661956742406
DMD B-Disease 1 0.9999967813491821
patients O 0 0.08764485269784927
. O 0 0.0008285203366540372

Complete O 0 0.0017844050889834762
analysis O 0 0.0003067170036956668
of O 0 0.00028056494193151593
the O 0 0.0004788567603100091
dystrophin O 0 0.3370242416858673
gene O 0 0.00028993687010370195
was O 0 0.0003045633202418685
performed O 0 0.00014604740135837346
to O 0 1.915182474476751e-05
define O 0 5.7674580602906644e-05
the O 0 6.193851731950417e-05
localization O 0 0.00047807872761040926
of O 0 0.00011896526120835915
deletions O 0 0.00035376453888602555
and O 0 5.955640153842978e-05
duplications O 0 0.00033957583946175873
in O 0 4.22873163188342e-05
relation O 0 7.794369594193995e-05
to O 0 3.176981408614665e-05
the O 0 9.349298488814384e-05
different O 0 0.00015880633145570755
DMD B-Disease 1 0.9998997449874878
promoters O 0 0.027673805132508278
. O 0 0.0012354119680821896

Qualitative O 0 0.0021714826580137014
analysis O 0 0.00031556052272208035
of O 0 0.0003523720661178231
the O 0 0.0003478029102552682
Dp71 O 0 0.22944152355194092
transcript O 0 0.0004898809711448848
and O 0 6.903902976773679e-05
testing O 0 5.863284968654625e-05
for O 0 1.4347393516800366e-05
the O 0 2.5148339773295447e-05
specific O 0 1.2540001080196816e-05
first O 0 5.027390943723731e-05
exon O 0 0.00031367293559014797
of O 0 0.00013957150804344565
Dp140 O 0 0.007597722113132477
were O 0 0.00010032129648607224
also O 0 6.370503979269415e-05
carried O 0 0.00016912184946704656
out O 0 0.00025900264154188335
. O 0 0.0004161351243965328

Neuropsychological O 0 0.011296369135379791
analysis O 0 0.0007027605315670371
assessed O 0 0.001009649015031755
verbal O 0 0.0011658275034278631
and O 0 0.00022152680321596563
visuospatial O 1 0.6515935659408569
intelligence O 0 0.0005445235874503851
, O 0 0.00018870369240175933
verbal O 0 0.001471916795708239
memory O 0 0.0811256393790245
, O 0 0.0001941824157256633
and O 0 0.0002659811289049685
reading O 0 0.0010755796683952212
skills O 0 0.0023257103748619556
. O 0 0.0010826245415955782

Comparison O 0 0.0012357220984995365
of O 0 0.0005713717546314001
molecular O 0 0.0006663301028311253
and O 0 0.00015915089170448482
psychometric O 0 0.0018998474115505815
findings O 0 0.0001858431496657431
demonstrated O 0 0.00032097994699142873
that O 0 4.320566586102359e-05
deletions O 0 0.00024271024449262768
and O 0 4.088019340997562e-05
duplications O 0 0.0003446503833401948
that O 0 1.734135003061965e-05
were O 0 2.2286272724159062e-05
localized O 0 0.0001020819618133828
in O 0 3.4182750823674724e-05
the O 0 6.167212995933369e-05
distal O 0 0.0005035342765040696
part O 0 4.8786503612063825e-05
of O 0 5.927277379669249e-05
the O 0 0.00010779022704809904
gene O 0 8.163538586813956e-05
seemed O 0 0.00010073570592794567
to O 0 1.883174445538316e-05
be O 0 2.1232941435300745e-05
preferentially O 0 0.00018204294610768557
associated O 0 0.00017821571964304894
with O 0 0.00024854153161868453
cognitive B-Disease 1 0.9967040419578552
impairment I-Disease 1 0.9998515844345093
. O 0 0.001971297897398472

Two O 0 0.0013209255412220955
altered O 0 0.002468259073793888
Dp71 O 0 0.01151699386537075
transcripts O 0 0.0007979512447491288
and O 0 0.00010106284025823697
two O 0 7.215106597868726e-05
deleted O 0 0.00035356005537323654
Dp140 O 0 0.0018784059211611748
DNA O 0 0.00012179028271930292
sequences O 0 3.109865065198392e-05
were O 0 2.3824743038858287e-05
found O 0 3.636246401583776e-05
in O 0 4.879553307546303e-05
four O 0 0.00012391360360197723
patients O 0 0.014777769334614277
with O 0 0.0450291633605957
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.7895545959472656

These O 0 0.000300987419905141
findings O 0 0.0002493975043762475
suggest O 0 9.946998034138232e-05
that O 0 2.1437259420054033e-05
some O 0 9.619613592803944e-06
sequences O 0 1.610567960597109e-05
located O 0 2.8990343707846478e-05
in O 0 1.3874569049221464e-05
the O 0 4.7817706217756495e-05
distal O 0 0.0002818440261762589
part O 0 5.324531230144203e-05
of O 0 4.9500380555400625e-05
the O 0 5.231089744484052e-05
gene O 0 4.220621849526651e-05
and O 0 2.2669153622700833e-05
, O 0 1.4964088222768623e-05
in O 0 1.3863418644177727e-05
particular O 0 2.906738518504426e-05
, O 0 3.80410929210484e-05
some O 0 4.787994475918822e-05
DMD B-Disease 1 0.7601938247680664
isoforms O 0 8.350742427865043e-05
expressed O 0 3.5292010579723865e-05
in O 0 3.950673635699786e-05
the O 0 0.00020928517915308475
brain O 1 0.5910348892211914
may O 0 5.333684021024965e-05
be O 0 2.064412365143653e-05
related O 0 4.524227915680967e-05
to O 0 3.5348090023035184e-05
the O 0 0.00024046281760092825
cognitive B-Disease 1 0.9849599003791809
impairment I-Disease 1 0.9999502897262573
associated O 0 0.0023195049725472927
with O 0 0.0012532919645309448
DMD B-Disease 1 0.9999984502792358
. O 0 0.0007446118979714811
. O 0 0.000912870280444622

I1307K O 1 0.9937315583229065
APC O 1 0.9769324064254761
and O 0 0.0009966351790353656
hMLH1 O 0 0.39285922050476074
mutations O 0 0.00024327044957317412
in O 0 7.524971442762762e-05
a O 0 0.00011506518785608932
non O 0 0.00012437162513379008
- O 0 0.00011149563215440139
Jewish O 0 0.00014320033369585872
family O 0 0.0001153070479631424
with O 0 0.0001037799593177624
hereditary B-Disease 1 0.9999678134918213
non I-Disease 1 0.9999794960021973
- I-Disease 1 0.9999990463256836
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.012074214406311512

We O 0 0.0005933393840678036
describe O 0 0.00040535308653488755
a O 0 0.00020897651847917587
French O 0 0.00041208782931789756
Canadian O 0 0.0008902571862563491
hereditary B-Disease 1 0.9982447624206543
non I-Disease 1 0.9991119503974915
- I-Disease 1 0.9999872446060181
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9980846643447876
HNPCC B-Disease 1 0.9999982118606567
) O 0 0.0002557234256528318
kindred O 0 0.00236086780205369
which O 0 5.483574568643235e-05
carries O 0 0.00010726605978561565
a O 0 0.00010980533988913521
novel O 0 0.0002332734875380993
truncating O 0 0.0025903668720275164
mutation O 0 0.0006337725790217519
in O 0 0.0002924680011346936
hMLH1 O 0 0.06418963521718979
. O 0 0.000816051964648068

Interestingly O 0 0.004442333709448576
, O 0 0.0004914397723041475
the O 0 0.0006248668069019914
I1307K O 1 0.9644836187362671
APC O 1 0.8367050886154175
polymorphism O 0 0.0005275508156046271
, O 0 5.923321805312298e-05
associated O 0 3.5857843613484874e-05
with O 0 1.5330770111177117e-05
an O 0 3.721406028489582e-05
increased O 0 0.00014504912542179227
risk O 0 0.0016509504057466984
of O 1 0.9980033040046692
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.00031184899853542447
is O 0 5.4451134928967804e-05
also O 0 2.4013797883526422e-05
present O 0 3.945831485907547e-05
in O 0 3.912744432454929e-05
this O 0 5.895776121178642e-05
family O 0 0.0003096658329013735
. O 0 0.0004155747592449188

The O 0 0.002197852125391364
I1307K O 0 0.46526798605918884
polymorphism O 0 0.0011901422403752804
has O 0 0.00010362095781601965
previously O 0 6.369671609718353e-05
only O 0 1.5662344594602473e-05
been O 0 1.8248883861815557e-05
identified O 0 1.6162499377969652e-05
in O 0 1.1966456440859474e-05
individuals O 0 8.696740223967936e-06
of O 0 5.656192297465168e-05
self O 0 0.0007243665168061852
- O 0 0.00036053694202564657
reported O 0 0.00013854692224413157
Ashkenazi O 0 0.0005331388674676418
Jewish O 0 0.0005007771542295814
origins O 0 0.0013238757383078337
. O 0 0.0007185773574747145

In O 0 0.0005790929426439106
addition O 0 0.00018554282723926008
, O 0 9.513390978099778e-05
in O 0 3.866490442305803e-05
this O 0 2.4586302970419638e-05
family O 0 5.543867882806808e-05
, O 0 3.154634032398462e-05
there O 0 2.9846061806892976e-05
appears O 0 4.452424400369637e-05
to O 0 1.104549301089719e-05
be O 0 8.441640602541156e-06
no O 0 2.0731165932375006e-05
relationship O 0 3.751947951968759e-05
between O 0 4.05467908421997e-05
the O 0 0.00011206609633518383
I1307K O 0 0.04900325462222099
polymorphism O 0 0.0001775347482180223
and O 0 3.8573598430957645e-05
the O 0 6.556785228895023e-05
presence O 0 0.00014948534953873605
or O 0 7.997421198524535e-05
absence O 0 0.0005513696814887226
of O 0 0.02350434474647045
cancer B-Disease 1 0.9999364614486694
. O 0 0.00029099275707267225
. O 0 0.00042655819561332464

Identification O 0 0.0009192146244458854
of O 0 0.00035556108923628926
a O 0 0.000260805623838678
novel O 0 0.000334699172526598
mutation O 0 0.00010852909326786175
of O 0 0.00010776545968838036
the O 0 0.00018715442274697125
CPO O 0 0.004179591778665781
gene O 0 7.566670683445409e-05
in O 0 3.647269113571383e-05
a O 0 0.00011605139297898859
Japanese O 0 0.0014684977941215038
hereditary B-Disease 1 0.994494616985321
coproporphyria I-Disease 1 0.9995620846748352
family O 0 0.002697934629395604
. O 0 0.0008822943200357258

Hereditary B-Disease 1 0.999106228351593
coproporphyria I-Disease 1 0.9997684359550476
( O 0 0.01249718852341175
HCP B-Disease 1 0.9986810088157654
) O 0 0.0002823889662977308
is O 0 0.00012116061407141387
an O 0 0.0002513971703592688
autosomal B-Disease 1 0.9109022617340088
dominant I-Disease 1 0.9998866319656372
disease I-Disease 1 0.9999984502792358
characterized O 1 0.8548874855041504
by O 0 0.00029571232153102756
a O 0 0.2785184383392334
deficiency B-Disease 1 0.9999983310699463
of I-Disease 1 0.7177498936653137
coproporphyrinogen I-Disease 1 0.9999951124191284
oxidase I-Disease 1 0.5878375768661499
( O 0 0.00030716272885911167
CPO O 0 0.0040712240152060986
) O 0 6.997819582466036e-05
caused O 0 0.0001261966535821557
by O 0 3.220467988285236e-05
a O 0 9.354506619274616e-05
mutation O 0 0.0001380504108965397
in O 0 7.330857624765486e-05
the O 0 0.000249999575316906
CPO O 0 0.03283338248729706
gene O 0 0.001019034767523408
. O 0 0.0008706112275831401

Only O 0 0.0004480829811654985
11 O 0 0.0004450781852938235
mutations O 0 0.00013635099458042532
of O 0 8.414177864324301e-05
the O 0 9.306495485361665e-05
gene O 0 7.88476609159261e-05
have O 0 2.8603162718354724e-05
been O 0 6.625514652114362e-05
reported O 0 0.00020051376486662775
in O 0 0.0003630530263762921
HCP B-Disease 1 0.9992545247077942
patients O 0 0.0051571959629654884
. O 0 0.0009987016674131155

We O 0 0.00045477604726329446
report O 0 0.00016061317001003772
another O 0 0.00016429100651293993
mutation O 0 0.0001411622652085498
in O 0 5.0936290790559724e-05
a O 0 0.00018999275926034898
Japanese O 0 0.001180238788947463
family O 0 0.0008162906742654741
. O 0 0.0008823780226521194

Polymerase O 0 0.008783898316323757
chain O 0 0.002582541899755597
reaction O 0 0.000972287671174854
- O 0 0.00038138622767291963
single O 0 0.00018686270050238818
strand O 0 0.000337674719048664
conformational O 0 0.0002834544575307518
polymorphism O 0 0.00015984712808858603
and O 0 2.6704365154728293e-05
direct O 0 3.556195224518888e-05
sequence O 0 4.4877637265017256e-05
analyses O 0 4.5883374696131796e-05
demonstrated O 0 7.55728833610192e-05
a O 0 5.34412101842463e-05
C O 0 0.00013757380656898022
to O 0 2.666273394424934e-05
T O 0 0.00021801848197355866
substitution O 0 6.078863225411624e-05
in O 0 1.7179329006467015e-05
exon O 0 0.00013375120761338621
1 O 0 2.830600533343386e-05
of O 0 2.955923628178425e-05
the O 0 6.563641363754869e-05
CPO O 0 0.0005781867657788098
gene O 0 3.9610171370441094e-05
at O 0 5.41633453394752e-05
nucleotide O 0 4.382062252261676e-05
position O 0 5.147224146639928e-05
85 O 0 7.723031012574211e-05
, O 0 2.3220824004965834e-05
which O 0 1.2323733244556934e-05
lies O 0 9.062998287845403e-05
in O 0 3.3007814636221156e-05
the O 0 8.132281072903425e-05
putative O 0 0.0009464925387874246
presequence O 0 0.005197934340685606
for O 0 0.00013252029020804912
targeting O 0 0.0003379457339178771
to O 0 0.00014223520702216774
mitochondria O 0 0.0028241511899977922
. O 0 0.0006105239153839648

This O 0 0.0006210964638739824
mutation O 0 0.0005005376297049224
changes O 0 0.00011965355224674568
the O 0 0.00011841679224744439
codon O 0 0.00027732516173273325
for O 0 4.6603057853644714e-05
glutamine O 0 0.00017678087169770151
to O 0 4.5733104343526065e-05
a O 0 0.00011261295003350824
termination O 0 0.0005733140860684216
codon O 0 0.00042320945067331195
at O 0 0.000198281355551444
amino O 0 0.00011648534564301372
acid O 0 0.0002363319945288822
position O 0 0.00037189509021118283
29 O 0 0.0010035199811682105
. O 0 0.0008620698936283588

MaeI O 0 0.029686953872442245
restriction O 0 0.0007979482761584222
analysis O 0 0.00011748259566957131
showed O 0 0.000170570143382065
two O 0 2.5600471417419612e-05
other O 0 2.100728488585446e-05
carriers O 0 5.7381032092962414e-05
in O 0 5.1773280574707314e-05
the O 0 0.00015045948384795338
family O 0 0.0005072819767519832
. O 0 0.0004916628240607679

The O 0 0.002855105558410287
C O 0 0.021377764642238617
- O 0 0.00686306320130825
T O 0 0.012556396424770355
mutation O 0 0.00012401195999700576
is O 0 2.9674836696358398e-05
located O 0 6.03035805397667e-05
within O 0 2.673351627890952e-05
a O 0 4.120096127735451e-05
recently O 0 9.290446905652061e-05
proposed O 0 8.478014933643863e-05
putative O 0 0.00018333230400457978
alternative O 0 9.199186752084643e-05
translation O 0 0.00012468273052945733
initiation O 0 0.00028981082141399384
codon O 0 0.0004284821916371584
( O 0 0.00011030150926671922
TIC O 0 0.0021441858261823654
- O 0 9.532624244457111e-05
1 O 0 5.3956977353664115e-05
) O 0 1.6025136574171484e-05
, O 0 1.696248546068091e-05
supporting O 0 4.878277832176536e-05
that O 0 2.673433300515171e-05
TIC O 0 0.010852772742509842
- O 0 0.00013870210386812687
1 O 0 5.372397936298512e-05
is O 0 2.7264411983196624e-05
the O 0 4.944168540532701e-05
real O 0 0.0001934266183525324
TIC O 0 0.0018515746342018247
rather O 0 8.045112917898223e-05
than O 0 8.873586193658412e-05
TIC O 0 0.2864350378513336
- O 0 0.00037405636976473033
2 O 0 0.00026227982016280293
. O 0 0.00015242131485138088
. O 0 0.00038371808477677405

Human B-Disease 0 0.0047806501388549805
complement I-Disease 0 0.040684230625629425
factor I-Disease 1 0.9990167617797852
H I-Disease 1 0.9999990463256836
deficiency I-Disease 1 1.0
associated O 1 0.9993835687637329
with O 1 0.9999673366546631
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9978744983673096

This O 0 0.0003773793578147888
study O 0 0.00012395474186632782
reports O 0 6.381489947671071e-05
on O 0 3.7891993997618556e-05
six O 0 4.599000021698885e-05
cases O 0 5.961072747595608e-05
of O 0 0.0005148717318661511
deficiency B-Disease 1 0.9999815225601196
in I-Disease 0 9.00690138223581e-05
the I-Disease 0 8.795147732598707e-05
human I-Disease 0 8.377709309570491e-05
complement I-Disease 0 0.00011673153494484723
regulatory I-Disease 0 9.680807124823332e-05
protein I-Disease 0 0.00014786214160267264
Factor I-Disease 0 0.000627413741312921
H I-Disease 0 0.2830455005168915
( O 0 0.00011106352758361027
FH O 0 0.0011536434758454561
) O 0 2.3818562112865038e-05
in O 0 1.75271798070753e-05
the O 0 3.444824324105866e-05
context O 0 8.960120612755418e-05
of O 0 0.000265007111011073
an O 1 0.9548322558403015
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9715511798858643

Five O 0 0.000471950217615813
of O 0 0.00026286463253200054
the O 0 0.0001796156429918483
cases O 0 7.527426350861788e-05
were O 0 5.855210838490166e-05
observed O 0 9.631884313421324e-05
in O 0 5.933894499321468e-05
children O 0 0.00014959998952690512
presenting O 0 0.0015968082007020712
with O 1 0.6107560992240906
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999997615814209
HUS B-Disease 1 1.0
) O 0 0.02482428029179573
. O 0 0.001917076762765646

Two O 0 0.0003009937354363501
of O 0 0.0002417990326648578
the O 0 0.00029324082424864173
children O 0 0.0003013897512573749
exhibited O 0 0.004243313800543547
a O 0 0.033734001219272614
homozygous O 1 0.9949965476989746
deficiency O 1 0.9999982118606567
characterized O 0 0.0027300328947603703
by O 0 5.720095577999018e-05
the O 0 7.561282836832106e-05
absence O 0 0.00016481836792081594
of O 0 7.012355490587652e-05
the O 0 6.899012805661187e-05
150 O 0 7.363731856457889e-05
- O 0 7.352322427323088e-05
kD O 0 0.0003228400892112404
form O 0 4.000650005764328e-05
of O 0 9.576658339938149e-05
Factor O 0 0.00037736675585620105
H O 0 0.0045073674991726875
and O 0 2.4356317226192914e-05
the O 0 3.8222256989683956e-05
presence O 0 8.166745828930289e-05
, O 0 2.207070792792365e-05
upon O 0 5.787550981040113e-05
immunoblotting O 0 0.0005415649502538145
, O 0 2.279236650792882e-05
of O 0 2.991935434693005e-05
the O 0 5.152380981598981e-05
42 O 0 0.0001278881391044706
- O 0 0.00018669709970708936
kD O 0 0.0011019832454621792
Factor O 0 0.00037668566801585257
H O 0 0.0021206855308264494
- O 0 0.00011561554129002616
like O 0 4.9578422476770356e-05
protein O 0 8.100956620182842e-05
1 O 0 6.87100546201691e-05
( O 0 8.34376915008761e-05
FHL O 0 0.0030567641369998455
- O 0 0.0001234600058523938
1 O 0 3.9931528590386733e-05
) O 0 1.8017355614574626e-05
and O 0 2.1046222173026763e-05
other O 0 2.6568972316454165e-05
FH O 0 0.004615439102053642
- O 0 0.00024049673811532557
related O 0 0.00012493216490838677
protein O 0 0.0002021490945480764
( O 0 0.0002808352583087981
FHR O 1 0.9572679400444031
) O 0 0.0003462697204668075
bands O 0 0.001062063965946436
. O 0 0.0007443686481565237

Southern O 0 0.0039384495466947556
blot O 0 0.005300426390022039
and O 0 0.0003722432302311063
PCR O 0 0.000460527982795611
analysis O 0 4.061889194417745e-05
of O 0 6.459719588747248e-05
DNA O 0 9.182763460557908e-05
of O 0 8.075158257270232e-05
one O 0 6.0134065279271454e-05
patient O 0 0.0002792348968796432
with O 0 0.00013686998863704503
homozygous O 0 0.14333245158195496
deficiency O 1 0.9999371767044067
ruled O 0 0.00017271954857278615
out O 0 4.062729931320064e-05
the O 0 2.8519571060314775e-05
presence O 0 2.922384192061145e-05
of O 0 3.488987567834556e-05
a O 0 3.780735642067157e-05
large O 0 3.975336585426703e-05
deletion O 0 0.00013662964920513332
of O 0 8.881781104719266e-05
the O 0 0.00017223258328158408
FH O 0 0.29058292508125305
gene O 0 0.00011639705917332321
as O 0 6.492716784123331e-05
the O 0 0.00012219627387821674
underlying O 0 0.11065495014190674
defect O 1 0.9995366334915161
for O 0 0.00043865502811968327
the O 0 0.16340471804141998
deficiency O 1 0.999998927116394
. O 0 0.002028409158810973

The O 0 0.0006558347376994789
other O 0 0.00012109776434954256
four O 0 0.00015760885435156524
children O 0 0.00019695053924806416
presented O 0 0.00038994482019916177
with O 0 0.000330490933265537
heterozygous O 0 0.07157339155673981
deficiency O 1 0.9999934434890747
and O 0 0.0001380641188006848
exhibited O 0 0.0010860746260732412
a O 0 0.00017406286497134715
normal O 0 0.00026015867479145527
immunoblotting O 0 0.00473994854837656
pattern O 0 0.00021065778855700046
of O 0 8.453336340608075e-05
proteins O 0 4.6508361265296116e-05
of O 0 8.256705041276291e-05
the O 0 0.0003784017462749034
FH O 1 0.9723683595657349
family O 0 0.0008914383361116052
. O 0 0.0004899963387288153

Factor B-Disease 1 0.9988092184066772
H I-Disease 1 0.999994158744812
deficiency I-Disease 1 0.9999901056289673
is O 0 0.0003289578889962286
the O 0 0.00030708187841810286
only O 0 0.00034429735387675464
complement B-Disease 1 0.9988823533058167
deficiency I-Disease 1 0.9999998807907104
associated O 0 0.008709615096449852
with O 0 0.0043089804239571095
HUS B-Disease 1 0.9999997615814209
. O 0 0.0029412154108285904

These O 0 0.00036441354313865304
observations O 0 0.000447567697847262
suggest O 0 0.0002068368048639968
a O 0 0.00016812450485303998
role O 0 0.00023709438391961157
for O 0 0.00013175584899727255
FH O 1 0.8828123807907104
and O 0 0.00017805401876103133
/ O 0 0.0013009022222831845
or O 0 0.0002205787895945832
FH O 0 0.29603666067123413
receptors O 0 0.00014100914995651692
in O 0 7.579966040793806e-05
the O 0 0.00021625455701723695
pathogenesis O 1 0.9956405162811279
of O 1 0.7753665447235107
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.0025213209446519613
. O 0 0.001010448089800775

Further O 0 0.0006419661804102361
evidence O 0 0.00031027811928652227
for O 0 7.990599260665476e-05
a O 0 0.00013317597040440887
major O 0 0.0005827033310197294
ancient O 0 0.006293911952525377
mutation O 1 0.7157363891601562
underlying O 1 0.9999432563781738
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 0.9999998807907104
from O 0 0.02568252570927143
linkage O 1 0.8807438015937805
disequilibrium O 1 0.7455611228942871
studies O 0 0.0001158218874479644
in O 0 9.074457921087742e-05
the O 0 0.00014497445954475552
Japanese O 0 0.0009230513242073357
population O 0 0.0002156444825232029
. O 0 0.000375995907234028

The O 1 0.8176012635231018
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9936803579330444
DM B-Disease 1 0.9999996423721313
) O 0 0.00026899451040662825
mutation O 0 0.00012335034261923283
is O 0 4.539903238764964e-05
an O 0 5.8725061535369605e-05
unstable O 0 0.0019549187272787094
( O 0 0.00015153530694078654
CTG O 0 0.05029572919011116
) O 0 6.228787242434919e-05
n O 0 0.00010548326827120036
repeat O 0 8.634915866423398e-05
, O 0 1.5824942238396034e-05
present O 0 2.3046561182127334e-05
at O 0 3.1731146009406075e-05
a O 0 2.105025851051323e-05
copy O 0 3.701715831994079e-05
number O 0 7.058473329379922e-06
of O 0 2.234942076029256e-05
5 O 0 3.906957499566488e-05
- O 0 4.017353057861328e-05
37 O 0 5.1268405513837934e-05
repeats O 0 6.113126437412575e-05
on O 0 2.8099713745177723e-05
normal O 0 5.697633241652511e-05
chromosomes O 0 5.7779117923928425e-05
but O 0 1.585001518833451e-05
amplified O 0 6.249826401472092e-05
to O 0 1.6386267816415057e-05
50 O 0 7.228252798086032e-05
- O 0 0.000121994387882296
3000 O 0 0.0005090548656880856
copies O 0 0.0001796152937458828
on O 0 0.00038753115222789347
DM B-Disease 1 0.9962568283081055
chromosomes O 0 0.002258296124637127
. O 0 0.0011330691631883383

Previous O 0 0.0011878365185111761
findings O 0 0.0004535108746495098
in O 0 0.00010526581900194287
Caucasian O 0 0.0005989118944853544
populations O 0 8.737009193282574e-05
of O 0 0.00014190450019668788
a O 0 0.0009838331025093794
DM B-Disease 1 0.9999983310699463
founder O 0 0.22047099471092224
chromosome O 0 0.000273336743703112
raise O 0 5.5918615544214845e-05
a O 0 2.853872865671292e-05
question O 0 2.8233374905539677e-05
about O 0 1.489131409471156e-05
the O 0 1.7579173800186254e-05
molecular O 0 3.877334529533982e-05
events O 0 3.9482478314312175e-05
involved O 0 4.216795787215233e-05
in O 0 3.834295057458803e-05
the O 0 0.00015436086687259376
expansion O 0 0.0014351282734423876
mutation O 0 0.0007194839417934418
. O 0 0.00046071410179138184

To O 0 0.0004048097471240908
investigate O 0 0.0006497083813883364
whether O 0 0.0001321044546784833
a O 0 0.0001920195936691016
founder O 0 0.0011867734137922525
chromosome O 0 0.00025361342704854906
for O 0 8.175364200724289e-05
the O 0 0.00026554634678177536
DM B-Disease 1 0.9999856948852539
mutation O 0 0.0001894648594316095
exists O 0 7.081794319674373e-05
in O 0 2.1813164494233206e-05
the O 0 4.574391641654074e-05
Japanese O 0 0.0001885927194962278
population O 0 2.3647346097277477e-05
, O 0 3.034190922335256e-05
we O 0 4.1162438719766214e-05
genotyped O 0 0.0006228125421330333
families O 0 4.110026566195302e-05
using O 0 3.3937223633984104e-05
polymorphic O 0 0.0002031147450907156
markers O 0 0.00022331817308440804
near O 0 0.0003537352313287556
the O 0 0.00014622129674535245
( O 0 0.00016680205590091646
CTG O 0 0.005854732356965542
) O 0 9.879804565571249e-05
n O 0 0.00029258348513394594
repeat O 0 0.00041920406511053443
region O 0 0.00023913901532068849
and O 0 0.00017354711599182338
constructed O 0 0.002243787981569767
haplotypes O 0 0.003904421115294099
. O 0 0.0011637333082035184

Six O 0 0.0006828815676271915
different O 0 0.0001133484547608532
haplotypes O 0 0.0004935734905302525
were O 0 9.691456216387451e-05
found O 0 9.067164501175284e-05
and O 0 0.00019112744485028088
DM B-Disease 1 0.9999533891677856
alleles O 0 0.00032195300445891917
were O 0 0.00011166874173795804
always O 0 0.0002470231556799263
haplotype O 0 0.0008228801307268441
A O 0 0.0013465615920722485
. O 0 0.0006826586904935539

To O 0 0.00039256105083040893
find O 0 0.00018079452274832875
an O 0 5.029730891692452e-05
origin O 0 5.161232911632396e-05
of O 0 5.316408351063728e-05
the O 0 7.349714724114165e-05
( O 0 0.00012966668873559684
CTG O 0 0.035578545182943344
) O 0 6.840746937086806e-05
n O 0 0.00011665696365525946
repeat O 0 0.00016497386968694627
mutation O 0 5.44157373951748e-05
and O 0 1.1022544640582055e-05
to O 0 8.288588105642702e-06
investigate O 0 4.585940041579306e-05
the O 0 3.181420106557198e-05
mechanism O 0 5.4957887186901644e-05
of O 0 3.2460571674164385e-05
the O 0 5.2439110731938854e-05
expansion O 0 0.00012421068095136434
mutation O 0 2.8724285584758036e-05
in O 0 1.148846058640629e-05
the O 0 3.1388499337481335e-05
Japanese O 0 0.0001138304578489624
population O 0 1.2917913409182802e-05
we O 0 7.677856046939269e-06
have O 0 6.19378124611103e-06
studied O 0 4.0276376239489764e-05
90 O 0 8.601704030297697e-05
Japanese O 0 0.0005441681132651865
DM B-Disease 1 0.8262861371040344
families O 0 9.457582200411707e-05
comprising O 0 0.00011083817662438378
190 O 0 0.00025618175277486444
affected O 0 0.00018282205564901233
and O 0 9.622025390854105e-05
130 O 0 0.000501308823004365
unaffected O 0 0.001268560066819191
members O 0 0.00023578418768011034
. O 0 0.0005586598999798298

The O 0 0.0009255920303985476
results O 0 0.0002669226087164134
suggest O 0 8.698087913217023e-05
that O 0 2.361615770496428e-05
a O 0 3.583794750738889e-05
few O 0 4.2007133743027225e-05
common O 0 4.8260611947625875e-05
ancestral O 0 0.0006750436150468886
mutations O 0 0.00010293883678968996
in O 0 3.506198481773026e-05
both O 0 3.511354952934198e-05
Caucasian O 0 0.00042525838944129646
and O 0 5.660244278260507e-05
Japanese O 0 0.00020308548118919134
populations O 0 2.364091960771475e-05
have O 0 9.511732969258446e-06
originated O 0 3.891247615683824e-05
by O 0 1.4024933079781476e-05
expansion O 0 5.2493298426270485e-05
of O 0 2.9633518352056853e-05
an O 0 1.6232846974162385e-05
ancestral O 0 0.00019903674547094852
n O 0 6.799721450079232e-05
= O 0 6.053450488252565e-05
5 O 0 2.8653370463871397e-05
repeat O 0 4.9780283006839454e-05
to O 0 1.5744799384265207e-05
n O 0 6.17354380665347e-05
= O 0 9.737505024531856e-05
19 O 0 0.00014760097838006914
- O 0 0.00017082146950997412
37 O 0 0.00031351958750747144
copies O 0 0.00030906853498890996
. O 0 0.0004909303970634937

These O 0 0.000587614718824625
data O 0 0.00019769876962527633
support O 0 0.00021804653806611896
multistep O 0 0.0010883428622037172
models O 0 0.0001722230517771095
of O 0 0.00015724063268862665
triplet O 0 0.009807265363633633
repeat O 0 0.00036713670124299824
expansion O 0 0.0001645609736442566
that O 0 1.712054836389143e-05
have O 0 9.459754437557422e-06
been O 0 1.818753662519157e-05
proposed O 0 3.5545643186196685e-05
for O 0 2.872866934922058e-05
both O 0 0.0001332610845565796
DM B-Disease 1 0.9999966621398926
and O 0 0.0018774332711473107
Friedreichs B-Disease 1 0.9999765157699585
ataxia I-Disease 1 0.9998055100440979
. O 0 0.0008222119649872184
. O 0 0.0009000847348943353

The O 0 0.0008650663658045232
molecular O 0 0.0006056741112843156
basis O 0 0.00026817710022442043
of O 0 0.05401340872049332
C6 B-Disease 1 1.0
deficiency I-Disease 1 0.9999996423721313
in O 0 0.00015596006414853036
the O 0 0.00017887864669319242
western O 0 0.00037401856388896704
Cape O 0 0.0011596223339438438
, O 0 0.00013885072257835418
South O 0 0.0006614114390686154
Africa O 0 0.000920813181437552
. O 0 0.000844781578052789

Deficiency B-Disease 1 0.9997623562812805
of I-Disease 0 0.0011007828870788217
the I-Disease 0 0.0005686552613042295
sixth I-Disease 0 0.08319982141256332
component I-Disease 0 0.0007159498636610806
of I-Disease 0 0.00015782058471813798
human I-Disease 0 0.0001867540559032932
complement I-Disease 0 0.0006655576871708035
( O 0 0.0002950341731775552
C6 O 1 0.9979904890060425
) O 0 4.321522283134982e-05
has O 0 1.932076338562183e-05
been O 0 1.76407556864433e-05
reported O 0 1.9199022062821314e-05
in O 0 8.657771104481071e-06
a O 0 2.0051043975399807e-05
number O 0 9.021812729770318e-06
of O 0 2.442053119011689e-05
families O 0 2.4485549147357233e-05
from O 0 2.2332269509206526e-05
the O 0 3.8598216633545235e-05
western O 0 0.0001282211160287261
Cape O 0 0.0008433492621406913
, O 0 0.00015322935360018164
South O 0 0.0005185218760743737
Africa O 0 0.0007802972104400396
. O 0 0.0006528781377710402

Meningococcal B-Disease 1 0.9999980926513672
disease I-Disease 1 0.9999819993972778
is O 0 0.00030580165912397206
endemic O 0 0.0009470029035583138
in O 0 7.041812932584435e-05
the O 0 0.0001018557813949883
Cape O 0 0.0003521687176544219
and O 0 2.8185599148855545e-05
almost O 0 3.3655669540166855e-05
all O 0 1.7461114111938514e-05
pedigrees O 0 0.00015727183199487627
of O 0 0.0001881008065538481
total O 0 0.0774853378534317
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.02436504326760769
C6Q0 O 1 0.9997785687446594
) O 0 9.148134267888963e-05
have O 0 3.108133751084097e-05
been O 0 5.468993913382292e-05
ascertained O 0 0.0004085586406290531
because O 0 0.000190787497558631
of O 0 0.0013653620844706893
recurrent O 1 0.9999966621398926
disease O 1 0.9999991655349731
. O 0 0.007312653586268425

We O 0 0.0004081392253283411
have O 0 6.61872691125609e-05
sequenced O 0 0.0001735779078444466
the O 0 8.801130024949089e-05
expressed O 0 7.455261220457032e-05
exons O 0 0.00020397003390826285
of O 0 8.575105312047526e-05
the O 0 0.00021266296971589327
C6 O 1 0.999398946762085
gene O 0 6.552816194016486e-05
from O 0 2.3557289750897326e-05
selected O 0 3.6897254176437855e-05
cases O 0 1.6569287254242226e-05
and O 0 1.2345270988589618e-05
have O 0 8.58758812682936e-06
found O 0 2.0050087186973542e-05
three O 0 3.8152520573930815e-05
molecular O 0 0.0004275375104043633
defects O 1 0.9361222982406616
leading O 0 0.0004115682386327535
to O 0 6.716598727507517e-05
total O 0 0.001978295622393489
deficiency O 1 0.9999991655349731
879delG O 1 0.997955322265625
, O 0 8.066068403422832e-05
which O 0 1.7810014469432645e-05
is O 0 1.5709147191955708e-05
the O 0 3.119976827292703e-05
common O 0 8.277154120150954e-05
defect O 0 0.43072015047073364
in O 0 6.43009043415077e-05
the O 0 0.00011402817472117022
Cape O 0 0.0006864448660053313
and O 0 7.145750714698806e-05
hitherto O 0 0.00034759772825054824
unreported O 0 0.000326055713230744
, O 0 6.094099808251485e-05
and O 0 5.630962550640106e-05
1195delC O 0 0.07358061522245407
and O 0 0.00010934580495813861
1936delG O 0 0.35598671436309814
, O 0 4.1114417399512604e-05
which O 0 1.4160701539367437e-05
have O 0 8.317592801176943e-06
been O 0 1.7439562725485303e-05
previously O 0 3.3180451282532886e-05
reported O 0 4.854124199482612e-05
in O 0 5.629351289826445e-05
African O 0 0.0003623657685238868
- O 0 0.0006176402675919235
Americans O 0 0.00036442410782910883
. O 0 0.00045607364154420793

We O 0 0.0007596915238536894
also O 0 0.00016038943431340158
show O 0 0.00018704793183133006
that O 0 3.309708336018957e-05
the O 0 0.00013850281538907439
879delG O 1 0.6169507503509521
and O 0 0.0006259438814595342
1195delC O 1 0.9999227523803711
defects O 1 0.9997474551200867
are O 0 4.545886258711107e-05
associated O 0 7.454372098436579e-05
with O 0 7.176541839726269e-05
characteristic O 1 0.9240542650222778
C6 O 1 0.9999995231628418
/ O 1 0.8482972383499146
C7 O 1 0.9984180927276611
region O 0 0.00034563092049211264
DNA O 0 0.0004188541788607836
marker O 0 0.0012824396835640073
haplotypes O 0 0.0007745425100438297
, O 0 9.43159029702656e-05
although O 0 5.6168144510593265e-05
small O 0 0.00010035966988652945
variations O 0 0.0001432138233212754
were O 0 0.00012629271077457815
observed O 0 0.0004554561455734074
. O 0 0.0004358810547273606

The O 0 0.003398239379748702
1936delG O 1 0.9976285099983215
defect O 1 0.9991011619567871
was O 0 0.001010586740449071
observed O 0 0.00013613936607725918
only O 0 3.1793391826795414e-05
once O 0 6.76020426908508e-05
in O 0 3.012176057382021e-05
the O 0 6.402629514923319e-05
Cape O 0 0.00034866321948356926
, O 0 4.084480679011904e-05
but O 0 2.559807944635395e-05
its O 0 2.778215639409609e-05
associated O 0 9.40481768338941e-05
haplotype O 0 0.0004518877249211073
could O 0 9.390810737386346e-05
be O 0 0.00010835444845724851
deduced O 0 0.0013649031752720475
. O 0 0.0005727558746002614

The O 0 0.0006073941476643085
data O 0 0.00015298392099794
from O 0 7.096375338733196e-05
the O 0 0.0001070385187631473
haplotypes O 0 0.00021486108016688377
indicate O 0 7.877715688664466e-05
that O 0 1.4485533938568551e-05
these O 0 8.45109661895549e-06
three O 0 2.850608689186629e-05
molecular O 0 0.00016770597721915692
defects O 0 0.04289562627673149
account O 0 2.441927426843904e-05
for O 0 1.7746520825312473e-05
the O 0 6.80442972225137e-05
defects O 0 0.23971059918403625
in O 0 2.0250994566595182e-05
all O 0 1.1135681234009098e-05
the O 0 3.0173168852343224e-05
38 O 0 0.00015567151422146708
unrelated O 0 0.0002478630340192467
C6Q0 O 1 0.9132140278816223
individuals O 0 3.340809780638665e-05
we O 0 1.8904367607319728e-05
have O 0 1.3193021004553884e-05
studied O 0 0.00010124148684553802
from O 0 8.170470391632989e-05
the O 0 0.00021510623628273606
Cape O 0 0.0028568084817379713
. O 0 0.0008779824711382389

We O 0 0.0007201579282991588
have O 0 0.00011473594349808991
also O 0 7.835341966710985e-05
observed O 0 0.00014431570889428258
the O 0 0.00016359941218979657
879delG O 0 0.2941684126853943
defect O 0 0.15721388161182404
in O 0 0.00014061830006539822
two O 0 0.00013160593516658992
Dutch O 0 0.07066100835800171
C6 B-Disease 1 0.9999996423721313
- I-Disease 0 0.3833713233470917
deficient I-Disease 1 0.9077667593955994
kindreds O 0 0.0017730664694681764
, O 0 6.766331352991983e-05
but O 0 3.707696669152938e-05
the O 0 0.00010735364776337519
879delG O 0 0.42142602801322937
defect O 0 0.28341734409332275
in O 0 0.00010302408918505535
the O 0 0.00020196357218082994
Cape O 0 0.0011500271502882242
probably O 0 0.00013991356536280364
did O 0 3.31607079715468e-05
not O 0 9.723986295284703e-06
come O 0 2.603189932415262e-05
from O 0 4.108627399546094e-05
The O 0 0.00011263861961197108
Netherlands O 0 0.0003227923298254609
. O 0 0.00020466862770263106
. O 0 0.0004157853836659342

Complement B-Disease 1 0.9992467164993286
C7 I-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
: O 0 0.0007191898766905069
seven O 0 0.0004363647603895515
further O 0 0.00042541572474874556
molecular O 0 0.013242253102362156
defects O 1 0.9989799857139587
and O 0 0.00017465604469180107
their O 0 0.00010404988279333338
associated O 0 0.0004536399501375854
marker O 0 0.024865273386240005
haplotypes O 0 0.006183673162013292
. O 0 0.0012213254813104868

Seven O 0 0.0015910896472632885
further O 0 0.00047508315765298903
molecular O 0 0.0008711735135875642
bases O 0 0.0011216411367058754
of O 1 0.6209819316864014
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.00028740978450514376
described O 0 0.001645163632929325
. O 0 0.000708460807800293

All O 0 0.0004453669534996152
these O 0 0.0001480585488025099
new O 0 0.00023216295812744647
molecular O 0 0.0007363418699242175
defects O 0 0.2548336684703827
involve O 0 0.0002399884833721444
single O 0 0.00012735719792544842
- O 0 0.00016564266115892678
nucleotide O 0 0.00015810075274202973
events O 0 7.816401193849742e-05
, O 0 5.348601916921325e-05
deletions O 0 0.00015460878785233945
and O 0 3.615058813011274e-05
substitutions O 0 0.0001110057273763232
, O 0 2.3968039386090823e-05
some O 0 1.3357984244066756e-05
of O 0 3.481755265966058e-05
which O 0 2.66653805738315e-05
alter O 0 9.874568058876321e-05
splice O 0 0.0004206538142170757
sites O 0 0.0001065563119482249
, O 0 5.8833189541473985e-05
and O 0 6.439196295104921e-05
others O 0 0.00020508548186626285
codons O 0 0.0007943680975586176
. O 0 0.0005330296698957682

They O 0 0.0003098627785220742
are O 0 5.316458918969147e-05
distributed O 0 6.443078018492088e-05
along O 0 0.00014349474804475904
the O 0 0.0002330267452634871
C7 O 1 0.999485969543457
gene O 0 0.00012524552585091442
, O 0 4.016452658106573e-05
but O 0 1.7900583770824596e-05
predominantly O 0 3.4609292924869806e-05
towards O 0 0.00011935045768041164
the O 0 8.907379378797486e-05
3 O 0 0.0002410183078609407
end O 0 0.0004697178374044597
. O 0 0.00046202357043512166

All O 0 0.0005226125358603895
were O 0 0.0001903973607113585
found O 0 0.00013815326383337379
in O 0 0.00025108380941674113
compound O 0 0.0027620368637144566
heterozygous O 0 0.0006772283813916147
individuals O 0 0.0002552207442931831
. O 0 0.0005512869684025645

The O 0 0.018917011097073555
C6 O 1 0.999977707862854
/ O 1 0.9754706621170044
C7 O 1 0.9998186230659485
marker O 0 0.015970522537827492
haplotypes O 0 0.0027217227034270763
associated O 0 0.00045670775580219924
with O 0 0.0002088617766276002
most O 0 0.001163999317213893
C7 B-Disease 1 0.9999995231628418
defects I-Disease 1 0.9999500513076782
are O 0 0.0001224915322382003
tabulated O 0 0.0006240915390662849
. O 0 0.0001957039930857718
. O 0 0.00046445935731753707

A O 0 0.0035253926180303097
genome O 0 0.0010201995028182864
- O 0 0.0003944368218071759
wide O 0 0.00019098992925137281
search O 0 0.00017462106188759208
for O 0 0.00011320867633912712
chromosomal O 0 0.009332491084933281
loci O 0 0.002001361921429634
linked O 0 0.0008653094992041588
to O 0 0.00021273110178299248
mental O 1 0.9997058510780334
health O 0 0.06826223433017731
wellness O 0 0.3589234948158264
in O 0 0.00010253091750200838
relatives O 0 0.00027180660981684923
at O 0 0.0006073507247492671
high O 0 0.0011671754764392972
risk O 0 0.000999861629679799
for O 0 0.001327001373283565
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 0.006426375824958086
the O 0 0.0011921244440600276
Old O 0 0.025172967463731766
Order O 0 0.0005781683139503002
Amish O 0 0.0030108385253697634
. O 0 0.0004158616648055613

Bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
( O 1 0.9999029636383057
BPAD B-Disease 1 1.0
; O 1 0.9944619536399841
manic B-Disease 1 1.0
- I-Disease 1 0.9999961853027344
depressive I-Disease 1 1.0
illness I-Disease 1 0.9999998807907104
) O 0 0.0001860638876678422
is O 0 6.135061994427815e-05
characterized O 0 9.581672929925844e-05
by O 0 3.123245915048756e-05
episodes O 0 0.00012660623178817332
of O 0 0.00029195871320553124
mania B-Disease 1 0.9999470710754395
and O 0 0.000354622898157686
/ O 0 0.02597701922059059
or O 0 0.00020664795010816306
hypomania B-Disease 1 0.9519829154014587
interspersed O 0 0.00041214717202819884
with O 0 8.270163380075246e-05
periods O 0 0.00035455753095448017
of O 0 0.0009512822143733501
depression B-Disease 1 0.9998655319213867
. O 0 0.001276383874937892

Compelling O 0 0.0027110502123832703
evidence O 0 0.0005763043300248682
supports O 0 0.00040651284507475793
a O 0 0.0001465083914808929
significant O 0 0.00014894467312842607
genetic O 0 0.00015477088163606822
component O 0 0.0003260146186221391
in O 0 6.252073944779113e-05
the O 0 0.00021430294145829976
susceptibility O 0 0.0018484031315892935
to O 0 0.00019353546667844057
develop O 0 0.0016947330441325903
BPAD B-Disease 1 0.9999650716781616
. O 0 0.0018770493334159255

To O 0 0.000525150157045573
date O 0 0.000410600274335593
, O 0 0.0001156879952759482
however O 0 7.571643800474703e-05
, O 0 6.517666770378128e-05
linkage O 0 0.0002521513670217246
studies O 0 3.945639400626533e-05
have O 0 1.3514205420506187e-05
attempted O 0 0.0001003456927719526
only O 0 2.125097125826869e-05
to O 0 2.279941145388875e-05
identify O 0 7.409163663396612e-05
chromosomal O 0 0.0014369901036843657
loci O 0 0.00035551877226680517
that O 0 4.316777631174773e-05
cause O 0 0.00039715232560411096
or O 0 4.4972832256462425e-05
increase O 0 3.83645310648717e-05
the O 0 6.676877819700167e-05
risk O 0 0.00013936206232756376
of O 0 0.0004377823497634381
developing O 0 0.02413102425634861
BPAD B-Disease 1 0.9999945163726807
. O 0 0.0014503109268844128

To O 0 0.0003430732467677444
determine O 0 0.00015941272431518883
whether O 0 7.813055708538741e-05
there O 0 4.570912278722972e-05
could O 0 4.761367381433956e-05
be O 0 4.190934123471379e-05
protective O 0 0.0005444088601507246
alleles O 0 0.0001266503968508914
that O 0 3.0179151508491486e-05
prevent O 0 8.979083213489503e-05
or O 0 2.967882937809918e-05
reduce O 0 3.843326339847408e-05
the O 0 4.655423981603235e-05
risk O 0 6.654471508227289e-05
of O 0 0.00012097219587303698
developing O 0 0.0011417065979912877
BPAD B-Disease 1 0.9999935626983643
, O 0 4.413028000271879e-05
similar O 0 1.578594856255222e-05
to O 0 1.0826899597304873e-05
what O 0 1.4424151231651194e-05
is O 0 1.5390040061902255e-05
observed O 0 2.685616709641181e-05
in O 0 2.444220081088133e-05
other O 0 3.950560494558886e-05
genetic B-Disease 1 0.998969316482544
disorders I-Disease 1 0.9999997615814209
, O 0 0.00029867005650885403
we O 0 7.928019476821646e-05
used O 0 0.00010487677354831249
mental O 1 0.9988983869552612
health O 0 0.006093465723097324
wellness O 1 0.6765046715736389
( O 0 8.919354877434671e-05
absence O 0 0.00013849700917489827
of O 0 9.413368388777599e-05
any O 0 0.0004589894670061767
psychiatric B-Disease 1 0.999998927116394
disorder I-Disease 1 0.9999995231628418
) O 0 7.975511107360944e-05
as O 0 4.879743937635794e-05
the O 0 6.5838590671774e-05
phenotype O 0 0.00016396783757954836
in O 0 3.331862899358384e-05
our O 0 6.855048559373245e-05
genome O 0 0.0001169152237707749
- O 0 0.00010019719047704712
wide O 0 9.779763058759272e-05
linkage O 0 0.00027709841378964484
scan O 0 0.0001254119852092117
of O 0 5.24303104612045e-05
several O 0 3.4804470487870276e-05
large O 0 0.00013285278691910207
multigeneration O 0 0.0031540049239993095
Old O 0 0.00043515802826732397
Order O 0 0.0001729388750391081
Amish O 0 0.0008765957900322974
pedigrees O 0 0.0005486755399033427
exhibiting O 0 0.0004484179662540555
an O 0 0.00011915122013306245
extremely O 0 0.0004976973286829889
high O 0 0.0010183447739109397
incidence O 0 0.09388551861047745
of O 0 0.009544065222144127
BPAD B-Disease 1 0.9999974966049194
. O 0 0.0017507584998384118

We O 0 0.0004868683172389865
have O 0 6.598943582503125e-05
found O 0 6.033683166606352e-05
strong O 0 8.050562610151246e-05
evidence O 0 6.852930528111756e-05
for O 0 3.215573451598175e-05
a O 0 7.750698568997905e-05
locus O 0 0.00025323170120827854
on O 0 0.00011109975457657129
chromosome O 0 0.0004593144403770566
4p O 0 0.31690046191215515
at O 0 0.0003673311439342797
D4S2949 O 0 0.0027114409022033215
( O 0 0.00014483986888080835
maximum O 0 0.0003241013328079134
GENEHUNTER O 0 0.015084723941981792
- O 0 0.00036352279130369425
PLUS O 0 0.00039757470949552953
nonparametric O 0 0.0010215031215921044
linkage O 0 0.0005113348597660661
score O 0 0.00011976451060036197
= O 0 0.00011121721036033705
4 O 0 9.329491149401292e-05
. O 0 3.362628194736317e-05
05 O 0 0.00043077627196907997
, O 0 5.773759039584547e-05
P O 0 0.00027463817968964577
= O 0 7.417463348247111e-05
5 O 0 3.4314045478822663e-05
. O 0 8.356304533663206e-06
22 O 0 2.7453465008875355e-05
x O 0 4.533030005404726e-05
10 O 0 3.29929607687518e-05
( O 0 3.3160962630063295e-05
- O 0 4.850042751058936e-05
4 O 0 4.440483826329e-05
) O 0 2.0522813429124653e-05
; O 0 3.214825119357556e-05
SIBPAL O 0 0.001331354840658605
Pempirical O 0 0.0007318847347050905
value O 0 6.96381539455615e-05
< O 0 0.00010699146514525637
3 O 0 3.776278390432708e-05
x O 0 4.241344140609726e-05
10 O 0 2.9060647648293525e-05
( O 0 2.84769030258758e-05
- O 0 4.728434942080639e-05
5 O 0 5.409190271166153e-05
) O 0 3.113319689873606e-05
) O 0 2.3653685275348835e-05
and O 0 2.7673633667291142e-05
suggestive O 0 0.00014741136692464352
evidence O 0 5.902155317016877e-05
for O 0 2.6620178687153384e-05
a O 0 9.143991337623447e-05
locus O 0 0.00032382801873609424
on O 0 0.00013936405593995005
chromosome O 0 0.0005923185963183641
4q O 0 0.0048404899425804615
at O 0 0.0003686829295475036
D4S397 O 0 0.003735428676009178
( O 0 0.00011540670675458387
maximum O 0 0.0002234700514236465
GENEHUNTER O 0 0.04496185481548309
- O 0 0.00029003003146499395
PLUS O 0 0.00031889090314507484
nonparametric O 0 0.0007652044296264648
linkage O 0 0.00044141258695162833
score O 0 7.774445839459077e-05
= O 0 8.488418097840622e-05
3 O 0 3.0345612685778178e-05
. O 0 1.1291090231679846e-05
29 O 0 4.8804093239596114e-05
, O 0 3.040424235223327e-05
P O 0 0.00020930873870383948
= O 0 6.781563570257276e-05
2 O 0 2.7244241209700704e-05
. O 0 1.0227156963082962e-05
57 O 0 6.147659587441012e-05
x O 0 5.0455942982807755e-05
10 O 0 3.0170662284945138e-05
( O 0 3.7145306123420596e-05
- O 0 5.91742827964481e-05
3 O 0 4.360227467259392e-05
) O 0 2.572621997387614e-05
; O 0 2.9168852051952854e-05
SIBPAL O 0 0.0012204904342070222
Pempirical O 0 0.0008315043523907661
value O 0 6.213718734215945e-05
< O 0 9.652360313339159e-05
1 O 0 3.0389226594706997e-05
x O 0 3.064047996303998e-05
10 O 0 2.3649037757422775e-05
( O 0 2.13704515772406e-05
- O 0 3.874536560033448e-05
3 O 0 3.625139288487844e-05
) O 0 1.5667988918721676e-05
) O 0 1.6523856174899265e-05
that O 0 1.9806453565252014e-05
are O 0 2.3230702936416492e-05
linked O 0 0.0003306863072793931
to O 0 0.00024502724409103394
mental O 1 0.9998915195465088
health O 1 0.9434124827384949
wellness O 1 0.9977579712867737
. O 0 0.0033664891961961985

These O 0 0.00024988592485897243
findings O 0 0.0001622410782147199
are O 0 2.2833526600152254e-05
consistent O 0 5.585268809227273e-05
with O 0 2.349496389797423e-05
the O 0 4.708304186351597e-05
hypothesis O 0 8.744443039176986e-05
that O 0 2.087850407406222e-05
certain O 0 3.552432463038713e-05
alleles O 0 0.00010437503078719601
could O 0 5.4685300710843876e-05
prevent O 0 9.892324305837974e-05
or O 0 4.4889358832733706e-05
modify O 0 8.070546755334362e-05
the O 0 7.146329153329134e-05
clinical O 0 0.00030367178260348737
manifestations O 0 0.037901170551776886
of O 0 0.07465936243534088
BPAD B-Disease 1 0.9999996423721313
and O 0 0.0003203345986548811
perhaps O 0 0.0003598177863750607
other O 0 0.00014147351612336934
related O 0 0.37160223722457886
affective B-Disease 1 0.9999994039535522
disorders I-Disease 1 0.9999997615814209
. O 0 0.027466854080557823

Segregation O 1 0.9990285634994507
distortion O 1 0.9998794794082642
in O 1 0.9638345837593079
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.019482702016830444

Myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 1.0
( O 1 0.994333028793335
DM B-Disease 1 0.9999996423721313
) O 0 0.00024123578623402864
is O 0 9.509681694908068e-05
an O 0 0.00011036737123504281
autosomal B-Disease 1 0.8381842374801636
dominant I-Disease 1 0.9997491240501404
disease I-Disease 1 0.9999961853027344
which O 0 4.6681649109814316e-05
, O 0 2.5276807718910277e-05
in O 0 1.5228827578539494e-05
the O 0 2.8458685846999288e-05
typical O 0 6.586684321518987e-05
pedigree O 0 0.00012344469723757356
, O 0 2.0194356693536974e-05
shows O 0 3.334243592689745e-05
a O 0 5.6478918850189075e-05
three O 0 7.597130752401426e-05
generation O 0 0.0012172467540949583
anticipation O 0 0.0022774075623601675
cascade O 0 0.017757229506969452
. O 0 0.00104644859675318

This O 0 0.0007895417511463165
results O 0 0.0006426615291275084
in O 0 0.0017687641084194183
infertility B-Disease 1 0.999998927116394
and O 1 0.9999738931655884
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9995896220207214
CDM B-Disease 1 0.9997163414955139
) O 0 9.310260065831244e-05
with O 0 3.476333586149849e-05
the O 0 0.00010198641393799335
disappearance O 0 0.0005812158342450857
of O 0 0.0005297139869071543
DM B-Disease 1 0.9999908208847046
in O 0 0.0002016164653468877
that O 0 0.00016103583038784564
pedigree O 0 0.0015961850294843316
. O 0 0.0006431358633562922

The O 0 0.001042714691720903
concept O 0 0.000737001362722367
of O 0 0.0005170484073460102
segregation O 1 0.8182440996170044
distortion O 1 0.729602038860321
, O 0 8.525767043465748e-05
where O 0 5.0900602218462154e-05
there O 0 3.0019327823538333e-05
is O 0 2.2269297915045172e-05
preferential O 0 8.274344145320356e-05
transmission O 0 6.857336848042905e-05
of O 0 3.8777860027039424e-05
the O 0 4.6150053094606847e-05
larger O 0 5.0468115659896284e-05
allele O 0 8.632660319563001e-05
at O 0 9.606732055544853e-05
the O 0 0.0001246646570507437
DM B-Disease 1 0.9999512434005737
locus O 0 0.0010937544284388423
, O 0 5.2034967666259035e-05
has O 0 2.7118656362290494e-05
been O 0 2.0704808775917627e-05
put O 0 3.555154034984298e-05
forward O 0 5.288662578095682e-05
to O 0 2.939159094239585e-05
explain O 0 0.00012086542119504884
partially O 0 0.00022089491540100425
the O 0 0.00011685660138027743
maintenance O 0 0.001030151266604662
of O 0 0.0005134448292665184
DM B-Disease 1 0.9999651908874512
in O 0 0.00013595723430626094
the O 0 0.00019183930999133736
population O 0 0.00011756991443689913
. O 0 0.00026803347282111645

In O 0 0.00042435029172338545
a O 0 0.0002954310330096632
survey O 0 0.00018835189985111356
of O 0 0.00018674515013117343
DM B-Disease 1 0.9992700219154358
in O 0 0.0001190266411867924
Northern O 0 0.00019590301963035017
Ireland O 0 0.0001345138589385897
, O 0 0.00010808201477630064
59 O 0 0.0005234873970039189
pedigrees O 0 0.0009714488405734301
were O 0 0.00037181706284172833
ascertained O 0 0.0049303434789180756
. O 0 0.0009381455602124333

Sibships O 0 0.025735894218087196
where O 0 0.0002595249388832599
the O 0 0.00010800979362102225
status O 0 4.0339957195101306e-05
of O 0 3.3065880415961146e-05
all O 0 1.1681032447086181e-05
the O 0 2.1481751900864765e-05
members O 0 1.6305595636367798e-05
had O 0 3.909711813321337e-05
been O 0 1.6589399820077233e-05
identified O 0 2.0955418222001754e-05
were O 0 1.5407236787723377e-05
examined O 0 3.651571023510769e-05
to O 0 8.617285857326351e-06
determine O 0 1.8101727619068697e-05
the O 0 3.164583904435858e-05
transmission O 0 0.00010344738984713331
of O 0 7.468024705303833e-05
the O 0 0.00024499991559423506
DM B-Disease 1 0.9999620914459229
expansion O 0 0.0004724259488284588
from O 0 6.253915489651263e-05
affected O 0 9.930412488756701e-05
parents O 0 4.781397001352161e-05
to O 0 3.068220757995732e-05
their O 0 5.3124091209610924e-05
offspring O 0 0.0007843489875085652
. O 0 0.0004403337952680886

Where O 0 0.0015950289089232683
the O 0 0.0009016180993057787
transmitting O 0 0.0024170693941414356
parent O 0 0.0008069670293480158
was O 0 0.000943973078392446
male O 0 0.0005844719125889242
, O 0 0.00028226597351022065
58 O 0 0.001602474949322641
. O 0 0.0009111873805522919

3 O 0 0.0005944983568042517
% O 0 0.00014122606080491096
of O 0 0.00011435244960011914
the O 0 9.867055632639676e-05
offspring O 0 0.0001459378399886191
were O 0 3.199340426363051e-05
affected O 0 5.081204653833993e-05
, O 0 1.462484124203911e-05
and O 0 1.2841439456678927e-05
in O 0 1.666740354266949e-05
the O 0 2.629888513183687e-05
case O 0 4.580726454150863e-05
of O 0 5.9578276704996824e-05
a O 0 0.00013157844659872353
female O 0 0.00042395867058075964
transmitting O 0 0.0012332057813182473
parent O 0 0.00042595542618073523
, O 0 0.00021150427346583456
68 O 0 0.0009945380734279752
. O 0 0.0006908653303980827

7 O 0 0.00234890915453434
% O 0 0.0005480591207742691
were O 0 0.0004846453375648707
affected O 0 0.0009348712046630681
. O 0 0.0006304684211499989

Studies O 0 0.0009746546857059002
on O 0 0.0006691626040264964
meiotic O 0 0.46332043409347534
drive O 0 0.0011509202886372805
in O 0 0.00020734660211019218
DM B-Disease 1 0.9997318387031555
have O 0 5.361767398426309e-05
shown O 0 7.360277959378436e-05
increased O 0 6.838164699729532e-05
transmission O 0 7.549632573500276e-05
of O 0 4.414648356032558e-05
the O 0 5.34266910108272e-05
larger O 0 5.8422654547030106e-05
allele O 0 7.951756560942158e-05
at O 0 8.61341759446077e-05
the O 0 0.00015457606059499085
DM B-Disease 1 0.9979509711265564
locus O 0 0.0006638864288106561
in O 0 0.00016346407937817276
non O 0 0.0006070839008316398
- O 0 0.0023607935290783644
DM O 1 0.9998587369918823
heterozygotes O 0 0.0064965495839715
for O 0 0.0004482598160393536
CTGn O 1 0.5466850996017456
. O 0 0.0014663201291114092

This O 0 0.0004083125968463719
study O 0 0.00015865950263105333
provides O 0 9.535960271023214e-05
further O 0 4.969974543200806e-05
evidence O 0 8.227075159084052e-05
that O 0 3.5570938052842394e-05
the O 0 0.00022670894395560026
DM B-Disease 1 0.999954342842102
expansion O 0 0.001021159696392715
tends O 0 0.00022525111853610724
to O 0 5.110302663524635e-05
be O 0 0.00011355052993167192
transmitted O 0 0.0005230709793977439
preferentially O 0 0.0013905188534408808
. O 0 0.000754588982090354

Diagnosis O 1 0.9979559183120728
of O 1 0.9720829129219055
hemochromatosis B-Disease 1 0.9999998807907104
. O 0 0.01895412616431713

If O 0 0.015408983454108238
untreated O 1 0.9999947547912598
, O 1 0.9502723217010498
hemochromatosis B-Disease 1 1.0
can O 0 0.01728734001517296
cause O 1 0.9999253749847412
serious O 1 0.999972939491272
illness O 1 0.9999964237213135
and O 0 0.0004937391495332122
early B-Disease 0 0.0005564197199419141
death I-Disease 0 0.08777081221342087
, O 0 3.4188840800197795e-05
but O 0 2.051302908512298e-05
the O 0 0.00012008655176032335
disease O 1 0.9861060380935669
is O 0 6.1029157222947106e-05
still O 0 6.717008363921195e-05
substantially O 0 0.0002643761981744319
under O 0 0.0005227754008956254
- O 0 0.04434366151690483
diagnosed O 1 0.998532772064209
. O 0 0.0008698438759893179

The O 0 0.0014944914728403091
cornerstone O 0 0.012284389697015285
of O 0 0.000567596114706248
screening O 0 0.0003151047567371279
and O 0 6.689094880130142e-05
case O 0 0.00015645693929400295
detection O 0 0.00014864403055980802
is O 0 3.62963619409129e-05
the O 0 6.074655902921222e-05
measurement O 0 0.00016212169430218637
of O 0 0.00018614994769450277
serum O 0 0.13020369410514832
transferrin O 0 0.15896593034267426
saturation O 0 0.0010134904878214002
and O 0 0.00011704260396072641
the O 0 0.0002978616103064269
serum O 0 0.08364170789718628
ferritin O 0 0.3632103204727173
level O 0 0.0010078493505716324
. O 0 0.0007203370332717896

Once O 0 0.002439359202980995
the O 0 0.0008123992010951042
diagnosis O 0 0.026698021218180656
is O 0 0.00014131875650491565
suspected O 0 0.0005418240907602012
, O 0 0.00010680248669814318
physicians O 0 0.00016550545115023851
must O 0 6.586822564713657e-05
use O 0 0.00010162071703234687
serum O 0 0.013472032733261585
ferritin O 1 0.8729904294013977
levels O 0 0.0007146079442463815
and O 0 0.0002579365682322532
hepatic O 1 0.9995452761650085
iron O 1 0.9998243451118469
stores O 0 0.0004140099626965821
on O 0 0.00026273331604897976
liver O 1 0.9951257109642029
biopsy O 0 0.06887345016002655
specimens O 0 0.0001565891579957679
to O 0 5.034967034589499e-05
assess O 0 0.00016246306768152863
patients O 0 0.00010615914652589709
for O 0 3.370181730133481e-05
the O 0 0.00011795698083005846
presence O 0 0.0005342108779586852
of O 0 0.0029255810659378767
iron B-Disease 1 0.9999984502792358
overload I-Disease 1 0.9999679327011108
. O 0 0.00206345715560019

Liver O 1 0.9999860525131226
biopsy O 1 0.9955921769142151
is O 0 0.0002779652422759682
also O 0 7.283315062522888e-05
used O 0 1.891284409794025e-05
to O 0 1.1892654583789408e-05
establish O 0 4.029923729831353e-05
the O 0 3.15816214424558e-05
presence O 0 8.31184588605538e-05
or O 0 3.836753239738755e-05
absence O 0 0.0002868458686862141
of O 0 0.0017673172987997532
cirrhosis B-Disease 1 0.9999996423721313
, O 0 0.0003829939232673496
which O 0 6.767118611605838e-05
can O 0 5.68355098948814e-05
affect O 0 0.00028845324413850904
prognosis O 1 0.6849993467330933
and O 0 0.0001914701861096546
management O 0 0.0014512821799144149
. O 0 0.0008255945867858827

A O 0 0.001662463415414095
DNA O 0 0.0005589999491348863
- O 0 0.00017394323367625475
based O 0 3.7015037378296256e-05
test O 0 6.523872434627265e-05
for O 0 2.160139410989359e-05
the O 0 0.00010308952914783731
HFE O 1 0.9310420751571655
gene O 0 9.420678543392569e-05
is O 0 2.463666896801442e-05
commercially O 0 3.774495780817233e-05
available O 0 8.54500012792414e-06
, O 0 7.107173587428406e-06
but O 0 5.313622750691138e-06
its O 0 7.2304146669921465e-06
place O 0 3.3575586712686345e-05
in O 0 3.218205165467225e-05
the O 0 0.0001071868246071972
diagnosis O 0 0.1002323254942894
of O 0 0.038545478135347366
hemochromatosis B-Disease 1 1.0
is O 0 0.0003594133595470339
still O 0 0.00017476282664574683
being O 0 0.0002504607546143234
evaluated O 0 0.0005638894508592784
. O 0 0.00035273152752779424

Currently O 0 0.0005104204174131155
, O 0 0.0001623723073862493
the O 0 7.067214755807072e-05
most O 0 2.3897218852653168e-05
useful O 0 3.5950084566138685e-05
role O 0 4.1345170757267624e-05
for O 0 1.2407495887600817e-05
this O 0 1.2858645277447067e-05
test O 0 2.1623593056574464e-05
is O 0 8.733376489544753e-06
in O 0 9.694654181657825e-06
the O 0 3.155049489578232e-05
detection O 0 0.000141336684464477
of O 0 0.0002390533045399934
hemochromatosis B-Disease 1 0.9999986886978149
in O 0 8.120122947730124e-05
the O 0 6.837186083430424e-05
family O 0 4.581215762300417e-05
members O 0 2.2311409338726662e-05
of O 0 5.8739122323459014e-05
patients O 0 7.208030001493171e-05
with O 0 3.299233139841817e-05
a O 0 0.00010597971413517371
proven O 0 0.0007021138444542885
case O 0 0.00018308563448954374
of O 0 0.000321042665746063
the O 0 0.014958814717829227
disease O 1 0.9999173879623413
. O 0 0.0008515871013514698

It O 0 0.0006823086878284812
is O 0 0.0002386970882071182
crucial O 0 0.0008004580158740282
to O 0 0.0007656198577024043
diagnose O 1 0.9999785423278809
hemochromatosis B-Disease 1 1.0
before O 1 0.9999693632125854
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9998977184295654
because O 0 0.07373038679361343
phlebotomy O 1 0.9999740123748779
therapy O 1 0.9976997971534729
can O 0 0.0002096320822602138
avert O 1 0.9997801184654236
serious O 1 0.9999996423721313
chronic O 1 1.0
disease O 1 1.0
and O 0 0.04898521676659584
can O 0 3.7537589378189296e-05
even O 0 3.209173519280739e-05
lead O 0 6.124633364379406e-05
to O 0 2.8345873943180777e-05
normal O 0 0.0001368092925986275
life O 0 0.0002816525229718536
expectancy O 0 0.000720714742783457
. O 0 0.0001300444855587557
. O 0 0.00038704805774614215

Prevalence O 0 0.0041768536902964115
of O 0 0.001043269643560052
the O 0 0.0010774991242215037
I1307K O 1 0.9995037317276001
APC B-Disease 1 0.9804609417915344
gene O 0 0.0003309086605440825
variant O 0 0.00016923362272791564
in O 0 4.1962728573707864e-05
Israeli O 0 0.00014994388038758188
Jews O 0 9.409671474713832e-05
of O 0 4.795845234184526e-05
differing O 0 3.035913141502533e-05
ethnic O 0 4.773565160576254e-05
origin O 0 7.781921158311889e-05
and O 0 0.00017573116929270327
risk O 0 0.02411474473774433
for O 0 0.19271929562091827
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.004141884855926037

BACKGROUND O 0 0.009056475013494492
& O 0 0.005503168795257807
AIMS O 0 0.0010203662095591426
Israeli O 0 0.00024410734476987273
Jews O 0 0.000129446285427548
of O 0 7.829709647921845e-05
European O 0 5.8976205764338374e-05
birth O 0 0.00019564318063203245
, O 0 3.7187452107900754e-05
i O 0 5.9354788390919566e-05
. O 0 1.833827445807401e-05
e O 0 3.1764120649313554e-05
. O 0 2.0242941900505684e-05
, O 0 4.0054979763226584e-05
Ashkenazim O 0 0.0002829139120876789
, O 0 2.602871973067522e-05
have O 0 1.714011887088418e-05
the O 0 0.00010064218804473057
highest O 1 0.995693564414978
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
incidence O 1 0.9754511713981628
of O 0 0.0004603563284035772
any O 0 0.0001094904073397629
Israeli O 0 0.00029863903182558715
ethnic O 0 0.0002084038278553635
group O 0 0.00022576199262402952
. O 0 0.00045189051888883114

The O 0 0.004111981485038996
I1307K O 1 0.9854807257652283
APC B-Disease 1 0.9549806118011475
gene O 0 0.0008657759171910584
variant O 0 0.0006565035437233746
was O 0 0.00033118168357759714
found O 0 7.201125117717311e-05
in O 0 0.0001161026448244229
6 O 0 0.0005675915163010359
. O 0 0.0005108390469104052

1 O 0 0.0004714659589808434
% O 0 8.275354048237205e-05
of O 0 0.0001079908397514373
American O 0 9.94625806924887e-05
Jews O 0 8.907311712391675e-05
, O 0 3.289023516117595e-05
28 O 0 5.945556767983362e-05
% O 0 2.4442853828077205e-05
of O 0 8.932770288083702e-05
their O 0 0.0001609039754839614
familial O 1 0.9999994039535522
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.07950161397457123
, O 0 5.71421260247007e-05
but O 0 1.890611747512594e-05
not O 0 9.79545984591823e-06
in O 0 2.6530309696681798e-05
non O 0 0.00011782522778958082
- O 0 0.00027350671007297933
Jews O 0 0.000502728100400418
. O 0 0.0003805111919064075

We O 0 0.0009675913606770337
assessed O 0 0.0009270845912396908
the O 0 0.0004973838804289699
I1307K O 0 0.054379209876060486
prevalence O 0 0.0006680079968646169
in O 0 7.005604129517451e-05
Israeli O 0 0.0002219054294982925
Jews O 0 0.00014124493463896215
of O 0 6.599717744393274e-05
differing O 0 4.555824853014201e-05
ethnic O 0 8.45696558826603e-05
origin O 0 8.841379167279229e-05
and O 0 0.00011726837692549452
risk O 0 0.017519230023026466
for O 0 0.15137644112110138
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.00576216634362936

METHODS O 0 0.0011211418313905597
DNA O 0 0.0003989551623817533
samples O 0 0.00012118925951654091
from O 0 9.554027201374993e-05
500 O 0 0.00024366295838262886
unrelated O 0 0.00013119571667630225
Jews O 0 8.103306026896462e-05
of O 0 6.47778797429055e-05
European O 0 4.68614962301217e-05
or O 0 3.7172452721279114e-05
non O 0 7.982617535162717e-05
- O 0 3.74195005861111e-05
European O 0 1.5373829228337854e-05
origin O 0 1.645115298742894e-05
, O 0 1.1994778105872683e-05
with O 0 8.792526386969257e-06
or O 0 1.4740386177436449e-05
without O 0 1.611618608876597e-05
a O 0 4.663221989176236e-05
personal O 0 0.00012678599159698933
and O 0 6.028460484230891e-05
/ O 0 0.0002656856086105108
or O 0 4.357118086772971e-05
family O 0 6.69403380015865e-05
history O 0 0.00010735815158113837
of O 0 0.00018237164476886392
neoplasia B-Disease 1 0.990041196346283
, O 0 4.276826439308934e-05
were O 0 2.8326308893156238e-05
examined O 0 6.587927782675251e-05
for O 0 1.616441113583278e-05
the O 0 7.68169411458075e-05
I1307K O 0 0.0028828333597630262
variant O 0 0.00011931061453651637
by O 0 2.576668339315802e-05
the O 0 5.3853240387979895e-05
allele O 0 9.301962563768029e-05
- O 0 6.668160494882613e-05
specific O 0 4.1238894482376054e-05
oligonucleotide O 0 0.0004686556349042803
( O 0 0.00017877668142318726
ASO O 0 0.1385425627231598
) O 0 0.00020726757065858692
method O 0 0.0003805725136771798
. O 0 0.0006685187690891325

RESULTS O 0 0.0008352367440238595
In O 0 0.00014641454617958516
persons O 0 0.00017746485536918044
at O 0 0.00019334733951836824
average O 0 0.00018074229592457414
risk O 0 0.00046589094563387334
for O 0 0.0006158872856758535
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
, O 0 0.0007156211067922413
I1307K O 1 0.9212157130241394
was O 0 0.00038027515984140337
found O 0 7.795431884005666e-05
in O 0 9.459781722398475e-05
5 O 0 0.00029096865910105407
. O 0 0.0003643048112280667

0 O 0 0.0005254578427411616
% O 0 0.00011865167471114546
of O 0 0.0001380620087729767
120 O 0 0.0002010413445532322
European O 0 0.00013077368203084916
and O 0 0.00014154006203170866
1 O 0 0.0004780228773597628
. O 0 0.0006527632940560579

6 O 0 0.0011268487432971597
% O 0 0.00016503993538208306
of O 0 0.0001768204674590379
188 O 0 0.00036815190105699003
non O 0 0.00016904300719033927
- O 0 0.00011366536637069657
European O 0 3.335728979436681e-05
Jews O 0 7.226625893963501e-05
( O 0 5.8899262512568384e-05
P O 0 0.00031673480407334864
= O 0 0.00015831027121748775
0 O 0 9.127639350481331e-05
. O 0 7.024905062280595e-05
08 O 0 0.0009627948747947812
) O 0 0.0002739707415457815
. O 0 0.00047564093256369233

It O 0 0.0007804451743140817
occurred O 0 0.0020435580518096685
in O 0 0.00041254001553170383
15 O 0 0.001215052790939808
. O 0 0.000819950073491782

4 O 0 0.0012159030884504318
% O 0 0.00024155661230906844
of O 0 0.0001551218010718003
52 O 0 0.00036673317663371563
Ashkenazi O 0 0.0004572420730255544
Israelis O 0 0.00027734736795537174
with O 0 9.540527389617637e-05
familial O 1 0.9427196383476257
cancer B-Disease 1 0.9983287453651428
( O 0 0.0002315971942152828
P O 0 0.001183869899250567
= O 0 0.00013705150922760367
0 O 0 4.540119698503986e-05
. O 0 2.1883464796701446e-05
02 O 0 0.000384188984753564
) O 0 1.9441082258708775e-05
and O 0 2.025323556154035e-05
was O 0 8.160861034411937e-05
not O 0 1.434146997780772e-05
detected O 0 6.247860437724739e-05
in O 0 2.850739110726863e-05
51 O 0 9.94984366116114e-05
non O 0 0.00010437224409542978
- O 0 8.972578507382423e-05
European O 0 3.795705924858339e-05
Jews O 0 0.00015810946933925152
at O 0 0.000426092476118356
increased O 0 0.0014710563700646162
cancer B-Disease 1 0.998711109161377
risk O 0 0.001937330700457096
. O 0 0.0005870050517842174

Colorectal B-Disease 1 0.9999830722808838
neoplasia I-Disease 1 0.9999178647994995
occurred O 0 0.23751352727413177
personally O 0 0.0014698852319270372
or O 0 7.51976331230253e-05
in O 0 2.8023980121361092e-05
the O 0 3.79657831217628e-05
families O 0 1.9642257029772736e-05
of O 0 3.024957186426036e-05
13 O 0 6.000259963911958e-05
of O 0 4.989153967471793e-05
20 O 0 9.373034117743373e-05
Ashkenazi O 0 0.00040163355879485607
I1307K O 0 0.003014370333403349
carriers O 0 6.955386197660118e-05
, O 0 1.730909752950538e-05
8 O 0 3.3915934182005e-05
of O 0 3.930725870304741e-05
whom O 0 6.550285615958273e-05
also O 0 3.094144994975068e-05
had O 0 5.8601708587957546e-05
a O 0 7.156013452913612e-05
personal O 0 0.00011265237117186189
or O 0 4.7118479415075853e-05
family O 0 0.00016207669978030026
history O 0 0.0005092276260256767
of O 0 0.007014472037553787
noncolonic O 1 0.9999698400497437
neoplasia B-Disease 1 0.9999229907989502
. O 0 0.0018528653308749199

CONCLUSIONS O 0 0.005368753336369991
The O 0 0.0029978228267282248
I1307K O 1 0.9961058497428894
APC O 1 0.9815315008163452
variant O 0 0.000994501169770956
may O 0 0.0001437594910385087
represent O 0 8.628149953437969e-05
a O 0 0.00010701299470383674
susceptibility O 0 0.0016430214745923877
gene O 0 0.00014573230873793364
for O 0 0.00010531400766922161
colorectal B-Disease 1 0.9999850988388062
, I-Disease 0 6.070087692933157e-05
or I-Disease 0 3.1604340620106086e-05
other I-Disease 0 1.546644307381939e-05
, I-Disease 0 3.876088885590434e-05
cancers I-Disease 0 0.0008673302945680916
in O 0 3.417730476940051e-05
Ashkenazi O 0 0.00035961077082902193
Jews O 0 0.0001447934628231451
, O 0 3.7630343285854906e-05
and O 0 2.9540577088482678e-05
partially O 0 0.00021158374147489667
explains O 0 9.661955118644983e-05
the O 0 7.253946387208998e-05
higher O 0 0.00015750234888400882
incidence O 0 0.45450422167778015
of O 1 0.9930889010429382
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999983310699463
in O 0 0.00030180293833836913
European O 0 0.00021469377679750323
Israelis O 0 0.0010158858494833112
. O 0 0.00045576898264698684

Systematic O 0 0.0037082990165799856
analysis O 0 0.0005347022670321167
of O 0 0.0011172480881214142
coproporphyrinogen O 1 0.9998743534088135
oxidase O 1 0.994979202747345
gene O 0 0.009219583123922348
defects O 1 0.9981531500816345
in O 0 0.0006011588266119361
hereditary B-Disease 1 0.9998297691345215
coproporphyria I-Disease 1 0.9999749660491943
and O 0 0.0012191300047561526
mutation O 0 0.0020213008392602205
update O 0 0.0012993767159059644
. O 0 0.000731657084543258

Hereditary B-Disease 1 0.9997292160987854
coproporphyria I-Disease 1 0.9999027252197266
( O 0 0.011196302250027657
HC B-Disease 1 0.9999250173568726
) O 0 0.0006688954308629036
is O 0 0.0004890802665613592
an O 0 0.008251617662608624
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.920646607875824
autosomal O 1 0.9997807145118713
dominant O 1 0.9993292093276978
inheritance O 1 0.9986502528190613
caused O 1 0.9991705417633057
by O 0 0.00023062279797159135
deficient B-Disease 0 0.006432151421904564
activity I-Disease 0 0.00022964307572692633
of I-Disease 0 0.000504577299579978
coproporphyrinogen I-Disease 1 0.9999226331710815
III I-Disease 1 0.9999579191207886
oxidase I-Disease 0 0.09223661571741104
( O 0 0.0006009612116031349
CPO O 0 0.006357868202030659
) O 0 0.00032505192211829126
. O 0 0.0005524710286408663

Clinical O 0 0.009385191835463047
manifestations O 0 0.1588931530714035
of O 0 0.006179639603942633
the O 1 0.8331254720687866
disease O 1 0.9999830722808838
are O 0 4.282295412849635e-05
characterized O 0 0.0019092715810984373
by O 0 0.00018451728101354092
acute O 1 0.9999921321868896
attacks O 1 0.777594804763794
of O 1 0.9999444484710693
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 0.138271763920784
precipitated O 1 0.9999018907546997
by O 0 0.00022608057770412415
drugs O 0 0.000494644045829773
, O 0 0.00011831159645225853
fasting O 0 0.000642909377347678
, O 0 9.883999155135825e-05
cyclical O 1 0.6496136784553528
hormonal O 1 0.9857187867164612
changes O 0 0.0005634102271869779
, O 0 0.0007083552191033959
or O 0 0.13852642476558685
infectious B-Disease 1 0.9999966621398926
diseases I-Disease 1 0.9999959468841553
. O 0 0.002441324759274721

Skin O 1 0.9999977350234985
photosensitivity O 1 0.9999821186065674
may O 0 0.0024359480012208223
also O 0 0.0003519499150570482
be O 0 0.00018153575365431607
present O 0 0.0005416578496806324
. O 0 0.0007002408383414149

The O 0 0.0006827627657912672
seven O 0 0.00033628594246692955
exons O 0 0.0006242173258215189
, O 0 9.794293146114796e-05
the O 0 0.00014650978846475482
exon O 0 0.0011231001699343324
/ O 0 0.00039217821904458106
intron O 0 0.0008553658262826502
boundaries O 0 6.906998169142753e-05
and O 0 3.747277878574096e-05
part O 0 5.98564074607566e-05
of O 0 6.027948984410614e-05
3 O 0 8.942937711253762e-05
noncoding O 0 0.00018341238319408149
sequence O 0 3.7627254641847685e-05
of O 0 5.0998896767850965e-05
the O 0 9.093705011764541e-05
CPO O 0 0.0016169470036402345
gene O 0 5.579705975833349e-05
were O 0 2.524765659472905e-05
systematically O 0 0.00010047389514511451
analyzed O 0 2.7916699764318764e-05
by O 0 1.7478556401329115e-05
an O 0 2.889115239668172e-05
exon O 0 0.0004431198176462203
- O 0 0.0001354151318082586
by O 0 4.828569944947958e-05
- O 0 0.00024258044140879065
exon O 0 0.0012481248704716563
denaturing O 0 0.00437149778008461
gradient O 0 0.003816632553935051
gel O 0 0.00557556189596653
electrophoresis O 0 0.001511903596110642
( O 0 0.0002645524509716779
DGGE O 0 0.06875003129243851
) O 0 4.577346408041194e-05
strategy O 0 7.784155604895204e-05
followed O 0 6.49420908303e-05
by O 0 2.0480816601775587e-05
direct O 0 4.1085844713961706e-05
sequencing O 0 0.00012938494910486042
in O 0 4.93410843773745e-05
seven O 0 0.00011657935101538897
unrelated O 0 0.00036093188100494444
heterozygous O 0 0.0005236194701865315
HC B-Disease 1 0.9990608096122742
patients O 0 0.0007260674028657377
from O 0 0.0001365720818284899
France O 0 0.00034836240229196846
, O 0 0.00012891291407868266
Holland O 0 0.0003420334542170167
, O 0 6.29320929874666e-05
and O 0 7.018416363280267e-05
Czech O 0 0.0004837132291868329
Republic O 0 0.0006125196232460439
. O 0 0.000760720344260335

Seven O 0 0.002512840088456869
novel O 0 0.001453347853384912
mutations O 0 0.00030780379893258214
and O 0 7.643149729119614e-05
two O 0 5.681512993760407e-05
new O 0 0.0001326476049143821
polymorphisms O 0 0.0005428289878182113
were O 0 0.0002811173035297543
detected O 0 0.0015505487099289894
. O 0 0.0007857527816668153

Among O 0 0.0009052080567926168
these O 0 8.837992209009826e-05
mutations O 0 0.00012327556032687426
two O 0 3.0460660127573647e-05
are O 0 1.9994655303889886e-05
missense O 0 0.0005153597448952496
( O 0 0.00012583892385009676
G197W O 0 0.11810353398323059
, O 0 0.00011018482473446056
W427R O 0 0.00408199755474925
) O 0 3.573863432393409e-05
, O 0 1.874954796221573e-05
two O 0 1.122052526625339e-05
are O 0 9.832457180891652e-06
nonsense O 0 0.00027604048955254257
( O 0 8.092827192740515e-05
Q306X O 0 0.010004546493291855
, O 0 9.785089059732854e-05
Q385X O 0 0.002805332187563181
) O 0 3.0184910428943112e-05
, O 0 1.6224224964389578e-05
two O 0 9.718889486975968e-06
are O 0 7.289451787073631e-06
small O 0 4.551117308437824e-05
deletions O 0 0.0002872591430786997
( O 0 0.00013897854660172015
662de14bp O 0 0.003928669262677431
; O 0 0.00011849970178445801
1168del3bp O 0 0.0014745844528079033
removing O 0 0.00031898971064947546
a O 0 8.59966385178268e-05
glycine O 0 0.00017685521743260324
at O 0 7.052162254694849e-05
position O 0 4.5983771997271106e-05
390 O 0 0.0001477485493524
) O 0 2.1832749553141184e-05
, O 0 1.567424988024868e-05
and O 0 1.1896147952938918e-05
one O 0 1.256812538485974e-05
is O 0 1.4077515515964478e-05
a O 0 4.044156230520457e-05
splicing O 0 0.00020093211787752807
mutation O 0 0.000132933899294585
( O 0 8.432886534137651e-05
IVS1 O 0 0.06121395528316498
- O 0 0.00023789642727933824
15c O 0 0.0015189398545771837
- O 0 0.0001938024943228811
- O 0 0.00010731702786870301
> O 0 0.00016669648175593466
g O 0 0.00013035994197707623
) O 0 2.1283300156937912e-05
which O 0 2.5072384232771583e-05
creates O 0 0.00010090201976709068
a O 0 8.642592729302123e-05
new O 0 8.456159412162378e-05
acceptor O 0 0.0006135256262496114
splice O 0 0.0026117705274373293
site O 0 0.001363961724564433
. O 0 0.00060524936998263

The O 0 0.0010236259549856186
pathological O 0 0.0020364869851619005
significance O 0 0.0005170107469893992
of O 0 0.00021761018433608115
the O 0 0.00018271034059580415
point O 0 0.0003657480701804161
mutations O 0 0.00025278879911638796
G197W O 0 0.11323831975460052
, O 0 0.0001054718013620004
W427R O 0 0.0018828704487532377
, O 0 3.765565270441584e-05
and O 0 2.4612623747088946e-05
the O 0 5.5557229643454775e-05
in O 0 5.411006713984534e-05
- O 0 0.0001954774052137509
frame O 0 0.0005122139700688422
deletion O 0 0.0003824196755886078
390delGly O 0 0.0016909850528463721
were O 0 6.598251638934016e-05
assessed O 0 8.747146057430655e-05
by O 0 1.837381387304049e-05
their O 0 1.5962265024427325e-05
respective O 0 3.608823681133799e-05
expression O 0 4.865506707574241e-05
in O 0 2.110885725414846e-05
a O 0 6.776198279112577e-05
prokaryotic O 0 0.0001903684897115454
system O 0 6.491608655778691e-05
using O 0 4.8789293941808864e-05
site O 0 0.0002733750734478235
- O 0 0.00039220217149704695
directed O 0 0.0004152734181843698
mutagenesis O 0 0.0027750376611948013
. O 0 0.0006549533572979271

These O 0 0.00038464812678284943
mutations O 0 0.0003912245447281748
resulted O 0 0.0003751876065507531
in O 0 5.649356899084523e-05
the O 0 9.459583088755608e-05
absence O 0 0.0002569736388977617
or O 0 0.00010223304707324132
a O 0 0.00018859827832784504
dramatic O 0 0.0007677008979953825
decrease O 0 0.0005804772372357547
of O 0 0.0007389329257421196
CPO O 0 0.043427977710962296
activity O 0 0.000876119825989008
. O 0 0.0006926135974936187

The O 0 0.0009568444220349193
two O 0 0.00020302935445215553
polymorphisms O 0 0.0004960813093930483
were O 0 9.370594489155337e-05
localized O 0 0.00020194260287098587
in O 0 5.439581218524836e-05
noncoding O 0 0.00029801041819155216
part O 0 7.451635610777885e-05
of O 0 3.3261421776842326e-05
the O 0 3.057649519178085e-05
gene O 0 2.9461805752362125e-05
1 O 0 2.9032449674559757e-05
) O 0 1.2878366760560311e-05
a O 0 4.1595823859097436e-05
C O 0 0.00018751740572042763
/ O 0 0.0001949192228494212
G O 0 0.0002162036398658529
polymorphism O 0 8.820403309073299e-05
in O 0 2.726370803429745e-05
the O 0 6.659632344963029e-05
promotor O 0 0.001199972815811634
region O 0 0.00010958672646665946
, O 0 4.7218112740665674e-05
142 O 0 0.00020837383635807782
bp O 0 0.0003416990512050688
upstream O 0 0.00011241436004638672
from O 0 2.4145285351551138e-05
the O 0 3.378768087713979e-05
transcriptional O 0 0.00012697304191533476
initiation O 0 0.00025402946630492806
site O 0 0.00013305956963449717
( O 0 7.231700146803632e-05
- O 0 0.0001474077143939212
142C O 0 0.002941217739135027
/ O 0 0.00036566786002367735
G O 0 0.000281267159152776
) O 0 2.1156945877010003e-05
, O 0 1.1951150554523338e-05
and O 0 1.1642595381999854e-05
2 O 0 2.292053250130266e-05
) O 0 1.4578095942852087e-05
a O 0 3.932799518224783e-05
6 O 0 0.00010542092786636204
bp O 0 0.00030778179643675685
deletion O 0 0.0001750061201164499
polymorphism O 0 7.814879791112617e-05
in O 0 2.6450605218997225e-05
the O 0 3.20946128340438e-05
3 O 0 5.0732593081193045e-05
noncoding O 0 0.0001530498848296702
part O 0 3.819605990429409e-05
of O 0 4.598021769197658e-05
the O 0 9.020723518915474e-05
CPO O 0 0.0016927149845287204
gene O 0 6.528104131575674e-05
, O 0 4.077693301951513e-05
574 O 0 0.0005386662087403238
bp O 0 0.0003188480332028121
downstream O 0 0.00014097434177529067
of O 0 5.151609730091877e-05
the O 0 3.6994399124523625e-05
last O 0 3.986152296420187e-05
base O 0 9.009711357066408e-05
of O 0 6.683222454739735e-05
the O 0 6.465704063884914e-05
normal O 0 0.0001983017718885094
termination O 0 0.0007528263959102333
codon O 0 0.0005634817644022405
( O 0 0.00018181292398367077
+ O 0 0.0007723935414105654
574 O 0 0.004997663665562868
delATTCTT O 0 0.013349946588277817
) O 0 0.0007827332010492682
. O 0 0.0009608726832084358

Five O 0 0.0025072384160012007
intragenic O 1 0.9970082640647888
dimorphisms O 1 0.8107077479362488
are O 0 8.190987864509225e-05
now O 0 8.596785482950509e-05
well O 0 6.009204298607074e-05
characterized O 0 0.0001051149592967704
and O 0 3.589630068745464e-05
the O 0 5.852760295965709e-05
high O 0 9.49515524553135e-05
degree O 0 0.00011551460193004459
of O 0 0.00014231076056603342
allelic O 0 0.0010197781957685947
heterogeneity O 0 0.0005760841304436326
in O 0 0.0001063062300090678
HC B-Disease 1 0.9894083738327026
is O 0 7.545378321083263e-05
demonstrated O 0 0.00011753392027458176
with O 0 1.5145662473514676e-05
seven O 0 2.168268838431686e-05
new O 0 1.4913698578311596e-05
different O 0 7.051119609968737e-06
mutations O 0 1.8511171219870448e-05
making O 0 1.4888346413499676e-05
a O 0 2.9200607968959957e-05
total O 0 2.9935679776826873e-05
of O 0 9.531615069136024e-05
nineteen O 0 0.0012506471248343587
CPO O 1 0.8949245810508728
gene B-Disease 0 0.0011739418841898441
defects I-Disease 1 0.9803259372711182
reported O 0 0.00010057944018626586
so O 0 6.617294275201857e-05
far O 0 0.00013891840353608131
. O 0 0.00012928605428896844
. O 0 0.00027916356339119375

Coincidence O 0 0.004985294304788113
of O 0 0.0005625830963253975
two O 0 0.0001904483651742339
novel O 0 0.0008607042254880071
arylsulfatase O 0 0.011172584258019924
A O 0 0.0004359500017017126
alleles O 0 0.00015921765589155257
and O 0 7.458929030690342e-05
mutation O 0 0.00019091290596406907
459 O 0 0.0020853658206760883
+ O 0 0.0009088867227546871
1G O 0 0.005189420189708471
> O 0 0.00022446943330578506
A O 0 0.0001511837326688692
within O 0 6.340217805700377e-05
a O 0 8.981669088825583e-05
family O 0 0.00012697750935330987
with O 0 0.00019806310592684895
metachromatic B-Disease 1 0.9999707937240601
leukodystrophy I-Disease 1 0.9999669790267944
: O 0 0.00022795394761487842
molecular O 0 0.00016271701315417886
basis O 0 0.00010459761688252911
of O 0 0.0002532918006181717
phenotypic O 0 0.001768935238942504
heterogeneity O 0 0.0046148342080414295
. O 0 0.0010590199381113052

In O 0 0.00041403440991416574
a O 0 0.00024384238349739462
family O 0 0.00012610331759788096
with O 0 4.2789397411979735e-05
three O 0 6.18783087702468e-05
siblings O 0 0.00024769603624008596
, O 0 6.124814535723999e-05
one O 0 6.861038855277002e-05
developed O 0 0.00019122898811474442
classical O 0 0.00044923962559551
late O 0 0.002810952253639698
infantile O 1 0.9999696016311646
metachromatic B-Disease 1 0.9999978542327881
leukodystrophy I-Disease 1 0.9999994039535522
( O 0 0.005087957717478275
MLD B-Disease 1 0.9999841451644897
) O 0 9.886364568956196e-05
, O 0 4.579227970680222e-05
fatal O 0 0.003135805716738105
at O 0 0.0001348611549474299
age O 0 5.7167140766978264e-05
5 O 0 4.54870933026541e-05
years O 0 3.817039032583125e-05
, O 0 3.1128060072660446e-05
with O 0 4.428314059623517e-05
deficient O 0 0.001289577572606504
arylsulfatase O 0 0.08122568577528
A O 0 0.0006959931924939156
( O 0 0.00020686931384261698
ARSA O 0 0.014473662711679935
) O 0 5.4799209465272725e-05
activity O 0 9.527680958854035e-05
and O 0 7.053453737171367e-05
increased O 0 0.00020780735940206796
galactosylsulfatide O 1 0.6085647940635681
( O 0 0.0008626599446870387
GS O 1 0.9997432827949524
) O 0 0.00044144876301288605
excretion O 0 0.002102278172969818
. O 0 0.00044391126721166074

The O 0 0.0007511244039051235
two O 0 0.00015618895122315735
other O 0 8.251840336015448e-05
siblings O 0 0.00036616341094486415
, O 0 7.43620257708244e-05
apparently O 0 0.00024016681709326804
healthy O 0 0.00012848536425735801
at O 0 5.689597674063407e-05
12 O 0 5.3004765504738316e-05
( O 0 2.2570722649106756e-05
1 O 0 3.2939642551355064e-05
/ O 0 5.979473644401878e-05
2 O 0 2.5794957764446735e-05
) O 0 9.593467439117376e-06
and O 0 8.932196578825824e-06
15 O 0 2.1789257516502403e-05
years O 0 2.062420935544651e-05
, O 0 1.794500531104859e-05
respectively O 0 2.551370744185988e-05
, O 0 1.479756974731572e-05
and O 0 2.1091955204610713e-05
their O 0 1.6389269148930907e-05
father O 0 0.00029913283651694655
, O 0 5.33767270098906e-05
apparently O 0 0.00015206070384010673
healthy O 0 9.97458046185784e-05
as O 0 2.2701908164890483e-05
well O 0 2.9559490940300748e-05
, O 0 5.1831120799761266e-05
presented O 0 0.0002650177339091897
ARSA O 1 0.9636440277099609
and O 0 0.00016770485672168434
GS O 0 0.26456356048583984
values O 0 8.517136302543804e-05
within O 0 4.532070306595415e-05
the O 0 9.152182610705495e-05
range O 0 0.00014154032396618277
of O 0 0.0008215043926611543
MLD B-Disease 1 0.9999982118606567
patients O 0 0.026390118524432182
. O 0 0.0008145354804582894

Mutation O 0 0.0024247122928500175
screening O 0 0.0005758716724812984
and O 0 0.0001048256890499033
sequence O 0 0.00010156792268389836
analysis O 0 5.827887071063742e-05
disclosed O 0 0.00012243700621183962
the O 0 4.114568218938075e-05
involvement O 0 0.00012169148249085993
of O 0 5.3229316108627245e-05
three O 0 3.870762520818971e-05
different O 0 4.277144398656674e-05
ARSA O 1 0.8583669066429138
mutations O 0 0.0001105589690268971
being O 0 4.79963309771847e-05
the O 0 5.31332116224803e-05
molecular O 0 0.0001399447937728837
basis O 0 0.0001151857286458835
of O 0 0.00032347903470508754
intrafamilial O 1 0.8270699977874756
phenotypic O 0 0.005052024498581886
heterogeneity O 0 0.006014703772962093
. O 0 0.0012501570163294673

The O 0 0.003211577655747533
late O 0 0.017454272136092186
infantile O 1 0.9999474287033081
patient O 1 0.5350479483604431
inherited O 1 0.9625093936920166
from O 0 0.00019249197794124484
his O 0 0.00036750826984643936
mother O 0 0.0003282342222519219
the O 0 7.958529749885201e-05
frequent O 0 0.00010245643352391198
0 O 0 9.690190199762583e-05
- O 0 0.00015766821161378175
type O 0 0.0001701054716249928
mutation O 0 0.0001863207871792838
459 O 0 0.0012036269763484597
+ O 0 0.0005933833890594542
1G O 0 0.004331909120082855
> O 0 0.00026724833878688514
A O 0 0.0001378002780256793
, O 0 2.97737933578901e-05
and O 0 2.093923649226781e-05
from O 0 2.973203118017409e-05
his O 0 9.448405035072938e-05
father O 0 0.0003724050766322762
a O 0 0.0001431885757483542
novel O 0 0.00019388491637073457
, O 0 6.836169632151723e-05
single O 0 0.00010115336772287264
basepair O 0 0.002011924283578992
microdeletion O 0 0.0013521775836125016
of O 0 0.00012640042405109853
guanine O 0 0.0002068225876428187
at O 0 8.629383228253573e-05
nucleotide O 0 6.869524077046663e-05
7 O 0 7.48218153603375e-05
in O 0 3.2465399272041395e-05
exon O 0 0.0005201063468120992
1 O 0 0.00022773105592932552
( O 0 0.0002758248010650277
7delG O 0 0.004684013780206442
) O 0 0.00036470749182626605
. O 0 0.0007328803767450154

The O 0 0.0014728863025084138
two O 0 0.00048439844977110624
clinically O 0 0.03354547917842865
unaffected O 0 0.001116274856030941
siblings O 0 0.00038117633084766567
carried O 0 0.00012422075087670237
the O 0 0.00010904570808634162
maternal O 0 0.0005984765011817217
mutation O 0 0.00024836763623170555
459 O 0 0.00309735513292253
+ O 0 0.0006971943657845259
1G O 0 0.005935673601925373
> O 0 0.00022219103993847966
A O 0 8.918632374843583e-05
and O 0 2.419728843960911e-05
, O 0 1.547349529573694e-05
on O 0 1.4262226613936946e-05
their O 0 1.7629656213102862e-05
paternal O 0 0.00024515853147022426
allele O 0 0.00010444642248330638
, O 0 3.9548875065520406e-05
a O 0 5.4074986110208556e-05
novel O 0 0.00012830967898480594
cytosine O 0 0.00022467585222329944
to O 0 4.1145915020024404e-05
thymidine O 0 0.00037801091093569994
transition O 0 0.0002741654170677066
at O 0 0.00016916975437197834
nucleotide O 0 0.0002952430222649127
2435 O 0 0.0020279595628380775
in O 0 6.138251774245873e-05
exon O 0 0.0003875324910040945
8 O 0 0.00013614975614473224
, O 0 5.574812166742049e-05
resulting O 0 9.679874347057194e-05
in O 0 3.4699347452260554e-05
substitution O 0 0.0001459171180613339
of O 0 0.00010932588338619098
alanine O 0 0.0004988023429177701
464 O 0 0.0013729294296354055
by O 0 0.00015234299644362181
valine O 0 0.027744758874177933
( O 0 0.0005151527002453804
A464V O 0 0.10264205187559128
) O 0 0.00040417833952233195
. O 0 0.0005274356808513403

The O 0 0.0031385887414216995
fathers O 0 0.005068544298410416
genotype O 0 0.0037436257116496563
thus O 0 0.001011508982628584
was O 0 0.0036362200044095516
7delG O 1 0.9951518774032593
/ O 0 0.18826055526733398
A464V O 1 0.8896095752716064
. O 0 0.0023443298414349556

Mutation O 0 0.005642422009259462
A464V O 0 0.38645240664482117
was O 0 0.000718895229510963
not O 0 4.717715273727663e-05
found O 0 8.560904825571924e-05
in O 0 9.650187712395564e-05
18 O 0 0.0004174601926933974
unrelated O 0 0.01472626905888319
MLD B-Disease 1 0.9999951124191284
patients O 0 0.001484196400269866
and O 0 0.00023253666586242616
50 O 0 0.0005826939013786614
controls O 0 0.0007217581151053309
. O 0 0.0007357627619057894

A464V O 1 0.6848294734954834
, O 0 0.0011308758985251188
although O 0 0.0005343471420928836
clearly O 0 0.000914455100428313
modifying O 0 0.0025560641661286354
ARSA O 1 0.9988816380500793
and O 0 0.0012488074135035276
GS O 1 0.999975323677063
levels O 0 0.000707712140865624
, O 0 0.00012338116357568651
apparently O 0 0.0002541725989431143
bears O 0 0.00021415852825157344
little O 0 0.00011991820792900398
significance O 0 0.00017376072355546057
for O 0 6.0985465097473934e-05
clinical O 0 0.0005241627804934978
manifestation O 1 0.9770201444625854
of O 0 0.2220519632101059
MLD B-Disease 1 0.9999995231628418
, O 0 0.0005209160735830665
mimicking O 0 0.0024221381172537804
the O 0 0.00039953156374394894
frequent O 0 0.001322358613833785
ARSA O 1 0.9987344145774841
pseudodeficiency O 1 0.9914132356643677
allele O 0 0.002848409814760089
. O 0 0.0007540980004705489

Our O 0 0.0014165692264214158
results O 0 0.0003304137208033353
demonstrate O 0 0.0002531261998228729
that O 0 3.347331585246138e-05
in O 0 3.697778083733283e-05
certain O 0 6.775694055249915e-05
genetic O 0 0.0005297089228406549
conditions O 0 0.05287943035364151
MLD B-Disease 1 0.9999994039535522
- O 0 0.05443247780203819
like O 0 0.0006789085455238819
ARSA O 1 0.9971833825111389
and O 0 0.0002186283963965252
GS O 1 0.9875482320785522
values O 0 7.242996798595414e-05
need O 0 2.911504816438537e-05
not O 0 9.852562470769044e-06
be O 0 1.364811305393232e-05
paralleled O 0 0.00018782266124617308
by O 0 6.94382906658575e-05
clinical O 0 0.12864883244037628
disease O 1 0.9997039437294006
, O 0 8.39869026094675e-05
a O 0 0.00010433423449285328
finding O 0 0.00010180685058003291
with O 0 8.48777053761296e-05
serious O 0 0.23981936275959015
diagnostic O 0 0.16043858230113983
and O 0 0.0008327611139975488
prognostic O 1 0.9963313937187195
implications O 0 0.004558627028018236
. O 0 0.0009999650064855814

Moreover O 0 0.0033829102758318186
, O 0 0.0008709667599759996
further O 0 0.001134234364144504
ARSA O 1 0.7584207057952881
alleles O 0 0.0009714803309179842
functionally O 0 0.0005838958895765245
similar O 0 9.38953016884625e-05
to O 0 6.1008555348962545e-05
A464V O 0 0.013293012045323849
might O 0 8.414676267420873e-05
exist O 0 2.5601595552871004e-05
which O 0 1.1452852959337179e-05
, O 0 1.1294408068351913e-05
together O 0 1.980664092116058e-05
with O 0 1.3025176485825796e-05
0 O 0 8.473464549751952e-05
- O 0 0.00014416278281714767
type O 0 0.0001429355179425329
mutations O 0 8.836390770738944e-05
, O 0 4.61384370282758e-05
may O 0 0.00010045617818832397
cause O 0 0.027062024921178818
pathological O 1 0.997825026512146
ARSA O 1 0.9999816417694092
and O 0 0.002297291997820139
GS O 1 0.999988317489624
levels O 0 0.0001200848346343264
, O 0 2.450988904456608e-05
but O 0 1.0457608368596993e-05
not O 0 1.0044106602435932e-05
clinical O 0 7.967551937326789e-05
outbreak O 0 0.01926949806511402
of O 0 0.0006558444583788514
the O 1 0.7114837765693665
disease O 1 0.9999912977218628
. O 0 0.00037450558738783
. O 0 0.00046246423153206706

Human O 1 0.9989525079727173
MLH1 O 1 0.9999992847442627
deficiency O 1 0.9999998807907104
predisposes O 1 0.9999072551727295
to O 0 0.014430372044444084
hematological B-Disease 1 0.9999904632568359
malignancy I-Disease 1 0.9999983310699463
and O 0 0.1886940449476242
neurofibromatosis B-Disease 1 0.9999947547912598
type I-Disease 0 0.22558872401714325
1 I-Disease 0 0.0017562254797667265
. O 0 0.0007557648350484669

Heterozygous O 0 0.01306216325610876
germ O 1 0.9876400828361511
- O 0 0.0021663776133209467
line O 0 0.0008946688612923026
mutations O 0 0.00018180737970396876
in O 0 4.706683466793038e-05
the O 0 0.0001583015255164355
DNA O 0 0.0007249856716953218
mismatch O 1 0.9882440567016602
repair O 1 0.8437886834144592
genes O 0 0.00022289188927970827
lead O 0 0.00040832170634530485
to O 0 0.0002841073146555573
hereditary B-Disease 1 0.9999984502792358
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.007594835013151169

The O 0 0.3666194677352905
disease O 1 0.9999755620956421
susceptibility O 0 0.26894646883010864
of O 0 0.0006615634192712605
individuals O 0 0.00010271665087202564
who O 0 0.00019416908617131412
constitutionally O 0 0.000436662434367463
lack O 0 0.00021155772265046835
both O 0 4.499445276451297e-05
wild O 0 0.00019176214118488133
- O 0 0.0002327458350919187
type O 0 0.00021206644305493683
alleles O 0 0.00017500962712801993
is O 0 9.953335393220186e-05
unknown O 0 0.0006314023048616946
. O 0 0.0006251384038478136

We O 0 0.0004069504211656749
have O 0 6.07759939157404e-05
identified O 0 7.932337757665664e-05
three O 0 4.105933112441562e-05
offspring O 0 0.00011687029473250732
in O 0 6.362579733831808e-05
a O 0 0.0006009842036291957
hereditary B-Disease 1 0.9999995231628418
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.1583459973335266
who O 0 0.0007579561206512153
developed O 0 0.026235593482851982
hematological B-Disease 1 0.9999393224716187
malignancy I-Disease 1 0.9999755620956421
at O 0 0.00028967217076569796
a O 0 5.1000159146497026e-05
very O 0 1.936935404955875e-05
early O 0 3.104815914412029e-05
age O 0 2.8301335987634957e-05
, O 0 1.4394566278497223e-05
and O 0 1.2189490917080548e-05
at O 0 2.437730108795222e-05
least O 0 1.2635399798455182e-05
two O 0 1.0789894076879136e-05
of O 0 3.166709211654961e-05
them O 0 3.029403160326183e-05
displayed O 0 0.00020596654212567955
signs O 0 0.0004556069616228342
of O 0 0.0005080525879748166
neurofibromatosis B-Disease 1 0.9999212026596069
type I-Disease 0 0.0034731521736830473
1 I-Disease 0 0.0005815803888253868
( O 0 0.0005217317375354469
NF1 B-Disease 0 0.0726485624909401
) O 0 0.00035235207178629935
. O 0 0.0006208884296938777

DNA O 0 0.0012447128538042307
sequence O 0 0.00029196764808148146
analysis O 0 0.00010421392653370276
and O 0 9.290074376622215e-05
allele O 0 0.00020489512826316059
- O 0 9.462163870921358e-05
specific O 0 4.271976285963319e-05
amplification O 0 0.00017737012240104377
in O 0 4.730771615868434e-05
two O 0 4.4756088755093515e-05
siblings O 0 0.00036156075657345355
revealed O 0 0.00033360556699335575
a O 0 0.00027523841708898544
homozygous O 0 0.0014279070310294628
MLH1 O 1 0.9907219409942627
mutation O 0 0.0005605585174635053
( O 0 0.00036528866621665657
C676T O 0 0.2724105417728424
- O 0 0.0012074634432792664
- O 0 0.0009487334173172712
> O 0 0.0014900435926392674
Arg226Stop O 0 0.08001849800348282
) O 0 0.0004081623919773847
. O 0 0.0007728238706476986

Thus O 0 0.0021958984434604645
, O 0 0.000526443007402122
a O 0 0.0006792301428504288
homozygous O 0 0.003674216102808714
germ O 1 0.9969611763954163
- O 0 0.0026229138020426035
line O 0 0.002566312439739704
MLH1 O 1 0.9979127049446106
mutation O 0 0.0008533151703886688
and O 0 0.00036853287019766867
consequent O 1 0.9998869895935059
mismatch O 1 0.9999998807907104
repair O 1 0.9999998807907104
deficiency O 1 0.9999997615814209
results O 0 0.00025462740450166166
in O 0 0.00010568876314209774
a O 0 0.00032075325725600123
mutator O 1 0.9974898099899292
phenotype O 0 0.007628761697560549
characterized O 0 0.0010609794408082962
by O 0 0.0002552440855652094
leukemia B-Disease 1 0.9999982118606567
and O 0 0.011416111141443253
/ O 1 0.9941893815994263
or O 0 0.2043956220149994
lymphoma B-Disease 1 1.0
associated O 0 0.0003126116353087127
with O 0 0.0001757973659550771
neurofibromatosis B-Disease 1 0.9999964237213135
type I-Disease 0 0.03169511258602142
1 I-Disease 0 0.000392205169191584
. O 0 0.000157245434820652
. O 0 0.0003638583002611995

Missense O 0 0.01069224439561367
mutations O 0 0.0006550932303071022
in O 0 0.00015462649753317237
the O 0 0.00013178976951166987
most O 0 3.8257559936027974e-05
ancient O 0 0.00016879464965313673
residues O 0 0.0001427766983397305
of O 0 0.0001432718854630366
the O 0 0.00028047614614479244
PAX6 O 1 0.9530216455459595
paired O 0 0.00048748060362413526
domain O 0 0.00024979154113680124
underlie O 0 0.0008009893936105072
a O 0 0.0003094400162808597
spectrum O 0 0.0015617195749655366
of O 0 0.45763030648231506
human O 1 0.9999955892562866
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 0.27309685945510864

Mutations O 0 0.0018468553898856044
of O 0 0.0006975709111429751
the O 0 0.0007306603365577757
human O 0 0.0029070982709527016
PAX6 O 1 0.9999775886535645
gene O 0 0.1052483394742012
underlie O 1 0.9999059438705444
aniridia B-Disease 1 0.9999998807907104
( O 1 0.9400197267532349
congenital B-Disease 1 0.9999997615814209
absence I-Disease 0 0.22271345555782318
of I-Disease 0 0.004690596368163824
the I-Disease 0 0.009231316857039928
iris I-Disease 1 0.8325472474098206
) O 0 5.253215567790903e-05
, O 0 3.303911944385618e-05
a O 0 8.870253077475354e-05
rare O 0 0.0003425242321100086
dominant O 0 0.010172710753977299
malformation B-Disease 1 0.9999783039093018
of I-Disease 0 0.0222260020673275
the I-Disease 0 0.4448559880256653
eye I-Disease 1 0.998803973197937
. O 0 0.0010517204646021128

The O 0 0.0012438809499144554
spectrum O 0 0.0014705340145155787
of O 0 0.001390571822412312
PAX6 O 1 0.9999606609344482
mutations O 0 0.001596476649865508
in O 0 0.0005730914417654276
aniridia B-Disease 1 0.9999939203262329
patients O 0 0.0012798034586012363
is O 0 5.7243469200329855e-05
highly O 0 0.00010482947982382029
biased O 0 9.475781553192064e-05
, O 0 2.4208529794123024e-05
with O 0 1.3932418369222432e-05
92 O 0 8.539681584807113e-05
% O 0 1.6759400750743225e-05
of O 0 2.3888445866759866e-05
all O 0 2.2673715648124926e-05
reported O 0 5.471132681122981e-05
mutations O 0 4.762829121318646e-05
leading O 0 9.793770004762337e-05
to O 0 3.960934191127308e-05
premature O 0 0.00021859235130250454
truncation O 0 0.0003786577144637704
of O 0 8.759382762946188e-05
the O 0 8.062100823735818e-05
protein O 0 8.106892346404493e-05
( O 0 5.1604307373054326e-05
nonsense O 0 0.0003338883980177343
, O 0 7.187630399130285e-05
splicing O 0 0.00021223878138698637
, O 0 6.302067777141929e-05
insertions O 0 0.00033992569660767913
and O 0 5.3238098189467564e-05
deletions O 0 0.00012600018817465752
) O 0 2.345846951357089e-05
and O 0 1.927785706357099e-05
just O 0 2.8981165087316185e-05
2 O 0 2.8538208425743505e-05
% O 0 1.746224552334752e-05
leading O 0 5.058747046859935e-05
to O 0 9.63893580774311e-06
substitution O 0 3.910606756107882e-05
of O 0 1.964838338608388e-05
one O 0 1.4816197108302731e-05
amino O 0 2.9742575861746445e-05
acid O 0 4.529978832579218e-05
by O 0 2.1340249077184126e-05
another O 0 7.885901140980422e-05
( O 0 9.654634050093591e-05
missense O 0 0.0007752152159810066
) O 0 0.00018423337314743549
. O 0 0.0003949214587919414

The O 0 0.0013647556770592928
extraordinary O 0 0.001197936711832881
conservation O 0 0.0005567282205447555
of O 0 0.0002952373761218041
the O 0 0.0002905135042965412
PAX6 O 0 0.21628440916538239
protein O 0 0.00015866571629885584
at O 0 0.00013699298142455518
the O 0 7.705067400820553e-05
amino O 0 0.00012757317745126784
acid O 0 0.0002902172855101526
level O 0 0.00015059253200888634
amongst O 0 0.00026211008662357926
vertebrates O 0 0.000556828745175153
predicts O 0 0.00031922516063787043
that O 0 5.133116792421788e-05
pathological O 0 0.0013078779447823763
missense O 0 0.0010808170773088932
mutations O 0 6.975692667765543e-05
should O 0 1.8831080524250865e-05
in O 0 1.5426938261953183e-05
fact O 0 3.149807162117213e-05
be O 0 1.4008171092427801e-05
common O 0 2.1386131265899166e-05
even O 0 1.7109874534071423e-05
though O 0 2.0663228497141972e-05
they O 0 1.0718125849962234e-05
are O 0 7.121448561520083e-06
hardly O 0 0.00011619490396697074
ever O 0 0.00017214458785019815
seen O 0 0.0002597014245111495
in O 0 0.0003548283129930496
aniridia B-Disease 1 0.999975323677063
patients O 0 0.025333736091852188
. O 0 0.0011265428038313985

This O 0 0.0004919070634059608
indicates O 0 0.00047314749099314213
that O 0 3.660116271930747e-05
there O 0 4.042347791255452e-05
is O 0 3.130616823909804e-05
a O 0 7.939595525385812e-05
heavy O 0 0.0007550680893473327
ascertainment O 0 0.15296120941638947
bias O 0 0.00017526044393889606
in O 0 3.0366023565875366e-05
the O 0 4.284905662643723e-05
selection O 0 5.387774217524566e-05
of O 0 0.00010530388681218028
patients O 0 0.00016267325554508716
for O 0 6.261112866923213e-05
PAX6 O 1 0.998531699180603
mutation O 0 8.932046330301091e-05
analysis O 0 2.531767495383974e-05
and O 0 2.2688054741593078e-05
that O 0 2.5336077669635415e-05
the O 0 0.00013383704936131835
missing O 0 0.0013123088283464313
PAX6 O 1 0.9987637996673584
missense O 0 0.00828905776143074
mutations O 0 0.0005785558605566621
frequently O 0 0.0002582564775366336
may O 0 0.0002763670345302671
underlie O 0 0.0025462235789746046
phenotypes O 0 0.0009076179121620953
distinct O 0 0.0002563202870078385
from O 0 0.0005790739087387919
textbook O 0 0.20682792365550995
aniridia B-Disease 1 0.9997898936271667
. O 0 0.0014545157318934798

Here O 0 0.0010654685320332646
we O 0 0.0002001082757487893
present O 0 0.00013251030759420246
four O 0 0.0001793129340512678
novel O 0 0.0009514921111986041
PAX6 O 1 0.9612491726875305
missense O 0 0.002053086180239916
mutations O 0 0.00019173618056811392
, O 0 6.663889507763088e-05
two O 0 2.5130620997515507e-05
in O 0 4.957180135534145e-05
association O 0 0.00017527597083244473
with O 0 0.00011530529445735738
atypical O 1 0.9976180195808411
phenotypes O 1 0.9755354523658752
ectopia B-Disease 1 0.9999610185623169
pupillae I-Disease 1 0.9997778534889221
( O 0 0.0003558541357051581
displaced B-Disease 0 0.0011125130113214254
pupils I-Disease 0 0.0006402910221368074
) O 0 0.0001977451756829396
and O 0 0.0005762057844549417
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9998977184295654
( O 0 0.0004360589082352817
searching B-Disease 0 0.0005940850242041051
gaze I-Disease 0 0.0015185803640633821
) O 0 4.316308331908658e-05
, O 0 2.6606194296618924e-05
and O 0 1.3631176443595905e-05
two O 0 1.3371699424169492e-05
in O 0 3.678413122543134e-05
association O 0 0.00010607515287119895
with O 0 5.262090780888684e-05
more O 0 0.00017186725744977593
recognizable O 0 0.24654248356819153
aniridia B-Disease 1 0.999962329864502
phenotypes O 0 0.045916203409433365
. O 0 0.0013024420477449894

Strikingly O 0 0.003607234451919794
, O 0 0.0003136930172331631
all O 0 7.455218292307109e-05
four O 0 8.125574822770432e-05
mutations O 0 6.855931133031845e-05
are O 0 1.2997617886867374e-05
located O 0 9.372551721753553e-05
within O 0 9.098961891140789e-05
the O 0 0.0002293710713274777
PAX6 O 0 0.49470311403274536
paired O 0 0.00022602907847613096
domain O 0 7.686903700232506e-05
and O 0 4.9966103688348085e-05
affect O 0 5.3765750635648146e-05
amino O 0 5.2916439017280936e-05
acids O 0 3.080114402109757e-05
which O 0 1.519059242127696e-05
are O 0 4.031493517686613e-06
highly O 0 2.1403247956186533e-05
conserved O 0 4.80682538182009e-05
in O 0 1.7632817616686225e-05
all O 0 1.6861393305589445e-05
known O 0 7.775326957926154e-05
paired O 0 0.0002445046848151833
domain O 0 0.0002510129997972399
proteins O 0 0.00032331005786545575
. O 0 0.0004038484476041049

Our O 0 0.0009718265500850976
results O 0 0.00022831065871287137
support O 0 9.725618292577565e-05
the O 0 7.36862129997462e-05
hypothesis O 0 8.621472079539672e-05
that O 0 1.5152741980273277e-05
the O 0 3.1547002436127514e-05
under O 0 3.757777449209243e-05
- O 0 5.783970482298173e-05
representation O 0 2.979879172926303e-05
of O 0 7.659252150915563e-05
missense O 0 0.0005781997460871935
mutations O 0 9.844463056651875e-05
is O 0 5.140450593899004e-05
caused O 0 0.00044265284668654203
by O 0 5.866304854862392e-05
ascertainment O 1 0.6383554935455322
bias O 0 0.00028305526939220726
and O 0 3.858018681057729e-05
suggest O 0 3.901916352333501e-05
that O 0 1.1521683518367354e-05
a O 0 3.0835377401672304e-05
substantial O 0 0.00010587992437649518
burden O 0 0.00048152211820706725
of O 0 0.001818114542402327
PAX6 B-Disease 1 0.9999986886978149
- I-Disease 1 0.6028488278388977
related I-Disease 0 0.01906474307179451
disease I-Disease 1 0.9993330836296082
remains O 0 0.00044851587153971195
to O 0 4.233501022099517e-05
be O 0 4.689323031925596e-05
uncovered O 0 0.0008232946856878698
. O 0 0.00011512225319165736
. O 0 0.00036808240110985935

The O 0 0.0011051006149500608
chromosomal O 0 0.0016450375551357865
order O 0 0.00017635861877352
of O 0 0.00019379620789550245
genes O 0 9.944892372004688e-05
controlling O 0 0.00020213348034303635
the O 0 0.00014069997996557504
major O 0 0.001982583897188306
histocompatibility O 1 0.9999054670333862
complex O 0 0.0008884912822395563
, O 0 0.00012944739137310535
properdin O 1 0.541634202003479
factor O 0 0.0004910281859338284
B O 0 0.0004083045932929963
, O 0 5.4454096243716776e-05
and O 0 7.000636105658486e-05
deficiency B-Disease 1 0.9256399273872375
of I-Disease 0 8.238804002758116e-05
the I-Disease 0 0.00016049161786213517
second I-Disease 0 0.00040485913632437587
component I-Disease 0 0.0008216257556341588
of I-Disease 0 0.00031756600947119296
complement I-Disease 0 0.0012782526900991797
. O 0 0.0008050557225942612

The O 0 0.000880601117387414
relationship O 0 0.0004300791770219803
of O 0 0.00015394944057334214
the O 0 0.00012263258395250887
genes O 0 0.00010855052823899314
coding O 0 0.00020611075160559267
for O 0 6.209500861587003e-05
HLA O 0 0.0026001501828432083
to O 0 3.9535942050861195e-05
those O 0 2.130602479155641e-05
coding O 0 0.00013411582040134817
for O 0 6.413886148948222e-05
properdin O 0 0.040290143340826035
Factor O 0 0.0007245094748213887
B O 0 0.0008720296900719404
allotypes O 0 0.0123562877997756
and O 0 5.989209603285417e-05
for O 0 5.510982373380102e-05
deficiency B-Disease 1 0.8732833862304688
of I-Disease 0 6.928252696525306e-05
the I-Disease 0 8.041554247029126e-05
second I-Disease 0 0.00017967866733670235
component I-Disease 0 0.0001484594540670514
of I-Disease 0 8.374274329980835e-05
complement I-Disease 0 0.0001905602402985096
( O 0 0.00010698748519644141
C2 O 0 0.00574035570025444
) O 0 3.6932953662471846e-05
was O 0 0.00010082872904604301
studied O 0 4.980312587576918e-05
in O 0 4.049829294672236e-05
families O 0 7.465433009201661e-05
of O 0 0.0002956294338218868
patients O 1 0.8768660426139832
with O 1 0.9842051863670349
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 0.060672577470541

Patients O 0 0.0033289866987615824
were O 0 0.00023872099700383842
selected O 0 0.00019430503016337752
because O 0 6.224833487067372e-05
they O 0 3.5065797419520095e-05
were O 0 8.794267341727391e-05
heterozygous O 0 0.0002874303318094462
or O 0 0.00017872282478492707
homozygous O 0 0.0015960931777954102
for O 0 0.002115344163030386
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
. O 0 0.0023209787905216217

12 O 0 0.0012439099373295903
families O 0 0.00025294191436842084
with O 0 8.556333341402933e-05
15 O 0 0.00026069674640893936
matings O 0 0.0021472261287271976
informative O 0 0.001225277897901833
for O 0 0.0017045431304723024
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
were O 0 0.0005336928297765553
found O 0 0.000643588718958199
. O 0 0.0007364358752965927

Of O 0 0.0017005022382363677
57 O 0 0.001578193623572588
informative O 0 0.0009854916715994477
meioses O 0 0.005199248902499676
, O 0 0.00012021863221889362
two O 0 4.2436382500454783e-05
crossovers O 0 0.00019562621309887618
were O 0 4.275402898201719e-05
noted O 0 6.4088475483004e-05
between O 0 0.00013280441635288298
the O 0 0.0014962429413571954
C2 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999997615814209
gene O 0 0.00021951906091999263
and O 0 5.744464942836203e-05
the O 0 0.00017976245726458728
HLA O 1 0.9997925162315369
- O 0 0.0004154898051638156
B O 0 0.0002789607970044017
gene O 0 3.596006354200654e-05
, O 0 9.683325515652541e-06
with O 0 1.1006399290636182e-05
a O 0 5.3036375902593136e-05
recombinant O 0 0.00021441270655486733
fraction O 0 0.00015536190767306834
of O 0 0.00014878541696816683
0 O 0 0.00024157689767889678
. O 0 0.00041541020618751645

035 O 1 0.8965181112289429
. O 0 0.012731941416859627

A O 0 0.0022112661972641945
lod O 0 0.0036146959755569696
score O 0 0.00026010238798335195
of O 0 0.0001509625872131437
13 O 0 0.00019823391630779952
was O 0 0.0002096051030093804
calculated O 0 7.485978858312592e-05
for O 0 4.628042006515898e-05
linkage O 0 0.001002984819933772
between O 0 0.003590373322367668
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
and O 0 0.026759250089526176
HLA O 1 0.9999815225601196
- O 0 0.0005509371403604746
B O 0 0.00020926962315570563
at O 0 7.867445674492046e-05
a O 0 3.5086774005321786e-05
maximum O 0 3.46027227351442e-05
likelihood O 0 2.4246421162388287e-05
value O 0 1.1278069905529264e-05
of O 0 2.8138758352724835e-05
the O 0 4.7994457418099046e-05
recombinant O 0 0.00028127574478276074
fraction O 0 0.0001916338223963976
of O 0 0.00018608002574183047
0 O 0 0.000429707724833861
. O 0 0.00043071777326986194

04 O 0 0.3209671378135681
. O 0 0.015291095711290836

18 O 0 0.0011517198290675879
families O 0 0.0002606997441034764
with O 0 9.134658466791734e-05
21 O 0 0.00021170362015254796
informative O 0 0.00027200262411497533
matings O 0 0.0004433954891283065
for O 0 4.441792407305911e-05
both O 0 5.923248318140395e-05
properdin O 0 0.024684708565473557
Factor O 0 0.0006265819538384676
B O 0 0.0012021266156807542
allotype O 0 0.32231447100639343
and O 0 0.00022275419905781746
HLA O 1 0.9993013143539429
- O 0 0.0005470302421599627
B O 0 0.000625456974375993
were O 0 0.00014566075697075576
found O 0 0.0003049965889658779
. O 0 0.000510243815369904

Of O 0 0.0015367856249213219
72 O 0 0.0015480909496545792
informative O 0 0.0010257972171530128
meioses O 0 0.005716782063245773
, O 0 9.490077354712412e-05
three O 0 5.553079608944245e-05
recombinants O 0 0.0017825134564191103
were O 0 3.1910400139167905e-05
found O 0 2.445826612529345e-05
, O 0 2.8186352210468613e-05
giving O 0 3.238079807488248e-05
a O 0 7.830067625036463e-05
recombinant O 0 0.00022403411276172847
fraction O 0 0.00024260194913949817
of O 0 0.00018258982163388282
0 O 0 0.00042091275099664927
. O 0 0.0005810110596939921

042 O 1 0.9717056751251221
. O 0 0.009993179701268673

A O 0 0.002045666566118598
lod O 0 0.004495568573474884
score O 0 0.00033322128001600504
of O 0 0.0002416575007373467
16 O 0 0.0002221870090579614
between O 0 0.00030575584969483316
HLA O 1 0.9985370635986328
- O 0 0.0003804303705692291
B O 0 0.000338246813043952
and O 0 4.427460953593254e-05
Factor O 0 0.0002069480688078329
B O 0 0.0004440608317963779
allotypes O 0 0.0018191870767623186
was O 0 0.00018671737052500248
calculated O 0 5.527376924874261e-05
at O 0 3.898289651260711e-05
a O 0 4.3525378714548424e-05
maximum O 0 4.565166454995051e-05
likelihood O 0 4.991428795619868e-05
value O 0 1.941014670592267e-05
of O 0 2.6837733457796276e-05
the O 0 4.594691199599765e-05
recombinant O 0 0.00022017621085979044
fraction O 0 0.00012521972530521452
of O 0 0.00016286804748233408
0 O 0 0.0003107864467892796
. O 0 0.0003949867677874863

04 O 0 0.3876590430736542
. O 0 0.014777054078876972

A O 0 0.002509335521608591
crossover O 0 0.0018219244666397572
was O 0 0.00043215867481194437
shown O 0 8.202007302315906e-05
to O 0 2.1500974980881438e-05
have O 0 1.6764197425800376e-05
occurred O 0 8.123399311443791e-05
between O 0 4.162975892540999e-05
genes O 0 3.138936517643742e-05
for O 0 2.521317765058484e-05
Factor O 0 0.00024018534168135375
B O 0 0.00024692120496183634
and O 0 0.00010512107110116631
HLA O 1 0.8779648542404175
- O 0 0.00028427367215044796
D O 0 0.00037404175964184105
, O 0 3.411413126741536e-05
in O 0 3.248409848310985e-05
which O 0 7.335207919823006e-05
HLA O 1 0.8319524526596069
- O 0 0.0005267029628157616
D O 0 0.0014415947953239083
segregared O 0 0.007711233105510473
with O 0 0.00023360733757726848
HLA O 1 0.9996034502983093
- O 0 0.0007300658617168665
A O 0 0.000682599435094744
and O 0 0.0003396632964722812
B O 0 0.0019358587451279163
. O 0 0.0005769174313172698

These O 0 0.0003229977155569941
studies O 0 0.00012773530033882707
suggest O 0 7.820784958312288e-05
that O 0 2.19490520976251e-05
the O 0 3.0766914278501645e-05
genes O 0 3.876843038597144e-05
for O 0 4.017839819425717e-05
Factor O 0 0.0003627423429861665
B O 0 0.004220675211399794
and O 0 0.0007693007355555892
C2 B-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.9999961853027344
are O 0 2.0272464098525234e-05
located O 0 6.168893742142245e-05
outside O 0 5.551713547902182e-05
those O 0 1.652218634262681e-05
for O 0 2.7562069590203464e-05
HLA O 0 0.31866320967674255
, O 0 2.780017712211702e-05
that O 0 8.265980795840733e-06
the O 0 1.8492892195354216e-05
order O 0 1.9570254153222777e-05
of O 0 5.7384531828574836e-05
genese O 0 0.05330285429954529
is O 0 0.00011277673183940351
HLA O 0 0.39905866980552673
- O 0 9.360680996906012e-05
A O 0 9.723382390802726e-05
, O 0 3.0126931960694492e-05
- O 0 7.1155525802169e-05
B O 0 9.44419953157194e-05
, O 0 2.9733562769251876e-05
- O 0 8.728090324439108e-05
D O 0 0.00028396997367963195
, O 0 4.299128340790048e-05
Factor O 0 0.00030806419090367854
B O 0 0.0013604179257526994
allotype O 1 0.9986732006072998
, O 0 0.010415826924145222
C2 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999994039535522
, O 0 0.00010216142982244492
that O 0 3.218711572117172e-05
the O 0 5.990431600366719e-05
genes O 0 9.492114622844383e-05
coding O 0 0.0003233390743844211
for O 0 0.0003065877826884389
C2 B-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999996423721313
and O 0 0.0003498025762382895
Factor O 0 0.0009232615702785552
B O 0 0.0003604363591875881
allotypes O 0 0.00043899010051973164
are O 0 6.9048746809130535e-06
approximately O 0 1.9853992853313684e-05
3 O 0 3.289340384071693e-05
- O 0 5.187108035897836e-05
- O 0 4.6804500016150996e-05
5 O 0 5.1835275371558964e-05
centimorgans O 0 0.0002942504361271858
from O 0 2.9094648198224604e-05
the O 0 6.740699609508738e-05
HLA O 1 0.6255610585212708
- O 0 0.00012525412603281438
A O 0 0.00019244076975155622
and O 0 0.00016896887973416597
HLA O 1 0.9992893934249878
- O 0 0.00044216724927537143
B O 0 0.00039974224637262523
loci O 0 0.00016055208106990904
, O 0 2.2282447389443405e-05
and O 0 1.4015814485901501e-05
that O 0 1.1356361028447282e-05
the O 0 3.516330980346538e-05
apparent O 0 0.0002284023503307253
lack O 0 0.00010343170288251713
of O 0 0.00011679821909638122
recombinants O 0 0.14818768203258514
between O 0 6.600277993129566e-05
the O 0 0.0001086311021936126
Factor O 0 0.0004320645530242473
B O 0 0.000978174270130694
gene O 0 0.00021481132716871798
and O 0 0.00080638169310987
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
gene O 0 0.0002773360174614936
suggests O 0 7.042504876153544e-05
that O 0 1.1236009413551074e-05
these O 0 5.17752232553903e-06
two O 0 9.356672308058478e-06
genes O 0 2.4190043404814787e-05
lie O 0 8.289238758152351e-05
in O 0 2.5636460122768767e-05
close O 0 9.920777665684e-05
proximity O 0 0.00013775362458545715
to O 0 4.8624726332491264e-05
one O 0 0.00010160861711483449
another O 0 0.0003663334355223924
. O 0 0.0004142274265177548

Distribution O 0 0.0010275777895003557
of O 0 0.0009453500970266759
emerin O 1 0.8848347067832947
and O 0 0.00036555793485604227
lamins O 0 0.08163923025131226
in O 0 0.00013721482537221164
the O 0 0.0002592576202005148
heart O 1 0.9697574973106384
and O 0 0.0001448451221222058
implications O 0 0.0007760599837638438
for O 0 0.0003556468873284757
Emery B-Disease 1 0.998536229133606
- I-Disease 1 0.9996696710586548
Dreifuss I-Disease 1 0.999998927116394
muscular I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999997615814209
. O 0 0.018720224499702454

Emerin O 0 0.15569385886192322
is O 0 0.0005508544272743165
a O 0 0.00034293869975954294
nuclear O 0 0.0006526021752506495
membrane O 0 0.0003302402619738132
protein O 0 8.616629929747432e-05
which O 0 2.3897879145806655e-05
is O 0 2.5936964448192157e-05
missing O 0 0.00013900849444326013
or O 0 9.455310646444559e-05
defective O 0 0.006132710259407759
in O 0 0.0002529124612919986
Emery B-Disease 1 0.9450023174285889
- I-Disease 1 0.9982866644859314
Dreifuss I-Disease 1 0.9999992847442627
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9995367527008057
EDMD B-Disease 1 0.9999997615814209
) O 0 0.0014090333133935928
. O 0 0.0009662906522862613

It O 0 0.00030777297797612846
is O 0 0.00010258039401378483
one O 0 4.9835573008749634e-05
member O 0 5.228815643931739e-05
of O 0 6.442966696340591e-05
a O 0 0.00010453460708959028
family O 0 0.00017446829588152468
of O 0 0.0005343912052921951
lamina O 1 0.9997156262397766
- O 0 0.0008761882781982422
associated O 0 9.2488837253768e-05
proteins O 0 4.693300070357509e-05
which O 0 4.250389611115679e-05
includes O 0 0.00010658578685251996
LAP1 O 1 0.980160653591156
, O 0 0.0002823251415975392
LAP2 O 1 0.8862411975860596
and O 0 0.0002259769244119525
lamin O 0 0.008392207324504852
B O 0 0.002651748713105917
receptor O 0 0.0008810120052658021
( O 0 0.00045290973503142595
LBR O 1 0.9521166086196899
) O 0 0.0005672627012245357
. O 0 0.0006109229288995266

A O 0 0.0022847389336675406
panel O 0 0.0005869108717888594
of O 0 0.00034177041379734874
16 O 0 0.0005459696403704584
monoclonal O 0 0.002145659178495407
antibodies O 0 0.0006042596651241183
( O 0 0.0002269926917506382
mAbs O 0 0.0014797693584114313
) O 0 6.65926345391199e-05
has O 0 3.220130020054057e-05
been O 0 2.7121313905809075e-05
mapped O 0 5.6497930927434936e-05
to O 0 1.2254470675543416e-05
six O 0 2.4911125365179032e-05
specific O 0 1.1521935448399745e-05
sites O 0 2.564042188168969e-05
throughout O 0 4.028682451462373e-05
the O 0 6.441277946578339e-05
emerin O 0 0.0016132870223373175
molecule O 0 0.00010414298594696447
using O 0 3.500585808069445e-05
phage O 0 0.0005738528561778367
- O 0 9.057632996700704e-05
displayed O 0 0.00012540565512608737
peptide O 0 0.00013398223381955177
libraries O 0 3.833750088233501e-05
and O 0 2.0605590179911815e-05
has O 0 1.4088516763877124e-05
been O 0 2.244168717879802e-05
used O 0 2.3531692932010628e-05
to O 0 3.626128091127612e-05
localize O 0 0.0008040545508265495
emerin O 0 0.01726943999528885
in O 0 0.00013687899627257138
human O 0 0.00021595763973891735
and O 0 0.00029588432516902685
rabbit O 1 0.9015874862670898
heart O 1 0.999177873134613
. O 0 0.0010702991858124733

Several O 0 0.0019160164520144463
mAbs O 0 0.0066271754913032055
against O 0 0.0005206457572057843
different O 0 0.00019682156562339514
emerin O 0 0.17035920917987823
epitopes O 0 0.0014233256224542856
did O 0 0.00014378936612047255
not O 0 3.6006287700729445e-05
recognize O 0 0.0001385450887028128
intercalated O 0 0.0017099734395742416
discs O 0 0.0003682796668726951
in O 0 7.18147202860564e-05
the O 0 0.00017957418458536267
heart O 1 0.7792895436286926
, O 0 5.748673720518127e-05
though O 0 2.2320771677186713e-05
they O 0 1.1151802027598023e-05
recognized O 0 7.401593757094815e-05
cardiomyocyte O 0 0.011195224709808826
nuclei O 0 0.00035907691926695406
strongly O 0 7.562739483546466e-05
, O 0 2.675095856830012e-05
both O 0 1.7189999198308215e-05
at O 0 7.829515379853547e-05
the O 0 8.511113264830783e-05
rim O 0 0.0004998165532015264
and O 0 6.83078687870875e-05
in O 0 0.00013495648454409093
intranuclear O 0 0.0935661569237709
spots O 0 0.0005893994821235538
or O 0 0.0001795022835722193
channels O 0 0.00028553997981362045
. O 0 0.00035738927545025945

A O 0 0.012467187829315662
polyclonal O 0 0.03236233815550804
rabbit O 0 0.00866683293133974
antiserum O 0 0.0096100689843297
against O 0 0.0007484144298359752
emerin O 1 0.6314182281494141
did O 0 0.00016425592184532434
recognize O 0 0.00012654370220843703
both O 0 5.728993346565403e-05
nuclear O 0 0.0006321510882116854
membrane O 0 0.0003684588009491563
and O 0 8.593416714575142e-05
intercalated O 0 0.002653480740264058
discs O 0 0.0003923831391148269
but O 0 4.389381501823664e-05
, O 0 4.348285074229352e-05
after O 0 0.00010457578173372895
affinity O 0 0.0001422505301889032
purification O 0 0.0012050517834722996
against O 0 0.0001395953440805897
a O 0 0.00019046544912271202
pure O 0 0.0012510950909927487
- O 0 0.0005186632624827325
emerin O 0 0.002048090798780322
band O 0 0.00014663794718217105
on O 0 2.8861355531262234e-05
a O 0 5.373458407120779e-05
western O 0 0.00011650700616883114
blot O 0 0.0007940279901959002
, O 0 6.447835039580241e-05
it O 0 3.768198439502157e-05
stained O 0 0.001428493415005505
only O 0 5.2897063142154366e-05
the O 0 0.0002127292682416737
nuclear O 0 0.0013178655644878745
membrane O 0 0.0012181340716779232
. O 0 0.0004729116626549512

These O 0 0.00024119023873936385
results O 0 9.240720828529447e-05
would O 0 2.5250568796764128e-05
not O 0 1.2722263818432111e-05
be O 0 1.3250077245174907e-05
expected O 0 4.107362110516988e-05
if O 0 3.351052509970032e-05
immunostaining O 0 0.0024512293748557568
at O 0 0.00024704341194592416
intercalated O 0 0.002696475014090538
discs O 0 0.00024330892483703792
were O 0 3.490678500384092e-05
due O 0 3.7739522667834535e-05
to O 0 1.0471440873516258e-05
a O 0 2.6522342523094267e-05
product O 0 4.681307473219931e-05
of O 0 4.2357300117146224e-05
the O 0 0.00010178491356782615
emerin O 1 0.7467877864837646
gene O 0 6.624239904340357e-05
and O 0 2.4381972252740525e-05
, O 0 2.4540107915527187e-05
therefore O 0 2.053536445600912e-05
, O 0 1.81394334504148e-05
cast O 0 3.7224952393444255e-05
some O 0 2.0534716895781457e-05
doubt O 0 7.650288171134889e-05
upon O 0 7.271912909345701e-05
the O 0 0.00011588441702770069
hypothesis O 0 0.0005704151699319482
that O 0 0.00031148322159424424
cardiac B-Disease 1 0.9999983310699463
defects I-Disease 1 0.9999939203262329
in O 0 0.03828595578670502
EDMD B-Disease 1 0.9999994039535522
are O 0 6.068559378036298e-05
caused O 0 0.0013019645120948553
by O 0 6.723654951201752e-05
absence O 0 0.00032326506334356964
of O 0 0.0004089963040314615
emerin O 1 0.9870296716690063
from O 0 0.0008524549193680286
intercalated O 1 0.8354928493499756
discs O 0 0.003811649978160858
. O 0 0.0008137580589391291

Although O 0 0.0020066318102180958
emerin O 0 0.04937177523970604
was O 0 0.0009152325219474733
abundant O 0 0.0003628303820732981
in O 0 6.753979687346146e-05
the O 0 7.627051672898233e-05
membranes O 0 0.00033601626637391746
of O 0 0.00023341098858509213
cardiomyocyte O 1 0.9982702732086182
nuclei O 0 0.000873416371177882
, O 0 5.0070564611814916e-05
it O 0 1.7349866539007053e-05
was O 0 0.00011485207505756989
absent O 0 9.432526712771505e-05
from O 0 2.7183723432244733e-05
many O 0 2.553585909481626e-05
non O 0 0.000147591985296458
- O 0 0.0003987671516370028
myocyte O 1 0.9838341474533081
cells O 0 0.000157649876200594
in O 0 8.38176129036583e-05
the O 0 0.00041140386019833386
heart O 1 0.8838916420936584
. O 0 0.000780864036642015

This O 0 0.0003938676090911031
distribution O 0 0.00017718148592393845
of O 0 0.00021485780598595738
emerin O 0 0.2950783371925354
was O 0 0.00027266418328508735
similar O 0 3.0975224944995716e-05
to O 0 1.2279657312319614e-05
that O 0 1.3157062312529888e-05
of O 0 5.5467502534156665e-05
lamin O 0 0.0006437070551328361
A O 0 0.00016184149717446417
, O 0 3.935887070838362e-05
a O 0 5.941028939560056e-05
candidate O 0 8.018275548238307e-05
gene O 0 6.408266199287027e-05
for O 0 3.171445132466033e-05
an O 0 6.51496957289055e-05
autosomal O 0 0.0005572033114731312
form O 0 0.0004339987353887409
of O 0 0.2650115489959717
EDMD B-Disease 1 0.9999995231628418
. O 0 0.0021375450305640697

In O 0 0.0010991875315085053
contrast O 0 0.0010448830435052514
, O 0 0.0004761589807458222
lamin O 0 0.3322093188762665
B1 O 1 0.9944275617599487
was O 0 0.0011759927729144692
absent O 0 0.0007811695104464889
from O 0 0.000292803073534742
cardiomyocyte O 0 0.4035486578941345
nuclei O 0 0.0009508834918960929
, O 0 0.0001340988092124462
showing O 0 0.0003212123119737953
that O 0 0.00010135392221855
lamin O 0 0.10054042935371399
B1 O 1 0.8259142637252808
is O 0 5.075175431557e-05
not O 0 1.6426663933089003e-05
essential O 0 6.951057002879679e-05
for O 0 3.222606028430164e-05
localization O 0 0.00030467601027339697
of O 0 0.00016893989231903106
emerin O 0 0.00289375358261168
to O 0 0.00010254187509417534
the O 0 0.000300761399557814
nuclear O 0 0.0033917620312422514
lamina O 1 0.6712871789932251
. O 0 0.0012034933315590024

Lamin O 1 0.9964279532432556
B1 O 1 0.9985637068748474
is O 0 0.0005241560284048319
also O 0 0.00022267841268330812
almost O 0 0.0002447988372296095
completely O 0 0.0007499097846448421
absent O 0 0.0026427244301885366
from O 0 0.0016389646334573627
skeletal O 1 0.9999933242797852
muscle O 1 0.9999632835388184
nuclei O 1 0.9130439758300781
. O 0 0.001816523727029562

In O 0 0.0018567760707810521
EDMD B-Disease 1 0.9995768666267395
, O 0 0.0002611203526612371
the O 0 0.00014425793779082596
additional O 0 9.375143417855725e-05
absence O 0 0.0003296595823485404
of O 0 0.0004168195591773838
lamin O 1 0.9986918568611145
B1 O 1 0.9999792575836182
from O 0 0.007799701765179634
heart O 1 0.9999873638153076
and O 0 0.09678469598293304
skeletal O 1 0.9999995231628418
muscle O 1 0.9999872446060181
nuclei O 1 0.75114506483078
which O 0 0.00014029082376509905
already O 0 0.00016833400877658278
lack O 0 0.00037216657074168324
emerin O 0 0.253768652677536
may O 0 5.229633461567573e-05
offer O 0 2.009392119362019e-05
an O 0 2.327190486539621e-05
alternative O 0 3.867803025059402e-05
explanation O 0 6.055090489098802e-05
of O 0 6.153601134428754e-05
why O 0 0.00013016854063607752
these O 0 4.6695986384293064e-05
tissues O 0 0.0004978577489964664
are O 0 3.265496343374252e-05
particularly O 0 0.00018538195581641048
affected O 0 0.00022306748724076897
. O 0 0.00017527397722005844
. O 0 0.0004039847699459642

Genetic O 0 0.0018705833936110139
mapping O 0 0.0011664095800369978
of O 0 0.0007321100565604866
the O 0 0.0010454854927957058
copper B-Disease 1 0.999101996421814
toxicosis I-Disease 1 0.9994176626205444
locus O 0 0.002031274139881134
in O 0 0.00018220269703306258
Bedlington O 0 0.019037198275327682
terriers O 0 0.0011480520479381084
to O 0 7.381955947494134e-05
dog O 0 0.0004470762796700001
chromosome O 0 0.00015253093442879617
10 O 0 3.649597056210041e-05
, O 0 1.9853141566272825e-05
in O 0 1.9912624338758178e-05
a O 0 5.638393486151472e-05
region O 0 0.00014044101408217102
syntenic O 0 0.0036246376112103462
to O 0 7.725138129899278e-05
human O 0 0.00018880087009165436
chromosome O 0 0.0005139500717632473
region O 0 0.0007386562065221369
2p13 O 1 0.9956545829772949
- O 0 0.003029045881703496
p16 O 0 0.013289108872413635
. O 0 0.0009584876825101674

Abnormal O 1 0.999962568283081
hepatic B-Disease 1 0.9999972581863403
copper I-Disease 1 0.9999499320983887
accumulation I-Disease 1 0.9451887607574463
is O 0 0.00017935106006916612
recognized O 0 0.00012790143955498934
as O 0 0.0001025599631248042
an O 0 0.0005408978904597461
inherited B-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
in O 0 0.00790548138320446
man O 1 0.821948766708374
, O 0 0.00029645071481354535
mouse O 0 0.0007449832046404481
, O 0 0.00016503443475812674
rat O 0 0.002944421721622348
and O 0 0.0002806454722303897
dog O 0 0.002509215148165822
. O 0 0.0006148649845272303

The O 0 0.0017775662709027529
major O 0 0.005642839707434177
cause O 1 0.8495349287986755
of O 1 0.7348762154579163
hepatic B-Disease 1 0.9999997615814209
copper I-Disease 1 0.9999967813491821
accumulation I-Disease 1 0.9968331456184387
in O 0 0.00021226954413577914
man O 0 0.0006002422887831926
is O 0 6.180047057569027e-05
a O 0 0.000171630599652417
dysfunctional O 0 0.08218755573034286
ATP7B O 1 0.999875545501709
gene O 0 0.0007978049688972533
, O 0 0.00024153449339792132
causing O 1 0.9948491454124451
Wilson B-Disease 1 0.9997381567955017
disease I-Disease 1 0.999997615814209
( O 0 0.015210546553134918
WD B-Disease 1 0.9990345239639282
) O 0 0.00043245338019914925
. O 0 0.000454484426882118

Mutations O 0 0.0016736326506361365
in O 0 0.00034005206543952227
the O 0 0.0004280800640117377
ATP7B O 1 0.9987697005271912
genes O 0 0.0001268084888579324
have O 0 2.0137931642238982e-05
also O 0 2.3958713427418843e-05
been O 0 3.772340278374031e-05
demonstrated O 0 0.0001864130172180012
in O 0 0.00015475628606509417
mouse O 0 0.0008314172737300396
and O 0 0.0003295301285106689
rat O 0 0.024258313700556755
. O 0 0.0009362694690935314

The O 0 0.003974914085119963
ATP7B O 1 0.9995947480201721
gene O 0 0.00047188252210617065
has O 0 8.961684216046706e-05
been O 0 6.745386781403795e-05
excluded O 0 0.00011508647003211081
in O 0 3.9092159568099305e-05
the O 0 7.706184987910092e-05
much O 0 0.0001848189131123945
rarer O 0 0.008697123266756535
human O 0 0.02644306793808937
copper B-Disease 1 0.9999957084655762
overload I-Disease 1 0.9999977350234985
disease O 1 0.9999644756317139
non B-Disease 0 0.0016006025252863765
- I-Disease 0 0.0006216801120899618
Indian I-Disease 0 0.0006081804749555886
childhood I-Disease 1 0.9579286575317383
cirrhosis I-Disease 1 0.9999977350234985
, O 0 0.0005703801289200783
indicating O 0 0.0019083295483142138
genetic O 0 0.0010879847686737776
heterogeneity O 0 0.004710631910711527
. O 0 0.0007909901323728263

By O 0 0.0012641004286706448
investigating O 0 0.002174673369154334
the O 0 0.0009081425960175693
common O 0 0.0020645828917622566
autosomal O 1 0.9988741278648376
recessive O 1 0.9999817609786987
copper B-Disease 1 0.9999996423721313
toxicosis I-Disease 1 0.9999996423721313
( O 0 0.003208643291145563
CT B-Disease 0 0.09810121357440948
) O 0 6.673338066320866e-05
in O 0 8.656804857309908e-05
Bedlington O 0 0.0564882829785347
terriers O 0 0.0009766502771526575
, O 0 3.579559415811673e-05
we O 0 1.7757491150405258e-05
have O 0 7.4556778599799145e-06
identified O 0 2.1259729692246765e-05
a O 0 3.972631020587869e-05
new O 0 6.56070769764483e-05
locus O 0 0.0003595125745050609
involved O 0 0.00027539278380572796
in O 0 0.0013660416007041931
progressive O 1 0.9999994039535522
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.046387530863285065

We O 0 0.0009074251283891499
examined O 0 0.0006797106470912695
whether O 0 0.0002031277253990993
the O 0 0.0004167465085629374
WD B-Disease 1 0.957932710647583
gene O 0 0.0008802077500149608
ATP7B O 1 0.9977732300758362
was O 0 0.0006812263163737953
also O 0 0.00015488118515349925
causative O 0 0.0008373141172342002
for O 0 7.94655570643954e-05
CT B-Disease 0 0.0010153072653338313
by O 0 5.863581463927403e-05
investigating O 0 0.00019131872977595776
the O 0 0.00028238975210115314
chromosomal O 0 0.007310494314879179
co O 0 0.0009699792135506868
- O 0 0.0005228030495345592
localization O 0 0.0011405195109546185
of O 0 0.0003084830241277814
ATP7B O 1 0.998100221157074
and O 0 0.0001532768364995718
C04107 O 0 0.004318797029554844
, O 0 7.36441943445243e-05
using O 0 3.529621972120367e-05
fluorescence O 0 0.00015130502288229764
in O 0 5.86076348554343e-05
situ O 0 0.000680037250276655
hybridization O 0 0.00028972409199923277
( O 0 0.00020449773001018912
FISH O 0 0.00040917957085184753
) O 0 0.0002329623093828559
. O 0 0.00031618299544788897

C04107 O 0 0.1297256201505661
is O 0 0.0008940421976149082
an O 0 0.0005917450180277228
anonymous O 0 0.0010721678845584393
microsatellite O 0 0.00532739982008934
marker O 0 0.00263440003618598
closely O 0 0.0004204801516607404
linked O 0 0.0008164459723047912
to O 0 0.000482252478832379
CT B-Disease 0 0.051810938864946365
. O 0 0.0012334167258813977

However O 0 0.002620565937831998
, O 0 0.0009928742656484246
BAC O 0 0.4191369414329529
clones O 0 0.004543333314359188
containing O 0 0.0007809026865288615
ATP7B O 1 0.9819021224975586
and O 0 0.0002757587644737214
C04107 O 0 0.0032166449818760157
mapped O 0 0.0002887451264541596
to O 0 4.594248457578942e-05
the O 0 0.0001440838968846947
canine O 0 0.0028018751181662083
chromosome O 0 0.0006399602862074971
regions O 0 0.00029096228536218405
CFA22q11 O 1 0.8907041549682617
and O 0 0.0003065062628593296
CFA10q26 O 1 0.8296219110488892
, O 0 0.00013882781786378473
respectively O 0 0.00018135373829863966
, O 0 8.501671254634857e-05
demonstrating O 0 0.00028445664793252945
that O 0 0.00010805717465700582
WD B-Disease 0 0.06976690143346786
cannot O 0 0.00020025525009259582
be O 0 5.9633188357111067e-05
homologous O 0 0.00047708311467431486
to O 0 0.0003103819617535919
CT B-Disease 0 0.011207235045731068
. O 0 0.0007804087363183498

The O 0 0.00506641436368227
copper O 1 0.8978514075279236
transport O 0 0.005139142740517855
genes O 0 0.0012126760557293892
CTR1 O 1 0.9992738366127014
and O 0 0.0004279101558495313
CTR2 O 1 0.9937009811401367
were O 0 0.0001055291504599154
also O 0 3.9995971746975556e-05
excluded O 0 0.00010138406651094556
as O 0 3.4696568036451936e-05
candidate O 0 4.73983891424723e-05
genes O 0 4.351446477812715e-05
for O 0 4.0841299778549e-05
CT B-Disease 0 0.0010033011203631759
since O 0 5.841168240294792e-05
they O 0 1.0973940334224608e-05
both O 0 1.4470198038907256e-05
mapped O 0 0.00010193527123192325
to O 0 7.777604332659394e-05
canine O 0 0.002754872664809227
chromosome O 0 0.0016067122342064977
region O 0 0.0010460139019414783
CFA11q22 O 1 0.9801511764526367
. O 0 0.0014827873092144728

2 O 0 0.0040107048116624355
- O 0 0.0031929973047226667
22 O 0 0.0022049008402973413
. O 0 0.0020057621877640486

5 O 0 0.010540995746850967
. O 0 0.005236717406660318

A O 0 0.0018137333681806922
transcribed O 0 0.0005519199767149985
sequence O 0 0.0001288166968151927
identified O 0 7.158647349569947e-05
from O 0 3.4496963053243235e-05
the O 0 9.830400813370943e-05
C04107 O 0 0.03640833497047424
- O 0 0.00032918000943027437
containing O 0 0.00021609730902127922
BAC O 0 0.0037632181774824858
was O 0 0.00015074668044690043
found O 0 2.7935024263570085e-05
to O 0 1.4942869711376261e-05
be O 0 1.084522227756679e-05
homologous O 0 5.002675243304111e-05
to O 0 1.3429908904072363e-05
a O 0 2.868844967451878e-05
gene O 0 3.1676394428359345e-05
expressed O 0 3.508754525682889e-05
from O 0 4.5019041863270104e-05
human O 0 0.00014072506746742874
chromosome O 0 0.0006499740993604064
2p13 O 1 0.9593404531478882
- O 0 0.0005843966500833631
p16 O 0 0.0012873808154836297
, O 0 5.8278590586269274e-05
a O 0 7.445392111549154e-05
region O 0 0.00014534722140524536
devoid O 0 0.0005422470276243985
of O 0 0.00010990821465384215
any O 0 0.00010319712600903586
positional O 0 0.0011367991100996733
candidate O 0 0.0005569091881625354
genes O 0 0.0005988585180602968
. O 0 0.0006114979623816907

Molecular O 0 0.00157057901378721
analysis O 0 0.00013580099039245397
of O 0 0.00014937306696083397
the O 0 0.00019883568165823817
APC B-Disease 0 0.008706106804311275
gene O 0 8.627417992101982e-05
in O 0 3.953141640522517e-05
205 O 0 0.00017104165453929454
families O 0 4.444457954377867e-05
: O 0 3.9282822399400175e-05
extended O 0 0.00010531601583352312
genotype O 0 0.00030144117772579193
- O 0 0.0002247268275823444
phenotype O 0 0.00025433555128984153
correlations O 0 0.00017066580767277628
in O 0 9.903848695103079e-05
FAP B-Disease 0 0.0844256654381752
and O 0 6.465925980592147e-05
evidence O 0 5.565623359871097e-05
for O 0 2.271348967042286e-05
the O 0 4.706337858806364e-05
role O 0 0.00011987384641543031
of O 0 0.00016157490608748049
APC B-Disease 0 0.12621821463108063
amino O 0 0.00029599573463201523
acid O 0 0.0008651277748867869
changes O 0 0.00038362081977538764
in O 0 0.1463201493024826
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
predisposition O 1 0.999967098236084
. O 0 0.0035442407242953777

BACKGROUND O 0 0.007612862158566713
/ O 0 0.002519553992897272
AIMS O 0 0.001602871692739427
The O 0 0.0003225299878977239
development O 0 0.0008237329311668873
of O 1 0.9869460463523865
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999980926513672
and O 0 0.0001569691812619567
a O 0 0.00012935313861817122
variable O 0 6.36324766674079e-05
range O 0 4.8736794269643724e-05
of O 0 0.00010015766019932926
extracolonic O 1 0.8659730553627014
manifestations O 0 0.11217925697565079
in O 0 0.0005128236953169107
familial B-Disease 1 0.9999957084655762
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9723789095878601
FAP B-Disease 1 0.9999510049819946
) O 0 4.9004022002918646e-05
is O 0 2.360829785175156e-05
the O 0 3.0360897653736174e-05
result O 0 2.6182024157606065e-05
of O 0 4.0758735849522054e-05
the O 0 9.112559928325936e-05
dominant O 0 0.000464240467408672
inheritance O 0 0.0007715619867667556
of O 0 0.07375767827033997
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999996423721313
( O 0 0.2114512324333191
APC B-Disease 1 0.9995957016944885
) O 0 0.0005265922518447042
gene O 0 0.0006369571201503277
mutations O 0 0.0007408302626572549
. O 0 0.0006439451826736331

In O 0 0.0006099074380472302
this O 0 0.0001424543879693374
study O 0 8.438742224825546e-05
, O 0 4.4724427425535396e-05
direct O 0 4.394671123009175e-05
mutation O 0 4.300297223380767e-05
analysis O 0 1.530802546767518e-05
of O 0 3.7664955016225576e-05
the O 0 9.165038500213996e-05
APC B-Disease 1 0.5218582153320312
gene O 0 0.00013293340452946723
was O 0 0.00012390073970891535
performed O 0 0.00011417920177336782
to O 0 2.1491914594662376e-05
determine O 0 7.100206858012825e-05
genotype O 0 0.0003163690271321684
- O 0 0.00016909425903577358
phenotype O 0 0.00021233125880826265
correlations O 0 0.00010943216329906136
for O 0 3.6297122278483585e-05
nine O 0 0.00017926728469319642
extracolonic O 0 0.402791291475296
manifestations O 0 0.0023611250799149275
and O 0 4.501753574004397e-05
to O 0 1.9774970496655442e-05
investigate O 0 8.470288594253361e-05
the O 0 8.543395233573392e-05
incidence O 0 0.0008540497510693967
of O 0 0.00027697530458681285
APC B-Disease 1 0.9420753121376038
mutations O 0 0.0002006116701522842
in O 0 0.00022911667474545538
non O 0 0.1307479739189148
- O 1 0.9995520710945129
FAP O 1 0.9999997615814209
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999985694885254
. O 0 0.003209936898201704

METHODS O 0 0.002177126007154584
The O 0 0.001378920627757907
APC B-Disease 1 0.7115721106529236
gene O 0 0.0005780914798378944
was O 0 0.0004678900877479464
analysed O 0 0.0003823289298452437
in O 0 0.00010317469423171133
190 O 0 0.00037373165832832456
unrelated O 0 0.0005434539052657783
FAP B-Disease 0 0.011294791474938393
and O 0 0.00016861768381204456
15 O 0 0.0003125059010926634
non O 0 0.02303873561322689
- O 1 0.9982251524925232
FAP O 1 0.9999997615814209
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
patients O 0 0.003938894718885422
using O 0 0.00020255254639778286
denaturing O 0 0.04504958912730217
gradient O 0 0.006695603486150503
gel O 0 0.0019533182494342327
electrophoresis O 0 0.000397973955841735
, O 0 4.805221033166163e-05
the O 0 6.84509941493161e-05
protein O 0 0.00010884936637012288
truncation O 0 0.0007985301781445742
test O 0 0.00013597810175269842
, O 0 6.151987327029929e-05
and O 0 6.03471853537485e-05
direct O 0 0.00018937294953502715
sequencing O 0 0.0009487089118920267
. O 0 0.0005086083547212183

RESULTS O 0 0.0036812780890613794
Chain O 0 0.002161908196285367
terminating O 0 0.0014012553729116917
signals O 0 0.00031673358171246946
were O 0 4.6258708607638255e-05
only O 0 2.3584399968967773e-05
identified O 0 4.4396205339580774e-05
in O 0 2.591481461422518e-05
patients O 0 5.217409125179984e-05
belonging O 0 6.56637130305171e-05
to O 0 2.2330566935124807e-05
the O 0 9.586443775333464e-05
FAP B-Disease 0 0.47316035628318787
group O 0 9.455904364585876e-05
( O 0 0.00011719638860085979
105 O 0 0.0005023551057092845
patients O 0 0.00034338783007115126
) O 0 0.00014695862773805857
. O 0 0.0003931383544113487

Amino O 0 0.0017754582222551107
acid O 0 0.0010103413369506598
changes O 0 0.00012427025649230927
were O 0 4.928944690618664e-05
identified O 0 4.823663766728714e-05
in O 0 3.567543171811849e-05
four O 0 4.6777557145105675e-05
patients O 0 5.956265522399917e-05
, O 0 2.134761780325789e-05
three O 0 1.891839929157868e-05
of O 0 4.950425136485137e-05
whom O 0 8.279806206701323e-05
belonged O 0 0.0002806275151669979
to O 0 4.391876791487448e-05
the O 0 0.00010803235636558384
non O 0 0.0003471182135399431
- O 0 0.0005949248443357646
FAP O 1 0.849365234375
group O 0 0.00036522909067571163
of O 1 0.9943647384643555
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9984433054924011
. O 0 0.0017109171021729708

Genotype O 0 0.05512969568371773
- O 0 0.004514504689723253
phenotype O 0 0.0014006543206050992
correlations O 0 0.00032038777135312557
identified O 0 0.00010261189891025424
significant O 0 9.12092364160344e-05
differences O 0 5.554758899961598e-05
in O 0 2.472859159752261e-05
the O 0 5.20661378686782e-05
nature O 0 7.754231774015352e-05
of O 0 7.786227070027962e-05
certain O 0 9.777738887351006e-05
extracolonic O 1 0.9934710264205933
manifestations O 1 0.8238698840141296
in O 0 0.00054728495888412
FAP B-Disease 1 0.9998006224632263
patients O 0 0.00029773442656733096
belonging O 0 0.00022964987147133797
to O 0 6.36305267107673e-05
three O 0 0.0001611988409422338
mutation O 0 0.0005053715431131423
subgroups O 0 0.000907891255337745
. O 0 0.0005170326912775636

CONCLUSIONS O 0 0.004002879839390516
Extended O 0 0.0028926078230142593
genotype O 0 0.0031724292784929276
- O 0 0.0009020747384056449
phenotype O 0 0.000651675509288907
correlations O 0 0.00023967567540239543
made O 0 5.606427657767199e-05
in O 0 2.3377984689432196e-05
this O 0 2.1519312213058583e-05
study O 0 2.2377593268174678e-05
may O 0 1.6904705262277275e-05
have O 0 4.541866928775562e-06
the O 0 1.7265507267438807e-05
potential O 0 3.655591353890486e-05
to O 0 1.0602960173855536e-05
determine O 0 1.7531092453282326e-05
the O 0 2.5672254196251743e-05
most O 0 1.6899370166356675e-05
appropriate O 0 4.445619561010972e-05
surveillance O 0 0.00012724744738079607
and O 0 6.306196883087978e-05
prophylactic O 0 0.054083097726106644
treatment O 0 0.05338525027036667
regimens O 0 0.0013969482388347387
for O 0 4.3404263124102727e-05
those O 0 3.0628678359789774e-05
patients O 0 0.00011277855810476467
with O 0 4.000668923254125e-05
mutations O 0 0.00017103740538004786
associated O 0 9.637874609325081e-05
with O 0 7.819189340807498e-05
life O 0 0.004277353640645742
threatening O 1 0.7301780581474304
conditions O 0 0.009462756104767323
. O 0 0.0008663589833304286

This O 0 0.00044511270243674517
study O 0 0.00017756268789526075
also O 0 5.599662836175412e-05
provided O 0 7.013746653683484e-05
evidence O 0 5.708412209060043e-05
for O 0 3.6142861063126475e-05
the O 0 0.00013173413753975183
pathological O 0 0.001231116708368063
nature O 0 0.0001809112582122907
of O 0 0.00015038072888273746
amino O 0 0.00011670614912873134
acid O 0 0.00015804721624590456
changes O 0 5.4575273679802194e-05
in O 0 4.0824830648489296e-05
APC O 0 0.0011859445367008448
associated O 0 4.138205622439273e-05
with O 0 2.731120002863463e-05
both O 0 5.0136499339714646e-05
FAP B-Disease 1 0.7043284177780151
and O 0 0.0002468732127454132
non O 0 0.3484145700931549
- O 1 0.9998441934585571
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9966918230056763
. O 0 0.000400525372242555
. O 0 0.0007041334174573421

Inherited B-Disease 1 0.9999995231628418
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9996436834335327
cancer B-Disease 1 0.9999966621398926
risk O 0 0.042993851006031036
of O 0 0.0023399097844958305
the O 0 0.0795421227812767
APC O 1 0.999931812286377
I1307K O 1 0.9992571473121643
polymorphism O 0 0.005010880995541811
. O 0 0.0008868444128893316

Germ O 1 0.9973090887069702
- O 0 0.00434919074177742
line O 0 0.00112813338637352
and O 0 0.00019797947607003152
somatic O 0 0.0010374952107667923
truncating O 0 0.0016885092481970787
mutations O 0 0.00011312710557831451
of O 0 0.00012409643386490643
the O 0 0.00016924556985031813
APC B-Disease 0 0.04493104666471481
gene O 0 6.141507037682459e-05
are O 0 8.99226597539382e-06
thought O 0 7.626935257576406e-05
to O 0 6.446636689361185e-05
initiate O 0 0.0036166678182780743
colorectal B-Disease 1 0.9999991655349731
tumor I-Disease 1 0.9999926090240479
formation O 1 0.9984083771705627
in O 1 0.6608278751373291
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999512434005737
sporadic O 1 0.9999996423721313
colorectal O 1 1.0
carcinogenesis O 1 0.9999997615814209
, O 0 0.006583968177437782
respectively O 0 0.0018499960424378514
. O 0 0.0005666720098815858

Recently O 0 0.0021672784350812435
, O 0 0.00042182154720649123
an O 0 0.0003501427127048373
isoleucine O 0 0.04947280511260033
- O 0 0.0007916624890640378
- O 0 0.0005705905496142805
> O 0 0.0007014553993940353
lysine O 0 0.0006107937078922987
polymorphism O 0 0.0004143514670431614
at O 0 0.0002747007238212973
codon O 0 0.0006823946023359895
1307 O 0 0.0027652003336697817
( O 0 0.00014041665417607874
I1307K O 0 0.0008001190726645291
) O 0 2.7926340408157557e-05
of O 0 5.347163823898882e-05
the O 0 8.238301234086975e-05
APC B-Disease 0 0.016002163290977478
gene O 0 4.415461444295943e-05
has O 0 1.0688881047826726e-05
been O 0 9.807397873373702e-06
identified O 0 9.247884008800611e-06
in O 0 8.703643288754392e-06
6 O 0 2.837169995473232e-05
% O 0 1.1197498679393902e-05
- O 0 4.330218871473335e-05
7 O 0 5.096884342492558e-05
% O 0 1.799880737962667e-05
of O 0 4.59386756119784e-05
the O 0 0.0001079113717423752
Ashkenazi O 0 0.000579508428927511
Jewish O 0 0.0004089752328582108
population O 0 0.0001886579702841118
. O 0 0.0004695391980931163

To O 0 0.00045043343561701477
assess O 0 0.0004847619857173413
the O 0 0.0001764780463417992
risk O 0 0.00015512813115492463
of O 0 9.119044261751696e-05
this O 0 7.178170926636085e-05
common O 0 0.0002209138619946316
APC B-Disease 1 0.8433334827423096
allelic O 0 0.1464018076658249
variant O 0 0.028458818793296814
in O 0 0.0035408593248575926
colorectal O 1 0.9999997615814209
carcinogenesis O 1 0.9999862909317017
, O 0 0.00016499542107339948
we O 0 3.6761968658538535e-05
have O 0 1.1410182196414098e-05
analyzed O 0 3.1870258681010455e-05
a O 0 2.721077180467546e-05
large O 0 4.881483982899226e-05
cohort O 0 0.000262690766248852
of O 0 0.00010540302901063114
unselected O 0 0.0030335087794810534
Ashkenazi O 0 0.0005599983269348741
Jewish O 0 0.00028172420570626855
subjects O 0 0.00021122797625139356
with O 0 0.00015104150224942714
adenomatous B-Disease 1 0.9999651908874512
polyps I-Disease 1 0.9992005228996277
and O 0 0.00028459582244977355
. O 0 0.0003419719869270921
or O 1 0.965070366859436
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999967813491821
, I-Disease 0 0.00020369113190099597
for O 0 0.00012225766840856522
the O 0 0.00041185496957041323
APC O 1 0.9708170890808105
I1307K O 1 0.9032581448554993
polymorphism O 0 0.0030711477156728506
. O 0 0.0008930885815061629

The O 0 0.005094556137919426
APC O 1 0.6208084225654602
I1307K O 0 0.13520865142345428
allele O 0 0.0006465900805778801
was O 0 0.00023296274594031274
identified O 0 5.927447637077421e-05
in O 0 2.759578637778759e-05
48 O 0 7.693760562688112e-05
( O 0 2.95162208203692e-05
10 O 0 3.2250471122097224e-05
. O 0 1.8631249986356124e-05
1 O 0 3.8899972423678264e-05
% O 0 3.0572649848181754e-05
) O 0 3.062055475311354e-05
of O 0 0.0002125235041603446
476 O 0 0.005990616511553526
patients O 0 0.0019061147468164563
. O 0 0.0008405512780882418

Compared O 0 0.0007922943914309144
with O 0 0.00010944907990051433
the O 0 7.473781442968175e-05
frequency O 0 3.720032691489905e-05
in O 0 1.2165497537353076e-05
two O 0 5.913581844652072e-06
separate O 0 9.664874596637674e-06
population O 0 1.2511845852714032e-05
control O 0 2.8282071070862003e-05
groups O 0 9.881883670459501e-06
, O 0 2.116114046657458e-05
the O 0 8.685845386935398e-05
APC O 1 0.5780081748962402
I1307K O 0 0.4600134789943695
allele O 0 0.00014912303595338017
is O 0 2.5827004719758406e-05
associated O 0 1.7390420907759108e-05
with O 0 1.1054851711378433e-05
an O 0 2.0883440811303444e-05
estimated O 0 8.25210809125565e-05
relative O 0 0.00013244361616671085
risk O 0 0.000142427918035537
of O 0 0.00014887709403410554
1 O 0 0.000383874517865479
. O 0 0.0005644896300509572

5 O 0 0.002696722513064742
- O 0 0.0022598470095545053
1 O 0 0.0010988147696480155
. O 0 0.0013362899189814925

7 O 0 0.0082839485257864
for O 0 0.0025056442245841026
colorectal B-Disease 1 0.9999850988388062
neoplasia I-Disease 1 0.9990742206573486
( O 0 0.0006805523298680782
both O 0 0.00030310111469589174
P O 0 0.00912377517670393
= O 0 0.0009425544994883239
. O 0 0.00017868740542326123
01 O 0 0.0050901491194963455
) O 0 0.0003134586149826646
. O 0 0.0005577152478508651

Furthermore O 0 0.0016881058691069484
, O 0 0.0003418943961150944
compared O 0 0.00019462690397631377
with O 0 0.00010856967855943367
noncarriers O 1 0.7311059236526489
, O 0 0.0005059981485828757
APC O 1 0.5564740300178528
I1307K O 1 0.5046703219413757
carriers O 0 0.0002920906990766525
had O 0 0.00011266859655734152
increased O 0 0.00011832197196781635
numbers O 0 5.449747186503373e-05
of O 0 0.00023011452867649496
adenomas B-Disease 1 0.9995120763778687
and O 0 0.004753602668642998
colorectal B-Disease 1 0.9999996423721313
cancers I-Disease 1 0.997620165348053
per O 0 0.00019633911142591387
patient O 0 0.0005181963206268847
( O 0 8.438476652372628e-05
P O 0 0.0005275136209093034
= O 0 0.0001622927375137806
. O 0 2.782765841402579e-05
03 O 0 0.00032424350501969457
) O 0 2.2924161385162733e-05
, O 0 2.1095796910231e-05
as O 0 2.4382039555348456e-05
well O 0 1.8730477677308954e-05
as O 0 3.531315451255068e-05
a O 0 7.416374137392268e-05
younger O 0 0.00043950596591457725
age O 0 0.0005776177858933806
at O 0 0.002366765635088086
diagnosis O 0 0.3299207091331482
. O 0 0.00139243237208575

We O 0 0.0005906648002564907
conclude O 0 0.000717794056981802
that O 0 0.00012755152420140803
the O 0 0.00022734791855327785
APC O 0 0.30281102657318115
I1307K O 0 0.2845326066017151
variant O 0 0.0006834235391579568
leads O 0 0.00025768487830646336
to O 0 9.036203846335411e-05
increased O 0 0.0005279086763039231
adenoma B-Disease 1 0.9999969005584717
formation O 0 0.018152685835957527
and O 0 5.270728433970362e-05
directly O 0 2.4405235308222473e-05
contributes O 0 4.163551420788281e-05
to O 0 1.1555927812878508e-05
3 O 0 2.130194116034545e-05
% O 0 1.0269475751556456e-05
- O 0 2.566123839642387e-05
4 O 0 2.3678283469052985e-05
% O 0 1.781828723323997e-05
of O 0 5.3894193115411326e-05
all O 0 6.356976518873125e-05
Ashkenazi O 0 0.0043964688666164875
Jewish O 1 0.969943642616272
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.999997615814209
. O 0 0.002527317265048623

The O 0 0.000782209390308708
estimated O 0 0.0004096324846614152
relative O 0 0.0003776028170250356
risk O 0 0.00018166718655265868
for O 0 5.5676191550446674e-05
carriers O 0 0.00010578344517853111
may O 0 3.9874747017165646e-05
justify O 0 8.14711456769146e-05
specific O 0 2.2042941054678522e-05
clinical O 0 0.0001032244908856228
screening O 0 7.039885531412438e-05
for O 0 2.0970532204955816e-05
the O 0 3.850395660265349e-05
360 O 0 0.00012381226406432688
, O 0 3.962959453929216e-05
000 O 0 7.72858620621264e-05
Americans O 0 3.095898136962205e-05
expected O 0 2.4013157599256374e-05
to O 0 1.3880960977985524e-05
harbor O 0 0.00021261937217786908
this O 0 1.8845399608835578e-05
allele O 0 4.779983646585606e-05
, O 0 1.3897013559471816e-05
and O 0 1.4297278539743274e-05
genetic O 0 3.2184845622396097e-05
testing O 0 2.2072665160521865e-05
in O 0 8.870474630384706e-06
the O 0 1.918542511702981e-05
setting O 0 3.908574944944121e-05
of O 0 3.18691018037498e-05
long O 0 6.182327342685312e-05
- O 0 7.852275302866474e-05
term O 0 6.317494990071282e-05
- O 0 5.976104876026511e-05
outcome O 0 4.1088896978180856e-05
studies O 0 2.677775773918256e-05
may O 0 3.9325179386651143e-05
impact O 0 0.00011223141336813569
significantly O 0 0.00016824813792482018
on O 0 0.002754009561613202
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
prevention O 1 0.9932935237884521
in O 0 0.0001576647482579574
this O 0 0.0001008356484817341
population O 0 0.00018544273916631937
. O 0 0.00037203956162557006

Localization O 0 0.009757827036082745
of O 0 0.0010403007036074996
human O 0 0.0005094546359032393
BRCA1 O 0 0.002493433188647032
and O 0 5.304249134496786e-05
its O 0 3.412483783904463e-05
loss O 0 0.00012191227870061994
in O 0 2.5442857804591767e-05
high O 0 0.00019741510914172977
- O 0 0.0002629799419082701
grade O 0 0.0007055486785247922
, O 0 0.00011789356358349323
non B-Disease 0 0.0009178621112369001
- I-Disease 0 0.08836791664361954
inherited I-Disease 1 0.9999734163284302
breast I-Disease 1 0.9999960660934448
carcinomas I-Disease 1 0.9999957084655762
. O 0 0.00265983073040843

Although O 0 0.0006387458997778594
the O 0 0.0003299900272395462
link O 0 0.00047356938011944294
between O 0 0.0001993254409171641
the O 0 0.0007681479910388589
BRCA1 O 1 0.9999310970306396
tumour B-Disease 1 0.9999998807907104
- O 0 0.49663448333740234
suppressor O 1 0.7303192019462585
gene O 0 0.00023010882432572544
and O 0 0.000207181423320435
hereditary B-Disease 1 0.9999954700469971
breast I-Disease 1 1.0
and I-Disease 1 0.9999934434890747
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
is O 0 0.0001291374646825716
established O 0 5.892454646527767e-05
, O 0 1.4979109437263105e-05
the O 0 2.0364250303828157e-05
role O 0 4.2634124838514253e-05
, O 0 1.323619744653115e-05
if O 0 8.30566386866849e-06
any O 0 9.690975275589153e-06
, O 0 1.561702993058134e-05
of O 0 4.548089054878801e-05
BRCA1 O 0 0.0052301641553640366
in O 0 0.00013763362949248403
non B-Disease 0 0.0024646478705108166
- I-Disease 0 0.1687927395105362
familial I-Disease 1 0.9995031356811523
cancers I-Disease 1 0.9995593428611755
is O 0 0.00042790730367414653
unclear O 0 0.0010590603342279792
. O 0 0.0006625659880228341

BRCA1 O 1 0.9587222933769226
mutations O 0 0.0008089645998552442
are O 0 7.64350697863847e-05
rare O 0 0.00028985811513848603
in O 0 0.00016847274673637003
sporadic B-Disease 0 0.07029622048139572
cancers I-Disease 1 0.9158808588981628
, O 0 9.430097270524129e-05
but O 0 4.793623520527035e-05
loss O 0 0.00048366852570325136
of O 0 0.00022191494645085186
BRCA1 O 1 0.6708728075027466
resulting O 0 0.00020894681802019477
from O 0 5.185797272133641e-05
reduced O 0 7.52279011067003e-05
expression O 0 7.006152009125799e-05
or O 0 4.4679494749289006e-05
incorrect O 0 0.00014488158922176808
subcellular O 0 0.0006326844450086355
localization O 0 0.000562969536986202
is O 0 3.619356357376091e-05
postulated O 0 0.00013815774582326412
to O 0 1.3961746844870504e-05
be O 0 1.095377047022339e-05
important O 0 2.9223228921182454e-05
in O 0 5.853558468515985e-05
non B-Disease 0 0.0006742589175701141
- I-Disease 0 0.24479351937770844
familial I-Disease 1 0.9999891519546509
breast I-Disease 1 0.9999998807907104
and I-Disease 1 0.9999891519546509
ovarian I-Disease 1 1.0
cancers I-Disease 1 0.9999996423721313
. O 0 0.006941721308976412

Epigenetic O 0 0.3001568019390106
loss O 0 0.4832785725593567
, O 0 0.00024428567849099636
however O 0 8.343865192728117e-05
, O 0 4.7079272917471826e-05
has O 0 2.391239831922576e-05
not O 0 1.1550539966265205e-05
received O 0 3.78857075702399e-05
general O 0 9.743896225700155e-05
acceptance O 0 0.00017650869267527014
due O 0 8.454586350126192e-05
to O 0 3.695434133987874e-05
controversy O 0 0.00027241965290158987
regarding O 0 9.994604624807835e-05
the O 0 0.00011976210225839168
subcellular O 0 0.0011254546698182821
localization O 0 0.0009886835468932986
of O 0 0.00025931053096428514
BRCA1 O 0 0.004272579215466976
proteins O 0 5.073994543636218e-05
, O 0 1.7856984413811006e-05
reports O 0 1.8007340258918703e-05
of O 0 2.3928161681396887e-05
which O 0 1.2034848623443395e-05
have O 0 9.034348295244854e-06
ranged O 0 4.801565592060797e-05
from O 0 1.6057076209108345e-05
exclusively O 0 3.4074921131832525e-05
nuclear O 0 9.183392830891535e-05
, O 0 1.7081050827982835e-05
to O 0 1.527671338408254e-05
conditionally O 0 0.00019674611394293606
nuclear O 0 0.00011428594734752551
, O 0 1.973977305169683e-05
to O 0 2.17130254895892e-05
the O 0 0.00011104043369414285
ER O 1 0.7489022612571716
/ O 0 0.0008505104924552143
golgi O 0 0.0040384382009506226
, O 0 0.00014042870316188782
to O 0 8.868290751706809e-05
cytoplasmic O 0 0.0005543712759390473
invaginations O 0 0.003140701912343502
into O 0 0.00023037532810121775
the O 0 0.0005563157610595226
nucleus O 0 0.0038697936106473207
. O 0 0.0008730432018637657

In O 0 0.0004425049410201609
an O 0 0.00015301267558243126
attempt O 0 0.00023035598860587925
to O 0 4.569914017338306e-05
resolve O 0 0.0001639465626794845
this O 0 3.9733658923069015e-05
issue O 0 9.019829303724691e-05
, O 0 5.340814823284745e-05
we O 0 3.222160739824176e-05
have O 0 3.0086564947851002e-05
comprehensively O 0 0.0005456382059492171
characterized O 0 0.0004810820973943919
19 O 0 0.0008631520322524011
anti O 0 0.20553620159626007
- O 0 0.04526665061712265
BRCA1 O 1 0.8963265419006348
antibodies O 0 0.0014229124644771218
. O 0 0.0007906966493465006

These O 0 0.0005332299042493105
reagents O 0 0.0015524390619248152
detect O 0 0.0005344877135939896
a O 0 0.00019631251052487642
220 O 0 0.000644081155769527
- O 0 0.0005515255033969879
kD O 0 0.0020191348157823086
protein O 0 0.00023383510415442288
localized O 0 0.00021159947209525853
in O 0 5.4361582442652434e-05
discrete O 0 0.00018915982218459249
nuclear O 0 0.00044048510608263314
foci O 0 0.0007098645437508821
in O 0 7.916891627246514e-05
all O 0 7.326210470637307e-05
epithelial O 1 0.6376159191131592
cell O 0 0.0004733667301479727
lines O 0 0.00013060691708233207
, O 0 4.0906630601966754e-05
including O 0 3.712183388415724e-05
those O 0 2.9026030460954644e-05
derived O 0 0.00012813287321478128
from O 0 0.00034215982304885983
breast B-Disease 1 0.9996984004974365
malignancies I-Disease 1 0.9984866380691528
. O 0 0.0008697493467479944

Immunohistochemical O 1 0.9236463904380798
staining O 0 0.13251151144504547
of O 0 0.003991625737398863
human O 0 0.05924814194440842
breast O 1 0.9980499744415283
specimens O 0 0.0006725614075548947
also O 0 0.0002174183464376256
revealed O 0 0.0009288945002481341
BRCA1 O 0 0.00848420336842537
nuclear O 0 0.0010391591349616647
foci O 0 0.00316043384373188
in O 0 0.000444000557763502
benign O 1 0.9999558925628662
breast O 1 0.999954342842102
, O 0 0.03512553870677948
invasive B-Disease 1 0.9999760389328003
lobular I-Disease 1 0.9999997615814209
cancers I-Disease 1 0.9998880624771118
and O 0 0.0008087126770988107
low B-Disease 0 0.039391860365867615
- I-Disease 0 0.11642540246248245
grade I-Disease 1 0.995187520980835
ductal I-Disease 1 0.9999938011169434
carcinomas I-Disease 1 0.9999536275863647
. O 0 0.002020411193370819

Conversely O 0 0.007460036315023899
, O 0 0.0007712751976214349
BRCA1 O 0 0.010130923241376877
expression O 0 0.000301056046737358
was O 0 0.00042223368654958904
reduced O 0 0.0001280042779399082
or O 0 4.648565663956106e-05
undetectable O 0 0.0002528531476855278
in O 0 1.2254435205250047e-05
the O 0 1.6885031072888523e-05
majority O 0 2.0355630113044754e-05
of O 0 4.693045048043132e-05
high O 0 0.00023420280194841325
- O 0 0.00042819089139811695
grade O 0 0.004908586386591196
, O 0 0.0002409916342003271
ductal B-Disease 1 0.9999881982803345
carcinomas I-Disease 1 0.9997599720954895
, O 0 0.00011944665311602876
suggesting O 0 0.0001520027290098369
that O 0 3.000112519657705e-05
absence O 0 0.00016505819803569466
of O 0 0.0003250826266594231
BRCA1 O 1 0.8182463645935059
may O 0 6.878058047732338e-05
contribute O 0 5.807193883811124e-05
to O 0 1.7795107851270586e-05
the O 0 4.951851224177517e-05
pathogenesis O 0 0.001323389122262597
of O 0 8.322282519657165e-05
a O 0 7.146078132791445e-05
significant O 0 7.572928734589368e-05
percentage O 0 0.00012388007598929107
of O 0 0.000309501716401428
sporadic B-Disease 1 0.9990135431289673
breast I-Disease 1 0.9999984502792358
cancers I-Disease 1 0.999797523021698
. O 0 0.0005417440552264452
. O 0 0.0009563052444718778

